<html lang="en"><head><!-- Shady DOM styles for custom-style --><!-- Shady DOM styles for dom-template --><!-- Shady DOM styles for dom-repeat --><!-- Shady DOM styles for array-selector --><!-- Shady DOM styles for dom-if --><!-- Shady DOM styles for state-modifier --><style scope="state-modifier">a[inherit].state-modifier {
  color: inherit;
}</style><!-- Shady DOM styles for browser-ui --><!-- Shady DOM styles for outlined-text-field --><style scope="outlined-text-field">outlined-text-field {
  display: flex;
  font-family: "Google Sans", Roboto, Arial, sans-serif;
  font-weight: 500;
  flex-direction: column;
}

outlined-text-field span.outlined-text-field {
  display: flex;
  flex-direction: row;
  align-items: center;
}

outlined-text-field input.outlined-text-field {
  height: 40px;
  padding: 0 33px 0 16px;
  
  border-color: #b0b3b6;
  border-width: 1px;
  border-style: solid;
  
  border-radius: 8px;
  caret-color: #3c78e0;
  color: #6a6c71;
  font-size: 14px;
  flex-grow: 1;
}

outlined-text-field[orig] input.outlined-text-field {
  border-color: #e5e5e5;
  
  border-radius: 0;
}

outlined-text-field[dense] input.outlined-text-field {
  height: 32px;
}

outlined-text-field[uppercase] input.outlined-text-field {
  text-transform: uppercase;
}

outlined-text-field:not([wizard-focused]):hover input.outlined-text-field {
  border-color: #737375;
  color: #414447;
}

outlined-text-field:not([wizard-focused]):focus-within input.outlined-text-field,outlined-text-field[wizard-focused] input.outlined-text-field {
  border-color: #3574e0;
  caret-color: #80a5f1;
}

outlined-text-field[wizard-focused] input.outlined-text-field {
  border-width: 2px;
}

outlined-text-field input.outlined-text-field::placeholder {
  color: #65686c;
}

outlined-text-field[uppercase] input.outlined-text-field::placeholder {
  text-transform: none;
}</style><!-- Shady DOM styles for mat-keyword-editor --><!-- Shady DOM styles for mat-chips-input --><!-- Shady DOM styles for mat-input-chip --><!-- Shady DOM styles for pat-dialog --><style scope="pat-dialog">pat-dialog {
  background: white;
  position: absolute;
  border-radius: 8px;
  
  box-shadow: 0 24px 38px 3px rgb(0 0 0 / 14%),
              0 9px 46px 8px rgb(0 0 0 / 12%),
              0 11px 15px -7px rgb(0 0 0 / 20%);
  z-index: 1;
  display: flex;
  flex-direction: column;
}

pat-dialog:not([open]) {
  display: none;
}</style><!-- Shady DOM styles for mat-tabs --><!-- Shady DOM styles for filter-chip --><style scope="filter-chip">filter-chip {
  align-items: center;
  background-color: #fff;
  border-color: #dadce0;
  border-radius: 8px;
  border-style: solid;
  border-width: 1px;
  color: #606368;
  cursor: pointer;
  font-family: "Google Sans", Roboto, Arial, sans-serif;
  font-size: 14px;
  font-weight: 500;
  height: 32px;
  letter-spacing: 0.2px;
  padding: 0 16px;
  user-select: none;
  display: inline-flex;
  white-space: nowrap;
}

filter-chip[disabled] {
  background-color: #e8e8e8;
  border-color: #e8e8e8;
  color: #a9abad;
  cursor: auto;
}

filter-chip svg.filter-chip {
  visibility: collapse;
  font-size: 18px;
  width: 0;
  height: 18px;
}

filter-chip[selected] svg.filter-chip {
  visibility: visible;
  margin: 0 8px;
  width: 18px;
}

filter-chip[selected] svg.filter-chip path.filter-chip {
  fill: #4577d1;
}

filter-chip:not([disabled]):hover {
  background-color: #f7f8f8;
  border-color: #d7d9dc;
  color: #454649;
}

filter-chip:not([disabled]):hover:active {
  background-color: #eff0f0;
  border-color: #d2d5d8;
  color: #222326;
}

filter-chip:not([disabled]):focus {
  background-color: #e7e8e8;
  border-color: #232528;
  color: #202124;
}

filter-chip:not([disabled])[selected] {
  background-color: #e9f0fd;
  border-color: #e9f0fd;
  color: #4577d1;
  padding-left: 0;
}

filter-chip:not([disabled]):focus[selected] {
  background-color: #d5e1fb;
  border-color: #d5e1fb;
  color: #2550a0;
}

filter-chip:not([disabled]):hover[selected] {
  box-shadow: rgba(0, 0, 0, 0.2) 0px 3px 1px -2px,
    rgba(0, 0, 0, 0.14) 0px 2px 2px 0px, rgba(0, 0, 0, 0.12) 0px 1px 5px 0px;
}

filter-chip:not([disabled]):hover:active[selected] {
  background-color: #abc8f2;
  border-color: #abc8f2;
  color: #2a54a3;
}</style><!-- Shady DOM styles for figure-callout --><!-- Shady DOM styles for mat-button --><style scope="mat-button-0">.mat-button-0 {
  ;
  align-items: center;
  border-radius: 4px;
  color: hsl(217 4% 39%); 
  cursor: pointer;
  font-family: "Google Sans", Roboto, Arial, sans-serif;
  font-size: 14px;
  font-weight: 500;
  height: 36px;
  letter-spacing: 0.2px;
  padding: 0 8px;
  user-select: none;
  display: inline-flex;
  white-space: nowrap;
}

.mat-button-0[filled] {
  background-color: hsl(217 73% 54%); 
  color: white;
}

.mat-button-0[filled]:hover {
  background-color: hsl(217 60% 47%);
}

.mat-button-0[filled]:focus {
  background-color: hsl(217 59% 44%);
}

.mat-button-0[filled]:active {
  background-color: hsl(217 59% 45%);
}

.mat-button-0[filled][disabled] {
  background-color: hsl(217 2% 90%); 
  color: hsl(217 1% 65%);
}</style><!-- Shady DOM styles for search-term-wizard --><style scope="search-term-wizard">search-term-wizard:not([open]) {
  display: none;
}

search-term-wizard .header.search-term-wizard {
  border-bottom: 1px solid #e5e5e5;
  padding: 24px;
  padding-bottom: 0;
}

search-term-wizard .title.search-term-wizard {
  color: #3c4043;
  font-family: Google Sans,Roboto,Arial,sans-serif;
  font-size: 22px;
  user-select: none;
  margin: 0 48px;
}

search-term-wizard #panels.search-term-wizard > *.search-term-wizard:not([selected]) {
  display: none;
}</style><!-- Shady DOM styles for outlined-textarea --><style scope="outlined-textarea">outlined-textarea {
  display: flex;
  font-family: "Google Sans", Roboto, Arial, sans-serif;
  font-weight: 500;
  flex-direction: row;
  
  position: relative;
}

outlined-textarea span.outlined-textarea {
  display: flex;
  flex-direction: column;
  flex-grow: 1;
  justify-content: center;
}

outlined-textarea span.right-button-container.outlined-textarea {
  position: absolute;
  right: 0;
  height: 100%;
}

outlined-textarea textarea.outlined-textarea {
  padding: 16px 16px 0 16px;
  border-color: #b0b3b6;
  border-width: 1px;
  border-style: solid;
  border-radius: 8px;
  caret-color: #3c78e0;
  color: #6a6c71;
  font-size: 14px;
  font-family: "Google Sans", Roboto, Arial, sans-serif;
  font-weight: 500;
  resize: none;
}

outlined-textarea[dense] textarea.outlined-textarea {
  padding: 8px;
}

outlined-textarea[has-icon] textarea.outlined-textarea {
  padding-right: 38px;
}

outlined-textarea[orig] textarea.outlined-textarea {
  border-color: #e5e5e5;
  
  border-radius: 0;
}

outlined-textarea:not([rows]) textarea.outlined-textarea {
  height: 40px;
}

outlined-textarea textarea.resizable.outlined-textarea {
  resize: vertical;
}

outlined-textarea textarea.outlined-textarea:focus,outlined-textarea[wizard-focused] textarea.outlined-textarea,outlined-textarea textarea.outlined-textarea:focus:hover {
  border-color: #3574e0 !important;
  
  outline: none !important;
}

outlined-textarea textarea.outlined-textarea:hover {
  border-color: #202124;
  color: #414447;
}

outlined-textarea.hasValue textarea.outlined-textarea {
  border-color: #888d91;
  color: #45474a;
}

outlined-textarea #helperText.outlined-textarea {
  color: #6a6c71;
  font-size: 12px;
  letter-spacing: 0.3px;
  margin-left: 17px;
  margin-top: 6px;
  user-select: none;
}

outlined-textarea:not([helper-text]) #helperText.outlined-textarea {
  display: none;
}

outlined-textarea[error] textarea.outlined-textarea {
  border-color: #cb4b3d;
  caret-color: #ca493a;
  color: #3d4043;
}

outlined-textarea textarea.outlined-textarea::placeholder {
  font-size: 14px;
  font-weight: 400;
}

outlined-textarea:not([error]):not([disabled]) textarea.outlined-textarea::placeholder {
  color: #6a6c71;
}

outlined-textarea[error] textarea.outlined-textarea::placeholder {
  color: #c84132;
}

outlined-textarea[error] #helperText.outlined-textarea {
  color: #cd5648;
}

outlined-textarea[error] textarea.outlined-textarea:focus {
  border-color: #c84031;
  border-width: 2px;
  outline: none !important;
}

outlined-textarea[error]:not([disabled]) textarea.outlined-textarea:hover {
  border-color: #97231b;
}

outlined-textarea[error]:not([disabled]) textarea.outlined-textarea:hover::placeholder,outlined-textarea[error]:not([disabled]) textarea.outlined-textarea:hover + #helperText.outlined-textarea {
  color: #a94945;
}

outlined-textarea[disabled] textarea.outlined-textarea {
  border-color: #e9e9e9;
  color: #b5b6b8;
}

outlined-textarea[disabled] #helperText.outlined-textarea {
  color: #c4c6c7;
}

outlined-textarea[error][disabled] {
  opacity: 50%;
}

outlined-textarea[error][disabled] textarea.outlined-textarea {
  border-color: #cb4b3d;
  caret-color: #ca493a;
}

outlined-textarea[error][disabled] #helperText.outlined-textarea,outlined-textarea[error][disabled] textarea.outlined-textarea {
  color: #a94945;
}

outlined-textarea[error][disabled] textarea.outlined-textarea::placeholder {
  color: #c84132;
}</style><!-- Shady DOM styles for chemistry-search-term-wizard --><style scope="chemistry-search-term-wizard">chemistry-search-term-wizard {
  display: flex;
  flex-direction: column;
  padding: 24px;
  padding-top: 0;
}

chemistry-search-term-wizard > span.chemistry-search-term-wizard {
  display: flex;
  flex-direction: row;
  align-items: center;
  flex-wrap: wrap;
  margin-top: 16px;
}

chemistry-search-term-wizard .suggestions.chemistry-search-term-wizard {
  margin-top: 4px;
}

chemistry-search-term-wizard > span.chemistry-search-term-wizard svg.chemistry-search-term-wizard {
  margin-right: 24px;
}

chemistry-search-term-wizard path.chemistry-search-term-wizard {
  fill: #5f6368;
}

chemistry-search-term-wizard .help.chemistry-search-term-wizard {
  margin-left: 12px;
  margin-right: 0;
  cursor: pointer;
}

chemistry-search-term-wizard outlined-text-field.chemistry-search-term-wizard {
  flex-grow: 1;
}

chemistry-search-term-wizard mat-button.chemistry-search-term-wizard {
  margin-left: 48px;
}

chemistry-search-term-wizard filter-chip.chemistry-search-term-wizard {
  margin-right: 4px;
}

chemistry-search-term-wizard outlined-textarea.chemistry-search-term-wizard {
  flex-grow: 1;
}

chemistry-search-term-wizard outlined-text-field[batchMode].chemistry-search-term-wizard {
  display: none;
}

chemistry-search-term-wizard outlined-textarea.chemistry-search-term-wizard:not([batchMode]) {
  display: none;
}</style><!-- Shady DOM styles for text-search-term-wizard --><style scope="text-search-term-wizard">text-search-term-wizard {
  display: flex;
  flex-direction: column;
  padding: 24px;
  padding-top: 0;
}

text-search-term-wizard > span.text-search-term-wizard {
  display: flex;
  flex-direction: row;
  align-items: center;
  flex-wrap: wrap;
  margin-top: 16px;
}

text-search-term-wizard > span.text-search-term-wizard svg.text-search-term-wizard {
  margin-right: 24px;
}

text-search-term-wizard path.text-search-term-wizard {
  fill: #5f6368;
}

text-search-term-wizard outlined-text-field.text-search-term-wizard {
  flex-grow: 1;
}

text-search-term-wizard mat-button.text-search-term-wizard {
  margin-left: 48px;
}

text-search-term-wizard filter-chip.text-search-term-wizard {
  margin-right: 4px;
}</style><!-- Shady DOM styles for classification-wizard --><style scope="classification-wizard">classification-wizard {
  display: flex;
  flex-direction: column;
  padding: 24px;
  padding-top: 0;
  max-width: 674px;
}

classification-wizard > span.classification-wizard {
  display: flex;
  flex-direction: row;
  align-items: center;
  flex-wrap: wrap;
  margin-top: 16px;
}

classification-wizard .suggestions.classification-wizard {
  margin-top: 4px;
}

classification-wizard > span.classification-wizard svg.classification-wizard {
  margin-right: 24px;
}

classification-wizard path.classification-wizard {
  fill: #5f6368;
}

classification-wizard outlined-text-field.classification-wizard {
  flex-grow: 1;
}

classification-wizard mat-button.classification-wizard {
  margin-left: 48px;
}

classification-wizard filter-chip.classification-wizard {
  margin-right: 4px;
}

classification-wizard .no-matches.classification-wizard {
  margin-left: 64px;
}

classification-wizard .table-container.classification-wizard {
  max-height: 300px;
  overflow: scroll;
  margin-top: 8px;
}

classification-wizard .table-container.classification-wizard::-webkit-scrollbar {
  -webkit-appearance: none;
  width: 10px;
}

classification-wizard .table-container.classification-wizard::-webkit-scrollbar-thumb {
  border-radius: 5px;
  background-color: #5f636880;
  -webkit-box-shadow: 0 0 1px rgba(255,255,255,.5);
}

classification-wizard table.classification-wizard {
  margin-left: 51px;
  max-width: 575px;
}

classification-wizard tr.classification-wizard {
  margin-top: 4px;
}

classification-wizard tr.classification-wizard suggestive-chip.classification-wizard {
  margin-right: 8px;
}

classification-wizard #spinner.classification-wizard {
  justify-content: space-around;
  margin-left: 48px;
  transform: scale(0.5);
}</style><!-- Shady DOM styles for suggestive-chip --><!-- Shady DOM styles for mat-checkbox --><!-- Shady DOM styles for measure-search-term-wizard --><style scope="measure-search-term-wizard">measure-search-term-wizard {
  display: flex;
  flex-direction: column;
  padding: 24px;
  padding-top: 0;
  max-width: 674px;
}

measure-search-term-wizard > span.measure-search-term-wizard {
  display: flex;
  flex-direction: row;
  align-items: center;
  flex-wrap: wrap;
  margin-top: 16px;
}

measure-search-term-wizard .suggestions.measure-search-term-wizard {
  margin-top: 4px;
}

measure-search-term-wizard > span.measure-search-term-wizard svg.measure-search-term-wizard {
  margin-right: 24px;
}

measure-search-term-wizard path.measure-search-term-wizard {
  fill: #5f6368;
}

measure-search-term-wizard outlined-text-field.measure-search-term-wizard {
  flex-grow: 1;
}

measure-search-term-wizard mat-button.measure-search-term-wizard {
  margin-left: 48px;
}

measure-search-term-wizard filter-chip.measure-search-term-wizard {
  margin-right: 4px;
}</style><!-- Shady DOM styles for numerical-search-term-wizard --><style scope="numerical-search-term-wizard">numerical-search-term-wizard {
  display: flex;
  flex-direction: column;
  padding: 24px;
  padding-top: 0;
  max-width: 674px;
}

numerical-search-term-wizard > span.numerical-search-term-wizard {
  display: flex;
  flex-direction: row;
  align-items: center;
  flex-wrap: wrap;
  margin-top: 16px;
}

numerical-search-term-wizard .suggestions.numerical-search-term-wizard {
  margin-top: 4px;
}

numerical-search-term-wizard > span.numerical-search-term-wizard svg.numerical-search-term-wizard {
  margin-right: 24px;
}

numerical-search-term-wizard path.numerical-search-term-wizard {
  fill: #5f6368;
}

numerical-search-term-wizard outlined-text-field.numerical-search-term-wizard,numerical-search-term-wizard outlined-textarea.numerical-search-term-wizard {
  flex-grow: 1;
}

numerical-search-term-wizard mat-button.numerical-search-term-wizard {
  margin-left: 48px;
}

numerical-search-term-wizard filter-chip.numerical-search-term-wizard {
  margin-right: 4px;
}

numerical-search-term-wizard #spinner.numerical-search-term-wizard {
  justify-content: space-around;
  margin-left: 48px;
  transform: scale(0.5);
}

numerical-search-term-wizard #suggestions.numerical-search-term-wizard {
  margin-left: 58px;
  display: flex;
  flex-direction: column;
  align-items: flex-start;
}

numerical-search-term-wizard .suggestion.numerical-search-term-wizard {
  display: flex;
  flex-direction: row;
  align-items: center;
}

numerical-search-term-wizard .suggestion.numerical-search-term-wizard mat-checkbox.numerical-search-term-wizard {
  margin-right: 8px;
}</style><!-- Shady DOM styles for text-button --><style scope="text-button">text-button {
  align-items: center;
  border-radius: 4px;
  cursor: pointer;
  font-family: "Google Sans", Roboto, Arial, sans-serif;
  font-size: 14px;
  font-weight: 500;
  height: 36px;
  letter-spacing: .25px;
  margin: 6px 0;
  padding: 0 8px;
  user-select: none;
  display: inline-flex;
  white-space: nowrap;
  line-height: 36px;
  text-decoration: none;
  text-transform: none;
  color: #5f6368;
}

text-button:hover {
  background-color: #f8f9fa;
}

text-button:active {
  background-color: #d5e2fa;
}

text-button[selected] {
  background-color: #e8f0fe;
  color: #1967d2;
}

text-button[selected]:active {
  background-color: #d2e3fc;
}</style><!-- Shady DOM styles for mat-spinner --><!-- Shady DOM styles for requery-tile --><style scope="requery-tile">requery-tile {
  display: flex;
  justify-content: space-between;
  align-items: center;
  box-sizing: border-box;
  min-height: 40px;
  padding: 8px 12px 8px 8px;
  gap: 8px;

  border-radius: 16px;
  background: #f7f8f9;
  color: #1f1f1f;
}

requery-tile:hover {
  background: #d7d8d9;
}

requery-tile > [slot="image"] {
  flex-shrink: 0;

  border-radius: 8px;

  background: #fff;
}

.label.requery-tile {
  flex-grow: 999;

  font: 16px/20px "Google Sans", Roboto, Arial, sans-serif;
  font-weight: 500;
}

.search-icon.requery-tile {
  flex-shrink: 0;

  width: 24px;
  height: 24px;
  background-image: url('https://fonts.gstatic.com/s/i/short-term/release/googlesymbols/search/default/24px.svg');
}</style><!-- Shady DOM styles for s-more-inline --><style scope="s-more-inline">s-more-inline {
  display: block;
  margin-top: 24px;
  padding: 16px;
  padding-top: 0;
  position: relative;

  line-height: 18px;
  text-overflow: ellipsis;
  white-space: nowrap;
  cursor: pointer;
}

hr.s-more-inline {
  background-color: #dadce0;
  margin-top: 18px;
  position: absolute;
  border: 0;
  height: 1px;
  left: 0;
  width: 100%;
}

.button.s-more-inline {
  display: flex;
  align-items: center;
  justify-content: center;

  position: relative; 
  margin: 0 auto;

  font: 400 14px Roboto, arial, sans-serif;
  height: 36px;
  width: 300px;
  border-radius: 18px;
  background-color: #f1f3f4;
}

.button.s-more-inline:hover {
  background-color: #d8d7dc;
}

.button.s-more-inline > [slot] {
  padding-right: 8px;
}

.expand.s-more-inline {
  display: inline-block;
  width: 20px;
  height: 20px;
}

.expand.less.s-more-inline {
  background-image: url('https://fonts.gstatic.com/s/i/short-term/release/googlesymbols/expand_less/default/20px.svg');
}

.expand.more.s-more-inline {
  background-image: url('https://fonts.gstatic.com/s/i/short-term/release/googlesymbols/expand_more/default/20px.svg');
}</style><!-- Shady DOM styles for workspace-ui-search --><!-- Shady DOM styles for keyword-wizard --><style scope="keyword-wizard">keyword-wizard {
  display: inline-block;
}

iron-icon.keyword-wizard {
  height: 20px;
    width: 20px;
    color: #999;
    cursor: pointer;
}

iron-icon[active].keyword-wizard {
  color: #4285f4 !important;
}

iron-icon.keyword-wizard:hover {
  color: #ccc;
}

#wizardIcon.keyword-wizard {
  padding-left: 1px;
    height: 16px;
    width: 16px;
    margin: 4px 1px 1px 1px;
}

#wizard.keyword-wizard {
  padding: 0;
    left: 0;
    top: 37px;
    position: absolute;
    background-color: white;
    z-index: 2;
    overflow: hidden;
}

.wizard-header.keyword-wizard {
  display: block;
    width: 100%;
    color: #737373;
    text-transform: uppercase;
    font-size: 13px;
    margin: 16px 0 6px 12px;
}

.filter-chips.keyword-wizard {
  margin-left: 20px;
}

.chip.keyword-wizard {
  background-color: #ebebeb;
    color: #6a6a6a;
    display: inline-block;
    font-size: 13px;
    font-family: inherit;
    border-radius: 12px;
    padding: 6px 12px;
}

.chip.keyword-wizard:hover {
  cursor: pointer;
}

.chip[selected].keyword-wizard {
  background-color: #4285f4;
    color: white;
}

.input-label.keyword-wizard {
  display: inline-block;
    font-size: 13px;
    font-family: inherit;
}

.keyword-input.keyword-wizard {
  display: inline-block;
    border-top: 0;
    border-left: 0;
    border-right: 0;
    border-bottom: 1px solid #dfe1e5;
    padding: 3px;
}

.keyword-input.keyword-wizard::placeholder {
  font-style: italic;
}

.keyword-input.keyword-wizard:hover,.keyword-input.keyword-wizard:focus {
  border-color: #4284f4;
    border-width: 1px;
    outline: none;
}

.cpc-field.keyword-wizard {
  display: inline-block;
    margin: 6px 0 0 24px;
}

#checkboxCPC.keyword-wizard:hover {
  cursor: pointer;
}

.checkbox-label.keyword-wizard {
  font-size: 13px;
    font-style: italic;
    color: #737373;
}

.chemistry-field.keyword-wizard {
  display: block;
}

#inputChem.input-batch.keyword-wizard {
  height: 150px;
    border: 1px solid #dfe1e5;
    padding: 6px;
}

#inputChem.keyword-wizard {
  resize: none;
    height: 15px;
    vertical-align: text-top;
    font-size: 13px;
    font-family: inherit;
    padding: 2px;
}

.chem-type-label.keyword-wizard {
  display: inline;
    font-size: 13px;
    margin-left: 12px;
    margin-right: 4px;
}

#chemType.keyword-wizard {
  border-top: 0;
    border-left: 0;
    border-right: 0;
    border-bottom: 1px solid #dfe1e5;
    margin: 6px;
    padding: 2px;
    outline: none;
    font-family: inherit;
    font-size: 13px;
}

.import.keyword-wizard {
  font-size: 13px;
    font-family: inherit;
}

.import-text.keyword-wizard {
  vertical-align: middle;
    display: inline-block;
}

.import-button.keyword-wizard {
  margin: 6px 0 0 24px;
}

.import-button.keyword-wizard button.keyword-wizard {
  border: 0;
    border-radius: 4px;
    padding: 6px 12px;
    font-family: inherit;
    background-color: #4284f4;
    color: white;
}

.import-button.keyword-wizard button.keyword-wizard:hover {
  cursor: pointer;
    background-color: #4284f4;
    color: white;
}

.wizard-buttons.keyword-wizard {
  float: right;
    padding: 12px;
}

.wizard-buttons.keyword-wizard button.keyword-wizard {
  border: 0;
    border-radius: 4px;
    padding: 6px 12px;
    margin: 2px;
    font-family: inherit;
    background-color: #4284f4;
    color: white;
}

.wizard-buttons.keyword-wizard button.keyword-wizard:hover {
  cursor: pointer;
}

@media screen and (max-width: 700px) {
#wizard.keyword-wizard {
  width: 275px;
}

.chip.keyword-wizard {
  margin: 4px 2px;
}

.keyword-input.keyword-wizard {
  width: 82%;
      margin: 4px 12px 12px 24px;
}

.search-within.keyword-wizard .input-label.keyword-wizard {
  display: none;
}

.cpc-field.keyword-wizard .keyword-input.keyword-wizard {
  width: 225px;
      margin: 12px 0 6px 0;
}

.find-patents.keyword-wizard .input-label.keyword-wizard {
  display: none;
}

.search-by.keyword-wizard .input-label.keyword-wizard {
  width: 55px;
      margin-left: 24px;
}

.search-by.keyword-wizard .keyword-input.keyword-wizard {
  margin-top: 6px;
}

#inputChem.keyword-wizard {
  width: 82%;
      padding: 2px;
      margin: 8px 12px 12px 24px;
}

#inputChem.input-batch.keyword-wizard {
  width: 220px;
      padding: 4px;
}

#chemType.keyword-wizard {
  width: 150px;
}

.import-text.keyword-wizard {
  margin: 6px 12px 6px 24px;
      width: 220px;
}

iron-icon.help-header.keyword-wizard {
  display: none;
}

}

@media screen and (min-width: 700px) {
#wizard.keyword-wizard {
  width: 540px;
}

.chip.keyword-wizard {
  margin: 0 2px;
}

.cpc-field.keyword-wizard .keyword-input.keyword-wizard {
  width: 240px;
      margin: 12px 16px 6px 6px;
}

.cpc-inputs.keyword-wizard {
  display: inline;
}

.find-patents.keyword-wizard .keyword-input.keyword-wizard {
  width: 53%;
      margin: 4px 10px;
}

.cpc-field.keyword-wizard .keyword-input.keyword-wizard::placeholder,#inputAnd.keyword-wizard::placeholder,#inputExact.keyword-wizard::placeholder,#inputOr.keyword-wizard::placeholder,#inputMinus.keyword-wizard::placeholder {
  color: white;
}

.find-patents.keyword-wizard .input-label.keyword-wizard {
  width: 35%;
      margin-left: 24px;
}

.search-by.keyword-wizard .keyword-input.keyword-wizard {
  width: 42%;
      margin: 6px 4px;
}

.search-by.keyword-wizard .input-label.keyword-wizard {
  width: 55px;
      margin-left: 24px;
}

#inputChem.keyword-wizard {
  width: 290px;
      margin: 2px 12px 2px 6px;
}

#inputChem.input-batch.keyword-wizard {
  width: 280px;
      padding: 6px;
}

.import-text.keyword-wizard {
  margin: 6px 12px;
      width: 415px;
}

#chemType.keyword-wizard {
  width: 105px;
}

iron-icon.keyword-wizard:hover.help-header {
  cursor: default;
}

iron-icon.help-header.keyword-wizard {
  height: 16px;
      padding: 0 2px 2px 2px;
      color: #a3a3a3;
}

.help.keyword-wizard p.keyword-wizard {
  margin: 0 0 8px 0
}

.help.keyword-wizard .q.keyword-wizard {
  font-family: monospace;
      color: #0b8043;
      white-space: nowrap;
}

.help.keyword-wizard {
  z-index: 4;
      position: absolute;
      right: 10px;
      padding: 12px;
      border-radius: 2px;
      border: 1px solid #e0e0e0;
      box-shadow: 0 2px 2px 0 rgba(0, 0, 0, 0.2), 0 6px 10px 0 rgba(0, 0, 0, 0.3);
      background: white;
      font-size: 13px;
      line-height: 20px;
      width: 450px;
      max-height: 400px;
      overflow: auto;
}

#withinHelp.keyword-wizard {
  top: 75px;
}

#chemHelp.keyword-wizard {
  top: 0;
}

#searchBooleanHelp.keyword-wizard {
  top: 140px;
}

}</style><!-- Shady DOM styles for bottom-bar --><style scope="bottom-bar">.fixed.bottom-bar {
  display: block;
  position: fixed;
  height: 46px;
  bottom: 0;
}

.fixed[medium].bottom-bar {
  height: 280px;
}

.fixed[large].bottom-bar {
  height: 480px;
}

.shadow.bottom-bar {
  background: white;
  padding: 16px;
  border-radius: 8px 8px 0px 0px;
  box-shadow: 0px 8px 10px 1px rgba(0,0,0,.14), 0px 3px 14px 2px rgba(0,0,0,.12), 0px 5px 5px -3px rgba(0,0,0,.2);
}

.oneline.bottom-bar {
  white-space: nowrap;
  overflow: hidden;
  text-overflow: ellipsis;
  cursor: pointer;
}

.button.bottom-bar {
  cursor: pointer;
}

.buttonAlign.bottom-bar {
  margin-top: -4px;
}

.header.bottom-bar {
  height: 30px;
  font-family: 'Google Sans';
  font-size: 18px;
  padding-bottom: 8px;
}

.list.bottom-bar {
  overflow-y: auto;
  line-height: 20px;
}

.definition.bottom-bar {
  padding: 0px 0px 4px 0px;
  cursor: pointer;
}

[medium].bottom-bar .content.bottom-bar {
  height: 230px;
}

[large].bottom-bar .content.bottom-bar {
  height: 430px;
}

[medium].bottom-bar .content.bottom-bar .list.bottom-bar {
  height: 200px;
}

[large].bottom-bar .content.bottom-bar .list.bottom-bar {
  height: 400px;
}

[hidden].bottom-bar {
  display: none;
}

.label.bottom-bar {
  font-family: 'Google Sans';
  font-size: 12px;
  line-height: 16px;
  font-weight: 400;
  padding: 6px 0px 4px 0px;
  color: #1f1f1f;
}

[pad].bottom-bar {
  margin-left: 16px;
}

.layout.vertical.bottom-bar {
  display: flex;
  flex-direction: column;
}

.layout.horizontal.bottom-bar {
  display: flex;
  flex-direction: row;
}

.flex.bottom-bar {
  flex: 1;
  flex-basis: 0.000000001px;
}

.layout.start.bottom-bar {
  align-items: flex-start;
}

.layout.center.bottom-bar {
  align-items: center;
}

.layout.end.bottom-bar {
  align-items: flex-end;
}

.flex-2.bottom-bar {
  flex: 2;
}

.flex-3.bottom-bar {
  flex: 3;
}

.flex-4.bottom-bar {
  flex: 4;
}

.flex-5.bottom-bar {
  flex: 5;
}

.flex-6.bottom-bar {
  flex: 6;
}

.flex-7.bottom-bar {
  flex: 7;
}

.flex-8.bottom-bar {
  flex: 8;
}

.flex-9.bottom-bar {
  flex: 9;
}

.flex-10.bottom-bar {
  flex: 10;
}

.flex-11.bottom-bar {
  flex: 11;
}

.flex-12.bottom-bar {
  flex: 12;
}</style><!-- Shady DOM styles for landscape-link --><!-- Shady DOM styles for landscape-summary-box --><!-- Shady DOM styles for search-state --><!-- Shady DOM styles for iron-overlay-backdrop --><!-- Shady DOM styles for opaque-animation --><!-- Shady DOM styles for iron-dropdown --><!-- Shady DOM styles for iron-meta --><!-- Shady DOM styles for iron-icon --><style scope="iron-icon-0">.iron-icon-0 {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;-ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;-ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
        position: relative;

        vertical-align: middle;

        fill: currentcolor;
        stroke: none;

        width: 24px;
        height: 24px;;
}

.iron-icon-0[hidden] {
  display: none;
}</style><!-- Shady DOM styles for iron-iconset-svg --><!-- Shady DOM styles for iron-list --><!-- Shady DOM styles for paper-icon-item --><!-- Shady DOM styles for paper-item-body --><!-- Shady DOM styles for paper-item --><!-- Shady DOM styles for dropdown-menu --><!-- Shady DOM styles for chips-input --><!-- Shady DOM styles for input-chip --><!-- Shady DOM styles for keyword-editor --><!-- Shady DOM styles for paper-ripple --><!-- Shady DOM styles for paper-button --><!-- Shady DOM styles for date-editor --><!-- Shady DOM styles for metadata-editor --><!-- Shady DOM styles for restrict-editor --><!-- Shady DOM styles for overlay-tooltip --><style scope="overlay-tooltip">overlay-tooltip {
  display: none;
        color: #fff;
        background-color: #000;
        padding: 10px 12px;
        border-radius: 3px;
        font-size: 13px;
        font-weight: normal;
        line-height: normal;
        position: fixed;
        z-index: 100;
}

#arrow.overlay-tooltip {
  width: 0;
        height: 0;
        border-style: solid;
        border-width: 0 6px 8px 6px;
        border-color: transparent transparent #000 transparent;
        position: absolute;
        top: -8px;
        left: calc(50% - 6px);
}</style><!-- Shady DOM styles for query-renderer --><!-- Shady DOM styles for result-nav --><style scope="result-nav">result-nav {
  display: block;
        white-space: nowrap;
        padding: 0 30px;
        line-height: 30px;
        height: 30px;
        margin-top: 17px;
        font-weight: 500;
        font-size: 15px;
}

state-modifier.result-nav {
  color: #333;
}

state-modifier[disabled].result-nav {
  pointer-events: none;
        color: #ccc;
}</style><!-- Shady DOM styles for raw-html --><!-- Shady DOM styles for paper-material --><style scope="paper-material-0">.paper-material-0 {
  display: block;
        position: relative;
}

.paper-material-0[elevation="1"] {
  box-shadow: 0 2px 2px 0 rgba(0, 0, 0, 0.14),
                    0 1px 5px 0 rgba(0, 0, 0, 0.12),
                    0 3px 1px -2px rgba(0, 0, 0, 0.2);
}

.paper-material-0[elevation="2"] {
  box-shadow: 0 4px 5px 0 rgba(0, 0, 0, 0.14),
                    0 1px 10px 0 rgba(0, 0, 0, 0.12),
                    0 2px 4px -1px rgba(0, 0, 0, 0.4);
}

.paper-material-0[elevation="3"] {
  box-shadow: 0 6px 10px 0 rgba(0, 0, 0, 0.14),
                    0 1px 18px 0 rgba(0, 0, 0, 0.12),
                    0 3px 5px -1px rgba(0, 0, 0, 0.4);
}

.paper-material-0[elevation="4"] {
  box-shadow: 0 8px 10px 1px rgba(0, 0, 0, 0.14),
                    0 3px 14px 2px rgba(0, 0, 0, 0.12),
                    0 5px 5px -3px rgba(0, 0, 0, 0.4);
}

.paper-material-0[elevation="5"] {
  box-shadow: 0 16px 24px 2px rgba(0, 0, 0, 0.14),
                    0  6px 30px 5px rgba(0, 0, 0, 0.12),
                    0  8px 10px -5px rgba(0, 0, 0, 0.4);
}

.paper-material-0[animated] {
  transition: box-shadow 0.28s cubic-bezier(0.4, 0, 0.2, 1);
}

.paper-material-0 {
  ;
}</style><!-- Shady DOM styles for search-box --><style scope="search-box">.layout.horizontal.search-box,.layout.vertical.search-box {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;
}

.layout.inline.search-box {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;
}

.layout.horizontal.search-box {
  -ms-flex-direction: row;
        -webkit-flex-direction: row;
        flex-direction: row;
}

.layout.vertical.search-box {
  -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
}

.layout.wrap.search-box {
  -ms-flex-wrap: wrap;
        -webkit-flex-wrap: wrap;
        flex-wrap: wrap;
}

.layout.no-wrap.search-box {
  -ms-flex-wrap: nowrap;
        -webkit-flex-wrap: nowrap;
        flex-wrap: nowrap;
}

.layout.center.search-box,.layout.center-center.search-box {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.center-justified.search-box,.layout.center-center.search-box {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.flex.search-box {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.flex-auto.search-box {
  -ms-flex: 1 1 auto;
        -webkit-flex: 1 1 auto;
        flex: 1 1 auto;
}

.flex-none.search-box {
  -ms-flex: none;
        -webkit-flex: none;
        flex: none;
}

.inputbox.search-box {
  border: 1px solid #ccc;
        padding: 0 12px;
        background: white;
}

.inputbox[focused].search-box {
  border: 1px solid #4285f4 !important;
}

.inputbox.search-box:hover {
  border: 1px solid #999;
}

#searchInput.search-box {
  font-family: inherit;
        font-size: 16px;
        padding: 8px 0;
        outline: none;
        border-right: none;
        width: 100%;
        margin-right: 0;
        border: 0;
}

#searchButton.search-box {
  cursor: pointer;
        background-color: #4285f4;
        border: none;
        color: #fff;
        vertical-align: top;
        width: 70px;
        height: 37px;
        outline: none;
}

.suggest-bg.search-box {
  display: inline-block;
        min-width: 0;
        white-space: nowrap;
}

#suggestMenu.search-box {
  position: absolute;
        margin-top: 38px;
        width: 100%;
        background: white;
        z-index: 1;
}

#suggestMenu.search-box .row.search-box {
  font-size: 13px;
        line-height: 28px;
        white-space: nowrap;
        overflow: hidden;
        text-overflow: ellipsis;
        padding: 4px 2px;
        cursor: pointer;
}

.row[selected].search-box {
  background: rgba(0, 0, 0, 0.05);
}

.suggest-icon.search-box {
  height: 20px;
        width: 20px;
        padding: 0 12px 0 6px;
        transition: transform .15s linear;
        transform: scale(1);
}

.suggest-icon[hide].search-box {
  transform: scale(0);
}

#corpora.search-box {
  padding: 6px 0;
        user-select: none;
}

#corpora.search-box iron-icon.search-box {
  height: 20px;
        width: 20px;
        color: #ccc;
        cursor: pointer;
}

#corpora.search-box iron-icon[active].search-box {
  color: #4285f4 !important;
}

#corpora.search-box iron-icon.search-box:hover {
  color: #999;
}</style><!-- Shady DOM styles for iron-media-query --><!-- Shady DOM styles for paper-header-panel --><!-- Shady DOM styles for iron-a11y-announcer --><style scope="iron-a11y-announcer">iron-a11y-announcer {
  display: inline-block;
        position: fixed;
        clip: rect(0px,0px,0px,0px);
}</style><!-- Shady DOM styles for iron-autogrow-textarea --><!-- Shady DOM styles for iron-input --><!-- Shady DOM styles for paper-input-char-counter --><!-- Shady DOM styles for paper-input-container --><!-- Shady DOM styles for paper-input-error --><!-- Shady DOM styles for paper-input --><!-- Shady DOM styles for paper-textarea --><!-- Shady DOM styles for paper-toast --><style scope="paper-toast-0">.paper-toast-0 {
  display: block;
        position: fixed;
        background-color: #323232;
        color: #f1f1f1;
        min-height: 48px;
        min-width: 288px;
        padding: 16px 24px;
        box-sizing: border-box;
        box-shadow: 0 2px 5px 0 rgba(0, 0, 0, 0.26);
        border-radius: 2px;
        margin: 12px;
        font-size: 14px;
        cursor: default;
        -webkit-transition: -webkit-transform 0.3s, opacity 0.3s;
        transition: transform 0.3s, opacity 0.3s;
        opacity: 0;
        -webkit-transform: translateY(100px);
        transform: translateY(100px);font-family: 'Roboto', 'Noto', sans-serif;
        -webkit-font-smoothing: antialiased;
}

.paper-toast-0.capsule {
  border-radius: 24px;
}

.paper-toast-0.fit-bottom {
  width: 100%;
        min-width: 0;
        border-radius: 0;
        margin: 0;
}

.paper-toast-0.paper-toast-open {
  opacity: 1;
        -webkit-transform: translateY(0px);
        transform: translateY(0px);
}</style><!-- Shady DOM styles for paper-toolbar --><!-- Shady DOM styles for search-footer --><style scope="search-footer">#footer.search-footer {
  font-size: 13px;
        margin-top: 10px;
        background: #fafafa;
        padding: 20px 10px;
        align-items: center;
        border-top: 1px solid #ebebeb;
}

#footer.search-footer .links.search-footer > *.search-footer {
  display: inline-block;
        margin: 0 12px;
}

.layout.horizontal.search-footer,.layout.vertical.search-footer {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;
}

.layout.inline.search-footer {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;
}

.layout.horizontal.search-footer {
  -ms-flex-direction: row;
        -webkit-flex-direction: row;
        flex-direction: row;
}

.layout.vertical.search-footer {
  -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
}

.layout.wrap.search-footer {
  -ms-flex-wrap: wrap;
        -webkit-flex-wrap: wrap;
        flex-wrap: wrap;
}

.layout.no-wrap.search-footer {
  -ms-flex-wrap: nowrap;
        -webkit-flex-wrap: nowrap;
        flex-wrap: nowrap;
}

.layout.center.search-footer,.layout.center-center.search-footer {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.center-justified.search-footer,.layout.center-center.search-footer {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.flex.search-footer {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.flex-auto.search-footer {
  -ms-flex: 1 1 auto;
        -webkit-flex: 1 1 auto;
        flex: 1 1 auto;
}

.flex-none.search-footer {
  -ms-flex: none;
        -webkit-flex: none;
        flex: none;
}

.layout.start.search-footer {
  -ms-flex-align: start;
        -webkit-align-items: flex-start;
        align-items: flex-start;
}

.layout.center.search-footer,.layout.center-center.search-footer {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.end.search-footer {
  -ms-flex-align: end;
        -webkit-align-items: flex-end;
        align-items: flex-end;
}

.layout.baseline.search-footer {
  -ms-flex-align: baseline;
        -webkit-align-items: baseline;
        align-items: baseline;
}

.layout.start-justified.search-footer {
  -ms-flex-pack: start;
        -webkit-justify-content: flex-start;
        justify-content: flex-start;
}

.layout.center-justified.search-footer,.layout.center-center.search-footer {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.layout.end-justified.search-footer {
  -ms-flex-pack: end;
        -webkit-justify-content: flex-end;
        justify-content: flex-end;
}

.layout.around-justified.search-footer {
  -ms-flex-pack: distribute;
        -webkit-justify-content: space-around;
        justify-content: space-around;
}

.layout.justified.search-footer {
  -ms-flex-pack: justify;
        -webkit-justify-content: space-between;
        justify-content: space-between;
}

.self-start.search-footer {
  -ms-align-self: flex-start;
        -webkit-align-self: flex-start;
        align-self: flex-start;
}

.self-center.search-footer {
  -ms-align-self: center;
        -webkit-align-self: center;
        align-self: center;
}

.self-end.search-footer {
  -ms-align-self: flex-end;
        -webkit-align-self: flex-end;
        align-self: flex-end;
}

.self-stretch.search-footer {
  -ms-align-self: stretch;
        -webkit-align-self: stretch;
        align-self: stretch;
}

.self-baseline.search-footer {
  -ms-align-self: baseline;
        -webkit-align-self: baseline;
        align-self: baseline;
}

.layout.start-aligned.search-footer {
  -ms-flex-line-pack: start;  
        -ms-align-content: flex-start;
        -webkit-align-content: flex-start;
        align-content: flex-start;
}

.layout.end-aligned.search-footer {
  -ms-flex-line-pack: end;  
        -ms-align-content: flex-end;
        -webkit-align-content: flex-end;
        align-content: flex-end;
}

.layout.center-aligned.search-footer {
  -ms-flex-line-pack: center;  
        -ms-align-content: center;
        -webkit-align-content: center;
        align-content: center;
}

.layout.between-aligned.search-footer {
  -ms-flex-line-pack: justify;  
        -ms-align-content: space-between;
        -webkit-align-content: space-between;
        align-content: space-between;
}

.layout.around-aligned.search-footer {
  -ms-flex-line-pack: distribute;  
        -ms-align-content: space-around;
        -webkit-align-content: space-around;
        align-content: space-around;
}</style><!-- Shady DOM styles for search-header --><style scope="search-header">search-header {
  display: block;
}

.lockup-logo.search-header,.lockup-text.search-header {
  display: inline-block;
}

.lockup-logo.search-header {
  width: 74px;
        height: 24px;
        background-image: url('https://www.gstatic.com/images/branding/googlelogo/1x/googlelogo_color_74x24dp.png');
        background-size: 74px 24px;
}

.lockup-text.search-header {
  font-family: "Product Sans", Arial, Helvetica, sans-serif;

        
        font-size: 22.1px;

        
        text-rendering: optimizeLegibility;

        
        position: relative;
        top: -6px;
        left: -5px;

        
        -webkit-font-smoothing: antialiased;
        -moz-osx-font-smoothing: grayscale;
}

.lockup-brand.search-header {
  opacity: 0.54;
}

@media (-webkit-min-device-pixel-ratio: 1.5), (min-resolution: 144dpi) {
.lockup-logo.search-header {
  background-image: url('https://www.gstatic.com/images/branding/googlelogo/2x/googlelogo_color_74x24dp.png');
}

.lockup-text.search-header {
  font-size: 21.3px;
          left: -7px;
}

}

header.search-header {
  background-color: #fafafa;
        border-bottom: 1px solid #ebebeb;
        color: #333;
        height: 60px;
        width: 100%;
        z-index: 1;
        display: block;
}

[latestStyle].search-header header.search-header {
  background-color: transparent;
}

.headerpad.search-header {
  margin-left: 16px;
}

[wide].search-header .headerpad.search-header {
  margin-left: 32px;
}

.leftheader.search-header {
  width: 322px;
}

header.search-header h1.search-header {
  display: none;
}

header.search-header h1.search-header state-modifier.search-header {
  color: #777;
        text-decoration: none;
        display: inline-block;
}

[wide].search-header header.search-header h1.search-header {
  box-sizing: border-box;
        margin: 0;
        padding: 20px 0 10px;
        font-size: 20px;
        font-weight: 400;
        white-space: nowrap;
        display: block;
}

search-box.search-header {
  height: 37px;
        padding: 0 16px;
        width: 900px;
        align-self: center;
}

.layout.horizontal.search-header,.layout.vertical.search-header {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;
}

.layout.inline.search-header {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;
}

.layout.horizontal.search-header {
  -ms-flex-direction: row;
        -webkit-flex-direction: row;
        flex-direction: row;
}

.layout.vertical.search-header {
  -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
}

.layout.wrap.search-header {
  -ms-flex-wrap: wrap;
        -webkit-flex-wrap: wrap;
        flex-wrap: wrap;
}

.layout.no-wrap.search-header {
  -ms-flex-wrap: nowrap;
        -webkit-flex-wrap: nowrap;
        flex-wrap: nowrap;
}

.layout.center.search-header,.layout.center-center.search-header {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.center-justified.search-header,.layout.center-center.search-header {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.flex.search-header {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.flex-auto.search-header {
  -ms-flex: 1 1 auto;
        -webkit-flex: 1 1 auto;
        flex: 1 1 auto;
}

.flex-none.search-header {
  -ms-flex: none;
        -webkit-flex: none;
        flex: none;
}

.layout.start.search-header {
  -ms-flex-align: start;
        -webkit-align-items: flex-start;
        align-items: flex-start;
}

.layout.center.search-header,.layout.center-center.search-header {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.end.search-header {
  -ms-flex-align: end;
        -webkit-align-items: flex-end;
        align-items: flex-end;
}

.layout.baseline.search-header {
  -ms-flex-align: baseline;
        -webkit-align-items: baseline;
        align-items: baseline;
}

.layout.start-justified.search-header {
  -ms-flex-pack: start;
        -webkit-justify-content: flex-start;
        justify-content: flex-start;
}

.layout.center-justified.search-header,.layout.center-center.search-header {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.layout.end-justified.search-header {
  -ms-flex-pack: end;
        -webkit-justify-content: flex-end;
        justify-content: flex-end;
}

.layout.around-justified.search-header {
  -ms-flex-pack: distribute;
        -webkit-justify-content: space-around;
        justify-content: space-around;
}

.layout.justified.search-header {
  -ms-flex-pack: justify;
        -webkit-justify-content: space-between;
        justify-content: space-between;
}

.self-start.search-header {
  -ms-align-self: flex-start;
        -webkit-align-self: flex-start;
        align-self: flex-start;
}

.self-center.search-header {
  -ms-align-self: center;
        -webkit-align-self: center;
        align-self: center;
}

.self-end.search-header {
  -ms-align-self: flex-end;
        -webkit-align-self: flex-end;
        align-self: flex-end;
}

.self-stretch.search-header {
  -ms-align-self: stretch;
        -webkit-align-self: stretch;
        align-self: stretch;
}

.self-baseline.search-header {
  -ms-align-self: baseline;
        -webkit-align-self: baseline;
        align-self: baseline;
}

.layout.start-aligned.search-header {
  -ms-flex-line-pack: start;  
        -ms-align-content: flex-start;
        -webkit-align-content: flex-start;
        align-content: flex-start;
}

.layout.end-aligned.search-header {
  -ms-flex-line-pack: end;  
        -ms-align-content: flex-end;
        -webkit-align-content: flex-end;
        align-content: flex-end;
}

.layout.center-aligned.search-header {
  -ms-flex-line-pack: center;  
        -ms-align-content: center;
        -webkit-align-content: center;
        align-content: center;
}

.layout.between-aligned.search-header {
  -ms-flex-line-pack: justify;  
        -ms-align-content: space-between;
        -webkit-align-content: space-between;
        align-content: space-between;
}

.layout.around-aligned.search-header {
  -ms-flex-line-pack: distribute;  
        -ms-align-content: space-around;
        -webkit-align-content: space-around;
        align-content: space-around;
}</style><!-- Shady DOM styles for search-ui --><style scope="search-ui-0">.search-ui-0 paper-button.search-ui {
  display: inline-block;
        text-align: center;
        font-family: inherit;
}

.search-ui-0 .layout.horizontal.search-ui,.search-ui-0 .layout.vertical.search-ui {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;
}

.search-ui-0 .layout.inline.search-ui {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;
}

.search-ui-0 .layout.horizontal.search-ui {
  -ms-flex-direction: row;
        -webkit-flex-direction: row;
        flex-direction: row;
}

.search-ui-0 .layout.vertical.search-ui {
  -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
}

.search-ui-0 .layout.wrap.search-ui {
  -ms-flex-wrap: wrap;
        -webkit-flex-wrap: wrap;
        flex-wrap: wrap;
}

.search-ui-0 .layout.no-wrap.search-ui {
  -ms-flex-wrap: nowrap;
        -webkit-flex-wrap: nowrap;
        flex-wrap: nowrap;
}

.search-ui-0 .layout.center.search-ui,.search-ui-0 .layout.center-center.search-ui {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.search-ui-0 .layout.center-justified.search-ui,.search-ui-0 .layout.center-center.search-ui {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.search-ui-0 .flex.search-ui {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.search-ui-0 .flex-auto.search-ui {
  -ms-flex: 1 1 auto;
        -webkit-flex: 1 1 auto;
        flex: 1 1 auto;
}

.search-ui-0 .flex-none.search-ui {
  -ms-flex: none;
        -webkit-flex: none;
        flex: none;
}

.search-ui-0 .layout.start.search-ui {
  -ms-flex-align: start;
        -webkit-align-items: flex-start;
        align-items: flex-start;
}

.search-ui-0 .layout.center.search-ui,.search-ui-0 .layout.center-center.search-ui {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.search-ui-0 .layout.end.search-ui {
  -ms-flex-align: end;
        -webkit-align-items: flex-end;
        align-items: flex-end;
}

.search-ui-0 .layout.baseline.search-ui {
  -ms-flex-align: baseline;
        -webkit-align-items: baseline;
        align-items: baseline;
}

.search-ui-0 .layout.start-justified.search-ui {
  -ms-flex-pack: start;
        -webkit-justify-content: flex-start;
        justify-content: flex-start;
}

.search-ui-0 .layout.center-justified.search-ui,.search-ui-0 .layout.center-center.search-ui {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.search-ui-0 .layout.end-justified.search-ui {
  -ms-flex-pack: end;
        -webkit-justify-content: flex-end;
        justify-content: flex-end;
}

.search-ui-0 .layout.around-justified.search-ui {
  -ms-flex-pack: distribute;
        -webkit-justify-content: space-around;
        justify-content: space-around;
}

.search-ui-0 .layout.justified.search-ui {
  -ms-flex-pack: justify;
        -webkit-justify-content: space-between;
        justify-content: space-between;
}

.search-ui-0 .self-start.search-ui {
  -ms-align-self: flex-start;
        -webkit-align-self: flex-start;
        align-self: flex-start;
}

.search-ui-0 .self-center.search-ui {
  -ms-align-self: center;
        -webkit-align-self: center;
        align-self: center;
}

.search-ui-0 .self-end.search-ui {
  -ms-align-self: flex-end;
        -webkit-align-self: flex-end;
        align-self: flex-end;
}

.search-ui-0 .self-stretch.search-ui {
  -ms-align-self: stretch;
        -webkit-align-self: stretch;
        align-self: stretch;
}

.search-ui-0 .self-baseline.search-ui {
  -ms-align-self: baseline;
        -webkit-align-self: baseline;
        align-self: baseline;
}

.search-ui-0 .layout.start-aligned.search-ui {
  -ms-flex-line-pack: start;  
        -ms-align-content: flex-start;
        -webkit-align-content: flex-start;
        align-content: flex-start;
}

.search-ui-0 .layout.end-aligned.search-ui {
  -ms-flex-line-pack: end;  
        -ms-align-content: flex-end;
        -webkit-align-content: flex-end;
        align-content: flex-end;
}

.search-ui-0 .layout.center-aligned.search-ui {
  -ms-flex-line-pack: center;  
        -ms-align-content: center;
        -webkit-align-content: center;
        align-content: center;
}

.search-ui-0 .layout.between-aligned.search-ui {
  -ms-flex-line-pack: justify;  
        -ms-align-content: space-between;
        -webkit-align-content: space-between;
        align-content: space-between;
}

.search-ui-0 .layout.around-aligned.search-ui {
  -ms-flex-line-pack: distribute;  
        -ms-align-content: space-around;
        -webkit-align-content: space-around;
        align-content: space-around;
}

.search-ui-0 {
  display: block;
        min-width: 350px;
        height: 100%;
}

.search-ui-0 #content.search-ui {
  height: 100%;
}

.search-ui-0 #leftBarOverflow.search-ui {
  padding-right: 16px;
}

.search-ui-0 [wide].search-ui #leftBarOverflow.search-ui {
  overflow: auto;
}

.search-ui-0 #leftBar.search-ui {
  box-sizing: border-box;
        color: #666;
        font-size: 13px;
        padding: 16px 0 16px 16px;
        border-bottom: 1px solid #e5e5e5;
}

.search-ui-0 [wide].search-ui #leftBar.search-ui {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;

        -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
        position: relative;
        width: 350px;
        margin-bottom: 0;
        padding-bottom: 0;
        border-bottom: none;
}

@media print {
.search-ui-0 #leftBar.search-ui {
  display: none !important;
}

}

.search-ui-0 #leftBar.search-ui h3.search-ui {
  text-transform: uppercase;
        font-size: 13px;
        font-weight: normal;
        margin-top: 6px;
        margin-bottom: 6px;
        cursor: default;
        display: inline-block;
        color: #a3a3a3;
}

.search-ui-0 #closeButton.search-ui {
  position: absolute;
        right: 0;
}

.search-ui-0 #searchTermsHeader.search-ui {
  position: relative;
}

.search-ui-0 #searchTermsQ.search-ui iron-icon.search-ui {
  height: 16px;
        padding: 0 2px 2px 2px;
        color: #a3a3a3;
}

.search-ui-0 #searchTermsHeader.search-ui:hover iron-icon.search-ui {
  color: #4285f4;
}

.search-ui-0 #closeLeftBar.search-ui {
  height: 16px;
        width: 16px;
        padding: 0 0 8px 0;
        cursor: pointer;
}

.search-ui-0 #compactQuery.search-ui iron-icon.search-ui {
  height: 20px;
}

.search-ui-0 #backToResultsButton.search-ui {
  color: #fff;
        background: #4285f4;
        margin-top: 20px;
        text-align: center;
}

.search-ui-0 #main.search-ui {
  display: block;
        min-height: calc(100vh - 127px);
}

@media print {
.search-ui-0 [wide].search-ui main.search-ui {
  margin-left: 0;
}

}</style><!-- Shady DOM styles for import-list --><!-- Shady DOM styles for iron-request --><!-- Shady DOM styles for iron-ajax --><!-- Shady DOM styles for paper-dialog --><!-- Shady DOM styles for coverage-stats --><!-- Shady DOM styles for iron-image --><!-- Shady DOM styles for iron-selector --><!-- Shady DOM styles for paper-card --><!-- Shady DOM styles for paper-checkbox --><!-- Shady DOM styles for landing-page --><!-- Shady DOM styles for remote-fetch --><!-- Shady DOM styles for paper-spinner --><style scope="paper-spinner-0">.paper-spinner-0 {
  display: inline-block;
        position: relative;
        width: 28px;
        height: 28px;
}

.paper-spinner-0 #spinnerContainer.paper-spinner {
  width: 100%;
        height: 100%;

        
        direction: ltr;
}

.paper-spinner-0 #spinnerContainer.active.paper-spinner {
  -webkit-animation: container-rotate-paper-spinner-0 1568ms linear infinite;
        animation: container-rotate-paper-spinner-0 1568ms linear infinite;
}

@-webkit-keyframes container-rotate-paper-spinner-0 {
to {
  -webkit-transform: rotate(360deg)
}

}

@keyframes container-rotate-paper-spinner-0 {
to {
  transform: rotate(360deg)
}

}

.paper-spinner-0 .spinner-layer.paper-spinner {
  position: absolute;
        width: 100%;
        height: 100%;
        opacity: 0;
        white-space: nowrap;
        color: #4285f4;
}

.paper-spinner-0 .layer-1.paper-spinner {
  color: #4285f4;
}

.paper-spinner-0 .layer-2.paper-spinner {
  color: #db4437;
}

.paper-spinner-0 .layer-3.paper-spinner {
  color: #f4b400;
}

.paper-spinner-0 .layer-4.paper-spinner {
  color: #0f9d58;
}

.paper-spinner-0 .active.paper-spinner .spinner-layer.paper-spinner {
  -webkit-animation-name: fill-unfill-rotate-paper-spinner-0;
        -webkit-animation-duration: 5332ms;
        -webkit-animation-timing-function: cubic-bezier(0.4, 0.0, 0.2, 1);
        -webkit-animation-iteration-count: infinite;
        animation-name: fill-unfill-rotate-paper-spinner-0;
        animation-duration: 5332ms;
        animation-timing-function: cubic-bezier(0.4, 0.0, 0.2, 1);
        animation-iteration-count: infinite;
        opacity: 1;
}

.paper-spinner-0 .active.paper-spinner .spinner-layer.layer-1.paper-spinner {
  -webkit-animation-name: fill-unfill-rotate-paper-spinner-0, layer-1-fade-in-out-paper-spinner-0;
        animation-name: fill-unfill-rotate-paper-spinner-0, layer-1-fade-in-out-paper-spinner-0;
}

.paper-spinner-0 .active.paper-spinner .spinner-layer.layer-2.paper-spinner {
  -webkit-animation-name: fill-unfill-rotate-paper-spinner-0, layer-2-fade-in-out-paper-spinner-0;
        animation-name: fill-unfill-rotate-paper-spinner-0, layer-2-fade-in-out-paper-spinner-0;
}

.paper-spinner-0 .active.paper-spinner .spinner-layer.layer-3.paper-spinner {
  -webkit-animation-name: fill-unfill-rotate-paper-spinner-0, layer-3-fade-in-out-paper-spinner-0;
        animation-name: fill-unfill-rotate-paper-spinner-0, layer-3-fade-in-out-paper-spinner-0;
}

.paper-spinner-0 .active.paper-spinner .spinner-layer.layer-4.paper-spinner {
  -webkit-animation-name: fill-unfill-rotate-paper-spinner-0, layer-4-fade-in-out-paper-spinner-0;
        animation-name: fill-unfill-rotate-paper-spinner-0, layer-4-fade-in-out-paper-spinner-0;
}

@-webkit-keyframes fill-unfill-rotate-paper-spinner-0 {
12.5% {
  -webkit-transform: rotate(135deg)
}

25% {
  -webkit-transform: rotate(270deg)
}

37.5% {
  -webkit-transform: rotate(405deg)
}

50% {
  -webkit-transform: rotate(540deg)
}

62.5% {
  -webkit-transform: rotate(675deg)
}

75% {
  -webkit-transform: rotate(810deg)
}

87.5% {
  -webkit-transform: rotate(945deg)
}

to {
  -webkit-transform: rotate(1080deg)
}

}

@keyframes fill-unfill-rotate-paper-spinner-0 {
12.5% {
  transform: rotate(135deg)
}

25% {
  transform: rotate(270deg)
}

37.5% {
  transform: rotate(405deg)
}

50% {
  transform: rotate(540deg)
}

62.5% {
  transform: rotate(675deg)
}

75% {
  transform: rotate(810deg)
}

87.5% {
  transform: rotate(945deg)
}

to {
  transform: rotate(1080deg)
}

}

@-webkit-keyframes layer-1-fade-in-out-paper-spinner-0 {
0% {
  opacity: 1
}

25% {
  opacity: 1
}

26% {
  opacity: 0
}

89% {
  opacity: 0
}

90% {
  opacity: 1
}

to {
  opacity: 1
}

}

@keyframes layer-1-fade-in-out-paper-spinner-0 {
0% {
  opacity: 1
}

25% {
  opacity: 1
}

26% {
  opacity: 0
}

89% {
  opacity: 0
}

90% {
  opacity: 1
}

to {
  opacity: 1
}

}

@-webkit-keyframes layer-2-fade-in-out-paper-spinner-0 {
0% {
  opacity: 0
}

15% {
  opacity: 0
}

25% {
  opacity: 1
}

50% {
  opacity: 1
}

51% {
  opacity: 0
}

to {
  opacity: 0
}

}

@keyframes layer-2-fade-in-out-paper-spinner-0 {
0% {
  opacity: 0
}

15% {
  opacity: 0
}

25% {
  opacity: 1
}

50% {
  opacity: 1
}

51% {
  opacity: 0
}

to {
  opacity: 0
}

}

@-webkit-keyframes layer-3-fade-in-out-paper-spinner-0 {
0% {
  opacity: 0
}

40% {
  opacity: 0
}

50% {
  opacity: 1
}

75% {
  opacity: 1
}

76% {
  opacity: 0
}

to {
  opacity: 0
}

}

@keyframes layer-3-fade-in-out-paper-spinner-0 {
0% {
  opacity: 0
}

40% {
  opacity: 0
}

50% {
  opacity: 1
}

75% {
  opacity: 1
}

76% {
  opacity: 0
}

to {
  opacity: 0
}

}

@-webkit-keyframes layer-4-fade-in-out-paper-spinner-0 {
0% {
  opacity: 0
}

65% {
  opacity: 0
}

75% {
  opacity: 1
}

90% {
  opacity: 1
}

to {
  opacity: 0
}

}

@keyframes layer-4-fade-in-out-paper-spinner-0 {
0% {
  opacity: 0
}

65% {
  opacity: 0
}

75% {
  opacity: 1
}

90% {
  opacity: 1
}

to {
  opacity: 0
}

}

.paper-spinner-0 .circle-clipper.paper-spinner {
  display: inline-block;
        position: relative;
        width: 50%;
        height: 100%;
        overflow: hidden;
}

.paper-spinner-0 .spinner-layer.paper-spinner::after {
  left: 45%;
        width: 10%;
        border-top-style: solid;
}

.paper-spinner-0 .spinner-layer.paper-spinner::after,.paper-spinner-0 .circle-clipper.paper-spinner::after {
  content: '';
        box-sizing: border-box;
        position: absolute;
        top: 0;
        border-width: 3px;
        border-radius: 50%;
}

.paper-spinner-0 .circle-clipper.paper-spinner::after {
  bottom: 0;
        width: 200%;
        border-style: solid;
        border-bottom-color: transparent !important;
}

.paper-spinner-0 .circle-clipper.left.paper-spinner::after {
  left: 0;
        border-right-color: transparent !important;
        -webkit-transform: rotate(129deg);
        transform: rotate(129deg);
}

.paper-spinner-0 .circle-clipper.right.paper-spinner::after {
  left: -100%;
        border-left-color: transparent !important;
        -webkit-transform: rotate(-129deg);
        transform: rotate(-129deg);
}

.paper-spinner-0 .active.paper-spinner .gap-patch.paper-spinner::after,.paper-spinner-0 .active.paper-spinner .circle-clipper.paper-spinner::after {
  -webkit-animation-duration: 1333ms;
        -webkit-animation-timing-function: cubic-bezier(0.4, 0.0, 0.2, 1);
        -webkit-animation-iteration-count: infinite;
        animation-duration: 1333ms;
        animation-timing-function: cubic-bezier(0.4, 0.0, 0.2, 1);
        animation-iteration-count: infinite;
}

.paper-spinner-0 .active.paper-spinner .circle-clipper.left.paper-spinner::after {
  -webkit-animation-name: left-spin-paper-spinner-0;
        animation-name: left-spin-paper-spinner-0;
}

.paper-spinner-0 .active.paper-spinner .circle-clipper.right.paper-spinner::after {
  -webkit-animation-name: right-spin-paper-spinner-0;
        animation-name: right-spin-paper-spinner-0;
}

@-webkit-keyframes left-spin-paper-spinner-0 {
0% {
  -webkit-transform: rotate(130deg)
}

50% {
  -webkit-transform: rotate(-5deg)
}

to {
  -webkit-transform: rotate(130deg)
}

}

@keyframes left-spin-paper-spinner-0 {
0% {
  transform: rotate(130deg)
}

50% {
  transform: rotate(-5deg)
}

to {
  transform: rotate(130deg)
}

}

@-webkit-keyframes right-spin-paper-spinner-0 {
0% {
  -webkit-transform: rotate(-130deg)
}

50% {
  -webkit-transform: rotate(5deg)
}

to {
  -webkit-transform: rotate(-130deg)
}

}

@keyframes right-spin-paper-spinner-0 {
0% {
  transform: rotate(-130deg)
}

50% {
  transform: rotate(5deg)
}

to {
  transform: rotate(-130deg)
}

}

.paper-spinner-0 #spinnerContainer.cooldown.paper-spinner {
  -webkit-animation: container-rotate-paper-spinner-0 1568ms linear infinite, fade-out-paper-spinner-0 400ms cubic-bezier(0.4, 0.0, 0.2, 1);
        animation: container-rotate-paper-spinner-0 1568ms linear infinite, fade-out-paper-spinner-0 400ms cubic-bezier(0.4, 0.0, 0.2, 1);
}

@-webkit-keyframes fade-out-paper-spinner-0 {
0% {
  opacity: 1
}

to {
  opacity: 0
}

}

@keyframes fade-out-paper-spinner-0 {
0% {
  opacity: 1
}

to {
  opacity: 0
}

}</style><!-- Shady DOM styles for paper-spinner-lite --><!-- Shady DOM styles for concept-card --><!-- Shady DOM styles for concept-mention --><style scope="concept-mention">.block.concept-mention {
  display: block;
}

[hidden].concept-mention {
  display: none !important;
}

.invisible.concept-mention {
  visibility: hidden !important;
}

.relative.concept-mention {
  position: relative;
}

.fit.concept-mention {
  position: absolute;
        top: 0;
        right: 0;
        bottom: 0;
        left: 0;
}

body.fullbleed.concept-mention {
  margin: 0;
        height: 100vh;
}

.scroll.concept-mention {
  -webkit-overflow-scrolling: touch;
        overflow: auto;
}

.fixed-bottom.concept-mention,.fixed-left.concept-mention,.fixed-right.concept-mention,.fixed-top.concept-mention {
  position: fixed;
}

.fixed-top.concept-mention {
  top: 0;
        left: 0;
        right: 0;
}

.fixed-right.concept-mention {
  top: 0;
        right: 0;
        bottom: 0;
}

.fixed-bottom.concept-mention {
  right: 0;
        bottom: 0;
        left: 0;
}

.fixed-left.concept-mention {
  top: 0;
        bottom: 0;
        left: 0;
}

#target.concept-mention:hover {
  background-color: #e8f0fe;
}

#target[noicon].concept-mention {
  padding: 1px;
}

#target.concept-mention:hover[noicon] {
  border: 1px solid #e8f0fe;
        padding: 0;
}

#target.concept-mention {
  display: inline-block;
}

.inline-icon.concept-mention {
  cursor: pointer;
        height: 12px;
        width: 12px;
        padding-left: 4px;
        color: #5e6368;
}

concept-card.concept-mention {
  z-index: 1;
        position: absolute;
}</style><!-- Shady DOM styles for fterm-concept-card --><!-- Shady DOM styles for fterm-concept-mention --><!-- Shady DOM styles for paper-fab --><!-- Shady DOM styles for paper-icon-button --><!-- Shady DOM styles for paper-icon-button-light --><!-- Shady DOM styles for classification-tree --><style scope="classification-tree">.layout.horizontal.classification-tree,.layout.vertical.classification-tree {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;
}

.layout.inline.classification-tree {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;
}

.layout.horizontal.classification-tree {
  -ms-flex-direction: row;
        -webkit-flex-direction: row;
        flex-direction: row;
}

.layout.vertical.classification-tree {
  -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
}

.layout.wrap.classification-tree {
  -ms-flex-wrap: wrap;
        -webkit-flex-wrap: wrap;
        flex-wrap: wrap;
}

.layout.no-wrap.classification-tree {
  -ms-flex-wrap: nowrap;
        -webkit-flex-wrap: nowrap;
        flex-wrap: nowrap;
}

.layout.center.classification-tree,.layout.center-center.classification-tree {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.center-justified.classification-tree,.layout.center-center.classification-tree {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.flex.classification-tree {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.flex-auto.classification-tree {
  -ms-flex: 1 1 auto;
        -webkit-flex: 1 1 auto;
        flex: 1 1 auto;
}

.flex-none.classification-tree {
  -ms-flex: none;
        -webkit-flex: none;
        flex: none;
}

classification-tree {
  display: block;
        line-height: 20px;
}

.wrap.classification-tree {
  padding: 6px 12px;
}

.wrap.classification-tree:hover {
  background: #fafafa;
}

.description.classification-tree {
  padding-left: 4px;
}

iron-icon.classification-tree {
  color: #eaeaea;
}

.code[first].classification-tree {
  font-weight: 500;
}

.code[additional].classification-tree {
  font-style: italic;
}</style><!-- Shady DOM styles for classification-viewer --><style scope="classification-viewer">.table.classification-viewer {
  border: 1px solid #eaeaea;
        display: block;
}

.more.classification-viewer {
  padding: 6px 12px;
        cursor: pointer;
        font-style: italic;
        color: #aaa;
}

.more.classification-viewer:hover {
  background: #fafafa;
}

.chip.classification-viewer {
  display: inline-block;
        padding: 4px 6px;
        border-radius: 2px;
}

.chip[additional].classification-viewer {
  font-style: italic;
}</style><!-- Shady DOM styles for image-carousel --><!-- Shady DOM styles for image-viewer --><!-- Shady DOM styles for patent-result --><style scope="patent-result">#wrapper.patent-result {
  padding: 20px;
        max-width: 1050px;
        outline: 0;
}

.scroll-target.patent-result:before {
  display: block;
        content: '';
        visibility: hidden;
}

h1.patent-result {
  font-weight: 500;
        font-size: 20px;
        margin: 0 0 20px 0;
}

h3.patent-result {
  font-size: 15px;
        font-weight: 500;
        margin: 28px 0 18px 0;
}

dl.patent-result {
  line-height: 1.5;
        font-size: 0;
}

dt.patent-result,dd.patent-result {
  display: inline;
        font-size: 13px;
        margin: 0;
}

dt.patent-result {
  font-weight: 500;
        color: #000;
}

dt.patent-result::after {
  content: ': ';
}

dd.patent-result {
  color: #aaa;
}

dd.patent-result ~ dd.patent-result::before {
  content: ', ';
}

dt.patent-result + dd.patent-result::before {
  content: '';
}

dd.patent-result ~ dt.patent-result::before {
  display: block;
        content: '';
        margin-top: 8px;
}

dd.patent-result core-icon.patent-result {
  width: 14px;
        height: 14px;
        vertical-align: top;
        color: inherit;
}

.table.patent-result {
  display: table;
        border-collapse: collapse;
        border-spacing: 0;
        border: 1px solid #eaeaea;
        width: 100%;
        box-sizing: border-box;
}

.tr.patent-result {
  display: table-row;
        border-bottom: 1px solid #eaeaea;
}

.th.patent-result,.td.patent-result {
  display: table-cell;
        padding: 10px 12px;
}

.thead.patent-result {
  display: table-header-group;
}

.tbody.patent-result {
  display: table-row-group;
}

.th.patent-result {
  text-align: left;
        white-space: nowrap;
        background-color: #fafafa;
        color: #757575;
}

.td.patent-result {
  vertical-align: top;
}

.td.patent-result > p.patent-result {
  margin-top: 0;
}

.nowrap.patent-result {
  white-space: nowrap;
}

.knowledge-card.patent-result {
  border: 1px solid #e5e5e5;
        border-radius: 2px;
}

.knowledge-card.patent-result > header.patent-result {
  -webkit-font-smoothing: antialiased;
        -moz-osx-font-smoothing: grayscale;
        background: #4285f4;
        color: #fff;
        padding: 20px 12px;
}

.knowledge-card.patent-result > header.patent-result state-modifier.patent-result,.knowledge-card.patent-result > header.patent-result a.patent-result {
  color: inherit;
        margin: 0 12px 0 0;
        display: inline-block;
}

.knowledge-card.patent-result > header.patent-result h2.patent-result,.knowledge-card.patent-result > header.patent-result .tagline.patent-result {
  margin: 0;
        font-weight: normal;
        padding-top: 4px;
}

.knowledge-card.patent-result > header.patent-result h2.patent-result {
  font-size: 20px;
}

.knowledge-card.patent-result .knowledge-card-action-bar.patent-result {
  background: #3367d6;
        padding: 10px 12px;
        margin: 20px -12px -20px;
}

.knowledge-card.patent-result .knowledge-card-action-bar.patent-result core-icon.patent-result {
  margin-right: 12px;
        width: 24px;
        height: 24px;
}

.knowledge-card.patent-result dl.patent-result {
  padding: 16px 12px;
}

.knowledge-card.patent-result hr.patent-result {
  border: none;
        height: 1px;
        background: #e5e5e5;
        margin: 0;
}

.main-link.patent-result {
  margin: 14px;
        font-weight: 500;
}

.footer.patent-result h3.patent-result state-modifier.patent-result,.footer.patent-result h3.patent-result a.patent-result {
  float: right;
        font-weight: 400;
        font-size: 13px;
        line-height: 24px;
}

.footer.patent-result dl.patent-result {
  margin-left: 30px;
}

.footer.patent-result > ul.patent-result > li.patent-result {
  margin-bottom: 8px;
}

h3.patent-result .righthead.patent-result {
  color: #aaa;
        font-weight: 400;
        font-size: 13px;
        cursor: help;
}

.tooltip-hint.patent-result {
  border-bottom: 1px dotted #ccc;
}

[marginRight].patent-result {
  margin-right: 60px;
}

.flex-width.patent-result {
  min-width: 0;
        word-break: break-word;
}

.responsive-table.patent-result {
  width: 100%;
        overflow-x: auto;
        overflow-y: hidden;
}

.layout.horizontal.patent-result,.layout.vertical.patent-result {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;
}

.layout.inline.patent-result {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;
}

.layout.horizontal.patent-result {
  -ms-flex-direction: row;
        -webkit-flex-direction: row;
        flex-direction: row;
}

.layout.vertical.patent-result {
  -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
}

.layout.wrap.patent-result {
  -ms-flex-wrap: wrap;
        -webkit-flex-wrap: wrap;
        flex-wrap: wrap;
}

.layout.no-wrap.patent-result {
  -ms-flex-wrap: nowrap;
        -webkit-flex-wrap: nowrap;
        flex-wrap: nowrap;
}

.layout.center.patent-result,.layout.center-center.patent-result {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.center-justified.patent-result,.layout.center-center.patent-result {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.flex.patent-result {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.flex-auto.patent-result {
  -ms-flex: 1 1 auto;
        -webkit-flex: 1 1 auto;
        flex: 1 1 auto;
}

.flex-none.patent-result {
  -ms-flex: none;
        -webkit-flex: none;
        flex: none;
}

.layout.start.patent-result {
  -ms-flex-align: start;
        -webkit-align-items: flex-start;
        align-items: flex-start;
}

.layout.center.patent-result,.layout.center-center.patent-result {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.end.patent-result {
  -ms-flex-align: end;
        -webkit-align-items: flex-end;
        align-items: flex-end;
}

.layout.baseline.patent-result {
  -ms-flex-align: baseline;
        -webkit-align-items: baseline;
        align-items: baseline;
}

.layout.start-justified.patent-result {
  -ms-flex-pack: start;
        -webkit-justify-content: flex-start;
        justify-content: flex-start;
}

.layout.center-justified.patent-result,.layout.center-center.patent-result {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.layout.end-justified.patent-result {
  -ms-flex-pack: end;
        -webkit-justify-content: flex-end;
        justify-content: flex-end;
}

.layout.around-justified.patent-result {
  -ms-flex-pack: distribute;
        -webkit-justify-content: space-around;
        justify-content: space-around;
}

.layout.justified.patent-result {
  -ms-flex-pack: justify;
        -webkit-justify-content: space-between;
        justify-content: space-between;
}

.self-start.patent-result {
  -ms-align-self: flex-start;
        -webkit-align-self: flex-start;
        align-self: flex-start;
}

.self-center.patent-result {
  -ms-align-self: center;
        -webkit-align-self: center;
        align-self: center;
}

.self-end.patent-result {
  -ms-align-self: flex-end;
        -webkit-align-self: flex-end;
        align-self: flex-end;
}

.self-stretch.patent-result {
  -ms-align-self: stretch;
        -webkit-align-self: stretch;
        align-self: stretch;
}

.self-baseline.patent-result {
  -ms-align-self: baseline;
        -webkit-align-self: baseline;
        align-self: baseline;
}

.layout.start-aligned.patent-result {
  -ms-flex-line-pack: start;  
        -ms-align-content: flex-start;
        -webkit-align-content: flex-start;
        align-content: flex-start;
}

.layout.end-aligned.patent-result {
  -ms-flex-line-pack: end;  
        -ms-align-content: flex-end;
        -webkit-align-content: flex-end;
        align-content: flex-end;
}

.layout.center-aligned.patent-result {
  -ms-flex-line-pack: center;  
        -ms-align-content: center;
        -webkit-align-content: center;
        align-content: center;
}

.layout.between-aligned.patent-result {
  -ms-flex-line-pack: justify;  
        -ms-align-content: space-between;
        -webkit-align-content: space-between;
        align-content: space-between;
}

.layout.around-aligned.patent-result {
  -ms-flex-line-pack: distribute;  
        -ms-align-content: space-around;
        -webkit-align-content: space-around;
        align-content: space-around;
}

.flex.patent-result,.flex-1.patent-result {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.flex-2.patent-result {
  -ms-flex: 2;
        -webkit-flex: 2;
        flex: 2;
}

.flex-3.patent-result {
  -ms-flex: 3;
        -webkit-flex: 3;
        flex: 3;
}

.flex-4.patent-result {
  -ms-flex: 4;
        -webkit-flex: 4;
        flex: 4;
}

.flex-5.patent-result {
  -ms-flex: 5;
        -webkit-flex: 5;
        flex: 5;
}

.flex-6.patent-result {
  -ms-flex: 6;
        -webkit-flex: 6;
        flex: 6;
}

.flex-7.patent-result {
  -ms-flex: 7;
        -webkit-flex: 7;
        flex: 7;
}

.flex-8.patent-result {
  -ms-flex: 8;
        -webkit-flex: 8;
        flex: 8;
}

.flex-9.patent-result {
  -ms-flex: 9;
        -webkit-flex: 9;
        flex: 9;
}

.flex-10.patent-result {
  -ms-flex: 10;
        -webkit-flex: 10;
        flex: 10;
}

.flex-11.patent-result {
  -ms-flex: 11;
        -webkit-flex: 11;
        flex: 11;
}

.flex-12.patent-result {
  -ms-flex: 12;
        -webkit-flex: 12;
        flex: 12;
}

@media print {
#text.patent-result {
  flex-direction: column-reverse !important;
}

}

patent-result-ref-list.patent-result {
  width: 100%;
}

patent-result-ref-list.patent-result + patent-result-ref-list.patent-result {
  margin-left: 10px;
}

[narrow].patent-result {
  flex-direction: column-reverse !important;
}

.famheader.patent-result {
  text-align: left;
        white-space: nowrap;
        background-color: #fafafa;
        color: #757575;
}

.collapse.patent-result {
  color: #616161;
        font-size: 13px;
        cursor: pointer;
}

#imageDrag.patent-result {
  position: fixed;
        cursor: col-resize;
}

#imageDrag.patent-result div.patent-result {
  width: 4px;
        height: 100%;
        margin: 0 4px;
        background: #eee;
}

#imageDrag.patent-result:hover {
  background: #eee;
}

#imageDrag.patent-result:hover div.patent-result {
  background: #ccc;
}

.imageWrapper.patent-result {
  position: fixed;
        top: 60px;
        background: white;
        margin-left: 12px;
}

#notices.patent-result {
  padding: 20px;
}

#figures.patent-result {
  background: #efefef;
}

.headerButton.patent-result {
  color: #3c80f6;
        cursor: pointer;
        display: inline-block;
        padding: 0 14px;
        line-height: 27px;
}

.headerButton.patent-result iron-icon.patent-result {
  width: 16px;
        height: 16px;
}

.tr.conceptDomain.patent-result {
  display: table-row;
}

.responsive-grid.patent-result {
  display: grid;
        gap: 8px;
        grid-template-columns: none;
}</style><!-- Shady DOM styles for family-viewer --><!-- Shady DOM styles for app-row --><!-- Shady DOM styles for application-timeline --><style scope="application-timeline">.layout.horizontal.application-timeline,.layout.vertical.application-timeline {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;
}

.layout.inline.application-timeline {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;
}

.layout.horizontal.application-timeline {
  -ms-flex-direction: row;
        -webkit-flex-direction: row;
        flex-direction: row;
}

.layout.vertical.application-timeline {
  -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
}

.layout.wrap.application-timeline {
  -ms-flex-wrap: wrap;
        -webkit-flex-wrap: wrap;
        flex-wrap: wrap;
}

.layout.no-wrap.application-timeline {
  -ms-flex-wrap: nowrap;
        -webkit-flex-wrap: nowrap;
        flex-wrap: nowrap;
}

.layout.center.application-timeline,.layout.center-center.application-timeline {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.center-justified.application-timeline,.layout.center-center.application-timeline {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.flex.application-timeline {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.flex-auto.application-timeline {
  -ms-flex: 1 1 auto;
        -webkit-flex: 1 1 auto;
        flex: 1 1 auto;
}

.flex-none.application-timeline {
  -ms-flex: none;
        -webkit-flex: none;
        flex: none;
}

.wrap.application-timeline {
  padding: 16px 12px;
}

.event.application-timeline {
  padding: 3px 0;
}

[date].application-timeline {
  color: #5f6368;
        font-size: 13px;
        padding: 3px 0;
        width: 70px;
        line-height: 16px;
}

[critical].application-timeline [date].application-timeline {
  color: #202124;
        font-weight: 500;
        line-height: 18px;
}

.line.application-timeline {
  margin: 9px 6px;
        border-radius: 4px;
        background: #dadce0;
        width: 4px;
        height: 4px;
}

.dot.application-timeline {
  margin: 3px 0;
        border-radius: 4px;
        background: #dadce0;
        width: 4px;
        height: 4px;
        display: inline-block;
}

[critical].application-timeline .line.application-timeline {
  background: #4285f4;
}

[current].application-timeline .line.application-timeline {
  background: #81c995;
}

[current][critical].application-timeline .line.application-timeline {
  background: #81c995;
}

.title.application-timeline {
  font-size: 13px;
        padding: 3px 0;
        line-height: 16px;
}

.title-text.application-timeline {
  color: #5f6368;
}

.description-item.application-timeline {
  font-size: 12px;
        padding: 6px 0;
        max-width: 300px;
}

#legal.application-timeline {
  height: 14px;
        width: 14px;
        padding: 0 3px 1px 3px;
        vertical-align: text-bottom;
}

#icon.application-timeline {
  height: 12px;
        width: 12px;
        padding: 0 3px 3px 3px;
        vertical-align: text-bottom;
}

.unknown.application-timeline {
  font-style: italic;
}

.not_active.application-timeline {
  text-decoration: line-through;
}

.active.application-timeline {
  font-weight: 500;
}

#cc[this].application-timeline {
  color: #202124 !important;
        text-decoration: underline;
}

#cc[this].not_active.application-timeline {
  text-decoration: line-through underline;
}

hr.application-timeline {
  border: none;
        height: 1px;
        background: #e5e5e5;
        margin: 10px 0 16px 0;
}

.header.application-timeline {
  font-size: 13px;
        line-height: 20px;
        font-weight: 500;
        color: #202124;
        padding-bottom: 8px;
}

.block.application-timeline {
  padding: 0 6px 0 0;
}

.year.application-timeline {
  color: #5f6368;
        font-size: 13px;
        font-weight: 500;
        padding: 3px 1px;
        width: 70px;
}

.expand.application-timeline {
  cursor: pointer;
        padding: 6px 0 3px 0;
}</style><!-- Shady DOM styles for patent-text --><style scope="patent-text">.layout.horizontal.patent-text,.layout.vertical.patent-text {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;
}

.layout.inline.patent-text {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;
}

.layout.horizontal.patent-text {
  -ms-flex-direction: row;
        -webkit-flex-direction: row;
        flex-direction: row;
}

.layout.vertical.patent-text {
  -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
}

.layout.wrap.patent-text {
  -ms-flex-wrap: wrap;
        -webkit-flex-wrap: wrap;
        flex-wrap: wrap;
}

.layout.no-wrap.patent-text {
  -ms-flex-wrap: nowrap;
        -webkit-flex-wrap: nowrap;
        flex-wrap: nowrap;
}

.layout.center.patent-text,.layout.center-center.patent-text {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.center-justified.patent-text,.layout.center-center.patent-text {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.flex.patent-text {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.flex-auto.patent-text {
  -ms-flex: 1 1 auto;
        -webkit-flex: 1 1 auto;
        flex: 1 1 auto;
}

.flex-none.patent-text {
  -ms-flex: none;
        -webkit-flex: none;
        flex: none;
}

.layout.start.patent-text {
  -ms-flex-align: start;
        -webkit-align-items: flex-start;
        align-items: flex-start;
}

.layout.center.patent-text,.layout.center-center.patent-text {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.end.patent-text {
  -ms-flex-align: end;
        -webkit-align-items: flex-end;
        align-items: flex-end;
}

.layout.baseline.patent-text {
  -ms-flex-align: baseline;
        -webkit-align-items: baseline;
        align-items: baseline;
}

.layout.start-justified.patent-text {
  -ms-flex-pack: start;
        -webkit-justify-content: flex-start;
        justify-content: flex-start;
}

.layout.center-justified.patent-text,.layout.center-center.patent-text {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.layout.end-justified.patent-text {
  -ms-flex-pack: end;
        -webkit-justify-content: flex-end;
        justify-content: flex-end;
}

.layout.around-justified.patent-text {
  -ms-flex-pack: distribute;
        -webkit-justify-content: space-around;
        justify-content: space-around;
}

.layout.justified.patent-text {
  -ms-flex-pack: justify;
        -webkit-justify-content: space-between;
        justify-content: space-between;
}

.self-start.patent-text {
  -ms-align-self: flex-start;
        -webkit-align-self: flex-start;
        align-self: flex-start;
}

.self-center.patent-text {
  -ms-align-self: center;
        -webkit-align-self: center;
        align-self: center;
}

.self-end.patent-text {
  -ms-align-self: flex-end;
        -webkit-align-self: flex-end;
        align-self: flex-end;
}

.self-stretch.patent-text {
  -ms-align-self: stretch;
        -webkit-align-self: stretch;
        align-self: stretch;
}

.self-baseline.patent-text {
  -ms-align-self: baseline;
        -webkit-align-self: baseline;
        align-self: baseline;
}

.layout.start-aligned.patent-text {
  -ms-flex-line-pack: start;  
        -ms-align-content: flex-start;
        -webkit-align-content: flex-start;
        align-content: flex-start;
}

.layout.end-aligned.patent-text {
  -ms-flex-line-pack: end;  
        -ms-align-content: flex-end;
        -webkit-align-content: flex-end;
        align-content: flex-end;
}

.layout.center-aligned.patent-text {
  -ms-flex-line-pack: center;  
        -ms-align-content: center;
        -webkit-align-content: center;
        align-content: center;
}

.layout.between-aligned.patent-text {
  -ms-flex-line-pack: justify;  
        -ms-align-content: space-between;
        -webkit-align-content: space-between;
        align-content: space-between;
}

.layout.around-aligned.patent-text {
  -ms-flex-line-pack: distribute;  
        -ms-align-content: space-around;
        -webkit-align-content: space-around;
        align-content: space-around;
}

patent-text {
  display: block;
}

#text.patent-text {
  line-height: 20px;
        min-width: 0;
}

#margin.patent-text {
  width: 16px;
}

#createHighlight.patent-text {
  position: relative;
        width: 16px;
        height: 16px;
        cursor: pointer;
}

.notranslate.patent-text > .google-src-text.patent-text {
  display: none;
}

.notranslate.patent-text:hover,mark.patent-text {
  background-color: #fbfcae;
}

.description-paragraph.patent-text {
  margin-block-start: 1em;
        margin-block-end: 1em;
}

.claim-text.patent-text {
  margin: 14px 0 0 20px;
}

.claim-dependent.patent-text {
  margin-left: 40px;
        color: #888;
}

[hide-claims].patent-text .claim-dependent.patent-text .claim-text.patent-text {
  height: 0;
        width: 0;
        visibility: hidden;
}

[hide-claims].patent-text .claim-dependent.patent-text .claim.patent-text:after {
  content: "…"
}

.patent-full-image.patent-text {
  max-width: 100%;
        height: auto;
}

.small-patent-image.patent-text {
  display: inline;
}

ul.patent-text {
  padding: 0 0 0 50px;
}

li.patent-text {
  list-style-type: none;
        position: relative;
}

ol.claims.patent-text li.patent-text {
  list-style-type: decimal;
        font-weight: bold;
}

ol.claims.patent-text li.patent-text > *.patent-text {
  font-weight: normal;
}

li.patent-text > para-num.patent-text {
  position: absolute;
        left: -45px;
        color: #888;
}

mark.patent-text {
  background: #fff59d;
}

mark.searchText.patent-text {
  background: #80deea;
}

.searchTextHeader.patent-text {
  font-weight: 500;
}

pre.patent-text {
  white-space: pre-wrap;
}

heading.patent-text {
  display: block;
        font-weight: 500;
        font-size: 13px;
}

#comment.patent-text {
  width: 16px;
        height: 16px;
}

[has-search][no-results].patent-text {
  display: none;
}

.highlight.patent-text {
  background-color: #fef7e0;
}</style><!-- Shady DOM styles for para-num --><!-- Shady DOM styles for result-container --><style scope="result-container">paper-spinner.result-container {
  position: absolute;
        
        top: calc(50%  + 56px - 16px);
        left: calc(50% + 175px - 16px);
}</style><!-- Shady DOM styles for scholar-result --><!-- Shady DOM styles for search-result --><style scope="search-result">.layout.horizontal.search-result,.layout.vertical.search-result {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;
}

.layout.inline.search-result {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;
}

.layout.horizontal.search-result {
  -ms-flex-direction: row;
        -webkit-flex-direction: row;
        flex-direction: row;
}

.layout.vertical.search-result {
  -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
}

.layout.wrap.search-result {
  -ms-flex-wrap: wrap;
        -webkit-flex-wrap: wrap;
        flex-wrap: wrap;
}

.layout.no-wrap.search-result {
  -ms-flex-wrap: nowrap;
        -webkit-flex-wrap: nowrap;
        flex-wrap: nowrap;
}

.layout.center.search-result,.layout.center-center.search-result {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.center-justified.search-result,.layout.center-center.search-result {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.flex.search-result {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.flex-auto.search-result {
  -ms-flex: 1 1 auto;
        -webkit-flex: 1 1 auto;
        flex: 1 1 auto;
}

.flex-none.search-result {
  -ms-flex: none;
        -webkit-flex: none;
        flex: none;
}

.layout.start.search-result {
  -ms-flex-align: start;
        -webkit-align-items: flex-start;
        align-items: flex-start;
}

.layout.center.search-result,.layout.center-center.search-result {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.end.search-result {
  -ms-flex-align: end;
        -webkit-align-items: flex-end;
        align-items: flex-end;
}

.layout.baseline.search-result {
  -ms-flex-align: baseline;
        -webkit-align-items: baseline;
        align-items: baseline;
}

.layout.start-justified.search-result {
  -ms-flex-pack: start;
        -webkit-justify-content: flex-start;
        justify-content: flex-start;
}

.layout.center-justified.search-result,.layout.center-center.search-result {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.layout.end-justified.search-result {
  -ms-flex-pack: end;
        -webkit-justify-content: flex-end;
        justify-content: flex-end;
}

.layout.around-justified.search-result {
  -ms-flex-pack: distribute;
        -webkit-justify-content: space-around;
        justify-content: space-around;
}

.layout.justified.search-result {
  -ms-flex-pack: justify;
        -webkit-justify-content: space-between;
        justify-content: space-between;
}

.self-start.search-result {
  -ms-align-self: flex-start;
        -webkit-align-self: flex-start;
        align-self: flex-start;
}

.self-center.search-result {
  -ms-align-self: center;
        -webkit-align-self: center;
        align-self: center;
}

.self-end.search-result {
  -ms-align-self: flex-end;
        -webkit-align-self: flex-end;
        align-self: flex-end;
}

.self-stretch.search-result {
  -ms-align-self: stretch;
        -webkit-align-self: stretch;
        align-self: stretch;
}

.self-baseline.search-result {
  -ms-align-self: baseline;
        -webkit-align-self: baseline;
        align-self: baseline;
}

.layout.start-aligned.search-result {
  -ms-flex-line-pack: start;  
        -ms-align-content: flex-start;
        -webkit-align-content: flex-start;
        align-content: flex-start;
}

.layout.end-aligned.search-result {
  -ms-flex-line-pack: end;  
        -ms-align-content: flex-end;
        -webkit-align-content: flex-end;
        align-content: flex-end;
}

.layout.center-aligned.search-result {
  -ms-flex-line-pack: center;  
        -ms-align-content: center;
        -webkit-align-content: center;
        align-content: center;
}

.layout.between-aligned.search-result {
  -ms-flex-line-pack: justify;  
        -ms-align-content: space-between;
        -webkit-align-content: space-between;
        align-content: space-between;
}

.layout.around-aligned.search-result {
  -ms-flex-line-pack: distribute;  
        -ms-align-content: space-around;
        -webkit-align-content: space-around;
        align-content: space-around;
}

search-result {
  display: block;
        font-size: 13px;
}

#mainContainer.search-result {
  min-height: calc(100vh - 127px);
        color: #333;
}

#compactQuery.search-result {
  padding: 18px 20px 10px 20px;
        cursor: pointer;
}

#compactQuery.search-result > span.search-result {
  padding: 0 14px 0 0;
}

#compactQuery.search-result iron-icon.search-result {
  padding-right: 6px;
        height: 16px;
        width: 16px;
}</style><!-- Shady DOM styles for webdoc-result --><!-- Shady DOM styles for iron-pages --><!-- Shady DOM styles for paper-tab --><!-- Shady DOM styles for paper-tabs --><!-- Shady DOM styles for debug-info --><!-- Shady DOM styles for search-paging --><!-- Shady DOM styles for search-result-item --><!-- Shady DOM styles for search-result-image --><!-- Shady DOM styles for search-result-entities --><!-- Shady DOM styles for search-result-measures --><!-- Shady DOM styles for search-results --><!-- Shady DOM styles for summary-box --><!-- Shady DOM styles for timeline-page --><!-- Shady DOM styles for iron-localstorage --><!-- Shady DOM styles for search-app --><style scope="search-app">search-app {
  display: block;
        height: 100%;
}

#toast.search-app {
  min-height: 64px;
        min-width: 742px;
}</style><style>body {transition: opacity ease-in 0.2s; } 
body[unresolved] {opacity: 0; display: block; overflow: hidden; position: relative; } 
</style>
    <title>CN110452242A - Pyrrolobenzodiazepines Zhuo and its conjugate 
        - Google Patents</title>

    <meta name="viewport" content="width=device-width, initial-scale=1">
    <meta charset="UTF-8">
    <meta name="referrer" content="origin-when-crossorigin">
    <link rel="canonical" href="https://patents.google.com/patent/CN110452242A/en">
    <meta name="description" content="
     The present invention relates to Pyrrolobenzodiazepines Zhuo and its conjugates.Specifically, the present invention relates to the compound of Formulas I and its salt and solvate, and further relate to the conjugate of the compound or its salt comprising Formulas I or solvate.   
   
   ">
    <meta name="DC.type" content="patent">
    <meta name="DC.title" content="Pyrrolobenzodiazepines Zhuo and its conjugate 
       ">
    <meta name="DC.date" content="2013-12-20" scheme="dateSubmitted">
    <meta name="DC.description" content="
     The present invention relates to Pyrrolobenzodiazepines Zhuo and its conjugates.Specifically, the present invention relates to the compound of Formulas I and its salt and solvate, and further relate to the conjugate of the compound or its salt comprising Formulas I or solvate.   
   
   ">
    <meta name="citation_patent_application_number" content="CN:201910749475.3A">
    <meta name="citation_pdf_url" content="https://patentimages.storage.googleapis.com/6f/fc/24/c9712b7ade7267/CN110452242A.pdf">
    <meta name="citation_patent_publication_number" content="CN:110452242:A">
    <meta name="DC.date" content="2019-11-15">
    <meta name="DC.contributor" content="菲利普·威尔逊·霍华德" scheme="inventor">
    <meta name="DC.contributor" content="ADC Therapeutics SA" scheme="assignee">
    <meta name="DC.relation" content="WO:2011130598:A1" scheme="references">
    <meta name="citation_reference" content="AHMED KAMAL等: &quot;Design, synthesis, and evaaffinity and potent cytotoxicityluation of mixed imine–amine pyrrolobenzodiazepine dimers with efficient DNA binding&quot;, 《BIOORGANIC&amp; MEDICINAL CHEMISTRY》" scheme="references">
    <meta name="citation_reference" content="AHMED KAMAL等: &quot;Design, Synthesis, and Evaluation of New Noncross-Linking Pyrrolobenzodiazepine Dimers with Efficient DNA Binding Ability and Potent Antitumor Activity&quot;, 《J. MED. CHEM.》" scheme="references">
    <meta name="citation_reference" content="AHMED KAMAL等: &quot;Pyrrolo[2,1-c][1,4]benzodiazepine-b-glucuronide prodrugs with a potential for selective therapy of solid tumors by PMT and ADEPT strategies&quot;, 《BIOORGANIC &amp; MEDICINAL CHEMISTRY LETTERS》" scheme="references">
    <link rel="stylesheet" href="https://fonts.googleapis.com/css?family=Roboto:400,400italic,500,500italic,700">
    <link rel="stylesheet" href="https://fonts.googleapis.com/css?family=Product+Sans">
    <link rel="stylesheet" href="https://fonts.googleapis.com/css2?family=Google+Sans:wght@400;500;700">

    <style>
      body { transition: none; }
    </style>

    <script src="https://apis.google.com/_/scs/abc-static/_/js/k=gapi.lb.en.IKZeRvoAYNY.O/m=client/rt=j/sv=1/d=1/ed=1/am=AAAQ/rs=AHpOoo-SMWTzMRJrTty6iE5dL_aWGYOnuw/cb=gapi.loaded_0?le=scs" async=""></script><script>
      window.version = 'patent-search.search_20240531_RC00';

      function sendFeedback() {
        userfeedback.api.startFeedback({
          'productId': '713680',
          'bucket': 'patent-search-web',
          'productVersion': window.version,
        });
      }

      window.experiments = {};
      window.experiments.patentCountries = "ae,ag,al,am,ao,ap,ar,at,au,aw,az,ba,bb,bd,be,bf,bg,bh,bj,bn,bo,br,bw,bx,by,bz,ca,cf,cg,ch,ci,cl,cm,cn,co,cr,cs,cu,cy,cz,dd,de,dj,dk,dm,do,dz,ea,ec,ee,eg,em,ep,es,fi,fr,ga,gb,gc,gd,ge,gh,gm,gn,gq,gr,gt,gw,hk,hn,hr,hu,ib,id,ie,il,in,ir,is,it,jo,jp,ke,kg,kh,km,kn,kp,kr,kw,kz,la,lc,li,lk,lr,ls,lt,lu,lv,ly,ma,mc,md,me,mg,mk,ml,mn,mo,mr,mt,mw,mx,my,mz,na,ne,ng,ni,nl,no,nz,oa,om,pa,pe,pg,ph,pl,pt,py,qa,ro,rs,ru,rw,sa,sc,sd,se,sg,si,sk,sl,sm,sn,st,su,sv,sy,sz,td,tg,th,tj,tm,tn,tr,tt,tw,tz,ua,ug,us,uy,uz,vc,ve,vn,wo,yu,za,zm,zw";
      
      
      window.experiments.keywordWizard = true;
      
      
      
      window.experiments.definitions = true;

      window.Polymer = {
        dom: 'shady',
        lazyRegister: true,
      };
    </script>

    <script src="//www.gstatic.com/patent-search/frontend/patent-search.search_20240531_RC00/scs/compiled_dir/webcomponentsjs/webcomponents-lite.min.js"></script>
    <style>[hidden]:not([style-scope]):not(.style-scope) {
  display: none !important;
}

</style><style></style><style></style><style></style><style></style><link rel="stylesheet" href="https://fonts.googleapis.com/css?family=Roboto:400,300,300italic,400italic,500,500italic,700,700italic"><link rel="stylesheet" href="https://fonts.googleapis.com/css?family=Roboto+Mono:400,700"><style></style><style></style><style>
  html, body {
    min-width: 100%;
    width: 100%;
    min-height: 100%;
    height: 100%;
  }

  body {
    background-color: #fff;
    font-family: 'Roboto', sans-serif;
    color: #333;
    margin: 0;
    padding: 0;
    /*
     * Turn off https://github.com/WICG/ScrollAnchoring/blob/master/explainer.md
     * https://memegen.googleplex.com/5230756293246976
     */
    overflow-anchor: none;
  }

  body h1, body h2, body h3 {
    -webkit-font-smoothing: antialiased;
    -moz-osx-font-smoothing: grayscale;
  }

  body a:link {
    color: #3c80f6;
    text-decoration: none;
  }

  body a:visited {
    color: #3c80f6;
  }

  body a[open-result]:visited {
    color: #7e57c2;
  }

  /* For Firefox */
  a:link {
    color: #3c80f6;
    text-decoration: none;
  }

  a:visited {
    color: #3c80f6;
  }

  a[open-result]:visited {
    color: #7e57c2;
  }

  ::selection , body ::selection {
    background-color: #c6dafc;
    color: #333;
  }
</style><link rel="import" href="//www.gstatic.com/patent-search/frontend/patent-search.search_20240531_RC00/scs/compiled_dir/search-app-vulcanized.html">
  <style>[hidden] { display: none !important; }</style><script type="text/javascript" charset="UTF-8" src="https://apis.google.com/js/client.js" gapi_processed="true"></script></head>
  <body>
    <script src="//www.gstatic.com/patent-search/frontend/patent-search.search_20240531_RC00/scs/compiled_dir/search-app-vulcanized.js"></script><span style="font-size: 13px; white-space: pre-wrap; display: inline-block; position: absolute; left: -99999px; top: -99999px; max-width: 217px;"></span><span style="font-size: 13px; white-space: pre-wrap; display: inline-block; position: absolute; left: -99999px; top: -99999px; max-width: 217px;"></span>
    <search-app>
    
    <remote-fetch class="style-scope search-app"></remote-fetch>
    <search-state class="style-scope search-app"></search-state>
    <browser-ui class="style-scope search-app"></browser-ui>
    <template is="dom-if" restamp="" class="style-scope search-app"></template>
    <template is="dom-if" restamp="" class="style-scope search-app"></template>
    
      <search-result id="result" class="style-scope search-app">
    
    
    <search-ui mode="result" class="style-scope search-result x-scope search-ui-0">
    
    
    
    <div id="content" class="style-scope search-ui" wide="">
      <search-header show-search="" class="style-scope search-ui">
    
    
    <div class="style-scope search-header" wide="">
      <header class="style-scope search-header">
        <div class="layout horizontal headerpad style-scope search-header">
          <div class="layout horizontal leftheader style-scope search-header">
            <h1 class="style-scope search-header">
              <state-modifier inherit="" act="{&quot;type&quot;: &quot;HOME&quot;}" class="style-scope search-header"><a id="link" href="#" class="style-scope state-modifier" inherit="">
                <div class="lockup style-scope search-header">
                  <span class="lockup-logo style-scope search-header"></span>
                  <span class="lockup-text style-scope search-header">
                    <span class="lockup-brand style-scope search-header">&nbsp;Patents</span>
                  </span>
                </div>
              </a></state-modifier>
            </h1>
          </div>
          
            <search-box class="style-scope search-header">
    
    <div class="layout horizontal style-scope search-box" style="position: relative;">
      <div class="inputbox flex layout horizontal style-scope search-box">
        <div class="suggest-bg flex style-scope search-box">
          <input name="q" id="searchInput" data-proto="SEARCH_INPUT" autocomplete="off" class="style-scope search-box">
        </div>
        <div id="corpora" class="style-scope search-box">
          <iron-icon icon="icons:lightbulb-outline" id="patentIcon" class="style-scope search-box x-scope iron-icon-0" active=""><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M9 21c0 .55.45 1 1 1h4c.55 0 1-.45 1-1v-1H9v1zm3-19C8.14 2 5 5.14 5 9c0 2.38 1.19 4.47 3 5.74V17c0 .55.45 1 1 1h6c.55 0 1-.45 1-1v-2.26c1.81-1.27 3-3.36 3-5.74 0-3.86-3.14-7-7-7zm2.85 11.1l-.85.6V16h-4v-2.3l-.85-.6C7.8 12.16 7 10.63 7 9c0-2.76 2.24-5 5-5s5 2.24 5 5c0 1.63-.8 3.16-2.15 4.1z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
          <overlay-tooltip positioning-target="#patentIcon" direction="bottom" class="style-scope search-box" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      Include patents
    </div>
  </overlay-tooltip>
          <iron-icon icon="social:school" id="nplIcon" class="style-scope search-box x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M5 13.18v4L12 21l7-3.82v-4L12 17l-7-3.82zM12 3L1 9l11 6 9-4.91V17h2V9L12 3z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
          <overlay-tooltip positioning-target="#nplIcon" direction="bottom" class="style-scope search-box" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      Include non-patent literature
    </div>
  </overlay-tooltip>
          <keyword-wizard id="wizardIcon" class="style-scope search-box">


<div id="wizardContainer" class="style-scope keyword-wizard">
  <iron-icon icon="image:tune" id="wizardIcon" class="style-scope keyword-wizard x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M3 17v2h6v-2H3zM3 5v2h10V5H3zm10 16v-2h8v-2h-8v-2h-2v6h2zM7 9v2H3v2h4v2h2V9H7zm14 4v-2H11v2h10zm-6-4h2V7h4V5h-4V3h-2v6z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
  <paper-material elevation="2" id="wizard" class="style-scope keyword-wizard x-scope paper-material-0" hidden="">
    
    

    
    
    <div class="search-within style-scope keyword-wizard">
      <span class="wizard-header style-scope keyword-wizard">
        Search within
        <iron-icon icon="icons:help-outline" class="help-header style-scope keyword-wizard x-scope iron-icon-0" id="within"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M11 18h2v-2h-2v2zm1-16C6.48 2 2 6.48 2 12s4.48 10 10 10 10-4.48 10-10S17.52 2 12 2zm0 18c-4.41 0-8-3.59-8-8s3.59-8 8-8 8 3.59 8 8-3.59 8-8 8zm0-14c-2.21 0-4 1.79-4 4h2c0-1.1.9-2 2-2s2 .9 2 2c0 2-3 1.75-3 5h2c0-2.25 3-2.5 3-5 0-2.21-1.79-4-4-4z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      </span>
      
      <div class="help style-scope keyword-wizard" id="withinHelp" hidden="">
        <p class="style-scope keyword-wizard"><b class="style-scope keyword-wizard">Search within the title, abstract, claims, or full patent document</b>: You can
          restrict your search to a specific field using field names.</p>
        <p class="style-scope keyword-wizard">Use <span class="q style-scope keyword-wizard">TI=</span> to search in the title, <span class="q style-scope keyword-wizard">AB=</span> for the
          abstract, <span class="q style-scope keyword-wizard">CL=</span> for the claims, or <span class="q style-scope keyword-wizard">TAC=</span> for
          all three. For example, <span class="q style-scope keyword-wizard">TI=(safety belt)</span>.
        </p>
        <p class="style-scope keyword-wizard"><b class="style-scope keyword-wizard">Search by Cooperative Patent Classifications (CPCs)</b>: These are commonly used to
          represent ideas in place of keywords, and can also be entered in a search term box. If
          you're searching for<span class="q style-scope keyword-wizard">seat belts</span>, you could also search for
          <span class="q style-scope keyword-wizard">B60R22/00</span> to retrieve documents that mention safety belts or body
          harnesses. <span class="q style-scope keyword-wizard">CPC=B60R22</span> will match documents with exactly this CPC,
          <span class="q style-scope keyword-wizard">CPC=B60R22/low</span> matches documents with this CPC or a child
          classification of this CPC.
        </p>
          <a href="https://support.google.com/faqs/answer/7049475" target="_blank" class="style-scope keyword-wizard">Learn More</a>
      </div>
      <div class="filter-chips style-scope keyword-wizard">
        <span class="chip style-scope keyword-wizard" id="title" selected="">Title</span>
        <span class="chip style-scope keyword-wizard" id="abstract" selected="">Abstract</span>
        <span class="chip style-scope keyword-wizard" id="claims" selected="">Claims</span>
        <span class="chip style-scope keyword-wizard" id="fullDoc" selected="">Full Document</span>
      </div>
      
      <div class="cpc-field style-scope keyword-wizard">
        <span class="input-label style-scope keyword-wizard"><label for="inputCPC" class="style-scope keyword-wizard">or CPC</label></span>
        <div class="cpc-inputs style-scope keyword-wizard">
          <input class="keyword-input style-scope keyword-wizard" id="inputCPC" placeholder="Or search with CPC">
          <input type="checkbox" id="childCPC" checked="" class="style-scope keyword-wizard">
          <label class="checkbox-label style-scope keyword-wizard" for="childCPC">
            Include child classifications
          </label>
        </div>
      </div>
    </div>
    
    <div class="find-patents style-scope keyword-wizard">
      <span class="wizard-header style-scope keyword-wizard">
        Find patents
        <iron-icon class="help-header style-scope keyword-wizard x-scope iron-icon-0" icon="icons:help-outline" id="searchBoolean"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M11 18h2v-2h-2v2zm1-16C6.48 2 2 6.48 2 12s4.48 10 10 10 10-4.48 10-10S17.52 2 12 2zm0 18c-4.41 0-8-3.59-8-8s3.59-8 8-8 8 3.59 8 8-3.59 8-8 8zm0-14c-2.21 0-4 1.79-4 4h2c0-1.1.9-2 2-2s2 .9 2 2c0 2-3 1.75-3 5h2c0-2.25 3-2.5 3-5 0-2.21-1.79-4-4-4z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      </span>
      
      <div class="help style-scope keyword-wizard" id="searchBooleanHelp" hidden="">
        <p class="style-scope keyword-wizard"><b class="style-scope keyword-wizard">Keywords and boolean syntax (USPTO or EPO format)</b>:
          <span class="q style-scope keyword-wizard">seat belt</span> searches these two words, or their plurals and close
          synonyms. <span class="q style-scope keyword-wizard">"seat belt"</span> searches this exact phrase, in order.
          <span class="q style-scope keyword-wizard">-seat -belt</span> searches for documents not containing either word.
        </p>
        <p class="style-scope keyword-wizard"><b class="style-scope keyword-wizard">For searches using boolean logic</b>, the default operator is
          <span class="q style-scope keyword-wizard">AND</span> with left associativity. <i class="style-scope keyword-wizard">Note:</i> this means
          <span class="q style-scope keyword-wizard">safety OR seat belt</span> is searched as <span class="q style-scope keyword-wizard">(safety OR seat)
          AND belt</span>. Each word automatically includes plurals and close synonyms. Adjacent
          words that are implicitly ANDed together, such as <span class="q style-scope keyword-wizard">(safety belt)</span>,
          are treated as a phrase when generating synonyms.
        </p>
        <a href="https://support.google.com/faqs/answer/7049475" target="_blank" class="style-scope keyword-wizard">Learn More</a>
      </div>
      <div class="style-scope keyword-wizard">
        <span class="input-label style-scope keyword-wizard"><label for="inputAnd" class="style-scope keyword-wizard">with ALL of the words</label></span>
        <input class="keyword-input style-scope keyword-wizard" id="inputAnd" placeholder="with ALL of the words">
      </div>
      <div class="style-scope keyword-wizard">
        <span class="input-label style-scope keyword-wizard"><label for="inputExact" class="style-scope keyword-wizard">with the EXACT PHRASE</label></span>
        <input class="keyword-input style-scope keyword-wizard" id="inputExact" placeholder="with the EXACT PHRASE"></div>
      <div class="style-scope keyword-wizard">
        <span class="input-label style-scope keyword-wizard"><label for="inputOr" class="style-scope keyword-wizard">with AT LEAST ONE of the words</label></span>
        <input class="keyword-input style-scope keyword-wizard" id="inputOr" placeholder="with AT LEAST ONE of the words"></div>
      <div class="style-scope keyword-wizard">
        <span class="input-label style-scope keyword-wizard"><label for="inputMinus" class="style-scope keyword-wizard">WITHOUT the words</label></span>
        <input class="keyword-input style-scope keyword-wizard" id="inputMinus" placeholder="WITHOUT the words"></div>
    </div>
    <div class="search-by style-scope keyword-wizard">
      <div class="wizard-header style-scope keyword-wizard">
          Search by
          <iron-icon icon="icons:help-outline" class="help-header style-scope keyword-wizard x-scope iron-icon-0" id="chem"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M11 18h2v-2h-2v2zm1-16C6.48 2 2 6.48 2 12s4.48 10 10 10 10-4.48 10-10S17.52 2 12 2zm0 18c-4.41 0-8-3.59-8-8s3.59-8 8-8 8 3.59 8 8-3.59 8-8 8zm0-14c-2.21 0-4 1.79-4 4h2c0-1.1.9-2 2-2s2 .9 2 2c0 2-3 1.75-3 5h2c0-2.25 3-2.5 3-5 0-2.21-1.79-4-4-4z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      </div>
      
      <div class="help style-scope keyword-wizard" id="chemHelp" hidden="">
        <p class="style-scope keyword-wizard"><b class="style-scope keyword-wizard">Chemistry searches</b> match terms (trade names, IUPAC names, etc.
          extracted from the entire document, and processed from .MOL files.)
        </p>
        <p class="style-scope keyword-wizard">Substructure (use <span class="q style-scope keyword-wizard">SSS=</span>) and similarity (use
          <span class="q style-scope keyword-wizard">~</span>) searches are limited to one per search at the top-level
          <span class="q style-scope keyword-wizard">AND</span> condition. Exact searches can be used multiple times throughout
          the search query.
        </p>
        <p class="style-scope keyword-wizard">Searching by SMILES or InChi key requires no special syntax. To search by SMARTS, use
          <span class="q style-scope keyword-wizard">SMARTS=</span>.
        </p>
        <p class="style-scope keyword-wizard">To search for multiple molecules, select "Batch" in the "Type" menu. Enter multiple
          molecules separated by whitespace or by comma.
        </p>
        <a href="https://support.google.com/faqs/answer/7049475" target="_blank" class="style-scope keyword-wizard">Learn More</a>
      </div>
      
      <div class="chemistry-field style-scope keyword-wizard">
          <span class="input-label style-scope keyword-wizard"><label for="inputChem" class="style-scope keyword-wizard">Chemistry</label></span>
          <span class="chem-type-label style-scope keyword-wizard"><label for="chemType" hidden="" class="style-scope keyword-wizard">Type</label></span>
          <select id="chemType" class="style-scope keyword-wizard">
            <option value="identical" class="style-scope keyword-wizard">Identical</option>
            <option value="substructure" class="style-scope keyword-wizard">Substructure</option>
            <option value="smarts" class="style-scope keyword-wizard">SMARTS</option>
            <option value="similarity" class="style-scope keyword-wizard">Similarity</option>
            <option value="batch" class="style-scope keyword-wizard">Batch</option>
          </select>
          <textarea class="keyword-input style-scope keyword-wizard" id="inputChem" placeholder="Trade name, SMILES, InChiKey"></textarea>
      </div>
      <div class="import style-scope keyword-wizard">
        <div class="wizard-header style-scope keyword-wizard">
          Patent numbers
        </div>
        <span class="import-button style-scope keyword-wizard">
          <a href="https://patents.google.com/import" class="style-scope keyword-wizard"><button class="style-scope keyword-wizard">Import</button></a>
        </span>
        <p class="import-text style-scope keyword-wizard">
          Search specific patents by importing a CSV or list of patent publication or application numbers.
        </p>
      </div>
    </div>
    
    <div class="wizard-buttons style-scope keyword-wizard">
      <button type="reset" class="style-scope keyword-wizard">Close</button>
      <button type="button" autofocus="" class="style-scope keyword-wizard">Add</button>
    </div>
  
  </paper-material>
</div>
</keyword-wizard>
          <overlay-tooltip positioning-target="#wizardIcon" direction="bottom" class="style-scope search-box" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      Display advanced search options
    </div>
  </overlay-tooltip>
        </div>
      </div>
      <paper-material id="suggestMenu" class="style-scope search-box x-scope paper-material-0" elevation="1" hidden="">
    
    

    
        <template is="dom-repeat" class="style-scope search-box"></template>
        <div class="row style-scope search-box" hidden="">
          <iron-icon class="suggest-icon style-scope search-box x-scope iron-icon-0" icon="error"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M12 2C6.48 2 2 6.48 2 12s4.48 10 10 10 10-4.48 10-10S17.52 2 12 2zm1 15h-2v-2h2v2zm0-4h-2V7h2v6z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon> Sorry, we couldn't find this patent number.
        </div>
        <div class="row style-scope search-box" hidden="">
          <iron-icon class="suggest-icon style-scope search-box x-scope iron-icon-0" icon="error"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M12 2C6.48 2 2 6.48 2 12s4.48 10 10 10 10-4.48 10-10S17.52 2 12 2zm1 15h-2v-2h2v2zm0-4h-2V7h2v6z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon> 
        </div>
      
  </paper-material>
      <button id="searchButton" class="style-scope search-box"><iron-icon class="style-scope search-box x-scope iron-icon-0" icon="search"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M15.5 14h-.79l-.28-.27C15.41 12.59 16 11.11 16 9.5 16 5.91 13.09 3 9.5 3S3 5.91 3 9.5 5.91 16 9.5 16c1.61 0 3.09-.59 4.23-1.57l.27.28v.79l5 4.99L20.49 19l-4.99-5zm-6 0C7.01 14 5 11.99 5 9.5S7.01 5 9.5 5 14 7.01 14 9.5 11.99 14 9.5 14z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon></button>
    </div>
  </search-box>
          <template is="dom-if" class="style-scope search-header"></template>
          <div class="flex style-scope search-header"></div>
          
            <div id="header-container" class="style-scope search-header">
              <result-nav class="style-scope search-header">
    
    <div class="style-scope result-nav" hidden="">
      <state-modifier id="current" act="{&quot;type&quot;: &quot;BACK_TO_RESULTS&quot;}" inherit="" class="style-scope result-nav"><a id="link" href="#" class="style-scope state-modifier" inherit=""><span class="style-scope result-nav"></span> of
      <template is="dom-if" class="style-scope result-nav"></template>
      0<template is="dom-if" class="style-scope result-nav"></template></a></state-modifier>
      <state-modifier id="prevResult" inherit="" act="{&quot;type&quot;: &quot;NAV_RESULT&quot;, &quot;result&quot;: &quot;$id&quot;, &quot;page&quot;: $page}" class="style-scope result-nav" disabled=""><a id="link" href="#" class="style-scope state-modifier" inherit="">
        <iron-icon icon="chevron-left" class="style-scope result-nav x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M15.41 7.41L14 6l-6 6 6 6 1.41-1.41L10.83 12z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      </a></state-modifier><state-modifier id="nextResult" inherit="" act="{&quot;type&quot;: &quot;NAV_RESULT&quot;, &quot;result&quot;: &quot;$id&quot;, &quot;page&quot;: $page}" class="style-scope result-nav" disabled=""><a id="link" href="#" class="style-scope state-modifier" inherit="">
        <iron-icon icon="chevron-right" class="style-scope result-nav x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M10 6L8.59 7.41 13.17 12l-4.58 4.59L10 18l6-6z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      </a></state-modifier>
      <overlay-tooltip positioning-target="#prevResult" direction="bottom" arrow="" class="style-scope result-nav" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip"></div>
    <div class="style-scope overlay-tooltip">
      Previous result
    </div>
  </overlay-tooltip>
      <overlay-tooltip positioning-target="#nextResult" direction="bottom" arrow="" class="style-scope result-nav" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip"></div>
    <div class="style-scope overlay-tooltip">
      Next result
    </div>
  </overlay-tooltip>
    </div>
  </result-nav>
            </div>
          <template is="dom-if" class="style-scope search-header"></template>
        </div>
      </header>
    </div>
  </search-header>

      <div class="layout horizontal style-scope search-ui">
        <template is="dom-if" class="style-scope search-ui"></template>

        <div id="main" class="style-scope search-ui">
          <search-term-wizard class="style-scope search-ui"><pat-dialog open="" class="style-scope search-term-wizard">
  <span class="header style-scope search-term-wizard">
    <span class="title style-scope search-term-wizard">Search tools</span>
    <span id="language" class="style-scope search-term-wizard">
      <text-button id="textButton" selected="" class="style-scope search-term-wizard">Text
</text-button>
      <text-button id="classificationButton" class="style-scope search-term-wizard">Classification
</text-button>
      <text-button id="chemistryButton" class="style-scope search-term-wizard">Chemistry
</text-button>
      <text-button id="measureButton" class="style-scope search-term-wizard">Measure
</text-button>
      <text-button id="numbersButton" class="style-scope search-term-wizard">Numbers
</text-button>
    </span>
  </span>
  <span id="panels" class="style-scope search-term-wizard">
    <text-search-term-wizard id="textPanel" class="style-scope search-term-wizard" selected=""><span class="style-scope text-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope text-search-term-wizard">
    <path d="M3.85 15.275V13h10.3v2.275Zm0-4.275V8.725h16.3V11Z" class="style-scope text-search-term-wizard"></path>
  </svg>
  <outlined-text-field id="textField" placeholder="Type a concept you want to search for here" class="style-scope text-search-term-wizard" value=""><span class="style-scope outlined-text-field">
  <input id="input" spellcheck="false" autocomplete="off" class="style-scope outlined-text-field" aria-disabled="false" placeholder="Type a concept you want to search for here">
  
</span>
</outlined-text-field>
</span>
<span class="style-scope text-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope text-search-term-wizard">
    <path d="M8 18.025h8v-2.1H8Zm0-4h8v-2.1H8ZM6.075 22.2q-.95 0-1.612-.662-.663-.663-.663-1.613V4.075q0-.95.663-1.613.662-.662 1.612-.662h8L20.2 7.925v12q0 .95-.662 1.613-.663.662-1.613.662Zm6.85-13.125v-5h-6.85v15.85h11.85V9.075Zm-6.85-5v5-5 15.85-15.85Z" class="style-scope text-search-term-wizard"></path>
  </svg>
  <filter-chip id="fullDocuments" selected="" class="style-scope text-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Full documents</filter-chip>
  <filter-chip id="title" class="style-scope text-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Title</filter-chip>
  <filter-chip id="abstract" class="style-scope text-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Abstract</filter-chip>
  <filter-chip id="claims" class="style-scope text-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Claims</filter-chip>
</span>
<span class="style-scope text-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope text-search-term-wizard">
    <path d="M16 16.925q2.05 0 3.488-1.437Q20.925 14.05 20.925 12t-1.437-3.488Q18.05 7.075 16 7.075q-.625 0-1.2.15t-1.075.425q.7.925 1.087 2.025.388 1.1.388 2.325t-.388 2.325q-.387 1.1-1.087 2.025.5.275 1.075.425.575.15 1.2.15Zm-4-2.075q.45-.575.688-1.313.237-.737.237-1.537 0-.8-.237-1.538Q12.45 9.725 12 9.15q-.45.575-.688 1.312-.237.738-.237 1.538t.237 1.537q.238.738.688 1.313Zm-4 2.075q.625 0 1.2-.15t1.075-.425q-.7-.925-1.087-2.025Q8.8 13.225 8.8 12t.388-2.325q.387-1.1 1.087-2.025-.5-.275-1.075-.425-.575-.15-1.2-.15-2.05 0-3.487 1.437Q3.075 9.95 3.075 12t1.438 3.488Q5.95 16.925 8 16.925ZM8 19.2q-3 0-5.1-2.1Q.8 15 .8 12q0-3 2.1-5.1Q5 4.8 8 4.8q1.125 0 2.137.312 1.013.313 1.863.913.85-.6 1.863-.913Q14.875 4.8 16 4.8q3 0 5.1 2.1Q23.2 9 23.2 12q0 3-2.1 5.1-2.1 2.1-5.1 2.1-1.125 0-2.137-.313-1.013-.312-1.863-.912-.85.6-1.863.912Q9.125 19.2 8 19.2Z" class="style-scope text-search-term-wizard"></path>
  </svg>
  <filter-chip id="all" selected="" class="style-scope text-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
All</filter-chip>
  <filter-chip id="any" class="style-scope text-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Any</filter-chip>
  <filter-chip id="exact" class="style-scope text-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Exact</filter-chip>
  <filter-chip id="not" class="style-scope text-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Not</filter-chip>
</span>
<span class="style-scope text-search-term-wizard">
  <mat-button id="button" filled="" class="style-scope text-search-term-wizard x-scope mat-button-0" disabled=""><span slot="label" class="style-scope text-search-term-wizard">Add AND condition</span></mat-button></span></text-search-term-wizard>
    <classification-wizard id="classificationPanel" class="style-scope search-term-wizard"><span class="style-scope classification-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope classification-wizard">
    <path d="M3.85 15.275V13h10.3v2.275Zm0-4.275V8.725h16.3V11Z" class="style-scope classification-wizard"></path>
  </svg>
  <outlined-text-field id="textField" placeholder="Enter a CPC here" uppercase="" class="style-scope classification-wizard" value=""><span class="style-scope outlined-text-field">
  <input id="input" spellcheck="false" autocomplete="off" class="style-scope outlined-text-field" aria-disabled="false" placeholder="Enter a CPC here">
  
</span>
</outlined-text-field>
</span>
<template is="dom-if" class="style-scope classification-wizard"></template>
<template is="dom-if" class="style-scope classification-wizard"></template>
<template is="dom-if" class="style-scope classification-wizard"></template>
<span class="style-scope classification-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope classification-wizard">
    <path d="M16 16.925q2.05 0 3.488-1.437Q20.925 14.05 20.925 12t-1.437-3.488Q18.05 7.075 16 7.075q-.625 0-1.2.15t-1.075.425q.7.925 1.087 2.025.388 1.1.388 2.325t-.388 2.325q-.387 1.1-1.087 2.025.5.275 1.075.425.575.15 1.2.15Zm-4-2.075q.45-.575.688-1.313.237-.737.237-1.537 0-.8-.237-1.538Q12.45 9.725 12 9.15q-.45.575-.688 1.312-.237.738-.237 1.538t.237 1.537q.238.738.688 1.313Zm-4 2.075q.625 0 1.2-.15t1.075-.425q-.7-.925-1.087-2.025Q8.8 13.225 8.8 12t.388-2.325q.387-1.1 1.087-2.025-.5-.275-1.075-.425-.575-.15-1.2-.15-2.05 0-3.487 1.437Q3.075 9.95 3.075 12t1.438 3.488Q5.95 16.925 8 16.925ZM8 19.2q-3 0-5.1-2.1Q.8 15 .8 12q0-3 2.1-5.1Q5 4.8 8 4.8q1.125 0 2.137.312 1.013.313 1.863.913.85-.6 1.863-.913Q14.875 4.8 16 4.8q3 0 5.1 2.1Q23.2 9 23.2 12q0 3-2.1 5.1-2.1 2.1-5.1 2.1-1.125 0-2.137-.313-1.013-.312-1.863-.912-.85.6-1.863.912Q9.125 19.2 8 19.2Z" class="style-scope classification-wizard"></path>
  </svg>
  <filter-chip id="notExact" class="style-scope classification-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>

    These CPCs and their children
  </filter-chip>
  <filter-chip selected="" id="exact" class="style-scope classification-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>

    These exact CPCs
  </filter-chip>
</span>
<span class="style-scope classification-wizard">
  <mat-button id="button" filled="" class="style-scope classification-wizard x-scope mat-button-0" disabled=""><span slot="label" class="style-scope classification-wizard">Add AND condition</span></mat-button>
</span></classification-wizard>
    <chemistry-search-term-wizard id="chemistryPanel" class="style-scope search-term-wizard"><span class="style-scope chemistry-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope chemistry-search-term-wizard">
    <path d="M3.85 15.275V13h10.3v2.275Zm0-4.275V8.725h16.3V11Z" class="style-scope chemistry-search-term-wizard"></path>
  </svg>
  <outlined-text-field id="textField" placeholder="Trade name, SMILES, InChI Key" class="style-scope chemistry-search-term-wizard" value=""><span class="style-scope outlined-text-field">
  <input id="input" spellcheck="false" autocomplete="off" class="style-scope outlined-text-field" aria-disabled="false" placeholder="Trade name, SMILES, InChI Key">
  
</span>
</outlined-text-field>
  <outlined-textarea id="textArea" placeholder="Enter multiple SMILES or InChI Keys, one per line" rows="4" class="style-scope chemistry-search-term-wizard"><span class="style-scope outlined-textarea">
  <textarea id="textarea" autocomplete="off" autocorrect="off" spellcheck="false" tabindex="0" aria-disabled="false" wrap="soft" class="style-scope outlined-textarea" rows="4" placeholder="Enter multiple SMILES or InChI Keys, one per line">  </textarea>
  <div id="helperText" class="style-scope outlined-textarea"> </div>
</span>
<span class="right-button-container style-scope outlined-textarea">
  
</span>
</outlined-textarea>
  <a href="https://support.google.com/faqs/answer/7049475#zippy=%2Csearching-by-chemistry" target="_blank" class="style-scope chemistry-search-term-wizard">
    <svg class="help style-scope chemistry-search-term-wizard" xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49">
      <path d="M11.95 18q.525 0 .888-.363.362-.362.362-.887t-.362-.887q-.363-.363-.888-.363t-.888.363q-.362.362-.362.887t.362.887q.363.363.888.363Zm-.9-3.85h1.85q0-.825.188-1.3.187-.475 1.062-1.3.65-.65 1.025-1.238.375-.587.375-1.412 0-1.4-1.025-2.15T12.1 6q-1.425 0-2.312.75-.888.75-1.238 1.8l1.65.65q.125-.45.563-.975Q11.2 7.7 12.1 7.7q.8 0 1.2.437.4.438.4.963 0 .5-.3.937-.3.438-.75.813-1.1.975-1.35 1.475-.25.5-.25 1.825ZM12 22q-2.075 0-3.9-.788-1.825-.787-3.175-2.137-1.35-1.35-2.137-3.175Q2 14.075 2 12t.788-3.9q.787-1.825 2.137-3.175 1.35-1.35 3.175-2.138Q9.925 2 12 2t3.9.787q1.825.788 3.175 2.138 1.35 1.35 2.137 3.175Q22 9.925 22 12t-.788 3.9q-.787 1.825-2.137 3.175-1.35 1.35-3.175 2.137Q14.075 22 12 22Zm0-2q3.35 0 5.675-2.325Q20 15.35 20 12q0-3.35-2.325-5.675Q15.35 4 12 4 8.65 4 6.325 6.325 4 8.65 4 12q0 3.35 2.325 5.675Q8.65 20 12 20Zm0-8Z" class="style-scope chemistry-search-term-wizard"></path>
    </svg>
  </a>
</span>
<span id="chemQuantifiers" class="style-scope chemistry-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope chemistry-search-term-wizard">
    <path d="M5 21.2q-1.4 0-2-1.25-.6-1.25.3-2.325l5.5-6.7V5.15h-.825q-.475 0-.8-.338Q6.85 4.475 6.85 4q0-.475.325-.813.325-.337.8-.337h8.05q.475 0 .8.337.325.338.325.813 0 .475-.325.812-.325.338-.8.338H15.2v5.775l5.5 6.7q.9 1.075.3 2.325-.6 1.25-2 1.25Zm2.15-3.275h9.7l-3.275-3.85h-3.15Zm-2 1h13.7l-5.925-7.2V5.15h-1.85v6.575Zm6.85-6.9Z" class="style-scope chemistry-search-term-wizard"></path>
  </svg>
  <filter-chip id="exact" selected="" class="style-scope chemistry-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Exact</filter-chip>
  <filter-chip id="exactBatch" class="style-scope chemistry-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Exact Batch</filter-chip>
  <filter-chip id="similar" class="style-scope chemistry-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Similar</filter-chip>
  <filter-chip id="substructure" class="style-scope chemistry-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Substructure</filter-chip>
  <filter-chip id="smarts" class="style-scope chemistry-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Substructure (SMARTS)</filter-chip>
</span>
<span id="location" class="style-scope chemistry-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope chemistry-search-term-wizard">
    <path d="M8 18.025h8v-2.1H8Zm0-4h8v-2.1H8ZM6.075 22.2q-.95 0-1.612-.662-.663-.663-.663-1.613V4.075q0-.95.663-1.613.662-.662 1.612-.662h8L20.2 7.925v12q0 .95-.662 1.613-.663.662-1.613.662Zm6.85-13.125v-5h-6.85v15.85h11.85V9.075Zm-6.85-5v5-5 15.85-15.85Z" class="style-scope chemistry-search-term-wizard"></path>
  </svg>
  <filter-chip id="fullDocuments" selected="" class="style-scope chemistry-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Full documents</filter-chip>
  <filter-chip id="claims" class="style-scope chemistry-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Claims only</filter-chip>
</span>
<span class="style-scope chemistry-search-term-wizard">
  <mat-button id="button" filled="" class="style-scope chemistry-search-term-wizard x-scope mat-button-0" disabled=""><span slot="label" class="style-scope chemistry-search-term-wizard">Add AND condition</span></mat-button>
</span>
</chemistry-search-term-wizard>
    <measure-search-term-wizard id="measurePanel" class="style-scope search-term-wizard"><span class="style-scope measure-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope measure-search-term-wizard">
    <path d="M4.1 18.15q-.95 0-1.612-.663-.663-.662-.663-1.612v-7.75q0-.95.663-1.613Q3.15 5.85 4.1 5.85h15.8q.95 0 1.613.662.662.663.662 1.613v7.75q0 .95-.662 1.612-.663.663-1.613.663Zm0-2.275h15.8v-7.75H17V12h-2V8.125h-2V12h-2V8.125H9V12H7V8.125H4.1v7.75ZM7 12h2Zm4 0h2Zm4 0h2Zm-3 0Z" class="style-scope measure-search-term-wizard"></path>
  </svg>
  <outlined-text-field id="measureExpression" placeholder="1.5 mm, 20 ft, 400-500 fahrenheit, 800 MHz, 0.01-100 mol" class="style-scope measure-search-term-wizard" value=""><span class="style-scope outlined-text-field">
  <input id="input" spellcheck="false" autocomplete="off" class="style-scope outlined-text-field" aria-disabled="false" placeholder="1.5 mm, 20 ft, 400-500 fahrenheit, 800 MHz, 0.01-100 mol">
  
</span>
</outlined-text-field>
</span>
<span class="style-scope measure-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope measure-search-term-wizard">
    <path d="M3.875 20.15V8.85h4.25v11.3Zm6 0V3.85h4.25v16.3Zm6 0v-7.3h4.25v7.3Z" class="style-scope measure-search-term-wizard"></path>
  </svg>
  <outlined-text-field id="context" placeholder="activity, wavelength, embossing depth, absorption" class="style-scope measure-search-term-wizard" value=""><span class="style-scope outlined-text-field">
  <input id="input" spellcheck="false" autocomplete="off" class="style-scope outlined-text-field" aria-disabled="false" placeholder="activity, wavelength, embossing depth, absorption">
  
</span>
</outlined-text-field>
</span>
<span class="style-scope measure-search-term-wizard">
  <mat-button id="button" filled="" class="style-scope measure-search-term-wizard x-scope mat-button-0" disabled=""><span slot="label" class="style-scope measure-search-term-wizard">Add AND condition</span></mat-button>
</span>
</measure-search-term-wizard>
    <numerical-search-term-wizard id="numericalPanel" class="style-scope search-term-wizard"><span class="style-scope numerical-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope numerical-search-term-wizard">
    <path d="M3.85 15.275V13h10.3v2.275Zm0-4.275V8.725h16.3V11Z" class="style-scope numerical-search-term-wizard"></path>
  </svg>
  <outlined-textarea id="batch" placeholder="Enter multiple Patent Application and Publication Numbers, one per line" rows="4" class="style-scope numerical-search-term-wizard"><span class="style-scope outlined-textarea">
  <textarea id="textarea" autocomplete="off" autocorrect="off" spellcheck="false" tabindex="0" aria-disabled="false" wrap="soft" class="style-scope outlined-textarea" rows="4" placeholder="Enter multiple Patent Application and Publication Numbers, one per line">  </textarea>
  <div id="helperText" class="style-scope outlined-textarea"> </div>
</span>
<span class="right-button-container style-scope outlined-textarea">
  
</span>
</outlined-textarea>
</span>
<template is="dom-if" class="style-scope numerical-search-term-wizard"></template>
<template is="dom-if" class="style-scope numerical-search-term-wizard"></template>
<span class="style-scope numerical-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope numerical-search-term-wizard">
    <path d="m10.825 23.45-1.6-1.625L10.9 20.15H8q-.35.9-1.162 1.488-.813.587-1.838.587-1.35 0-2.287-.937-.938-.938-.938-2.288 0-1.025.588-1.837Q2.95 16.35 3.85 16V8q-.9-.35-1.487-1.163Q1.775 6.025 1.775 5q0-1.35.938-2.288Q3.65 1.775 5 1.775q1.025 0 1.838.587Q7.65 2.95 8 3.85h2.9L9.225 2.175l1.6-1.625L15.275 5l-4.45 4.45-1.6-1.625L10.9 6.15H8q-.25.65-.725 1.125T6.15 8v8q.65.25 1.125.725T8 17.85h2.9l-1.675-1.675 1.6-1.625 4.45 4.45ZM19 22.225q-1.35 0-2.287-.937-.938-.938-.938-2.288 0-1.05.588-1.863.587-.812 1.487-1.137V8q-.9-.325-1.487-1.137-.588-.813-.588-1.863 0-1.35.938-2.288.937-.937 2.287-.937 1.35 0 2.288.937.937.938.937 2.288 0 1.05-.587 1.863Q21.05 7.675 20.15 8v8q.9.35 1.488 1.163.587.812.587 1.837 0 1.35-.937 2.288-.938.937-2.288.937ZM5 19.95q.4 0 .675-.275T5.95 19q0-.4-.275-.675T5 18.05q-.4 0-.675.275T4.05 19q0 .4.275.675T5 19.95Zm14 0q.4 0 .675-.275T19.95 19q0-.4-.275-.675T19 18.05q-.4 0-.675.275T18.05 19q0 .4.275.675t.675.275Zm-14-14q.4 0 .675-.275T5.95 5q0-.4-.275-.675T5 4.05q-.4 0-.675.275T4.05 5q0 .4.275.675T5 5.95Zm14 0q.4 0 .675-.275T19.95 5q0-.4-.275-.675T19 4.05q-.4 0-.675.275T18.05 5q0 .4.275.675T19 5.95ZM5 19Zm14 0ZM5 5Zm14 0Z" class="style-scope numerical-search-term-wizard"></path>
  </svg>
  <filter-chip id="applicationNumbers" class="style-scope numerical-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Application Numbers</filter-chip>
  <filter-chip id="publicationNumbers" class="style-scope numerical-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Publication Numbers</filter-chip>
  <filter-chip id="either" selected="" class="style-scope numerical-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Either</filter-chip>
</span>
<span class="style-scope numerical-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope numerical-search-term-wizard">
    <path d="M12 22.2q-2.1 0-3.962-.8-1.863-.8-3.25-2.175Q3.4 17.85 2.6 15.988 1.8 14.125 1.8 12t.8-3.988q.8-1.862 2.188-3.237Q6.175 3.4 8.038 2.6 9.9 1.8 12 1.8q2.125 0 3.988.8 1.862.8 3.237 2.175Q20.6 6.15 21.4 8.012q.8 1.863.8 3.988t-.8 3.988q-.8 1.862-2.175 3.237Q17.85 20.6 15.988 21.4q-1.863.8-3.988.8Zm-1-2.325v-1.95q-.8 0-1.387-.575-.588-.575-.588-1.4v-.975L4.275 10.2q-.075.45-.137.9-.063.45-.063.9 0 3 1.975 5.25T11 19.875Zm6.85-2.525q.5-.55.888-1.175.387-.625.65-1.313.262-.687.4-1.412.137-.725.137-1.45 0-2.425-1.338-4.438-1.337-2.012-3.612-2.887v.375q0 .825-.587 1.4-.588.575-1.388.575h-2v2q0 .4-.287.687-.288.288-.688.288h-2v2h5.95q.425 0 .713.287.287.288.287.688v2.975h1q.65 0 1.163.387.512.388.712 1.013Z" class="style-scope numerical-search-term-wizard"></path>
  </svg>
  <outlined-text-field id="countryFilter" placeholder="Restrict search to these countries" class="style-scope numerical-search-term-wizard" value=""><span class="style-scope outlined-text-field">
  <input id="input" spellcheck="false" autocomplete="off" class="style-scope outlined-text-field" aria-disabled="false" placeholder="Restrict search to these countries">
  
</span>
</outlined-text-field>
</span>
<span class="style-scope numerical-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope numerical-search-term-wizard">
    <path d="M2.85 18.225V15.95h6.3v2.275Zm0-5.075v-2.3h12.3v2.3Zm0-5.1V5.775h18.3V8.05Z" class="style-scope numerical-search-term-wizard"></path>
  </svg>
  <outlined-text-field id="countryOrder" placeholder="Prefer results from these countries in this order" class="style-scope numerical-search-term-wizard" value="US, EP, WO, JP, CN"><span class="style-scope outlined-text-field">
  <input id="input" spellcheck="false" autocomplete="off" class="style-scope outlined-text-field" aria-disabled="false" placeholder="Prefer results from these countries in this order">
  
</span>
</outlined-text-field>
</span>
<span class="style-scope numerical-search-term-wizard">
  <mat-button id="button" filled="" class="style-scope numerical-search-term-wizard x-scope mat-button-0" disabled=""><span slot="label" class="style-scope numerical-search-term-wizard">Add AND condition</span></mat-button>
</span>
</numerical-search-term-wizard>
  </span>

</pat-dialog>
</search-term-wizard>
          
      <div content="" class="style-scope search-result">
        <div id="mainContainer" class="vertical layout style-scope search-result">
          <template is="dom-if" class="style-scope search-result"></template>
          <result-container class="style-scope search-result">
    

    <paper-spinner class="style-scope result-container x-scope paper-spinner-0" aria-hidden="true" hidden=""><div id="spinnerContainer" class="  style-scope paper-spinner"><div class="spinner-layer layer-1 style-scope paper-spinner"><div class="circle-clipper left style-scope paper-spinner"></div><div class="circle-clipper right style-scope paper-spinner"></div></div><div class="spinner-layer layer-2 style-scope paper-spinner"><div class="circle-clipper left style-scope paper-spinner"></div><div class="circle-clipper right style-scope paper-spinner"></div></div><div class="spinner-layer layer-3 style-scope paper-spinner"><div class="circle-clipper left style-scope paper-spinner"></div><div class="circle-clipper right style-scope paper-spinner"></div></div><div class="spinner-layer layer-4 style-scope paper-spinner"><div class="circle-clipper left style-scope paper-spinner"></div><div class="circle-clipper right style-scope paper-spinner"></div></div></div></paper-spinner>
    
      <patent-result class="style-scope result-container">
    
    
    <div class="layout horizontal style-scope patent-result">
      <div style="width: 1200px; height: auto; overflow: auto;" class="style-scope patent-result">
        <div id="wrapper" tabindex="0" class="style-scope patent-result">
          <result-tags class="style-scope patent-result"></result-tags>
          <h1 id="title" class="scroll-target style-scope patent-result">
            Pyrrolobenzodiazepines Zhuo and its conjugate 
       </h1>
          <div class="horizontal layout style-scope patent-result">
            
            <div class="flex-3 style-scope patent-result" style="margin-top:-20px;overflow:hidden;" marginright="">
              <section id="abstract" class="style-scope patent-result">
                <h3 class="layout horizontal style-scope patent-result">
                  <div class="flex style-scope patent-result">Abstract</div>
                  <div class="righthead style-scope patent-result" hidden="">translated from </div>
                </h3>
                <patent-text name="abstract" class="style-scope patent-result" style="padding-top: 0px;">
    
    
    <template is="dom-if" restamp="" class="style-scope patent-text"></template>
    <overlay-tooltip id="tooltip" class="style-scope patent-text" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
    </div>
  </overlay-tooltip>
    <div class="layout horizontal style-scope patent-text">
      <section id="text" class="flex style-scope patent-text"><abstract mxw-id="PA342145717" lang="EN" load-source="patent-office" class="style-scope patent-text">
    <div num="0001" class="abstract style-scope patent-text">The present invention relates to Pyrrolobenzodiazepines Zhuo and its conjugates.Specifically, the present invention relates to the compound of Formulas I and its salt and solvate, and further relate to the conjugate of the compound or its salt comprising Formulas I or solvate.</div>
  </abstract>
  </section>
      <div id="margin" class="style-scope patent-text">
        <div id="createHighlight" style="top: 0px;" class="style-scope patent-text" hidden="">
          <iron-icon id="comment" icon="editor:insert-comment" class="style-scope patent-text x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M20 2H4c-1.1 0-2 .9-2 2v12c0 1.1.9 2 2 2h14l4 4V4c0-1.1-.9-2-2-2zm-2 12H6v-2h12v2zm0-3H6V9h12v2zm0-3H6V6h12v2z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
        </div>
      </div>
    </div>
  </patent-text>
              </section>
              
              <template is="dom-if" class="style-scope patent-result"></template>
              
              <section id="classifications" class="style-scope patent-result">
                <h3 class="layout horizontal style-scope patent-result">
                  <div class="flex style-scope patent-result">Classifications</div>
                  <div id="machineClassifiedWarning" class="righthead tooltip-hint style-scope patent-result" hidden="">machine-classified</div>
                  <div id="machineClassifiedCPCWarning" class="righthead tooltip-hint style-scope patent-result" hidden="">cpc-machine-classified</div>
                  <div id="machineClassifiedFtermWarning" class="righthead tooltip-hint style-scope patent-result" hidden="">fterm-machine-classified</div>
                  <div class="style-scope patent-result" hidden="">&nbsp;</div>
                  <div id="familyClassifiedFtermWarning" class="righthead tooltip-hint style-scope patent-result" hidden="">fterm-family-classified</div>
                </h3>
                <overlay-tooltip positioning-target="#machineClassifiedWarning" direction="bottom" class="style-scope patent-result" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      The classifications are assigned by a computer and are not a legal conclusion. <br class="style-scope patent-result"> Google has not performed a legal analysis and makes no representation as to the accuracy of the classifications listed.
    </div>
  </overlay-tooltip>
                <overlay-tooltip positioning-target="#machineClassifiedCPCWarning" direction="bottom" class="style-scope patent-result" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      The CPC classifications are assigned by a computer and are not a legal conclusion. <br class="style-scope patent-result"> Google has not performed a legal analysis and makes no representation as to the accuracy of the classifications listed.
    </div>
  </overlay-tooltip>
                <overlay-tooltip positioning-target="#familyClassifiedFtermWarning" direction="bottom" class="style-scope patent-result" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      The F-term classifications are assigned based on a patent family member containing these classification codes.
    </div>
  </overlay-tooltip>
                <overlay-tooltip positioning-target="#machineClassifiedFtermWarning" direction="bottom" class="style-scope patent-result" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      The F-term classifications are assigned by a computer and are not a legal conclusion. <br class="style-scope patent-result"> Google has not performed a legal analysis and makes no representation as to the accuracy of the classifications listed.
    </div>
  </overlay-tooltip>
                <classification-viewer class="style-scope patent-result">
    
    <div class="table style-scope classification-viewer">
      
        <classification-tree class="style-scope classification-viewer">
    
    <div class="style-scope classification-tree">
      <div class="layout horizontal wrap style-scope classification-tree">
        <div class="flex style-scope classification-tree">
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C"><a id="link" href="#" class="style-scope state-modifier">C</a></state-modifier>
                  <span class="description style-scope classification-tree">CHEMISTRY; METALLURGY</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07"><a id="link" href="#" class="style-scope state-modifier">C07</a></state-modifier>
                  <span class="description style-scope classification-tree">ORGANIC CHEMISTRY</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07D"><a id="link" href="#" class="style-scope state-modifier">C07D</a></state-modifier>
                  <span class="description style-scope classification-tree">HETEROCYCLIC COMPOUNDS</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07D487/00"><a id="link" href="#" class="style-scope state-modifier">C07D487/00</a></state-modifier>
                  <span class="description style-scope classification-tree">Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07D487/02"><a id="link" href="#" class="style-scope state-modifier">C07D487/02</a></state-modifier>
                  <span class="description style-scope classification-tree">Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" first="true" data-cpc="C07D487/04"><a id="link" href="#" class="style-scope state-modifier">C07D487/04</a></state-modifier>
                  <span class="description style-scope classification-tree">Ortho-condensed systems</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          <template is="dom-repeat" class="style-scope classification-tree"></template>
        </div>
      </div>
    </div>
  </classification-tree>
      <template is="dom-repeat" class="style-scope classification-viewer"></template>
      
      <div class="style-scope classification-viewer">
        
          <classification-tree class="style-scope classification-viewer">
    
    <div class="style-scope classification-tree">
      <div class="layout horizontal wrap style-scope classification-tree">
        <div class="flex style-scope classification-tree">
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A"><a id="link" href="#" class="style-scope state-modifier">A</a></state-modifier>
                  <span class="description style-scope classification-tree">HUMAN NECESSITIES</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61"><a id="link" href="#" class="style-scope state-modifier">A61</a></state-modifier>
                  <span class="description style-scope classification-tree">MEDICAL OR VETERINARY SCIENCE; HYGIENE</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61K"><a id="link" href="#" class="style-scope state-modifier">A61K</a></state-modifier>
                  <span class="description style-scope classification-tree">PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61K31/00"><a id="link" href="#" class="style-scope state-modifier">A61K31/00</a></state-modifier>
                  <span class="description style-scope classification-tree">Medicinal preparations containing organic active ingredients</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61K31/33"><a id="link" href="#" class="style-scope state-modifier">A61K31/33</a></state-modifier>
                  <span class="description style-scope classification-tree">Heterocyclic compounds</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61K31/395"><a id="link" href="#" class="style-scope state-modifier">A61K31/395</a></state-modifier>
                  <span class="description style-scope classification-tree">Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61K31/55"><a id="link" href="#" class="style-scope state-modifier">A61K31/55</a></state-modifier>
                  <span class="description style-scope classification-tree">Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61K31/551"><a id="link" href="#" class="style-scope state-modifier">A61K31/551</a></state-modifier>
                  <span class="description style-scope classification-tree">Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61K31/5513"><a id="link" href="#" class="style-scope state-modifier">A61K31/5513</a></state-modifier>
                  <span class="description style-scope classification-tree">1,4-Benzodiazepines, e.g. diazepam or clozapine</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61K31/5517"><a id="link" href="#" class="style-scope state-modifier">A61K31/5517</a></state-modifier>
                  <span class="description style-scope classification-tree">1,4-Benzodiazepines, e.g. diazepam or clozapine condensed with five-membered rings having nitrogen as a ring hetero atom, e.g. imidazobenzodiazepines, triazolam</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          <template is="dom-repeat" class="style-scope classification-tree"></template>
        </div>
      </div>
    </div>
  </classification-tree>
        
          <classification-tree class="style-scope classification-viewer">
    
    <div class="style-scope classification-tree">
      <div class="layout horizontal wrap style-scope classification-tree">
        <div class="flex style-scope classification-tree">
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A"><a id="link" href="#" class="style-scope state-modifier">A</a></state-modifier>
                  <span class="description style-scope classification-tree">HUMAN NECESSITIES</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61"><a id="link" href="#" class="style-scope state-modifier">A61</a></state-modifier>
                  <span class="description style-scope classification-tree">MEDICAL OR VETERINARY SCIENCE; HYGIENE</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61K"><a id="link" href="#" class="style-scope state-modifier">A61K</a></state-modifier>
                  <span class="description style-scope classification-tree">PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61K47/00"><a id="link" href="#" class="style-scope state-modifier">A61K47/00</a></state-modifier>
                  <span class="description style-scope classification-tree">Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61K47/50"><a id="link" href="#" class="style-scope state-modifier">A61K47/50</a></state-modifier>
                  <span class="description style-scope classification-tree">Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61K47/51"><a id="link" href="#" class="style-scope state-modifier">A61K47/51</a></state-modifier>
                  <span class="description style-scope classification-tree">Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61K47/68"><a id="link" href="#" class="style-scope state-modifier">A61K47/68</a></state-modifier>
                  <span class="description style-scope classification-tree">Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61K47/6801"><a id="link" href="#" class="style-scope state-modifier">A61K47/6801</a></state-modifier>
                  <span class="description style-scope classification-tree">Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61K47/6803"><a id="link" href="#" class="style-scope state-modifier">A61K47/6803</a></state-modifier>
                  <span class="description style-scope classification-tree">Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          <template is="dom-repeat" class="style-scope classification-tree"></template>
        </div>
      </div>
    </div>
  </classification-tree>
        
          <classification-tree class="style-scope classification-viewer">
    
    <div class="style-scope classification-tree">
      <div class="layout horizontal wrap style-scope classification-tree">
        <div class="flex style-scope classification-tree">
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A"><a id="link" href="#" class="style-scope state-modifier">A</a></state-modifier>
                  <span class="description style-scope classification-tree">HUMAN NECESSITIES</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61"><a id="link" href="#" class="style-scope state-modifier">A61</a></state-modifier>
                  <span class="description style-scope classification-tree">MEDICAL OR VETERINARY SCIENCE; HYGIENE</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61K"><a id="link" href="#" class="style-scope state-modifier">A61K</a></state-modifier>
                  <span class="description style-scope classification-tree">PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61K47/00"><a id="link" href="#" class="style-scope state-modifier">A61K47/00</a></state-modifier>
                  <span class="description style-scope classification-tree">Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61K47/50"><a id="link" href="#" class="style-scope state-modifier">A61K47/50</a></state-modifier>
                  <span class="description style-scope classification-tree">Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61K47/51"><a id="link" href="#" class="style-scope state-modifier">A61K47/51</a></state-modifier>
                  <span class="description style-scope classification-tree">Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61K47/68"><a id="link" href="#" class="style-scope state-modifier">A61K47/68</a></state-modifier>
                  <span class="description style-scope classification-tree">Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61K47/6835"><a id="link" href="#" class="style-scope state-modifier">A61K47/6835</a></state-modifier>
                  <span class="description style-scope classification-tree">Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61K47/6851"><a id="link" href="#" class="style-scope state-modifier">A61K47/6851</a></state-modifier>
                  <span class="description style-scope classification-tree">Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a determinant of a tumour cell</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          <template is="dom-repeat" class="style-scope classification-tree"></template>
        </div>
      </div>
    </div>
  </classification-tree>
        
          <classification-tree class="style-scope classification-viewer">
    
    <div class="style-scope classification-tree">
      <div class="layout horizontal wrap style-scope classification-tree">
        <div class="flex style-scope classification-tree">
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A"><a id="link" href="#" class="style-scope state-modifier">A</a></state-modifier>
                  <span class="description style-scope classification-tree">HUMAN NECESSITIES</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61"><a id="link" href="#" class="style-scope state-modifier">A61</a></state-modifier>
                  <span class="description style-scope classification-tree">MEDICAL OR VETERINARY SCIENCE; HYGIENE</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61K"><a id="link" href="#" class="style-scope state-modifier">A61K</a></state-modifier>
                  <span class="description style-scope classification-tree">PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61K47/00"><a id="link" href="#" class="style-scope state-modifier">A61K47/00</a></state-modifier>
                  <span class="description style-scope classification-tree">Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61K47/50"><a id="link" href="#" class="style-scope state-modifier">A61K47/50</a></state-modifier>
                  <span class="description style-scope classification-tree">Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61K47/51"><a id="link" href="#" class="style-scope state-modifier">A61K47/51</a></state-modifier>
                  <span class="description style-scope classification-tree">Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61K47/68"><a id="link" href="#" class="style-scope state-modifier">A61K47/68</a></state-modifier>
                  <span class="description style-scope classification-tree">Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61K47/6889"><a id="link" href="#" class="style-scope state-modifier">A61K47/6889</a></state-modifier>
                  <span class="description style-scope classification-tree">Conjugates wherein the antibody being the modifying agent and wherein the linker, binder or spacer confers particular properties to the conjugates, e.g. peptidic enzyme-labile linkers or acid-labile linkers, providing for an acid-labile immuno conjugate wherein the drug may be released from its antibody conjugated part in an acidic, e.g. tumoural or environment</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          <template is="dom-repeat" class="style-scope classification-tree"></template>
        </div>
      </div>
    </div>
  </classification-tree>
        
          <classification-tree class="style-scope classification-viewer">
    
    <div class="style-scope classification-tree">
      <div class="layout horizontal wrap style-scope classification-tree">
        <div class="flex style-scope classification-tree">
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A"><a id="link" href="#" class="style-scope state-modifier">A</a></state-modifier>
                  <span class="description style-scope classification-tree">HUMAN NECESSITIES</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61"><a id="link" href="#" class="style-scope state-modifier">A61</a></state-modifier>
                  <span class="description style-scope classification-tree">MEDICAL OR VETERINARY SCIENCE; HYGIENE</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61P"><a id="link" href="#" class="style-scope state-modifier">A61P</a></state-modifier>
                  <span class="description style-scope classification-tree">SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61P35/00"><a id="link" href="#" class="style-scope state-modifier">A61P35/00</a></state-modifier>
                  <span class="description style-scope classification-tree">Antineoplastic agents</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          <template is="dom-repeat" class="style-scope classification-tree"></template>
        </div>
      </div>
    </div>
  </classification-tree>
        
          <classification-tree class="style-scope classification-viewer">
    
    <div class="style-scope classification-tree">
      <div class="layout horizontal wrap style-scope classification-tree">
        <div class="flex style-scope classification-tree">
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A"><a id="link" href="#" class="style-scope state-modifier">A</a></state-modifier>
                  <span class="description style-scope classification-tree">HUMAN NECESSITIES</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61"><a id="link" href="#" class="style-scope state-modifier">A61</a></state-modifier>
                  <span class="description style-scope classification-tree">MEDICAL OR VETERINARY SCIENCE; HYGIENE</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61P"><a id="link" href="#" class="style-scope state-modifier">A61P</a></state-modifier>
                  <span class="description style-scope classification-tree">SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61P35/00"><a id="link" href="#" class="style-scope state-modifier">A61P35/00</a></state-modifier>
                  <span class="description style-scope classification-tree">Antineoplastic agents</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61P35/02"><a id="link" href="#" class="style-scope state-modifier">A61P35/02</a></state-modifier>
                  <span class="description style-scope classification-tree">Antineoplastic agents specific for leukemia</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          <template is="dom-repeat" class="style-scope classification-tree"></template>
        </div>
      </div>
    </div>
  </classification-tree>
        <template is="dom-repeat" class="style-scope classification-viewer"></template>
        <div class="more style-scope classification-viewer" style="" hidden="">View 6 more classifications</div>
        <div class="more style-scope classification-viewer">Hide more classifications</div>
      </div>
      <template is="dom-if" class="style-scope classification-viewer"></template>
    </div>
  </classification-viewer>
              </section>
              
              <template is="dom-if" class="style-scope patent-result"></template>
              
              <template is="dom-if" class="style-scope patent-result"></template>
              
              
                <section class="style-scope patent-result">
                  <h3 class="layout horizontal style-scope patent-result">
                    <div class="flex style-scope patent-result">Landscapes</div>
                  </h3>
                  <div class="responsive-grid style-scope patent-result">
                    
                      <landscape-link class="style-scope patent-result"><state-modifier act="{&quot;type&quot;:&quot;QUERY_SET_TERM&quot;,&quot;term&quot;:&quot;$term&quot;,&quot;origin&quot;:&quot;LANDSCAPE_LINK&quot;}" class="style-scope landscape-link" data-term="Health &amp; Medical Sciences"><a id="link" href="#" class="style-scope state-modifier">
  <requery-tile class="area style-scope landscape-link">
<span class="label style-scope requery-tile">
    Health &amp; Medical Sciences
  </span>
<span class="search-icon style-scope requery-tile"></span>
</requery-tile>
</a></state-modifier>
</landscape-link>
                    
                      <landscape-link class="style-scope patent-result"><state-modifier act="{&quot;type&quot;:&quot;QUERY_SET_TERM&quot;,&quot;term&quot;:&quot;$term&quot;,&quot;origin&quot;:&quot;LANDSCAPE_LINK&quot;}" class="style-scope landscape-link" data-term="Chemical &amp; Material Sciences"><a id="link" href="#" class="style-scope state-modifier">
  <requery-tile class="area style-scope landscape-link">
<span class="label style-scope requery-tile">
    Chemical &amp; Material Sciences
  </span>
<span class="search-icon style-scope requery-tile"></span>
</requery-tile>
</a></state-modifier>
</landscape-link>
                    <template is="dom-repeat" class="style-scope patent-result"></template>
                  </div>
                  <s-more-inline class="style-scope patent-result"><hr aria-hidden="true" class="style-scope s-more-inline">

<div class="button style-scope s-more-inline">
  <span slot="expand_text" class="style-scope patent-result">Show more</span>
  <span class="expand more style-scope s-more-inline"></span>
</div>
<div class="button style-scope s-more-inline" hidden="">
  <span slot="collapse_text" class="style-scope patent-result">Show less</span>
  <span class="expand less style-scope s-more-inline"></span>
</div>
</s-more-inline>
                </section>
              <template is="dom-if" class="style-scope patent-result"></template>
            </div>
            <div class="flex-2 style-scope patent-result">
              <section class="knowledge-card style-scope patent-result">
                <header class="style-scope patent-result">
                  <h2 id="pubnum" class="style-scope patent-result">CN110452242A</h2>
                  <p class="tagline style-scope patent-result">China</p>
                  <overlay-tooltip positioning-target="#pubnum" direction="bottom" class="style-scope patent-result" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                    <div style="max-width: 300px;" class="style-scope patent-result">Unexaminded application</div>
                  
    </div>
  </overlay-tooltip>

                  <div class="knowledge-card-action-bar style-scope patent-result">
                    <a target="_blank" class="style-scope patent-result" href="https://patentimages.storage.googleapis.com/6f/fc/24/c9712b7ade7267/CN110452242A.pdf"><iron-icon icon="description" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M14 2H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c1.1 0 2-.9 2-2V8l-6-6zm2 16H8v-2h8v2zm0-4H8v-2h8v2zm-3-5V3.5L18.5 9H13z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon> Download PDF</a>
                    <state-modifier inherit="" act="{&quot;type&quot;: &quot;QUERY_FIND_PRIOR_ART&quot;, &quot;keywords&quot;: $keywords, &quot;before&quot;: &quot;$before&quot;}" class="style-scope patent-result" data-keywords="[&quot;group&quot;,&quot;antibody&quot;,&quot;genbank&quot;,&quot;alkyl&quot;,&quot;accession number&quot;]" data-before="20121221"><a id="link" href="#" class="style-scope state-modifier" inherit="">
                      <iron-icon icon="find-in-page" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M20 19.59V8l-6-6H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c.45 0 .85-.15 1.19-.4l-4.43-4.43c-.8.52-1.74.83-2.76.83-2.76 0-5-2.24-5-5s2.24-5 5-5 5 2.24 5 5c0 1.02-.31 1.96-.83 2.75L20 19.59zM9 13c0 1.66 1.34 3 3 3s3-1.34 3-3-1.34-3-3-3-3 1.34-3 3z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon> Find Prior Art
                    </a></state-modifier>
                    <state-modifier inherit="" act="{&quot;type&quot;: &quot;QUERY_SIMILAR_DOCUMENTS&quot;, &quot;id&quot;: &quot;$id&quot;}" class="style-scope patent-result" data-id="patent/CN110452242A"><a id="link" href="#" class="style-scope state-modifier" inherit="">
                      <iron-icon icon="editor:functions" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M18 4H6v2l6.5 6L6 18v2h12v-3h-7l5-5-5-5h7z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon> Similar
                    </a></state-modifier>
                  </div>
                </header>

                <dl class="important-people style-scope patent-result">
                  
                    <dt class="style-scope patent-result">Other languages</dt>
                    <dd class="style-scope patent-result"><state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/CN110452242A/zh"><a id="link" href="#" class="style-scope state-modifier">Chinese</a></state-modifier></dd><template is="dom-repeat" strip-whitespace="" class="style-scope patent-result"></template>
                  <template is="dom-if" class="style-scope patent-result"></template>
                  
                  <dt class="style-scope patent-result">Inventor</dt>
                  <dd class="style-scope patent-result"><state-modifier act="{&quot;type&quot;: &quot;QUERY_SEARCH_INVENTOR&quot;, &quot;inventor&quot;: &quot;$inventor&quot;}" class="style-scope patent-result" data-inventor="菲利普·威尔逊·霍华德"><a id="link" href="#" class="style-scope state-modifier">菲利普·威尔逊·霍华德</a></state-modifier></dd><template is="dom-repeat" strip-whitespace="" class="style-scope patent-result"></template>
                  <template is="dom-if" class="style-scope patent-result"></template>

                  
                  <dt class="style-scope patent-result">
                    <span class="tooltip-hint style-scope patent-result" id="assigneeWarning">Current Assignee</span>
                    <overlay-tooltip positioning-target="#assigneeWarning" direction="bottom" class="style-scope patent-result" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                      The listed assignees may be inaccurate.<br class="style-scope patent-result">
                      Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.
                    
    </div>
  </overlay-tooltip>
                  </dt>
                  <dd class="style-scope patent-result">
                    
    ADC Therapeutics SA
  
                  </dd><dd class="style-scope patent-result">
                    
    MedImmune Ltd
  
                  </dd><template is="dom-repeat" strip-whitespace="" class="style-scope patent-result"></template>
                  <template is="dom-if" class="style-scope patent-result"></template>
                </dl>

                <hr class="style-scope patent-result">

                <application-timeline class="style-scope patent-result">
    
    
    <div class="wrap style-scope application-timeline">
      <div class="header style-scope application-timeline">Worldwide applications</div>
      <div class="event style-scope application-timeline">
        
          <span class="block style-scope application-timeline">
            <span class="year style-scope application-timeline">2013</span>
            <span class="dot style-scope application-timeline"></span>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/EA031585B1/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="not_active style-scope application-timeline">EA</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: EA201590999A</div>
                <div class="style-scope application-timeline">Filing date: 2013-12-20</div>
                <div class="style-scope application-timeline">Legal status: IP Right Cessation</div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/BR112015014669B1/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="active style-scope application-timeline">BR</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: BR112015014669-4A</div>
                <div class="style-scope application-timeline">Filing date: 2013-12-20</div>
                <div class="style-scope application-timeline">Legal status: IP Right Grant</div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/JP6307519B2/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="active style-scope application-timeline">JP</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: JP2015548635A</div>
                <div class="style-scope application-timeline">Filing date: 2013-12-20</div>
                <div class="style-scope application-timeline">Legal status: Active</div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/US9562049B2/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="active style-scope application-timeline">US</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: US14/654,065</div>
                <div class="style-scope application-timeline">Filing date: 2013-12-20</div>
                <div class="style-scope application-timeline">Legal status: Active</div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/AU2013366493B2/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="active style-scope application-timeline">AU</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: AU2013366493A</div>
                <div class="style-scope application-timeline">Filing date: 2013-12-20</div>
                <div class="style-scope application-timeline">Legal status: Active</div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/WO2014096368A1/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="active style-scope application-timeline">WO</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: PCT/EP2013/077705</div>
                <div class="style-scope application-timeline">Filing date: 2013-12-20</div>
                <div class="style-scope application-timeline">Legal status: Application Filing</div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/EP2935268B2/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="active style-scope application-timeline">EP</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: EP13814939.8A</div>
                <div class="style-scope application-timeline">Filing date: 2013-12-20</div>
                <div class="style-scope application-timeline">Legal status: Active</div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/CA2894961C/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="active style-scope application-timeline">CA</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: CA2894961A</div>
                <div class="style-scope application-timeline">Filing date: 2013-12-20</div>
                <div class="style-scope application-timeline">Legal status: Active</div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/CN105189507A/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="active style-scope application-timeline">CN</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: CN201380073613.1A</div>
                <div class="style-scope application-timeline">Filing date: 2013-12-20</div>
                <div class="style-scope application-timeline">Legal status: Pending</div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/CN110452242A/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="active style-scope application-timeline" this="">CN</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: CN201910749475.3A</div>
                <div class="style-scope application-timeline">Filing date: 2013-12-20</div>
                <div class="style-scope application-timeline">Legal status: Pending</div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/ES2658888T5/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="active style-scope application-timeline">ES</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: ES13814939T</div>
                <div class="style-scope application-timeline">Filing date: 2013-12-20</div>
                <div class="style-scope application-timeline">Legal status: Active</div>
              
    </div>
  </overlay-tooltip>
            <template is="dom-repeat" class="style-scope application-timeline"></template>
          </span>
        
          <span class="block style-scope application-timeline">
            <span class="year style-scope application-timeline">2016</span>
            <span class="dot style-scope application-timeline"></span>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/HK1216638A1/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="active style-scope application-timeline">HK</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: HK16104281.2A</div>
                <div class="style-scope application-timeline">Filing date: 2016-04-14</div>
                <div class="style-scope application-timeline">Legal status: IP Right Maintenance</div>
              
    </div>
  </overlay-tooltip>
            <template is="dom-repeat" class="style-scope application-timeline"></template>
          </span>
        <template is="dom-repeat" class="style-scope application-timeline"></template>
      </div>
      <hr class="style-scope application-timeline">
      <div class="header style-scope application-timeline">Application CN201910749475.3A events <iron-icon id="legal" icon="icons:help-outline" class="style-scope application-timeline x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M11 18h2v-2h-2v2zm1-16C6.48 2 2 6.48 2 12s4.48 10 10 10 10-4.48 10-10S17.52 2 12 2zm0 18c-4.41 0-8-3.59-8-8s3.59-8 8-8 8 3.59 8 8-3.59 8-8 8zm0-14c-2.21 0-4 1.79-4 4h2c0-1.1.9-2 2-2s2 .9 2 2c0 2-3 1.75-3 5h2c0-2.25 3-2.5 3-5 0-2.21-1.79-4-4-4z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
        <overlay-tooltip positioning-target="#legal" direction="right" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
          <div style="max-width: 300px;" class="style-scope application-timeline">
            A timeline of key events for this patent application, including priority claims, publications, legal status, reassignments, and litigation.<br class="style-scope application-timeline"><br class="style-scope application-timeline">
            Google has not performed a legal analysis and makes no representation as to the accuracy or completeness of the events listed.
          </div>
        
    </div>
  </overlay-tooltip>
      </div>
      <div class="event layout horizontal style-scope application-timeline" critical=""><div date="" class="litigation style-scope application-timeline"></div><div class="line style-scope application-timeline"></div><div class="flex title style-scope application-timeline"><a target="_blank" class="style-scope application-timeline" href="https://patents.darts-ip.com/?family=49886925&amp;utm_source=google_patent&amp;utm_medium=platform_link&amp;utm_campaign=public_patent_search&amp;patent=CN110452242(A)"><span class="title-text style-scope application-timeline">First worldwide family litigation filed</span></a><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><iron-icon id="icon" icon="icons:help-outline" class="style-scope application-timeline x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M11 18h2v-2h-2v2zm1-16C6.48 2 2 6.48 2 12s4.48 10 10 10 10-4.48 10-10S17.52 2 12 2zm0 18c-4.41 0-8-3.59-8-8s3.59-8 8-8 8 3.59 8 8-3.59 8-8 8zm0-14c-2.21 0-4 1.79-4 4h2c0-1.1.9-2 2-2s2 .9 2 2c0 2-3 1.75-3 5h2c0-2.25 3-2.5 3-5 0-2.21-1.79-4-4-4z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon><overlay-tooltip positioning-target="#icon" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      <div class="description-item style-scope application-timeline">"Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.</div><template is="dom-repeat" class="style-scope application-timeline"></template>
    </div>
  </overlay-tooltip><template is="dom-if" class="style-scope application-timeline"></template></div></div><div class="event layout horizontal style-scope application-timeline" critical=""><div date="" class="filed style-scope application-timeline">2013-12-20</div><div class="line style-scope application-timeline"></div><div class="flex title style-scope application-timeline"><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><state-modifier act="{&quot;type&quot;: &quot;QUERY_SEARCH_ASSIGNEE&quot;, &quot;assignee&quot;: &quot;$assignee&quot;}" class="style-scope application-timeline" data-assignee="ADC Therapeutics SA"><a id="link" href="#" class="style-scope state-modifier"><span class="title-text style-scope application-timeline">Application filed by ADC Therapeutics SA</span></a></state-modifier><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template></div></div><div class="event layout horizontal style-scope application-timeline" critical=""><div date="" class="publication style-scope application-timeline">2019-11-15</div><div class="line style-scope application-timeline"></div><div class="flex title style-scope application-timeline"><template is="dom-if" class="style-scope application-timeline"></template><state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/CN110452242A/en"><a id="link" href="#" class="style-scope state-modifier"><span class="title-text style-scope application-timeline">Publication of CN110452242A</span></a></state-modifier><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template></div></div><div class="event layout horizontal style-scope application-timeline" current="" critical=""><div date="" class="legal-status style-scope application-timeline">Status</div><div class="line style-scope application-timeline"></div><div class="flex title style-scope application-timeline"><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><span class="title-text style-scope application-timeline">Pending</span><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template></div></div><template is="dom-repeat" strip-whitespace="" class="style-scope application-timeline"></template>
      <template is="dom-if" class="style-scope application-timeline"></template>
    </div>
  </application-timeline>
                <hr class="style-scope patent-result">

                <dl class="links style-scope patent-result">
                  <dt class="style-scope patent-result">Info</dt>

                  
                  <dd class="style-scope patent-result"><a href="#patentCitations" class="style-scope patent-result">Patent citations (329)</a></dd>
                  <template is="dom-if" restamp="" class="style-scope patent-result"></template>

                  
                  <dd class="style-scope patent-result"><a href="#nplCitations" class="style-scope patent-result">Non-patent citations (3)</a></dd>
                  <template is="dom-if" restamp="" class="style-scope patent-result"></template>

                  
                  <dd class="style-scope patent-result"><a href="#citedBy" class="style-scope patent-result">Cited by (58)</a></dd>
                  <template is="dom-if" restamp="" class="style-scope patent-result"></template>

                  
                  <dd class="style-scope patent-result"><a href="#legalEvents" class="style-scope patent-result">Legal events</a></dd>
                  <template is="dom-if" restamp="" class="style-scope patent-result"></template>

                  
                  <dd class="style-scope patent-result"><a href="#similarDocuments" class="style-scope patent-result">Similar documents</a></dd>
                  <template is="dom-if" restamp="" class="style-scope patent-result"></template>

                  
                  <dd class="style-scope patent-result"><a href="#relatedApplications" class="style-scope patent-result">Priority and Related Applications</a></dd>
                  <template is="dom-if" restamp="" class="style-scope patent-result"></template>

                  <dt class="style-scope patent-result">External links</dt>

                  <dd class="style-scope patent-result"><a target="_blank" class="style-scope patent-result" href="https://worldwide.espacenet.com/publicationDetails/biblio?CC=CN&amp;NR=110452242A&amp;KC=A&amp;FT=D">Espacenet</a></dd><dd class="style-scope patent-result"><a target="_blank" class="style-scope patent-result" href="https://globaldossier.uspto.gov/#/result/publication/CN/110452242/1">Global Dossier</a></dd><dd class="style-scope patent-result"><a target="_blank" class="style-scope patent-result" href="https://patents.stackexchange.com/questions/tagged/CN110452242A">Discuss</a></dd><template is="dom-repeat" strip-whitespace="" class="style-scope patent-result"></template>
                </dl>
              </section>
            </div>
          </div>

          <div id="text" class="horizontal layout style-scope patent-result">
            <div class="flex flex-width style-scope patent-result" marginright="">
              <section id="description" class="style-scope patent-result">
                <h3 class="layout horizontal style-scope patent-result">
                  <div class="flex style-scope patent-result">Description</div>
                  <div class="righthead style-scope patent-result" hidden="">translated from </div>
                </h3>
                <patent-text name="description" id="descriptionText" class="style-scope patent-result" style="padding-top: 0px;">
    
    
    <template is="dom-if" restamp="" class="style-scope patent-text"></template>
    <overlay-tooltip id="tooltip" class="style-scope patent-text" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
    </div>
  </overlay-tooltip>
    <div class="layout horizontal style-scope patent-text">
      <section id="text" class="flex style-scope patent-text"><div mxw-id="PDES223909040" lang="EN" load-source="patent-office" class="description style-scope patent-text">
    <invention-title lang="EN" id="title1" class="style-scope patent-text">Pyrrolobenzodiazepines Zhuo and its conjugate</invention-title>
    <div id="p0001" num="0001" class="description-paragraph style-scope patent-text">The application is entitled " Pyrrolobenzodiazepines Zhuo and its conjugate " for being on December 20th, 2013 applying date
The divisional application of Chinese Patent Application No. 201380073613.1.</div>
    <technical-field class="style-scope patent-text">
      <div id="p0002" num="0002" class="description-paragraph style-scope patent-text">Technical field</div>
      <div id="p0003" num="0003" class="description-paragraph style-scope patent-text">The present invention relates to the tall and erect (Pyrrolobenzodiazepines of Pyrrolobenzodiazepines<span class="patent-image-not-available style-scope patent-text"></span>PBD it) and included in targeting combines
Pyrrolobenzodiazepines in object are tall and erect.PBD of the invention is with mixed dimer form, wherein is wrapped a part PBD
It include amine or amino group containing the imines and another part having for being connected to the unstable N10 group of cell binding agent.</div>
    </technical-field>
    <background-art class="style-scope patent-text">
      <div id="p0004" num="0004" class="description-paragraph style-scope patent-text">Background technique</div>
      <div id="p0005" num="0005" class="description-paragraph style-scope patent-text">Pyrrolobenzodiazepines are tall and erect</div>
      <div id="p0006" num="0006" class="description-paragraph style-scope patent-text">Some Pyrrolobenzodiazepines tall and erect (PBD) have the ability for identifying and combining specific dna sequence；Preferred sequence
Column are PuGPu.Have found the first PBD antitumor antibiotics in nineteen sixty-five, Anthramycin (Leimgruber, et al.,
J.Am.Chem.Soc.,87,5793-5795(1965)； Leimgruber,et al.,J.Am.Chem.Soc.,87,5791-
5793(1965)).Hereafter, it has been reported that a large amount of naturally occurring PBD, and developed for various analogs super
Cross 10 kinds of route of synthesis (Thurston, et al., Chem.Rev.1994,433-465 (1994)).Family member includes red
Mycin (abbeymycin) (Hochlowski, et al., J.Antibiotics, 40,145-148 (1987)), contract card mycin
(chicamycin) (Konishi, et al., J.Antibiotics, 37,200-206 (1984)), DC-81 (Japan Patent
58-180487；Thurston,et al.,Chem.Brit.,26, 767-772(1990)；Bose,et al.,
Tetrahedron, 48,751-758 (1992)), mazethramycin (Kuminoto, et al., J.Antibiotics, 33,
665-667 (1980)), neothramycin (neothramycin) A and B (Takeuchi, et al., J.Antibiotics, 29,
93-96 (1976)), general sieve Anthramycin (porothramycin) (Tsunakawa, et al., J.Antibiotics, 41,
1366-1373 (1988)), pula this block plain (prothracarcin) (Shimizu, et al, J.Antibiotics, 29,
2492-2503(1982)；Langley and Thurston, J.Org.Chem., 52,91-97 (1987)), sibanomicin
(sibanomicin)(DC-102)(Hara,et al.,J.Antibiotics,41,702-704 (1988)；Itoh,et
Al., J.Antibiotics, 41,1281-1284 (1988)), sibiromycin (sibiromycin) (Leber, et al.,
J.Am.Chem.Soc., (1988) 110,2992-2993) and tomamycin (tomamycin) (Arima, et al.,
J.Antibiotics,25,437-444(1972)).PBD is following general structure:</div>
      <div id="p0007" num="0007" class="description-paragraph style-scope patent-text">
        <span class="patent-image-not-available style-scope patent-text"></span>
      </div>
      <div id="p0008" num="0008" class="description-paragraph style-scope patent-text">Their difference is the quantity, type and position of substituent group, is their aromatic series A ring and pyrrolo- C ring
The two, and it is C ring filling degree.In B ring, the position N10-C11 (its be responsible for making DNA it is alkylated it is electrophilic in
The heart) at there are imines (N=C), carbinolamine (NH-CH (OH)) or carbinolamine methyl ethers (NH-CH (OMe)).It is all known natural
Product has (S)-configuration all at the chiral position C11a, and when from C circumferential direction A ring, this is configured as them and provides the right hand
Torsion.This give they for the ditch of B-form DNA etc. helicities (isohelicity) 3D shape appropriate, obtain
Must be slidably matched at binding site (Kohn, In Antibiotics III.Springer-Verlag, New York,
pp.3-11(1975)；Hurley and Needham-VanDevanter,Acc.Chem.Res.,19,230-237(1986)).
The ability that they form adduct in ditch allows them to the processing of interference DNA, therefore they can be used as antitumor agent.</div>
      <div id="p0009" num="0009" class="description-paragraph style-scope patent-text">It discloses before by their C8/C '-hydroxy functional group that two PBD are mono- via flexible alkylene linker
Member be combined together can reinforce these molecules bioactivity (Bose, D.S., et al., J.Am.Chem.Soc., 114,
4939-4941(1992)；Thurston,D.E.,et al.,J.Org.Chem., 61,8141-8147(1996)).Think PBD
The DNA damage of dimer formation sequence selectivity, as palindrome 5 '-Pu-GATC-Py-3 ' interchain linkage (Smellie, M.,
et al.,Biochemistry, 42,8232-8239(2003)；Martin,C.,et al.,Biochemistry,44,
4135-4147), it is believed that the main reason for this is their bioactivity.One example of PBD dimer, SG2000 (SJG-
136):</div>
      <div id="p0010" num="0010" class="description-paragraph style-scope patent-text">
        <span class="patent-image-not-available style-scope patent-text"></span>
      </div>
      <div id="p0011" num="0011" class="description-paragraph style-scope patent-text">II clinical trial phase (Gregson, S., the et al., J. of oncology are come into recent years
Med.Chem.,44,737-748(2001)；Alley,M.C.,et al.,Cancer Research,64, 6700-6706
(2004)；Hartley,J.A.,et al.,Cancer Research,64,6693-6699 (2004)).</div>
      <div id="p0012" num="0012" class="description-paragraph style-scope patent-text">WO 2011/130598 discloses conjugate, and specifically discloses the antibody comprising PBD dimer and combine
Object, the PBD dimer are connected to cell binding agent via connector by the position N10 on a part PBD.In October, 2012
Co-pending International Application Serial No. PCT/the US2012/59864 submitted for 12nd is disclosed to be passed through by the position N10 on a part PBD
The PBD dimer of cell binding agent is connected to by sulfur-bearing connector.</div>
      <div id="p0013" num="0013" class="description-paragraph style-scope patent-text">In 2002, Kamal, which is described, had amide group with imine linkage in a PBD and in another PBD
The synthesis and assessment (Kamal, A, et al., J. Med.Chem., 2002,4679-4688) of PBD dimer, such as:</div>
      <div id="p0014" num="0014" class="description-paragraph style-scope patent-text">
        <span class="patent-image-not-available style-scope patent-text"></span>
      </div>
      <div id="p0015" num="0015" class="description-paragraph style-scope patent-text">In 2004, it described the PBD dimerization with imine linkage in a PBD and in another PBD with amine key
The synthesis and assessment (Kamal, A, et al., Bioorg.Med.Chem., 12 (2004) 5427-5436) of object, such as:</div>
      <div id="p0016" num="0016" class="description-paragraph style-scope patent-text">
        <span class="patent-image-not-available style-scope patent-text"></span>
      </div>
      <div id="p0017" num="0017" class="description-paragraph style-scope patent-text">These compounds cannot be crosslinked DNA, but show with some cytotoxicities.</div>
    </background-art>
    <disclosure class="style-scope patent-text">
      <div id="p0018" num="0018" class="description-paragraph style-scope patent-text">Summary of the invention</div>
      <div id="p0019" num="0019" class="description-paragraph style-scope patent-text">One aspect of the present invention includes the compound with Formulas I:</div>
      <div id="p0020" num="0020" class="description-paragraph style-scope patent-text">
        <span class="patent-image-not-available style-scope patent-text"></span>
      </div>
      <div id="p0021" num="0021" class="description-paragraph style-scope patent-text">And its salt and solvate, in which:</div>
      <div id="p0022" num="0022" class="description-paragraph style-scope patent-text">When between C2 and C3 there are when double bond, R<sup class="style-scope patent-text">2</sup>Selected from the group being made up of:</div>
      <div id="p0023" num="0023" class="description-paragraph style-scope patent-text">(ia)C<sub class="style-scope patent-text">5-10</sub>Aryl group, optionally by selected from include below group in one or more substituent groups replace: halogen
Element, nitro, cyano, ether, carboxyl, ester, C<sub class="style-scope patent-text">1-7</sub>Alkyl, C<sub class="style-scope patent-text">3-7</sub>Heterocycle and double-oxygroup-C<sub class="style-scope patent-text">1-3</sub>Alkylidene；</div>
      <div id="p0024" num="0024" class="description-paragraph style-scope patent-text">(ib)C<sub class="style-scope patent-text">1-5</sub>Representative examples of saturated aliphatic alkyl；</div>
      <div id="p0025" num="0025" class="description-paragraph style-scope patent-text">(ic)C<sub class="style-scope patent-text">3-6</sub>Saturated cyclic alkyls；</div>
      <div id="p0026" num="0026" class="description-paragraph style-scope patent-text">(id)<span class="patent-image-not-available style-scope patent-text"></span>Wherein, R<sup class="style-scope patent-text">11</sup>、R<sup class="style-scope patent-text">12</sup>And R<sup class="style-scope patent-text">13</sup>Each of independently selected from H, C<sub class="style-scope patent-text">1-3</sub>Saturated alkyl, C<sub class="style-scope patent-text">2-3</sub>Alkene
Base, C<sub class="style-scope patent-text">2-3</sub>Alkynyl and cyclopropyl, wherein R<sup class="style-scope patent-text">2</sup>The sum of carbon atom is not more than 5 in group；</div>
      <div id="p0027" num="0027" class="description-paragraph style-scope patent-text">(ie)<span class="patent-image-not-available style-scope patent-text"></span>Wherein, R<sup class="style-scope patent-text">15a</sup>And R<sup class="style-scope patent-text">15b</sup>In one be H, and another is selected from: phenyl, the benzene
Base is optionally replaced by the group selected from halogen, methyl, methoxyl group；Pyridyl group；And thiophenyl；With</div>
      <div id="p0028" num="0028" class="description-paragraph style-scope patent-text">(if)<span class="patent-image-not-available style-scope patent-text"></span>Wherein, R<sup class="style-scope patent-text">14</sup>It is selected from: H；C<sub class="style-scope patent-text">1-3</sub>Saturated alkyl；C<sub class="style-scope patent-text">2-3</sub>Alkenyl；C<sub class="style-scope patent-text">2-3</sub>Alkynyl；Cyclopropyl；Benzene
Base, the phenyl are optionally replaced by the group selected from halogen, methyl, methoxyl group；Pyridyl group；And thiophenyl；</div>
      <div id="p0029" num="0029" class="description-paragraph style-scope patent-text">When between C2 and C3 there are when singly-bound,</div>
      <div id="p0030" num="0030" class="description-paragraph style-scope patent-text">R<sup class="style-scope patent-text">2</sup>It is<span class="patent-image-not-available style-scope patent-text"></span>Wherein, R<sup class="style-scope patent-text">16a</sup>And R<sup class="style-scope patent-text">16b</sup>Independently selected from H, F, C<sub class="style-scope patent-text">1-4</sub>Saturated alkyl, C<sub class="style-scope patent-text">2-3</sub>Alkenyl, the alkyl
Optionally C is selected from alkenyl group<sub class="style-scope patent-text">1-4</sub>Alkyl amino and C<sub class="style-scope patent-text">1-4</sub>The group of Arrcostab replaces；Or work as R<sup class="style-scope patent-text">16a</sup>And R<sup class="style-scope patent-text">16b</sup>In one
When being H, another is selected from nitrile and C<sub class="style-scope patent-text">1-4</sub>Arrcostab；As C2 ' and C3 ' between there are when double bond, R<sup class="style-scope patent-text">12</sup>Selected from the group being made up of:</div>
      <div id="p0031" num="0031" class="description-paragraph style-scope patent-text">(ia)C<sub class="style-scope patent-text">5-10</sub>Aryl group, optionally by selected from include below group in one or more substituent groups replace: halogen
Element, nitro, cyano, ether, carboxyl, ester, C<sub class="style-scope patent-text">1-7</sub>Alkyl, C<sub class="style-scope patent-text">3-7</sub>Heterocycle and double-oxygroup-C<sub class="style-scope patent-text">1-3</sub>Alkylidene；</div>
      <div id="p0032" num="0032" class="description-paragraph style-scope patent-text">(ib)C<sub class="style-scope patent-text">1-5</sub>Representative examples of saturated aliphatic alkyl；</div>
      <div id="p0033" num="0033" class="description-paragraph style-scope patent-text">(ic)C<sub class="style-scope patent-text">3-6</sub>Saturated cyclic alkyls；</div>
      <div id="p0034" num="0034" class="description-paragraph style-scope patent-text">(id)<span class="patent-image-not-available style-scope patent-text"></span>Wherein, R<sup class="style-scope patent-text">21</sup>、R<sup class="style-scope patent-text">22</sup>And R<sup class="style-scope patent-text">23</sup>Each of independently selected from H, C<sub class="style-scope patent-text">1-3</sub>Saturated alkyl, C<sub class="style-scope patent-text">2-3</sub>Alkene
Base, C<sub class="style-scope patent-text">2-3</sub>Alkynyl and cyclopropyl, wherein R<sup class="style-scope patent-text">12</sup>The sum of carbon atom is not more than 5 in group；</div>
      <div id="p0035" num="0035" class="description-paragraph style-scope patent-text">(ie)<span class="patent-image-not-available style-scope patent-text"></span>Wherein, R<sup class="style-scope patent-text">25a</sup>And R<sup class="style-scope patent-text">25b</sup>In one be H, and another is selected from: phenyl, which can
Selection of land is replaced by the group selected from halogen, methyl, methoxyl group；Pyridyl group；And thiophenyl；With</div>
      <div id="p0036" num="0036" class="description-paragraph style-scope patent-text">(if)<span class="patent-image-not-available style-scope patent-text"></span>Wherein, R<sup class="style-scope patent-text">24</sup>It is selected from: H；C<sub class="style-scope patent-text">1-3</sub>Saturated alkyl；C<sub class="style-scope patent-text">2-3</sub>Alkenyl；C<sub class="style-scope patent-text">2-3</sub>Alkynyl；Cyclopropyl；Benzene
Base, the phenyl are optionally replaced by the group selected from halogen, methyl, methoxyl group；Pyridyl group；And thiophenyl；</div>
      <div id="p0037" num="0037" class="description-paragraph style-scope patent-text">As C2 ' and C3 ' between there are when singly-bound,</div>
      <div id="p0038" num="0038" class="description-paragraph style-scope patent-text">R<sup class="style-scope patent-text">12</sup>It is<span class="patent-image-not-available style-scope patent-text"></span>Wherein, R<sup class="style-scope patent-text">26a</sup>And R<sup class="style-scope patent-text">26b</sup>Independently selected from H, F, C<sub class="style-scope patent-text">1-4</sub>Saturated alkyl, C<sub class="style-scope patent-text">2-3</sub>Alkenyl, the alkyl and
Alkenyl group is optionally selected from C<sub class="style-scope patent-text">1-4</sub>Alkyl amino and C<sub class="style-scope patent-text">1-4</sub>The group of Arrcostab replaces；Or, working as R<sup class="style-scope patent-text">26a</sup>And R<sup class="style-scope patent-text">26b</sup>In one be
When H, another is selected from nitrile and C<sub class="style-scope patent-text">1-4</sub>Arrcostab；R<sup class="style-scope patent-text">6</sup>And R<sup class="style-scope patent-text">9</sup>Independently selected from H, R, OH, OR, SH, SR, NH<sub class="style-scope patent-text">2</sub>, NHR, NRR ', nitre
Base, Me<sub class="style-scope patent-text">3</sub>Sn and halogen；</div>
      <div id="p0039" num="0039" class="description-paragraph style-scope patent-text">Wherein, R and R ' is independently selected from optionally substituted C<sub class="style-scope patent-text">1-12</sub>Alkyl, C<sub class="style-scope patent-text">3-20</sub>Heterocycle and C<sub class="style-scope patent-text">5-20</sub>Aryl group；</div>
      <div id="p0040" num="0040" class="description-paragraph style-scope patent-text">R<sup class="style-scope patent-text">7</sup>Selected from H, R, OH, OR, SH, SR, NH<sub class="style-scope patent-text">2</sub>, NHR, NHRR ', nitro, Me<sub class="style-scope patent-text">3</sub>Sn and halogen；</div>
      <div id="p0041" num="0041" class="description-paragraph style-scope patent-text">R " is C<sub class="style-scope patent-text">3-12</sub>Alkylidene group, the chain can be interrupted by item below one or more: hetero atom, such as O, S,
NR<sup class="style-scope patent-text">N2</sup>(wherein, R<sup class="style-scope patent-text">N2</sup>It is H or C<sub class="style-scope patent-text">1-4</sub>Alkyl) and/or aromatic ring, such as benzene or pyridine；</div>
      <div id="p0042" num="0042" class="description-paragraph style-scope patent-text">Y and Y ' is selected from O, S or NH；</div>
      <div id="p0043" num="0043" class="description-paragraph style-scope patent-text">R<sup class="style-scope patent-text">6’</sup>、R<sup class="style-scope patent-text">7’</sup>、R<sup class="style-scope patent-text">9’</sup>It is respectively selected from and R<sup class="style-scope patent-text">6</sup>、R<sup class="style-scope patent-text">7</sup>And R<sup class="style-scope patent-text">9</sup>Identical group；</div>
      <div id="p0044" num="0044" class="description-paragraph style-scope patent-text">R<sup class="style-scope patent-text">20</sup>It is H or Me and R<sup class="style-scope patent-text">21a</sup>And R<sup class="style-scope patent-text">21b</sup>All it is H or is formed together=O；</div>
      <div id="p0045" num="0045" class="description-paragraph style-scope patent-text">R<sup class="style-scope patent-text">L</sup>It is the connector for being connected to cell binding agent；</div>
      <div id="p0046" num="0046" class="description-paragraph style-scope patent-text">R<sup class="style-scope patent-text">11b</sup>Selected from OH, OR<sup class="style-scope patent-text">A</sup>, wherein R<sup class="style-scope patent-text">A</sup>It is C<sub class="style-scope patent-text">1-4</sub>Alkyl and SO<sub class="style-scope patent-text">z</sub>M, wherein z be 2 or 3 and M be unit price it is medicinal sun from
Son.</div>
      <div id="p0047" num="0047" class="description-paragraph style-scope patent-text">The compound that the second aspect of the present invention provides the first aspect of the present invention is being manufactured for treating proliferative disease
Purposes in the medicament of disease.Second aspect additionally provides the first aspect of the present invention used in the treatment of proliferative diseases
Compound.</div>
      <div id="p0048" num="0048" class="description-paragraph style-scope patent-text">Those of ordinary skill in the art can be readily determined whether candidate compound treats any particular cell types
Proliferative disorders.For example, describing measuring method in the following examples, they may be conveniently used evaluation specific compound
Provided activity.</div>
      <div id="p0049" num="0049" class="description-paragraph style-scope patent-text">The third aspect of the present invention provides the method for the compound of production the first aspect of the present invention, including with following
At least one of method and step out.</div>
      <div id="p0050" num="0050" class="description-paragraph style-scope patent-text">In fourth aspect, the present invention relates to the conjugate of the dimer of the PBD comprising being connected to targeting agent or its pharmaceutical salts
Or solvate (ibid), wherein PBD dimer is the derivative of Formulas I.</div>
      <div id="p0051" num="0051" class="description-paragraph style-scope patent-text">In some embodiments, conjugate has following formula IV:</div>
      <div id="p0052" num="0052" class="description-paragraph style-scope patent-text">L-(R<sup class="style-scope patent-text">L’</sup>-D)<sub class="style-scope patent-text">p</sub>(IV),</div>
      <div id="p0053" num="0053" class="description-paragraph style-scope patent-text">Or its pharmaceutical salts or solvate, wherein L is with body unit (that is, targeting agent), R<sup class="style-scope patent-text">L</sup>' it is connector unit and D
It is drug unit, which is the PBD dimer of Formulas I, in addition to R<sup class="style-scope patent-text">L’</sup>Instead of R<sup class="style-scope patent-text">L</sup>.Therefore, D is Formula II:</div>
      <div id="p0054" num="0054" class="description-paragraph style-scope patent-text">
        <span class="patent-image-not-available style-scope patent-text"></span>
      </div>
      <div id="p0055" num="0055" class="description-paragraph style-scope patent-text">Wherein, wave indicates R<sup class="style-scope patent-text">L’</sup>Attachment point.</div>
      <div id="p0056" num="0056" class="description-paragraph style-scope patent-text">Subscript p in formula IV is integer of 1 to 20.Therefore, conjugate includes and is covalently attached at least by connector unit
One drug unit matches body unit.It is the targeting agent for being bound to targeting moiety with body unit, is hereafter more fully retouched
It states.For example, can definitely be bound to cellular component (cell binding agent) with body unit or be bound to other interested targets point
Son.Therefore, the present invention also provides the methods for treating for example various cancers and autoimmune disease.These method packets
Include the use of conjugate, wherein with body unit be the targeting agent for being definitely bound to target molecule.It can be such as egg with body unit
White matter, polypeptide or the peptide such as antigen-binding fragment of antibody, antibody or other bonding agents, such as Fc fusion protein.</div>
      <div id="p0057" num="0057" class="description-paragraph style-scope patent-text">Drugloading rate (drug loading) is represented by p, often matches the number of body unit (for example, antibody) drug molecule.Carry medicine
Amount can be in the range of often matching body unit (for example, Ab or mAb) 1 to 20 drug unit (D).For composition, p is represented
The drug loading of conjugate in the composition, and p is in the range of 1 to 20.</div>
      <div id="p0058" num="0058" class="description-paragraph style-scope patent-text">A further aspect of the invention provides the compound of formula A:</div>
      <div id="p0059" num="0059" class="description-paragraph style-scope patent-text">
        <span class="patent-image-not-available style-scope patent-text"></span>
      </div>
      <div id="p0060" num="0060" class="description-paragraph style-scope patent-text">And its salt and solvate, wherein all substituent groups are as defined above.</div>
    </disclosure>
    <mode-for-invention class="style-scope patent-text">
      <div id="p0061" num="0061" class="description-paragraph style-scope patent-text">Specific embodiment</div>
      <div id="p0062" num="0062" class="description-paragraph style-scope patent-text">Definition</div>
      <div id="p0063" num="0063" class="description-paragraph style-scope patent-text">Medicinal cation</div>
      <div id="p0064" num="0064" class="description-paragraph style-scope patent-text">Discussed in Berge, et al., J.Pharm.Sci., 66,1-19 (1977) it is medicinal unit price and divalent sun from
The example of son, is incorporated by reference herein.</div>
      <div id="p0065" num="0065" class="description-paragraph style-scope patent-text">Medicinal cation can be inorganic cation or organic cation.</div>
      <div id="p0066" num="0066" class="description-paragraph style-scope patent-text">The example of medicinal monovalent inorganic cation includes but is not limited to alkali metal ion such as Na<sup class="style-scope patent-text">+</sup>And K<sup class="style-scope patent-text">+</sup>.Medicinal divalent inorganic
The example of cation includes but is not limited to alkaline earth metal cation such as Ca<sup class="style-scope patent-text">2+</sup>And Mg<sup class="style-scope patent-text">2+</sup>.The example of medicinal organic cation include but
Ammonium ion is not limited to (that is, NH<sub class="style-scope patent-text">4</sub> <sup class="style-scope patent-text">+</sup>) and replace ammonium ion (for example, NH<sub class="style-scope patent-text">3</sub>R<sup class="style-scope patent-text">+</sup>、NH<sub class="style-scope patent-text">2</sub>R<sub class="style-scope patent-text">2</sub> <sup class="style-scope patent-text">+</sup>、NHR<sub class="style-scope patent-text">3</sub> <sup class="style-scope patent-text">+</sup>、NR<sub class="style-scope patent-text">4</sub> <sup class="style-scope patent-text">+</sup>).Some suitable substitutions
Ammonium ion example be derived from it is those of following: ethamine, diethylamine, dicyclohexyl amine, triethylamine, butylamine, ethylenediamine, ethyl alcohol
Amine, diethanol amine, piperazine, benzylamine, phenylbenzylamine, choline, meglumine and tromethamine and amino acid, such as lysine and essence
Propylhomoserin.The example of common quaternary ammonium ion is N (CH<sub class="style-scope patent-text">3</sub>)<sub class="style-scope patent-text">4</sub> <sup class="style-scope patent-text">+</sup>。</div>
      <div id="p0067" num="0067" class="description-paragraph style-scope patent-text">Substituent group</div>
      <div id="p0068" num="0068" class="description-paragraph style-scope patent-text">As it is used herein, phrase " optionally substituted " be related to its can be it is unsubstituted or its can be it is substituted
Female group.</div>
      <div id="p0069" num="0069" class="description-paragraph style-scope patent-text">Otherwise the term as used herein " substituted " is related to the mother with one or more substituent groups unless otherwise specified,
Group.Term " substituent group " be herein defined as in a conventional sense using and refer to such chemical part, be covalently attached
In, or if applicable, condense in female group.Various substituent groups are well-known, and for they formation and
The method for being introduced to various female groups is also well-known.</div>
      <div id="p0070" num="0070" class="description-paragraph style-scope patent-text">The example of substituent group is hereinafter more fully described.</div>
      <div id="p0071" num="0071" class="description-paragraph style-scope patent-text">C<sub class="style-scope patent-text">1-12</sub>Alkyl: as it is used herein, term " C<sub class="style-scope patent-text">1-12</sub>Alkyl " be related to by from 1 to 12 carbon atom hydrocarbon
The carbon atom of compound removes the obtained monovalent moiety of hydrogen atom, can be aliphatic or alicyclic, and it can be
Saturated or unsaturated (such as part is unsaturated, completely unsaturated).As it is used herein, term " C<sub class="style-scope patent-text">1-4</sub>Alkyl " relates to
It, can be with and by removing the obtained monovalent moiety of hydrogen atom from the carbon atom of the hydrocarbon compound with 1 to 4 carbon atom
It is aliphatic or alicyclic, and it can be saturated or unsaturated (such as part is unsaturated, completely unsaturated).
Therefore, term " alkyl " includes subclass discussed below: alkenyl, alkynyl, naphthenic base etc..</div>
      <div id="p0072" num="0072" class="description-paragraph style-scope patent-text">The example of saturated alkyl group includes but is not limited to methyl (C<sub class="style-scope patent-text">1</sub>), ethyl (C<sub class="style-scope patent-text">2</sub>), propyl (C<sub class="style-scope patent-text">3</sub>), butyl (C<sub class="style-scope patent-text">4</sub>), penta
Base (C<sub class="style-scope patent-text">5</sub>), hexyl (C<sub class="style-scope patent-text">6</sub>) and heptyl (C<sub class="style-scope patent-text">7</sub>)。</div>
      <div id="p0073" num="0073" class="description-paragraph style-scope patent-text">The example of saturated linear alkyl group includes but is not limited to methyl (C<sub class="style-scope patent-text">1</sub>), ethyl (C<sub class="style-scope patent-text">2</sub>), n-propyl (C<sub class="style-scope patent-text">3</sub>), normal-butyl
(C<sub class="style-scope patent-text">4</sub>), n-pentyl (amyl) (C<sub class="style-scope patent-text">5</sub>), n-hexyl (C<sub class="style-scope patent-text">6</sub>) and n-heptyl (C<sub class="style-scope patent-text">7</sub>)。</div>
      <div id="p0074" num="0074" class="description-paragraph style-scope patent-text">The example for being saturated branched alkyl group includes isopropyl (C<sub class="style-scope patent-text">3</sub>), isobutyl group (C<sub class="style-scope patent-text">4</sub>), sec-butyl (C<sub class="style-scope patent-text">4</sub>), tert-butyl
(C<sub class="style-scope patent-text">4</sub>), isopentyl (C<sub class="style-scope patent-text">5</sub>) and neopentyl (C<sub class="style-scope patent-text">5</sub>)。</div>
      <div id="p0075" num="0075" class="description-paragraph style-scope patent-text">C<sub class="style-scope patent-text">2-12</sub>Alkenyl: used herein, term " C<sub class="style-scope patent-text">2-12</sub>Alkenyl " is related to the alkyl with one or more carbon-carbon double bonds
Group.</div>
      <div id="p0076" num="0076" class="description-paragraph style-scope patent-text">The example of unsaturated alkenyl group includes but is not limited to vinyl (ethenyl) (vinyl (vinyl) ,-CH=
CH<sub class="style-scope patent-text">2</sub>), 1- acrylic (- CH=CH-CH<sub class="style-scope patent-text">3</sub>), 2- acrylic (allyl ,-CH-CH=CH<sub class="style-scope patent-text">2</sub>), isopropenyl (1- ethylene methacrylic
Base ,-C (CH<sub class="style-scope patent-text">3</sub>)=CH<sub class="style-scope patent-text">2</sub>), cyclobutenyl (C<sub class="style-scope patent-text">4</sub>), pentenyl (C<sub class="style-scope patent-text">5</sub>) and hexenyl (C<sub class="style-scope patent-text">6</sub>)。</div>
      <div id="p0077" num="0077" class="description-paragraph style-scope patent-text">C<sub class="style-scope patent-text">2-12</sub>Alkynyl: as it is used herein, term " C<sub class="style-scope patent-text">2-12</sub>Alkynyl " is related to the alkane with one or more carbon-carbon triple bonds
Base group.</div>
      <div id="p0078" num="0078" class="description-paragraph style-scope patent-text">The example of unsaturated alkynyl group include but is not limited to acetenyl (- C ≡ CH) and 2-propynyl (propargyl ,-
CH<sub class="style-scope patent-text">2</sub>-C≡CH)。</div>
      <div id="p0079" num="0079" class="description-paragraph style-scope patent-text">C<sub class="style-scope patent-text">3-12</sub>Naphthenic base: as it is used herein, term " C<sub class="style-scope patent-text">3-12</sub>Naphthenic base " is related to alkyl group, is also ring group base
Group；That is, by removing the monovalent moiety that hydrogen atom obtains, monovalent moiety tool from the alicyclic ring atom of cyclic hydrocarbon (carbocyclic ring) compound
There are 3 to 7 carbon atoms, including 3 to 7 annular atoms.</div>
      <div id="p0080" num="0080" class="description-paragraph style-scope patent-text">The example of group of naphthene base include but is not limited to be originated from it is those of following:</div>
      <div id="p0081" num="0081" class="description-paragraph style-scope patent-text">It is saturated monocycle hydrocarbon compound:</div>
      <div id="p0082" num="0082" class="description-paragraph style-scope patent-text">Cyclopropane (C<sub class="style-scope patent-text">3</sub>), cyclobutane (C<sub class="style-scope patent-text">4</sub>), pentamethylene (C<sub class="style-scope patent-text">5</sub>), hexamethylene (C<sub class="style-scope patent-text">6</sub>), cycloheptane (C<sub class="style-scope patent-text">7</sub>), methyl cyclopropane (C<sub class="style-scope patent-text">4</sub>)、
Dimethylcyclopropane (C<sub class="style-scope patent-text">5</sub>), methyl cyclobutane (C<sub class="style-scope patent-text">5</sub>), dimethylcyclobutane (C<sub class="style-scope patent-text">6</sub>), methyl cyclopentane (C<sub class="style-scope patent-text">6</sub>), dimethylcyclopentane
(C<sub class="style-scope patent-text">7</sub>) and hexahydrotoluene (C<sub class="style-scope patent-text">7</sub>)；Unsaturated monocyclic hydrocarbon compound:</div>
      <div id="p0083" num="0083" class="description-paragraph style-scope patent-text">Cyclopropylene (C<sub class="style-scope patent-text">3</sub>), cyclobutane (C<sub class="style-scope patent-text">4</sub>), cyclopentene (C<sub class="style-scope patent-text">5</sub>), cyclohexene (C<sub class="style-scope patent-text">6</sub>), methyl cyclopropene (C<sub class="style-scope patent-text">4</sub>), dimethyl cyclopropyl
Alkene (C<sub class="style-scope patent-text">5</sub>), methyl cyclobutane (C<sub class="style-scope patent-text">5</sub>), dimethyl cyclobutane (C<sub class="style-scope patent-text">6</sub>), methyl cyclopentene (C<sub class="style-scope patent-text">6</sub>), dimethylcyclopentene (C<sub class="style-scope patent-text">7</sub>) and methyl ring
Hexene (C<sub class="style-scope patent-text">7</sub>)；And</div>
      <div id="p0084" num="0084" class="description-paragraph style-scope patent-text">It is saturated polycyclic hydrocarbon compounds:</div>
      <div id="p0085" num="0085" class="description-paragraph style-scope patent-text">Norcarane (C<sub class="style-scope patent-text">7</sub>), norpinane (C<sub class="style-scope patent-text">7</sub>), norcamphane (C<sub class="style-scope patent-text">7</sub>)。</div>
      <div id="p0086" num="0086" class="description-paragraph style-scope patent-text">C<sub class="style-scope patent-text">3-20</sub>Heterocycle: as it is used herein, term " C<sub class="style-scope patent-text">3-20</sub>Heterocycle " is related to former by the ring from heterocyclic compound
The monovalent moiety that hydrogen atom obtains is removed on son, which has 3 to 20 annular atoms, wherein 1 to 10 is ring hetero atom.
Preferably, each ring has 3 to 7 annular atoms, wherein 1 to 4 is ring hetero atom.</div>
      <div id="p0087" num="0087" class="description-paragraph style-scope patent-text">In this context, prefix (such as C<sub class="style-scope patent-text">3-20</sub>、C<sub class="style-scope patent-text">3-7</sub>、C<sub class="style-scope patent-text">5-6</sub>Deng) indicate the number of annular atom or the number of annular atom
Range, but regardless of being carbon atom or hetero atom.For example, as it is used herein, term " C<sub class="style-scope patent-text">5-6</sub>Heterocycle " is related to having 5 or 6
The heterocyclyl groups of a annular atom.</div>
      <div id="p0088" num="0088" class="description-paragraph style-scope patent-text">The example of monocyclic heterocycles base group include but is not limited to be originated from it is those of following:</div>
      <div id="p0089" num="0089" class="description-paragraph style-scope patent-text">N<sub class="style-scope patent-text">1</sub>: aziridine (C<sub class="style-scope patent-text">3</sub>), azetidine (C<sub class="style-scope patent-text">4</sub>), pyrrolidines (tetrahydropyrrole) (C<sub class="style-scope patent-text">5</sub>), pyrrolin (for example,
3- pyrrolin, 2,5- pyrrolin) (C<sub class="style-scope patent-text">5</sub>), 2H- pyrroles or 3H- pyrroles (different pyrroles, isoxazole) (C<sub class="style-scope patent-text">5</sub>), piperidines (C<sub class="style-scope patent-text">6</sub>), dihydro
Pyridine (C<sub class="style-scope patent-text">6</sub>), tetrahydropyridine (C<sub class="style-scope patent-text">6</sub>), azatropylidene (C<sub class="style-scope patent-text">7</sub>)；</div>
      <div id="p0090" num="0090" class="description-paragraph style-scope patent-text">O<sub class="style-scope patent-text">1</sub>: oxirane (C<sub class="style-scope patent-text">3</sub>), oxetanes (C<sub class="style-scope patent-text">4</sub>), tetrahydrofuran (tetrahydrofuran) (C<sub class="style-scope patent-text">5</sub>), oxygen Polymorphs two
Alkene (dihydrofuran) (C<sub class="style-scope patent-text">5</sub>), oxepane (oxinane) (C<sub class="style-scope patent-text">6</sub>), dihydropyran (C<sub class="style-scope patent-text">6</sub>), pyrans (C<sub class="style-scope patent-text">6</sub>), oxa- Zhuo ((C<sub class="style-scope patent-text">7</sub>)；</div>
      <div id="p0091" num="0091" class="description-paragraph style-scope patent-text">S<sub class="style-scope patent-text">1</sub>: thiirane (C<sub class="style-scope patent-text">3</sub>), Thietane (C<sub class="style-scope patent-text">4</sub>), tiacyclopentane (thiophane) (C<sub class="style-scope patent-text">5</sub>), thia hexamethylene
(tetrahydric thiapyran) (C<sub class="style-scope patent-text">6</sub>), thia cycloheptane (thiepane) (C<sub class="style-scope patent-text">7</sub>)；</div>
      <div id="p0092" num="0092" class="description-paragraph style-scope patent-text">O<sub class="style-scope patent-text">2</sub>: dioxolane (C<sub class="style-scope patent-text">5</sub>), dioxane (C<sub class="style-scope patent-text">6</sub>) and Dioxepane (C<sub class="style-scope patent-text">7</sub>)；</div>
      <div id="p0093" num="0093" class="description-paragraph style-scope patent-text">O<sub class="style-scope patent-text">3</sub>: trioxane (C<sub class="style-scope patent-text">6</sub>)；</div>
      <div id="p0094" num="0094" class="description-paragraph style-scope patent-text">N<sub class="style-scope patent-text">2</sub>: imidazolidine (C<sub class="style-scope patent-text">5</sub>), pyrazolidine (two azo alkane) (C<sub class="style-scope patent-text">5</sub>), imidazoline (C<sub class="style-scope patent-text">5</sub>), pyrazoline (pyrazoline) (C<sub class="style-scope patent-text">5</sub>), piperazine
Piperazine (C<sub class="style-scope patent-text">6</sub>)；</div>
      <div id="p0095" num="0095" class="description-paragraph style-scope patent-text">N<sub class="style-scope patent-text">1</sub>O<sub class="style-scope patent-text">1</sub>: tetrahydro oxazole (C<sub class="style-scope patent-text">5</sub>), dihydro-oxazole (C<sub class="style-scope patent-text">5</sub>), tetrahydro isoxazole (C<sub class="style-scope patent-text">5</sub>), dihydro-isoxazole (C<sub class="style-scope patent-text">5</sub>), morpholine (C<sub class="style-scope patent-text">6</sub>)、
Tetrahydro oxazines (C<sub class="style-scope patent-text">6</sub>), dihydro oxazines (C<sub class="style-scope patent-text">6</sub>), oxazines (C<sub class="style-scope patent-text">6</sub>)；</div>
      <div id="p0096" num="0096" class="description-paragraph style-scope patent-text">N<sub class="style-scope patent-text">1</sub>S<sub class="style-scope patent-text">1</sub>: thiazoline (C<sub class="style-scope patent-text">5</sub>), thiazolidine (C<sub class="style-scope patent-text">5</sub>), thiomorpholine (C<sub class="style-scope patent-text">6</sub>)；</div>
      <div id="p0097" num="0097" class="description-paragraph style-scope patent-text">N<sub class="style-scope patent-text">2</sub>O<sub class="style-scope patent-text">1</sub>: oxadiazines (C<sub class="style-scope patent-text">6</sub>)；</div>
      <div id="p0098" num="0098" class="description-paragraph style-scope patent-text">O<sub class="style-scope patent-text">1</sub>S<sub class="style-scope patent-text">1</sub>: oxygen dithiole (oxathiole) (C<sub class="style-scope patent-text">5</sub>) and thioxane (C<sub class="style-scope patent-text">6</sub>)；With</div>
      <div id="p0099" num="0099" class="description-paragraph style-scope patent-text">N<sub class="style-scope patent-text">1</sub>O<sub class="style-scope patent-text">1</sub>S<sub class="style-scope patent-text">1</sub>: dislike thiazine (C<sub class="style-scope patent-text">6</sub>)。</div>
      <div id="p0100" num="0100" class="description-paragraph style-scope patent-text">The example of substituted monocyclic heterocycles base group includes those of the carbohydrate from loop type, for example, furanose (C<sub class="style-scope patent-text">5</sub>)
Such as arabinofuranose, lysol furanose, ribofuranose and furyl xylose and pyranose (C<sub class="style-scope patent-text">6</sub>) such as pyrans allose, pyrans Ah
Tall and erect sugar, glucopyranose, mannopyranose, pyrans gulose, pyrans idose (idopyranose), galactopyranose and pyrrole
Mutter talose (talopyranose).</div>
      <div id="p0101" num="0101" class="description-paragraph style-scope patent-text">C<sub class="style-scope patent-text">5-20</sub>Aryl: as it is used herein, term " C<sub class="style-scope patent-text">5-20</sub>Aryl " is related to former by the aromatic ring from aromatic compound
The monovalent moiety that hydrogen atom obtains is removed on son, which has 3 to 20 annular atoms.As used herein, term " C<sub class="style-scope patent-text">5-7</sub>Virtue
Base " is related to removing the monovalent moiety that hydrogen atom obtains from the aromatic ring atom of aromatic compound, which has 5 to 7 ring originals
Son, and as used herein, term " C<sub class="style-scope patent-text">5-10</sub>Aryl " is related to obtaining from the aromatic ring atom of aromatic compound removing hydrogen atom
Monovalent moiety, the part have 5 to 10 annular atoms.Preferably, each ring has 5 to 7 annular atoms.</div>
      <div id="p0102" num="0102" class="description-paragraph style-scope patent-text">In this context, prefix (such as C<sub class="style-scope patent-text">3-20</sub>、C<sub class="style-scope patent-text">5-7</sub>、C<sub class="style-scope patent-text">5-6</sub>、C<sub class="style-scope patent-text">5-10</sub>Deng) indicate annular atom (carbon atom or hetero atom)
Number or annular atom number range.For example, as it is used herein, term " C<sub class="style-scope patent-text">5-6</sub>Aryl " is related to having 5 or 6 ring originals
The aryl group of son.</div>
      <div id="p0103" num="0103" class="description-paragraph style-scope patent-text">Such as in " carbon aryl group ", annular atom can be entirely carbon atom.</div>
      <div id="p0104" num="0104" class="description-paragraph style-scope patent-text">The example of carbon aryl group include but is not limited to be originated from it is those of following: benzene (that is, phenyl) (C<sub class="style-scope patent-text">6</sub>), naphthalene (C<sub class="style-scope patent-text">10</sub>), Azulene
(C<sub class="style-scope patent-text">10</sub>), anthracene (C<sub class="style-scope patent-text">14</sub>), phenanthrene (C<sub class="style-scope patent-text">14</sub>), aphthacene (C<sub class="style-scope patent-text">18</sub>) and pyrene (C<sub class="style-scope patent-text">16</sub>)。</div>
      <div id="p0105" num="0105" class="description-paragraph style-scope patent-text">The example of aryl group comprising condensed ring (therein at least one be aromatic ring) include but is not limited to be originated from it is below
Group: indane (for example, 2,3- dihydro -1H- indenes) (C<sub class="style-scope patent-text">9</sub>), indenes (C<sub class="style-scope patent-text">9</sub>), different indenes (C<sub class="style-scope patent-text">9</sub>), tetrahydronaphthalene (1,2,3,4-tetralin)
(C<sub class="style-scope patent-text">10</sub>), acenaphthene (C<sub class="style-scope patent-text">12</sub>), fluorenes (C<sub class="style-scope patent-text">13</sub>), non-that alkene (C<sub class="style-scope patent-text">13</sub>), vinegar phenanthrene (C<sub class="style-scope patent-text">15</sub>) and aceanthrene (C<sub class="style-scope patent-text">16</sub>)。</div>
      <div id="p0106" num="0106" class="description-paragraph style-scope patent-text">Alternatively, such as in " heteroaryl groups ", annular atom may include one or more hetero atoms.Monocycle heteroaryl
The example of base group include but is not limited to be originated from it is those of following:</div>
      <div id="p0107" num="0107" class="description-paragraph style-scope patent-text">N<sub class="style-scope patent-text">1</sub>: pyrroles (azoles) (C<sub class="style-scope patent-text">5</sub>), pyridine (azine) (C<sub class="style-scope patent-text">6</sub>)；</div>
      <div id="p0108" num="0108" class="description-paragraph style-scope patent-text">O<sub class="style-scope patent-text">1</sub>: furans (divinylene oxide, oxole) (C<sub class="style-scope patent-text">5</sub>)；</div>
      <div id="p0109" num="0109" class="description-paragraph style-scope patent-text">S<sub class="style-scope patent-text">1</sub>: thiophene (thiophene) (thiophene, thiole) (C<sub class="style-scope patent-text">5</sub>)；</div>
      <div id="p0110" num="0110" class="description-paragraph style-scope patent-text">N<sub class="style-scope patent-text">1</sub>O<sub class="style-scope patent-text">1</sub>: oxazole (C<sub class="style-scope patent-text">5</sub>), isoxazole (C<sub class="style-scope patent-text">5</sub>), isooxazine (C<sub class="style-scope patent-text">6</sub>)；</div>
      <div id="p0111" num="0111" class="description-paragraph style-scope patent-text">N<sub class="style-scope patent-text">2</sub>O<sub class="style-scope patent-text">1</sub>: oxadiazoles (furazan) (C<sub class="style-scope patent-text">5</sub>)；</div>
      <div id="p0112" num="0112" class="description-paragraph style-scope patent-text">N<sub class="style-scope patent-text">3</sub>O<sub class="style-scope patent-text">1</sub>: dislike triazole (C<sub class="style-scope patent-text">5</sub>)；</div>
      <div id="p0113" num="0113" class="description-paragraph style-scope patent-text">N<sub class="style-scope patent-text">1</sub>S<sub class="style-scope patent-text">1</sub>: thiazole (C<sub class="style-scope patent-text">5</sub>), isothiazole (C<sub class="style-scope patent-text">5</sub>)；</div>
      <div id="p0114" num="0114" class="description-paragraph style-scope patent-text">N<sub class="style-scope patent-text">2</sub>: imidazoles (1,3- diazole) (C<sub class="style-scope patent-text">5</sub>), pyrazoles (1,2- diazole) (C<sub class="style-scope patent-text">5</sub>), pyridazine (1,2- diazine) (C<sub class="style-scope patent-text">6</sub>), pyrimidine (1,3-
Diazine) (C<sub class="style-scope patent-text">6</sub>) (for example, cytimidine, thymidine, uracil), pyrazine (1,4-diazines) (C<sub class="style-scope patent-text">6</sub>)；</div>
      <div id="p0115" num="0115" class="description-paragraph style-scope patent-text">N<sub class="style-scope patent-text">3</sub>: triazole (C<sub class="style-scope patent-text">5</sub>), triazine (C<sub class="style-scope patent-text">6</sub>)；With</div>
      <div id="p0116" num="0116" class="description-paragraph style-scope patent-text">N<sub class="style-scope patent-text">4</sub>: tetrazolium (C<sub class="style-scope patent-text">5</sub>)。</div>
      <div id="p0117" num="0117" class="description-paragraph style-scope patent-text">The example of heteroaryl comprising condensed ring includes but is not limited to:</div>
      <div id="p0118" num="0118" class="description-paragraph style-scope patent-text">From benzofuran (O<sub class="style-scope patent-text">1</sub>), isobenzofuran (O<sub class="style-scope patent-text">1</sub>), indoles (N<sub class="style-scope patent-text">1</sub>), iso-indoles (N<sub class="style-scope patent-text">1</sub>), benzazole (N<sub class="style-scope patent-text">1</sub>), indoline
(N<sub class="style-scope patent-text">1</sub>), isoindoline (N<sub class="style-scope patent-text">1</sub>), purine (N<sub class="style-scope patent-text">4</sub>) (for example, adenine, guanine), benzimidazole (N<sub class="style-scope patent-text">2</sub>), indazole (N<sub class="style-scope patent-text">2</sub>), benzoxazoles
(N<sub class="style-scope patent-text">1</sub>O<sub class="style-scope patent-text">1</sub>), benzo isoxazole (N<sub class="style-scope patent-text">1</sub>O<sub class="style-scope patent-text">1</sub>), benzo two dislike cyclopentadienyl (O<sub class="style-scope patent-text">2</sub>), benzofuraxan (N<sub class="style-scope patent-text">2</sub>O<sub class="style-scope patent-text">1</sub>), benzotriazole (N<sub class="style-scope patent-text">3</sub>), benzothiophene
(S<sub class="style-scope patent-text">1</sub>), benzothiazole (N<sub class="style-scope patent-text">1</sub>S<sub class="style-scope patent-text">1</sub>), diazosulfide ((N<sub class="style-scope patent-text">2</sub>S C)<sub class="style-scope patent-text">9</sub>(there are 2 condensed ring)；</div>
      <div id="p0119" num="0119" class="description-paragraph style-scope patent-text">From chromene (O<sub class="style-scope patent-text">1</sub>), heterochromatic alkene (O<sub class="style-scope patent-text">1</sub>), chroman (O<sub class="style-scope patent-text">1</sub>), heterochromatic full (O<sub class="style-scope patent-text">1</sub>), benzdioxan (O<sub class="style-scope patent-text">2</sub>), quinoline (N<sub class="style-scope patent-text">1</sub>), it is different
Quinoline (N<sub class="style-scope patent-text">1</sub>), quinolizine (N<sub class="style-scope patent-text">1</sub>), benzoxazine (N<sub class="style-scope patent-text">1</sub>O<sub class="style-scope patent-text">1</sub>), benzodiazine (N<sub class="style-scope patent-text">2</sub>), pyridopyridine (N<sub class="style-scope patent-text">2</sub>), quinoxaline (N<sub class="style-scope patent-text">2</sub>), quinazoline
(N<sub class="style-scope patent-text">2</sub>), cinnolines (N<sub class="style-scope patent-text">2</sub>), phthalazines (N<sub class="style-scope patent-text">2</sub>), naphthyridines (N<sub class="style-scope patent-text">2</sub>), pteridine (N<sub class="style-scope patent-text">4</sub>) C<sub class="style-scope patent-text">10</sub>(there are 2 condensed ring)；</div>
      <div id="p0120" num="0120" class="description-paragraph style-scope patent-text">From benzodiazepine (N<sub class="style-scope patent-text">2</sub>) C<sub class="style-scope patent-text">11</sub>(there are 2 condensed ring)；</div>
      <div id="p0121" num="0121" class="description-paragraph style-scope patent-text">From carbazole (N<sub class="style-scope patent-text">1</sub>), dibenzofurans (O<sub class="style-scope patent-text">1</sub>), dibenzothiophenes (S<sub class="style-scope patent-text">1</sub>), carboline (N<sub class="style-scope patent-text">2</sub>), pyridine (N pah<sub class="style-scope patent-text">2</sub>), pyrido Yin
Diindyl (N<sub class="style-scope patent-text">2</sub>) C<sub class="style-scope patent-text">13</sub>(there are 3 condensed ring)；With</div>
      <div id="p0122" num="0122" class="description-paragraph style-scope patent-text">From acridine (N<sub class="style-scope patent-text">1</sub>), xanthene (O<sub class="style-scope patent-text">1</sub>), thioxanthene (S<sub class="style-scope patent-text">1</sub>), oxa- xanthene (O<sub class="style-scope patent-text">2</sub>), phenoxazine thiophene (O<sub class="style-scope patent-text">1</sub>S<sub class="style-scope patent-text">1</sub>), azophenlyene (N<sub class="style-scope patent-text">2</sub>), phenoxazine
Piperazine (N<sub class="style-scope patent-text">1</sub>O<sub class="style-scope patent-text">1</sub>), phenthazine (N<sub class="style-scope patent-text">1</sub>S<sub class="style-scope patent-text">1</sub>), thianthrene (S<sub class="style-scope patent-text">2</sub>), phenanthridines (N<sub class="style-scope patent-text">1</sub>), phenanthroline (N<sub class="style-scope patent-text">2</sub>), azophenlyene (N<sub class="style-scope patent-text">2</sub>) C<sub class="style-scope patent-text">14</sub>(there are 3 condensed ring).</div>
      <div id="p0123" num="0123" class="description-paragraph style-scope patent-text">The above group, no matter individually or as another substituent group a part, its own can optionally by be selected from itself
With one or more replaced other substituent groups set forth below.</div>
      <div id="p0124" num="0124" class="description-paragraph style-scope patent-text">Halogen :-F ,-Cl ,-Br and-I.</div>
      <div id="p0125" num="0125" class="description-paragraph style-scope patent-text">Hydroxyl :-OH.</div>
      <div id="p0126" num="0126" class="description-paragraph style-scope patent-text">Ether :-OR, wherein R is ether substituent group, for example, C<sub class="style-scope patent-text">1-7</sub>Alkyl group (also referred to as C<sub class="style-scope patent-text">1-7</sub>Alkoxy base is begged for following
By), C<sub class="style-scope patent-text">3-20</sub>Heterocyclyl groups (also referred to as C<sub class="style-scope patent-text">3-20</sub>Heterocyclyloxy groups) or C<sub class="style-scope patent-text">5-20</sub>Aryl group (also referred to as C<sub class="style-scope patent-text">5-20</sub>Aryloxy group base
Group), preferably C<sub class="style-scope patent-text">1-7</sub>Alkyl group.</div>
      <div id="p0127" num="0127" class="description-paragraph style-scope patent-text">Alkoxy :-OR, wherein R is alkyl group, for example, C<sub class="style-scope patent-text">1-7</sub>Alkyl group.C<sub class="style-scope patent-text">1-7</sub>The example of alkyl group include but
It is not limited to-OMe (methoxyl group) ,-OEt (ethyoxyl) ,-O (nPr) (positive propoxy) ,-O (iPr) (isopropoxy) ,-O (nBu)
(n-butoxy) ,-O (sBu) (sec-butoxy) ,-O (iBu) (isobutoxy) and-O (tBu) (t-butoxy).</div>
      <div id="p0128" num="0128" class="description-paragraph style-scope patent-text">Acetal :-CH (OR<sup class="style-scope patent-text">1</sup>)(OR<sup class="style-scope patent-text">2</sup>), wherein R<sup class="style-scope patent-text">1</sup>And R<sup class="style-scope patent-text">2</sup>It is independently acetal substitutent group, for example, C<sub class="style-scope patent-text">1-7</sub>Alkyl group, C<sub class="style-scope patent-text">3-20</sub>
Heterocyclyl groups or C<sub class="style-scope patent-text">5-20</sub>Aryl group, preferably C<sub class="style-scope patent-text">1-7</sub>Alkyl group, or in the case where " ring " acetal groups, R<sup class="style-scope patent-text">1</sup>And R<sup class="style-scope patent-text">2</sup>
And two oxygen atoms that they are attached and the carbon atom that they are attached are formed together the heterocycle with 4 to 8 annular atoms.Acetal
The example of group includes but is not limited to-CH (OMe)<sub class="style-scope patent-text">2</sub>、-CH(OEt)<sub class="style-scope patent-text">2</sub>With-CH (OMe) (OEt).</div>
      <div id="p0129" num="0129" class="description-paragraph style-scope patent-text">Hemiacetal :-CH (OH) (OR<sup class="style-scope patent-text">1</sup>), wherein R<sup class="style-scope patent-text">1</sup>It is hemiacetal substituent group, for example, C<sub class="style-scope patent-text">1-7</sub>Alkyl group, C<sub class="style-scope patent-text">3-20</sub>Heterocycle
Group or C<sub class="style-scope patent-text">5-20</sub>Aryl group, preferably C<sub class="style-scope patent-text">1-7</sub>Alkyl group.The example of hemiacetal group includes but is not limited to-CH (OH)
(OMe) and-CH (OH) (OEt).</div>
      <div id="p0130" num="0130" class="description-paragraph style-scope patent-text">Ketal :-CR (OR<sup class="style-scope patent-text">1</sup>)(OR<sup class="style-scope patent-text">2</sup>), wherein R<sup class="style-scope patent-text">1</sup>And R<sup class="style-scope patent-text">2</sup>As defined to acetal, and R is that ketal except dehydrogenation takes
Dai Ji, for example, C<sub class="style-scope patent-text">1-7</sub>Alkyl group, C<sub class="style-scope patent-text">3-20</sub>Heterocyclyl groups or C<sub class="style-scope patent-text">5-20</sub>Aryl group, preferably C<sub class="style-scope patent-text">1-7</sub>Alkyl group.Ketal group
The example of group includes but is not limited to-C (Me) (OMe)<sub class="style-scope patent-text">2</sub>、-C(Me)(OEt)<sub class="style-scope patent-text">2</sub>、-C(Me)(OMe)(OEt)、-C(Et)(OMe)<sub class="style-scope patent-text">2</sub>、
-C(Et)(OEt)<sub class="style-scope patent-text">2</sub>With-C (Et) (OMe) (OEt).</div>
      <div id="p0131" num="0131" class="description-paragraph style-scope patent-text">Hemiketal :-CR (OH) (OR<sup class="style-scope patent-text">1</sup>), wherein R<sup class="style-scope patent-text">1</sup>As defined to hemiacetal, and R is that hemiketal except dehydrogenation takes
Dai Ji, for example, C<sub class="style-scope patent-text">1-7</sub>Alkyl group, C<sub class="style-scope patent-text">3-20</sub>Heterocyclyl groups or C<sub class="style-scope patent-text">5-20</sub>Aryl group, preferably C<sub class="style-scope patent-text">1-7</sub>Alkyl group.Hemiketal
The example of group includes but is not limited to-C (Me) (OH) (OMe) ,-C (Et) (OH) (OMe) ,-C (Me) (OH) (OEt) and-C
(Et)(OH)(OEt)。</div>
      <div id="p0132" num="0132" class="description-paragraph style-scope patent-text">Oxo (ketone group, -one) :=O.</div>
      <div id="p0133" num="0133" class="description-paragraph style-scope patent-text">Thioketones (Thione) (thio ketone (thioketone)) :=S.</div>
      <div id="p0134" num="0134" class="description-paragraph style-scope patent-text">Imino group (imines) :=NR, wherein R is imino group substituent group, for example, hydrogen, C<sub class="style-scope patent-text">1-7</sub>Alkyl group, C<sub class="style-scope patent-text">3-20</sub>Heterocycle
Group or C<sub class="style-scope patent-text">5-20</sub>Aryl group, preferably hydrogen or C<sub class="style-scope patent-text">1-7</sub>Alkyl group.The example of ester group include but is not limited to=NH ,=
NMe ,=NEt and=NPh.</div>
      <div id="p0135" num="0135" class="description-paragraph style-scope patent-text">Formoxyl (carboxaldehyde radicals (carbaldehyde), formaldehyde (carboxaldehyde)) :-C (=O) H.</div>
      <div id="p0136" num="0136" class="description-paragraph style-scope patent-text">Acyl group (ketone group) :-C (=O) R, wherein R is acyl substituent, for example, C<sub class="style-scope patent-text">1-7</sub>Alkyl group (also referred to as C<sub class="style-scope patent-text">1-7</sub>Alkane
Carboxyl groups or C<sub class="style-scope patent-text">1-7</sub>Alkanoyl (alkanoyl)), C<sub class="style-scope patent-text">3-20</sub>Heterocyclyl groups (also referred to as C<sub class="style-scope patent-text">3-20</sub>Heterocyclic acyl group) or C<sub class="style-scope patent-text">5-20</sub>Virtue
Base group (also referred to as C<sub class="style-scope patent-text">5-20</sub>Aroyl radicals), preferably C<sub class="style-scope patent-text">1-7</sub>Alkyl group.The example of carboxyl groups include but is not limited to-
C (=O) CH<sub class="style-scope patent-text">3</sub>(acetyl group) ,-C (=O) CH<sub class="style-scope patent-text">2</sub>CH<sub class="style-scope patent-text">3</sub>(propiono) ,-C (=O) C (CH<sub class="style-scope patent-text">3</sub>)<sub class="style-scope patent-text">3</sub>(tert- bytyry) and-C (=O) Ph
(benzoyl, acyl benzene).</div>
      <div id="p0137" num="0137" class="description-paragraph style-scope patent-text">Carboxyl (carboxylic acid) :-C (=O) OH.</div>
      <div id="p0138" num="0138" class="description-paragraph style-scope patent-text">Thiocarboxyl group (thiocarboxylic acid) :-C (=S) SH.</div>
      <div id="p0139" num="0139" class="description-paragraph style-scope patent-text">Monothio carboxyl (monothiocarboxylic acid) :-C (=O) SH.</div>
      <div id="p0140" num="0140" class="description-paragraph style-scope patent-text">Thion carboxyl (thiono carboxylic acid) :-C (=S) OH.</div>
      <div id="p0141" num="0141" class="description-paragraph style-scope patent-text">Imidic acid :-C (=NH) OH.</div>
      <div id="p0142" num="0142" class="description-paragraph style-scope patent-text">Hydroxamic acid :-C (=NOH) OH.</div>
      <div id="p0143" num="0143" class="description-paragraph style-scope patent-text">Ester (carboxylate (carboxylate), carboxylate (carboxylic acid ester), oxygen carbonyl) :-C (=
O) OR, wherein R is ester substituent group, for example, C<sub class="style-scope patent-text">1-7</sub>Alkyl group, C<sub class="style-scope patent-text">3-20</sub>Heterocyclyl groups or C<sub class="style-scope patent-text">5-20</sub>Aryl group, preferably
C<sub class="style-scope patent-text">1-7</sub>Alkyl group.The example of ester group includes but is not limited to-C (=O) OCH<sub class="style-scope patent-text">3</sub>,-C (=O) OCH<sub class="style-scope patent-text">2</sub>CH<sub class="style-scope patent-text">3</sub>,-C (=O) OC (CH<sub class="style-scope patent-text">3</sub>)<sub class="style-scope patent-text">3</sub>
With-C (=O) OPh.</div>
      <div id="p0144" num="0144" class="description-paragraph style-scope patent-text">Acyloxy (reversed ester) :-OC (=O) R, wherein R is acyloxy substituent group, for example, C<sub class="style-scope patent-text">1-7</sub>Alkyl group, C<sub class="style-scope patent-text">3-20</sub>It is miscellaneous
Cyclic groups or C<sub class="style-scope patent-text">5-20</sub>Aryl group, preferably C<sub class="style-scope patent-text">1-7</sub>Alkyl group.The example of acyloxy group includes but is not limited to-OC
(=O) CH<sub class="style-scope patent-text">3</sub>(acetoxyl group) ,-OC (=O) CH<sub class="style-scope patent-text">2</sub>CH<sub class="style-scope patent-text">3</sub>,-OC (=O) C (CH<sub class="style-scope patent-text">3</sub>)<sub class="style-scope patent-text">3</sub>,-OC (=O) Ph and-OC (=O) CH<sub class="style-scope patent-text">2</sub>Ph。</div>
      <div id="p0145" num="0145" class="description-paragraph style-scope patent-text">Oxygroup carbonyloxy group (oxycarboyloxy) :-OC (=O) OR, wherein R is ester substituent group, for example, C<sub class="style-scope patent-text">1-7</sub>Alkyl base
Group, C<sub class="style-scope patent-text">3-20</sub>Heterocyclyl groups or C<sub class="style-scope patent-text">5-20</sub>Aryl group, preferably C<sub class="style-scope patent-text">1-7</sub>Alkyl group.The example of ester group include but is not limited to-
OC (=O) OCH<sub class="style-scope patent-text">3</sub>,-OC (=O) OCH<sub class="style-scope patent-text">2</sub>CH<sub class="style-scope patent-text">3</sub>,-OC (=O) OC (CH<sub class="style-scope patent-text">3</sub>)<sub class="style-scope patent-text">3</sub>With-OC (=O) OPh.</div>
      <div id="p0146" num="0146" class="description-paragraph style-scope patent-text">Amino :-NR<sup class="style-scope patent-text">1</sup>R<sup class="style-scope patent-text">2</sup>, wherein R<sup class="style-scope patent-text">1</sup>And R<sup class="style-scope patent-text">2</sup>It is independently amino-substituent, for example, hydrogen, C<sub class="style-scope patent-text">1-7</sub>Alkyl group is (also referred to as
C<sub class="style-scope patent-text">1-7</sub>Alkyl amino or two-C<sub class="style-scope patent-text">1-7</sub>Alkyl amino), C<sub class="style-scope patent-text">3-20</sub>Heterocyclyl groups or C<sub class="style-scope patent-text">5-20</sub>Aryl group, preferably H or C<sub class="style-scope patent-text">1-7</sub>Alkyl
Group, or in the case where " ring " amino group, R<sup class="style-scope patent-text">1</sup>And R<sup class="style-scope patent-text">2</sup>And the nitrogen-atoms that they are attached is formed together with 4 to 8 ring originals
The heterocycle of son.Amino group can be primary amino group (- NH<sub class="style-scope patent-text">2</sub>), secondary amino group (- NHR<sup class="style-scope patent-text">1</sup>) or tertiary amino (- NHR<sup class="style-scope patent-text">1</sup>R<sup class="style-scope patent-text">2</sup>), and with sun
Ionic species, can be quaternary ammonium (-<sup class="style-scope patent-text">+</sup>NR<sup class="style-scope patent-text">1</sup>R<sup class="style-scope patent-text">2</sup>R<sup class="style-scope patent-text">3</sup>).The example of amino group includes but is not limited to-NH<sub class="style-scope patent-text">2</sub>、-NHCH<sub class="style-scope patent-text">3</sub>、-NHC
(CH<sub class="style-scope patent-text">3</sub>)<sub class="style-scope patent-text">2</sub>、-N(CH<sub class="style-scope patent-text">3</sub>)<sub class="style-scope patent-text">2</sub>、-N(CH<sub class="style-scope patent-text">2</sub>CH<sub class="style-scope patent-text">3</sub>)<sub class="style-scope patent-text">2</sub>With-NHPh.The example of ring type amidogen group includes but is not limited to aziridinyl, azepine
Cyclobutyl, pyrrolidinyl, piperidyl, piperazinyl, morpholino and thiomorpholine generation.</div>
      <div id="p0147" num="0147" class="description-paragraph style-scope patent-text">Acylamino- (carbamoyl, carbamyl, amino carbonyl, formamide) :-C (=O) NR<sup class="style-scope patent-text">1</sup>R<sup class="style-scope patent-text">2</sup>, wherein R<sup class="style-scope patent-text">1</sup>And R<sup class="style-scope patent-text">2</sup>
It is independently the amino-substituent such as defined to amino group.The example of amido groups includes but is not limited to-C (=O)
NH<sub class="style-scope patent-text">2</sub>,-C (=O) NHCH<sub class="style-scope patent-text">3</sub>,-C (=O) N (CH<sub class="style-scope patent-text">3</sub>)<sub class="style-scope patent-text">2</sub>,-C (=O) NHCH<sub class="style-scope patent-text">2</sub>CH<sub class="style-scope patent-text">3</sub>With-C (=O) N (CH<sub class="style-scope patent-text">2</sub>CH<sub class="style-scope patent-text">3</sub>)<sub class="style-scope patent-text">2</sub>And amino base
Group, wherein R<sup class="style-scope patent-text">1</sup>And R<sup class="style-scope patent-text">2</sup>And the nitrogen-atoms that they are attached is formed together heterocycle structure, for example, piperidinyl carbonyl, morpholino carbonyl, sulphur
For morpholino carbonyl and piperazine carbonyl.</div>
      <div id="p0148" num="0148" class="description-paragraph style-scope patent-text">Thio acylamino (thiocarbamoyl) :-C (=S) NR<sup class="style-scope patent-text">1</sup>R<sup class="style-scope patent-text">2</sup>, wherein R<sup class="style-scope patent-text">1</sup>And R<sup class="style-scope patent-text">2</sup>It is independently such as to amino base
The amino-substituent of group's definition.The example of amido groups includes but is not limited to-C (=S) NH<sub class="style-scope patent-text">2</sub>,-C (=S) NHCH<sub class="style-scope patent-text">3</sub>,-C (=
S)N(CH<sub class="style-scope patent-text">3</sub>)<sub class="style-scope patent-text">2</sub>With-C (=S) NHCH<sub class="style-scope patent-text">2</sub>CH<sub class="style-scope patent-text">3</sub>。</div>
      <div id="p0149" num="0149" class="description-paragraph style-scope patent-text">Acylamido (acylamino-) :-NR<sup class="style-scope patent-text">1</sup>C (=O) R<sup class="style-scope patent-text">2</sup>, wherein R<sup class="style-scope patent-text">1</sup>It is amide substituents, for example, hydrogen, C<sub class="style-scope patent-text">1-7</sub>Alkyl base
Group, C<sub class="style-scope patent-text">3-20</sub>Heterocyclyl groups or C<sub class="style-scope patent-text">5-20</sub>Aryl group, preferably hydrogen or C<sub class="style-scope patent-text">1-7</sub>Alkyl group and R<sup class="style-scope patent-text">2</sup>It is acyl substituent, example
Such as, C<sub class="style-scope patent-text">1-7</sub>Alkyl group, C<sub class="style-scope patent-text">3-20</sub>Heterocyclyl groups or C<sub class="style-scope patent-text">5-20</sub>Aryl group, preferably hydrogen or C<sub class="style-scope patent-text">1-7</sub>Alkyl group.Amide group
Example include but is not limited to-NHC (=O) CH<sub class="style-scope patent-text">3</sub>,-NHC (=O) CH<sub class="style-scope patent-text">2</sub>CH<sub class="style-scope patent-text">3</sub>With-NHC (=O) Ph.R<sup class="style-scope patent-text">1</sup>And R<sup class="style-scope patent-text">2</sup>It can shape together
At ring structure, for example, in succinimido, dimaleoyl imino and phthalimide group:</div>
      <div id="p0150" num="0150" class="description-paragraph style-scope patent-text">
        <span class="patent-image-not-available style-scope patent-text"></span>
      </div>
      <div id="p0151" num="0151" class="description-paragraph style-scope patent-text">Amino carbonyloxy group :-OC (=O) NR<sup class="style-scope patent-text">1</sup>R<sup class="style-scope patent-text">2</sup>, wherein R<sup class="style-scope patent-text">1</sup>And R<sup class="style-scope patent-text">2</sup>It is independently such as to be taken to the amino that amino group defines
Dai Ji.The example of amino carbonyloxy group group includes but is not limited to-OC (=O) NH<sub class="style-scope patent-text">2</sub>,-OC (=O) NHMe ,-OC (=O) NMe<sub class="style-scope patent-text">2</sub>With-
OC (=O) NEt<sub class="style-scope patent-text">2</sub>。</div>
      <div id="p0152" num="0152" class="description-paragraph style-scope patent-text">Urea groups :-N (R<sup class="style-scope patent-text">1</sup>)CONR<sup class="style-scope patent-text">2</sup>R<sup class="style-scope patent-text">3</sup>, wherein R<sup class="style-scope patent-text">2</sup>And R<sup class="style-scope patent-text">3</sup>It is independently the amino-substituent such as defined to amino group, and
And R<sup class="style-scope patent-text">1</sup>It is Carbamido substituted base, for example, hydrogen, C<sub class="style-scope patent-text">1-7</sub>Alkyl group, C<sub class="style-scope patent-text">3-20</sub>Heterocyclyl groups or C<sub class="style-scope patent-text">5-20</sub>Aryl group, preferably hydrogen or
C<sub class="style-scope patent-text">1-7</sub>Alkyl group.The example of ureido groups includes but is not limited to-NHCONH<sub class="style-scope patent-text">2</sub>、-NHCONHMe、-NHCONHEt、-NHCONMe<sub class="style-scope patent-text">2</sub>、
-NHCONEt<sub class="style-scope patent-text">2</sub>、-NMeCONH<sub class="style-scope patent-text">2</sub>、-NMeCONHMe、-NMeCONHEt、-NMeCONMe<sub class="style-scope patent-text">2</sub>With-NMeCONEt<sub class="style-scope patent-text">2</sub>。</div>
      <div id="p0153" num="0153" class="description-paragraph style-scope patent-text">Guanidine radicals :-NH-C (=NH) NH<sub class="style-scope patent-text">2</sub>。</div>
      <div id="p0154" num="0154" class="description-paragraph style-scope patent-text">Tetrazole radical: five yuan of aromatic rings with 4 nitrogen-atoms and 1 carbon atom,</div>
      <div id="p0155" num="0155" class="description-paragraph style-scope patent-text">
        <span class="patent-image-not-available style-scope patent-text"></span>
      </div>
      <div id="p0156" num="0156" class="description-paragraph style-scope patent-text">Imino group :=NR, wherein R is imino group substituent group, for example, hydrogen, C<sub class="style-scope patent-text">1-7</sub>Alkyl group, C<sub class="style-scope patent-text">3-20</sub>Heterocyclyl groups
Or C<sub class="style-scope patent-text">5-20</sub>Aryl group, preferably H or C<sub class="style-scope patent-text">1-7</sub>Alkyl group.The example of imino group includes but is not limited to=NH ,=NMe
With=NEt.</div>
      <div id="p0157" num="0157" class="description-paragraph style-scope patent-text">Amidine (amidino groups) :-C (=NR) NR<sub class="style-scope patent-text">2</sub>, wherein each R is amidine substituent group, for example, hydrogen, C<sub class="style-scope patent-text">1-7</sub>Alkyl group, C<sub class="style-scope patent-text">3-20</sub>Heterocycle
Base group or C<sub class="style-scope patent-text">5-20</sub>Aryl group, preferably H or C<sub class="style-scope patent-text">1-7</sub>Alkyl group.The example of amidine group includes but is not limited to-C (=NH)
NH<sub class="style-scope patent-text">2</sub>,-C (=NH) NMe<sub class="style-scope patent-text">2</sub>With-C (=NMe) NMe<sub class="style-scope patent-text">2</sub>。</div>
      <div id="p0158" num="0158" class="description-paragraph style-scope patent-text">Nitro :-NO<sub class="style-scope patent-text">2</sub>。</div>
      <div id="p0159" num="0159" class="description-paragraph style-scope patent-text">Nitroso :-NO.</div>
      <div id="p0160" num="0160" class="description-paragraph style-scope patent-text">Azido :-N<sub class="style-scope patent-text">3</sub>。</div>
      <div id="p0161" num="0161" class="description-paragraph style-scope patent-text">Cyano (nitrile (nitrile), nitrile (carbonitrile)) :-CN.</div>
      <div id="p0162" num="0162" class="description-paragraph style-scope patent-text">Isocyano group :-NC.</div>
      <div id="p0163" num="0163" class="description-paragraph style-scope patent-text">Cyanato :-OCN.</div>
      <div id="p0164" num="0164" class="description-paragraph style-scope patent-text">Isocyanato :-NCO.</div>
      <div id="p0165" num="0165" class="description-paragraph style-scope patent-text">Thiocyano (sulphur cyanato) :-SCN.</div>
      <div id="p0166" num="0166" class="description-paragraph style-scope patent-text">Different thiocyano (isothiocyano) :-NCS.</div>
      <div id="p0167" num="0167" class="description-paragraph style-scope patent-text">Sulfydryl (sulfhydryl) (mercaptan (thiol), sulfydryl (mercapto)) :-SH.</div>
      <div id="p0168" num="0168" class="description-paragraph style-scope patent-text">Thioether (sulfide) :-SR, wherein R is thioether substituent, for example, C<sub class="style-scope patent-text">1-7</sub>Alkyl group (also referred to as C<sub class="style-scope patent-text">1-7</sub>Alkylthio group
Group), C<sub class="style-scope patent-text">3-20</sub>Heterocyclyl groups or C<sub class="style-scope patent-text">5-20</sub>Aryl group, preferably C<sub class="style-scope patent-text">1-7</sub>Alkyl group.C<sub class="style-scope patent-text">1-7</sub>The example packet of alkylthio radicals
It includes but is not limited to-SCH<sub class="style-scope patent-text">3</sub>With-SCH<sub class="style-scope patent-text">2</sub>CH<sub class="style-scope patent-text">3</sub>。</div>
      <div id="p0169" num="0169" class="description-paragraph style-scope patent-text">Disulphide :-SS-R, wherein R is disulphide substituent group, for example, C<sub class="style-scope patent-text">1-7</sub>Alkyl group, C<sub class="style-scope patent-text">3-20</sub>Heterocycle base
Group or C<sub class="style-scope patent-text">5-20</sub>Aryl group, preferably C<sub class="style-scope patent-text">1-7</sub>Alkyl group (referred to herein as C<sub class="style-scope patent-text">1-7</sub>Alkyl disulfide).C<sub class="style-scope patent-text">1-7</sub>Alkyl
The example of disulphide group includes but is not limited to-SSCH<sub class="style-scope patent-text">3</sub>With-SSCH<sub class="style-scope patent-text">2</sub>CH<sub class="style-scope patent-text">3</sub>。</div>
      <div id="p0170" num="0170" class="description-paragraph style-scope patent-text">Sulfonium compound (sulfinyl, sulfoxide) :-S (=O) R, wherein R is sulfonium compound substituent group, for example, C<sub class="style-scope patent-text">1-7</sub>Alkyl base
Group, C<sub class="style-scope patent-text">3-20</sub>Heterocyclyl groups or C<sub class="style-scope patent-text">5-20</sub>Aryl group, preferably C<sub class="style-scope patent-text">1-7</sub>Alkyl group.The example of sulfonium compound group includes but not
It is limited to-S (=O) CH<sub class="style-scope patent-text">3</sub>With-S (=O) CH<sub class="style-scope patent-text">2</sub>CH<sub class="style-scope patent-text">3</sub>。</div>
      <div id="p0171" num="0171" class="description-paragraph style-scope patent-text">Sulfone (sulfonyl) :-S (=O)<sub class="style-scope patent-text">2</sub>R, wherein R is sulfone substituent group, for example, C<sub class="style-scope patent-text">1-7</sub>Alkyl group, C<sub class="style-scope patent-text">3-20</sub>Heterocyclyl groups
Or C<sub class="style-scope patent-text">5-20</sub>Aryl group, preferably C<sub class="style-scope patent-text">1-7</sub>Alkyl group, including, for example, fluorination or perfluorinated C<sub class="style-scope patent-text">1-7</sub>Alkyl group.Sulfone group
Example include but is not limited to-S (=O)<sub class="style-scope patent-text">2</sub>CH<sub class="style-scope patent-text">3</sub>(mesyl (methanesulfonyl), mesyl (mesyl)) ,-S
(=O)<sub class="style-scope patent-text">2</sub>CF<sub class="style-scope patent-text">3</sub>(trifyl) ,-S (=O)<sub class="style-scope patent-text">2</sub>CH<sub class="style-scope patent-text">2</sub>CH<sub class="style-scope patent-text">3</sub>(ethylsulfonyl) ,-S (=O)<sub class="style-scope patent-text">2</sub>C<sub class="style-scope patent-text">4</sub>F<sub class="style-scope patent-text">9</sub>(nine fluorine fourth sulfonyls) ,-S
(=O)<sub class="style-scope patent-text">2</sub>CH<sub class="style-scope patent-text">2</sub>CF<sub class="style-scope patent-text">3</sub>(trifluoro ethylsulfonyl) ,-S (=O)<sub class="style-scope patent-text">2</sub>CH<sub class="style-scope patent-text">2</sub>CH<sub class="style-scope patent-text">2</sub>NH<sub class="style-scope patent-text">2</sub>(tauryl-) ,-S (=O)<sub class="style-scope patent-text">2</sub>Ph (benzenesulfonyl, benzene sulphur
Acyl group), 4- Methyl benzenesulfonyl base (tosyl), 4- chlorobenzenesulfonyl (chlorobenzenesulfonyl), 4- bromobenzenesulfonyl (bromobenzene
Sulfonyl), 4- nitrobenzophenone (nitrobenzenesulfonyl), 2- napsylate (naphthalene sulfonyl base) and 5- dimethylamino-naphthalene -1- base
Sulphonic acid ester (dansyl).</div>
      <div id="p0172" num="0172" class="description-paragraph style-scope patent-text">Sulfinic acid (sulfino) :-S (=O) OH ,-SO<sub class="style-scope patent-text">2</sub>H。</div>
      <div id="p0173" num="0173" class="description-paragraph style-scope patent-text">Sulfonic acid (sulfo group) :-S (=O)<sub class="style-scope patent-text">2</sub>OH、-SO<sub class="style-scope patent-text">3</sub>H。</div>
      <div id="p0174" num="0174" class="description-paragraph style-scope patent-text">Sulfinat (sulfinate) (sulfinic acid ester, sulfinic acid ester) :-S (=O) OR；Wherein, R
It is sulfinic acid ester substituent group, for example, C<sub class="style-scope patent-text">1-7</sub>Alkyl group, C<sub class="style-scope patent-text">3-20</sub>Heterocyclyl groups or C<sub class="style-scope patent-text">5-20</sub>Aryl group, preferably C<sub class="style-scope patent-text">1-7</sub>Alkyl
Group.The example of sulfinate groups includes but is not limited to-S (=O) OCH<sub class="style-scope patent-text">3</sub>(methoxyl group sulfinyl；Sulfinic acid methyl esters) and-
S (=O) OCH<sub class="style-scope patent-text">2</sub>CH<sub class="style-scope patent-text">3</sub>(ethyoxyl sulfinyl；Sulfinic acid ethyl ester).</div>
      <div id="p0175" num="0175" class="description-paragraph style-scope patent-text">Sulphonic acid ester (sulfonate) (sulphonic acid ester (sulfonic acid ester)) :-S (=O)<sub class="style-scope patent-text">2</sub>OR；Wherein, R is sulphur
Acid esters substituent group, for example, C<sub class="style-scope patent-text">1-7</sub>Alkyl group, C<sub class="style-scope patent-text">3-20</sub>Heterocyclyl groups or C<sub class="style-scope patent-text">5-20</sub>Aryl group, preferably C<sub class="style-scope patent-text">1-7</sub>Alkyl group.
The example of sulfonate ester group includes but is not limited to-S (=O)<sub class="style-scope patent-text">2</sub>OCH<sub class="style-scope patent-text">3</sub>(methoxysulfonyl；Methylmesylate) and-S (=O)<sub class="style-scope patent-text">2</sub>OCH<sub class="style-scope patent-text">2</sub>CH<sub class="style-scope patent-text">3</sub>(ethoxysulfonyl；Sulfonic acid).</div>
      <div id="p0176" num="0176" class="description-paragraph style-scope patent-text">Sulfenyl oxygroup :-OS (=O) R, wherein R is sulfenyl oxy substituents, for example, C<sub class="style-scope patent-text">1-7</sub>Alkyl group, C<sub class="style-scope patent-text">3-20</sub>It is miscellaneous
Cyclic groups or C<sub class="style-scope patent-text">5-20</sub>Aryl group, preferably C<sub class="style-scope patent-text">1-7</sub>Alkyl group.The example of sulfenyl oxygroup group include but is not limited to-
OS (=O) CH<sub class="style-scope patent-text">3</sub>With-OS (=O) CH<sub class="style-scope patent-text">2</sub>CH<sub class="style-scope patent-text">3</sub>。</div>
      <div id="p0177" num="0177" class="description-paragraph style-scope patent-text">Sulfonyloxy :-OS (=O)<sub class="style-scope patent-text">2</sub>R, wherein R is sulfonyloxy substituent, for example, C<sub class="style-scope patent-text">1-7</sub>Alkyl group, C<sub class="style-scope patent-text">3-20</sub>Heterocycle
Base group or C<sub class="style-scope patent-text">5-20</sub>Aryl group, preferably C<sub class="style-scope patent-text">1-7</sub>Alkyl group.The example of sulfonyloxy group includes but is not limited to-OS
(=O)<sub class="style-scope patent-text">2</sub>CH<sub class="style-scope patent-text">3</sub>(methanesulfonates) and-OS (=O)<sub class="style-scope patent-text">2</sub>CH<sub class="style-scope patent-text">2</sub>CH<sub class="style-scope patent-text">3</sub>(esilate).</div>
      <div id="p0178" num="0178" class="description-paragraph style-scope patent-text">Sulfuric ester :-OS (=O)<sub class="style-scope patent-text">2</sub>OR；Wherein, R is sulfuric ester substituent group, for example, C<sub class="style-scope patent-text">1-7</sub>Alkyl group, C<sub class="style-scope patent-text">3-20</sub>Heterocycle base
Group or C<sub class="style-scope patent-text">5-20</sub>Aryl group, preferably C<sub class="style-scope patent-text">1-7</sub>Alkyl group.The example of sulfate group includes but is not limited to-OS (=O)<sub class="style-scope patent-text">2</sub>OCH<sub class="style-scope patent-text">3</sub>With-SO (=O)<sub class="style-scope patent-text">2</sub>OCH<sub class="style-scope patent-text">2</sub>CH<sub class="style-scope patent-text">3</sub>。</div>
      <div id="p0179" num="0179" class="description-paragraph style-scope patent-text">Sulfonamides (sulfamoyl；Sulfinic acid amide；Sulfenamide) :-S (=O) NR<sup class="style-scope patent-text">1</sup>R<sup class="style-scope patent-text">2</sup>, wherein R<sup class="style-scope patent-text">1</sup>And R<sup class="style-scope patent-text">2</sup>It is independently
The amino-substituent that such as amino group is defined.The example of sulfamoyl group includes but is not limited to-S (=O) NH<sub class="style-scope patent-text">2</sub>,-S (=O)
NH(CH<sub class="style-scope patent-text">3</sub>) ,-S (=O) N (CH<sub class="style-scope patent-text">3</sub>)<sub class="style-scope patent-text">2</sub>,-S (=O) NH (CH<sub class="style-scope patent-text">2</sub>CH<sub class="style-scope patent-text">3</sub>) ,-S (=O) N (CH<sub class="style-scope patent-text">2</sub>CH<sub class="style-scope patent-text">3</sub>)<sub class="style-scope patent-text">2</sub>With-S (=O) NHPh.</div>
      <div id="p0180" num="0180" class="description-paragraph style-scope patent-text">Sulfonamido (sulfonimide groups；Sulfonic acid amides；Sulfonamides) :-S (=O)<sub class="style-scope patent-text">2</sub>NR<sup class="style-scope patent-text">1</sup>R<sup class="style-scope patent-text">2</sup>, wherein R<sup class="style-scope patent-text">1</sup>And R<sup class="style-scope patent-text">2</sup>Independently
It is the amino-substituent such as defined to amino group.The example of sulfonamido group includes but is not limited to-S (=O)<sub class="style-scope patent-text">2</sub>NH<sub class="style-scope patent-text">2</sub>、-S
(=O)<sub class="style-scope patent-text">2</sub>NH(CH<sub class="style-scope patent-text">3</sub>) ,-S (=O)<sub class="style-scope patent-text">2</sub>N(CH<sub class="style-scope patent-text">3</sub>)<sub class="style-scope patent-text">2</sub>,-S (=O)<sub class="style-scope patent-text">2</sub>NH(CH<sub class="style-scope patent-text">2</sub>CH<sub class="style-scope patent-text">3</sub>) ,-S (=O)<sub class="style-scope patent-text">2</sub>N(CH<sub class="style-scope patent-text">2</sub>CH<sub class="style-scope patent-text">3</sub>)<sub class="style-scope patent-text">2</sub>With-S (=O)<sub class="style-scope patent-text">2</sub>NHPh。</div>
      <div id="p0181" num="0181" class="description-paragraph style-scope patent-text">Sulfoamino-group :-NR<sup class="style-scope patent-text">1</sup>S (=O)<sub class="style-scope patent-text">2</sub>OH, wherein R<sup class="style-scope patent-text">1</sup>It is the amino-substituent such as defined to amino group.Sulfoamino-group group
Example include but is not limited to-NHS (=O)<sub class="style-scope patent-text">2</sub>OH and-N (CH<sub class="style-scope patent-text">3</sub>) S (=O)<sub class="style-scope patent-text">2</sub>OH。</div>
      <div id="p0182" num="0182" class="description-paragraph style-scope patent-text">Sulfonamido :-NR<sup class="style-scope patent-text">1</sup>S (=O)<sub class="style-scope patent-text">2</sub>R, wherein R<sup class="style-scope patent-text">1</sup>It is the amino-substituent such as defined to amino group, and R is sulphur
Amido substituent, for example, C<sub class="style-scope patent-text">1-7</sub>Alkyl group, C<sub class="style-scope patent-text">3-20</sub>Heterocyclyl groups or C<sub class="style-scope patent-text">5-20</sub>Aryl group, preferably C<sub class="style-scope patent-text">1-7</sub>Alkyl base
Group.The example of sulfonylamino group includes but is not limited to-NHS (=O)<sub class="style-scope patent-text">2</sub>CH<sub class="style-scope patent-text">3</sub>With-N (CH<sub class="style-scope patent-text">3</sub>) S (=O)<sub class="style-scope patent-text">2</sub>C<sub class="style-scope patent-text">6</sub>H<sub class="style-scope patent-text">5</sub>。</div>
      <div id="p0183" num="0183" class="description-paragraph style-scope patent-text">Sulfonamido :-NR<sup class="style-scope patent-text">1</sup>S (=O) R, wherein R<sup class="style-scope patent-text">1</sup>It is the amino-substituent such as defined to amino group, and R is
Sulfinamino substituent, for example, C<sub class="style-scope patent-text">1-7</sub>Alkyl group, C<sub class="style-scope patent-text">3-20</sub>Heterocyclyl groups or C<sub class="style-scope patent-text">5-20</sub>Aryl group, preferably C<sub class="style-scope patent-text">1-7</sub>Alkane
Base group.The example of sulfonamido group includes but is not limited to-NHS (=O) CH<sub class="style-scope patent-text">3</sub>With-N (CH<sub class="style-scope patent-text">3</sub>) S (=O) C<sub class="style-scope patent-text">6</sub>H<sub class="style-scope patent-text">5</sub>。</div>
      <div id="p0184" num="0184" class="description-paragraph style-scope patent-text">Phosphino- (phosphine) :-PR<sub class="style-scope patent-text">2</sub>；Wherein, R is phosphino- substituent group, for example,-H, C<sub class="style-scope patent-text">1-7</sub>Alkyl group, C<sub class="style-scope patent-text">3-20</sub>Heterocyclyl groups or
C<sub class="style-scope patent-text">5-20</sub>Aryl group, preferably-H, C<sub class="style-scope patent-text">1-7</sub>Alkyl group or C<sub class="style-scope patent-text">5-20</sub>Aryl group.The example of phosphino- group include but is not limited to-
PH<sub class="style-scope patent-text">2</sub>、-P(CH<sub class="style-scope patent-text">3</sub>)<sub class="style-scope patent-text">2</sub>、-P(CH<sub class="style-scope patent-text">2</sub>CH<sub class="style-scope patent-text">3</sub>)<sub class="style-scope patent-text">2</sub>、-P(t-Bu)<sub class="style-scope patent-text">2</sub>With-P (Ph)<sub class="style-scope patent-text">2</sub>。</div>
      <div id="p0185" num="0185" class="description-paragraph style-scope patent-text">Dioxy phosphino :-P (=O)<sub class="style-scope patent-text">2</sub>。</div>
      <div id="p0186" num="0186" class="description-paragraph style-scope patent-text">Phosphoryl (phosphine oxide) :-P (=O) R<sub class="style-scope patent-text">2</sub>；Wherein, R is phosphoryl substituent group, for example, C<sub class="style-scope patent-text">1-7</sub>Alkyl group, C<sub class="style-scope patent-text">3-20</sub>It is miscellaneous
Cyclic groups or C<sub class="style-scope patent-text">5-20</sub>Aryl group, preferably C<sub class="style-scope patent-text">1-7</sub>Alkyl group or C<sub class="style-scope patent-text">5-20</sub>Aryl group.The example of phosphoryl group includes
But it is not limited to-P (=O) (CH<sub class="style-scope patent-text">3</sub>)<sub class="style-scope patent-text">2</sub>,-P (=O) (CH<sub class="style-scope patent-text">2</sub>CH<sub class="style-scope patent-text">3</sub>)<sub class="style-scope patent-text">2</sub>,-P (=O) (t-Bu)<sub class="style-scope patent-text">2</sub>With-P (=O) (Ph)<sub class="style-scope patent-text">2</sub>。</div>
      <div id="p0187" num="0187" class="description-paragraph style-scope patent-text">Phosphonic acids (phosphono) :-P (=O) (OH)<sub class="style-scope patent-text">2</sub>。</div>
      <div id="p0188" num="0188" class="description-paragraph style-scope patent-text">Phosphonate ester (phosphono base ester) :-P (=O) (OR)<sub class="style-scope patent-text">2</sub>；Wherein, R is phosphonate substituted base, for example,-H, C<sub class="style-scope patent-text">1-7</sub>Alkyl base
Group, C<sub class="style-scope patent-text">3-20</sub>Heterocyclyl groups or C<sub class="style-scope patent-text">5-20</sub>Aryl group, preferably-H, C<sub class="style-scope patent-text">1-7</sub>Alkyl group or C<sub class="style-scope patent-text">5-20</sub>Aryl group.Phosphonate group
The example of group includes but is not limited to-P (=O) (OCH<sub class="style-scope patent-text">3</sub>)<sub class="style-scope patent-text">2</sub>,-P (=O) (OCH<sub class="style-scope patent-text">2</sub>CH<sub class="style-scope patent-text">3</sub>)<sub class="style-scope patent-text">2</sub>,-P (=O) (O-t-Bu)<sub class="style-scope patent-text">2</sub>With-P (=O)
(OPh)<sub class="style-scope patent-text">2</sub>。</div>
      <div id="p0189" num="0189" class="description-paragraph style-scope patent-text">Phosphoric acid (phosphonato) :-OP (=O) (OH)<sub class="style-scope patent-text">2</sub>。</div>
      <div id="p0190" num="0190" class="description-paragraph style-scope patent-text">Phosphate (phosphonato ester) :-OP (=O) (OR)<sub class="style-scope patent-text">2</sub>；Wherein, R is phosphate ester substituents, for example,-H, C<sub class="style-scope patent-text">1-7</sub>Alkane
Base group, C<sub class="style-scope patent-text">3-20</sub>Heterocyclyl groups or C<sub class="style-scope patent-text">5-20</sub>Aryl group, preferably-H, C<sub class="style-scope patent-text">1-7</sub>Alkyl group or C<sub class="style-scope patent-text">5-20</sub>Aryl group.Phosphoric acid
The example of ester group includes but is not limited to-OP (=O) (OCH<sub class="style-scope patent-text">3</sub>)<sub class="style-scope patent-text">2</sub>,-OP (=O) (OCH<sub class="style-scope patent-text">2</sub>CH<sub class="style-scope patent-text">3</sub>)<sub class="style-scope patent-text">2</sub>,-OP (=O) (O-t-Bu)<sub class="style-scope patent-text">2</sub>With
- OP (=O) (OPh)<sub class="style-scope patent-text">2</sub>。</div>
      <div id="p0191" num="0191" class="description-paragraph style-scope patent-text">Phosphorous acid :-OP (OH)<sub class="style-scope patent-text">2</sub>。</div>
      <div id="p0192" num="0192" class="description-paragraph style-scope patent-text">Phosphite ester :-OP (OR)<sub class="style-scope patent-text">2</sub>；Wherein, R is phosphite ester substituent group, for example,-H, C<sub class="style-scope patent-text">1-7</sub>Alkyl group, C<sub class="style-scope patent-text">3-20</sub>Heterocycle
Base group or C<sub class="style-scope patent-text">5-20</sub>Aryl group, preferably-H, C<sub class="style-scope patent-text">1-7</sub>Alkyl group or C<sub class="style-scope patent-text">5-20</sub>Aryl group.The example of phosphite group
Including but not limited to-OP (OCH<sub class="style-scope patent-text">3</sub>)<sub class="style-scope patent-text">2</sub>、 -OP(OCH<sub class="style-scope patent-text">2</sub>CH<sub class="style-scope patent-text">3</sub>)<sub class="style-scope patent-text">2</sub>、-OP(O-t-Bu)<sub class="style-scope patent-text">2</sub>With-OP (OPh)<sub class="style-scope patent-text">2</sub>。</div>
      <div id="p0193" num="0193" class="description-paragraph style-scope patent-text">Phosphoramidite :-OP (OR<sup class="style-scope patent-text">1</sup>)-NR<sup class="style-scope patent-text">2</sup> <sub class="style-scope patent-text">2</sub>；Wherein, R<sup class="style-scope patent-text">1</sup>And R<sup class="style-scope patent-text">2</sup>It is phosphoramidite substituent group, for example,-H, (optionally substituted
) C<sub class="style-scope patent-text">1-7</sub>Alkyl group, C<sub class="style-scope patent-text">3-20</sub>Heterocyclyl groups or C<sub class="style-scope patent-text">5-20</sub>Aryl group, preferably-H, C<sub class="style-scope patent-text">1-7</sub>Alkyl group or C<sub class="style-scope patent-text">5-20</sub>Aryl
Group.The example of phosphoramidite group includes but is not limited to-OP (OCH<sub class="style-scope patent-text">2</sub>CH<sub class="style-scope patent-text">3</sub>)-N(CH<sub class="style-scope patent-text">3</sub>)<sub class="style-scope patent-text">2</sub>、-OP(OCH<sub class="style-scope patent-text">2</sub>CH<sub class="style-scope patent-text">3</sub>)-N(i-Pr)<sub class="style-scope patent-text">2</sub>
With-OP (OCH<sub class="style-scope patent-text">2</sub>CH<sub class="style-scope patent-text">2</sub>CN)-N(i-Pr)<sub class="style-scope patent-text">2</sub>。</div>
      <div id="p0194" num="0194" class="description-paragraph style-scope patent-text">Phosphoramidate :-OP (=O) (OR<sup class="style-scope patent-text">1</sup>)-NR<sup class="style-scope patent-text">2</sup> <sub class="style-scope patent-text">2</sub>；Wherein, R<sup class="style-scope patent-text">1</sup>And R<sup class="style-scope patent-text">2</sup>It is phosphoramidate substituent group, for example,-H,
(optionally substituted) C<sub class="style-scope patent-text">1-7</sub>Alkyl group, C<sub class="style-scope patent-text">3-20</sub>Heterocyclyl groups or C<sub class="style-scope patent-text">5-20</sub>Aryl group, preferably-H, C<sub class="style-scope patent-text">1-7</sub>Alkyl group or
C<sub class="style-scope patent-text">5-20</sub>Aryl group.The example of phosphoramidic acid ester group includes but is not limited to-OP (=O) (OCH<sub class="style-scope patent-text">2</sub>CH<sub class="style-scope patent-text">3</sub>)-N(CH<sub class="style-scope patent-text">3</sub>)<sub class="style-scope patent-text">2</sub>,-OP (=
O)(OCH<sub class="style-scope patent-text">2</sub>CH<sub class="style-scope patent-text">3</sub>)-N(i-Pr)<sub class="style-scope patent-text">2</sub>With-OP (=O) (OCH<sub class="style-scope patent-text">2</sub>CH<sub class="style-scope patent-text">2</sub>CN)-N(i-Pr)<sub class="style-scope patent-text">2</sub>。</div>
      <div id="p0195" num="0195" class="description-paragraph style-scope patent-text">Alkylidene</div>
      <div id="p0196" num="0196" class="description-paragraph style-scope patent-text">C<sub class="style-scope patent-text">3-12</sub>Alkylidene: as it is used herein, term " C<sub class="style-scope patent-text">3-12</sub>Alkylidene " is related to by from 3 to 12 carbon atoms
(unless specified otherwise) identical carbon atoms of hydrocarbon compound remove two hydrogen atoms or respectively remove one from two different carbon atoms
Two toothed portions that a hydrogen atom obtains can be aliphatic or alicyclic and can be saturation, part insatiable hunger and/or complete
It is complete unsaturated.Therefore, term " alkylidene " includes subclass discussed below: alkenylene, alkynylene, ring alkylidene etc..</div>
      <div id="p0197" num="0197" class="description-paragraph style-scope patent-text">Linear saturation C<sub class="style-scope patent-text">3-12</sub>The example of alkylidene group includes but is not limited to-(CH<sub class="style-scope patent-text">2</sub>)<sub class="style-scope patent-text">n</sub>, wherein n is 3 to 12 integer,
For example,-CH<sub class="style-scope patent-text">2</sub>CH<sub class="style-scope patent-text">2</sub>CH<sub class="style-scope patent-text">2</sub>(propylidene) ,-CH<sub class="style-scope patent-text">2</sub>CH<sub class="style-scope patent-text">2</sub>CH<sub class="style-scope patent-text">2</sub>CH<sub class="style-scope patent-text">2</sub>(butylidene) ,-CH<sub class="style-scope patent-text">2</sub>CH<sub class="style-scope patent-text">2</sub>CH<sub class="style-scope patent-text">2</sub>CH<sub class="style-scope patent-text">2</sub>CH<sub class="style-scope patent-text">2</sub>(pentylidene) and-
CH<sub class="style-scope patent-text">2</sub>CH<sub class="style-scope patent-text">2</sub>CH<sub class="style-scope patent-text">2</sub>CH<sub class="style-scope patent-text">2</sub>CH<sub class="style-scope patent-text">2</sub>CH<sub class="style-scope patent-text">2</sub>CH<sub class="style-scope patent-text">2</sub>(heptamethylene).</div>
      <div id="p0198" num="0198" class="description-paragraph style-scope patent-text">Branch is saturated C<sub class="style-scope patent-text">3-12</sub>The example of alkylidene group includes but is not limited to-CH (CH<sub class="style-scope patent-text">3</sub>)CH<sub class="style-scope patent-text">2</sub>-、 -CH(CH<sub class="style-scope patent-text">3</sub>)CH<sub class="style-scope patent-text">2</sub>CH<sub class="style-scope patent-text">2</sub>-、-
CH(CH<sub class="style-scope patent-text">3</sub>)CH<sub class="style-scope patent-text">2</sub>CH<sub class="style-scope patent-text">2</sub>CH<sub class="style-scope patent-text">2</sub>-、-CH<sub class="style-scope patent-text">2</sub>CH(CH<sub class="style-scope patent-text">3</sub>)CH<sub class="style-scope patent-text">2</sub>-、 -CH<sub class="style-scope patent-text">2</sub>CH(CH<sub class="style-scope patent-text">3</sub>)CH<sub class="style-scope patent-text">2</sub>CH<sub class="style-scope patent-text">2</sub>-、-CH(CH<sub class="style-scope patent-text">2</sub>CH<sub class="style-scope patent-text">3</sub>)-、-CH(CH<sub class="style-scope patent-text">2</sub>CH<sub class="style-scope patent-text">3</sub>)CH<sub class="style-scope patent-text">2</sub>-
With-CH<sub class="style-scope patent-text">2</sub>CH(CH<sub class="style-scope patent-text">2</sub>CH<sub class="style-scope patent-text">3</sub>)CH<sub class="style-scope patent-text">2</sub>-。</div>
      <div id="p0199" num="0199" class="description-paragraph style-scope patent-text">Linear fraction unsaturation C<sub class="style-scope patent-text">3-12</sub>Alkylidene group (C<sub class="style-scope patent-text">3-12</sub>Alkenylene and alkynylene group) example include but unlimited
In-CH=CH-CH<sub class="style-scope patent-text">2</sub>-、-CH<sub class="style-scope patent-text">2</sub>- CH=CH<sub class="style-scope patent-text">2</sub>,-CH=CH-CH<sub class="style-scope patent-text">2</sub>-CH<sub class="style-scope patent-text">2</sub>,-CH=CH-CH<sub class="style-scope patent-text">2</sub>-CH<sub class="style-scope patent-text">2</sub>-CH<sub class="style-scope patent-text">2</sub>,-CH=CH-CH=
CH- ,-CH=CH-CH=CH-CH<sub class="style-scope patent-text">2</sub>,-CH=CH-CH=CH-CH<sub class="style-scope patent-text">2</sub>-CH<sub class="style-scope patent-text">2</sub>,-CH=CH-CH<sub class="style-scope patent-text">2</sub>- CH=CH- ,-CH=CH-
CH<sub class="style-scope patent-text">2</sub>-CH<sub class="style-scope patent-text">2</sub>- CH=CH- and-CH<sub class="style-scope patent-text">2</sub>-C≡C-CH<sub class="style-scope patent-text">2</sub>-。</div>
      <div id="p0200" num="0200" class="description-paragraph style-scope patent-text">Branched fraction unsaturation C<sub class="style-scope patent-text">3-12</sub>Alkylidene group (C<sub class="style-scope patent-text">3-12</sub>Alkenylene and alkynylene group) example include but unlimited
In-C (CH<sub class="style-scope patent-text">3</sub>)=CH- ,-C (CH<sub class="style-scope patent-text">3</sub>)=CH-CH<sub class="style-scope patent-text">2</sub>,-CH=CH-CH (CH<sub class="style-scope patent-text">3</sub>)-and-C ≡ C-CH (CH<sub class="style-scope patent-text">3</sub>)-。</div>
      <div id="p0201" num="0201" class="description-paragraph style-scope patent-text">Alicyclic saturation C<sub class="style-scope patent-text">3-12</sub>Alkylidene group (C<sub class="style-scope patent-text">3-12</sub>Ring alkylidene) example include but is not limited to cyclopentylene (example
Such as, cyclopenta -1,3- subunit) and cyclohexylidene (for example, cyclohexyl-Isosorbide-5-Nitrae-subunit).</div>
      <div id="p0202" num="0202" class="description-paragraph style-scope patent-text">Cycloaliphatic moiety unsaturation C<sub class="style-scope patent-text">3-12</sub>Alkylidene group (C<sub class="style-scope patent-text">3-12</sub>Ring alkylidene) example include but is not limited to sub- ring penta
Alkenyl (for example, 4- cyclopentene -1,3- subunit), cyclohexadienylidene are (for example, 2- cyclohexene-Isosorbide-5-Nitrae-subunit；3- cyclohexene -1,2-
Subunit；2,5- cyclohexadiene -1,4- subunit).</div>
      <div id="p0203" num="0203" class="description-paragraph style-scope patent-text">Carbamate nitrogen-protecting group group: term " carbamate nitrogen-protecting group group " is related to sheltering the nitrogen in imine linkage
Part, and they are well known in the art.These groups have a structure that</div>
      <div id="p0204" num="0204" class="description-paragraph style-scope patent-text">
        <span class="patent-image-not-available style-scope patent-text"></span>
      </div>
      <div id="p0205" num="0205" class="description-paragraph style-scope patent-text">Wherein, R '<sup class="style-scope patent-text">10</sup>It is R as defined above.A large amount of proper group is described in Greene, T.W. and Wuts, G.M.,
Protective Groups in Organic Synthesis, the 3rd edition, the of John Wiley&amp;Sons, Inc., 1999
It page 503 to 549, is incorporated by reference herein.</div>
      <div id="p0206" num="0206" class="description-paragraph style-scope patent-text">Hemiacetal amine nitrogen-protecting group group: term " hemiacetal amine nitrogen-protecting group group " is related to the group having following structure:</div>
      <div id="p0207" num="0207" class="description-paragraph style-scope patent-text">
        <span class="patent-image-not-available style-scope patent-text"></span>
      </div>
      <div id="p0208" num="0208" class="description-paragraph style-scope patent-text">Wherein, R '<sup class="style-scope patent-text">10</sup>It is R as defined above.The a large amount of proper group as amide blocking group is described in
Greene, T.W. and Wuts, G.M., Protective Groups in Organic Synthesis, the 3rd edition, John
Page 633 to 647 of Wiley&amp;Sons, Inc., 1999, are incorporated by reference herein.</div>
      <div id="p0209" num="0209" class="description-paragraph style-scope patent-text">Group carbamate nitrogen-protecting group group and hemiacetal amine nitrogen-protecting group group can be in conjunction with referred to as " for synthesis
Nitrogen-protecting group group ".</div>
      <div id="p0210" num="0210" class="description-paragraph style-scope patent-text">Detailed description of the invention</div>
      <div id="p0211" num="0211" class="description-paragraph style-scope patent-text">The present invention provides the combinations of the PBD compound comprising being connected to cell binding agent via connector by the position N10
Object.In one embodiment, conjugate includes cell binding agent (also referred to as " the ligand list for being connected to introns linking group
Member "), the introns that are connected to trigger, the position N10 for being connected to the trigger of selfdecomposition connector and being connected to PBD compound
Selfdecomposition connector.Following illustrate this conjugates:</div>
      <div id="p0212" num="0212" class="description-paragraph style-scope patent-text">
        <span class="patent-image-not-available style-scope patent-text"></span>
      </div>
      <div id="p0213" num="0213" class="description-paragraph style-scope patent-text">Wherein, as described herein, CBA is cell binding agent (also referred to as " with body unit ") and PBD is pyrrolo-
Benzodiazepine compound.Illustrate to show the R corresponding in certain embodiments of the invention<sup class="style-scope patent-text">L’</sup>、A、L<sup class="style-scope patent-text">1</sup>And L<sup class="style-scope patent-text">2</sup>Portion
Point.</div>
      <div id="p0214" num="0214" class="description-paragraph style-scope patent-text">The present invention is suitable for providing the purposes in PBD compound preferred site into subject.In preferred embodiment
In, conjugate allows to discharge the active PBD compound for not retaining any junction portion.There is no can influence PBD compound
The residual (stub) of reactivity.</div>
      <div id="p0215" num="0215" class="description-paragraph style-scope patent-text">In some embodiments, the present invention provides the conjugate comprising PBD dimer group, the PBD dimer bases
Group has the connector for being connected to cell binding agent.Synthetic method is described herein in the present inventor, by using novel
PBD goes non-symmetric technique that can prepare this dimerization combination.</div>
      <div id="p0216" num="0216" class="description-paragraph style-scope patent-text">This application in particular to has those of the carbamate for being connected to the position N10 R<sup class="style-scope patent-text">L</sup>Group.</div>
      <div id="p0217" num="0217" class="description-paragraph style-scope patent-text">Connector, by cell binding agent (CBA/L), such as antibody, is attached to PBD drug moiety D by covalent bond.Connector is
Difunctionality or polyfunctional part can be used for connecting one or more drug moieties (D) and antibody units (Ab) to be formed
Antibody-drug conjugates (ADC).Connector (R<sup class="style-scope patent-text">L’</sup>) on the outside of cell (that is, extracellular) can be that stable or it can pass through enzyme
Activity, hydrolysis or the cutting of other metabolism conditions.Use the reactive functionality having for being bound to drug moiety and antibody
Connector prepare antibody-drug conjugates (ADC) with can be convenient.The cysteine mercaptan or amine of antibody (Ab), such as N-terminal
Or amino acid side chain (such as lysine), it can be with connector or introns reagent, PBD drug moiety (D) or agent-linker reagent
(D-R<sup class="style-scope patent-text">L</sup>) functional group formed key.</div>
      <div id="p0218" num="0218" class="description-paragraph style-scope patent-text">The many functional groups being attached on the connector of the position N10 of the part PBD can be used for reacting with cell binding agent.
For example, ester, thioesters, amide, sulphamide, carbamate, thiocarbamate, urea, thiocarbamide, ether, thioether or disulphide
Connection can be formed by the reaction of connector-PBD pharmaceutical intermediate and cell binding agent.</div>
      <div id="p0219" num="0219" class="description-paragraph style-scope patent-text">The connector of ADC is preferably prevented from the aggregation of ADC molecule, and ADC is kept to be soluble in aqueous medium and protected
It holds in free state.</div>
      <div id="p0220" num="0220" class="description-paragraph style-scope patent-text">The connector of ADC is preferably extracellularly being stablized.Before conveying or being delivered to cell, antibody-drug conjugates
(ADC) it is preferably stable and keeps complete, that is, antibody remains attached to drug moiety.Connector is steady outside target cell
Fixed, and can be cut in the cell with effective speed.Effective connector is incited somebody to action: the specific binding of (i) holding antibody
Matter；(ii) allow the Intracellular delivery of conjugate or drug moiety；(iii) keep stable and complete, that is, until conjugate quilt
The target site for delivering or being delivered to it is just cut；And (iv) keeps cytotoxic effect, the cell of PBD drug moiety to kill
Dead effect or cyto-inhibition.It can be measured by standard analytical techniques such as mass spectrum, HPLC and separation/analytical technology LC/MS
The stability of ADC.</div>
      <div id="p0221" num="0221" class="description-paragraph style-scope patent-text">The covalent attachment of antibody and drug moiety needs connector tool, and there are two reactive functional groups, that is, in reaction meaning
Divalent.It can be used for being attached two or more funtion parts or biologically-active moiety, such as peptide, nucleic acid, drug, toxin, antibody, half
The bivalent linker reagent of antigen and reporter group is known, and has had method to describe the conjugate that they are obtained
(Hermanson,G.T.(1996) Bioconjugate Techniques；Academic Press:New York,p 234-
242)。</div>
      <div id="p0222" num="0222" class="description-paragraph style-scope patent-text">In another embodiment, connector can be replaced by adjusting aggregation, solubility or reactive group.For example,
Sulfonate substituent can increase the water solubility of reagent and promote the coupling of linker reagents and antibody or drug moiety anti-
It answers, or promotes the coupling reaction of Ab-L and D or D-L and Ab, this depends on preparing the route of synthesis that ADC is used.</div>
      <div id="p0223" num="0223" class="description-paragraph style-scope patent-text">In one embodiment, L-R<sup class="style-scope patent-text">L’</sup>It is following group:</div>
      <div id="p0224" num="0224" class="description-paragraph style-scope patent-text">
        <span class="patent-image-not-available style-scope patent-text"></span>
      </div>
      <div id="p0225" num="0225" class="description-paragraph style-scope patent-text">Wherein, asterisk indicates the point for being attached to the position N10, and CBA is cell binding agent (L), L<sup class="style-scope patent-text">1</sup>It is connector, A is by L<sup class="style-scope patent-text">1</sup>Even
It is connected to the linking group of cell binding agent, L<sup class="style-scope patent-text">2</sup>Be covalent bond or with-OC (=O)-be formed together the connector and L of selfdecomposition<sup class="style-scope patent-text">1</sup>Or
L<sup class="style-scope patent-text">2</sup>It is cleavable connector.</div>
      <div id="p0226" num="0226" class="description-paragraph style-scope patent-text">L<sup class="style-scope patent-text">1</sup>Preferably cleavable connector, and the trigger for activating joint cutting can be referred to as.</div>
      <div id="p0227" num="0227" class="description-paragraph style-scope patent-text">When it is present, L<sup class="style-scope patent-text">1</sup>And L<sup class="style-scope patent-text">2</sup>Property can change extensively.These groups are the Cutting features based on them to select
, it can be determined by the condition in the site that conjugate is delivered.Although also can be used by pH variation (for example, acid or
Alkali unstability), temperature or by radiation (for example, photo-labile) cleavable connector, but cut by the effect of enzyme
Those of connector be preferred.Cleavable connector under reduction or oxidizing condition can also be used in the present invention.</div>
      <div id="p0228" num="0228" class="description-paragraph style-scope patent-text">L<sup class="style-scope patent-text">1</sup>It may include the continuous sequence of amino acid.Amino acid sequence can be the target substrate cut for digestion, to permit
Perhaps L-R<sup class="style-scope patent-text">L’</sup>It is discharged from the position N10.</div>
      <div id="p0229" num="0229" class="description-paragraph style-scope patent-text">In one embodiment, L<sup class="style-scope patent-text">1</sup>It can be cut by the effect of enzyme.In one embodiment, enzyme is esterase or peptase.</div>
      <div id="p0230" num="0230" class="description-paragraph style-scope patent-text">In one embodiment, there are L<sup class="style-scope patent-text">2</sup>And its connector that selfdecomposition is formed together with-C (=O) O-.At one
In embodiment, L<sup class="style-scope patent-text">2</sup>It is the substrate for enzymatic activity, to allow L-R<sup class="style-scope patent-text">L’</sup>It is discharged from the position N10.</div>
      <div id="p0231" num="0231" class="description-paragraph style-scope patent-text">In one embodiment, work as L<sup class="style-scope patent-text">1</sup>It can be cut by the effect of enzyme and there are L<sup class="style-scope patent-text">2</sup>When, L is cut in digestion<sup class="style-scope patent-text">1</sup>And L<sup class="style-scope patent-text">2</sup>Between
Key.</div>
      <div id="p0232" num="0232" class="description-paragraph style-scope patent-text">L<sup class="style-scope patent-text">1</sup>And L<sup class="style-scope patent-text">2</sup>(when it is present) key connection selected from the following can be passed through:</div>
      <div id="p0233" num="0233" class="description-paragraph style-scope patent-text">- C (=O) NH-,</div>
      <div id="p0234" num="0234" class="description-paragraph style-scope patent-text">- C (=O) O-,</div>
      <div id="p0235" num="0235" class="description-paragraph style-scope patent-text">- NHC (=O)-,</div>
      <div id="p0236" num="0236" class="description-paragraph style-scope patent-text">- OC (=O)-,</div>
      <div id="p0237" num="0237" class="description-paragraph style-scope patent-text">- OC (=O) O-,</div>
      <div id="p0238" num="0238" class="description-paragraph style-scope patent-text">- NHC (=O) O-,</div>
      <div id="p0239" num="0239" class="description-paragraph style-scope patent-text">- OC (=O) NH- and</div>
      <div id="p0240" num="0240" class="description-paragraph style-scope patent-text">- NHC (=O) NH-.</div>
      <div id="p0241" num="0241" class="description-paragraph style-scope patent-text">It is connected to L<sup class="style-scope patent-text">2</sup>L<sup class="style-scope patent-text">1</sup>Amino group can be the N-terminal of amino acid, or amino acid side chain can be originated from and (such as rely ammonia
Acid amino acid side chain) amino group.</div>
      <div id="p0242" num="0242" class="description-paragraph style-scope patent-text">It is connected to L<sup class="style-scope patent-text">2</sup>L<sup class="style-scope patent-text">1</sup>Carboxylic group can be the C-terminal of amino acid, or amino acid side chain (such as paddy ammonia can be originated from
Acid amino acid side chain) carboxylic group.</div>
      <div id="p0243" num="0243" class="description-paragraph style-scope patent-text">It is connected to L<sup class="style-scope patent-text">2</sup>L<sup class="style-scope patent-text">1</sup>Hydroxyl group can be originated from amino acid side chain (such as amino acid side chain of serine) hydroxyl
Base group.</div>
      <div id="p0244" num="0244" class="description-paragraph style-scope patent-text">Term " amino acid side chain " includes those of discovery group in the following: (i) naturally occurring amino acid, such as third
Propylhomoserin, arginine, asparagine, aspartic acid, cysteine, glutamine, glutamic acid, glycine, histidine, different bright ammonia
Acid, leucine, lysine, methionine, phenylalanine, proline, serine, threonine, tryptophan, tyrosine and figured silk fabrics ammonia
Acid；(ii) micro-amino acid (minor amino acids), such as ornithine and citrulling；(iii) unnatural amino acid, β-
The synthetic analogues and derivative of amino acid, naturally occurring amino acid；And it is (iv) all enantiomters, diastereomeric different
Structure body, the isomer being rich in, isotope labelling (for example,<sup class="style-scope patent-text">2</sup>H、 <sup class="style-scope patent-text">3</sup>H、<sup class="style-scope patent-text">14</sup>C、<sup class="style-scope patent-text">15</sup>N), protected form and the outer of them disappear
Revolve mixture.</div>
      <div id="p0245" num="0245" class="description-paragraph style-scope patent-text">In one embodiment ,-C (=O) O- and L<sup class="style-scope patent-text">2</sup>It is formed together following group:</div>
      <div id="p0246" num="0246" class="description-paragraph style-scope patent-text">
        <span class="patent-image-not-available style-scope patent-text"></span>
      </div>
      <div id="p0247" num="0247" class="description-paragraph style-scope patent-text">Wherein, asterisk indicates the point for being attached to the position N10, and wave expression is attached to connector L<sup class="style-scope patent-text">1</sup>Point, Y is-N
(H)-,-O- ,-C (=O) N (H)-or-C (=O) O-, and n is 0 to 3.Phenylene ring is optionally by described herein one
A, two or three substituent groups replace.In one embodiment, subphenyl group is optionally by halogen, NO<sub class="style-scope patent-text">2</sub>, R or OR take
Generation.</div>
      <div id="p0248" num="0248" class="description-paragraph style-scope patent-text">In one embodiment, Y is NH.</div>
      <div id="p0249" num="0249" class="description-paragraph style-scope patent-text">In one embodiment, n is 0 or 1.Preferably, n is 0.</div>
      <div id="p0250" num="0250" class="description-paragraph style-scope patent-text">Wherein, Y is NH and n is 0, and the connector of selfdecomposition can be referred to as p- aminobenzyl carbonyl linker (PABC).</div>
      <div id="p0251" num="0251" class="description-paragraph style-scope patent-text">When distal site activation, the connector of selfdecomposition will allow shielded compound to discharge, along as shown below
Route carries out (for n=0):</div>
      <div id="p0252" num="0252" class="description-paragraph style-scope patent-text">
        <span class="patent-image-not-available style-scope patent-text"></span>
      </div>
      <div id="p0253" num="0253" class="description-paragraph style-scope patent-text">Wherein, L<sup class="style-scope patent-text">*</sup>It is the activated form of connector remainder.These groups, which have to separate from shielded compound, to be activated
The advantage in site.As described above, subphenyl group, which can be, optionally replaces.</div>
      <div id="p0254" num="0254" class="description-paragraph style-scope patent-text">In an embodiment described herein, group L<sup class="style-scope patent-text">*</sup>It is connector L as described herein<sup class="style-scope patent-text">1</sup>, may include
Dipeptides group.</div>
      <div id="p0255" num="0255" class="description-paragraph style-scope patent-text">In another embodiment ,-C (=O) O- and L<sup class="style-scope patent-text">2</sup>It is formed together group selected from the following:</div>
      <div id="p0256" num="0256" class="description-paragraph style-scope patent-text">
        <span class="patent-image-not-available style-scope patent-text"></span>
      </div>
      <div id="p0257" num="0257" class="description-paragraph style-scope patent-text">Wherein, asterisk, wave, Y and n are as defined above.Each phenylene ring is optionally by described herein one
A, two or three substituent groups replace.In one embodiment, with Y substituent group phenylene ring be it is optionally substituted and
And the phenylene ring for not having Y substituent group is unsubstituted.In one embodiment, the phenylene ring with Y substituent group is
Phenylene ring that is unsubstituted and not having Y substituent group optionally replaces.</div>
      <div id="p0258" num="0258" class="description-paragraph style-scope patent-text">In another embodiment ,-C (=O) O- and L<sup class="style-scope patent-text">2</sup>It is formed together group selected from the following:</div>
      <div id="p0259" num="0259" class="description-paragraph style-scope patent-text">
        <span class="patent-image-not-available style-scope patent-text"></span>
      </div>
      <div id="p0260" num="0260" class="description-paragraph style-scope patent-text">Wherein, asterisk, wave, Y and n are as defined above, and E is O, S or NR, and D is N, CH or CR, and F is N, CH
Or CR.</div>
      <div id="p0261" num="0261" class="description-paragraph style-scope patent-text">In one embodiment, D is N.</div>
      <div id="p0262" num="0262" class="description-paragraph style-scope patent-text">In one embodiment, D is CH.</div>
      <div id="p0263" num="0263" class="description-paragraph style-scope patent-text">In one embodiment, E is O or S.</div>
      <div id="p0264" num="0264" class="description-paragraph style-scope patent-text">In one embodiment, F is CH.</div>
      <div id="p0265" num="0265" class="description-paragraph style-scope patent-text">In one preferred embodiment, connector is cathepsin unstability connector.</div>
      <div id="p0266" num="0266" class="description-paragraph style-scope patent-text">In one embodiment, L<sup class="style-scope patent-text">1</sup>Including dipeptides.The dipeptides can be by-NH-X<sub class="style-scope patent-text">1</sub>-X<sub class="style-scope patent-text">2</sub>- CO- is indicated, wherein-NH-
Amino acid group X is respectively indicated with-CO-<sub class="style-scope patent-text">1</sub>And X<sub class="style-scope patent-text">2</sub>N-terminal and C-terminal.Amino acid in dipeptides can be any of natural amino acid
Combination.When connector is cathepsin unstability connector, dipeptides can be the effect position of the cutting of cathepsin mediation
Point.</div>
      <div id="p0267" num="0267" class="description-paragraph style-scope patent-text">In addition, such as Glu and Lys are distinguished for those of carboxyl or amino side chain functional group amino acid group,
CO and NH can represent the side chain functionalities.</div>
      <div id="p0268" num="0268" class="description-paragraph style-scope patent-text">In one embodiment, dipeptides-NH-X<sub class="style-scope patent-text">1</sub>-X<sub class="style-scope patent-text">2</sub>Group-X in-CO-<sub class="style-scope patent-text">1</sub>-X<sub class="style-scope patent-text">2</sub>It is selected from:</div>
      <div id="p0269" num="0269" class="description-paragraph style-scope patent-text">-Phe-Lys-、</div>
      <div id="p0270" num="0270" class="description-paragraph style-scope patent-text">-Val-Ala-、</div>
      <div id="p0271" num="0271" class="description-paragraph style-scope patent-text">-Val-Lys-、</div>
      <div id="p0272" num="0272" class="description-paragraph style-scope patent-text">-Ala-Lys-、</div>
      <div id="p0273" num="0273" class="description-paragraph style-scope patent-text">-Val-Cit-、</div>
      <div id="p0274" num="0274" class="description-paragraph style-scope patent-text">-Phe-Cit-、</div>
      <div id="p0275" num="0275" class="description-paragraph style-scope patent-text">-Leu-Cit-、</div>
      <div id="p0276" num="0276" class="description-paragraph style-scope patent-text">-Ile-Cit-、</div>
      <div id="p0277" num="0277" class="description-paragraph style-scope patent-text">-Phe-Arg-、</div>
      <div id="p0278" num="0278" class="description-paragraph style-scope patent-text">- Trp-Cit-,</div>
      <div id="p0279" num="0279" class="description-paragraph style-scope patent-text">Wherein, Cit is citrulling.</div>
      <div id="p0280" num="0280" class="description-paragraph style-scope patent-text">Preferably, dipeptides-NH-X<sub class="style-scope patent-text">1</sub>-X<sub class="style-scope patent-text">2</sub>Group-X in-CO-<sub class="style-scope patent-text">1</sub>-X<sub class="style-scope patent-text">2</sub>It is selected from:</div>
      <div id="p0281" num="0281" class="description-paragraph style-scope patent-text">-Phe-Lys-、</div>
      <div id="p0282" num="0282" class="description-paragraph style-scope patent-text">-Val-Ala-、</div>
      <div id="p0283" num="0283" class="description-paragraph style-scope patent-text">-Val-Lys-、</div>
      <div id="p0284" num="0284" class="description-paragraph style-scope patent-text">-Ala-Lys-、</div>
      <div id="p0285" num="0285" class="description-paragraph style-scope patent-text">-Val-Cit-。</div>
      <div id="p0286" num="0286" class="description-paragraph style-scope patent-text">It is highly preferred that dipeptides-NH-X<sub class="style-scope patent-text">1</sub>-X<sub class="style-scope patent-text">2</sub>Group-X in-CO-<sub class="style-scope patent-text">1</sub>-X<sub class="style-scope patent-text">2</sub>It is-Phe-Lys- or-Val-Ala-.</div>
      <div id="p0287" num="0287" class="description-paragraph style-scope patent-text">Other dipeptides combinations can be used comprising Dubowchik et al., Bioconjugate Chemistry,
Those of 2002,13,855-869 descriptions, are incorporated by reference herein.</div>
      <div id="p0288" num="0288" class="description-paragraph style-scope patent-text">In one embodiment, in the appropriate case, amino acid side chain is derivative.For example, the ammonia of amino acid side chain
Base group or carboxylic group can be derivative.</div>
      <div id="p0289" num="0289" class="description-paragraph style-scope patent-text">In one embodiment, the amino group NH of side chain amino acid (such as lysine)<sub class="style-scope patent-text">2</sub>It is derivative selected from by NHR and
The group of NRR ' composition.</div>
      <div id="p0290" num="0290" class="description-paragraph style-scope patent-text">In one embodiment, the carboxylic group COOH of side chain amino acid (such as aspartic acid) it is derivative selected from by COOR,
CONH<sub class="style-scope patent-text">2</sub>, CONHR and CONRR ' composition group.</div>
      <div id="p0291" num="0291" class="description-paragraph style-scope patent-text">In one embodiment, in the appropriate case, amino acid side chain is by chemoproection.Side chain protecting group
It can be below in relation to group R<sup class="style-scope patent-text">L</sup>The group of discussion.The present inventor established shielded amino acid sequence be can be by
What digestion was cut.Such as, it has been determined that the dipeptide sequence of the Lys residue comprising Boc side chain protection can be cut by cathepsin.</div>
      <div id="p0292" num="0292" class="description-paragraph style-scope patent-text">Blocking group for amino acid side chain is well known in the art and describes in Novabiochem
In catalogue.Other protections are described in the Protective Groups in Organic Synthesis of Greene and Wuts
Group strategy.</div>
      <div id="p0293" num="0293" class="description-paragraph style-scope patent-text">For shown below possible side chain protecting group with those of reactive side chain functional group amino acid:</div>
      <div id="p0294" num="0294" class="description-paragraph style-scope patent-text">Arg:Z, Mtr, Tos；</div>
      <div id="p0295" num="0295" class="description-paragraph style-scope patent-text">Asn:Trt, Xan；</div>
      <div id="p0296" num="0296" class="description-paragraph style-scope patent-text">Asp:Bzl, t-Bu；</div>
      <div id="p0297" num="0297" class="description-paragraph style-scope patent-text">Cys:Acm, Bzl, Bzl-OMe, Bzl-Me, Trt；</div>
      <div id="p0298" num="0298" class="description-paragraph style-scope patent-text">Glu:Bzl, t-Bu；</div>
      <div id="p0299" num="0299" class="description-paragraph style-scope patent-text">Gln:Trt, Xan；</div>
      <div id="p0300" num="0300" class="description-paragraph style-scope patent-text">His:Boc, Dnp, Tos, Trt；</div>
      <div id="p0301" num="0301" class="description-paragraph style-scope patent-text">Lys:Boc, Z-Cl, Fmoc, Z, Alloc；</div>
      <div id="p0302" num="0302" class="description-paragraph style-scope patent-text">Ser:Bzl, TBDMS, TBDPS；</div>
      <div id="p0303" num="0303" class="description-paragraph style-scope patent-text">Thr:Bz；</div>
      <div id="p0304" num="0304" class="description-paragraph style-scope patent-text">Trp:Boc；</div>
      <div id="p0305" num="0305" class="description-paragraph style-scope patent-text">Tyr:Bzl, Z, Z-Br.</div>
      <div id="p0306" num="0306" class="description-paragraph style-scope patent-text">In one embodiment, when it is present, selection side chain protecting group with be provided as end-capping group or part seal
The group of end group group is orthogonal.Therefore, remove side chain protecting group will not remove end-capping group or it is any be one of end-capping group
The blocking group functional group divided.</div>
      <div id="p0307" num="0307" class="description-paragraph style-scope patent-text">In other embodiments of the present invention, the amino acid of selection is that do not have those of reactive side chain functional group.
For example, amino acid can be selected from: Ala, Gly, Ile, Leu, Met, Phe, Pro and Val.</div>
      <div id="p0308" num="0308" class="description-paragraph style-scope patent-text">In one embodiment, dipeptides and the splice combinations of selfdecomposition use.The connector of selfdecomposition can connect to-
X<sub class="style-scope patent-text">2</sub>-。</div>
      <div id="p0309" num="0309" class="description-paragraph style-scope patent-text">When there are the connector of selfdecomposition ,-X<sub class="style-scope patent-text">2</sub>It is connected directly to the connector of selfdecomposition.Preferably, group-X<sub class="style-scope patent-text">2</sub>- CO- connects
It is connected to Y, wherein Y is NH, to form group-X<sub class="style-scope patent-text">2</sub>-CO-NH-。</div>
      <div id="p0310" num="0310" class="description-paragraph style-scope patent-text">-NH-X<sub class="style-scope patent-text">1</sub>It is connected directly to A.A may include functional group-CO-, thus with-X<sub class="style-scope patent-text">1</sub>Form amide connection.</div>
      <div id="p0311" num="0311" class="description-paragraph style-scope patent-text">In one embodiment, L<sup class="style-scope patent-text">1</sup>And L<sup class="style-scope patent-text">2</sup>It together include group NH-X with-OC (=O)-<sub class="style-scope patent-text">1</sub>-X<sub class="style-scope patent-text">2</sub>-CO-PABC-。PABC
Group is connected directly to the position N10.Preferably, the connector and dipeptides of selfdecomposition are formed together group-NH-Phe-Lys-CO-
NH-PABC-, described below:</div>
      <div id="p0312" num="0312" class="description-paragraph style-scope patent-text">
        <span class="patent-image-not-available style-scope patent-text"></span>
      </div>
      <div id="p0313" num="0313" class="description-paragraph style-scope patent-text">Wherein, asterisk indicates that the point for being attached to the position N10 and wave expression are attached to connector L<sup class="style-scope patent-text">1</sup>Remainder
Point or be attached to the point of A.Preferably, wave indicates the point for being attached to A.The side chain of Lys amino acid can be protected
, for example, by the protection of Boc, Fmoc or Alloc described above.</div>
      <div id="p0314" num="0314" class="description-paragraph style-scope patent-text">Alternatively, the connector and dipeptides of selfdecomposition are formed together group-NH-Val-Ala-CO-NH-PABC-,
It is described below:</div>
      <div id="p0315" num="0315" class="description-paragraph style-scope patent-text">
        <span class="patent-image-not-available style-scope patent-text"></span>
      </div>
      <div id="p0316" num="0316" class="description-paragraph style-scope patent-text">Wherein, asterisk and wave are as defined above.</div>
      <div id="p0317" num="0317" class="description-paragraph style-scope patent-text">Alternatively, the connector and dipeptides of selfdecomposition are formed together group-NH-Val-Cit-CO-NH-PABC-,
It is described below:</div>
      <div id="p0318" num="0318" class="description-paragraph style-scope patent-text">
        <span class="patent-image-not-available style-scope patent-text"></span>
      </div>
      <div id="p0319" num="0319" class="description-paragraph style-scope patent-text">Wherein, asterisk and wave are as defined above.</div>
      <div id="p0320" num="0320" class="description-paragraph style-scope patent-text">In one embodiment, A is covalent bond.Therefore, L<sup class="style-scope patent-text">1</sup>It is directly connected to cell binding agent.For example, in L<sup class="style-scope patent-text">1</sup>
In the case where continuous amino acid sequence, the N-terminal of sequence can be directly connected to cell binding agent.</div>
      <div id="p0321" num="0321" class="description-paragraph style-scope patent-text">Therefore, in the case where A is covalent bond, cell binding agent and L<sup class="style-scope patent-text">1</sup>Between connection can be selected from:</div>
      <div id="p0322" num="0322" class="description-paragraph style-scope patent-text">- C (=O) NH-,</div>
      <div id="p0323" num="0323" class="description-paragraph style-scope patent-text">- C (=O) O-,</div>
      <div id="p0324" num="0324" class="description-paragraph style-scope patent-text">- NHC (=O)-,</div>
      <div id="p0325" num="0325" class="description-paragraph style-scope patent-text">- OC (=O)-,</div>
      <div id="p0326" num="0326" class="description-paragraph style-scope patent-text">- OC (=O) O-,</div>
      <div id="p0327" num="0327" class="description-paragraph style-scope patent-text">- NHC (=O) O-,</div>
      <div id="p0328" num="0328" class="description-paragraph style-scope patent-text">- OC (=O) NH-,</div>
      <div id="p0329" num="0329" class="description-paragraph style-scope patent-text">- NHC (=O) NH-,</div>
      <div id="p0330" num="0330" class="description-paragraph style-scope patent-text">- C (=O) NHC (=O)-,</div>
      <div id="p0331" num="0331" class="description-paragraph style-scope patent-text">-S-、</div>
      <div id="p0332" num="0332" class="description-paragraph style-scope patent-text">-S-S-、</div>
      <div id="p0333" num="0333" class="description-paragraph style-scope patent-text">-CH<sub class="style-scope patent-text">2</sub>C (=O)-and</div>
      <div id="p0334" num="0334" class="description-paragraph style-scope patent-text">=N-NH-.</div>
      <div id="p0335" num="0335" class="description-paragraph style-scope patent-text">It is connected to the L of cell binding agent<sup class="style-scope patent-text">1</sup>Amino group can be the N-terminal of amino acid, or amino acid side chain can be originated from
The amino group of (such as amino acid side chain of lysine).</div>
      <div id="p0336" num="0336" class="description-paragraph style-scope patent-text">It is connected to the L of cell binding agent<sup class="style-scope patent-text">1</sup>Carboxylic group can be the C-terminal of amino acid, or amino acid side chain can be originated from
The carboxylic group of (such as amino acid side chain of glutamic acid).</div>
      <div id="p0337" num="0337" class="description-paragraph style-scope patent-text">It is connected to the L of cell binding agent<sup class="style-scope patent-text">1</sup>Hydroxyl group can be originated from amino acid side chain (such as the amino acid of serine
Side chain) hydroxyl group.</div>
      <div id="p0338" num="0338" class="description-paragraph style-scope patent-text">It is connected to the L of cell binding agent<sup class="style-scope patent-text">1</sup>Thiol group can be originated from amino acid side chain (such as the amino acid of serine
Side chain) thiol group.</div>
      <div id="p0339" num="0339" class="description-paragraph style-scope patent-text">Above with respect to L<sup class="style-scope patent-text">1</sup>Amino, carboxyl, hydroxyl and thiol group annotation can also be applied to cell binding agent.</div>
      <div id="p0340" num="0340" class="description-paragraph style-scope patent-text">In one embodiment, L<sup class="style-scope patent-text">2</sup>It is represented together with-OC (=O)-:</div>
      <div id="p0341" num="0341" class="description-paragraph style-scope patent-text">
        <span class="patent-image-not-available style-scope patent-text"></span>
      </div>
      <div id="p0342" num="0342" class="description-paragraph style-scope patent-text">Wherein, asterisk indicates the point for being attached to the position N10, and wave expression is attached to L<sup class="style-scope patent-text">1</sup>Point, n be 0 to 3, Y be altogether
Valence link or functional group and E be can activated group, such as can be activated by enzyme effect or light, to generate the list of selfdecomposition
Member.Phenylene ring is optionally further substituted with by one, two or three substituent group described herein.In an embodiment party
In formula, subphenyl group is optionally by halogen, NO<sub class="style-scope patent-text">2</sub>, R or OR be further substituted with.Preferably, n is 0 or 1, most preferably 0.</div>
      <div id="p0343" num="0343" class="description-paragraph style-scope patent-text">Selection E makes group be easy to activate, for example, by light or passing through the acting activating of enzyme.E can be-NO<sub class="style-scope patent-text">2</sub>Or Portugal
Grape uronic acid.The former may may be vulnerable to the effect of GRD beta-glucuronidase vulnerable to the effect of nitroreductase, the latter.</div>
      <div id="p0344" num="0344" class="description-paragraph style-scope patent-text">In this embodiment, when E is activated, the connector of selfdecomposition will allow shielded compound to discharge, along with
Route shown in lower carries out (for n=0):</div>
      <div id="p0345" num="0345" class="description-paragraph style-scope patent-text">
        <span class="patent-image-not-available style-scope patent-text"></span>
      </div>
      <div id="p0346" num="0346" class="description-paragraph style-scope patent-text">Wherein, asterisk indicates the point for being attached to the position N10, and E* is the activated form of E, and Y is as described above.This
A little groups have the advantage that activation site is separated from shielded compound.As described above, subphenyl group can be
Optionally it is further substituted with.</div>
      <div id="p0347" num="0347" class="description-paragraph style-scope patent-text">Group Y can be to L<sup class="style-scope patent-text">1</sup>Covalent bond.</div>
      <div id="p0348" num="0348" class="description-paragraph style-scope patent-text">Group Y can be functional group selected from the following:</div>
      <div id="p0349" num="0349" class="description-paragraph style-scope patent-text">- C (=O)-,</div>
      <div id="p0350" num="0350" class="description-paragraph style-scope patent-text">-NH-、</div>
      <div id="p0351" num="0351" class="description-paragraph style-scope patent-text">-O-、</div>
      <div id="p0352" num="0352" class="description-paragraph style-scope patent-text">- C (=O) NH-,</div>
      <div id="p0353" num="0353" class="description-paragraph style-scope patent-text">- C (=O) O-,</div>
      <div id="p0354" num="0354" class="description-paragraph style-scope patent-text">- NHC (=O)-,</div>
      <div id="p0355" num="0355" class="description-paragraph style-scope patent-text">- OC (=O)-,</div>
      <div id="p0356" num="0356" class="description-paragraph style-scope patent-text">- OC (=O) O-,</div>
      <div id="p0357" num="0357" class="description-paragraph style-scope patent-text">- NHC (=O) O-,</div>
      <div id="p0358" num="0358" class="description-paragraph style-scope patent-text">- OC (=O) NH-,</div>
      <div id="p0359" num="0359" class="description-paragraph style-scope patent-text">- NHC (=O) NH-,</div>
      <div id="p0360" num="0360" class="description-paragraph style-scope patent-text">- NHC (=O) NH,</div>
      <div id="p0361" num="0361" class="description-paragraph style-scope patent-text">- C (=O) NHC (=O)-and</div>
      <div id="p0362" num="0362" class="description-paragraph style-scope patent-text">-S-。</div>
      <div id="p0363" num="0363" class="description-paragraph style-scope patent-text">Work as L<sup class="style-scope patent-text">1</sup>When being dipeptides, preferably Y is-NH- or-C (=O)-, to form L<sup class="style-scope patent-text">1</sup>Amido bond between Y.At this
In embodiment, the substrate that dipeptide sequence is enzymatic activity is not needed.</div>
      <div id="p0364" num="0364" class="description-paragraph style-scope patent-text">In another embodiment, A is spacer groups.Therefore, L<sup class="style-scope patent-text">1</sup>It is indirect connection with cell binding agent.</div>
      <div id="p0365" num="0365" class="description-paragraph style-scope patent-text">L<sup class="style-scope patent-text">1</sup>Key connection selected from the following can be passed through with A:</div>
      <div id="p0366" num="0366" class="description-paragraph style-scope patent-text">- C (=O) NH-,</div>
      <div id="p0367" num="0367" class="description-paragraph style-scope patent-text">- C (=O) O-,</div>
      <div id="p0368" num="0368" class="description-paragraph style-scope patent-text">- NHC (=O)-,</div>
      <div id="p0369" num="0369" class="description-paragraph style-scope patent-text">- OC (=O)-,</div>
      <div id="p0370" num="0370" class="description-paragraph style-scope patent-text">- OC (=O) O-,</div>
      <div id="p0371" num="0371" class="description-paragraph style-scope patent-text">- NHC (=O) O-,</div>
      <div id="p0372" num="0372" class="description-paragraph style-scope patent-text">- OC (=O) NH- and</div>
      <div id="p0373" num="0373" class="description-paragraph style-scope patent-text">- NHC (=O) NH-.</div>
      <div id="p0374" num="0374" class="description-paragraph style-scope patent-text">In one embodiment, group A is:</div>
      <div id="p0375" num="0375" class="description-paragraph style-scope patent-text">
        <span class="patent-image-not-available style-scope patent-text"></span>
      </div>
      <div id="p0376" num="0376" class="description-paragraph style-scope patent-text">Wherein, asterisk expression is attached to L<sup class="style-scope patent-text">1</sup>Point, wave indicates to be attached to the point of cell binding agent, and n be 0 to
6.In one embodiment, n is 5.</div>
      <div id="p0377" num="0377" class="description-paragraph style-scope patent-text">In one embodiment, group A is:</div>
      <div id="p0378" num="0378" class="description-paragraph style-scope patent-text">
        <span class="patent-image-not-available style-scope patent-text"></span>
      </div>
      <div id="p0379" num="0379" class="description-paragraph style-scope patent-text">Wherein, asterisk expression is attached to L<sup class="style-scope patent-text">1</sup>Point, wave indicates to be attached to the point of cell binding agent, and n be 0 to
6.In one embodiment, n is 5.</div>
      <div id="p0380" num="0380" class="description-paragraph style-scope patent-text">In one embodiment, group A is:</div>
      <div id="p0381" num="0381" class="description-paragraph style-scope patent-text">
        <span class="patent-image-not-available style-scope patent-text"></span>
      </div>
      <div id="p0382" num="0382" class="description-paragraph style-scope patent-text">Wherein, asterisk expression is attached to L<sup class="style-scope patent-text">1</sup>Point, wave indicates to be attached to the point of cell binding agent, and n is 0 or 1, and
And m is 0 to 30.In one preferred embodiment, it is 0 to 10,1 to 8, preferably 4 to 8 and optimal that n, which is 1 and m,
Selection of land 4 or 8.In another embodiment, m is 10 to 30, and preferably 20 to 30.Alternatively, m is 0 to 50.
In this embodiment, m is preferably 10-40, and n is 1.</div>
      <div id="p0383" num="0383" class="description-paragraph style-scope patent-text">In one embodiment, group A is:</div>
      <div id="p0384" num="0384" class="description-paragraph style-scope patent-text">
        <span class="patent-image-not-available style-scope patent-text"></span>
      </div>
      <div id="p0385" num="0385" class="description-paragraph style-scope patent-text">Wherein, asterisk expression is attached to L<sup class="style-scope patent-text">1</sup>Point, wave indicates to be attached to the point of cell binding agent, and n is 0 or 1, and
And m is 0 to 30.In one preferred embodiment, it is 0 to 10,1 to 8, preferably 4 to 8 and optimal that n, which is 1 and m,
Selection of land 4 or 8.In another embodiment, m is 10 to 30, and preferably 20 to 30.Alternatively, m is 0 to 50.
In this embodiment, m is preferably 10-40, and n is 1.</div>
      <div id="p0386" num="0386" class="description-paragraph style-scope patent-text">In one embodiment, the connection between cell binding agent and A be by the thiol residue of cell binding agent and
The maleimide base group of A.</div>
      <div id="p0387" num="0387" class="description-paragraph style-scope patent-text">In one embodiment, the connection between cell binding agent and A is:</div>
      <div id="p0388" num="0388" class="description-paragraph style-scope patent-text">
        <span class="patent-image-not-available style-scope patent-text"></span>
      </div>
      <div id="p0389" num="0389" class="description-paragraph style-scope patent-text">Wherein, asterisk indicates that the point for being attached to the remainder of A and wave expression are attached to cell binding agent
The point of remainder.In this embodiment, S atom generally originates from cell binding agent.</div>
      <div id="p0390" num="0390" class="description-paragraph style-scope patent-text">In each of embodiment of above, alternative functional group can be used instead of as shown below and be originated from horse
Carry out imido group:</div>
      <div id="p0391" num="0391" class="description-paragraph style-scope patent-text">
        <span class="patent-image-not-available style-scope patent-text"></span>
      </div>
      <div id="p0392" num="0392" class="description-paragraph style-scope patent-text">Wherein, wave indicates the point for being attached to cell binding agent as before, and asterisk is indicated to A group
The key of remainder.</div>
      <div id="p0393" num="0393" class="description-paragraph style-scope patent-text">In one embodiment, the group from maleimide is replaced with following group:</div>
      <div id="p0394" num="0394" class="description-paragraph style-scope patent-text">
        <span class="patent-image-not-available style-scope patent-text"></span>
      </div>
      <div id="p0395" num="0395" class="description-paragraph style-scope patent-text">Wherein, wave indicates the point for being attached to cell binding agent, and asterisk is indicated to the remainder of A group
Key.</div>
      <div id="p0396" num="0396" class="description-paragraph style-scope patent-text">In one embodiment, the group from maleimide is replaced by group, the group optionally with cell knot
Mixture is selected from together:</div>
      <div id="p0397" num="0397" class="description-paragraph style-scope patent-text">- C (=O) NH-,</div>
      <div id="p0398" num="0398" class="description-paragraph style-scope patent-text">- C (=O) O-,</div>
      <div id="p0399" num="0399" class="description-paragraph style-scope patent-text">- NHC (=O)-,</div>
      <div id="p0400" num="0400" class="description-paragraph style-scope patent-text">- OC (=O)-,</div>
      <div id="p0401" num="0401" class="description-paragraph style-scope patent-text">- OC (=O) O-,</div>
      <div id="p0402" num="0402" class="description-paragraph style-scope patent-text">- NHC (=O) O-,</div>
      <div id="p0403" num="0403" class="description-paragraph style-scope patent-text">- OC (=O) NH-,</div>
      <div id="p0404" num="0404" class="description-paragraph style-scope patent-text">- NHC (=O) NH-,</div>
      <div id="p0405" num="0405" class="description-paragraph style-scope patent-text">- NHC (=O) NH,</div>
      <div id="p0406" num="0406" class="description-paragraph style-scope patent-text">- C (=O) NHC (=O)-,</div>
      <div id="p0407" num="0407" class="description-paragraph style-scope patent-text">-S-、</div>
      <div id="p0408" num="0408" class="description-paragraph style-scope patent-text">-S-S-、</div>
      <div id="p0409" num="0409" class="description-paragraph style-scope patent-text">-CH<sub class="style-scope patent-text">2</sub>C (=O)-,</div>
      <div id="p0410" num="0410" class="description-paragraph style-scope patent-text">- C (=O) CH<sub class="style-scope patent-text">2</sub>-、</div>
      <div id="p0411" num="0411" class="description-paragraph style-scope patent-text">=N-NH- and</div>
      <div id="p0412" num="0412" class="description-paragraph style-scope patent-text">- NH-N=.</div>
      <div id="p0413" num="0413" class="description-paragraph style-scope patent-text">In one embodiment, the group from maleimide is replaced by group, the group optionally with cell knot
Mixture is selected from together:</div>
      <div id="p0414" num="0414" class="description-paragraph style-scope patent-text">
        <span class="patent-image-not-available style-scope patent-text"></span>
      </div>
      <div id="p0415" num="0415" class="description-paragraph style-scope patent-text">Wherein, wave indicates to be attached to the point of cell binding agent or the key of the remainder to A group, and asterisk
Indicate the key for being attached to the other point or the remainder to A group of cell binding agent.</div>
      <div id="p0416" num="0416" class="description-paragraph style-scope patent-text">It describes and is suitable for L in WO 2005/082023<sup class="style-scope patent-text">1</sup>It is connected to the other groups of cell binding agent.</div>
      <div id="p0417" num="0417" class="description-paragraph style-scope patent-text">Group R<sup class="style-scope patent-text">L’</sup>It may originate from group R<sup class="style-scope patent-text">L</sup>.By the way that cell binding agent is connected to R<sup class="style-scope patent-text">L</sup>Functional group can be by group R<sup class="style-scope patent-text">L</sup>It is converted into
Group R<sup class="style-scope patent-text">L’</sup>.Other steps can be taken R<sup class="style-scope patent-text">L</sup>It is converted into R<sup class="style-scope patent-text">L’</sup>.These steps may include removing existing blocking group or introducing
Functional group appropriate.</div>
      <div id="p0418" num="0418" class="description-paragraph style-scope patent-text">R<sup class="style-scope patent-text">L</sup> </div>
      <div id="p0419" num="0419" class="description-paragraph style-scope patent-text">In one embodiment, R<sup class="style-scope patent-text">L</sup>It is the connector for being connected to cell binding agent.</div>
      <div id="p0420" num="0420" class="description-paragraph style-scope patent-text">In one embodiment, connector is provided with functional group to be formed to the connection of cell binding agent.This application is special
It is related to having and is connected to those of the carbamate of the position N10 R<sup class="style-scope patent-text">L</sup>Group.The above R<sup class="style-scope patent-text">L’</sup>The discussion of middle linking group further relates to this
Locate their intermediate precursors.</div>
      <div id="p0421" num="0421" class="description-paragraph style-scope patent-text">In one embodiment, R<sup class="style-scope patent-text">L</sup>It is following group:</div>
      <div id="p0422" num="0422" class="description-paragraph style-scope patent-text">
        <span class="patent-image-not-available style-scope patent-text"></span>
      </div>
      <div id="p0423" num="0423" class="description-paragraph style-scope patent-text">Wherein, asterisk indicates the point for being attached to the position N10, G<sup class="style-scope patent-text">1</sup>It is to be formed to the functional group of the connection of cell binding agent, L<sup class="style-scope patent-text">1</sup>
It is connector, L<sup class="style-scope patent-text">2</sup>Be covalent bond or with-OC (=O)-be formed together the connector and L of selfdecomposition<sup class="style-scope patent-text">1</sup>Or L<sup class="style-scope patent-text">2</sup>It is cleavable connector.</div>
      <div id="p0424" num="0424" class="description-paragraph style-scope patent-text">As defined above, L<sup class="style-scope patent-text">1</sup>And L<sup class="style-scope patent-text">2</sup>With R<sup class="style-scope patent-text">L’</sup>It is related.Refer to that the connection to A can be construed to refer to G herein<sup class="style-scope patent-text">1</sup>'s
Connection.</div>
      <div id="p0425" num="0425" class="description-paragraph style-scope patent-text">In one embodiment, in L<sup class="style-scope patent-text">1</sup>In the case where amino acid, the side chain of the amino acid can be protected
's.Any suitable blocking group can be used.It in one embodiment, if it does, can be with other in the compound
Blocking group removes side chain protecting group.In other embodiments, if it does, blocking group and other guarantors in molecule
Shield group can be orthogonal (adjacent, orthogonal).</div>
      <div id="p0426" num="0426" class="description-paragraph style-scope patent-text">The suitable blocking group of amino acid side chain includes that being described in Novabiochem catalogue 2006/2007
A bit.The blocking group used in the unstable connector of cathepsin is also discussed in Dubowchik et al..</div>
      <div id="p0427" num="0427" class="description-paragraph style-scope patent-text">In some embodiments of the present invention, group L<sup class="style-scope patent-text">1</sup>Include Lys amino acid residue.It can be protected with Boc or Alloc
Protect the side chain of the radical protection amino acid.Boc blocking group is most preferred.</div>
      <div id="p0428" num="0428" class="description-paragraph style-scope patent-text">Functional group G<sup class="style-scope patent-text">1</sup>Linking group A is formed by reacting with cell binding agent.</div>
      <div id="p0429" num="0429" class="description-paragraph style-scope patent-text">In one embodiment, functional group G<sup class="style-scope patent-text">1</sup>It is or comprising amino, carboxylic acid, hydroxyl, mercaptan or maleimide base group
For being reacted with group appropriate on cell binding agent.In one preferred embodiment, G<sup class="style-scope patent-text">1</sup>Include dimaleoyl imino
Group.</div>
      <div id="p0430" num="0430" class="description-paragraph style-scope patent-text">In one embodiment, group G<sup class="style-scope patent-text">1</sup>It is alkyl maleimide group.The group is suitable for and is present in cell
Thiol group reaction in bonding agent (for example, being present in antibody), especially reacts with cysteine thiol group.</div>
      <div id="p0431" num="0431" class="description-paragraph style-scope patent-text">In one embodiment, group G<sup class="style-scope patent-text">1</sup>It is:</div>
      <div id="p0432" num="0432" class="description-paragraph style-scope patent-text">
        <span class="patent-image-not-available style-scope patent-text"></span>
      </div>
      <div id="p0433" num="0433" class="description-paragraph style-scope patent-text">Wherein, asterisk expression is attached to L<sup class="style-scope patent-text">1</sup>Point, and n is 0 to 6.In one embodiment, n is 5.</div>
      <div id="p0434" num="0434" class="description-paragraph style-scope patent-text">In one embodiment, group G<sup class="style-scope patent-text">1</sup>It is:</div>
      <div id="p0435" num="0435" class="description-paragraph style-scope patent-text">
        <span class="patent-image-not-available style-scope patent-text"></span>
      </div>
      <div id="p0436" num="0436" class="description-paragraph style-scope patent-text">Wherein, asterisk expression is attached to L<sup class="style-scope patent-text">1</sup>Point, and n is 0 to 6.In one embodiment, n is 5.</div>
      <div id="p0437" num="0437" class="description-paragraph style-scope patent-text">In one embodiment, group G<sup class="style-scope patent-text">1</sup>It is:</div>
      <div id="p0438" num="0438" class="description-paragraph style-scope patent-text">
        <span class="patent-image-not-available style-scope patent-text"></span>
      </div>
      <div id="p0439" num="0439" class="description-paragraph style-scope patent-text">Wherein, asterisk expression is attached to L<sup class="style-scope patent-text">1</sup>Point, n is 0 or 1, and m is 0 to 30.In a preferred embodiment
In, n is that 1 and m is 0 to 10,1 to 2, preferably 4 to 8 and most preferably 4 or 8.Alternatively, m is 0 to 50.At this
In embodiment, m is preferably 10-40, and n is 1.</div>
      <div id="p0440" num="0440" class="description-paragraph style-scope patent-text">In one embodiment, group G<sup class="style-scope patent-text">1</sup>It is:</div>
      <div id="p0441" num="0441" class="description-paragraph style-scope patent-text">
        <span class="patent-image-not-available style-scope patent-text"></span>
      </div>
      <div id="p0442" num="0442" class="description-paragraph style-scope patent-text">Wherein, asterisk expression is attached to L<sup class="style-scope patent-text">1</sup>Point, n is 0 or 1, and m is 0 to 30.In a preferred embodiment
In, n is that 1 and m is 0 to 10,1 to 8, preferably 4 to 8 and most preferably 4 or 8.Alternatively, m is 0 to 50.At this
In embodiment, m is preferably 10-40, and n is 1.</div>
      <div id="p0443" num="0443" class="description-paragraph style-scope patent-text">In each of embodiment of above, alternative functional group can replace maleimide as shown below
Group uses:</div>
      <div id="p0444" num="0444" class="description-paragraph style-scope patent-text">
        <span class="patent-image-not-available style-scope patent-text"></span>
      </div>
      <div id="p0445" num="0445" class="description-paragraph style-scope patent-text">Wherein, asterisk indicates the key with the remainder of G group.</div>
      <div id="p0446" num="0446" class="description-paragraph style-scope patent-text">In one embodiment, the group from maleimide is replaced with following group:</div>
      <div id="p0447" num="0447" class="description-paragraph style-scope patent-text">
        <span class="patent-image-not-available style-scope patent-text"></span>
      </div>
      <div id="p0448" num="0448" class="description-paragraph style-scope patent-text">Wherein, asterisk indicates the key with the remainder of G group.</div>
      <div id="p0449" num="0449" class="description-paragraph style-scope patent-text">In one embodiment, maleimide base group is replaced with group selected from the following:</div>
      <div id="p0450" num="0450" class="description-paragraph style-scope patent-text">- C (=O) OH,</div>
      <div id="p0451" num="0451" class="description-paragraph style-scope patent-text">-OH、</div>
      <div id="p0452" num="0452" class="description-paragraph style-scope patent-text">-NH<sub class="style-scope patent-text">2</sub>、</div>
      <div id="p0453" num="0453" class="description-paragraph style-scope patent-text">-SH、</div>
      <div id="p0454" num="0454" class="description-paragraph style-scope patent-text">- C (=O) CH<sub class="style-scope patent-text">2</sub>D (wherein, D is Cl, Br or I),</div>
      <div id="p0455" num="0455" class="description-paragraph style-scope patent-text">CHO、</div>
      <div id="p0456" num="0456" class="description-paragraph style-scope patent-text">NHNH<sub class="style-scope patent-text">2</sub>、</div>
      <div id="p0457" num="0457" class="description-paragraph style-scope patent-text">C ≡ CH and</div>
      <div id="p0458" num="0458" class="description-paragraph style-scope patent-text">N<sub class="style-scope patent-text">3</sub>(azide).</div>
      <div id="p0459" num="0459" class="description-paragraph style-scope patent-text">In one embodiment, there are L<sup class="style-scope patent-text">1</sup>In the case where, G<sup class="style-scope patent-text">1</sup>It is-NH<sub class="style-scope patent-text">2</sub>,-NHMe ,-COOH ,-OH or-SH.</div>
      <div id="p0460" num="0460" class="description-paragraph style-scope patent-text">In one embodiment, there are L<sup class="style-scope patent-text">1</sup>In the case where, G<sup class="style-scope patent-text">1</sup>It is-NH<sub class="style-scope patent-text">2</sub>Or-NHMe.Each group can be L<sup class="style-scope patent-text">1</sup>Ammonia
The N-terminal of base acid sequence.</div>
      <div id="p0461" num="0461" class="description-paragraph style-scope patent-text">In one embodiment, there are L<sup class="style-scope patent-text">1</sup>In the case where, G<sup class="style-scope patent-text">1</sup>It is-NH<sub class="style-scope patent-text">2</sub>, and L<sup class="style-scope patent-text">1</sup>It is above with respect to R<sup class="style-scope patent-text">10</sup>Defined ammonia
Base acid sequence-X<sub class="style-scope patent-text">1</sub>-X<sub class="style-scope patent-text">2</sub>-。</div>
      <div id="p0462" num="0462" class="description-paragraph style-scope patent-text">In one embodiment, there are L<sup class="style-scope patent-text">1</sup>In the case where, G<sup class="style-scope patent-text">1</sup>It is COOH.The group can be L<sup class="style-scope patent-text">1</sup>Amino acid sequence
C-terminal.</div>
      <div id="p0463" num="0463" class="description-paragraph style-scope patent-text">In one embodiment, there are L<sup class="style-scope patent-text">1</sup>In the case where, G<sup class="style-scope patent-text">1</sup>It is OH.</div>
      <div id="p0464" num="0464" class="description-paragraph style-scope patent-text">In one embodiment, there are L<sup class="style-scope patent-text">1</sup>In the case where, G<sup class="style-scope patent-text">1</sup>It is SH.</div>
      <div id="p0465" num="0465" class="description-paragraph style-scope patent-text">Group G<sup class="style-scope patent-text">1</sup>It can be from a kind of functional group to another functional group conversions.In one embodiment, there are L<sup class="style-scope patent-text">1</sup>'s
In the case of, G<sup class="style-scope patent-text">1</sup>It is-NH<sub class="style-scope patent-text">2</sub>.The group can be to another group G comprising maleimide base group<sup class="style-scope patent-text">1</sup>Conversion.For example, group-NH<sub class="style-scope patent-text">2</sub>
Can with include those of maleimide illustrated above G<sup class="style-scope patent-text">1</sup>The acid of group or the acid of activation are (for example, N- succinimide shape
Formula) reaction.</div>
      <div id="p0466" num="0466" class="description-paragraph style-scope patent-text">Therefore, group G<sup class="style-scope patent-text">1</sup>The functional group more suitable for reacting with cell binding agent can be converted into.</div>
      <div id="p0467" num="0467" class="description-paragraph style-scope patent-text">In other embodiments, R<sup class="style-scope patent-text">L</sup>It is the group as the precursor for the connector for being provided with functional group.</div>
      <div id="p0468" num="0468" class="description-paragraph style-scope patent-text">As mentioned above, in one embodiment, there are L<sup class="style-scope patent-text">1</sup>In the case where, G<sup class="style-scope patent-text">1</sup>It is-NH<sub class="style-scope patent-text">2</sub>、 -NHMe、-
COOH ,-OH or-SH.In a further embodiment, these groups are provided with chemical protected form.Therefore, change
It learns protected form and is to provide the precursor for having the connector of functional group.</div>
      <div id="p0469" num="0469" class="description-paragraph style-scope patent-text">In one embodiment, G<sup class="style-scope patent-text">1</sup>It is chemical protected form-NH<sub class="style-scope patent-text">2</sub>.It can be protected with carbamate protecting group
Protect the group.Carbamate protecting group can be selected from the group being made up of:</div>
      <div id="p0470" num="0470" class="description-paragraph style-scope patent-text">Alloc, Fmoc, Boc, Troc, Teoc, Cbz and PNZ.</div>
      <div id="p0471" num="0471" class="description-paragraph style-scope patent-text">Preferably, in G<sup class="style-scope patent-text">1</sup>It is-NH<sub class="style-scope patent-text">2</sub>In the case where, with Alloc or Fmoc radical protection it.</div>
      <div id="p0472" num="0472" class="description-paragraph style-scope patent-text">In one embodiment, in G<sub class="style-scope patent-text">1</sub>It is-NH<sub class="style-scope patent-text">2</sub>In the case where, with Fmoc radical protection it.</div>
      <div id="p0473" num="0473" class="description-paragraph style-scope patent-text">Chemical protecting group be can remove to provide the functional group for forming connection with cell binding agent.Optionally, the function
Then group can be converted into another functional group described above.</div>
      <div id="p0474" num="0474" class="description-paragraph style-scope patent-text">In one embodiment, active group is amine.The amine is preferably the N-terminal of peptide, and can be of the invention preferred
Dipeptides N-terminal.</div>
      <div id="p0475" num="0475" class="description-paragraph style-scope patent-text">Active group can be made to react to generate the functional group for being intended to form connection with cell binding agent.</div>
      <div id="p0476" num="0476" class="description-paragraph style-scope patent-text">In other embodiments, which is the precursor of the connector of active group.In this embodiment, it connects
Head includes active group, the protected radical protection of the active group.The blocking group be can remove to provide active group
Connector.</div>
      <div id="p0477" num="0477" class="description-paragraph style-scope patent-text">In the case where active group is amine, blocking group can be amine protecting group group, as described in Green and Wuts
Those of.</div>
      <div id="p0478" num="0478" class="description-paragraph style-scope patent-text">Blocking group preferably with group R<sup class="style-scope patent-text">L</sup>In other blocking group (if present)s be orthogonal.</div>
      <div id="p0479" num="0479" class="description-paragraph style-scope patent-text">In some embodiments, connector includes the electrophilic official for reacting with the nucleophilic functional group on cell binding agent
It can group.Nucleophilic group on antibody includes but is not limited to: (i) N-terminal amine groups, (ii) side chain amine groups, such as lysine,
(iii) side chain thiol moiety, such as cysteine, and (iv) sugared hydroxyl or amino group, wherein antibody is glycosylated.
Amine, mercaptan and hydroxyl group are nucleophilicities and can form covalent bond, and connector with the electrophilic group reactions on junction portion
Reagent includes: (i) maleimide base group, the disulphide of (ii) activation, (iii) active ester such as NHS (N- hydroxysuccinimidyl acyl
Imines) ester, HOBt (N- hydroxybenzotriazole) ester, haloformate and acyl halide；(iv) alkyl and benzylic halides are for example halogenated
Acetamide；And it (v) aldehyde, ketone, carboxyl and is exemplified as more below:</div>
      <div id="p0480" num="0480" class="description-paragraph style-scope patent-text">
        <span class="patent-image-not-available style-scope patent-text"></span>
      </div>
      <div id="p0481" num="0481" class="description-paragraph style-scope patent-text">Certain antibody have disulphide in reducible chain, that is, cysteine bridge.For and linker reagents combination,
Antibody can be made to become that there is reactivity by being handled with reducing agent such as DTT (dithiothreitol (DTT)).Therefore, theoretically each half
Cystine bridge will form two reactive nucleophilic thiol bodies.By obtaining the lysine and 2- imino group of the conversion of amine to mercaptan
The reaction of thiophene (TrautShi reagent), other nucleophilic group can be introduced in antibody.By introducing 1,2,3,4 or more
Most cystine residues (for example, the mutant antibodies of preparation comprising one or more non-natural cysteine residues) can will be anti-
The thiol group of answering property is introduced to antibody (or their segment).The introduction of US 7521541 is by introducing reactive cysteine
Amino acid designerantibodies.</div>
      <div id="p0482" num="0482" class="description-paragraph style-scope patent-text">In some embodiments, connector has the reactive nucleophilic group with the electrophilic group reactions being present on antibody
Group.Useful electrophilic group includes but is not limited to aldehyde and ketone carbonyl group on antibody.The hetero atom of the nucleophilic group of connector can be with
With the covalent bond of the electrophilic group reactions on antibody and formation and antibody units.Useful nucleophilic group includes but not on connector
It is limited to hydrazides, oxime, amino, hydroxyl, hydrazine, thiosemicarbazones, hydrazinecarboxylate and aryl hydrazide.Electrophilic group on antibody provides
Facilitate site for be attached to connector.</div>
      <div id="p0483" num="0483" class="description-paragraph style-scope patent-text">It is described in WO 2005/082023 and is suitable for forming L<sup class="style-scope patent-text">1</sup>Other functions of connection between cell binding agent
Group.</div>
      <div id="p0484" num="0484" class="description-paragraph style-scope patent-text">Connector may include the peptide moiety of albumen enzyme cleavable, and it includes one or more Amino Acid Units.It can pass through
Chemistry of peptides, including t-BOC chemistry (Geiser et al " Automation of solid-phase peptide
Synthesis " is in Macromolecular Sequencing and Synthesis, Alan R.Liss, Inc., 1988,
) and Fmoc/HBTU chemistry (Fields, G. and Noble, R. (1990) " Solid phase peptide pp.199-218
synthesis utilizing 9-fluoroenylmethoxycarbonyl amino acids",Int.J.Peptide
Protein Res. 35:161-214) the well-known solid phase in field or liquid-phase synthesis process (E.<span class="patent-image-not-available style-scope patent-text"></span>With K.L ü
Bke, The Peptides, volume 1, pp 76-136 (1965) Academic publishing house), automated synthesiser such as
Rainin Symphony peptide synthesizer (Protein Technologies, Inc., Tucson, AZ) or Model 433
In (Applied Biosystems, Foster City, CA), peptide linker reagent is prepared.</div>
      <div id="p0485" num="0485" class="description-paragraph style-scope patent-text">Illustrative Amino acid linker includes dipeptides, tripeptides, tetrapeptide or pentapeptide.Illustrative dipeptides includes: valine-
Citrulling (vc or val-cit), alanine-phenylalanine (af or ala-phe).Illustrative tripeptides includes: glycine-figured silk fabrics
Propylhomoserin-citrulling (gly-val-cit) and Gly-Gly-glycine (gly-gly-gly).Include Amino acid linker group
Point amino acid residue include those of naturally occurring and micro-amino acid and non-naturally occurring amino acid analogue, such as
Citrulling.It can design and optimize Amino acid linker component to certain enzyme, such as the relevant protease of tumour, cathepsin
B, the selectivity that the digestion of C and D or plasmase is cut.</div>
      <div id="p0486" num="0486" class="description-paragraph style-scope patent-text">Amino acid side chain include those of naturally occurring and micro-amino acid and non-naturally occurring amino acids seemingly
Object, such as citrulling.Amino acid side chain include hydrogen, methyl, isopropyl, isobutyl group, sec-butyl, benzyl, p- hydroxybenzyl ,-
CH<sub class="style-scope patent-text">2</sub>OH、-CH(OH)CH<sub class="style-scope patent-text">3</sub>、-CH<sub class="style-scope patent-text">2</sub>CH<sub class="style-scope patent-text">2</sub>SCH<sub class="style-scope patent-text">3</sub>、 -CH<sub class="style-scope patent-text">2</sub>CONH<sub class="style-scope patent-text">2</sub>、-CH<sub class="style-scope patent-text">2</sub>COOH、-CH<sub class="style-scope patent-text">2</sub>CH<sub class="style-scope patent-text">2</sub>CONH<sub class="style-scope patent-text">2</sub>、-CH<sub class="style-scope patent-text">2</sub>CH<sub class="style-scope patent-text">2</sub>COOH、 -(CH<sub class="style-scope patent-text">2</sub>)<sub class="style-scope patent-text">3</sub>NHC (=NH) NH<sub class="style-scope patent-text">2</sub>、-(CH<sub class="style-scope patent-text">2</sub>)<sub class="style-scope patent-text">3</sub>NH<sub class="style-scope patent-text">2</sub>、-(CH<sub class="style-scope patent-text">2</sub>)<sub class="style-scope patent-text">3</sub>NHCOCH<sub class="style-scope patent-text">3</sub>、-(CH<sub class="style-scope patent-text">2</sub>)<sub class="style-scope patent-text">3</sub>NHCHO、 -(CH<sub class="style-scope patent-text">2</sub>)<sub class="style-scope patent-text">4</sub>NHC (=NH) NH<sub class="style-scope patent-text">2</sub>、-(CH<sub class="style-scope patent-text">2</sub>)<sub class="style-scope patent-text">4</sub>NH<sub class="style-scope patent-text">2</sub>、-(CH<sub class="style-scope patent-text">2</sub>)<sub class="style-scope patent-text">4</sub>NHCOCH<sub class="style-scope patent-text">3</sub>、-(CH<sub class="style-scope patent-text">2</sub>)<sub class="style-scope patent-text">4</sub>NHCHO、 -(CH<sub class="style-scope patent-text">2</sub>)<sub class="style-scope patent-text">3</sub>NHCONH<sub class="style-scope patent-text">2</sub>、-(CH<sub class="style-scope patent-text">2</sub>)<sub class="style-scope patent-text">4</sub>NHCONH<sub class="style-scope patent-text">2</sub>、-CH<sub class="style-scope patent-text">2</sub>CH<sub class="style-scope patent-text">2</sub>CH(OH)
CH<sub class="style-scope patent-text">2</sub>NH<sub class="style-scope patent-text">2</sub>, 2- picolyl, 3- pyridylmethyl, 4- pyridylmethyl, phenyl, cyclohexyl and with flowering structure:</div>
      <div id="p0487" num="0487" class="description-paragraph style-scope patent-text">
        <span class="patent-image-not-available style-scope patent-text"></span>
      </div>
      <div id="p0488" num="0488" class="description-paragraph style-scope patent-text">When amino acid side chain includes other hydrogen (glycine), the carbon atom of amino acid side chain attachment is chiral.Amino
Each carbon atom of sour side chain attachment is independently (S) or (R) configuration or racemic mixture.Therefore, agent-linker reagent
Can be enantiomer-pure, it is racemic or diastereomer.</div>
      <div id="p0489" num="0489" class="description-paragraph style-scope patent-text">In an exemplary embodiment, amino acid side chain is selected from those of natural and unnatural amino acid, including the third ammonia
Acid, 2- amino -2- cyclohexyl-acetic acid, 2- amino -2- phenylacetic acid, arginine, asparagine, aspartic acid, cysteine,
Glutamine, glutamic acid, glycine, histidine, isoleucine, leucine, lysine, methionine, nor-leucine, phenylpropyl alcohol
Propylhomoserin, proline, serine, threonine, tryptophan, tyrosine, valine, γ-aminobutyric acid, alpha, alpha-dimethyl γ-ammonia
Base butyric acid, beta, beta-dimethyl γ-aminobutyric acid, ornithine and citrulling (Cit).</div>
      <div id="p0490" num="0490" class="description-paragraph style-scope patent-text">Introns with p- aminobenzyl carbamyl (PAB) selfdecomposition are suitable for constituting for combination cell knot
The exemplary valine-citrulline (val-cit or vc) two of the connector-PBD drug moiety intermediate of mixture (for example, antibody)
Peptide linker reagent has a structure that</div>
      <div id="p0491" num="0491" class="description-paragraph style-scope patent-text">
        <span class="patent-image-not-available style-scope patent-text"></span>
      </div>
      <div id="p0492" num="0492" class="description-paragraph style-scope patent-text">Wherein, Q is C<sub class="style-scope patent-text">1</sub>-C<sub class="style-scope patent-text">8</sub>Alkyl ,-O- (C<sub class="style-scope patent-text">1</sub>-C<sub class="style-scope patent-text">8</sub>Alkyl) ,-halogen ,-NO<sub class="style-scope patent-text">2</sub>Or-CN；And m is whole within the scope of 0-4
Number.</div>
      <div id="p0493" num="0493" class="description-paragraph style-scope patent-text">Exemplary phe-lys (Mtr) dipeptides linker reagents with p- aminobenzyl group can basis
Dubowchik, et al. (1997) Tetrahedron Letters, 38:5257-60 are prepared and are had a structure that</div>
      <div id="p0494" num="0494" class="description-paragraph style-scope patent-text">
        <span class="patent-image-not-available style-scope patent-text"></span>
      </div>
      <div id="p0495" num="0495" class="description-paragraph style-scope patent-text">Wherein, Mtr is mono- 4- Methoxytrityl, and Q is C<sub class="style-scope patent-text">1</sub>-C<sub class="style-scope patent-text">8</sub>Alkyl ,-O- (C<sub class="style-scope patent-text">1</sub>-C<sub class="style-scope patent-text">8</sub>Alkyl) ,-halogen ,-NO<sub class="style-scope patent-text">2</sub>
Or-CN；And m is the integer of 0-4 range.</div>
      <div id="p0496" num="0496" class="description-paragraph style-scope patent-text">" connector of selfdecomposition " PAB (p- amino benzyloxy carbamyl) is in antibody drug conjugate by drug moiety
It is attached to antibody (Carl et al (1981) J.Med.Chem.24:479-480； Chakravarty et al(1983)
J.Med.Chem.26:638-644；US 6214345； US20030130189；US20030096743；US6759509；
US20040052793； US6218519；US6835807；US6268488；US20040018194；WO98/13059；
US20040052793；US6677435；US5621002；US20040121940； WO2004/032828).In addition to PAB, from
Other examples of the introns of decomposition include but is not limited to: (i) charge is similar to the aromatic compound of PAB group, such as 2- ammonia
Base imidazoles -5- carbinol derivatives (Hay et al. (1999) Bioorg.Med.Chem.Lett.9:2237), thiazole (US
7375078) PAB unit (de Groot et al (2001) J.Org.Chem. 66:8815-8830) that is, more, extending；With it is o-
Or p- aminobenzene acetal；And the styryl PAB analog (US 7223837) of (ii) confirmation.It can be used and pass through amide
The introns of key hydrolysis experience cyclisation, such as substitution and unsubstituted 4-Aminobutanoicacid amide (Rodrigues et al (1995)
Chemistry Biology 2:223), bicyclic [2.2.1] ring system that suitably replaces and bicyclic [2.2.2] ring system (Storm
Et al (1972) J.Amer.Chem.Soc.94:5815) and 2- aminophenyl propionic acid (Amsberry, et al
(1990)J.Org.Chem.55:5867).(the Kingsbury et al containing drug amine of the cancellation replaced at glycine
(1984) J.Med.Chem.27:1447) be also useful selfdecomposition introns in the adc example.</div>
      <div id="p0497" num="0497" class="description-paragraph style-scope patent-text">In one embodiment, valine-citrulline dipeptides PAB analog reagent has 2,6 3,5-dimethylphenyl groups
And it has a structure that</div>
      <div id="p0498" num="0498" class="description-paragraph style-scope patent-text">
        <span class="patent-image-not-available style-scope patent-text"></span>
      </div>
      <div id="p0499" num="0499" class="description-paragraph style-scope patent-text">The linker reagents of antibody drug conjugate for use in the present invention include but is not limited to: BMPEO, BMPS, EMCS,
GMBS, HBVS, LC-SMCC, MBS, MPBH, SBAP, SIA, SIAB, SMCC, SMPB, SMPH, sulfo group-EMCS, sulfo group-GMBS,
Sulfo group-KMUS, sulfo group-MBS, sulfo group-SIAB, sulfo group-SMCC and sulfo group-SMPB and SVSB (succinimido-(4-
Vinyl sulfone) benzoic ether) and double-maleimide reagent: DTME, BMB, BMDB, BMH, BMOE, 1,8- be bis--Malaysia acyl
Imines diethylene glycol (DEG) (BM (PEO)<sub class="style-scope patent-text">2</sub>) and 1,11- it is bis--maleimide triethylene glycol (BM (PEO)<sub class="style-scope patent-text">3</sub>), by Pierce
Biotechnology, Inc., ThermoScientific, Rockford, IL and other reagent suppliers business can get.Double-
The free thiol group of the cysteine of antibody is attached to by maleimide reagent permission in a manner of serially or simultaneously to be contained
Drug moiety, label or the connector intermediate of mercaptan.In addition to maleimide, in antibody, PBD drug moiety or connector
Other functional groups of the thiol group reaction of mesosome include iodoacetamide, acetbromamide, vinylpyridine, disulphide, pyridine
Based bisulfide, isocyanates and isothiocyanates.</div>
      <div id="p0500" num="0500" class="description-paragraph style-scope patent-text">
        <span class="patent-image-not-available style-scope patent-text"></span>
      </div>
      <div id="p0501" num="0501" class="description-paragraph style-scope patent-text">The other embodiments of linker reagents are: N- succinimido -4- (2- pyridylthio) valerate (SPP),
N- succinimido -3- (2- pyridyl group two is thio) propionic ester (SPDP, Carlsson et al (1978)
Biochem.J.173:723-737), succinimido -4- (N- Maleimidomethyl) hexamethylene -1- carboxylate
(SMCC), iminothiolane (IT), the bifunctional derivative (such as dimethyl adipimide ester HCl) of polyurethane, active ester
(such as two succinimide suberates), aldehyde (such as glutaraldehyde), double azido compound (as bis- (p- iodine benzyl) hexamethylene diamines),
Double-diazo compound derivative (such as bis- (p- diazoniumbenzoyl)-ethylenediamines), diisocyanate (such as toluene 2,6- diisocyanate)
With double activated fluorine compounds (such as fluoro- 2,4- dinitrobenzene of 1,5- bis-).Pass through other commercial sources, such as Molecular
Biosciences Inc. (Boulder, CO) also available useful linker reagents, or according to Toki et al (2002)
J.Org.Chem.67:1866-1872；US 6214345；WO 02/088172；US 2003130189；US2003096743；WO
03/026577；WO 03/043583；Useful linker reagents can also be synthesized with step described in WO 04/032828.</div>
      <div id="p0502" num="0502" class="description-paragraph style-scope patent-text">Connector can be for being covalently attached more than one drug moiety extremely by branching, polyfunctional junction portion
Dendritic type fittings (the US 2006/116422 of antibody；US 2005/271615；de Groot et al(2003)
Angew.Chem.Int.Ed.42:4490-4494； Amir et al(2003)Angew.Chem.Int.Ed.42:4494-
4499；Shamis et al(2004)J. Am.Chem.Soc.126:1726-1731；Sun et al(2002)
Bioorganic&amp;Medicinal Chemistry Letters 12:2213-2215；Sun et al(2003)
Bioorganic&amp;Medicinal Chemistry 11:1761-1768；King et al(2002)Tetrahedron
Letters 43:1987-1990).Dendritic connector can increase the molar ratio of drug and antibody, that is, drugloading rate,
It is related to the effect of ADC.Therefore, in the case where antibody only has a reactive cysteine thiol group, most medicines
Object part can be attached by dendritic or branch chain joint.</div>
      <div id="p0503" num="0503" class="description-paragraph style-scope patent-text">One illustrative embodiments of dendritic type fittings have a structure that</div>
      <div id="p0504" num="0504" class="description-paragraph style-scope patent-text">
        <span class="patent-image-not-available style-scope patent-text"></span>
      </div>
      <div id="p0505" num="0505" class="description-paragraph style-scope patent-text">Wherein, asterisk indicates the point for being attached to the position N10 of the part PBD.</div>
      <div id="p0506" num="0506" class="description-paragraph style-scope patent-text">R<sup class="style-scope patent-text">L</sup>/R<sup class="style-scope patent-text">L’</sup>Certain embodiments</div>
      <div id="p0507" num="0507" class="description-paragraph style-scope patent-text">In the certain embodiments of conjugate of the invention, L-R<sup class="style-scope patent-text">L’</sup>It can be Formula X:</div>
      <div id="p0508" num="0508" class="description-paragraph style-scope patent-text">
        <span class="patent-image-not-available style-scope patent-text"></span>
      </div>
      <div id="p0509" num="0509" class="description-paragraph style-scope patent-text">Wherein, Q is selected from the group of singly-bound and formula Q1 or Q2:</div>
      <div id="p0510" num="0510" class="description-paragraph style-scope patent-text">
        <span class="patent-image-not-available style-scope patent-text"></span>
      </div>
      <div id="p0511" num="0511" class="description-paragraph style-scope patent-text">Wherein, N shows the point that group is bound to the N10 of the part PBD；</div>
      <div id="p0512" num="0512" class="description-paragraph style-scope patent-text">R<sup class="style-scope patent-text">Q1</sup>And R<sup class="style-scope patent-text">Q2</sup>Carbon atom independently selected from H and methyl or in conjunction with them is formed together cyclopropylene group；And</div>
      <div id="p0513" num="0513" class="description-paragraph style-scope patent-text">CBA represents cell binding agent.</div>
      <div id="p0514" num="0514" class="description-paragraph style-scope patent-text">Therefore, according to Q, the group of Formula X is selected from following formula X-I, X-II and X-III:</div>
      <div id="p0515" num="0515" class="description-paragraph style-scope patent-text">
        <span class="patent-image-not-available style-scope patent-text"></span>
      </div>
      <div id="p0516" num="0516" class="description-paragraph style-scope patent-text">In some embodiments, R<sup class="style-scope patent-text">Q1</sup>And R<sup class="style-scope patent-text">Q2</sup>It is H.In other embodiments, R<sup class="style-scope patent-text">Q1</sup>And R<sup class="style-scope patent-text">Q2</sup>It is methyl.Further
In embodiment, R<sup class="style-scope patent-text">Q1</sup>And R<sup class="style-scope patent-text">Q2</sup>In one be H and the other is methyl；In these embodiments, the carbon that they are combined is former
Son is chiral centre.</div>
      <div id="p0517" num="0517" class="description-paragraph style-scope patent-text">In some embodiments, Q is singly-bound.</div>
      <div id="p0518" num="0518" class="description-paragraph style-scope patent-text">In other embodiments, Q is<span class="patent-image-not-available style-scope patent-text"></span> </div>
      <div id="p0519" num="0519" class="description-paragraph style-scope patent-text">In further embodiment, Q is<span class="patent-image-not-available style-scope patent-text"></span> </div>
      <div id="p0520" num="0520" class="description-paragraph style-scope patent-text">L-R<sup class="style-scope patent-text">L’</sup>The conjugate for being Formula X can be by wherein R<sup class="style-scope patent-text">L</sup>It is that the compound of Formula XI is formed:</div>
      <div id="p0521" num="0521" class="description-paragraph style-scope patent-text">
        <span class="patent-image-not-available style-scope patent-text"></span>
      </div>
      <div id="p0522" num="0522" class="description-paragraph style-scope patent-text">Wherein, R<sup class="style-scope patent-text">Q1</sup>、R<sup class="style-scope patent-text">Q2</sup>With Q as defined in the group for being directed to Formula X.</div>
      <div id="p0523" num="0523" class="description-paragraph style-scope patent-text">Formula XI is equally applicable to for the preference of the group expression of Formula X.</div>
      <div id="p0524" num="0524" class="description-paragraph style-scope patent-text">Cell binding agent</div>
      <div id="p0525" num="0525" class="description-paragraph style-scope patent-text">Cell binding agent can be any type, and including peptide and non-peptide.These may include comprising at least one combination
The antibody of site, lymphokine, hormone, growth factor, Nutrient transport molecule or any other cell-binding molecules or substance or
The segment of antibody.</div>
      <div id="p0526" num="0526" class="description-paragraph style-scope patent-text">Peptide</div>
      <div id="p0527" num="0527" class="description-paragraph style-scope patent-text">In one embodiment, cell binding agent is straight comprising the continuous amino acid residue of 4-30, preferably 6-20
Chain or cyclic peptide.In such an embodiment it is preferred that cell binding agent is connected to a monomer or dimer pyrrolo- benzo
Diazepine compound.</div>
      <div id="p0528" num="0528" class="description-paragraph style-scope patent-text">In one embodiment, cell binding agent includes to combine integral protein α<sub class="style-scope patent-text">ν</sub>β<sub class="style-scope patent-text">6</sub>Peptide.The peptide may be right by XYS
α<sub class="style-scope patent-text">ν</sub>β<sub class="style-scope patent-text">6</sub>It is selective.</div>
      <div id="p0529" num="0529" class="description-paragraph style-scope patent-text">In one embodiment, cell binding agent includes A20FMDV-Cys polypeptide.A20FMDV-Cys has sequence:
NAVPNLRGDLQVLAQKVARTC.Alternatively, the variant of A20FMDV-Cys sequence can be used, wherein one, two,
Three, four, five, six, seven, eight, nine or ten amino acid residues are replaced by another amino acid residue.This
Outside, polypeptide can have sequence NAVXXXXXXXXXXXXXXXRTC.</div>
      <div id="p0530" num="0530" class="description-paragraph style-scope patent-text">Antibody</div>
      <div id="p0531" num="0531" class="description-paragraph style-scope patent-text">The term " antibody " of this paper be use and definitely cover in the broadest sense monoclonal antibody, polyclonal antibody,
Dimer, polymer, multi-specificity antibody (for example, bispecific antibody) and antibody fragment, if they show it is desired
Bioactivity (Miller et al (2003) Jour.of Immunology 170:4854-4861).It is anti-that antibody can be Muridae
Body, human antibodies, humanized antibody, chimeric antibody or the antibody from other species.Antibody is can to identify and be bound to spy
The protein of Specific Antigen generated by immune system.(Janeway,C.,Travers,P.,Walport,M.,
Shlomchik(2001)Immuno Biology,5th Ed.,Garland Publishing,New York).Target antigen is logical
Often with there are many binding sites, also referred to as epitope, identified by the CDR on Multiple Antibodies.It is specifically bound to different tables
Every kind of antibody of position has different structures.Therefore, a kind of antigen can have more than one correspondence antibody.Antibody includes
The immunoactive portions of full-length immunoglobulin molecule or full-length immunoglobulin molecule, that is, combine sense comprising immunologic specificity
The molecule of the antigen binding site of the antigen of target of interest or part thereof, this target include but is not limited to cancer cell or generate with
The cell of the relevant autoimmune antibody of autoimmune disease.Immunoglobulin can be appointing for immunoglobulin molecules
What type (such as IgG, IgE, IgM, IgD and IgA), classification (such as IgG1, IgG2, IgG3, IgG4, IgA1 and IgA2) or
Subclass.Immunoglobulin can be originated from any species, including source of people, source of mouse or rabbit source.</div>
      <div id="p0532" num="0532" class="description-paragraph style-scope patent-text">" antibody fragment " includes a part of full length antibody, usually its antigen binding domain or variable region.Antibody fragment
Example includes Fab, Fab', F (ab')<sub class="style-scope patent-text">2</sub>With scFv segment；Binary；Linear antibodies；The segment that Fab expression library generates resists only
Special type (anti-Id) antibody, CDR (complementary determining region) and any above immunologic specificity are bound to cancer cell antigen, viral antigen
Or the epitope binding fragments of microbial antigen, single-chain antibody molecules and the multi-specificity antibody formed by antibody fragment.</div>
      <div id="p0533" num="0533" class="description-paragraph style-scope patent-text">As used herein, term " monoclonal antibody " refers to is resisted by what the group of substantially homogeneity antibody obtained
Body, that is, in addition to the possible naturally occurring mutation that can be existed in a small amount, the single antibody including the group is identical
's.Monoclonal antibody is high degree of specificity for single antigen site.In addition, relative to polyclonal antibody preparations comprising
For the different antibodies of different determinants (epitope), each monoclonal antibody is for the single determinant on antigen.Except they
Other than specificity, monoclonal antibody is advantageous, because they can be synthesized without being polluted by other antibody.Modifier
" monoclonal " indicates the characteristic of the antibody obtained by the substantially homogeneous population of antibody, and is not construed as needing to pass through
Any ad hoc approach produces antibody.For example, being described for the first time by Kohler et al (1975) Nature 256:495 miscellaneous
It hands over tumor method that can make, or list used according to the invention can be made by DNA recombination method (referring to US 4816567)
Clonal antibody.Also Clackson et al (1991) Nature, 352:624-628 can be used；Marks et al(1991)
J.Mol.Biol., technology described in 222:581-597 is from phage antibody library or from carrying complete human immunoglobulin
The transgenic mice (Lonberg (2008) Curr.Opinion 20 (4): 450-459) of system separates monoclonal antibody.</div>
      <div id="p0534" num="0534" class="description-paragraph style-scope patent-text">The monoclonal antibody of this paper definitely includes the segment of " chimeric " antibody and this antibody, as long as they are showed
Desired bioactivity out, wherein heavy chain and/or chain moiety are identical as the corresponding sequence in the antibody for being originated from particular species
Or it is homologous or belong to specific specific antibodies classification or subclass, and the remainder of chain be originated from the antibody of another species
Corresponding sequence is identical or homologous or belongs to another antibody isotype or subclass (US 4816567；With Morrison et al
(1984) Proc.Natl.Acad.Sci.USA,81:6851-6855).Chimeric antibody includes comprising being originated from non-human primates
The variable domains antigen-binding subsequences of animal (for example, Old World Monkeys or ape and monkey) and " Primates of human constant regions sequence
Change " antibody.</div>
      <div id="p0535" num="0535" class="description-paragraph style-scope patent-text">" complete antibody " of this paper is comprising VL and VH structural domain and light chain constant domain (CL) and light chain constant knot
The antibody of structure domain CH1, CH2 and CH3.Constant domain can be natural sequence constant domains (for example, the natural sequence of the mankind
Column constant domain) or its amino acid sequence variation.Complete antibody can have one or more " effector functions ",
Refer to the bioactivity as caused by the region Fc (native sequence Fc region or the region amino acid sequence variation Fc) of antibody.Antibody
The example of effector function includes that C1q is combined；The cell toxicant of Complement Dependent；Fc receptor combines；Antibody-dependant it is cell-mediated
Cell toxicant (ADCC)；Phagocytosis；With the downward of cell surface receptor (such as B cell receptor and BCR).</div>
      <div id="p0536" num="0536" class="description-paragraph style-scope patent-text">According to the amino acid sequence of the constant domain of their heavy chain, complete antibody can be divided into different " classifications ".
There are 5 kinds of primary categories of complete antibody: IgA, IgD, IgE, IgG and IgM, and some in these can further divide
For " subclass " (homotype), for example, IgG1, IgG2, IgG3, IgG4, IgA and IgA2.Different classes of weight corresponding to antibody
Chain constant domain is referred to as α, δ, ε, γ and μ.The different classes of sub-unit structure of immunoglobulin and three kinds of size structures
Type is well-known.</div>
      <div id="p0537" num="0537" class="description-paragraph style-scope patent-text">Humanization</div>
      <div id="p0538" num="0538" class="description-paragraph style-scope patent-text">The technology for reducing the vivo immunogenicity of non-human antibody or antibody fragment includes being referred to as those of " humanization ".</div>
      <div id="p0539" num="0539" class="description-paragraph style-scope patent-text">" humanized antibody " refers to the polypeptide of the Variable Area at least partly modified comprising human antibodies, wherein part
Variable Area is preferably significantly less than the part of complete human variable-domain, by the correspondence from non-human species
Sequence substitutions, and wherein, the Variable Area of modification is connected at least another part of another protein, is preferably coupled to
The constant region of human antibodies.Expressing " humanized antibody " includes human antibodies, wherein one or more complementary determining regions
(" CDR ") amino acid residue and/or one or more framework region (" FW " or " FR ") amino acid residues are come from rodent
Or the same function site (analogous) displacement in other non-human antibodies.Expressing " humanized antibody " also includes immunoglobulin
Amino acid sequence or its segment comprising there is the FR of the amino acid sequence of human immunoglobulin substantially and have substantially
The CDR of the amino acid sequence of non-human immunoglobulin.</div>
      <div id="p0540" num="0540" class="description-paragraph style-scope patent-text">Non-human (for example, Muridae) antibody of " humanization " form is comprising the minimum from non-human immunoglobulin
The chimeric antibody of sequence.Or see in another way, humanized antibody is also comprising replacing human sequence, from non-human (example
Such as, Muridae) antibody selected sequence human antibodies.Humanized antibody further includes combination and/or the biology for not significantly changing it
Active conservative amino acid displacement or non-natural residues from identical or different species.This antibody is non-comprising being originated from
The chimeric antibody of the minmal sequence of human immunoglobulin.</div>
      <div id="p0541" num="0541" class="description-paragraph style-scope patent-text">There are a large amount of humanization technologies, including ' CDR transplanting ', ' M8003 line ', ' going to be immunized ', ' resurfacing ' (also claim
For ' exterior trim ' (veneering)), ' compound antibody ', ' mankind's chain content optimizes (Human String Content
Optimisation it) ' is mixed with frame.</div>
      <div id="p0542" num="0542" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">CDR transplanting</u>
      </div>
      <div id="p0543" num="0543" class="description-paragraph style-scope patent-text">In the art, humanized antibody is human immunoglobulin (receptor antibody), wherein from receptor antibody
The residue of complementary determining region (CDR) is come from non-human species such as mouse, rat, camel, ox, goat with desirable properties
Or the CDR (donor antibody) of rabbit replaces (in fact, non-human CDR is by ' shifting ' to human framework).In some embodiments,
Framework region (FR) residue of human immunoglobulin is replaced by corresponding non-human residues (for example, this can occur in Dang Te
When fixed FR residue is to antigen is combined with remarkable effect).</div>
      <div id="p0544" num="0544" class="description-paragraph style-scope patent-text">In addition, humanized antibody may be embodied in and cannot all find in receptor antibody or the CDR or Frame sequence of implantation
Residue.These modifications are carried out further to improve and maximize antibody performance.Therefore, in general, humanized antibody will include
At least one and two kinds of whole variable domains in one aspect, wherein the height of all hypervariable region ring or whole can
Become area's ring and correspond to those of non-human immunoglobulin, and the area all or essentially all of FR is human immunoglobulin
Those of sequence.Humanized antibody optionally also exempts from least part comprising constant region for immunoglobulin (Fc) or the mankind
At least part of epidemic disease globulin.</div>
      <div id="p0545" num="0545" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">M8003 line</u>
      </div>
      <div id="p0546" num="0546" class="description-paragraph style-scope patent-text">This method is made up of: by the V of the given non-human antibody to defined epitope specificity<sub class="style-scope patent-text">H</sub>Or V<sub class="style-scope patent-text">L</sub>Structural domain and people
Class V<sub class="style-scope patent-text">H</sub>Or V<sub class="style-scope patent-text">L</sub>Libraries Combinatorial and special mankind's V structure domain is selected for interested antigen.Then by the selected mankind
VH generates complete mankind VHxVL with VL libraries Combinatorial and combines.Nature Biotechnology(N.Y.)12,(1994)
This method is described in 899-903.</div>
      <div id="p0547" num="0547" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Compound antibody</u>
      </div>
      <div id="p0548" num="0548" class="description-paragraph style-scope patent-text">In the method, two or more sections (segment) combination of the amino acid sequence from human antibodies is existed
In final antibody molecule.They are constructed and combining multiple mankind VH and VL sequence section in assembly, the combination
Body limits or avoids human T cell epitopes in the final area compound antibody V.When needed, by with avoiding t cell epitope
The replacement of alternative section cause or encode trivial section of the V of t cell epitope to limit or avoid t cell epitope.US 2008/
This method is described in 0206239 A1.</div>
      <div id="p0549" num="0549" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">It goes to be immunized</u>
      </div>
      <div id="p0550" num="0550" class="description-paragraph style-scope patent-text">This method is related to removing the mankind (or other second species) T cell from the area V of therapeutic antibodies (or other molecules)
Epitope.For example, by comparing with MHC binding motif (" motif " database e.g., being stored in www.wehi.edu.au), point
Analyse the presence of MHC class II binding motif in therapeutic antibodies V region sequence.Alternatively, it can be used such as Altuvia et al.
The computational threads method of (J. Mol.Biol.249 244-250 (1995)) design identifies MHC class II binding motif；At these
In method, the combination energy of they and MHC class II protein is tested for the continuous overlapping peptide from V region sequence.Then will
Information in the data and other sequences feature, the information are related to successfully presenting peptide, such as amphipathic, Rothbard motif and
The cleavage site of cathepsin B and other processive enzymes.</div>
      <div id="p0551" num="0551" class="description-paragraph style-scope patent-text">It is one or more by changing when the t cell epitope of identified possible second species (for example, mankind)
Amino acid eliminates them.The amino acid of modification can also close on the primary of protein usually in t cell epitope itself
Or the epitope (therefore, may be not close in primary structure) of secondary structure.Most commonly, change is by displacement
Mode, but in some cases, amino acid adds or deletes more appropriate.</div>
      <div id="p0552" num="0552" class="description-paragraph style-scope patent-text">All changes may be implemented by DNA recombinant technique, allow to by using the method well established (as determined
To mutagenesis) final molecule prepared by the expression of recombinant host.It is also possible, however, to use protein chemistry or any other point
Son shifts gears.</div>
      <div id="p0553" num="0553" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Resurfacing</u>
      </div>
      <div id="p0554" num="0554" class="description-paragraph style-scope patent-text">This method is related to:</div>
      <div id="p0555" num="0555" class="description-paragraph style-scope patent-text">(a) by the threedimensional model of building non-human antibody variable region, non-human (for example, rodent) antibody is determined
The conformational structure of (or its segment)；</div>
      <div id="p0556" num="0556" class="description-paragraph style-scope patent-text">(b) use can reach to be distributed relatively is penetrated by the x- of enough non-humans and human antibody variable domains heavy chain and light chain
Line crystal structure formation sequence alignment, to provide one group of heavy chain and light chain framework position, wherein aligned position is enough 98%
Non-human antibody's heavy chain and light chain in be identical；</div>
      <div id="p0557" num="0557" class="description-paragraph style-scope patent-text">(c) define the non-human antibody to humanization using the frame position group generated in step (b), one group of heavy chain and
The amino acid residue of light chain surface exposure；</div>
      <div id="p0558" num="0558" class="description-paragraph style-scope patent-text">(d) amino acid residue of one group of heavy chain and light chain surface exposure, the amino are identified by human antibodies amino acid sequence
Sour residue and the amino acid residue of the exposure of one group of surface defined in step (c) are the most similar, wherein from human antibodies
Heavy chain and light chain are naturally in pairs or cannot naturally in pairs；</div>
      <div id="p0559" num="0559" class="description-paragraph style-scope patent-text">(e) in the amino acid sequence to the non-human antibody of humanization, with the one group of heavy chain identified in step (d) and
One group of heavy chain defined in the radical amino acid replacement step (c) of light chain surface exposure and the amino acid of light chain surface exposure are residual
Base；</div>
      <div id="p0560" num="0560" class="description-paragraph style-scope patent-text">(f) threedimensional model of the variable region of the non-human antibody obtained by the specified displacement of step (e) is constructed；</div>
      <div id="p0561" num="0561" class="description-paragraph style-scope patent-text">(g) by comparing the threedimensional model constructed in step (a) and (f), identification step (c) or (d) in the group that identifies
Any amino acid residue, the amino acid residue the complementary determining region to humanizing non-human antibodies any residue it is any
In 5 angstroms of atom；And</div>
      <div id="p0562" num="0562" class="description-paragraph style-scope patent-text">(h) any residue identified in step (g) is changed from human amino acid residues as original non-human amino acid
Residue, to define non-human antibody's humanization group of the amino acid residue of surface exposure；Condition is not need to be walked first
Suddenly (a), but step (a) must be carried out before step (g).</div>
      <div id="p0563" num="0563" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Super humanized</u>
      </div>
      <div id="p0564" num="0564" class="description-paragraph style-scope patent-text">This method compares non-human sequence and functional human reproduction's germ line genes pedigree.Selection coding and non-human sequence
Arrange those of identical or closely related typical case (canonical) structure human gene.There to be highest homology in CDR
These selected genes be elected to be FR donor.Finally, non-human CDR is transplanted on these mankind FR.Patent WO 2005/
This method is described in 079479 A2.</div>
      <div id="p0565" num="0565" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">The optimization of mankind's chain content</u>
      </div>
      <div id="p0566" num="0566" class="description-paragraph style-scope patent-text">This method compares the pedigree of non-human (for example, mouse) sequence Yu human reproduction system gene, and difference is divided
For mankind's chain content (HSC) of the Quantitative Sequence in possible MHC/T cell epitope degree.Then by making the HSC of target sequence
It maximizes rather than target sequence humanization is generated to a variety of different humanization variants (In using global identity measurement
Molecular Immunology, 44, describe in (2007) 1986-1998).</div>
      <div id="p0567" num="0567" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Frame mixing</u>
      </div>
      <div id="p0568" num="0568" class="description-paragraph style-scope patent-text">It will be fused in the CDR frame of non-human antibody comprising all known heavy chains and light chain human reproduction system gene frame
In the pond cDNA of frame.Then humanized antibody is selected for example, by screening the antibody library of phage display.This is in Methods
36,43-60 is described in (2005).</div>
      <div id="p0569" num="0569" class="description-paragraph style-scope patent-text">The example of cell binding agent is included in WO 2007/085930 description and those of uses reagent, and passing through reference will
It is hereby incorporated by.</div>
      <div id="p0570" num="0570" class="description-paragraph style-scope patent-text">Tumor associated antigen and homologous antibody for embodiments of the present invention are being listed below.</div>
      <div id="p0571" num="0571" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Tumor associated antigen and homologous antibody</u>
      </div>
      <div id="p0572" num="0572" class="description-paragraph style-scope patent-text">(1) BMPR1B (bone morphogenetic protein receptor-IB type)</div>
      <div id="p0573" num="0573" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Nucleotide</u>
      </div>
      <div id="p0574" num="0574" class="description-paragraph style-scope patent-text">Genbank accession number NM_001203</div>
      <div id="p0575" num="0575" class="description-paragraph style-scope patent-text">Genbank version number NM_001203.2 GI:169790809</div>
      <div id="p0576" num="0576" class="description-paragraph style-scope patent-text">Genbank records update date: on September 23rd, 2012,02:06PM</div>
      <div id="p0577" num="0577" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Polypeptide</u>
      </div>
      <div id="p0578" num="0578" class="description-paragraph style-scope patent-text">Genbank accession number NP_001194</div>
      <div id="p0579" num="0579" class="description-paragraph style-scope patent-text">Genbank version number NP_001194.1 GI:4502431</div>
      <div id="p0580" num="0580" class="description-paragraph style-scope patent-text">Genbank records update date: on September 23rd, 2012,02:06PM</div>
      <div id="p0581" num="0581" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Cross reference</u>
      </div>
      <div id="p0582" num="0582" class="description-paragraph style-scope patent-text">ten Dijke,P.,et al Science 264(5155):101-104(1994),Oncogene 14 10
(11):1377-1382(1997))；WO2004/063362 (claim 2)；WO2003/042661 (claim 12)；</div>
      <div id="p0583" num="0583" class="description-paragraph style-scope patent-text">US2003/134790-A1 (the 38-39 pages)；WO2002/102235 (claim 13；Page 296)；
WO2003/055443 (the 91-92 pages)；WO2002/99122 (embodiment 2；The 528-530 pages)；WO2003/029421 (power
6) benefit requires；WO2003/024392 (claim 2；Figure 112)；WO2002/98358 (claim 1；Page 183)；
WO2002/54940 (the 100-101 pages)；WO2002/59377 (the 349-350 pages)；WO2002/30268 (claim
27；Page 376)；15WO2001/48204 (embodiment；Fig. 4)；NP_001194 bone morphogenetic protein receptor, 1B type/pid
=NP_001194.1.；MIM:603248；AY065994</div>
      <div id="p0584" num="0584" class="description-paragraph style-scope patent-text">(2) E16 (LAT1, SLC7A5)</div>
      <div id="p0585" num="0585" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Nucleotide</u>
      </div>
      <div id="p0586" num="0586" class="description-paragraph style-scope patent-text">Genbank accession number NM_003486</div>
      <div id="p0587" num="0587" class="description-paragraph style-scope patent-text">Genbank version number NM_003486.5 GI:71979931</div>
      <div id="p0588" num="0588" class="description-paragraph style-scope patent-text">Genbank records update date: on June 27th, 2012,12:06PM</div>
      <div id="p0589" num="0589" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Polypeptide</u>
      </div>
      <div id="p0590" num="0590" class="description-paragraph style-scope patent-text">Genbank accession number NP_003477</div>
      <div id="p0591" num="0591" class="description-paragraph style-scope patent-text">Genbank version number NP_003477.4 GI:71979932</div>
      <div id="p0592" num="0592" class="description-paragraph style-scope patent-text">Genbank records update date: on June 27th, 2012,12:06PM</div>
      <div id="p0593" num="0593" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Cross reference</u>
      </div>
      <div id="p0594" num="0594" class="description-paragraph style-scope patent-text">Biochem.Biophys.Res.</div>
      <div id="p0595" num="0595" class="description-paragraph style-scope patent-text">Commun.255(2),283-288(1999),Nature 395(6699):288-291(1998),
Gaugitsch,H.W.,et20al(1992)J.Biol.Chem.267(16):11267-11273)；WO2004/048938 is (real
Apply example 2)；WO2004/032842 (embodiment IV)；WO2003/042661 (claim 12)；WO2003/016475 (right
It is required that 1)；WO2002/78524 (embodiment 2)；WO2002/99074 (claim 19；The 127-129 pages)；WO2002/
86443 (claims 27；Page 222,393)；WO2003/003906 (claim 10；Page 293)； WO2002/
64798 (claims 33；The 93-95 pages)；WO2000/14228 (claim 5；The 133-136 pages)；US2003/
224454 (Fig. 3)；25WO2003/025138 (claim 12；Page 150)；NP_003477 sapiens's Solute Carrier family 7 (sun from
Sub- amino acid carrier, y+ system), member 5/pid=NP_003477.3- homo sapiens；MIM:600182；NM_015923.</div>
      <div id="p0596" num="0596" class="description-paragraph style-scope patent-text">(3) STEAP1 (six kinds of cross-film epithelium antigens of prostate)</div>
      <div id="p0597" num="0597" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Nucleotide</u>
      </div>
      <div id="p0598" num="0598" class="description-paragraph style-scope patent-text">Genbank accession number NM_012449</div>
      <div id="p0599" num="0599" class="description-paragraph style-scope patent-text">Genbank version number NM_012449.2 GI:22027487</div>
      <div id="p0600" num="0600" class="description-paragraph style-scope patent-text">Genbank records update date: on September 9th, 2012,02:57PM</div>
      <div id="p0601" num="0601" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Polypeptide</u>
      </div>
      <div id="p0602" num="0602" class="description-paragraph style-scope patent-text">Genbank accession number NP_036581</div>
      <div id="p0603" num="0603" class="description-paragraph style-scope patent-text">Genbank version number NP_036581.1 GI:9558759</div>
      <div id="p0604" num="0604" class="description-paragraph style-scope patent-text">Genbank records update date: on September 9th, 2012,02:57PM</div>
      <div id="p0605" num="0605" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Cross reference</u>
      </div>
      <div id="p0606" num="0606" class="description-paragraph style-scope patent-text">Cancer Res.61(15),5857-5860(2001),Hubert,R.S.,et al(1999)
Proc.Natl.Acad.Sci.U.S.A.96(25):14523-14528)；WO2004/065577 (claim 6)；
WO2004/027049 (Fig. 1 L)；EP1394274 (embodiment 11)；WO2004/016225 (claim 2)；WO2003/
042661 (claim 12)；US2003/157089 (embodiment 5)；US2003/185830 (embodiment 5)；US2003/
064397 (Fig. 2)；WO2002/89747 (embodiment 5；The 618-619 pages)；WO2003/022995 (embodiment 9；Figure 13 A,
35；Embodiment 53；Page 173, embodiment 2；Fig. 2A)；Six kinds of cross-film epithelium antigens of prostate； MIM:604415.</div>
      <div id="p0607" num="0607" class="description-paragraph style-scope patent-text">(4) 0772P (CA125, MUC16)</div>
      <div id="p0608" num="0608" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Nucleotide</u>
      </div>
      <div id="p0609" num="0609" class="description-paragraph style-scope patent-text">Genbank accession number AF361486</div>
      <div id="p0610" num="0610" class="description-paragraph style-scope patent-text">Genbank version number AF361486.3 GI:34501466</div>
      <div id="p0611" num="0611" class="description-paragraph style-scope patent-text">Genbank records update date: on March 11st, 2010,07:56AM</div>
      <div id="p0612" num="0612" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Polypeptide</u>
      </div>
      <div id="p0613" num="0613" class="description-paragraph style-scope patent-text">Genbank accession number AAK74120</div>
      <div id="p0614" num="0614" class="description-paragraph style-scope patent-text">Genbank version number AAK74120.3 GI:34501467</div>
      <div id="p0615" num="0615" class="description-paragraph style-scope patent-text">Genbank records update date: on March 11st, 2010,07:56AM</div>
      <div id="p0616" num="0616" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Cross reference</u>
      </div>
      <div id="p0617" num="0617" class="description-paragraph style-scope patent-text">J.Biol.Chem.276(29):27371-27375(2001))；WO2004/045553 (claim 14)；
WO2002/92836 (claim 6；Figure 12)；WO2002/83866 (claim 15；The 116-121 pages)；US2003/
124140 (embodiments 16)；GI:34501467；</div>
      <div id="p0618" num="0618" class="description-paragraph style-scope patent-text">(5) MPF (MPF, MSLN, SMR, megacaryocyte intensifier, mesothelin)</div>
      <div id="p0619" num="0619" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Nucleotide</u>
      </div>
      <div id="p0620" num="0620" class="description-paragraph style-scope patent-text">Genbank accession number NM_005823</div>
      <div id="p0621" num="0621" class="description-paragraph style-scope patent-text">Genbank version number NM_005823.5 GI:293651528</div>
      <div id="p0622" num="0622" class="description-paragraph style-scope patent-text">Genbank records update date: on September 2nd, 2012,01:47PM</div>
      <div id="p0623" num="0623" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Polypeptide</u>
      </div>
      <div id="p0624" num="0624" class="description-paragraph style-scope patent-text">Genbank accession number NP_005814</div>
      <div id="p0625" num="0625" class="description-paragraph style-scope patent-text">Genbank version number NP_005814.2 GI:53988378</div>
      <div id="p0626" num="0626" class="description-paragraph style-scope patent-text">Genbank records update date: on September 2nd, 2012,01:47PM</div>
      <div id="p0627" num="0627" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Cross reference</u>
      </div>
      <div id="p0628" num="0628" class="description-paragraph style-scope patent-text">Yamaguchi,N.,et al Biol.Chem.269(2),805-808(1994),
Proc.Natl.Acad.Sci.U.S.A.96(20):11531-11536(1999),
Proc.Natl.Acad.Sci.U.S.A.93 10(1):136-140(1996),J.Biol.Chem.270 (37):21984-
21990(1995))；WO2003/101283 (claim 14)；WO2002/102235 (claim 13；287-288
Page)；WO2002/101075 (claim 4；The 308-309 pages)；WO2002/71928 (the 320-321 pages)；WO94/
10312 (the 52-57 pages)； IM:601051.</div>
      <div id="p0629" num="0629" class="description-paragraph style-scope patent-text">(6) Napi3b (NAPI-3B, NPTIIb, SLC34A2, sapiens's Solute Carrier family 34 (sodium phosphate),</div>
      <div id="p0630" num="0630" class="description-paragraph style-scope patent-text">Member 2, II type Na-dependent phosphate carrier 3b</div>
      <div id="p0631" num="0631" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Nucleotide</u>
      </div>
      <div id="p0632" num="0632" class="description-paragraph style-scope patent-text">Genbank accession number NM_006424</div>
      <div id="p0633" num="0633" class="description-paragraph style-scope patent-text">Genbank version number NM_006424.2 GI:110611905</div>
      <div id="p0634" num="0634" class="description-paragraph style-scope patent-text">Genbank records update date: on July 22nd, 2012,03:39PM</div>
      <div id="p0635" num="0635" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Polypeptide</u>
      </div>
      <div id="p0636" num="0636" class="description-paragraph style-scope patent-text">Genbank accession number NP_006415</div>
      <div id="p0637" num="0637" class="description-paragraph style-scope patent-text">Genbank version number NP_006415.2 GI:110611906</div>
      <div id="p0638" num="0638" class="description-paragraph style-scope patent-text">Genbank records update date: on July 22nd, 2012,03:39PM</div>
      <div id="p0639" num="0639" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Cross reference</u>
      </div>
      <div id="p0640" num="0640" class="description-paragraph style-scope patent-text">J.Biol.Chem.277(22):19665-19672(2002),Genomics 62(2):281-284(1999),
Feild,J.A.,et al(1999)Biochem.Biophys.Res.Commun.258(3):578-582)； WO2004/
022778 (claim 2)；EP1394274 (embodiment 11)；WO2002/102235 (claim 13；Page 20 326)；
EP0875569 (claim 1；The 17-19 pages)；WO2001/57188 (claim 20；Page 329)；WO2004/
032842 (embodiment IV)；WO2001/75177 (claim 24；The 139-140 pages)；MIM:604217.</div>
      <div id="p0641" num="0641" class="description-paragraph style-scope patent-text">(7) Sema 5b (FLJ10372, KIAA1445, Mm.42015, SEMA5B, SEMAG, brain signal albumen 5b
Hlog, 25sema structural domain, seven kinds of thrombospondins repeat (1 type of 1 type and class), transmembrane domain (TM) and short cell
Matter structural domain, (brain signal albumen) 5B)</div>
      <div id="p0642" num="0642" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Nucleotide</u>
      </div>
      <div id="p0643" num="0643" class="description-paragraph style-scope patent-text">Genbank accession number AB040878</div>
      <div id="p0644" num="0644" class="description-paragraph style-scope patent-text">Genbank version number AB040878.1 GI:7959148</div>
      <div id="p0645" num="0645" class="description-paragraph style-scope patent-text">Genbank records update date: on August 2nd, 2006,05:40PM</div>
      <div id="p0646" num="0646" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Polypeptide</u>
      </div>
      <div id="p0647" num="0647" class="description-paragraph style-scope patent-text">Genbank accession number BAA95969</div>
      <div id="p0648" num="0648" class="description-paragraph style-scope patent-text">Genbank version number BAA95969.1 GI:7959149</div>
      <div id="p0649" num="0649" class="description-paragraph style-scope patent-text">Genbank records update date: on August 2nd, 2006,05:40PM</div>
      <div id="p0650" num="0650" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Cross reference</u>
      </div>
      <div id="p0651" num="0651" class="description-paragraph style-scope patent-text">Nagase T.,et al(2000)DNA Res.7(2):143-150)；WO2004/000997 (claim 1)；
WO2003/003984 (claim 1)；WO2002/06339 (claim 1；Page 50)；WO2001/88133 (want by right
Ask 1；41-43,48-58 page)；WO2003/054152 (claim 20)；WO2003/101400 (claim 11)；It steps on
Record: 30Q9P283；Genew； HGNC:10737</div>
      <div id="p0652" num="0652" class="description-paragraph style-scope patent-text">(8) PSCA hlg (2700050C12Rik, C530008O16Rik, RIKEN cDNA 2700050C12, RIKEN
CDNA 2700050C12 gene)</div>
      <div id="p0653" num="0653" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Nucleotide</u>
      </div>
      <div id="p0654" num="0654" class="description-paragraph style-scope patent-text">Genbank accession number AY358628</div>
      <div id="p0655" num="0655" class="description-paragraph style-scope patent-text">Genbank version number AY358628.1 GI:37182377</div>
      <div id="p0656" num="0656" class="description-paragraph style-scope patent-text">Genbank records update date: on December 1st, 2009,04:15AM</div>
      <div id="p0657" num="0657" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Polypeptide</u>
      </div>
      <div id="p0658" num="0658" class="description-paragraph style-scope patent-text">Genbank accession number AAQ88991</div>
      <div id="p0659" num="0659" class="description-paragraph style-scope patent-text">Genbank version number AAQ88991.1 GI:37182378</div>
      <div id="p0660" num="0660" class="description-paragraph style-scope patent-text">Genbank records update date: on December 1st, 2009,04:15AM</div>
      <div id="p0661" num="0661" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Cross reference</u>
      </div>
      <div id="p0662" num="0662" class="description-paragraph style-scope patent-text">Ross et al(2002)Cancer Res.62:2546-2553；US2003/129192 (claim 2)；
US2004/044180 (claim 12)；US2004/044179 35 (claim 11)；US2003/096961 (want by right
It asks 11)；US2003/232056 (embodiment 5)；WO2003/105758 16 (claim 12)；US2003/206918 (is implemented
Example 5)；EP1347046 (claim 1)；WO2003/025148 (claim 20)；GI:37182378.</div>
      <div id="p0663" num="0663" class="description-paragraph style-scope patent-text">(9) ETBR (endothelin receptor B)</div>
      <div id="p0664" num="0664" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Nucleotide</u>
      </div>
      <div id="p0665" num="0665" class="description-paragraph style-scope patent-text">Genbank accession number AY275463</div>
      <div id="p0666" num="0666" class="description-paragraph style-scope patent-text">Genbank version number AY275463.1 GI:30526094</div>
      <div id="p0667" num="0667" class="description-paragraph style-scope patent-text">Genbank records update date: on March 11st, 2010,02:26AM</div>
      <div id="p0668" num="0668" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Polypeptide</u>
      </div>
      <div id="p0669" num="0669" class="description-paragraph style-scope patent-text">Genbank accession number AAP32295</div>
      <div id="p0670" num="0670" class="description-paragraph style-scope patent-text">Genbank version number AAP32295.1 GI:30526095</div>
      <div id="p0671" num="0671" class="description-paragraph style-scope patent-text">Genbank records update date: on March 11st, 2010,02:26AM</div>
      <div id="p0672" num="0672" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Cross reference</u>
      </div>
      <div id="p0673" num="0673" class="description-paragraph style-scope patent-text">Nakamuta M.,et al Biochem.Biophys.Res.Commun.177,34-39,1991；Ogawa Y.,
et al Biochem.Biophys.Res.Commun.178,248-255,1991；Arai H.,et al
Jpn.Circ.J.56,1303-1307,1992；Arai H.,et al J.Biol.Chem.268,3463-3470, 1993；
Sakamoto A.,Yanagisawa M.,et al Biochem.Biophys.Res.Commun.178, 656-663,1991；
Elshourbagy N.A.,et al J.Biol.Chem.268,3873-3879,1993； Haendler B.,et al
J.Cardiovasc.Pharmacol.20,s1-S4,1992；Tsutsumi M.,et al Gene 228,43-49,1999；
Strausberg R.L.,et al Proc.Natl.Acad.Sci.U.S.A.99, 16899-16903,2002；Bourgeois
C.,et al J.Clin.Endocrinol.Metab.82, 3116-3123,1997；</div>
      <div id="p0674" num="0674" class="description-paragraph style-scope patent-text">Okamoto Y.,et al Biol.Chem.272,21589-21596,1997；Verheij J.B.,et al
Am.J. Med.Genet.108,223-225,2002；Hofstra R.M.W.,et al Eur.J.Hum.Genet.5, 180-
185,1997；Puffenberger E.G.,et al Cell 79,1257-1266,1994；Attie T.,et al,
Hum.Mol.Genet.4,2407-15 2409,1995；Auricchio A.,et al Hum.Mol.Genet.5:351-354,
1996；Amiel J.,et al Hum.Mol.</div>
      <div id="p0675" num="0675" class="description-paragraph style-scope patent-text">Genet.5,355-357,1996；Hofstra R.M.W.,et al Nat.Genet.12,445-447,1996；
Svensson P.J.,et al Hum.Genet.103,145-148,1998；Fuchs S.,et al Mol.Med.7, 115-
124,2001；Pingault V.,et al(2002)Hum.Genet.111,198-206；WO2004/045516 (claim
1)；WO2004/048938 (embodiment 2)；WO2004/040000 (claim 151)；WO2003/087768 (claim
1)；20 WO2003/016475 (claim 1)；WO2003/016475 (claim 1)；WO2002/61087 (Fig. 1)；
WO2003/016494 (Fig. 6)；WO2003/025138 (claim 12；Page 144)；WO2001/98351 (claim 1；
The 124-125 pages)；EP0522868 (claim 8；Page 2)；WO2001/77172 (claim 1；The 297-299 pages)；
US2003/109676；US6518404 (Fig. 3)；US5773223 (claim 1a；Col 31-34)； WO2004/001004.</div>
      <div id="p0676" num="0676" class="description-paragraph style-scope patent-text">(10) MSG783 (RNF124, it is assumed that protein FLJ20315)</div>
      <div id="p0677" num="0677" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Nucleotide</u>
      </div>
      <div id="p0678" num="0678" class="description-paragraph style-scope patent-text">Genbank accession number NM_017763</div>
      <div id="p0679" num="0679" class="description-paragraph style-scope patent-text">Genbank version number NM_017763.4 GI:167830482</div>
      <div id="p0680" num="0680" class="description-paragraph style-scope patent-text">Genbank records update date: on July 22nd, 2012,12:34AM</div>
      <div id="p0681" num="0681" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Polypeptide</u>
      </div>
      <div id="p0682" num="0682" class="description-paragraph style-scope patent-text">Genbank accession number NP_060233</div>
      <div id="p0683" num="0683" class="description-paragraph style-scope patent-text">Genbank version number NP_060233.3 GI:56711322</div>
      <div id="p0684" num="0684" class="description-paragraph style-scope patent-text">Genbank records update date: on July 22nd, 2012,12:34AM</div>
      <div id="p0685" num="0685" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Cross reference</u>
      </div>
      <div id="p0686" num="0686" class="description-paragraph style-scope patent-text">WO2003/104275 (claim 1)；WO2004/046342 (embodiment 2)；WO2003/042661 (want by right
It asks 12)；WO2003/083074 (claim 14；Page 61)；WO2003/018621 (claim 1)；WO2003/
024392 (claim 2；Figure 93)；WO2001/66689 (embodiment 6)；LocusID:54894.</div>
      <div id="p0687" num="0687" class="description-paragraph style-scope patent-text">(11) (HGNC_8639, IPCA-1, PCANAP1, STAMP1, STEAP2, STMP, prostate cancer are related by STEAP2
Gene 1, prostate cancer related protein 1, six kinds of cross-film epithelium antigens of prostate 2, six kinds of cross-film prostatein matter)</div>
      <div id="p0688" num="0688" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Nucleotide</u>
      </div>
      <div id="p0689" num="0689" class="description-paragraph style-scope patent-text">Genbank accession number AF455138</div>
      <div id="p0690" num="0690" class="description-paragraph style-scope patent-text">Genbank version number AF455138.1 GI:22655487</div>
      <div id="p0691" num="0691" class="description-paragraph style-scope patent-text">Genbank records update date: on March 11st, 2010,01:54AM</div>
      <div id="p0692" num="0692" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Polypeptide</u>
      </div>
      <div id="p0693" num="0693" class="description-paragraph style-scope patent-text">Genbank accession number AAN04080</div>
      <div id="p0694" num="0694" class="description-paragraph style-scope patent-text">Genbank version number AAN04080.1 GI:22655488</div>
      <div id="p0695" num="0695" class="description-paragraph style-scope patent-text">Genbank records update date: on March 11st, 2010,1:54AM</div>
      <div id="p0696" num="0696" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Cross reference</u>
      </div>
      <div id="p0697" num="0697" class="description-paragraph style-scope patent-text">Lab.Invest.82(11):1573-1582(2002))；WO2003/087306；US2003/064397 (right
It is required that 1；Fig. 1)；WO2002/72596 (claim 13；The 54-55 pages)；WO2001/72962 (claim 1；Fig. 4 B)；
35WO2003/104270 (claim 11)；WO2003/104270 (claim 16)；US2004/005598 (claim
22)；WO2003/042661 (claim 12)；US2003/060612 (claim 12；Figure 10)；WO2002/26822 (power
Benefit requires 23；Fig. 2)；WO2002/16429 (claim 12；Figure 10) GI:22655488.</div>
      <div id="p0698" num="0698" class="description-paragraph style-scope patent-text">(12) TrpM4 (BR22450, FLJ20041, TRPM4, TRPM4B, transient receptor potential cationic channel 5, subfamily
M, member 4)</div>
      <div id="p0699" num="0699" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Nucleotide</u>
      </div>
      <div id="p0700" num="0700" class="description-paragraph style-scope patent-text">Genbank accession number NM_017636</div>
      <div id="p0701" num="0701" class="description-paragraph style-scope patent-text">Genbank version number NM_017636.3 GI:304766649</div>
      <div id="p0702" num="0702" class="description-paragraph style-scope patent-text">Genbank records update date: on June 29th, 2012,11:27AM</div>
      <div id="p0703" num="0703" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Polypeptide</u>
      </div>
      <div id="p0704" num="0704" class="description-paragraph style-scope patent-text">Genbank accession number NP_060106</div>
      <div id="p0705" num="0705" class="description-paragraph style-scope patent-text">Genbank version number NP_060106.2 GI:21314671</div>
      <div id="p0706" num="0706" class="description-paragraph style-scope patent-text">Genbank records update date: on June 29th, 2012,11:27AM</div>
      <div id="p0707" num="0707" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Cross reference</u>
      </div>
      <div id="p0708" num="0708" class="description-paragraph style-scope patent-text">Xu,X.Z.,et al Proc.Natl.Acad.Sci.U.S.A.98(19):10692-10697(2001),Cell
109(3):397-407(2002),J.Biol.Chem.278(33):30813-30820(2003))；US2003/143557 (power
4) benefit requires；WO2000/40614 (claim 14；The 100-103 pages)；WO2002/10382 (claim 1；Fig. 9 A)；
WO2003/042661 (claim 12)；WO2002/30268 (claim 27；Page 391)；US2003/219806 (power
4) benefit requires；WO2001/62794 (claim 10 14；Figure 1A-D)；MIM:606936.</div>
      <div id="p0709" num="0709" class="description-paragraph style-scope patent-text">(13) CRIPTO (CR, CR1, CRGF, CRIPTO, TDGF1, teratoma derived growth factor)</div>
      <div id="p0710" num="0710" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Nucleotide</u>
      </div>
      <div id="p0711" num="0711" class="description-paragraph style-scope patent-text">Genbank accession number NM_003212</div>
      <div id="p0712" num="0712" class="description-paragraph style-scope patent-text">Genbank version number NM_003212.3 GI:292494881</div>
      <div id="p0713" num="0713" class="description-paragraph style-scope patent-text">Genbank records update date: on September 23rd, 2012,02:27PM</div>
      <div id="p0714" num="0714" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Polypeptide</u>
      </div>
      <div id="p0715" num="0715" class="description-paragraph style-scope patent-text">Genbank accession number NP_003203</div>
      <div id="p0716" num="0716" class="description-paragraph style-scope patent-text">Genbank version number NP_003203.1 GI:4507425</div>
      <div id="p0717" num="0717" class="description-paragraph style-scope patent-text">Genbank records update date: on September 23rd, 2012,02:27PM</div>
      <div id="p0718" num="0718" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Cross reference</u>
      </div>
      <div id="p0719" num="0719" class="description-paragraph style-scope patent-text">Ciccodicola,A.,et al EMBO J.8(7):1987-1991(1989),Am.J.Hum.Genet.49
(3):555-565(1991))；US2003/224411 (claim 1)；WO2003/083041 (embodiment 1)；WO2003/
034984 (claim 12)；WO2002/88170 (claim 2；The 52-53 pages)；WO2003/024392 (claim
2；Figure 58)；WO2002/16413 (claim 1；94-95, page 105)；WO2002/22808 (claim 2；Fig. 1)；
US5854399 (embodiment 2；Col 17-18)；US5792616 (Fig. 2)；MIM:187395.</div>
      <div id="p0720" num="0720" class="description-paragraph style-scope patent-text">(14) CD21 (CR2 (complement receptor 2) or C3DR (C3d/EB virus receptor) or Hs.73792)</div>
      <div id="p0721" num="0721" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Nucleotide</u>
      </div>
      <div id="p0722" num="0722" class="description-paragraph style-scope patent-text">Genbank accession number M26004</div>
      <div id="p0723" num="0723" class="description-paragraph style-scope patent-text">Genbank version number M26004.1 GI:181939</div>
      <div id="p0724" num="0724" class="description-paragraph style-scope patent-text">Genbank records update date: on June 23rd, 2012,08:47AM</div>
      <div id="p0725" num="0725" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Polypeptide</u>
      </div>
      <div id="p0726" num="0726" class="description-paragraph style-scope patent-text">Genbank accession number AAA35786</div>
      <div id="p0727" num="0727" class="description-paragraph style-scope patent-text">Genbank version number AAA35786.1 GI:181940</div>
      <div id="p0728" num="0728" class="description-paragraph style-scope patent-text">Genbank records update date: on June 23rd, 2010,08:47AM</div>
      <div id="p0729" num="0729" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Cross reference</u>
      </div>
      <div id="p0730" num="0730" class="description-paragraph style-scope patent-text">Fujisaku et al(1989)J.Biol.Chem.264(4):2118-2125)；Weis J.J.,et al J.
Exp.Med.167,1047-1066,1988；Moore M.,et al Proc.Natl.Acad.Sci.U.S.A.84, 9194-
9198,1987；Barel M.,et al Mol.Immunol.35,1025-1031,1998；Weis J.J., et al
Proc.Natl.Acad.Sci.U.S.A.83,5639-5643,1986；Sinha S.K.,et al(1993)J.
Immunol.150,5311-5320；WO2004/045520 (embodiment 4)；US2004/005538 (embodiment 1)；WO2003/
062401 (claim 9)；WO2004/045520 (embodiment 4)；WO91/02536 (Fig. 9 .1-9.9)；WO2004/020595
(claim 1)；It logs in: P20023； Q13866；Q14212；EMBL；M26004；AAA35786.1.</div>
      <div id="p0731" num="0731" class="description-paragraph style-scope patent-text">(15) CD79b (CD79B, CD79 β, IGb (immunoglobulin correlation β), B29)</div>
      <div id="p0732" num="0732" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Nucleotide</u>
      </div>
      <div id="p0733" num="0733" class="description-paragraph style-scope patent-text">Genbank accession number NM_000626</div>
      <div id="p0734" num="0734" class="description-paragraph style-scope patent-text">Genbank version number NM_000626.2 GI:90193589</div>
      <div id="p0735" num="0735" class="description-paragraph style-scope patent-text">Genbank records update date: on June 26th, 2012,01:53PM</div>
      <div id="p0736" num="0736" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Polypeptide</u>
      </div>
      <div id="p0737" num="0737" class="description-paragraph style-scope patent-text">Genbank accession number NP_000617</div>
      <div id="p0738" num="0738" class="description-paragraph style-scope patent-text">Genbank version number NP_000617.1 GI:11038674</div>
      <div id="p0739" num="0739" class="description-paragraph style-scope patent-text">Genbank records update date: on June 26th, 2012,01:53PM</div>
      <div id="p0740" num="0740" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Cross reference</u>
      </div>
      <div id="p0741" num="0741" class="description-paragraph style-scope patent-text">Proc.Natl.Acad.Sci.U.S.A.(2003)100(7):4126- 4131,Blood(2002)100(9):
3068-3076,Muller et al(1992)Eur.J.Immunol.22 (6):1621-1625)；WO2004/016225 (power
Benefit requires 2, Figure 140)；WO2003/087768, US2004/101874 (claim 1, page 102)；WO2003/062401
(claim 9)；WO2002/78524 (embodiment 2)；US2002/150573 (claim 35 5, page 15)；
US5644033；WO2003/048202 (claim 1, page 306 and 309)；(right is wanted by WO 99/58658, US6534482
Seek 13, Figure 17 A/B)；WO2000/55351 (claim 11, the 1145-1146 pages)；MIM:147245</div>
      <div id="p0742" num="0742" class="description-paragraph style-scope patent-text">(16) FcRH2 (IFGP4, IRTA4, SPAP1A (SH2 comprising 5 1a of phosphatase ankyrin matter), SPAP1B,
SPAP1C)</div>
      <div id="p0743" num="0743" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Nucleotide</u>
      </div>
      <div id="p0744" num="0744" class="description-paragraph style-scope patent-text">Genbank accession number NM_030764</div>
      <div id="p0745" num="0745" class="description-paragraph style-scope patent-text">Genbank version number NM_030764.3 GI:227430280</div>
      <div id="p0746" num="0746" class="description-paragraph style-scope patent-text">Genbank records update date: on June 30th, 2012,12:30AM</div>
      <div id="p0747" num="0747" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Polypeptide</u>
      </div>
      <div id="p0748" num="0748" class="description-paragraph style-scope patent-text">Genbank accession number NP_110391</div>
      <div id="p0749" num="0749" class="description-paragraph style-scope patent-text">Genbank version number NP_110391.2 GI:19923629</div>
      <div id="p0750" num="0750" class="description-paragraph style-scope patent-text">Genbank records update date: on June 30th, 2012,12:30AM</div>
      <div id="p0751" num="0751" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Cross reference</u>
      </div>
      <div id="p0752" num="0752" class="description-paragraph style-scope patent-text">AY358130)；Genome Res.13(10):2265-2270(2003),Immunogenetics 54 (2):87-
95(2002),Blood 99(8):2662-2669(2002),Proc.Natl.Acad.Sci.U.S.A.98 (17):9772-
9777(2001),Xu,M.J.,et al(2001) Biochem.Biophys.Res.Commun.280(3):768-775；
WO2004/016225 (claim 2)；WO2003/077836；WO2001/38490 (claim 5；Figure 18 D-1-18D-
2)；WO2003/097803 (claim 12)；</div>
      <div id="p0753" num="0753" class="description-paragraph style-scope patent-text">10WO2003/089624 (claim 25)；: MIM:606509.</div>
      <div id="p0754" num="0754" class="description-paragraph style-scope patent-text">(17)HER2(ErbB2)</div>
      <div id="p0755" num="0755" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Nucleotide</u>
      </div>
      <div id="p0756" num="0756" class="description-paragraph style-scope patent-text">Genbank accession number M11730</div>
      <div id="p0757" num="0757" class="description-paragraph style-scope patent-text">Genbank version number M11730.1 GI:183986</div>
      <div id="p0758" num="0758" class="description-paragraph style-scope patent-text">Genbank records update date: on June 23rd, 2010,08:47AM</div>
      <div id="p0759" num="0759" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Polypeptide</u>
      </div>
      <div id="p0760" num="0760" class="description-paragraph style-scope patent-text">Genbank accession number AAA75493</div>
      <div id="p0761" num="0761" class="description-paragraph style-scope patent-text">Genbank version number AAA75493.1 GI:306840</div>
      <div id="p0762" num="0762" class="description-paragraph style-scope patent-text">Genbank records update date: on June 23rd, 2010,08:47AM</div>
      <div id="p0763" num="0763" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Cross reference</u>
      </div>
      <div id="p0764" num="0764" class="description-paragraph style-scope patent-text">Coussens L.,et al Science(1985)230(4730):1132-1139)；Yamamoto T.,et al
Nature 319,230-234,1986；Semba K.,et al Proc.Natl.Acad.Sci.U.S.A.82, 6497-
6501,1985；Swiercz J.M.,et al J.Cell Biol.165,869-15 880,2004； Kuhns J.J.,et
al J.Biol.Chem.274,36422-36427,1999；Cho H.-S.,et al Nature 421,756-760,2003；
Ehsani A.,et al(1993)Genomics 15,426-429；WO2004/048938 (embodiment 2)；WO2004/
027049 (Fig. 1 I)；WO2004/009622； WO2003/081210；</div>
      <div id="p0765" num="0765" class="description-paragraph style-scope patent-text">WO2003/089904 (claim 9)；WO2003/016475 (claim 1)； US2003/118592；
WO2003/008537 (claim 1)；WO2003/055439 (claim 29)；Figure 1A-B)；WO2003/025228 (power
Benefit requires 37；Fig. 5 C)；20 WO2002/22636 (embodiment 13；The 95-107 pages)；WO2002/12341 (claim 68；
Fig. 7)；WO2002/13847 (the 71-74 pages)；WO2002/14503 (the 114-117 pages)；WO2001/53463 (claim
2；The 41-46 pages)；WO2001/41787 (page 15)；WO2000/44899 (claim 52；Fig. 7)；WO2000/20579
(claim 3；Fig. 2)；US5869445 (claim 3；Col 31-38)；WO9630514 (claim 2；56-61
Page)；EP1439393 (claim 7)；WO2004/043361 (claim 7)； WO2004/022709；WO2001/00244
25 (embodiments 3；Fig. 4)；It logs in: P04626； EMBL；M11767；AAA35808.1.EMBL；M11761；AAA35808.1</div>
      <div id="p0766" num="0766" class="description-paragraph style-scope patent-text">Antibody</div>
      <div id="p0767" num="0767" class="description-paragraph style-scope patent-text">Abbott:US20110177095</div>
      <div id="p0768" num="0768" class="description-paragraph style-scope patent-text">For example, the antibody comprising CDR, the sequence of the CDR whole at least 80% with have SEQ ID NO:3 (CDR-H1),
SEQ ID NO:4 (CDR-H2), SEQ ID NO:5 (CDR-H3), SEQ ID NO:104 and/or SEQ ID NO:6 (CDR-
L1), the CDR of the amino acid sequence of SEQ ID NO:7 (CDR-L2) and SEQ ID NO:8 (CDR-L3) is identical, wherein anti-
HER2 antibody or anti-HER2 binding fragment drop compared with the antibody of the VL of the VH and SEQ ID NO:2 with SEQ ID NO:1
Low immunogenicity.</div>
      <div id="p0769" num="0769" class="description-paragraph style-scope patent-text">Biogen:US20100119511</div>
      <div id="p0770" num="0770" class="description-paragraph style-scope patent-text">For example, ATCC accession number: PTA-10355, PTA-10356, PTA-10357, PTA-10358 are for example, purifying resists
Body molecule, be bound to comprising from antibody all six kinds of CDR or comprising it is identical as the CDR or with the CDR not
The HER2 of the CDR changed more than two kinds, all six kinds of CDR be selected from by BIIB71F10 (SEQ ID NO:11,13),
BIIB69A09 (SEQ ID NO:15,17)；BIIB67F10 (SEQ ID NO:19,21)；BIIB67F11(SEQ ID NO:
23,25), BIIB66A12 (SEQ ID NO:27,29), BIIB66C01 (SEQ ID NO:31,33), BIIB65C10 (SEQ ID
NO:35,37), the group of BIIB65H09 (SEQ ID NO:39,41) and BIIB65B03 (SEQ ID NO:43,45) composition.</div>
      <div id="p0771" num="0771" class="description-paragraph style-scope patent-text">Trastuzumab (Genentech)-US6,054,297；The appropriate pearl of ATCC accession number CRL-10463 (Genentech) pa is single
Anti- (Genentech)</div>
      <div id="p0772" num="0772" class="description-paragraph style-scope patent-text">US20110117097</div>
      <div id="p0773" num="0773" class="description-paragraph style-scope patent-text">For example, with reference to SEQ ID No.15&amp;16, SEQ ID No.17&amp;18, SEQ ID No.23&amp;24 &amp;ATCC accession number
HB-12215、HB-12216、CRL 10463、HB-12697。</div>
      <div id="p0774" num="0774" class="description-paragraph style-scope patent-text">US20090285837</div>
      <div id="p0775" num="0775" class="description-paragraph style-scope patent-text">US20090202546</div>
      <div id="p0776" num="0776" class="description-paragraph style-scope patent-text">For example, ATCC accession number: HB-12215, HB-12216, CRL 10463, HB-12698.</div>
      <div id="p0777" num="0777" class="description-paragraph style-scope patent-text">US20060088523</div>
      <div id="p0778" num="0778" class="description-paragraph style-scope patent-text">For example, ATCC accession number: HB-12215, HB-12216</div>
      <div id="p0779" num="0779" class="description-paragraph style-scope patent-text">For example, separately including lighten amino acid sequence and the Weight variable amino acid sequence in SEQ ID NO.3 and 4
Antibody.</div>
      <div id="p0780" num="0780" class="description-paragraph style-scope patent-text">For example, comprising the light-chain amino acid sequence selected from SEQ ID No.15 and 23 and selected from SEQ ID No.16 and
The antibody of 24 heavy chain amino acid sequence</div>
      <div id="p0781" num="0781" class="description-paragraph style-scope patent-text">US20060018899</div>
      <div id="p0782" num="0782" class="description-paragraph style-scope patent-text">For example, ATCC accession number: (7C2) HB-12215, (7F3) HB-12216, (4D5) CRL-10463, (2C4) HB-
12697。</div>
      <div id="p0783" num="0783" class="description-paragraph style-scope patent-text">For example, comprising in SEQ ID No.23 amino acid sequence or its remove the antibody of amide groups and/or oxidized variant.</div>
      <div id="p0784" num="0784" class="description-paragraph style-scope patent-text">US2011/0159014</div>
      <div id="p0785" num="0785" class="description-paragraph style-scope patent-text">For example, the antibody of the light variable domains with the quick evolving region comprising SEQ ID NO:1 ".</div>
      <div id="p0786" num="0786" class="description-paragraph style-scope patent-text">For example, the antibody of the heavy-chain variable domains with the quick evolving region comprising SEQ ID NO:2.</div>
      <div id="p0787" num="0787" class="description-paragraph style-scope patent-text">US20090187007</div>
      <div id="p0788" num="0788" class="description-paragraph style-scope patent-text">Glycotope:TrasGEX antibody http://www.glycotope.com/pipeline</div>
      <div id="p0789" num="0789" class="description-paragraph style-scope patent-text">For example, with reference to international arthrocarcinoma research institute (International Joint Cancer Institute) and length
Extra large Cancer center, hospital (Changhai Hospital Cancer Cent): HMTI-Fc Ab-Gao J., et al BMB
Rep.2009 October 31；42(10):636-41.</div>
      <div id="p0790" num="0790" class="description-paragraph style-scope patent-text">Symphogen:US20110217305</div>
      <div id="p0791" num="0791" class="description-paragraph style-scope patent-text">China joint stem cell and genetic engineering (Union Stem Cell&amp;Gene Engineering, China)-Liu
HQ., et al Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi.2010 May；26(5):456-8.</div>
      <div id="p0792" num="0792" class="description-paragraph style-scope patent-text">(18)NCA(CEACAM6)</div>
      <div id="p0793" num="0793" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Nucleotide</u>
      </div>
      <div id="p0794" num="0794" class="description-paragraph style-scope patent-text">Genbank accession number M18728</div>
      <div id="p0795" num="0795" class="description-paragraph style-scope patent-text">Genbank version number M18728.1 GI:189084</div>
      <div id="p0796" num="0796" class="description-paragraph style-scope patent-text">Genbank records update date: on June 23rd, 2010,08:48AM</div>
      <div id="p0797" num="0797" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Polypeptide</u>
      </div>
      <div id="p0798" num="0798" class="description-paragraph style-scope patent-text">Genbank accession number AAA59907</div>
      <div id="p0799" num="0799" class="description-paragraph style-scope patent-text">Genbank version number AAA59907.1 GI:189085</div>
      <div id="p0800" num="0800" class="description-paragraph style-scope patent-text">Genbank records update date: on June 23rd, 2010,08:48AM</div>
      <div id="p0801" num="0801" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Cross reference</u>
      </div>
      <div id="p0802" num="0802" class="description-paragraph style-scope patent-text">Barnett T.,et al Genomics 3,59-66,1988；Tawaragi Y.,et al
Biochem.Biophys.Res.Commun.150,89-96,1988；Strausberg R.L.,et al
Proc.Natl.Acad.Sci.U.S.A.99:16899-16903,2002；WO2004/063709；EP1439393 (want by right
It asks 7)；WO2004/044178 (embodiment 4)；WO2004/031238；WO2003/042661 (claim 12)；WO2002/
78524 (embodiments 2)；WO2002/86443 (claim 27；Page 427)；WO2002/60317 (claim 2)；It steps on
Record: P40199； Q14920；EMBL；M29541；AAA59915.1.</div>
      <div id="p0803" num="0803" class="description-paragraph style-scope patent-text">EMBL；M18728.</div>
      <div id="p0804" num="0804" class="description-paragraph style-scope patent-text">(19)MDP(DPEP1)</div>
      <div id="p0805" num="0805" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Nucleotide</u>
      </div>
      <div id="p0806" num="0806" class="description-paragraph style-scope patent-text">Genbank accession number BC017023</div>
      <div id="p0807" num="0807" class="description-paragraph style-scope patent-text">Genbank version number BC017023.1 GI:16877538</div>
      <div id="p0808" num="0808" class="description-paragraph style-scope patent-text">Genbank records update date: on March 6th, 2012,01:00PM</div>
      <div id="p0809" num="0809" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Polypeptide</u>
      </div>
      <div id="p0810" num="0810" class="description-paragraph style-scope patent-text">Genbank accession number AAH17023</div>
      <div id="p0811" num="0811" class="description-paragraph style-scope patent-text">Genbank version number AAH17023.1 GI:16877539</div>
      <div id="p0812" num="0812" class="description-paragraph style-scope patent-text">Genbank records update date: on March 6th, 2012,01:00PM</div>
      <div id="p0813" num="0813" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Cross reference</u>
      </div>
      <div id="p0814" num="0814" class="description-paragraph style-scope patent-text">Proc.Natl.Acad.Sci.U.S.A.99(26):16899-16903(2002))；WO2003/016475 (power
1) benefit requires；WO2002/64798 (claim 33；The 85-87 pages)；JP05003790 (Fig. 6-8)；WO99/46284 (figure
9)；MIM:179780.</div>
      <div id="p0815" num="0815" class="description-paragraph style-scope patent-text">(20) IL20R- α (IL20Ra, ZCYTOR7)</div>
      <div id="p0816" num="0816" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Nucleotide</u>
      </div>
      <div id="p0817" num="0817" class="description-paragraph style-scope patent-text">Genbank accession number AF184971</div>
      <div id="p0818" num="0818" class="description-paragraph style-scope patent-text">Genbank version number AF184971.1 GI:6013324</div>
      <div id="p0819" num="0819" class="description-paragraph style-scope patent-text">Genbank records update date: on March 10th, 2010,10:00PM</div>
      <div id="p0820" num="0820" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Polypeptide</u>
      </div>
      <div id="p0821" num="0821" class="description-paragraph style-scope patent-text">Genbank accession number AAF01320</div>
      <div id="p0822" num="0822" class="description-paragraph style-scope patent-text">Genbank version number AAF01320.1 GI:6013325</div>
      <div id="p0823" num="0823" class="description-paragraph style-scope patent-text">Genbank records update date: on March 10th, 2010,10:00PM</div>
      <div id="p0824" num="0824" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Cross reference</u>
      </div>
      <div id="p0825" num="0825" class="description-paragraph style-scope patent-text">Clark H.F.,et al Genome Res.13,2265-2270,2003；Mungall A.J.,et al
Nature 425,805-811,2003；Blumberg H.,et al Cell 104,9-19,2001；Dumoutier L.,et
al J.Immunol.167,3545-3549, 2001；Parrish-Novak J.,et al J.Biol.Chem.277,
47517-47523,2002；Pletnev S., et al(2003)10Biochemistry 42:12617-12624；Sheikh
F.,et al(2004)J. Immunol.172,2006-2010；EP1394274 (embodiment 11)；US2004/005320 (is implemented
Example 5)；WO2003/029262 (the 74-75 pages)；WO2003/002717 (claim 2；Page 63)；WO2002/22153
(the 45-47 pages)；US2002/042366 (the 20-21 pages)；WO2001/46261 (the 57-59 pages)；WO2001/46232 (the
63-65 pages)；WO98/37193 (claim 1；The 55-59 pages)；It logs in: Q9UHF4；Q6UWA9；Q96SH8；EMBL；
AF184971；AAF01320.1.</div>
      <div id="p0826" num="0826" class="description-paragraph style-scope patent-text">(21) brevican (BCAN, BEHAB)</div>
      <div id="p0827" num="0827" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Nucleotide</u>
      </div>
      <div id="p0828" num="0828" class="description-paragraph style-scope patent-text">Genbank accession number AF229053</div>
      <div id="p0829" num="0829" class="description-paragraph style-scope patent-text">Genbank version number AF229053.1 GI:10798902</div>
      <div id="p0830" num="0830" class="description-paragraph style-scope patent-text">Genbank records update date: on March 11st, 2010,12:58AM</div>
      <div id="p0831" num="0831" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Polypeptide</u>
      </div>
      <div id="p0832" num="0832" class="description-paragraph style-scope patent-text">Genbank accession number AAG23135</div>
      <div id="p0833" num="0833" class="description-paragraph style-scope patent-text">Genbank version number AAG23135.1 GI:10798903</div>
      <div id="p0834" num="0834" class="description-paragraph style-scope patent-text">Genbank records update date: on March 11st, 2010,12:58AM</div>
      <div id="p0835" num="0835" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Cross reference</u>
      </div>
      <div id="p0836" num="0836" class="description-paragraph style-scope patent-text">Gary S.C.,et al Gene 256,139-147,2000；Clark H.F.,et al Genome Res.13,
2265-2270,2003；Strausberg R.L.,et al Proc.Natl.Acad.Sci.U.S.A.99, 16899-
16903,2002；US2003/186372 (claim 11)；US2003/186373 (claim 11)；US2003/119131
(claim 1；Figure 52)；US2003/119122 (claim 1；20 Figure 52)；US2003/119126 (claim 1)；
US2003/119121 (claim 1；Figure 52)；US2003/119129 (claim 1)；US2003/119130 (want by right
It asks 1)；US2003/119128 (claim 1；Figure 52)；US2003/119125 (claim 1)；WO2003/016475 (power
1) benefit requires；WO2002/02634 (claim 1)</div>
      <div id="p0837" num="0837" class="description-paragraph style-scope patent-text">(22) EphB2R (DRT, ERK, Hek5, EPHT3, Tyro5)</div>
      <div id="p0838" num="0838" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Nucleotide</u>
      </div>
      <div id="p0839" num="0839" class="description-paragraph style-scope patent-text">Genbank accession number NM_004442</div>
      <div id="p0840" num="0840" class="description-paragraph style-scope patent-text">Genbank version number NM_004442.6 GI:111118979</div>
      <div id="p0841" num="0841" class="description-paragraph style-scope patent-text">Genbank records update date: on September 8th, 2012,04:43PM</div>
      <div id="p0842" num="0842" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Polypeptide</u>
      </div>
      <div id="p0843" num="0843" class="description-paragraph style-scope patent-text">Genbank accession number NP_004433</div>
      <div id="p0844" num="0844" class="description-paragraph style-scope patent-text">Genbank version number NP_004433.2 GI:21396504</div>
      <div id="p0845" num="0845" class="description-paragraph style-scope patent-text">Genbank records update date: on September 8th, 2012,04:43PM</div>
      <div id="p0846" num="0846" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Cross reference</u>
      </div>
      <div id="p0847" num="0847" class="description-paragraph style-scope patent-text">Chan, J. and Watt, V.M., Oncogene 6 (6), 1057-1061 (1991) Oncogene 10 (5): 897-
905(1995),Annu.Rev.Neurosci.21:309-345(1998),Int.Rev. Cytol.196:177-244
(2000))；WO2003042661 (claim 12)；WO200053216 (claim 1；Page 41)；WO2004065576
(claim 1)；WO2004020583 (claim 9)；WO2003004529 (the 128-132 pages)；WO200053216 (power
Benefit requires 1；Page 42)；MIM:600997.</div>
      <div id="p0848" num="0848" class="description-paragraph style-scope patent-text">(23)ASLG659(B7h)</div>
      <div id="p0849" num="0849" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Nucleotide</u>
      </div>
      <div id="p0850" num="0850" class="description-paragraph style-scope patent-text">Genbank accession number AX092328</div>
      <div id="p0851" num="0851" class="description-paragraph style-scope patent-text">Genbank version number AX092328.1 GI:13444478</div>
      <div id="p0852" num="0852" class="description-paragraph style-scope patent-text">Genbank records update date: on January 26th, 2011,07:37AM</div>
      <div id="p0853" num="0853" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Cross reference</u>
      </div>
      <div id="p0854" num="0854" class="description-paragraph style-scope patent-text">US2004/0101899 (claim 2)；WO2003104399 (claim 11)；WO2004000221 (figure
3)；US2003/165504 (claim 1)；US2003/124140 (embodiment 2)；US2003/065143 (Figure 60)；
WO2002/102235 (claim 13；Page 299) US2003/091580 (embodiment 2)；WO2002/10187 (want by right
Ask 6；Figure 10)；WO2001/94641 (claim 12；Fig. 7 b)；WO2002/02624 (claim 13；Figure 1A -1B)；
US2002/034749 (claim 54；The 45-46 pages)；WO2002/06317 (embodiment 2；The 320-321 pages, right is wanted
Ask 34；The 321-322 pages)；WO2002/71928 (the 468-469 pages)；WO2002/02587 (embodiment 1；Fig. 1)；
WO2001/40269 (embodiment 3；The 190-192 pages)；WO2000/36107 (embodiment 2；The 205-207 pages)； WO2004/
053079 (claim 12)；WO2003/004989 (claim 1)；WO2002/71928 (233-234,452-453
Page)；WO 01/16318.</div>
      <div id="p0855" num="0855" class="description-paragraph style-scope patent-text">(24) PSCA (prostate stem cell antigen precursor)</div>
      <div id="p0856" num="0856" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Nucleotide</u>
      </div>
      <div id="p0857" num="0857" class="description-paragraph style-scope patent-text">Genbank accession number AJ297436</div>
      <div id="p0858" num="0858" class="description-paragraph style-scope patent-text">Genbank version number AJ297436.1 GI:9367211</div>
      <div id="p0859" num="0859" class="description-paragraph style-scope patent-text">Genbank record update date: on 2 1st, 2011,11:25AM</div>
      <div id="p0860" num="0860" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Polypeptide</u>
      </div>
      <div id="p0861" num="0861" class="description-paragraph style-scope patent-text">Genbank accession number CAB97347</div>
      <div id="p0862" num="0862" class="description-paragraph style-scope patent-text">Genbank version number CAB97347.1 GI:9367212</div>
      <div id="p0863" num="0863" class="description-paragraph style-scope patent-text">Genbank record update date: on 2 1st, 2011,11:25AM</div>
      <div id="p0864" num="0864" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Cross reference</u>
      </div>
      <div id="p0865" num="0865" class="description-paragraph style-scope patent-text">Reiter R.E.,et al Proc.Natl.Acad.Sci.U.S.A.95,1735-1740,1998；Gu Z.,et
al Oncogene 19, 1288-1296,2000；Biochem.Biophys.Res.Commun.(2000)275(3):783-
788； WO2004/022709；EP1394274 (embodiment 11)；US2004/018553 (claim 17)； WO2003/
008537 (claim 1)；WO2002/81646 (claim 1；Page 164)；WO2003/003906 (claim 10；
Page 288)；WO2001/40309 (embodiment 1；Figure 17)；US2001/055751 (embodiment 1；Fig. 1 b)；WO2000/32752
(claim 18；Fig. 1)；WO98/51805 (claim 17；Page 97)；WO98/51824 (claim 10；94th
Page)；WO98/40403 (claim 2；Figure 1B)；It logs in: O43653； EMBL；AF043498；AAC39607.1</div>
      <div id="p0866" num="0866" class="description-paragraph style-scope patent-text">(25)GEDA</div>
      <div id="p0867" num="0867" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Nucleotide</u>
      </div>
      <div id="p0868" num="0868" class="description-paragraph style-scope patent-text">Genbank accession number AY260763</div>
      <div id="p0869" num="0869" class="description-paragraph style-scope patent-text">Genbank version number AY260763.1 GI:30102448</div>
      <div id="p0870" num="0870" class="description-paragraph style-scope patent-text">Genbank records update date: on March 11st, 2010,02:24AM</div>
      <div id="p0871" num="0871" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Polypeptide</u>
      </div>
      <div id="p0872" num="0872" class="description-paragraph style-scope patent-text">Genbank accession number AAP14954</div>
      <div id="p0873" num="0873" class="description-paragraph style-scope patent-text">Genbank version number AAP14954.1 GI:30102449</div>
      <div id="p0874" num="0874" class="description-paragraph style-scope patent-text">Genbank records update date: on March 11st, 2010,02:24AM</div>
      <div id="p0875" num="0875" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Cross reference</u>
      </div>
      <div id="p0876" num="0876" class="description-paragraph style-scope patent-text">AP14954 lipoma HMGIC fusion-companion's sample protein/pid=AAP14954.1- homo sapiens (mankind)
(AP14954lipoma HMGIC fusion-partnerlike protein/pid=AAP14954.1- Homo sapiens
(human))；WO2003/054152 (claim 20)；WO2003/000842 (claim 1)；WO2003/023013 is (real
Apply example 3, claim 20)；US2003/194704 (claim 45)；GI:30102449；</div>
      <div id="p0877" num="0877" class="description-paragraph style-scope patent-text">(26) BAFF-R (B cell activity factor receptor, BLyS receptor 3, BR3)</div>
      <div id="p0878" num="0878" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Nucleotide</u>
      </div>
      <div id="p0879" num="0879" class="description-paragraph style-scope patent-text">Genbank accession number AF116456</div>
      <div id="p0880" num="0880" class="description-paragraph style-scope patent-text">Genbank version number AF116456.1 GI:4585274</div>
      <div id="p0881" num="0881" class="description-paragraph style-scope patent-text">Genbank records update date: on March 10th, 2010,09:44PM</div>
      <div id="p0882" num="0882" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Polypeptide</u>
      </div>
      <div id="p0883" num="0883" class="description-paragraph style-scope patent-text">Genbank accession number AAD25356</div>
      <div id="p0884" num="0884" class="description-paragraph style-scope patent-text">Genbank version number AAD25356.1 GI:4585275</div>
      <div id="p0885" num="0885" class="description-paragraph style-scope patent-text">Genbank records update date: on March 10th, 2010,09:44PM</div>
      <div id="p0886" num="0886" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Cross reference</u>
      </div>
      <div id="p0887" num="0887" class="description-paragraph style-scope patent-text">BAFF receptor/pid=NP_443177.1- homo sapiens (BAFF receptor/pid=NP_443177.1- Homo
Sapiens): Thompson, J.S., et al Science 293 (5537), 2108-2111 (2001)； WO2004/
058309；WO2004/011611；WO2003/045422 (embodiment；The 32-33 pages)；WO2003/014294 (claim
35；Fig. 6 B)；WO2003/035846 (claim 70；The 615-616 pages)；WO2002/94852(Col 136-137)；
25 (claim 3 of WO2002/38766；Page 133)；WO2002/24909 (embodiment 3；Fig. 3)；MIM:606269； NP_
443177.1；NM_052945_1；AF132600</div>
      <div id="p0888" num="0888" class="description-paragraph style-scope patent-text">(27) CD22 (B-cell receptor CD22-B isotype, BL-CAM, Lyb-8, Lyb8, SIGLEC-2, FLJ22814)</div>
      <div id="p0889" num="0889" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Nucleotide</u>
      </div>
      <div id="p0890" num="0890" class="description-paragraph style-scope patent-text">Genbank accession number AK026467</div>
      <div id="p0891" num="0891" class="description-paragraph style-scope patent-text">Genbank version number AK026467.1 GI:10439337</div>
      <div id="p0892" num="0892" class="description-paragraph style-scope patent-text">Genbank records update date: on September 11st, 2006,11:24PM</div>
      <div id="p0893" num="0893" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Polypeptide</u>
      </div>
      <div id="p0894" num="0894" class="description-paragraph style-scope patent-text">Genbank accession number BAB15489</div>
      <div id="p0895" num="0895" class="description-paragraph style-scope patent-text">Genbank version number BAB15489.1 GI:10439338</div>
      <div id="p0896" num="0896" class="description-paragraph style-scope patent-text">Genbank records update date: on September 11st, 2006,11:24PM</div>
      <div id="p0897" num="0897" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Cross reference</u>
      </div>
      <div id="p0898" num="0898" class="description-paragraph style-scope patent-text">Wilson et al(1991)J.Exp.Med.173:137-146；30WO2003/072036 (claim 1；Figure
1)；IM:107266；NP_001762.1；NM_001771_1.</div>
      <div id="p0899" num="0899" class="description-paragraph style-scope patent-text">(27a) CD22 (CD22 molecule)</div>
      <div id="p0900" num="0900" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Nucleotide</u>
      </div>
      <div id="p0901" num="0901" class="description-paragraph style-scope patent-text">Genbank accession number X52785</div>
      <div id="p0902" num="0902" class="description-paragraph style-scope patent-text">Genbank version number X52785.1 GI:29778</div>
      <div id="p0903" num="0903" class="description-paragraph style-scope patent-text">Genbank record update date: on 2 2nd, 2011,10:09AM</div>
      <div id="p0904" num="0904" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Polypeptide</u>
      </div>
      <div id="p0905" num="0905" class="description-paragraph style-scope patent-text">Genbank accession number CAA36988</div>
      <div id="p0906" num="0906" class="description-paragraph style-scope patent-text">Genbank version number CAA36988.1 GI:29779</div>
      <div id="p0907" num="0907" class="description-paragraph style-scope patent-text">Genbank record update date: on 2 2nd, 2011,10:09AM</div>
      <div id="p0908" num="0908" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Cross reference</u>
      </div>
      <div id="p0909" num="0909" class="description-paragraph style-scope patent-text">Stamenkovic I.et al., Nature 345 (6270), 74-77 (1990)</div>
      <div id="p0910" num="0910" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Other information</u>
      </div>
      <div id="p0911" num="0911" class="description-paragraph style-scope patent-text">Official signs: CD22</div>
      <div id="p0912" num="0912" class="description-paragraph style-scope patent-text">Other alias: SIGLEC-2, SIGLEC2</div>
      <div id="p0913" num="0913" class="description-paragraph style-scope patent-text">Other names: B-cell receptor CD22；Bone-marrow-derived lymphocyte adhesion molecule；BL-CAM；CD22 antigen；T cell surface is anti-
Former Leu-14；Sialic acid combination Ig sample agglutinin 2 (sialic acid binding Ig-like lectin 2)；Sialic acid knot
Close Ig sample agglutinin 2</div>
      <div id="p0914" num="0914" class="description-paragraph style-scope patent-text">Antibody</div>
      <div id="p0915" num="0915" class="description-paragraph style-scope patent-text">G5/44 (Yi Zhu monoclonal antibody (Inotuzumab)): DiJoseph JF., et al Cancer Immunol
Immunother.2005 January；54(1):11-24.</div>
      <div id="p0916" num="0916" class="description-paragraph style-scope patent-text">Epratuzumab (Epratuzumab)-Goldenberg DM., et al Expert Rev Anticancer
Ther.6(10):1341-53,2006.</div>
      <div id="p0917" num="0917" class="description-paragraph style-scope patent-text">(28) CD79a (CD79A, CD79 α), immunoglobulin correlation α, with Ig β (CD79B) covalent interaction and
The B cell specific protein of complex compound is formed on surface with 35 molecule of Ig M, transduction participates in the signal of B cell differentiation),
pI:4.84,MW:25028TM:2</div>
      <div id="p0918" num="0918" class="description-paragraph style-scope patent-text">[P] gene chromosome: 19q13.2)</div>
      <div id="p0919" num="0919" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Nucleotide</u>
      </div>
      <div id="p0920" num="0920" class="description-paragraph style-scope patent-text">Genbank accession number NM_001783</div>
      <div id="p0921" num="0921" class="description-paragraph style-scope patent-text">Genbank version number NM_001783.3 GI:90193587</div>
      <div id="p0922" num="0922" class="description-paragraph style-scope patent-text">Genbank record update date: on June 26th, 2012 01:48PM</div>
      <div id="p0923" num="0923" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Polypeptide</u>
      </div>
      <div id="p0924" num="0924" class="description-paragraph style-scope patent-text">Genbank accession number NP_001774</div>
      <div id="p0925" num="0925" class="description-paragraph style-scope patent-text">Genbank version number .NP_001774.1 GI:4502685</div>
      <div id="p0926" num="0926" class="description-paragraph style-scope patent-text">Genbank record update date: on June 26th, 2012 01:48PM</div>
      <div id="p0927" num="0927" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Cross reference</u>
      </div>
      <div id="p0928" num="0928" class="description-paragraph style-scope patent-text">WO2003/088808,US2003/0228319；WO2003/062401 (claim 9)； US2002/150573
(claim 4, the 13-14 pages)；WO99/58658 (claim 13, Figure 16)；WO92/07574 (Fig. 1)；US5644033；
Ha et al(1992)J. Immunol.148(5):1526-1531；Müller et al(1992)
Eur.J.Immunol..22:1621-1625；Hashimoto et al(1994)Immunogenetics 40(4):287-
295；Preud'homme et al(1992)Clin.Exp.</div>
      <div id="p0929" num="0929" class="description-paragraph style-scope patent-text">5Immunol.90(1):141-146；Yu et al(1992)J.Immunol.148(2)633-637；
Sakaguchi et al(1988)</div>
      <div id="p0930" num="0930" class="description-paragraph style-scope patent-text">EMBO J.7(11):3457-3464</div>
      <div id="p0931" num="0931" class="description-paragraph style-scope patent-text">(29) CXCR5 (Burkitt's lymthoma receptor 1, the G-protein conjugated receptor activated by CXCL13, in lymph
It works in cell migration and humoral defense, 10 is played in HIV-2 infection and acts on and AIDS, lymthoma, marrow may be developed
Tumor and leukaemia)；372aa, pI:8.54MW:41959TM:7 [P] gene chromosome: 11q23.3,</div>
      <div id="p0932" num="0932" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Nucleotide</u>
      </div>
      <div id="p0933" num="0933" class="description-paragraph style-scope patent-text">Genbank accession number NM_001716</div>
      <div id="p0934" num="0934" class="description-paragraph style-scope patent-text">Genbank version number NM_001716.4 GI:342307092</div>
      <div id="p0935" num="0935" class="description-paragraph style-scope patent-text">Genbank records update date: on September 30th, 2012,01:49PM</div>
      <div id="p0936" num="0936" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Polypeptide</u>
      </div>
      <div id="p0937" num="0937" class="description-paragraph style-scope patent-text">Genbank accession number NP_001707</div>
      <div id="p0938" num="0938" class="description-paragraph style-scope patent-text">Genbank version number NP_001707.1 GI:4502415</div>
      <div id="p0939" num="0939" class="description-paragraph style-scope patent-text">Genbank records update date: on September 30th, 2012,01:49PM</div>
      <div id="p0940" num="0940" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Cross reference</u>
      </div>
      <div id="p0941" num="0941" class="description-paragraph style-scope patent-text">WO2004/040000；WO2004/015426；US2003/105292 (embodiment 2)；US6555339 (embodiment
2)；WO2002/61087 (Fig. 1)；WO2001/57188 (claim 20, page 269)；WO2001/72830 (12-13
Page)；WO2000/22129 (embodiment 1, the 152-153 pages, 15 embodiments 2, the 254-256 pages) WO99/28468 (want by right
Ask page 1,38)；US5440021 (embodiment 2, col 49-52)；WO94/28931 (the 56-58 pages)； WO92/17497
(claim 7, Fig. 5)；Dobner et al(1992) Eur.J.Immunol.22:2795-2799；Barella et al
(1995)Biochem.J.309:773-779</div>
      <div id="p0942" num="0942" class="description-paragraph style-scope patent-text">(30) (they simultaneously 20 are presented that (Ia is anti-to the MHC II class molecule of CD4+T lymphocyte to HLA-DOB by binding peptide
It is former) subelement, 273aa, pI:56, MW:30820.TM:1 [P] gene chromosome: 6p21.3)</div>
      <div id="p0943" num="0943" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Nucleotide</u>
      </div>
      <div id="p0944" num="0944" class="description-paragraph style-scope patent-text">Genbank accession number NM_002120</div>
      <div id="p0945" num="0945" class="description-paragraph style-scope patent-text">Genbank version number NM_002120.3 GI:118402587</div>
      <div id="p0946" num="0946" class="description-paragraph style-scope patent-text">Genbank records update date: on September 8th, 2012,04:46PM</div>
      <div id="p0947" num="0947" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Polypeptide</u>
      </div>
      <div id="p0948" num="0948" class="description-paragraph style-scope patent-text">Genbank accession number NP_002111</div>
      <div id="p0949" num="0949" class="description-paragraph style-scope patent-text">Genbank version number NP_002111.1 GI:4504403</div>
      <div id="p0950" num="0950" class="description-paragraph style-scope patent-text">Genbank records update date: on September 8th, 2012,04:46PM</div>
      <div id="p0951" num="0951" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Cross reference</u>
      </div>
      <div id="p0952" num="0952" class="description-paragraph style-scope patent-text">Tonnelle et al(1985)EMBO J.4(11):2839-2847；Jonsson et al(1989)</div>
      <div id="p0953" num="0953" class="description-paragraph style-scope patent-text">Immunogenetics 29(6):411-413；Beck et al(1992)J.Mol.Biol.228:433-441；
Strausberg et al(2002)Proc.Natl.Acad.Sci USA 99:16899-16903；Servenius et al
(1987)J.Biol.Chem.262:8759-8766；Beck et al(1996)J.Mol.Biol.25 255:1-13；Naruse
et al(2002)Tissue Antigens 59:512-519；WO99/58658 (claim 13, Figure 15)；US6153408
(Col 35-38)；US5976551(col 168-170)； US6011146(col 145-146)；Kasahara et al
(1989)Immunogenetics 30(1):66-68；Larhammar et al(1985)J.Biol.Chem.260(26):
14111-14119</div>
      <div id="p0954" num="0954" class="description-paragraph style-scope patent-text">(31) (purinoceptor P2X ligand-gated ion channel 5, the ion channel gated by effect of extracellular ATP, can be with by P2X5
It is related to cynapse transmitting and nerve to occur, lacks the pathology that may cause idiopathic detrusor instability)；422aa), pI:7.63,
MW:47206TM:1 [P] gene chromosome: 17p13.3).</div>
      <div id="p0955" num="0955" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Nucleotide</u>
      </div>
      <div id="p0956" num="0956" class="description-paragraph style-scope patent-text">Genbank accession number NM_002561</div>
      <div id="p0957" num="0957" class="description-paragraph style-scope patent-text">Genbank version number NM_002561.3 GI:325197202</div>
      <div id="p0958" num="0958" class="description-paragraph style-scope patent-text">Genbank records update date: on June 27th, 2012,12:41AM</div>
      <div id="p0959" num="0959" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Polypeptide</u>
      </div>
      <div id="p0960" num="0960" class="description-paragraph style-scope patent-text">Genbank accession number NP_002552</div>
      <div id="p0961" num="0961" class="description-paragraph style-scope patent-text">Genbank version number .NP_002552.2 GI:28416933</div>
      <div id="p0962" num="0962" class="description-paragraph style-scope patent-text">Genbank records update date: on June 27th, 2012,12:41AM</div>
      <div id="p0963" num="0963" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Cross reference</u>
      </div>
      <div id="p0964" num="0964" class="description-paragraph style-scope patent-text">Le et al(1997)FEBS Lett.418(1-2):195-199；WO2004/047749； WO2003/072035
(claim 10) Touchman et al (2000) Genome Res.10:165-173；WO2002/22660 (claim
20)；WO2003/093444 (claim 1)；WO2003/087768 (claim 1)；WO2003/029277 (page 82)</div>
      <div id="p0965" num="0965" class="description-paragraph style-scope patent-text">(32) CD72 (B cell differentiation antigen CD72, Lyb-2)；359aa, pI:8.66, MW:40225, TM:1 5 [P] base
Because of chromosome: 9p13.3).</div>
      <div id="p0966" num="0966" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Nucleotide</u>
      </div>
      <div id="p0967" num="0967" class="description-paragraph style-scope patent-text">Genbank accession number NM_001782</div>
      <div id="p0968" num="0968" class="description-paragraph style-scope patent-text">Genbank version number NM_001782.2 GI:194018444</div>
      <div id="p0969" num="0969" class="description-paragraph style-scope patent-text">Genbank records update date: on June 26th, 2012,01:43PM</div>
      <div id="p0970" num="0970" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Polypeptide</u>
      </div>
      <div id="p0971" num="0971" class="description-paragraph style-scope patent-text">Genbank accession number NP_001773</div>
      <div id="p0972" num="0972" class="description-paragraph style-scope patent-text">Genbank version number NP_001773.1 GI:4502683</div>
      <div id="p0973" num="0973" class="description-paragraph style-scope patent-text">Genbank records update date: on June 26th, 2012,01:43PM</div>
      <div id="p0974" num="0974" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Cross reference</u>
      </div>
      <div id="p0975" num="0975" class="description-paragraph style-scope patent-text">WO2004042346 (claim 65)；WO2003/026493 (51-52,57-58 page)； WO2000/75655
(the 105-106 pages)；Von Hoegen et al(1990)J. Immunol.144(12):4870-4877；Strausberg
et al(2002)Proc.Natl.Acad.Sci USA 99:16899-16903.</div>
      <div id="p0976" num="0976" class="description-paragraph style-scope patent-text">(33) (lymphocyte antigen 64 (RP105), memebrane protein of the I type rich in leucine repeat (LRR) family, adjust LY64
Activation and the Apoptosis of B cell are saved, function is lost related to the aggravation of systemic loupus erythematosus in patient)；661aa,
PI:6.20, MW:74147TM:1 [P] gene chromosome: 5q12).</div>
      <div id="p0977" num="0977" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Nucleotide</u>
      </div>
      <div id="p0978" num="0978" class="description-paragraph style-scope patent-text">Genbank accession number NM_005582</div>
      <div id="p0979" num="0979" class="description-paragraph style-scope patent-text">Genbank version number NM_005582.2 GI:167555126</div>
      <div id="p0980" num="0980" class="description-paragraph style-scope patent-text">Genbank records update date: on September 2nd, 2012,01:50PM</div>
      <div id="p0981" num="0981" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Polypeptide</u>
      </div>
      <div id="p0982" num="0982" class="description-paragraph style-scope patent-text">Genbank accession number NP_005573</div>
      <div id="p0983" num="0983" class="description-paragraph style-scope patent-text">Genbank version number NP_005573.2 GI:167555127</div>
      <div id="p0984" num="0984" class="description-paragraph style-scope patent-text">Genbank records update date: on September 2nd, 2012,01:50PM</div>
      <div id="p0985" num="0985" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Cross reference</u>
      </div>
      <div id="p0986" num="0986" class="description-paragraph style-scope patent-text">US2002/193567；WO97/07198 (claim 11, the 39-42 pages)；Miura et al(1996)
15Genomics 38(3):299-304；Miura et al(1998)Blood 92:2815-2822； WO2003/083047；
WO97/44452 (claim 8, the 57-61 pages)；WO2000/12130 (the 24-26 pages).</div>
      <div id="p0987" num="0987" class="description-paragraph style-scope patent-text">(34) FcRH1 (F receptor-like protein matter 1, to contain the immunoglobulin Fc of C2 type Ig sample and ITAM structural domain
The hypothesis receptor of structural domain may play a role in the differentiation of bone-marrow-derived lymphocyte 20)；429aa, pI:5.28, MW:46925TM:1
[P] gene chromosome: 1q21-1q22)</div>
      <div id="p0988" num="0988" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Nucleotide</u>
      </div>
      <div id="p0989" num="0989" class="description-paragraph style-scope patent-text">Genbank accession number NM_052938</div>
      <div id="p0990" num="0990" class="description-paragraph style-scope patent-text">Genbank version number NM_052938.4 GI:226958543</div>
      <div id="p0991" num="0991" class="description-paragraph style-scope patent-text">Genbank records update date: on September 2nd, 2012,01:43PM</div>
      <div id="p0992" num="0992" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Polypeptide</u>
      </div>
      <div id="p0993" num="0993" class="description-paragraph style-scope patent-text">Genbank accession number NP_443170</div>
      <div id="p0994" num="0994" class="description-paragraph style-scope patent-text">Genbank version number NP_443170.1 GI:16418419</div>
      <div id="p0995" num="0995" class="description-paragraph style-scope patent-text">Genbank records update date: on September 2nd, 2012,01:43PM</div>
      <div id="p0996" num="0996" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Cross reference</u>
      </div>
      <div id="p0997" num="0997" class="description-paragraph style-scope patent-text">WO2003/077836；WO2001/38490 (claim 6, Figure 18 E-1-18-E-2)；Davis et al
(2001)Proc.Natl.Acad.Sci USA 98(17):9772-9777；WO2003/089624 (claim 8)；
EP1347046 (claim 1)；WO2003/089624 (claim 7).</div>
      <div id="p0998" num="0998" class="description-paragraph style-scope patent-text">(35) (immunoglobulin superfamily receptor transposition correlation 2, can in B cell development and lymthoma generate by IRTA2
Active immunity receptor；The gene as caused by transposition relaxs control generation in some B cell malignant tumours)；977aa,
PI:6.88, MW:106468, TM:1 [P] gene chromosome: 1q21)</div>
      <div id="p0999" num="0999" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Nucleotide</u>
      </div>
      <div id="p1000" num="1000" class="description-paragraph style-scope patent-text">Genbank accession number AF343662</div>
      <div id="p1001" num="1001" class="description-paragraph style-scope patent-text">Genbank version number AF343662.1 GI:13591709</div>
      <div id="p1002" num="1002" class="description-paragraph style-scope patent-text">Genbank records update date: on March 11st, 2010,01:16AM</div>
      <div id="p1003" num="1003" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Polypeptide</u>
      </div>
      <div id="p1004" num="1004" class="description-paragraph style-scope patent-text">Genbank accession number AAK31325</div>
      <div id="p1005" num="1005" class="description-paragraph style-scope patent-text">Genbank version number AAK31325.1 GI:13591710</div>
      <div id="p1006" num="1006" class="description-paragraph style-scope patent-text">Genbank records update date: on March 11st, 2010,01:16AM</div>
      <div id="p1007" num="1007" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Cross reference</u>
      </div>
      <div id="p1008" num="1008" class="description-paragraph style-scope patent-text">AF343663、AF343664、AF343665、AF369794、AF397453、AK090423、 AK090475、
AL834187,AY358085；Mouse: AK089756, AY158090, AY506558； NP_112571.1；WO2003/024392
(claim 2, Figure 97)；Nakayama et al(2000) Biochem.Biophys.Res.Commun.277(1):124-
127；WO2003/077836；WO2001/38490 (claim 3, Figure 18 B-1-18B-2).</div>
      <div id="p1009" num="1009" class="description-paragraph style-scope patent-text">(36) TENB2 (TMEFF2, brain tumor cancer suppressor protein (tomoregulin), TPEF, HPP1, TR, it is assumed that cross-film
35 proteoglycans are related to the EGF/ heregulin family of growth factor and follistatin)；374aa)</div>
      <div id="p1010" num="1010" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Nucleotide</u>
      </div>
      <div id="p1011" num="1011" class="description-paragraph style-scope patent-text">Genbank accession number AF179274</div>
      <div id="p1012" num="1012" class="description-paragraph style-scope patent-text">Genbank version number AF179274.2 GI:12280939</div>
      <div id="p1013" num="1013" class="description-paragraph style-scope patent-text">Genbank records update date: on March 11st, 2010,01:05AM</div>
      <div id="p1014" num="1014" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Polypeptide</u>
      </div>
      <div id="p1015" num="1015" class="description-paragraph style-scope patent-text">Genbank accession number AAD55776</div>
      <div id="p1016" num="1016" class="description-paragraph style-scope patent-text">Genbank version number AAD55776.2 GI:12280940</div>
      <div id="p1017" num="1017" class="description-paragraph style-scope patent-text">Genbank records update date: on March 11st, 2010,01:05AM</div>
      <div id="p1018" num="1018" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Cross reference</u>
      </div>
      <div id="p1019" num="1019" class="description-paragraph style-scope patent-text">NCBI is logged in: AAD55776, AAF91397, AAG49451, NCBI reference sequences: NP_057276；NCBI
Gene:23671；OMIM:605734；SwissProt Q9UIK5； AY358907,CAF85723,CQ782436；WO2004/
074320；JP2004113151； WO2003/042661；WO2003/009814；EP1295944 (the 69-70 pages)；
WO2002/30268 (page 329)；WO2001/90304；US2004/249130； US2004/022727；WO2004/
063355；US2004/197325；US2003/232350；5 US2004/005563；US2003/124579；Horie et al
(2000)Genomics 67:146-152； Uchida et al(1999)Biochem.Biophys.Res.Commun.266:
593-602；Liang et al (2000)Cancer Res.60:4907-12；Glynne-Jones et al(2001)Int J
Cancer.Oct 15； 94(2):178-84.</div>
      <div id="p1020" num="1020" class="description-paragraph style-scope patent-text">(37) PSMA-FOLH1 (folic acid hydrolase (prostate-specific membrane antigen) 1)</div>
      <div id="p1021" num="1021" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Nucleotide</u>
      </div>
      <div id="p1022" num="1022" class="description-paragraph style-scope patent-text">Genbank accession number M99487</div>
      <div id="p1023" num="1023" class="description-paragraph style-scope patent-text">Genbank version number M99487.1 GI:190663</div>
      <div id="p1024" num="1024" class="description-paragraph style-scope patent-text">Genbank records update date: on June 23rd, 2010,08:48AM</div>
      <div id="p1025" num="1025" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Polypeptide</u>
      </div>
      <div id="p1026" num="1026" class="description-paragraph style-scope patent-text">Genbank accession number AAA60209</div>
      <div id="p1027" num="1027" class="description-paragraph style-scope patent-text">Genbank version number AAA60209.1 GI:190664</div>
      <div id="p1028" num="1028" class="description-paragraph style-scope patent-text">Genbank records update date: on June 23rd, 2010,08:48AM</div>
      <div id="p1029" num="1029" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Cross reference</u>
      </div>
      <div id="p1030" num="1030" class="description-paragraph style-scope patent-text">Israeli R.S.,et al Cancer Res.53(2),227-230(1993)</div>
      <div id="p1031" num="1031" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Other information</u>
      </div>
      <div id="p1032" num="1032" class="description-paragraph style-scope patent-text">Official signs (official's mark, Official Symbol): FOLH1</div>
      <div id="p1033" num="1033" class="description-paragraph style-scope patent-text">Other alias: GIG27, FGCP, FOLH, GCP2, GCPII, NAALAD1, NAALAdase, PSM, PSMA, mGCP</div>
      <div id="p1034" num="1034" class="description-paragraph style-scope patent-text">Other names: the acidic dipeptidase 1 of N- acetylation α connection；N- acetylation-α-connection acidic dipeptidase I；
NAALADase I；27 protein of cell growth suppressor gene；Leaf acyl poly-gamma-glutamic acid carboxypeptidase；Glutamic acid carboxylase II；
Glutamate carboxypeptidase 2；Glutamate carboxypeptidase II；Film glutamate carboxypeptidase；Prostate-specific membrane antigen variant F；Pteroyl is poly-
Gamma-glutamic acid carboxypeptidase</div>
      <div id="p1035" num="1035" class="description-paragraph style-scope patent-text">Antibody</div>
      <div id="p1036" num="1036" class="description-paragraph style-scope patent-text">US 7,666,425:</div>
      <div id="p1037" num="1037" class="description-paragraph style-scope patent-text">By the antibody with following ATCC reference of hybridoma (Hybridomas) production: ATCC accession number HB-
12101, ATCC accession number HB-12109, ATCC accession number HB-12127 and ATCC accession number HB-12126.</div>
      <div id="p1038" num="1038" class="description-paragraph style-scope patent-text">Proscan: the monoclonal antibody selected from the group being made up of: 8H12,3E11,17G1,29B4,30C1 and
20F2(US 7,811,564；Moffett S.,et al Hybridoma(Larchmt).2007 Dec；26(6):363-72).</div>
      <div id="p1039" num="1039" class="description-paragraph style-scope patent-text">Cytogen: monoclonal antibody 7E11-C5 (ATCC accession number HB 10494) and 9H10-A4 (ATCC accession number
HB11430)–US 5,763,202</div>
      <div id="p1040" num="1040" class="description-paragraph style-scope patent-text">GlycoMimetics:NUH2-ATCC accession number HB 9762 (US 7,135,301)</div>
      <div id="p1041" num="1041" class="description-paragraph style-scope patent-text">Human genome science (Human Genome Science): HPRAJ70-ATCC accession number 97131 (US 6,
824,993)；As American Type Culture Collection (American Type Culture Collection) ("
ATCC ") deposit number 97131 preservation by cDNA clone (HPRAJ70) encode amino acid sequence</div>
      <div id="p1042" num="1042" class="description-paragraph style-scope patent-text">Medarex: lack the anti-PSMA antibody-US 7,875,278 of fucosido residue</div>
      <div id="p1043" num="1043" class="description-paragraph style-scope patent-text">The anti-PSMA antibody of mouse include 3F5.4G6,3D7.1.1,4E10-1.14,3E11,4D8,3E6,3C9,2C7,
1G3,3C4,3C6,4D4,1G9,5C8B9,3G6,4C8B9 and monoclonal antibody.Hybridoma secretion 3F5.4G6,
3D7.1.1,4E10-1.14,3E11,4D8,3E6,3C9,2C7,1G3,3C4,3C6,4D4,1G9,5C8B9,3G6 or 4C8B9
It has disclosed preservation and is described in U.S. Patent number 6,159,508.Relevant hybridoma has disclosed preservation and retouches
It is set forth in U.S. Patent number 6,107,090.In addition, the anti-PSMA antibody of humanization, the humanization version including J591, into one
Step is described in detail in PCT Publication WO 02/098897.</div>
      <div id="p1044" num="1044" class="description-paragraph style-scope patent-text">Other mouse anti human class PSMA antibody have been described in this field, such as mAb 107-1A4 (Wang, S.et
Al. (2001) Int.J.Cancer 92:871-876) and mAb 2C9 (Kato, K.et al. (2003) Int.J.Urol.10:
439-444)。</div>
      <div id="p1045" num="1045" class="description-paragraph style-scope patent-text">The example of the anti-PSMA monoclonal antibody of the mankind includes such as on 2 18th, the 2005 entitled " Human submitted
The PCT Publication of Monoclonal Antibodies to Prostate Specific Membrane Antigen (PSMA) "
WO 01/09192 and WO 03/064606 and the initially described separation and knot of U.S.Provisional Serial 60/654,125
4A3,7F12,8C12,8A11,16F9,2A10,2C6,2F5 and 1C3 antibody of structure characterization.4A3,7F12,8C12,8A11,
The V.sub.H amino acid sequence of 16F9,2A10,2C6,2F5 and 1C3 are shown respectively in SEQ ID NO:1-9.4A3,
The V.sub.L amino acid sequence of 7F12,8C12,8A11,16F9,2A10,2C6,2F5 and 1C3 are shown respectively in SEQ ID NO:
In 10-18.</div>
      <div id="p1046" num="1046" class="description-paragraph style-scope patent-text">Other anti-PSMA antibody of the mankind include being disclosed in PCT Publication WO 03/034903 and U.S. Application No. 2004/
Antibody in 0033229.</div>
      <div id="p1047" num="1047" class="description-paragraph style-scope patent-text">NW Biotherapeutics: the hybridoma cell line selected from the group being made up of: there is ATCC accession number
The 3F5.4G6 of HB12060, the 3D7-1.I. with ATCC accession number HB12309, with ATCC accession number HB12310's
4E10-1.14、3E11(ATCC HB12488)、4D8(ATCC HB12487)、3E6(ATCC HB12486)、3C9(ATCC
HB12484)、2C7(ATCC HB12490)、1G3(ATCC HB12489)、3C4(ATCC HB12494)、3C6(ATCC
HB12491), 4D4 (ATCC HB12493), 1G9 (ATCC HB12495), 5C8B9 (ATCC HB12492) and 3G6 (ATCC
HB12485)-referring to US 6,150,508</div>
      <div id="p1048" num="1048" class="description-paragraph style-scope patent-text">PSMA Development Company/Progenics/Cytogen-Seattle Genetics: by being deposited in
MAb 3.9 that hybridoma under ATCC accession number PTA-3258 generates or by being deposited under ATCC accession number PTA-3347
Hybridoma generate mAb 10.3-US 7,850,971</div>
      <div id="p1049" num="1049" class="description-paragraph style-scope patent-text">The composition (US 20080286284, table 1) of PSMA Development Company-PSMA antibody</div>
      <div id="p1050" num="1050" class="description-paragraph style-scope patent-text">This application be the U.S. Patent Application Serial Number 10/395,894 submitted on March 21st, 2003 division (US 7,
850,971)。</div>
      <div id="p1051" num="1051" class="description-paragraph style-scope patent-text">University Hospital Freiburg, Germany-mAbs 3/A12,3/E7 and 3/F11 (Wolf P.,
et al Prostate.2010Apr 1；70(5):562-9).</div>
      <div id="p1052" num="1052" class="description-paragraph style-scope patent-text">(38) SST (somatostatin receptor；Notice that there are 5 kinds of hypotypes)</div>
      <div id="p1053" num="1053" class="description-paragraph style-scope patent-text">(38.1) SSTR2 (somatostatin receptor 2)</div>
      <div id="p1054" num="1054" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Nucleotide</u>
      </div>
      <div id="p1055" num="1055" class="description-paragraph style-scope patent-text">Genbank accession number NM_001050</div>
      <div id="p1056" num="1056" class="description-paragraph style-scope patent-text">Genbank version number NM_001050.2 GI:44890054</div>
      <div id="p1057" num="1057" class="description-paragraph style-scope patent-text">Genbank records update date: on August 19th, 2012,01:37PM</div>
      <div id="p1058" num="1058" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Polypeptide</u>
      </div>
      <div id="p1059" num="1059" class="description-paragraph style-scope patent-text">Genbank accession number NP_001041</div>
      <div id="p1060" num="1060" class="description-paragraph style-scope patent-text">Genbank version number NP_001041.1 GI:4557859</div>
      <div id="p1061" num="1061" class="description-paragraph style-scope patent-text">Genbank records update date: on August 19th, 2012,01:37PM</div>
      <div id="p1062" num="1062" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Cross reference</u>
      </div>
      <div id="p1063" num="1063" class="description-paragraph style-scope patent-text">Yamada Y.,et al Proc.Natl.Acad.Sci.U.S.A.89(1),251-255(1992)；Susini
C., et al Ann Oncol.2006Dec；17(12):1733-42</div>
      <div id="p1064" num="1064" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Other information</u>
      </div>
      <div id="p1065" num="1065" class="description-paragraph style-scope patent-text">Official signs: SSTR2</div>
      <div id="p1066" num="1066" class="description-paragraph style-scope patent-text">Other names: SRIF-1；SS2R；2 type of somatostatin receptor</div>
      <div id="p1067" num="1067" class="description-paragraph style-scope patent-text">(38.2) SSTR5 (somatostatin receptor 5)</div>
      <div id="p1068" num="1068" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Nucleotide</u>
      </div>
      <div id="p1069" num="1069" class="description-paragraph style-scope patent-text">Genbank accession number D16827</div>
      <div id="p1070" num="1070" class="description-paragraph style-scope patent-text">Genbank version number D16827.1 GI:487683</div>
      <div id="p1071" num="1071" class="description-paragraph style-scope patent-text">Genbank records update date: on August 1st, 2006,12:45PM</div>
      <div id="p1072" num="1072" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Polypeptide</u>
      </div>
      <div id="p1073" num="1073" class="description-paragraph style-scope patent-text">Genbank accession number BAA04107</div>
      <div id="p1074" num="1074" class="description-paragraph style-scope patent-text">Genbank version number BAA04107.1 GI:487684</div>
      <div id="p1075" num="1075" class="description-paragraph style-scope patent-text">Genbank records update date: on August 1st, 2006,12:45PM</div>
      <div id="p1076" num="1076" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Cross reference</u>
      </div>
      <div id="p1077" num="1077" class="description-paragraph style-scope patent-text">Yamada,Y.,et al Biochem.Biophys.Res.Commun.195(2),844-852(1993)</div>
      <div id="p1078" num="1078" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Other information</u>
      </div>
      <div id="p1079" num="1079" class="description-paragraph style-scope patent-text">Official signs: SSTR5</div>
      <div id="p1080" num="1080" class="description-paragraph style-scope patent-text">Other alias: SS-5-R</div>
      <div id="p1081" num="1081" class="description-paragraph style-scope patent-text">Other names: somatostatin receptor subtype 5；5 type of somatostatin receptor</div>
      <div id="p1082" num="1082" class="description-paragraph style-scope patent-text">(38.3)SSTR1</div>
      <div id="p1083" num="1083" class="description-paragraph style-scope patent-text">(38.4)SSTR3</div>
      <div id="p1084" num="1084" class="description-paragraph style-scope patent-text">(38.5)SSTR4</div>
      <div id="p1085" num="1085" class="description-paragraph style-scope patent-text">Two seed units of AvB6- (39+40)</div>
      <div id="p1086" num="1086" class="description-paragraph style-scope patent-text">(39) ITGAV (integral protein, α V；</div>
      <div id="p1087" num="1087" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Nucleotide</u>
      </div>
      <div id="p1088" num="1088" class="description-paragraph style-scope patent-text">Genbank accession number M14648J02826M18365</div>
      <div id="p1089" num="1089" class="description-paragraph style-scope patent-text">Genbank version number M14648.1 GI:340306</div>
      <div id="p1090" num="1090" class="description-paragraph style-scope patent-text">Genbank records update date: on June 23rd, 2010,08:56AM</div>
      <div id="p1091" num="1091" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Polypeptide</u>
      </div>
      <div id="p1092" num="1092" class="description-paragraph style-scope patent-text">Genbank accession number AAA36808</div>
      <div id="p1093" num="1093" class="description-paragraph style-scope patent-text">Genbank version number AAA36808.1 GI:340307</div>
      <div id="p1094" num="1094" class="description-paragraph style-scope patent-text">Genbank records update date: on June 23rd, 2010,08:56AM</div>
      <div id="p1095" num="1095" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Cross reference</u>
      </div>
      <div id="p1096" num="1096" class="description-paragraph style-scope patent-text">Suzuki S.,et al Proc.Natl.Acad.Sci.U.S.A.83(22),8614-8618(1986)</div>
      <div id="p1097" num="1097" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Other information</u>
      </div>
      <div id="p1098" num="1098" class="description-paragraph style-scope patent-text">Official signs: ITGAV</div>
      <div id="p1099" num="1099" class="description-paragraph style-scope patent-text">Other alias: CD51, MSK8, VNRA, VTNR</div>
      <div id="p1100" num="1100" class="description-paragraph style-scope patent-text">Other names: the antigen identified by monoclonal antibody L230；Integral protein α V；Integral protein α V β 3；Integrate egg
It is white, α V (Vitronectic receptor, α polypeptide, antigens c D51)；Vitronectic receptor α subelement</div>
      <div id="p1101" num="1101" class="description-paragraph style-scope patent-text">(40) ITGB6 (integral protein, β 6)</div>
      <div id="p1102" num="1102" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Nucleotide</u>
      </div>
      <div id="p1103" num="1103" class="description-paragraph style-scope patent-text">Genbank accession number NM_000888</div>
      <div id="p1104" num="1104" class="description-paragraph style-scope patent-text">Genbank version number .NM_000888.3 GI:9966771</div>
      <div id="p1105" num="1105" class="description-paragraph style-scope patent-text">Genbank records update date: on June 27th, 2012,12:46AM</div>
      <div id="p1106" num="1106" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Polypeptide</u>
      </div>
      <div id="p1107" num="1107" class="description-paragraph style-scope patent-text">Genbank accession number NP_000879</div>
      <div id="p1108" num="1108" class="description-paragraph style-scope patent-text">Genbank version number NP_000879.2 GI:9625002</div>
      <div id="p1109" num="1109" class="description-paragraph style-scope patent-text">Genbank records update date: on June 27th, 2012,12:46AM</div>
      <div id="p1110" num="1110" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Cross reference</u>
      </div>
      <div id="p1111" num="1111" class="description-paragraph style-scope patent-text">Sheppard D.J.,et al Biol.Chem.265(20),11502-11507(1990)</div>
      <div id="p1112" num="1112" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Other information</u>
      </div>
      <div id="p1113" num="1113" class="description-paragraph style-scope patent-text">Official signs: ITGB6</div>
      <div id="p1114" num="1114" class="description-paragraph style-scope patent-text">Other names: integral protein β 6</div>
      <div id="p1115" num="1115" class="description-paragraph style-scope patent-text">Antibody</div>
      <div id="p1116" num="1116" class="description-paragraph style-scope patent-text">Hybridoma cell clone the body 6.3G9 and 6.8G6 of Biogen:US 7,943,742- by ATCC preservation, accession number
Respectively ATCC PTA-3649 and -3645.</div>
      <div id="p1117" num="1117" class="description-paragraph style-scope patent-text">Biogen:US7,465,449- in some embodiments, antibody include with by hybridoma 6.1A8,
The identical heavy chain of antibody that 6.3G9,6.8G6,6.2B1,6.2B10,6.2A1,6.2E5,7.1G10,7.7G5 or 7.1C5 are generated
And light chain polypeptide sequence.</div>
      <div id="p1118" num="1118" class="description-paragraph style-scope patent-text">Centocor (J&amp;J): US7,550,142；US7,163,681</div>
      <div id="p1119" num="1119" class="description-paragraph style-scope patent-text">For example, in US 7,550,142-there is the amino comprising being illustrated in SEQ ID NO:7 and SEQ ID NO:8
The human heavy chain of acid sequence and the antibody in human light chain variable region.</div>
      <div id="p1120" num="1120" class="description-paragraph style-scope patent-text">Seattle Genetics:15H3 (Ryan MC., et al Cancer Res on April 15th, 2012；72 (8 increasings
Periodical): 4630)</div>
      <div id="p1121" num="1121" class="description-paragraph style-scope patent-text">(41) CEACAM5 (the relevant cell adhesion molecule 5 of carcinomebryonic antigen)</div>
      <div id="p1122" num="1122" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Nucleotide</u>
      </div>
      <div id="p1123" num="1123" class="description-paragraph style-scope patent-text">Genbank accession number M17303</div>
      <div id="p1124" num="1124" class="description-paragraph style-scope patent-text">Genbank version number M17303.1 GI:178676</div>
      <div id="p1125" num="1125" class="description-paragraph style-scope patent-text">Genbank records update date: on June 23rd, 2010,08:47AM</div>
      <div id="p1126" num="1126" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Polypeptide</u>
      </div>
      <div id="p1127" num="1127" class="description-paragraph style-scope patent-text">Genbank accession number AAB59513</div>
      <div id="p1128" num="1128" class="description-paragraph style-scope patent-text">Genbank version number AAB59513.1 GI:178677</div>
      <div id="p1129" num="1129" class="description-paragraph style-scope patent-text">Genbank records update date: on June 23rd, 2010,08:47AM</div>
      <div id="p1130" num="1130" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Cross reference</u>
      </div>
      <div id="p1131" num="1131" class="description-paragraph style-scope patent-text">Beauchemin N.,et al Mol.Cell.Biol.7(9),3221-3230(1987)</div>
      <div id="p1132" num="1132" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Other information</u>
      </div>
      <div id="p1133" num="1133" class="description-paragraph style-scope patent-text">Official signs: CEACAM5</div>
      <div id="p1134" num="1134" class="description-paragraph style-scope patent-text">Other alias: CD66e, CEA</div>
      <div id="p1135" num="1135" class="description-paragraph style-scope patent-text">Other names: tire just antigen 1 00</div>
      <div id="p1136" num="1136" class="description-paragraph style-scope patent-text">Antibody</div>
      <div id="p1137" num="1137" class="description-paragraph style-scope patent-text">AstraZeneca-MedImmune:US 20100330103；US20080057063；</div>
      <div id="p1138" num="1138" class="description-paragraph style-scope patent-text">US20020142359</div>
      <div id="p1139" num="1139" class="description-paragraph style-scope patent-text">Such as with complementary determining region (CDR) and following sequence of antibody: heavy chain； CDR1-DNYMH,CDR2-
WIDPENGDTE YAPKFRG,CDR3-LIYAGYLAMD Y；With light chain CDR1-SASSSVTYMH, CDR2-STSNLAS, CDR3-
QQRSTYPLT。</div>
      <div id="p1140" num="1140" class="description-paragraph style-scope patent-text">Preservation be European Cell Culture Collection (European Collection of Cell Cultures,
ECACC hybridoma 806.077), deposit number 96022936.</div>
      <div id="p1141" num="1141" class="description-paragraph style-scope patent-text">Research Corporation Technologies,Inc.:US5,047,507</div>
      <div id="p1142" num="1142" class="description-paragraph style-scope patent-text">Bayer Corporation:US6,013,772</div>
      <div id="p1143" num="1143" class="description-paragraph style-scope patent-text">BioAlliance:US7,982,017；US7,674,605</div>
      <div id="p1144" num="1144" class="description-paragraph style-scope patent-text">·US 7,674,605</div>
      <div id="p1145" num="1145" class="description-paragraph style-scope patent-text">Comprising the amino acid sequence from SEQ ID NO:1 weight chain variabl area sequence and from SEQ ID NO:2's
The antibody of the light-chain variable sequence of amino acid sequence.</div>
      <div id="p1146" num="1146" class="description-paragraph style-scope patent-text">Comprising the amino acid sequence from SEQ ID NO:5 weight chain variabl area sequence and from SEQ ID NO:6's
The antibody of the light-chain variable sequence of amino acid sequence.</div>
      <div id="p1147" num="1147" class="description-paragraph style-scope patent-text">Celltech Therapeutics Limited:US5,877,293</div>
      <div id="p1148" num="1148" class="description-paragraph style-scope patent-text">The Dow Chemical Company:US5,472,693；US6,417,337；US6,333,405</div>
      <div id="p1149" num="1149" class="description-paragraph style-scope patent-text">US5,472,693-for example, ATCC CRL-11215</div>
      <div id="p1150" num="1150" class="description-paragraph style-scope patent-text">US6,417,337-for example, ATCC CRL-12208</div>
      <div id="p1151" num="1151" class="description-paragraph style-scope patent-text">US6,333,405-for example, ATCC CRL-12208</div>
      <div id="p1152" num="1152" class="description-paragraph style-scope patent-text">Immunomedics, Inc:US7,534,431；US7,230,084；US7,300,644； US6,730,300；</div>
      <div id="p1153" num="1153" class="description-paragraph style-scope patent-text">US20110189085</div>
      <div id="p1154" num="1154" class="description-paragraph style-scope patent-text">It includes KASQDVGTSVA (SEQ ID NO:20) that the antibody of CDR with light chain variable region, which includes: CDR1,；
CDR2 includes WTSTRHT (SEQ ID NO:21) and CDR3 includes QQYSLYRS (SEQ ID NO:22)；</div>
      <div id="p1155" num="1155" class="description-paragraph style-scope patent-text">And it includes TYWMS (SEQ ID NO:23) that the CDR of the heavy chain variable region of the CEA antibodie, which includes: CDR1,；
CDR2 includes EIHPDSSTINYAPSLKD (SEQ ID NO:24)；And CDR3 include LYFGFPWFAY (SEQ ID NO:
25)。</div>
      <div id="p1156" num="1156" class="description-paragraph style-scope patent-text">US20100221175；US20090092598；US20070202044；US20110064653；
US20090185974；US20080069775.</div>
      <div id="p1157" num="1157" class="description-paragraph style-scope patent-text">(42) MET (met proto-oncogene；Hepatocyte growth factor receptor)</div>
      <div id="p1158" num="1158" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Nucleotide</u>
      </div>
      <div id="p1159" num="1159" class="description-paragraph style-scope patent-text">Genbank accession number M35073</div>
      <div id="p1160" num="1160" class="description-paragraph style-scope patent-text">Genbank version number M35073.1 GI:187553</div>
      <div id="p1161" num="1161" class="description-paragraph style-scope patent-text">Genbank records update date: on March 6th, 2012,11:12AM</div>
      <div id="p1162" num="1162" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Polypeptide</u>
      </div>
      <div id="p1163" num="1163" class="description-paragraph style-scope patent-text">Genbank accession number AAA59589</div>
      <div id="p1164" num="1164" class="description-paragraph style-scope patent-text">Genbank version number AAA59589.1 GI:553531</div>
      <div id="p1165" num="1165" class="description-paragraph style-scope patent-text">Genbank records update date: on March 6th, 2012,11:12AM</div>
      <div id="p1166" num="1166" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Cross reference</u>
      </div>
      <div id="p1167" num="1167" class="description-paragraph style-scope patent-text">Dean M.,et al Nature 318(6044),385-388(1985)</div>
      <div id="p1168" num="1168" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Other information</u>
      </div>
      <div id="p1169" num="1169" class="description-paragraph style-scope patent-text">Official signs: MET</div>
      <div id="p1170" num="1170" class="description-paragraph style-scope patent-text">Other alias: AUTS9, HGFR, RCCP2, c-Met</div>
      <div id="p1171" num="1171" class="description-paragraph style-scope patent-text">Other names: HGF receptor；HGF/SF receptor；SF receptor；Hepatocyte growth factor receptor；Met proto-oncogene junket
Histidine kinase；Immunohistochemistry；Hepatocyte growth factor；Tyrosine-protein kinase Met</div>
      <div id="p1172" num="1172" class="description-paragraph style-scope patent-text">Antibody</div>
      <div id="p1173" num="1173" class="description-paragraph style-scope patent-text">Abgenix/Pfizer:US20100040629</div>
      <div id="p1174" num="1174" class="description-paragraph style-scope patent-text">For example, by the hybridoma with American Type Culture Collection (ATCC) accession number PTA-5026
13.3.2 the antibody generated；The antibody generated by the hybridoma 9.1.2 with ATCC accession number PTA-5027；By having
The antibody that the hybridoma 8.70.2 of ATCC accession number PTA-5028 is generated；By with the miscellaneous of ATCC accession number PTA-5029
The antibody for handing over oncocyte 6.90.3 to generate.</div>
      <div id="p1175" num="1175" class="description-paragraph style-scope patent-text">Amgen/Pfizer:US20050054019</div>
      <div id="p1176" num="1176" class="description-paragraph style-scope patent-text">For example, comprising with amino acid sequence described in SEQ ID NO:2 heavy chain and have SEQ ID NO:4 in explain
The light chain for the amino acid sequence stated is without the antibody of signal sequence, wherein X2 is glutamic acid and X4 is serine, and X8 is
Alanine；Comprising the heavy chain with amino acid sequence described in SEQ ID NO:6 and have described in SEQ ID NO:8
The light chain of amino acid sequence is without the antibody of signal sequence；Comprising with amino acid sequence described in SEQ ID NO:10
Heavy chain and light chain with amino acid sequence described in SEQ ID NO:12 without the antibody of signal sequence；Include tool
There is the heavy chain of amino acid sequence described in SEQ ID NO:14 and with amino acid sequence described in SEQ ID NO:16
Light chain is without the antibody of signal sequence.</div>
      <div id="p1177" num="1177" class="description-paragraph style-scope patent-text">Agouron Pharmaceuticals (existing name Pfizer): US20060035907</div>
      <div id="p1178" num="1178" class="description-paragraph style-scope patent-text">Eli Lilly:US20100129369</div>
      <div id="p1179" num="1179" class="description-paragraph style-scope patent-text">Genentech:US5,686,292；US20100028337；US20100016241； US20070129301；
US20070098707；US20070092520,US20060270594； US20060134104；US20060035278；
US20050233960；US20050037431</div>
      <div id="p1180" num="1180" class="description-paragraph style-scope patent-text">US 5,686,292-is for example, ATCC HB-11894 and ATCC HB-11895</div>
      <div id="p1181" num="1181" class="description-paragraph style-scope patent-text">US 20100016241-is for example, ATCC HB-11894 (hybridoma 1A3.3.13) or HB-11895 (hybridization
Oncocyte 5D5.11.6)</div>
      <div id="p1182" num="1182" class="description-paragraph style-scope patent-text">Lu RM.,et al Biomaterials.2011Apr；32(12):3265-74.</div>
      <div id="p1183" num="1183" class="description-paragraph style-scope patent-text">Novartis:US20090175860</div>
      <div id="p1184" num="1184" class="description-paragraph style-scope patent-text">For example, the sequence of CDR1, CDR2 and CDR3 comprising heavy chain 4687 and CDR1, CDR2 and CDR3 of light chain 5097
Sequence antibody, wherein the sequence of CDR1, CDR2 and CDR3 of heavy chain 4687 are the residue of SEQ ID NO:58 respectively
26-35,50-65 and 98-102；Wherein, the sequence of CDR1, CDR2 and CDR3 of light chain 5097 are the residual of SEQ ID NO:37
Base 24-39,55-61 and 94-100.</div>
      <div id="p1185" num="1185" class="description-paragraph style-scope patent-text">Pharmacia Corporation:US20040166544</div>
      <div id="p1186" num="1186" class="description-paragraph style-scope patent-text">Pierre Fabre:US20110239316, US20110097262, US20100115639</div>
      <div id="p1187" num="1187" class="description-paragraph style-scope patent-text">Sumsung:US 20110129481-is for example, by with accession number KCLRF-BP-00219 or accession number KCLRF-
The monoclonal antibody that the hybridoma of BP-00223 generates.</div>
      <div id="p1188" num="1188" class="description-paragraph style-scope patent-text">Samsung:US 20110104176-by the hybridoma with accession number KCLRF-BP-00220 for example, produced
Raw antibody.</div>
      <div id="p1189" num="1189" class="description-paragraph style-scope patent-text">Turin University Medical College (University of Turin Medical School): DN-30Pacchiana G.,
et al J Biol Chem.2010Nov 12；285(46):36149-57</div>
      <div id="p1190" num="1190" class="description-paragraph style-scope patent-text">Pacify Dare research institute (Van Andel Research Institute): Jiao Y., et al Mol
Biotechnol.2005Sep；31(1):41-54.</div>
      <div id="p1191" num="1191" class="description-paragraph style-scope patent-text">(43) MUC1 (the relevant mucin 1 of cell surface)</div>
      <div id="p1192" num="1192" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Nucleotide</u>
      </div>
      <div id="p1193" num="1193" class="description-paragraph style-scope patent-text">Genbank accession number J05581</div>
      <div id="p1194" num="1194" class="description-paragraph style-scope patent-text">Genbank version number J05581.1 GI:188869</div>
      <div id="p1195" num="1195" class="description-paragraph style-scope patent-text">Genbank records update date: on June 23rd, 2010,08:48AM</div>
      <div id="p1196" num="1196" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Polypeptide</u>
      </div>
      <div id="p1197" num="1197" class="description-paragraph style-scope patent-text">Genbank accession number AAA59876</div>
      <div id="p1198" num="1198" class="description-paragraph style-scope patent-text">Genbank version number AAA59876.1 GI:188870</div>
      <div id="p1199" num="1199" class="description-paragraph style-scope patent-text">Genbank records update date: on June 23rd, 2010,08:48AM</div>
      <div id="p1200" num="1200" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Cross reference</u>
      </div>
      <div id="p1201" num="1201" class="description-paragraph style-scope patent-text">Gendler S.J.,et al J.Biol.Chem.265(25),15286-15293(1990)</div>
      <div id="p1202" num="1202" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Other information</u>
      </div>
      <div id="p1203" num="1203" class="description-paragraph style-scope patent-text">Official signs: MUC1</div>
      <div id="p1204" num="1204" class="description-paragraph style-scope patent-text">Other alias: RP11-263K19.2, CD227, EMA, H23AG, KL-6, MAM6, MUC-1, MUC-1/SEC,
MUC-1/X, MUC1/ZD, PEM, PEMT, PUM other names: DF3 antigen；H23 antigen；Breast cancer correlation antigen DF3；Cancer phase
Close mucoprotein；Epithelial membrane antigen (episialin)；Alveolar cell surface antigen 6；Mucin 1, cross-film；Mucin1；Peanut
Reactive uromucoid；Polymorphic epithelial mucin；The relevant mucins of tumour；The relevant epithelial membrane antigen of tumour；Tumour
Relevant mucoprotein</div>
      <div id="p1205" num="1205" class="description-paragraph style-scope patent-text">Antibody</div>
      <div id="p1206" num="1206" class="description-paragraph style-scope patent-text">AltaRex-Quest Pharma Tech:US 6,716,966-is for example, by hybridoma ATCC PTA-
The 975 Alt-1 antibody generated.</div>
      <div id="p1207" num="1207" class="description-paragraph style-scope patent-text">AltaRex-Quest Pharma Tech:US7,147,850</div>
      <div id="p1208" num="1208" class="description-paragraph style-scope patent-text">CRT:5E5-<span class="patent-image-not-available style-scope patent-text"></span>AL.,et al Glycobiology vol.16no.2pp.96–107,2006；
HMFG2–Burchell J.,et al Cancer Res.,47,5476–5482(1987)</div>
      <div id="p1209" num="1209" class="description-paragraph style-scope patent-text">Glycotope GT-MAB:GT-MAB 2.5-GEX (network address: http://www.glycotope.com/
pipeline/pankomab-gex)</div>
      <div id="p1210" num="1210" class="description-paragraph style-scope patent-text">Immunogen:US7,202,346</div>
      <div id="p1211" num="1211" class="description-paragraph style-scope patent-text">For example, antibody MJ-170: hybridoma cell line MJ-170, ATCC accession number PTA-5286；Monoclonal antibody MJ-
171: hybridoma cell line MJ-171, ATCC accession number PTA-5287；Monoclonal antibody MJ-172: hybridoma cell line MJ-
172, ATCC accession number PTA-5288；Or monoclonal antibody MJ-173: hybridoma cell line MJ-173, ATCC accession number PTA-
5302</div>
      <div id="p1212" num="1212" class="description-paragraph style-scope patent-text">Immunomedics:US 6,653,104</div>
      <div id="p1213" num="1213" class="description-paragraph style-scope patent-text">Ramot Tel Aviv Uni:US7,897,351</div>
      <div id="p1214" num="1214" class="description-paragraph style-scope patent-text">Regents Uni.CA:US 7,183,388；US20040005647；US20030077676.</div>
      <div id="p1215" num="1215" class="description-paragraph style-scope patent-text">Roche GlycArt:US8,021,856</div>
      <div id="p1216" num="1216" class="description-paragraph style-scope patent-text">Russian country's Cancer Research Center (Russian National Cancer Research Center):
Imuteran-Ivanov PK.,et al Biotechnol J.2007Jul；2(7):863-70</div>
      <div id="p1217" num="1217" class="description-paragraph style-scope patent-text">Technische Univ Braunschweig:(IIB6, HT186-B7, HT186-D11, HT186-G2,
HT200-3A-C1, HT220-M-D1, HT220-M-G8)-Thie H., et al PLoS One.2011 Jan 14；6(1):
e15921</div>
      <div id="p1218" num="1218" class="description-paragraph style-scope patent-text">(44) CA9 (carboxylic acid anhydrides enzyme IX)</div>
      <div id="p1219" num="1219" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Nucleotide</u>
      </div>
      <div id="p1220" num="1220" class="description-paragraph style-scope patent-text">Genbank accession number X66839</div>
      <div id="p1221" num="1221" class="description-paragraph style-scope patent-text">Genbank version number X66839.1 GI:1000701</div>
      <div id="p1222" num="1222" class="description-paragraph style-scope patent-text">Genbank record update date: on 2 2nd, 2011,10:15AM</div>
      <div id="p1223" num="1223" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Polypeptide</u>
      </div>
      <div id="p1224" num="1224" class="description-paragraph style-scope patent-text">Genbank accession number CAA47315</div>
      <div id="p1225" num="1225" class="description-paragraph style-scope patent-text">Genbank version number CAA47315.1 GI:1000702</div>
      <div id="p1226" num="1226" class="description-paragraph style-scope patent-text">Genbank record update date: on 2 2nd, 2011,10:15AM</div>
      <div id="p1227" num="1227" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Cross reference</u>
      </div>
      <div id="p1228" num="1228" class="description-paragraph style-scope patent-text">Pastorek J.,et al Oncogene 9(10),2877-2888(1994)</div>
      <div id="p1229" num="1229" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Other information</u>
      </div>
      <div id="p1230" num="1230" class="description-paragraph style-scope patent-text">Official signs: CA9</div>
      <div id="p1231" num="1231" class="description-paragraph style-scope patent-text">Other alias: CAIX, MN</div>
      <div id="p1232" num="1232" class="description-paragraph style-scope patent-text">Other names: CA-IX；P54/58N；RCC related antigen G250；RCC related protein G250；Carbonic acid dehydration of salt
Enzyme IX；Carbonic anhydrase 9；Carbonic acid hydrolase；Membranous antigen MN；pMW1；Clear-cell carcinoma related antigen G250</div>
      <div id="p1233" num="1233" class="description-paragraph style-scope patent-text">Antibody</div>
      <div id="p1234" num="1234" class="description-paragraph style-scope patent-text">Abgenix/Amgen:US20040018198</div>
      <div id="p1235" num="1235" class="description-paragraph style-scope patent-text">Affibody: anti-CAIX affinity body (Anti-CAIX Affibody) molecule</div>
      <div id="p1236" num="1236" class="description-paragraph style-scope patent-text">(http://www.affibody.com/en/Product-Portfolio/Pipeline/)</div>
      <div id="p1237" num="1237" class="description-paragraph style-scope patent-text">Bayer:US7,462,696</div>
      <div id="p1238" num="1238" class="description-paragraph style-scope patent-text">Bayer/Morphosys:3ee9mAb-Petrul HM., et al Mol Cancer Ther.2012 Feb；11
(2):340-9</div>
      <div id="p1239" num="1239" class="description-paragraph style-scope patent-text">Harvard medical school (Harvard Medical School): antibody G10, G36, G37, G39, G45, G57, G106,
G119, G6, G27, G40 and G125.Xu C.,et al PLoS One.2010Mar 10；5(3):e9625</div>
      <div id="p1240" num="1240" class="description-paragraph style-scope patent-text">Virological investigation institute, the academy of sciences, Slovakia (Institute of Virology, Slovak Academy of
Sciences)(Bayer)-US5,955,075</div>
      <div id="p1241" num="1241" class="description-paragraph style-scope patent-text">For example, M75-ATCC accession number HB 11128 or MN12-ATCC accession number HB 11647</div>
      <div id="p1242" num="1242" class="description-paragraph style-scope patent-text">Virological investigation institute, the academy of sciences, Slovakia (Institute of Virology, Slovak Academy of
Sciences): US7,816,493</div>
      <div id="p1243" num="1243" class="description-paragraph style-scope patent-text">For example, the M75 monoclonal antibody secreted by hybridoma VU-M75, the VU-M75 is in ATCC HB 11128
Under be deposited in American Type Culture Collection；Or the V/10 monoclonal antibody secreted by hybridoma V/10-VU, in V/
Gent, the Laboratorium of the Universeit Gent of Belgium are deposited under 10-VU accession number LMBP 6009CB
The Belgian microbial synergy collection of voor Moleculaire Bioloqie-Plasmidencollectie (LMBP)
The International Depository Authority of (Belgian Coordinated Collection of Microorganisms, BCCM)
(International Depository Authority)。</div>
      <div id="p1244" num="1244" class="description-paragraph style-scope patent-text">Virological investigation institute, the academy of sciences, Slovakia US20080177046；US20080176310；
US20080176258；US20050031623</div>
      <div id="p1245" num="1245" class="description-paragraph style-scope patent-text">Novartis:US20090252738</div>
      <div id="p1246" num="1246" class="description-paragraph style-scope patent-text">Wilex:US7,691,375-for example, the antibody generated by hybridoma cell line DSM ASC 2526.</div>
      <div id="p1247" num="1247" class="description-paragraph style-scope patent-text">Wilex:US20110123537；Rencarex:Kennett RH.,et al Curr Opin Mol
Ther.2003Feb；5(1):70-5</div>
      <div id="p1248" num="1248" class="description-paragraph style-scope patent-text">Xencor:US20090162382</div>
      <div id="p1249" num="1249" class="description-paragraph style-scope patent-text">(45) EGFRvIII (EGF-R ELISA (EGFR), transcriptional variants 3,</div>
      <div id="p1250" num="1250" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Nucleotide</u>
      </div>
      <div id="p1251" num="1251" class="description-paragraph style-scope patent-text">Genbank accession number NM_201283</div>
      <div id="p1252" num="1252" class="description-paragraph style-scope patent-text">Genbank version number NM_201283.1GI:41327733</div>
      <div id="p1253" num="1253" class="description-paragraph style-scope patent-text">Genbank records update date: on September 30th, 2012,01:47PM</div>
      <div id="p1254" num="1254" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Polypeptide</u>
      </div>
      <div id="p1255" num="1255" class="description-paragraph style-scope patent-text">Genbank accession number NP_958440</div>
      <div id="p1256" num="1256" class="description-paragraph style-scope patent-text">Genbank version number NP_958440.1GI:41327734</div>
      <div id="p1257" num="1257" class="description-paragraph style-scope patent-text">Genbank records update date: on September 30th, 2012,01:47PM</div>
      <div id="p1258" num="1258" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Cross reference</u>
      </div>
      <div id="p1259" num="1259" class="description-paragraph style-scope patent-text">Batra SK.,et al Cell Growth Differ 1995；6:1251–1259.</div>
      <div id="p1260" num="1260" class="description-paragraph style-scope patent-text">Antibody:</div>
      <div id="p1261" num="1261" class="description-paragraph style-scope patent-text">US7,628,986 and US7,736,644 (Amgen)</div>
      <div id="p1262" num="1262" class="description-paragraph style-scope patent-text">For example, being selected from the heavy chain variable amino acid sequence for the group being made of SEQ ID NO:142 and variant and being selected from
By the chain variable region amino acid sequence for the group that SEQ ID NO:144 and variant form.</div>
      <div id="p1263" num="1263" class="description-paragraph style-scope patent-text">US20100111979(Amgen)</div>
      <div id="p1264" num="1264" class="description-paragraph style-scope patent-text">For example, the antibody comprising containing heavy chain amino acid sequence below:</div>
      <div id="p1265" num="1265" class="description-paragraph style-scope patent-text">By selected from by being used for antibody 13.1.2 (SEQ ID NO:138), 131 (SEQ ID NO:2), 170 (SEQ ID
NO:4)、150(SEQ ID NO:5)、095(SEQ ID NO:7)、250(SEQ ID NO:9)、139(SEQ ID NO:10)、
211 (SEQ ID NO:12), 124 (SEQ ID NO:13), 318 (SEQ ID NO:15), 342 (SEQ ID NO:16) and 333
The CDR1 of the sequence composition of the group of the amino acid sequence composition in the area CDR1 of (SEQ ID NO:17)；</div>
      <div id="p1266" num="1266" class="description-paragraph style-scope patent-text">Selected from by for antibody 13.1.2 (SEQ ID NO:138), 131 (SEQ ID NO:2), 170 (SEQ ID NO:
4)、150(SEQ ID NO:5)、095(SEQ ID NO:7)、250(SEQ ID NO:9)、 139(SEQ ID NO:10)、211
(SEQ ID NO:12), 124 (SEQ ID NO:13), 318 (SEQ ID NO:15), 342 (SEQ ID NO:16 and 333 (SEQ
ID NO:17) the area CDR2 amino acid sequence composition group sequence composition CDR2；And</div>
      <div id="p1267" num="1267" class="description-paragraph style-scope patent-text">Selected from by for antibody 13.1.2 (SEQ ID NO:138), 131 (SEQ ID NO:2), 170 (SEQ ID NO:
4)、150(SEQ ID NO:5)、095(SEQ ID NO:7)、250(SEQ ID NO:9)、 139(SEQ ID NO:10)、211
(SEQ ID NO:12), 124 (SEQ ID NO:13), 318 (SEQ ID NO:15), 342 (SEQ ID NO:16 and 333 (SEQ
ID NO:17) the area CDR3 amino acid sequence composition group sequence composition CDR3.</div>
      <div id="p1268" num="1268" class="description-paragraph style-scope patent-text">US20090240038(Amgen)</div>
      <div id="p1269" num="1269" class="description-paragraph style-scope patent-text">Include amino acid identical with the amino acid sequence in the group being made up of at least 90% for example, having
The heavy chain polypeptide of sequence or the antibody of at least one of light chain polypeptide: SEQ ID NO:2, SEQ ID NO:19, SEQ ID
NO:142, SEQ ID NO:144 and their any combination.</div>
      <div id="p1270" num="1270" class="description-paragraph style-scope patent-text">US20090175887(Amgen)</div>
      <div id="p1271" num="1271" class="description-paragraph style-scope patent-text">For example, having the anti-of the heavy chain amino acid sequence selected from the group being made of the heavy chain amino acid sequence of following antibody
Body: 13.1.2 (SEQ ID NO:138), 131 (SEQ ID NO:2), 170 (SEQ ID NO:4), 150 (SEQ ID NO:5),
095(SEQ ID NO:7)、250(SEQ ID NO:9)、 139(SEQ ID NO:10)、211(SEQ ID NO:12)、124
(SEQ ID NO:13), 318 (SEQ ID NO:15), 342 (SEQ ID NO:16 and 333 (SEQ ID NO:17).</div>
      <div id="p1272" num="1272" class="description-paragraph style-scope patent-text">US20090156790(Amgen)</div>
      <div id="p1273" num="1273" class="description-paragraph style-scope patent-text">For example, the antibody with heavy chain polypeptide and light chain polypeptide, wherein at least one of heavy chain or light chain polypeptide packet
Containing amino acid sequence identical with the amino acid sequence in the group being made up of at least 90%: SEQ ID NO:2, SEQ
ID NO:19, SEQ ID NO:142, SEQ ID NO:144 and their any combination.</div>
      <div id="p1274" num="1274" class="description-paragraph style-scope patent-text">US20090155282, US20050059087 and US20050053608 (Amgen)</div>
      <div id="p1275" num="1275" class="description-paragraph style-scope patent-text">For example, having the heavy chain amino acid sequence in the group that the heavy chain amino acid sequence by following antibody forms
Antibody: 13.1.2 (SEQ ID NO:138), 131 (SEQ ID NO:2), 170 (SEQ ID NO:4), 150 (SEQ ID NO:
5)、095(SEQ ID NO:7)、250(SEQ ID NO:9)、 139(SEQ ID NO:10)、211(SEQ ID NO:12)、124
(SEQ ID NO:13), 318 (SEQ ID NO:15), 342 (SEQ ID NO:16) and 333 (SEQ ID NO:17).</div>
      <div id="p1276" num="1276" class="description-paragraph style-scope patent-text">MR1-1(US7,129,332；Duke)</div>
      <div id="p1277" num="1277" class="description-paragraph style-scope patent-text">For example, with SEQ ID NO.18 sequence variant antibodies, wherein replaced in CDR3VH S98P-T99Y with
And F92W is replaced in CDR3VL.</div>
      <div id="p1278" num="1278" class="description-paragraph style-scope patent-text">L8A4, H10, Y10 (Wikstrand CJ., et al Cancer Res.1995Jul 15；55(14):3140-8；
Duke)</div>
      <div id="p1279" num="1279" class="description-paragraph style-scope patent-text">US20090311803 (Ha Fu university)</div>
      <div id="p1280" num="1280" class="description-paragraph style-scope patent-text">For example, for the SEQ ID NO:9 of antibody heavy chain variable region and for chain variable region amino acid sequence
SEQ ID NO:3。</div>
      <div id="p1281" num="1281" class="description-paragraph style-scope patent-text">US20070274991 (EMD72000, also referred to as matuzumab；Ha Fu university)</div>
      <div id="p1282" num="1282" class="description-paragraph style-scope patent-text">For example, being respectively used to the SEQ ID NO:3&amp;9 of light chain and heavy chain</div>
      <div id="p1283" num="1283" class="description-paragraph style-scope patent-text">US6,129,915(Schering)</div>
      <div id="p1284" num="1284" class="description-paragraph style-scope patent-text">For example, SEQ.ID NO:1,2,3,4,5 and 6.</div>
      <div id="p1285" num="1285" class="description-paragraph style-scope patent-text">mAb CH12-Wang H.,et al FASEB J.2012Jan；26 (1): (Shanghai Inst. of Tumor 73-80
(Shanghai Cancer Institute))。</div>
      <div id="p1286" num="1286" class="description-paragraph style-scope patent-text">RAbDMvIII-Gupta P.,et al BMC Biotechnol.2010Oct 7；10:72 (Stanford University doctor
Center).</div>
      <div id="p1287" num="1287" class="description-paragraph style-scope patent-text">mAb Ua30-Ohman L.,et al Tumour Biol.2002Mar-Apr；23 (2): (Uppsala 61-9
University).</div>
      <div id="p1288" num="1288" class="description-paragraph style-scope patent-text">Han DG.,et al Nan Fang Yi Ke Da Xue Xue Bao.2010Jan；30 (1): 25-9 (is handed in Xi'an
Logical university).</div>
      <div id="p1289" num="1289" class="description-paragraph style-scope patent-text">(46) CD33 (CD33 molecule)</div>
      <div id="p1290" num="1290" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Nucleotide</u>
      </div>
      <div id="p1291" num="1291" class="description-paragraph style-scope patent-text">Genbank accession number M_23197</div>
      <div id="p1292" num="1292" class="description-paragraph style-scope patent-text">Genbank version number NM_23197.1 GI:180097</div>
      <div id="p1293" num="1293" class="description-paragraph style-scope patent-text">Genbank records update date: on June 23rd, 2010,08:47AM</div>
      <div id="p1294" num="1294" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Polypeptide</u>
      </div>
      <div id="p1295" num="1295" class="description-paragraph style-scope patent-text">Genbank accession number AAA51948</div>
      <div id="p1296" num="1296" class="description-paragraph style-scope patent-text">Genbank version number AAA51948.1 GI:188098</div>
      <div id="p1297" num="1297" class="description-paragraph style-scope patent-text">Genbank records update date: on June 23rd, 2010,08:47AM</div>
      <div id="p1298" num="1298" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Cross reference</u>
      </div>
      <div id="p1299" num="1299" class="description-paragraph style-scope patent-text">Simmons D.,et al J.Immunol.141(8),2797-2800(1988)</div>
      <div id="p1300" num="1300" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Other information</u>
      </div>
      <div id="p1301" num="1301" class="description-paragraph style-scope patent-text">Official signs: CD33</div>
      <div id="p1302" num="1302" class="description-paragraph style-scope patent-text">Other alias: SIGLEC-3, SIGLEC3, p67</div>
      <div id="p1303" num="1303" class="description-paragraph style-scope patent-text">Other names: CD33 antigen (gp67)；gp67；Bone marrow cell surface antigen CD33；Sialic acid Ig sample agglutinin 3；
Sialic acid Ig sample agglutinin</div>
      <div id="p1304" num="1304" class="description-paragraph style-scope patent-text">Antibody</div>
      <div id="p1305" num="1305" class="description-paragraph style-scope patent-text">H195 (lintuzumab)-Raza A., et al Leuk Lymphoma.2009Aug；50(8):1336-44；
US6,759,045(Seattle Genetics/Immunomedics)</div>
      <div id="p1306" num="1306" class="description-paragraph style-scope patent-text">MAb OKT9:Sutherland, D.R.et al.Proc Natl Acad Sci USA 78 (7): 4515-4519
1981,Schneider,C.,et al J Biol Chem 257,8516-8522(1982)</div>
      <div id="p1307" num="1307" class="description-paragraph style-scope patent-text">MAb E6:Hoogenboom, H.R., et al J Immunol 144,3211-3217 (1990)</div>
      <div id="p1308" num="1308" class="description-paragraph style-scope patent-text">US6,590,088 (human genome science (Human Genome Sciences))</div>
      <div id="p1309" num="1309" class="description-paragraph style-scope patent-text">For example, SEQ ID NO:1 and 2 and ATCC accession number 97521</div>
      <div id="p1310" num="1310" class="description-paragraph style-scope patent-text">US7,557,189(Immunogen)</div>
      <div id="p1311" num="1311" class="description-paragraph style-scope patent-text">For example, the antibody comprising heavy chain variable region and light chain variable region or their segment, which includes tool
There are three kinds of CDR of the amino acid sequence of SEQ ID NO:1-3, which includes the amino with SEQ ID NO:4-6
Three kinds of CDR of acid sequence.</div>
      <div id="p1312" num="1312" class="description-paragraph style-scope patent-text">(47) CD19 (CD19 molecule)</div>
      <div id="p1313" num="1313" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Nucleotide</u>
      </div>
      <div id="p1314" num="1314" class="description-paragraph style-scope patent-text">Genbank accession number NM_001178098</div>
      <div id="p1315" num="1315" class="description-paragraph style-scope patent-text">Genbank version number NM_001178098.1 GI:296010920</div>
      <div id="p1316" num="1316" class="description-paragraph style-scope patent-text">Genbank records update date: on September 10th, 2012,12:43AM</div>
      <div id="p1317" num="1317" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Polypeptide</u>
      </div>
      <div id="p1318" num="1318" class="description-paragraph style-scope patent-text">Genbank accession number NP_001171569</div>
      <div id="p1319" num="1319" class="description-paragraph style-scope patent-text">Genbank version number NP_001171569.1 GI:296010921</div>
      <div id="p1320" num="1320" class="description-paragraph style-scope patent-text">Genbank records update date: on September 10th, 2012,12:43AM</div>
      <div id="p1321" num="1321" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Cross reference</u>
      </div>
      <div id="p1322" num="1322" class="description-paragraph style-scope patent-text">Tedder TF.,et al J.Immunol.143(2):712-7(1989)</div>
      <div id="p1323" num="1323" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Other information</u>
      </div>
      <div id="p1324" num="1324" class="description-paragraph style-scope patent-text">Official signs: CD19</div>
      <div id="p1325" num="1325" class="description-paragraph style-scope patent-text">Other alias: B4, CVID3</div>
      <div id="p1326" num="1326" class="description-paragraph style-scope patent-text">Other names: bone-marrow-derived lymphocyte CD19；Bone-marrow-derived lymphocyte surface antigen B4；T cell surface antigen Leu-12；Differentiation
Antigens c D19</div>
      <div id="p1327" num="1327" class="description-paragraph style-scope patent-text">Antibody</div>
      <div id="p1328" num="1328" class="description-paragraph style-scope patent-text">Immunogen:HuB4-Al-Katib AM., et al Clin Cancer Res.2009Jun 15；15(12):
4038-45.</div>
      <div id="p1329" num="1329" class="description-paragraph style-scope patent-text">4G7:K ü gler M., et al Protein Eng Des Sel.2009Mar；22(3):135-47</div>
      <div id="p1330" num="1330" class="description-paragraph style-scope patent-text">For example, Knappik, A.et al.J Mol Biol 2000Feb；296 (1): the sequence in Fig. 3 in 57-86</div>
      <div id="p1331" num="1331" class="description-paragraph style-scope patent-text">AstraZeneca/MedImmune:MEDI-551-Herbst R., et al J Pharmacol Exp
Ther.2010Oct；335(1):213-22</div>
      <div id="p1332" num="1332" class="description-paragraph style-scope patent-text">Glenmark Pharmaceuticals:GBR-401-Hou S., et al Mol Cancer Ther 2011
November 10 (meeting digest supplementary issue (Meeting Abstract Supplement)) C164</div>
      <div id="p1333" num="1333" class="description-paragraph style-scope patent-text">US7,109,304(Immunomedics)</div>
      <div id="p1334" num="1334" class="description-paragraph style-scope patent-text">For example, the antibody of the sequence comprising hA19Vk (SEQ ID NO:7) and the sequence of hA19VH (SEQ ID NO:10)</div>
      <div id="p1335" num="1335" class="description-paragraph style-scope patent-text">US7,902,338(Immunomedics)</div>
      <div id="p1336" num="1336" class="description-paragraph style-scope patent-text">For example, comprising complementary determining region of light chain CDR sequence and heavy CDR sequences, but also include one or more frames
The human antibodies frame (FR) and constant region that area's amino acid residue is replaced by the associated frame members region sequence of parent murine antibodies
The antibody of sequence or their antigen-binding fragment, the complementary determining region of light chain CDR sequence include SEQ ID NO:16
(KASQSVDYDGDSYLN) CDR1；The CDR2 of SEQ ID NO:17 (DASNLVS)；With SEQ ID NO:18
(QQSTEDPWT) CDR3；The heavy CDR sequences include the CDR1 of SEQ ID NO:19 (SYWMN)；SEQ ID NO:20
(QIWPGDGDTNYNGKFKG) CDR2；With the CDR3 of SEQ ID NO:21 (RETTTVGRYYYAMDY), and wherein, institute
The FR residue for stating displacement includes displacement of the serine to phenylalanine at the Kabat residue 91 of heavy chain variable region.</div>
      <div id="p1337" num="1337" class="description-paragraph style-scope patent-text">Medarex:MDX-1342-Cardarelli PM., et al Cancer Immunol Immunother.2010
Feb；59(2):257-65.</div>
      <div id="p1338" num="1338" class="description-paragraph style-scope patent-text">MorphoSys/Xencor:MOR-208/XmAb-5574-Zalevsky J., et al Blood.2009 Apr
16；113(16):3735-43</div>
      <div id="p1339" num="1339" class="description-paragraph style-scope patent-text">US7,968,687(Seattle Genetics)</div>
      <div id="p1340" num="1340" class="description-paragraph style-scope patent-text">Antibody or antigen-binding fragment comprising heavy-chain variable domains and light variable domains, the weight chain variable knot
Structure domain includes the amino acid sequence of SEQ ID NO:9, which includes the amino acid sequence of SEQ ID NO:24
Column.</div>
      <div id="p1341" num="1341" class="description-paragraph style-scope patent-text">4G7chim-Lang P., et al Blood.2004 May 15；103 (10): (T ü bingen is big by 3982-5
It learns)</div>
      <div id="p1342" num="1342" class="description-paragraph style-scope patent-text">For example, Fig. 6 and SEQ ID No:80 of US20120082664</div>
      <div id="p1343" num="1343" class="description-paragraph style-scope patent-text">Medical College of Zhejiang Univ. (Zhejiang University School of Medicine): 2E8-Zhang J.,
et al J Drug Target.2010Nov；18(9):675-8</div>
      <div id="p1344" num="1344" class="description-paragraph style-scope patent-text">(48) IL2RA (IL-2R, α)；NCBI reference sequences: NM_000417.2)；</div>
      <div id="p1345" num="1345" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Nucleotide</u>
      </div>
      <div id="p1346" num="1346" class="description-paragraph style-scope patent-text">Genbank accession number NM_000417</div>
      <div id="p1347" num="1347" class="description-paragraph style-scope patent-text">Genbank version number NM_000417.2 GI:269973860</div>
      <div id="p1348" num="1348" class="description-paragraph style-scope patent-text">Genbank records update date: on September 9th, 2012,04:59PM</div>
      <div id="p1349" num="1349" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Polypeptide</u>
      </div>
      <div id="p1350" num="1350" class="description-paragraph style-scope patent-text">Genbank accession number NP_000408</div>
      <div id="p1351" num="1351" class="description-paragraph style-scope patent-text">Genbank version number NP_000408.1 GI:4557667</div>
      <div id="p1352" num="1352" class="description-paragraph style-scope patent-text">Genbank records update date: on September 9th, 2012,04:59PM</div>
      <div id="p1353" num="1353" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Cross reference</u>
      </div>
      <div id="p1354" num="1354" class="description-paragraph style-scope patent-text">Kuziel W.A.,et al J.Invest.Dermatol.94(6SUPPL),27S-32S(1990)</div>
      <div id="p1355" num="1355" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Other information</u>
      </div>
      <div id="p1356" num="1356" class="description-paragraph style-scope patent-text">Official signs: IL2RA</div>
      <div id="p1357" num="1357" class="description-paragraph style-scope patent-text">Other alias: RP11-536K7.1, CD25, IDDM10, IL2R, TCGFR</div>
      <div id="p1358" num="1358" class="description-paragraph style-scope patent-text">Other names: FIL-2 receptor alpha subelement；IL-2-RA；IL-2R α subelement；IL2-RA；TAC antigen；Bai Jie
Plain-2 acceptor α subelement；p55</div>
      <div id="p1359" num="1359" class="description-paragraph style-scope patent-text">Antibody</div>
      <div id="p1360" num="1360" class="description-paragraph style-scope patent-text">US6,383,487 (Novartis/UCL: Bacchus monoclonal antibody (Baxilisimab) [Simulect])</div>
      <div id="p1361" num="1361" class="description-paragraph style-scope patent-text">US6,521,230 (Novartis/UCL: Bacchus monoclonal antibody (Baxilisimab) [Simulect])</div>
      <div id="p1362" num="1362" class="description-paragraph style-scope patent-text">For example, the antibody with antigen binding site includes at least one structural domain, which includes to have
The CDR1 of amino acid sequence in SEQ.ID.NO:7, the CDR2 with the amino acid sequence in SEQ.ID.NO:8 and have
The CDR3 of amino acid sequence in SEQ.ID.NO:9；Or the sequence of described CDR1, CDR2 and CDR3 integrally include with
The identical amino acid sequence of whole sequence at least 90% of SEQ.ID.NO:7,8 and 9.</div>
      <div id="p1363" num="1363" class="description-paragraph style-scope patent-text">Daclizumab-Rech AJ.,et al Ann N Y Acad Sci.2009Sep；1174:99-106(Roche)
(49) AXL (axl receptor tyrosine kinase)</div>
      <div id="p1364" num="1364" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Nucleotide</u>
      </div>
      <div id="p1365" num="1365" class="description-paragraph style-scope patent-text">Genbank accession number M76125</div>
      <div id="p1366" num="1366" class="description-paragraph style-scope patent-text">Genbank version number M76125.1GI:292869</div>
      <div id="p1367" num="1367" class="description-paragraph style-scope patent-text">Genbank records update date: on June 23rd, 2010,08:53AM</div>
      <div id="p1368" num="1368" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Polypeptide</u>
      </div>
      <div id="p1369" num="1369" class="description-paragraph style-scope patent-text">Genbank accession number AAA61243</div>
      <div id="p1370" num="1370" class="description-paragraph style-scope patent-text">Genbank version number AAA61243.1 GI:29870</div>
      <div id="p1371" num="1371" class="description-paragraph style-scope patent-text">Genbank records update date: on June 23rd, 2010,08:53AM</div>
      <div id="p1372" num="1372" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Cross reference</u>
      </div>
      <div id="p1373" num="1373" class="description-paragraph style-scope patent-text">O'Bryan J.P.,et al Mol.Cell.Biol.11(10),5016-5031(1991)；Bergsagel
P.L.,et al J.Immunol.148(2),590-596(1992)</div>
      <div id="p1374" num="1374" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Other information</u>
      </div>
      <div id="p1375" num="1375" class="description-paragraph style-scope patent-text">Official signs: AXL</div>
      <div id="p1376" num="1376" class="description-paragraph style-scope patent-text">Other alias: JTK11, UFO</div>
      <div id="p1377" num="1377" class="description-paragraph style-scope patent-text">Other names: AXL proto-oncogene；AXL transforming sequence/gene；Proto-oncogene AXL；Tyrosine-protein kinase
Receptor UFO</div>
      <div id="p1378" num="1378" class="description-paragraph style-scope patent-text">Antibody</div>
      <div id="p1379" num="1379" class="description-paragraph style-scope patent-text">YW327.6S2-Ye X.,et al Oncogene.2010Sep 23；29(38):5254-64.(Genentech)
BergenBio:BGB324(http://www.bergenbio.com/BGB324)</div>
      <div id="p1380" num="1380" class="description-paragraph style-scope patent-text">(50) CD30-TNFRSF8 (tumor necrosis factor receptor super family, member 8)</div>
      <div id="p1381" num="1381" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Nucleotide</u>
      </div>
      <div id="p1382" num="1382" class="description-paragraph style-scope patent-text">Genbank accession number M83554</div>
      <div id="p1383" num="1383" class="description-paragraph style-scope patent-text">Genbank version number M83554.1 GI:180095</div>
      <div id="p1384" num="1384" class="description-paragraph style-scope patent-text">Genbank records update date: on June 23rd, 2010,08:53AM</div>
      <div id="p1385" num="1385" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Polypeptide</u>
      </div>
      <div id="p1386" num="1386" class="description-paragraph style-scope patent-text">Genbank accession number AAA51947</div>
      <div id="p1387" num="1387" class="description-paragraph style-scope patent-text">Genbank version number AAA51947.1 GI:180096</div>
      <div id="p1388" num="1388" class="description-paragraph style-scope patent-text">Genbank records update date: on June 23rd, 2010,08:53AM</div>
      <div id="p1389" num="1389" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Cross reference</u>
      </div>
      <div id="p1390" num="1390" class="description-paragraph style-scope patent-text">Durkop H.,et al Cell 68(3),421-427(1992)</div>
      <div id="p1391" num="1391" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Other information</u>
      </div>
      <div id="p1392" num="1392" class="description-paragraph style-scope patent-text">Official signs: TNFRSF8</div>
      <div id="p1393" num="1393" class="description-paragraph style-scope patent-text">Other alias: CD30, D1S166E, Ki-1</div>
      <div id="p1394" num="1394" class="description-paragraph style-scope patent-text">Other names: CD30L receptor；Ki-1 antigen；Cytokine Receptor CD30；Lymphocyte activation antigens CD30；It is swollen
Tumor necrosis factor receptor superfamily member 8</div>
      <div id="p1395" num="1395" class="description-paragraph style-scope patent-text">(51) BCMA (B cell maturation antigen)-TNFRSF17 (tumor necrosis factor receptor super family, member 17)</div>
      <div id="p1396" num="1396" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Nucleotide</u>
      </div>
      <div id="p1397" num="1397" class="description-paragraph style-scope patent-text">Genbank accession number Z29574</div>
      <div id="p1398" num="1398" class="description-paragraph style-scope patent-text">Genbank version number Z29574.1 GI:471244</div>
      <div id="p1399" num="1399" class="description-paragraph style-scope patent-text">Genbank record update date: on 2 2nd, 2011,10:40AM</div>
      <div id="p1400" num="1400" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Polypeptide</u>
      </div>
      <div id="p1401" num="1401" class="description-paragraph style-scope patent-text">Genbank accession number CAA82690</div>
      <div id="p1402" num="1402" class="description-paragraph style-scope patent-text">Genbank version number CAA82690.1 GI:471245</div>
      <div id="p1403" num="1403" class="description-paragraph style-scope patent-text">Genbank record update date: on 2 2nd, 2011,10:40AM</div>
      <div id="p1404" num="1404" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Cross reference</u>
      </div>
      <div id="p1405" num="1405" class="description-paragraph style-scope patent-text">Laabi Y.,et al Nucleic Acids Res.22(7),1147-1154(1994)</div>
      <div id="p1406" num="1406" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Other information</u>
      </div>
      <div id="p1407" num="1407" class="description-paragraph style-scope patent-text">Official signs: TNFRSF17</div>
      <div id="p1408" num="1408" class="description-paragraph style-scope patent-text">Other alias: BCM, BCMA, CD269</div>
      <div id="p1409" num="1409" class="description-paragraph style-scope patent-text">Other names: B cell maturation antigen；Bcell maturation factor；B cell mature protein；Tumor necrosis factor by
Body superfamily member 17</div>
      <div id="p1410" num="1410" class="description-paragraph style-scope patent-text">(52) CT Ags-CTA (cancer-testis antigen)</div>
      <div id="p1411" num="1411" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Cross reference</u>
      </div>
      <div id="p1412" num="1412" class="description-paragraph style-scope patent-text">Fratta E.,et al.Mol Oncol.2011Apr；5(2):164-82；Lim SH.,at al Am J
Blood Res.2012；2(1):29-35.</div>
      <div id="p1413" num="1413" class="description-paragraph style-scope patent-text">(53) CD174 (Lewis Y)-FUT3 (fucosyl transferase 3 (galactoside 3 (4)-L-fucose transferase,
Lewis blood group)</div>
      <div id="p1414" num="1414" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Nucleotide</u>
      </div>
      <div id="p1415" num="1415" class="description-paragraph style-scope patent-text">Genbank accession number NM000149</div>
      <div id="p1416" num="1416" class="description-paragraph style-scope patent-text">Genbank version number NM000149.3 GI:148277008</div>
      <div id="p1417" num="1417" class="description-paragraph style-scope patent-text">Genbank records update date: on June 26th, 2012,04:49PM</div>
      <div id="p1418" num="1418" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Polypeptide</u>
      </div>
      <div id="p1419" num="1419" class="description-paragraph style-scope patent-text">Genbank accession number NP_000140</div>
      <div id="p1420" num="1420" class="description-paragraph style-scope patent-text">Genbank version number NP_000140.1 GI:4503809</div>
      <div id="p1421" num="1421" class="description-paragraph style-scope patent-text">Genbank records update date: on June 26th, 2012,04:49PM</div>
      <div id="p1422" num="1422" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Cross reference</u>
      </div>
      <div id="p1423" num="1423" class="description-paragraph style-scope patent-text">Kukowska-Latallo,J.F.,et al Genes Dev.4(8),1288-1303(1990)</div>
      <div id="p1424" num="1424" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Other information</u>
      </div>
      <div id="p1425" num="1425" class="description-paragraph style-scope patent-text">Official signs: FUT3</div>
      <div id="p1426" num="1426" class="description-paragraph style-scope patent-text">Other alias: CD174, FT3B, FucT-III, LE, Les</div>
      <div id="p1427" num="1427" class="description-paragraph style-scope patent-text">Other names: Lewis FT；α-(1,3/1,4)-fucosyl transferase；The transfer of blood group Lewis α -4- fucose
Enzyme；Fucosyl transferase III；Galactoside 3 (4)-L-fucose transferase</div>
      <div id="p1428" num="1428" class="description-paragraph style-scope patent-text">(54) CLEC14A (c-type lectin family, member A；Genbank accession number NM175060)</div>
      <div id="p1429" num="1429" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Nucleotide</u>
      </div>
      <div id="p1430" num="1430" class="description-paragraph style-scope patent-text">Genbank accession number NM175060</div>
      <div id="p1431" num="1431" class="description-paragraph style-scope patent-text">Genbank version number NM175060.2 GI:371123930</div>
      <div id="p1432" num="1432" class="description-paragraph style-scope patent-text">Genbank records update date: on April 1st, 2012,03:34PM</div>
      <div id="p1433" num="1433" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Polypeptide</u>
      </div>
      <div id="p1434" num="1434" class="description-paragraph style-scope patent-text">Genbank accession number NP_778230</div>
      <div id="p1435" num="1435" class="description-paragraph style-scope patent-text">Genbank version number NP_778230.1 GI:28269707</div>
      <div id="p1436" num="1436" class="description-paragraph style-scope patent-text">Genbank records update date: on April 1st, 2012,03:34PM</div>
      <div id="p1437" num="1437" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Other information</u>
      </div>
      <div id="p1438" num="1438" class="description-paragraph style-scope patent-text">Official signs: CLEC14A</div>
      <div id="p1439" num="1439" class="description-paragraph style-scope patent-text">Other alias: UNQ236/PRO269, C14orf27, CEG1, EGFR-5</div>
      <div id="p1440" num="1440" class="description-paragraph style-scope patent-text">Other names: 14 member A of c-type Lectin domain family；ClECT and EGF spline structure domain comprising protein；
EGF-R ELISA 5</div>
      <div id="p1441" num="1441" class="description-paragraph style-scope patent-text">(55) GRP78-HSPA5 (heat shock 70kDa protein 5 (the glycoregulatory protein of grape, 78kDa)</div>
      <div id="p1442" num="1442" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Nucleotide</u>
      </div>
      <div id="p1443" num="1443" class="description-paragraph style-scope patent-text">Genbank accession number NM005347</div>
      <div id="p1444" num="1444" class="description-paragraph style-scope patent-text">Genbank version number NM005347.4 GI:305855105</div>
      <div id="p1445" num="1445" class="description-paragraph style-scope patent-text">Genbank records update date: on September 30th, 2012,01:42PM</div>
      <div id="p1446" num="1446" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Polypeptide</u>
      </div>
      <div id="p1447" num="1447" class="description-paragraph style-scope patent-text">Genbank accession number NP_005338</div>
      <div id="p1448" num="1448" class="description-paragraph style-scope patent-text">Genbank version number NP_005338.1 GI:16507237</div>
      <div id="p1449" num="1449" class="description-paragraph style-scope patent-text">Genbank records update date: on September 30th, 2012,01:42PM</div>
      <div id="p1450" num="1450" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Cross reference</u>
      </div>
      <div id="p1451" num="1451" class="description-paragraph style-scope patent-text">Ting J.,et al DNA 7(4),275-286(1988)</div>
      <div id="p1452" num="1452" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Other information</u>
      </div>
      <div id="p1453" num="1453" class="description-paragraph style-scope patent-text">Official signs: HSPA5</div>
      <div id="p1454" num="1454" class="description-paragraph style-scope patent-text">Other alias: BIP, GRP78, MIF2</div>
      <div id="p1455" num="1455" class="description-paragraph style-scope patent-text">Other names: the glycoregulatory protein of 78kDa grape；Endoplasmic Ca (2+) conjugated protein grp78；It is immune
Immunoglobulin heavy chain conjugated protein</div>
      <div id="p1456" num="1456" class="description-paragraph style-scope patent-text">(56) CD70 (CD70 molecule) L08096</div>
      <div id="p1457" num="1457" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Nucleotide</u>
      </div>
      <div id="p1458" num="1458" class="description-paragraph style-scope patent-text">Genbank accession number L08096</div>
      <div id="p1459" num="1459" class="description-paragraph style-scope patent-text">Genbank version number L08096.1 GI:307127</div>
      <div id="p1460" num="1460" class="description-paragraph style-scope patent-text">Genbank records update date: on June 23rd, 2012,08:54AM</div>
      <div id="p1461" num="1461" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Polypeptide</u>
      </div>
      <div id="p1462" num="1462" class="description-paragraph style-scope patent-text">Genbank accession number AAA36175</div>
      <div id="p1463" num="1463" class="description-paragraph style-scope patent-text">Genbank version number AAA36175.1 GI:307128</div>
      <div id="p1464" num="1464" class="description-paragraph style-scope patent-text">Genbank records update date: on June 23rd, 2012,08:54AM</div>
      <div id="p1465" num="1465" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Cross reference</u>
      </div>
      <div id="p1466" num="1466" class="description-paragraph style-scope patent-text">Goodwin R.G.,et al Cell 73(3),447-456(1993)</div>
      <div id="p1467" num="1467" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Other information</u>
      </div>
      <div id="p1468" num="1468" class="description-paragraph style-scope patent-text">Official signs: CD70</div>
      <div id="p1469" num="1469" class="description-paragraph style-scope patent-text">Other alias: CD27L, CD27LG, TNFSF7</div>
      <div id="p1470" num="1470" class="description-paragraph style-scope patent-text">Other names: CD27 ligand；CD27-L；CD70 antigen；Ki-24 antigen；Surface antigen CD70；Tumor necrosis factor
Sub (ligand) superfamily, member 7；7 antibody of Tumor necrosis factor ligand superfamily member</div>
      <div id="p1471" num="1471" class="description-paragraph style-scope patent-text">For the MDX-1411 (Medarex) of CD70</div>
      <div id="p1472" num="1472" class="description-paragraph style-scope patent-text">h1F6(Oflazoglu,E.,et al,Clin Cancer Res.2008Oct 1；14(19):6171-80；
Seattle Genetics)</div>
      <div id="p1473" num="1473" class="description-paragraph style-scope patent-text">For example, with reference to US20060083736SEQ ID NO:1,2,11 and 12 and Fig. 1.</div>
      <div id="p1474" num="1474" class="description-paragraph style-scope patent-text">(57) stem cell specific antigen.Such as:</div>
      <div id="p1475" num="1475" class="description-paragraph style-scope patent-text">5T4 (referring to following entry (63))</div>
      <div id="p1476" num="1476" class="description-paragraph style-scope patent-text">CD25 (referring to entries above (48))</div>
      <div id="p1477" num="1477" class="description-paragraph style-scope patent-text">·CD32</div>
      <div id="p1478" num="1478" class="description-paragraph style-scope patent-text">ο polypeptide</div>
      <div id="p1479" num="1479" class="description-paragraph style-scope patent-text">■ Genbank accession number ABK42161</div>
      <div id="p1480" num="1480" class="description-paragraph style-scope patent-text">■ Genbank version number ABK42161.1GI:117616286</div>
      <div id="p1481" num="1481" class="description-paragraph style-scope patent-text">■ Genbank records update date: on June 25th, 2007,03:00PM</div>
      <div id="p1482" num="1482" class="description-paragraph style-scope patent-text">·LGR5/GPR49</div>
      <div id="p1483" num="1483" class="description-paragraph style-scope patent-text">ο nucleotide</div>
      <div id="p1484" num="1484" class="description-paragraph style-scope patent-text">■ Genbank accession number NM_003667</div>
      <div id="p1485" num="1485" class="description-paragraph style-scope patent-text">■ Genbank version number NM_003667.2GI:24475886</div>
      <div id="p1486" num="1486" class="description-paragraph style-scope patent-text">■ Genbank records update date: on July 22nd, 2012,03:38PM</div>
      <div id="p1487" num="1487" class="description-paragraph style-scope patent-text">ο polypeptide</div>
      <div id="p1488" num="1488" class="description-paragraph style-scope patent-text">■ Genbank accession number NP_003658</div>
      <div id="p1489" num="1489" class="description-paragraph style-scope patent-text">■ Genbank version number NP_003658.1GI:4504379</div>
      <div id="p1490" num="1490" class="description-paragraph style-scope patent-text">■ Genbank records update date: on July 22nd, 2012,03:38PM</div>
      <div id="p1491" num="1491" class="description-paragraph style-scope patent-text">·Prominin/CD133</div>
      <div id="p1492" num="1492" class="description-paragraph style-scope patent-text">ο nucleotide</div>
      <div id="p1493" num="1493" class="description-paragraph style-scope patent-text">■ Genbank accession number NM_006017</div>
      <div id="p1494" num="1494" class="description-paragraph style-scope patent-text">■ Genbank version number NM_006017.2GI:224994187</div>
      <div id="p1495" num="1495" class="description-paragraph style-scope patent-text">■ Genbank records update date: on September 30th, 2012,01:47PM</div>
      <div id="p1496" num="1496" class="description-paragraph style-scope patent-text">ο polypeptide</div>
      <div id="p1497" num="1497" class="description-paragraph style-scope patent-text">■ Genbank accession number NP_006008</div>
      <div id="p1498" num="1498" class="description-paragraph style-scope patent-text">■ Genbank version number NP_006008.1GI:5174387</div>
      <div id="p1499" num="1499" class="description-paragraph style-scope patent-text">■ Genbank records update date: on September 30th, 2012,01:47PM</div>
      <div id="p1500" num="1500" class="description-paragraph style-scope patent-text">(58)ASG-5</div>
      <div id="p1501" num="1501" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Cross reference</u>
      </div>
      <div id="p1502" num="1502" class="description-paragraph style-scope patent-text">(Smith L.M., et.al AACR 2010Annual Meeting (abstract #2590)；Gudas J.M.,
Et.al.AACR 2010Annual Meeting (abstract #4393)</div>
      <div id="p1503" num="1503" class="description-paragraph style-scope patent-text">Antibody</div>
      <div id="p1504" num="1504" class="description-paragraph style-scope patent-text">Anti- AGS-5 antibody: M6.131 (Smith, L.M., et.al AACR 2010Annual Meeting (abstract #
2590))</div>
      <div id="p1505" num="1505" class="description-paragraph style-scope patent-text">(59) ENPP3 (pyrophosphatase/phosphodiesterase 3 in nucleotide)</div>
      <div id="p1506" num="1506" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Nucleotide</u>
      </div>
      <div id="p1507" num="1507" class="description-paragraph style-scope patent-text">Genbank accession number AF005632</div>
      <div id="p1508" num="1508" class="description-paragraph style-scope patent-text">Genbank version number AF005632.2 GI:4432589</div>
      <div id="p1509" num="1509" class="description-paragraph style-scope patent-text">Genbank records update date: on March 10th, 2010,09:41PM</div>
      <div id="p1510" num="1510" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Polypeptide</u>
      </div>
      <div id="p1511" num="1511" class="description-paragraph style-scope patent-text">Genbank accession number AAC51813</div>
      <div id="p1512" num="1512" class="description-paragraph style-scope patent-text">Genbank version number AAC51813.1 GI:2465540</div>
      <div id="p1513" num="1513" class="description-paragraph style-scope patent-text">Genbank records update date: on March 10th, 2010,09:41PM</div>
      <div id="p1514" num="1514" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Cross reference</u>
      </div>
      <div id="p1515" num="1515" class="description-paragraph style-scope patent-text">Jin-Hua P.,et al Genomics 45(2),412-415(1997)</div>
      <div id="p1516" num="1516" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Other information</u>
      </div>
      <div id="p1517" num="1517" class="description-paragraph style-scope patent-text">Official signs: ENPP3</div>
      <div id="p1518" num="1518" class="description-paragraph style-scope patent-text">Other alias: RP5-988G15.3, B10, CD203c, NPP3, PD-IBETA, PDNP3 other names: E-NPP
3；DJ1005H11.3 (phosphodiesterase I/ nuotide pyrophosphatase 3)；DJ914N13.3 (phosphodiesterase/nucleotide coke phosphorus
Sour enzyme 3)；Pyrophosphatase/phosphodiesterase family member 3 in nucleotide；gp130RB13-6；β phosphodiesterase I；Di(2-ethylhexyl)phosphate
Esterase I/ nuotide pyrophosphatase 3；β phosphodiesterase-I</div>
      <div id="p1519" num="1519" class="description-paragraph style-scope patent-text">(60) PRR4 (Pro-rich 4 (lachrymal gland))</div>
      <div id="p1520" num="1520" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Nucleotide</u>
      </div>
      <div id="p1521" num="1521" class="description-paragraph style-scope patent-text">Genbank accession number NM_007244</div>
      <div id="p1522" num="1522" class="description-paragraph style-scope patent-text">Genbank version number NM_007244.2 GI:154448885</div>
      <div id="p1523" num="1523" class="description-paragraph style-scope patent-text">Genbank records update date: on June 28th, 2012,12:39PM</div>
      <div id="p1524" num="1524" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Polypeptide</u>
      </div>
      <div id="p1525" num="1525" class="description-paragraph style-scope patent-text">Genbank accession number NP_009175</div>
      <div id="p1526" num="1526" class="description-paragraph style-scope patent-text">Genbank version number NP_009175.2 GI:154448886</div>
      <div id="p1527" num="1527" class="description-paragraph style-scope patent-text">Genbank records update date: on June 28th, 2012,12:39PM</div>
      <div id="p1528" num="1528" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Cross reference</u>
      </div>
      <div id="p1529" num="1529" class="description-paragraph style-scope patent-text">Dickinson D.P.,et al Invest.Ophthalmol.Vis.Sci.36(10),2020-2031(1995)</div>
      <div id="p1530" num="1530" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Other information</u>
      </div>
      <div id="p1531" num="1531" class="description-paragraph style-scope patent-text">Official signs: PRR4</div>
      <div id="p1532" num="1532" class="description-paragraph style-scope patent-text">Other alias: LPRP, PROL4</div>
      <div id="p1533" num="1533" class="description-paragraph style-scope patent-text">Other names: the protein rich in lachrymal gland proline；The protein 4 of the relevant Pro-rich of nasopharyngeal carcinoma；It is rich in
The polypeptide 4 of proline；The protein 4 of Pro-rich</div>
      <div id="p1534" num="1534" class="description-paragraph style-scope patent-text">(61) GCC-GUCY2C (guanylate cyclase 2C (heat-staple enterotoxin receptor)</div>
      <div id="p1535" num="1535" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Nucleotide</u>
      </div>
      <div id="p1536" num="1536" class="description-paragraph style-scope patent-text">Genbank accession number NM_004963</div>
      <div id="p1537" num="1537" class="description-paragraph style-scope patent-text">Genbank version number NM_004963.3 GI:222080082</div>
      <div id="p1538" num="1538" class="description-paragraph style-scope patent-text">Genbank records update date: on September 2nd, 2012,01:50PM</div>
      <div id="p1539" num="1539" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Polypeptide</u>
      </div>
      <div id="p1540" num="1540" class="description-paragraph style-scope patent-text">Genbank accession number NP_004954</div>
      <div id="p1541" num="1541" class="description-paragraph style-scope patent-text">Genbank version number NP_004954.2 GI:222080083</div>
      <div id="p1542" num="1542" class="description-paragraph style-scope patent-text">Genbank records update date: on September 2nd, 2012,01:50PM</div>
      <div id="p1543" num="1543" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Cross reference</u>
      </div>
      <div id="p1544" num="1544" class="description-paragraph style-scope patent-text">De Sauvage F.J.,et al J.Biol.Chem.266(27),17912-17918(1991)；Singh S.,
et al Biochem.Biophys.Res.Commun.179(3),1455-1463(1991)</div>
      <div id="p1545" num="1545" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Other information</u>
      </div>
      <div id="p1546" num="1546" class="description-paragraph style-scope patent-text">Official signs: GUCY2C</div>
      <div id="p1547" num="1547" class="description-paragraph style-scope patent-text">Other alias: DIAR6, GUC2C, MUCIL, STAR</div>
      <div id="p1548" num="1548" class="description-paragraph style-scope patent-text">Other names: GC-C；STA receptor；Guanosine cyclic mono-phosphate；hSTAR；Heat-staple enterotoxin receptor；Enteron aisle bird
Thuja acid cyclase</div>
      <div id="p1549" num="1549" class="description-paragraph style-scope patent-text">(62) Liv-1-SLC39A6 (sapiens's Solute Carrier family 39 (zinc carrier), member 6)</div>
      <div id="p1550" num="1550" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Nucleotide</u>
      </div>
      <div id="p1551" num="1551" class="description-paragraph style-scope patent-text">Genbank accession number U41060</div>
      <div id="p1552" num="1552" class="description-paragraph style-scope patent-text">Genbank version number U41060.2 GI:12711792</div>
      <div id="p1553" num="1553" class="description-paragraph style-scope patent-text">Genbank records update date: on November 30th, 2009,04:35PM</div>
      <div id="p1554" num="1554" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Polypeptide</u>
      </div>
      <div id="p1555" num="1555" class="description-paragraph style-scope patent-text">Genbank accession number AAA96258</div>
      <div id="p1556" num="1556" class="description-paragraph style-scope patent-text">Genbank version number AAA96258.2 GI:12711793</div>
      <div id="p1557" num="1557" class="description-paragraph style-scope patent-text">Genbank records update date: on November 30th, 2009,04:35PM</div>
      <div id="p1558" num="1558" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Cross reference</u>
      </div>
      <div id="p1559" num="1559" class="description-paragraph style-scope patent-text">Taylor KM.,et al Biochim Biophys Acta.2003Apr 1；1611(1-2):16-30</div>
      <div id="p1560" num="1560" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Other information</u>
      </div>
      <div id="p1561" num="1561" class="description-paragraph style-scope patent-text">Official signs: SLC39A6</div>
      <div id="p1562" num="1562" class="description-paragraph style-scope patent-text">Other alias: LIV-1</div>
      <div id="p1563" num="1563" class="description-paragraph style-scope patent-text">Other names: the LIV-1 protein that estrogen is adjusted；ZIP-6；The Protein L IV-1 that estrogen is adjusted；Solute
Carrier families 39 (metal ion carrier), member 6；39 member 6 of sapiens's Solute Carrier family；Zinc carrier ZIP6；Zrt and Irt sample
Protein 6</div>
      <div id="p1564" num="1564" class="description-paragraph style-scope patent-text">(63) 5T4, trophoderm glycoprotein, TPBG-TPBG (trophoderm glycoprotein)</div>
      <div id="p1565" num="1565" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Nucleotide</u>
      </div>
      <div id="p1566" num="1566" class="description-paragraph style-scope patent-text">Genbank accession number AJ012159</div>
      <div id="p1567" num="1567" class="description-paragraph style-scope patent-text">Genbank version number AJ012159.1 GI:3805946</div>
      <div id="p1568" num="1568" class="description-paragraph style-scope patent-text">Genbank record update date: on 2 1st, 2011,10:27AM</div>
      <div id="p1569" num="1569" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Polypeptide</u>
      </div>
      <div id="p1570" num="1570" class="description-paragraph style-scope patent-text">Genbank accession number CAA09930</div>
      <div id="p1571" num="1571" class="description-paragraph style-scope patent-text">Genbank version number CAA09930.1 GI:3805947</div>
      <div id="p1572" num="1572" class="description-paragraph style-scope patent-text">Genbank record update date: on 2 1st, 2011,10:27AM</div>
      <div id="p1573" num="1573" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Cross reference</u>
      </div>
      <div id="p1574" num="1574" class="description-paragraph style-scope patent-text">King K.W.,et al Biochim.Biophys.Acta 1445(3),257-270(1999)</div>
      <div id="p1575" num="1575" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Other information</u>
      </div>
      <div id="p1576" num="1576" class="description-paragraph style-scope patent-text">● official signs: TPBG</div>
      <div id="p1577" num="1577" class="description-paragraph style-scope patent-text">Other alias: 5T4,5T4AG, M6P1</div>
      <div id="p1578" num="1578" class="description-paragraph style-scope patent-text">Other names: 5T4 carcinomebryonic antigen；5T4 cancer embryo trophoderm glycoprotein (5T4 oncofetal trophoblast
glycoprotein)；5T4 cancer embryo trophoderm glycoprotein (5T4 oncotrophoblast glycoprotein)</div>
      <div id="p1579" num="1579" class="description-paragraph style-scope patent-text">(64) CD56-NCMA1 (N-CAM 1)</div>
      <div id="p1580" num="1580" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Nucleotide</u>
      </div>
      <div id="p1581" num="1581" class="description-paragraph style-scope patent-text">Genbank accession number NM_000615</div>
      <div id="p1582" num="1582" class="description-paragraph style-scope patent-text">Genbank version number NM_000615.6 GI:336285433</div>
      <div id="p1583" num="1583" class="description-paragraph style-scope patent-text">Genbank records update date: on September 23rd, 2012,02:32PM</div>
      <div id="p1584" num="1584" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Polypeptide</u>
      </div>
      <div id="p1585" num="1585" class="description-paragraph style-scope patent-text">Genbank accession number NP_000606</div>
      <div id="p1586" num="1586" class="description-paragraph style-scope patent-text">Genbank version number NP_000606.3 GI:94420689</div>
      <div id="p1587" num="1587" class="description-paragraph style-scope patent-text">Genbank records update date: on September 23rd, 2012,02:32PM</div>
      <div id="p1588" num="1588" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Cross reference</u>
      </div>
      <div id="p1589" num="1589" class="description-paragraph style-scope patent-text">Dickson,G.,et al,Cell 50(7),1119-1130(1987)</div>
      <div id="p1590" num="1590" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Other information</u>
      </div>
      <div id="p1591" num="1591" class="description-paragraph style-scope patent-text">Official signs: NCAM1</div>
      <div id="p1592" num="1592" class="description-paragraph style-scope patent-text">Other alias: CD56, MSK39, NCAM</div>
      <div id="p1593" num="1593" class="description-paragraph style-scope patent-text">Other names: the antigen identified by monoclonal antibody 5.1H11；N-CAM, NCAM antibody</div>
      <div id="p1594" num="1594" class="description-paragraph style-scope patent-text">Immunogen:HuN901 (Smith SV., et al Curr Opin Mol Ther.2005 Aug；7(4):
394-401)</div>
      <div id="p1595" num="1595" class="description-paragraph style-scope patent-text">Murine N901 antibody is obtained for example, with reference to humanization.Referring to Roguska, M.A., et al.Proc Natl
Acad Sci USA Feb 1994；Fig. 1 b and 1e of 91:969-973.</div>
      <div id="p1596" num="1596" class="description-paragraph style-scope patent-text">(65) CanAg (tumor associated antigen CA242)</div>
      <div id="p1597" num="1597" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Cross reference</u>
      </div>
      <div id="p1598" num="1598" class="description-paragraph style-scope patent-text">Haglund C.,et al Br J Cancer 60:845-851,1989；Baeckstrom D.,et al J
Biol Chem 266:21537-21547,1991</div>
      <div id="p1599" num="1599" class="description-paragraph style-scope patent-text">Antibody</div>
      <div id="p1600" num="1600" class="description-paragraph style-scope patent-text">huC242(Tolcher AW et al.,J Clin Oncol.2003Jan 15；21(2):211-22；
Immunogen)</div>
      <div id="p1601" num="1601" class="description-paragraph style-scope patent-text">For example, with reference to US20080138898A1 SEQ ID NO:1 and 2</div>
      <div id="p1602" num="1602" class="description-paragraph style-scope patent-text">(66) FOLR1 (folacin receptor 1)</div>
      <div id="p1603" num="1603" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Nucleotide</u>
      </div>
      <div id="p1604" num="1604" class="description-paragraph style-scope patent-text">Genbank accession number J05013</div>
      <div id="p1605" num="1605" class="description-paragraph style-scope patent-text">Genbank version number J05013.1 GI:182417</div>
      <div id="p1606" num="1606" class="description-paragraph style-scope patent-text">Genbank records update date: on June 23rd, 2010,08:47AM</div>
      <div id="p1607" num="1607" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Polypeptide</u>
      </div>
      <div id="p1608" num="1608" class="description-paragraph style-scope patent-text">Genbank accession number AAA35823</div>
      <div id="p1609" num="1609" class="description-paragraph style-scope patent-text">Genbank version number AAA35823.1 GI:182418</div>
      <div id="p1610" num="1610" class="description-paragraph style-scope patent-text">Genbank records update date: on June 23rd, 2010,08:47AM</div>
      <div id="p1611" num="1611" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Cross reference</u>
      </div>
      <div id="p1612" num="1612" class="description-paragraph style-scope patent-text">Elwood P.C.,et al J.Biol.Chem.264(25),14893-14901(1989)</div>
      <div id="p1613" num="1613" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Other information</u>
      </div>
      <div id="p1614" num="1614" class="description-paragraph style-scope patent-text">Official signs: FOLR1</div>
      <div id="p1615" num="1615" class="description-paragraph style-scope patent-text">Other alias: FBP, FOLR</div>
      <div id="p1616" num="1616" class="description-paragraph style-scope patent-text">Other names: FR- α；KB cell FBP；Adult folate binding protein matter；Folate binding protein matter；Folic acid α receptor；
Adult folacin receptor；Ovarian neoplasm related antigen MOv18</div>
      <div id="p1617" num="1617" class="description-paragraph style-scope patent-text">Antibody</div>
      <div id="p1618" num="1618" class="description-paragraph style-scope patent-text">M9346A-Whiteman KR.,et al Cancer Res April 15,2012；72 (8 supplementary issues): 4628
(Immunogen)</div>
      <div id="p1619" num="1619" class="description-paragraph style-scope patent-text">(67) GPNMB (glycoprotein (cross-film) nmb)</div>
      <div id="p1620" num="1620" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Nucleotide</u>
      </div>
      <div id="p1621" num="1621" class="description-paragraph style-scope patent-text">Genbank accession number X76534</div>
      <div id="p1622" num="1622" class="description-paragraph style-scope patent-text">Genbank version number X76534.1 GI:666042</div>
      <div id="p1623" num="1623" class="description-paragraph style-scope patent-text">Genbank record update date: on 2 2nd, 2011,10:10AM</div>
      <div id="p1624" num="1624" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Polypeptide</u>
      </div>
      <div id="p1625" num="1625" class="description-paragraph style-scope patent-text">Genbank accession number CAA54044</div>
      <div id="p1626" num="1626" class="description-paragraph style-scope patent-text">Genbank version number CAA54044.1 GI:666043</div>
      <div id="p1627" num="1627" class="description-paragraph style-scope patent-text">Genbank record update date: on 2 2nd, 2011,10:10AM</div>
      <div id="p1628" num="1628" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Cross reference</u>
      </div>
      <div id="p1629" num="1629" class="description-paragraph style-scope patent-text">Weterman M.A.,et al Int.J.Cancer 60(1),73-81(1995)</div>
      <div id="p1630" num="1630" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Other information</u>
      </div>
      <div id="p1631" num="1631" class="description-paragraph style-scope patent-text">Official signs: GPNMB</div>
      <div id="p1632" num="1632" class="description-paragraph style-scope patent-text">Other alias: UNQ1725/PRO9925, HGFIN, NMB</div>
      <div id="p1633" num="1633" class="description-paragraph style-scope patent-text">Other names: glycoprotein NMB；Glycoprotein nmb sample protein；osteoactivin；Transmembrane glycoprotein HGFIN；Across
Membrane glycoprotein NMB</div>
      <div id="p1634" num="1634" class="description-paragraph style-scope patent-text">Antibody</div>
      <div id="p1635" num="1635" class="description-paragraph style-scope patent-text">Celldex Therapeutics:CR011 (Tse KF., et al Clin Cancer Res.2006Feb 15；
12(4):1373-82)</div>
      <div id="p1636" num="1636" class="description-paragraph style-scope patent-text">For example, with reference to EP1827492B1 SEQ ID NO:22,24,26,31,33 and 35</div>
      <div id="p1637" num="1637" class="description-paragraph style-scope patent-text">(68) TIM-1-HAVCR1 (hepatitis A virus cell receptor 1)</div>
      <div id="p1638" num="1638" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Nucleotide</u>
      </div>
      <div id="p1639" num="1639" class="description-paragraph style-scope patent-text">Genbank accession number AF043724</div>
      <div id="p1640" num="1640" class="description-paragraph style-scope patent-text">Genbank version number AF043724.1 GI:2827453</div>
      <div id="p1641" num="1641" class="description-paragraph style-scope patent-text">Genbank records update date: on March 10th, 2010,06:24PM</div>
      <div id="p1642" num="1642" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Polypeptide</u>
      </div>
      <div id="p1643" num="1643" class="description-paragraph style-scope patent-text">Genbank accession number AAC39862</div>
      <div id="p1644" num="1644" class="description-paragraph style-scope patent-text">Genbank version number AAC39862.1 GI:2827454</div>
      <div id="p1645" num="1645" class="description-paragraph style-scope patent-text">Genbank records update date: on March 10th, 2010,06:24PM</div>
      <div id="p1646" num="1646" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Cross reference</u>
      </div>
      <div id="p1647" num="1647" class="description-paragraph style-scope patent-text">Feigelstock D.,et al J.Virol.72(8),6621-6628(1998)</div>
      <div id="p1648" num="1648" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Other information</u>
      </div>
      <div id="p1649" num="1649" class="description-paragraph style-scope patent-text">Official signs: HAVCR1</div>
      <div id="p1650" num="1650" class="description-paragraph style-scope patent-text">Other alias: HAVCR, HAVCR-1, KIM-1, KIM1, TIM, TIM-1, TIM1, TIMD-1, TIMD1</div>
      <div id="p1651" num="1651" class="description-paragraph style-scope patent-text">Other names: T cell immunoglobulin domains and mucin domain protein 1；T cell memebrane protein 1；
Kidney injury molecule 1</div>
      <div id="p1652" num="1652" class="description-paragraph style-scope patent-text">(69) RG-1/ tumor of prostate targets Mindin-Mindin/RG-1</div>
      <div id="p1653" num="1653" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Cross reference</u>
      </div>
      <div id="p1654" num="1654" class="description-paragraph style-scope patent-text">Parry R.,et al Cancer Res.2005Sep 15；65(18):8397-405</div>
      <div id="p1655" num="1655" class="description-paragraph style-scope patent-text">(70) B7-H4-VTCN1 (the V-set structural domain comprising T cell activation inhibitor 1</div>
      <div id="p1656" num="1656" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Nucleotide</u>
      </div>
      <div id="p1657" num="1657" class="description-paragraph style-scope patent-text">Genbank accession number BX648021</div>
      <div id="p1658" num="1658" class="description-paragraph style-scope patent-text">Genbank version number BX648021.1 GI:34367180</div>
      <div id="p1659" num="1659" class="description-paragraph style-scope patent-text">Genbank record update date: on 2 2nd, 2011,08:40AM</div>
      <div id="p1660" num="1660" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Cross reference</u>
      </div>
      <div id="p1661" num="1661" class="description-paragraph style-scope patent-text">Sica GL.,et al Immunity.2003Jun；18(6):849-61</div>
      <div id="p1662" num="1662" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Other information</u>
      </div>
      <div id="p1663" num="1663" class="description-paragraph style-scope patent-text">Official signs: VTCN1</div>
      <div id="p1664" num="1664" class="description-paragraph style-scope patent-text">Other alias: RP11-229A19.4, B7-H4, B7H4, B7S1, B7X, B7h.5, PRO1291, VCTN1</div>
      <div id="p1665" num="1665" class="description-paragraph style-scope patent-text">Other names: B7 family member H4；B7 superfamily member 1；T cell costimulatory molecules B7x；T- cell co-stimulatory
Molecule B7x；V-set structural domain comprising T cell activation inhibitor 1；Immune costimulation PROTEIN B 7-H4</div>
      <div id="p1666" num="1666" class="description-paragraph style-scope patent-text">(71) PTK7 (PTK7 protein tyrosine kinase 7)</div>
      <div id="p1667" num="1667" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Nucleotide</u>
      </div>
      <div id="p1668" num="1668" class="description-paragraph style-scope patent-text">Genbank accession number AF447176</div>
      <div id="p1669" num="1669" class="description-paragraph style-scope patent-text">Genbank version number AF447176.1 GI:17432420</div>
      <div id="p1670" num="1670" class="description-paragraph style-scope patent-text">Genbank records update date: on November 28th, 2008,01:51PM</div>
      <div id="p1671" num="1671" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Polypeptide</u>
      </div>
      <div id="p1672" num="1672" class="description-paragraph style-scope patent-text">Genbank accession number AAL39062</div>
      <div id="p1673" num="1673" class="description-paragraph style-scope patent-text">Genbank version number AAL39062.1 GI:17432421</div>
      <div id="p1674" num="1674" class="description-paragraph style-scope patent-text">Genbank records update date: on November 28th, 2008,01:51PM</div>
      <div id="p1675" num="1675" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Cross reference</u>
      </div>
      <div id="p1676" num="1676" class="description-paragraph style-scope patent-text">Park S.K.,et al J.Biochem.119(2),235-239(1996)</div>
      <div id="p1677" num="1677" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Other information</u>
      </div>
      <div id="p1678" num="1678" class="description-paragraph style-scope patent-text">Official signs: PTK7</div>
      <div id="p1679" num="1679" class="description-paragraph style-scope patent-text">Other alias: CCK-4, CCK4</div>
      <div id="p1680" num="1680" class="description-paragraph style-scope patent-text">Other names: colon cancer kinases 4；Sluggish tyrosine-protein kinase 7；Pseudo- tyrosine kinase receptor 7；Junket
Propylhomoserin-protein kinase sample 7</div>
      <div id="p1681" num="1681" class="description-paragraph style-scope patent-text">(72) CD37 (CD37 molecule)</div>
      <div id="p1682" num="1682" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Nucleotide</u>
      </div>
      <div id="p1683" num="1683" class="description-paragraph style-scope patent-text">Genbank accession number NM_001040031</div>
      <div id="p1684" num="1684" class="description-paragraph style-scope patent-text">Genbank version number NM_001040031.1 GI:91807109</div>
      <div id="p1685" num="1685" class="description-paragraph style-scope patent-text">Genbank records update date: on July 29th, 2012,02:08PM</div>
      <div id="p1686" num="1686" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Polypeptide</u>
      </div>
      <div id="p1687" num="1687" class="description-paragraph style-scope patent-text">Genbank accession number NP_001035120</div>
      <div id="p1688" num="1688" class="description-paragraph style-scope patent-text">Genbank version number NP_001035120.1 GI:91807110</div>
      <div id="p1689" num="1689" class="description-paragraph style-scope patent-text">Genbank records update date: on July 29th, 2012,02:08PM</div>
      <div id="p1690" num="1690" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Cross reference</u>
      </div>
      <div id="p1691" num="1691" class="description-paragraph style-scope patent-text">Schwartz-Albiez R.,et al J.Immunol.140(3),905-914(1988)</div>
      <div id="p1692" num="1692" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Other information</u>
      </div>
      <div id="p1693" num="1693" class="description-paragraph style-scope patent-text">Official signs: CD37</div>
      <div id="p1694" num="1694" class="description-paragraph style-scope patent-text">Other alias: GP52-40, TSPAN26</div>
      <div id="p1695" num="1695" class="description-paragraph style-scope patent-text">Other names: CD37 antigen；Cell differentiation antigen 37；Leukocyte antigen CD37；Swine lymphocyte antigen CD37；
Four membrane-spanning proteins 26；tspan-26</div>
      <div id="p1696" num="1696" class="description-paragraph style-scope patent-text">Antibody</div>
      <div id="p1697" num="1697" class="description-paragraph style-scope patent-text">(Heider KH., the et al Blood.2011Oct 13 of Boehringer Ingelheim:mAb 37.1；118
(15):4159-68)</div>
      <div id="p1698" num="1698" class="description-paragraph style-scope patent-text">Trubion:CD37-SMIP (G28-1scFv-Ig) ((Zhao X., et al Blood.2007；110:2569-
2577)</div>
      <div id="p1699" num="1699" class="description-paragraph style-scope patent-text">For example, with reference to US20110171208A1 SEQ ID NO:253</div>
      <div id="p1700" num="1700" class="description-paragraph style-scope patent-text">Immunogen:K7153A (Deckert J., et al Cancer Res on April 15th, 2012；72 (8 increasings
Periodical): 4625)</div>
      <div id="p1701" num="1701" class="description-paragraph style-scope patent-text">(73) CD138-SDC1 (syndecan 1)</div>
      <div id="p1702" num="1702" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Nucleotide</u>
      </div>
      <div id="p1703" num="1703" class="description-paragraph style-scope patent-text">Genbank accession number AJ551176</div>
      <div id="p1704" num="1704" class="description-paragraph style-scope patent-text">Genbank version number AJ551176.1 GI:29243141</div>
      <div id="p1705" num="1705" class="description-paragraph style-scope patent-text">Genbank record update date: on 2 1st, 2011,12:09PM</div>
      <div id="p1706" num="1706" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Polypeptide</u>
      </div>
      <div id="p1707" num="1707" class="description-paragraph style-scope patent-text">Genbank accession number CAD80245</div>
      <div id="p1708" num="1708" class="description-paragraph style-scope patent-text">Genbank version number CAD80245.1 GI:29243142</div>
      <div id="p1709" num="1709" class="description-paragraph style-scope patent-text">Genbank record update date: on 2 1st, 2011,12:09PM</div>
      <div id="p1710" num="1710" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Cross reference</u>
      </div>
      <div id="p1711" num="1711" class="description-paragraph style-scope patent-text">O'Connell FP.,et al Am J Clin Pathol.2004Feb；121(2):254-63</div>
      <div id="p1712" num="1712" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Other information</u>
      </div>
      <div id="p1713" num="1713" class="description-paragraph style-scope patent-text">Official signs: SDC1</div>
      <div id="p1714" num="1714" class="description-paragraph style-scope patent-text">Other alias: CD138, SDC, SYND1, syndecan</div>
      <div id="p1715" num="1715" class="description-paragraph style-scope patent-text">Other names: CD138 antigen；Heparan sulfate proteoglycan fibroblast growth factor acceptor；Multiple ligand
Glycan proteoglycan 1；Syndecan 1</div>
      <div id="p1716" num="1716" class="description-paragraph style-scope patent-text">Antibody</div>
      <div id="p1717" num="1717" class="description-paragraph style-scope patent-text">Biotest: chimeric MAb (nBT062)-(Jagannath S., et al Poster ASH#3060,2010；
WIPO patent application WO/2010/128087)</div>
      <div id="p1718" num="1718" class="description-paragraph style-scope patent-text">For example, with reference to US20090232810 SEQ ID NO:1 and 2</div>
      <div id="p1719" num="1719" class="description-paragraph style-scope patent-text">Immunogen:B-B4 (Tassone P., et al Blood 104_3688-3696)</div>
      <div id="p1720" num="1720" class="description-paragraph style-scope patent-text">For example, with reference to US20090175863A1SEQ ID NO:1 and 2</div>
      <div id="p1721" num="1721" class="description-paragraph style-scope patent-text">(74) CD74 (CD74 molecule, main histocompatibility complex, II class invariant chain)</div>
      <div id="p1722" num="1722" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Nucleotide</u>
      </div>
      <div id="p1723" num="1723" class="description-paragraph style-scope patent-text">Genbank accession number NM_004355</div>
      <div id="p1724" num="1724" class="description-paragraph style-scope patent-text">Genbank version number NM_004355.1 GI:343403784</div>
      <div id="p1725" num="1725" class="description-paragraph style-scope patent-text">Genbank records update date: on September 23rd, 2012,02:30PM</div>
      <div id="p1726" num="1726" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Polypeptide</u>
      </div>
      <div id="p1727" num="1727" class="description-paragraph style-scope patent-text">Genbank accession number NP_004346</div>
      <div id="p1728" num="1728" class="description-paragraph style-scope patent-text">Genbank version number NP_004346.1 GI:10835071</div>
      <div id="p1729" num="1729" class="description-paragraph style-scope patent-text">Genbank records update date: on September 23rd, 2012,02:30PM</div>
      <div id="p1730" num="1730" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Cross reference</u>
      </div>
      <div id="p1731" num="1731" class="description-paragraph style-scope patent-text">Kudo,J.,et al Nucleic Acids Res.13(24),8827-8841(1985)</div>
      <div id="p1732" num="1732" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Other information</u>
      </div>
      <div id="p1733" num="1733" class="description-paragraph style-scope patent-text">Official signs: CD74</div>
      <div id="p1734" num="1734" class="description-paragraph style-scope patent-text">Other alias: DHLAG, HLADG, II, Ia-GAMMA</div>
      <div id="p1735" num="1735" class="description-paragraph style-scope patent-text">Other names: CD74 antigen (the constant polypeptide of the relevant main histocompatibility complex of II class antigen)；
HLA II class loading compatibility antigen γ chain；The relevant invariant chain of HLA-DR antigen； HLA-DR-γ；The relevant invariant chain of Ia；
MHC HLA-DR γ chain；The γ chain of II class antigen；P33 antibody</div>
      <div id="p1736" num="1736" class="description-paragraph style-scope patent-text">Immunomedics:hLL1 (meter La Zhu monoclonal antibody (Milatuzumab))-Berkova Z., et al Expert
Opin Investig Drugs.2010Jan；19(1):141-9)</div>
      <div id="p1737" num="1737" class="description-paragraph style-scope patent-text">For example, with reference to US20040115193 SEQ ID NO:19,20,21,22,23 and 24</div>
      <div id="p1738" num="1738" class="description-paragraph style-scope patent-text">Genmab:HuMax-CD74 (referring to network address)</div>
      <div id="p1739" num="1739" class="description-paragraph style-scope patent-text">(75) Claudins-CLs (Occludin)</div>
      <div id="p1740" num="1740" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Cross reference</u>
      </div>
      <div id="p1741" num="1741" class="description-paragraph style-scope patent-text">Offner S., et al Cancer Immunol Immunother.2005 May；54(5):431-45,
Suzuki H.,et al Ann N Y Acad Sci.2012Jul；1258:65-70)</div>
      <div id="p1742" num="1742" class="description-paragraph style-scope patent-text">In the mankind, 24 members-of family are described referring to bibliography</div>
      <div id="p1743" num="1743" class="description-paragraph style-scope patent-text">(76) EGFR (EGF-R ELISA)</div>
      <div id="p1744" num="1744" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Nucleotide</u>
      </div>
      <div id="p1745" num="1745" class="description-paragraph style-scope patent-text">Genbank accession number NM_005228</div>
      <div id="p1746" num="1746" class="description-paragraph style-scope patent-text">Genbank version number NM_005228.3 GI:41927737</div>
      <div id="p1747" num="1747" class="description-paragraph style-scope patent-text">Genbank records update date: on September 30th, 2012,01:47PM</div>
      <div id="p1748" num="1748" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Polypeptide</u>
      </div>
      <div id="p1749" num="1749" class="description-paragraph style-scope patent-text">Genbank accession number NP_005219</div>
      <div id="p1750" num="1750" class="description-paragraph style-scope patent-text">Genbank version number NP_005219.2 GI:29725609</div>
      <div id="p1751" num="1751" class="description-paragraph style-scope patent-text">Genbank records update date: on September 30th, 2012,01:47PM</div>
      <div id="p1752" num="1752" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Cross reference</u>
      </div>
      <div id="p1753" num="1753" class="description-paragraph style-scope patent-text">Dhomen NS.,et al Crit Rev Oncog.2012；17(1):31-50</div>
      <div id="p1754" num="1754" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Other information</u>
      </div>
      <div id="p1755" num="1755" class="description-paragraph style-scope patent-text">Official signs: EGFR</div>
      <div id="p1756" num="1756" class="description-paragraph style-scope patent-text">Other alias: ERBB, ERBB1, HER1, PIG61, mENA</div>
      <div id="p1757" num="1757" class="description-paragraph style-scope patent-text">Other names: viral (v-erb-b) the oncogene autoploid of bird flu into erythrocyte leukemia；Cell growth suppression
Protein 40 processed；Cell Proliferation inducible protein matter 61；Proto-oncogene c-ErbB-1；Receptor tyrosine-protein kinase erbB-1</div>
      <div id="p1758" num="1758" class="description-paragraph style-scope patent-text">Antibody</div>
      <div id="p1759" num="1759" class="description-paragraph style-scope patent-text">BMS: Cetuximab (Erbitux)-Broadbridge VT., et al Expert Rev Anticancer
Ther.2012 May；12(5):555-65.</div>
      <div id="p1760" num="1760" class="description-paragraph style-scope patent-text">For example, with reference to US6217866-ATTC deposit number 9764.</div>
      <div id="p1761" num="1761" class="description-paragraph style-scope patent-text">Amgen: Victibix (Vectibix)-Argiles G., et al Future Oncol.2012 Apr；8(4):
373-89</div>
      <div id="p1762" num="1762" class="description-paragraph style-scope patent-text">For example, with reference to US6235883 SEQ ID NO:23-38.</div>
      <div id="p1763" num="1763" class="description-paragraph style-scope patent-text">Genmab: Shandong mesh monoclonal antibody (Zalutumumab)-Rivera F., et al Expert Opin Biol is pricked
Ther.2009 May；9(5):667-74.</div>
      <div id="p1764" num="1764" class="description-paragraph style-scope patent-text">YM Biosciences: Buddhist nun trastuzumab-Ramakrishnan MS., et al MAbs.2009 Jan-Feb；1
(1):41-8.</div>
      <div id="p1765" num="1765" class="description-paragraph style-scope patent-text">For example, with reference to US5891996 SEQ ID NO:27-34.</div>
      <div id="p1766" num="1766" class="description-paragraph style-scope patent-text">(77) Her3 (ErbB3)-ERBB3 (v-erb-b2 into erythrocyte leukemia viral oncogenes autoploid (fowl stream
Sense))</div>
      <div id="p1767" num="1767" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Nucleotide</u>
      </div>
      <div id="p1768" num="1768" class="description-paragraph style-scope patent-text">Genbank accession number M34309</div>
      <div id="p1769" num="1769" class="description-paragraph style-scope patent-text">Genbank version number M34309.1 GI:183990</div>
      <div id="p1770" num="1770" class="description-paragraph style-scope patent-text">Genbank records update date: on June 23rd, 2010,08:47PM</div>
      <div id="p1771" num="1771" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Polypeptide</u>
      </div>
      <div id="p1772" num="1772" class="description-paragraph style-scope patent-text">Genbank accession number AAA35979</div>
      <div id="p1773" num="1773" class="description-paragraph style-scope patent-text">Genbank version number AAA35979.1 GI:306841</div>
      <div id="p1774" num="1774" class="description-paragraph style-scope patent-text">Genbank records update date: on June 23rd, 2010,08:47PM</div>
      <div id="p1775" num="1775" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Cross reference</u>
      </div>
      <div id="p1776" num="1776" class="description-paragraph style-scope patent-text">Plowman,G.D.,et al.,Proc.Natl.Acad.Sci.U.S.A.87(13),4905-4909(1990)</div>
      <div id="p1777" num="1777" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Other information</u>
      </div>
      <div id="p1778" num="1778" class="description-paragraph style-scope patent-text">Official signs: ERBB3</div>
      <div id="p1779" num="1779" class="description-paragraph style-scope patent-text">Other alias: ErbB-3, HER3, LCCS2, MDA-BF-1, c-erbB-3, c-erbB3, erbB3-S, p180-
ErbB3, p45-sErbB3, p85-sErbB3</div>
      <div id="p1780" num="1780" class="description-paragraph style-scope patent-text">Other names: proto-oncogene sample protein c-ErbB-3；Receptor tyrosine-protein kinase erbB-3；Tyrosine
Kinases type cell surface receptor HER3</div>
      <div id="p1781" num="1781" class="description-paragraph style-scope patent-text">Antibody</div>
      <div id="p1782" num="1782" class="description-paragraph style-scope patent-text">Merimack Pharma:MM-121 (Schoeberl B., et al Cancer Res.2010Mar 15；70
(6):2485-2494)</div>
      <div id="p1783" num="1783" class="description-paragraph style-scope patent-text">For example, with reference to US2011028129 SEQ ID NO:1,2,3,4,5,6,7 and 8.</div>
      <div id="p1784" num="1784" class="description-paragraph style-scope patent-text">(78) RON-MST1R (1 receptor of macrophage-stimulating (c-met related tyrosine kinases))</div>
      <div id="p1785" num="1785" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Nucleotide</u>
      </div>
      <div id="p1786" num="1786" class="description-paragraph style-scope patent-text">Genbank accession number X70040</div>
      <div id="p1787" num="1787" class="description-paragraph style-scope patent-text">Genbank version number X70040.1 GI:36109</div>
      <div id="p1788" num="1788" class="description-paragraph style-scope patent-text">Genbank record update date: on 2 2nd, 2011,10:17PM</div>
      <div id="p1789" num="1789" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Polypeptide</u>
      </div>
      <div id="p1790" num="1790" class="description-paragraph style-scope patent-text">Genbank accession number CCA49634</div>
      <div id="p1791" num="1791" class="description-paragraph style-scope patent-text">Genbank version number CCA49634.1 GI:36110</div>
      <div id="p1792" num="1792" class="description-paragraph style-scope patent-text">Genbank record update date: on 2 2nd, 2011,10:17PM</div>
      <div id="p1793" num="1793" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Cross reference</u>
      </div>
      <div id="p1794" num="1794" class="description-paragraph style-scope patent-text">Ronsin C.,et al Oncogene 8(5),1195-1202(1993)</div>
      <div id="p1795" num="1795" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Other information</u>
      </div>
      <div id="p1796" num="1796" class="description-paragraph style-scope patent-text">Official signs: MST1R</div>
      <div id="p1797" num="1797" class="description-paragraph style-scope patent-text">Other alias: CD136, CDw136, PTK8, RON</div>
      <div id="p1798" num="1798" class="description-paragraph style-scope patent-text">Other names: MSP receptor；MST1R variant RON30；MST1R variant RON62；PTK8 protein tyrosine kinase
8；RON variant E2E3；C-met- related tyrosine kinases；Macrophage-stimulating protein receptor body；p185-Ron；Solute RON becomes
Body 1；Solute RON variant 2；Solute RON variant 3；Solute RON variant 4</div>
      <div id="p1799" num="1799" class="description-paragraph style-scope patent-text">(79) EPHA2 (EPH receptor A2)</div>
      <div id="p1800" num="1800" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Nucleotide</u>
      </div>
      <div id="p1801" num="1801" class="description-paragraph style-scope patent-text">Genbank accession number BC037166</div>
      <div id="p1802" num="1802" class="description-paragraph style-scope patent-text">Genbank version number BC037166.2 GI:33879863</div>
      <div id="p1803" num="1803" class="description-paragraph style-scope patent-text">Genbank records update date: on March 6th, 2012,01:59PM</div>
      <div id="p1804" num="1804" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Polypeptide</u>
      </div>
      <div id="p1805" num="1805" class="description-paragraph style-scope patent-text">Genbank accession number AAH37166</div>
      <div id="p1806" num="1806" class="description-paragraph style-scope patent-text">Genbank version number AAH37166.1 GI:22713539</div>
      <div id="p1807" num="1807" class="description-paragraph style-scope patent-text">Genbank records update date: on March 6th, 2012,01:59PM</div>
      <div id="p1808" num="1808" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Cross reference</u>
      </div>
      <div id="p1809" num="1809" class="description-paragraph style-scope patent-text">Strausberg R.L.,et al Proc.Natl.Acad.Sci.U.S.A.99(26),16899-16903
(2002)</div>
      <div id="p1810" num="1810" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Other information</u>
      </div>
      <div id="p1811" num="1811" class="description-paragraph style-scope patent-text">Official signs: EPHA2</div>
      <div id="p1812" num="1812" class="description-paragraph style-scope patent-text">Other alias: ARCC2, CTPA, CTPP1, ECK</div>
      <div id="p1813" num="1813" class="description-paragraph style-scope patent-text">Other names: ephrins type A receptor 2；Epithelial receptor protein tyrosine kinase；Solute EPHA2 variant
1；Tyrosine-protein kinase receptor ECK</div>
      <div id="p1814" num="1814" class="description-paragraph style-scope patent-text">Antibody</div>
      <div id="p1815" num="1815" class="description-paragraph style-scope patent-text">Medimmune:1C1 (Lee JW., et al Clin Cancer Res.2010 May 1；16(9):2562-
2570)</div>
      <div id="p1816" num="1816" class="description-paragraph style-scope patent-text">For example, with reference to US20090304721A1 Fig. 7 and 8.</div>
      <div id="p1817" num="1817" class="description-paragraph style-scope patent-text">(80) CD20-MS4A1 (cross-film 4- structural domain, sub-family A, member 1)</div>
      <div id="p1818" num="1818" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Nucleotide</u>
      </div>
      <div id="p1819" num="1819" class="description-paragraph style-scope patent-text">Genbank accession number M27394</div>
      <div id="p1820" num="1820" class="description-paragraph style-scope patent-text">Genbank version number M27394.1 GI:179307</div>
      <div id="p1821" num="1821" class="description-paragraph style-scope patent-text">Genbank records update date: on November 30th, 2009,11:16AM</div>
      <div id="p1822" num="1822" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Polypeptide</u>
      </div>
      <div id="p1823" num="1823" class="description-paragraph style-scope patent-text">Genbank accession number AAA35581</div>
      <div id="p1824" num="1824" class="description-paragraph style-scope patent-text">Genbank version number AAA35581.1 GI:179308</div>
      <div id="p1825" num="1825" class="description-paragraph style-scope patent-text">Genbank records update date: on November 30th, 2009,11:16AM</div>
      <div id="p1826" num="1826" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Cross reference</u>
      </div>
      <div id="p1827" num="1827" class="description-paragraph style-scope patent-text">Tedder T.F.,et al Proc.Natl.Acad.Sci.U.S.A.85(1),208-212(1988)</div>
      <div id="p1828" num="1828" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Other information</u>
      </div>
      <div id="p1829" num="1829" class="description-paragraph style-scope patent-text">Official signs: MS4A1</div>
      <div id="p1830" num="1830" class="description-paragraph style-scope patent-text">Other alias: B1, Bp35, CD20, CVID5, LEU-16, MS4A2, S7</div>
      <div id="p1831" num="1831" class="description-paragraph style-scope patent-text">Other names: bone-marrow-derived lymphocyte antigens c D20；Bone-marrow-derived lymphocyte surface antigen B1；CD20 antigen；CD20 receptor；It is white
Cell surface antigen Leu-16</div>
      <div id="p1832" num="1832" class="description-paragraph style-scope patent-text">Antibody</div>
      <div id="p1833" num="1833" class="description-paragraph style-scope patent-text">Genentech/Roche: Rituximab-Abdulla NE., et al BioDrugs.2012Apr 1；26
(2):71-82.</div>
      <div id="p1834" num="1834" class="description-paragraph style-scope patent-text">For example, with reference to US5736137, ATCC deposit number HB-69119.</div>
      <div id="p1835" num="1835" class="description-paragraph style-scope patent-text">GSK/Genmab: difficult to understand (Ofatumumab)-Nightingale G., et al Ann
Pharmacother.2011Oct；45(10):1248-55.</div>
      <div id="p1836" num="1836" class="description-paragraph style-scope patent-text">For example, with reference to US20090169550A1SEQ ID NO:2,4 and 5.</div>
      <div id="p1837" num="1837" class="description-paragraph style-scope patent-text">Immunomedics: dimension trastuzumab (Veltuzumab)-Goldenberg DM., et al Leuk
Lymphoma.2010 May；51(5):747-55.</div>
      <div id="p1838" num="1838" class="description-paragraph style-scope patent-text">For example, with reference to US7919273B2SEQ ID NO:1,2,3,4,5 and 6.</div>
      <div id="p1839" num="1839" class="description-paragraph style-scope patent-text">(81) tenascin C-TNC (tenascin C)</div>
      <div id="p1840" num="1840" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Nucleotide</u>
      </div>
      <div id="p1841" num="1841" class="description-paragraph style-scope patent-text">Genbank accession number NM_002160</div>
      <div id="p1842" num="1842" class="description-paragraph style-scope patent-text">Genbank version number NM_002160.3 GI:340745336</div>
      <div id="p1843" num="1843" class="description-paragraph style-scope patent-text">Genbank records update date: on September 23rd, 2012,02:33PM</div>
      <div id="p1844" num="1844" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Polypeptide</u>
      </div>
      <div id="p1845" num="1845" class="description-paragraph style-scope patent-text">Genbank accession number NP_002151</div>
      <div id="p1846" num="1846" class="description-paragraph style-scope patent-text">Genbank version number NP_002151.2 GI:153946395</div>
      <div id="p1847" num="1847" class="description-paragraph style-scope patent-text">Genbank records update date: on September 23rd, 2012,02:33PM</div>
      <div id="p1848" num="1848" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Cross reference</u>
      </div>
      <div id="p1849" num="1849" class="description-paragraph style-scope patent-text">Nies D.E.,et al J.Biol.Chem.266(5),2818-2823(1991)；Siri A.,et al
Nucleic Acids Res.19(3),525-531(1991)</div>
      <div id="p1850" num="1850" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Other information</u>
      </div>
      <div id="p1851" num="1851" class="description-paragraph style-scope patent-text">Official signs: TNC</div>
      <div id="p1852" num="1852" class="description-paragraph style-scope patent-text">Other alias: 150-225, GMEM, GP, HXB, JI, TN, TN-C</div>
      <div id="p1853" num="1853" class="description-paragraph style-scope patent-text">Other names: GP 150-225；Tenascin (cytotactin)；The relevant extracellular matrix of glioma
Antigen；Tenascin (hexabrachion) (tenascin)；Myotendinous antigen；Neuronectin；Tenascin；Tendon raw egg
White C isotype 14/AD1/16</div>
      <div id="p1854" num="1854" class="description-paragraph style-scope patent-text">Antibody</div>
      <div id="p1855" num="1855" class="description-paragraph style-scope patent-text">Philogen:G11 (von Lukowicz T., et al J Nucl Med.2007Apr；48 (4): 582-7) and
F16(Pedretti M.,et al Lung Cancer.2009Apr；64(1):28-33)</div>
      <div id="p1856" num="1856" class="description-paragraph style-scope patent-text">For example, with reference to US7968685SEQ ID NO:29,35,45 and 47.</div>
      <div id="p1857" num="1857" class="description-paragraph style-scope patent-text">(82) FAP (fibroblast activation protein matter, α)</div>
      <div id="p1858" num="1858" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Nucleotide</u>
      </div>
      <div id="p1859" num="1859" class="description-paragraph style-scope patent-text">Genbank accession number U09278</div>
      <div id="p1860" num="1860" class="description-paragraph style-scope patent-text">Genbank version number U09278.1 GI:1888315</div>
      <div id="p1861" num="1861" class="description-paragraph style-scope patent-text">Genbank records update date: on June 23rd, 2010,09:22AM</div>
      <div id="p1862" num="1862" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Polypeptide</u>
      </div>
      <div id="p1863" num="1863" class="description-paragraph style-scope patent-text">Genbank accession number AAB49652</div>
      <div id="p1864" num="1864" class="description-paragraph style-scope patent-text">Genbank version number AAB49652.1 GI:1888316</div>
      <div id="p1865" num="1865" class="description-paragraph style-scope patent-text">Genbank records update date: on June 23rd, 2010,09:22AM</div>
      <div id="p1866" num="1866" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Cross reference</u>
      </div>
      <div id="p1867" num="1867" class="description-paragraph style-scope patent-text">Scanlan,M.J.,et al Proc.Natl.Acad.Sci.U.S.A.91(12),5657-5661(1994)</div>
      <div id="p1868" num="1868" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Other information</u>
      </div>
      <div id="p1869" num="1869" class="description-paragraph style-scope patent-text">Official signs: FAP</div>
      <div id="p1870" num="1870" class="description-paragraph style-scope patent-text">Other alias: DPPIV, FAPA</div>
      <div id="p1871" num="1871" class="description-paragraph style-scope patent-text">Other names: the gelatinase that 170kDa melanoma film combines；In serine protease in film； seprase</div>
      <div id="p1872" num="1872" class="description-paragraph style-scope patent-text">(83) DKK-1 (1 autoploid of Dickkopf (xenopous laevis (Xenopus laevis))</div>
      <div id="p1873" num="1873" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Nucleotide</u>
      </div>
      <div id="p1874" num="1874" class="description-paragraph style-scope patent-text">Genbank accession number NM_012242</div>
      <div id="p1875" num="1875" class="description-paragraph style-scope patent-text">Genbank version number NM_012242.2 GI:61676924</div>
      <div id="p1876" num="1876" class="description-paragraph style-scope patent-text">Genbank records update date: on September 30th, 2012,01:48PM</div>
      <div id="p1877" num="1877" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Polypeptide</u>
      </div>
      <div id="p1878" num="1878" class="description-paragraph style-scope patent-text">Genbank accession number NP_036374</div>
      <div id="p1879" num="1879" class="description-paragraph style-scope patent-text">Genbank version number NP_036374.1 GI:7110719</div>
      <div id="p1880" num="1880" class="description-paragraph style-scope patent-text">Genbank records update date: on September 30th, 2012,01:48PM</div>
      <div id="p1881" num="1881" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Cross reference</u>
      </div>
      <div id="p1882" num="1882" class="description-paragraph style-scope patent-text">Fedi P.et al J.Biol.Chem.274(27),19465-19472(1999)</div>
      <div id="p1883" num="1883" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Other information</u>
      </div>
      <div id="p1884" num="1884" class="description-paragraph style-scope patent-text">Official signs: DKK1</div>
      <div id="p1885" num="1885" class="description-paragraph style-scope patent-text">Other alias: UNQ492/PRO1008, DKK-1, SK</div>
      <div id="p1886" num="1886" class="description-paragraph style-scope patent-text">Other names: dickkopf related protein 1；Dickkopf-1 sample；Dickkopf sample protein 1；
Dickkopf- related protein 1；hDkk-1</div>
      <div id="p1887" num="1887" class="description-paragraph style-scope patent-text">Antibody</div>
      <div id="p1888" num="1888" class="description-paragraph style-scope patent-text">Novartis:BHQ880 (Fulciniti M., et al Blood.2009Jul 9；114 (2): 371-379) example
Such as, referring to US20120052070A1SEQ ID NO:100 and 108.</div>
      <div id="p1889" num="1889" class="description-paragraph style-scope patent-text">(84) CD52 (CD52 molecule)</div>
      <div id="p1890" num="1890" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Nucleotide</u>
      </div>
      <div id="p1891" num="1891" class="description-paragraph style-scope patent-text">Genbank accession number NM_001803</div>
      <div id="p1892" num="1892" class="description-paragraph style-scope patent-text">Genbank version number NM_001803.2 GI:68342029</div>
      <div id="p1893" num="1893" class="description-paragraph style-scope patent-text">Genbank records update date: on September 30th, 2012,01:48PM</div>
      <div id="p1894" num="1894" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Polypeptide</u>
      </div>
      <div id="p1895" num="1895" class="description-paragraph style-scope patent-text">Genbank accession number NP_001794</div>
      <div id="p1896" num="1896" class="description-paragraph style-scope patent-text">Genbank version number NP_001794.2 GI:68342030</div>
      <div id="p1897" num="1897" class="description-paragraph style-scope patent-text">Genbank records update date: on September 30th, 2012,01:48PM</div>
      <div id="p1898" num="1898" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Cross reference</u>
      </div>
      <div id="p1899" num="1899" class="description-paragraph style-scope patent-text">Xia M.Q.,et al Eur.J.Immunol.21(7),1677-1684(1991)</div>
      <div id="p1900" num="1900" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Other information</u>
      </div>
      <div id="p1901" num="1901" class="description-paragraph style-scope patent-text">Official signs: CD52</div>
      <div id="p1902" num="1902" class="description-paragraph style-scope patent-text">Other alias: CDW52</div>
      <div id="p1903" num="1903" class="description-paragraph style-scope patent-text">Other names: CAMPATH-1 antigen；CD52 antigen (CAMPATH-1 antigen)；(CAMPATH-1 is anti-for CDW52 antigen
It is former)；1 antigen of Cambridge (cambridge) pathology；Epididymal secretory protein E5；he5；Human epididymal specific proteins 5</div>
      <div id="p1904" num="1904" class="description-paragraph style-scope patent-text">Antibody</div>
      <div id="p1905" num="1905" class="description-paragraph style-scope patent-text">Alemtuzumab (Alemtuzumab) (Campath)-Skoetz N., et al Cochrane Database Syst
Rev.2012Feb 15；2:CD008078.</div>
      <div id="p1906" num="1906" class="description-paragraph style-scope patent-text">For example, with reference to Drugbank Acc.No.DB00087 (BIOD00109, BTD00109) (85) CS1-SLAMF7
(SLAM family member 7)</div>
      <div id="p1907" num="1907" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Nucleotide</u>
      </div>
      <div id="p1908" num="1908" class="description-paragraph style-scope patent-text">Genbank accession number NM_021181</div>
      <div id="p1909" num="1909" class="description-paragraph style-scope patent-text">Genbank version number NM_021181.3 GI:1993571</div>
      <div id="p1910" num="1910" class="description-paragraph style-scope patent-text">Genbank records update date: on June 29th, 2012,11:24AM</div>
      <div id="p1911" num="1911" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Polypeptide</u>
      </div>
      <div id="p1912" num="1912" class="description-paragraph style-scope patent-text">Genbank accession number NP_067004</div>
      <div id="p1913" num="1913" class="description-paragraph style-scope patent-text">Genbank version number NP_067004.3 GI:19923572</div>
      <div id="p1914" num="1914" class="description-paragraph style-scope patent-text">Genbank records update date: on June 29th, 2012,11:24AM</div>
      <div id="p1915" num="1915" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Cross reference</u>
      </div>
      <div id="p1916" num="1916" class="description-paragraph style-scope patent-text">Boles K.S.,et al Immunogenetics 52(3-4),302-307(2001)</div>
      <div id="p1917" num="1917" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Other information</u>
      </div>
      <div id="p1918" num="1918" class="description-paragraph style-scope patent-text">Official signs: SLAMF7</div>
      <div id="p1919" num="1919" class="description-paragraph style-scope patent-text">Other alias: UNQ576/PRO1138,19A, CD319, CRACC, CS1</div>
      <div id="p1920" num="1920" class="description-paragraph style-scope patent-text">Other names: 19A24 protein；CD2 subset 1；CD2 sample receptor activation cytotoxic cell；CD2 sample receptor-swashs
Living cells toxic cell；Memebrane protein FOAP-12；Novel LY9 (lymphocyte antigen 9) sample protein；Protein 19A</div>
      <div id="p1921" num="1921" class="description-paragraph style-scope patent-text">Antibody</div>
      <div id="p1922" num="1922" class="description-paragraph style-scope patent-text">BMS: angstrom sieve trastuzumab (elotuzumab)/HuLuc63 (Benson DM., et al J Clin
Oncol.2012Jun 1；30(16):2013-2015)</div>
      <div id="p1923" num="1923" class="description-paragraph style-scope patent-text">For example, with reference to US20110206701SEQ ID NO:9,10,11,12,13,14,15 and 16.</div>
      <div id="p1924" num="1924" class="description-paragraph style-scope patent-text">(86) Endoglin-ENG (Endoglin)</div>
      <div id="p1925" num="1925" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Nucleotide</u>
      </div>
      <div id="p1926" num="1926" class="description-paragraph style-scope patent-text">Genbank accession number AF035753</div>
      <div id="p1927" num="1927" class="description-paragraph style-scope patent-text">Genbank version number AF035753.1 GI:3452260</div>
      <div id="p1928" num="1928" class="description-paragraph style-scope patent-text">Genbank records update date: on March 10th, 2010,06:36PM</div>
      <div id="p1929" num="1929" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Polypeptide</u>
      </div>
      <div id="p1930" num="1930" class="description-paragraph style-scope patent-text">Genbank accession number AAC32802</div>
      <div id="p1931" num="1931" class="description-paragraph style-scope patent-text">Genbank version number AAC32802.1 GI:3452261</div>
      <div id="p1932" num="1932" class="description-paragraph style-scope patent-text">Genbank records update date: on March 10th, 2010,06:36PM</div>
      <div id="p1933" num="1933" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Cross reference</u>
      </div>
      <div id="p1934" num="1934" class="description-paragraph style-scope patent-text">Rius C.,et al Blood 92(12),4677-4690(1998)</div>
      <div id="p1935" num="1935" class="description-paragraph style-scope patent-text">Official signs: ENG</div>
      <div id="p1936" num="1936" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Other information</u>
      </div>
      <div id="p1937" num="1937" class="description-paragraph style-scope patent-text">Other alias: RP11-228B15.2, CD105, END, HHT1, ORW, ORW1</div>
      <div id="p1938" num="1938" class="description-paragraph style-scope patent-text">Other names: CD105 antigen</div>
      <div id="p1939" num="1939" class="description-paragraph style-scope patent-text">(87) Annexin A1-ANXA1 (annexin)</div>
      <div id="p1940" num="1940" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Nucleotide</u>
      </div>
      <div id="p1941" num="1941" class="description-paragraph style-scope patent-text">Genbank accession number X05908</div>
      <div id="p1942" num="1942" class="description-paragraph style-scope patent-text">Genbank version number X05908.1 GI:34387</div>
      <div id="p1943" num="1943" class="description-paragraph style-scope patent-text">Genbank record update date: on 2 2nd, 2011,10:02AM</div>
      <div id="p1944" num="1944" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Polypeptide</u>
      </div>
      <div id="p1945" num="1945" class="description-paragraph style-scope patent-text">Genbank accession number CCA29338</div>
      <div id="p1946" num="1946" class="description-paragraph style-scope patent-text">Genbank version number CCA29338.1 GI:34388</div>
      <div id="p1947" num="1947" class="description-paragraph style-scope patent-text">Genbank record update date: on 2 2nd, 2011,10:02AM</div>
      <div id="p1948" num="1948" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Cross reference</u>
      </div>
      <div id="p1949" num="1949" class="description-paragraph style-scope patent-text">Wallner B.P.,et al Nature 320(6057),77-81(1986)</div>
      <div id="p1950" num="1950" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Other information</u>
      </div>
      <div id="p1951" num="1951" class="description-paragraph style-scope patent-text">Official signs: ANXA1</div>
      <div id="p1952" num="1952" class="description-paragraph style-scope patent-text">Other alias: RP11-71A24.1, ANX1, LPC1</div>
      <div id="p1953" num="1953" class="description-paragraph style-scope patent-text">Other names: annexin I (lipocortin I)；Annexin Ⅰ；Calcium-dependent protein II；Calcium-dependent protein -2；It is thermophilic
Chromium burl hop protein -9；Lipocortin I；p35；Macrocortin</div>
      <div id="p1954" num="1954" class="description-paragraph style-scope patent-text">(88) V-CAM (CD106)-(VCAM1 (Vcam1)</div>
      <div id="p1955" num="1955" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Nucleotide</u>
      </div>
      <div id="p1956" num="1956" class="description-paragraph style-scope patent-text">Genbank accession number M60335</div>
      <div id="p1957" num="1957" class="description-paragraph style-scope patent-text">Genbank version number M60335.1 GI:340193</div>
      <div id="p1958" num="1958" class="description-paragraph style-scope patent-text">Genbank records update date: on June 23rd, 2010,08:56AM</div>
      <div id="p1959" num="1959" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Polypeptide</u>
      </div>
      <div id="p1960" num="1960" class="description-paragraph style-scope patent-text">Genbank accession number AAA61269</div>
      <div id="p1961" num="1961" class="description-paragraph style-scope patent-text">Genbank version number AAA61269.1 GI:340194</div>
      <div id="p1962" num="1962" class="description-paragraph style-scope patent-text">Genbank records update date: on June 23rd, 2010,08:56AM</div>
      <div id="p1963" num="1963" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Cross reference</u>
      </div>
      <div id="p1964" num="1964" class="description-paragraph style-scope patent-text">Hession C.,et al J.Biol.Chem.266(11),6682-6685(1991)</div>
      <div id="p1965" num="1965" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Other information</u>
      </div>
      <div id="p1966" num="1966" class="description-paragraph style-scope patent-text">Official signs: VCAM1</div>
      <div id="p1967" num="1967" class="description-paragraph style-scope patent-text">Other alias: CD106, INCAM-100</div>
      <div id="p1968" num="1968" class="description-paragraph style-scope patent-text">Other names: CD106 antigen；Vascular cell adhesion albumen 1</div>
      <div id="p1969" num="1969" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Antibody sequence</u>
      </div>
      <div id="p1970" num="1970" class="description-paragraph style-scope patent-text">Anti- αvβ6 Integrin</div>
      <div id="p1971" num="1971" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">RHAB6.2</u>
      </div>
      <div id="p1972" num="1972" class="description-paragraph style-scope patent-text">
        <span class="patent-image-not-available style-scope patent-text"></span>
      </div>
      <div id="p1973" num="1973" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">RHCB6.2</u>
      </div>
      <div id="p1974" num="1974" class="description-paragraph style-scope patent-text">
        <span class="patent-image-not-available style-scope patent-text"></span>
      </div>
      <div id="p1975" num="1975" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">RHF</u>
      </div>
      <div id="p1976" num="1976" class="description-paragraph style-scope patent-text">
        <span class="patent-image-not-available style-scope patent-text"></span>
      </div>
      <div id="p1977" num="1977" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">RHFB6</u>
      </div>
      <div id="p1978" num="1978" class="description-paragraph style-scope patent-text">
        <span class="patent-image-not-available style-scope patent-text"></span>
      </div>
      <div id="p1979" num="1979" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">RHAY100bP</u>
      </div>
      <div id="p1980" num="1980" class="description-paragraph style-scope patent-text">
        <span class="patent-image-not-available style-scope patent-text"></span>
      </div>
      <div id="p1981" num="1981" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">RKF</u>
      </div>
      <div id="p1982" num="1982" class="description-paragraph style-scope patent-text">
        <span class="patent-image-not-available style-scope patent-text"></span>
      </div>
      <div id="p1983" num="1983" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">RKFL36L50</u>
      </div>
      <div id="p1984" num="1984" class="description-paragraph style-scope patent-text">
        <span class="patent-image-not-available style-scope patent-text"></span>
      </div>
      <div id="p1985" num="1985" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">RKC</u>
      </div>
      <div id="p1986" num="1986" class="description-paragraph style-scope patent-text">
        <span class="patent-image-not-available style-scope patent-text"></span>
      </div>
      <div id="p1987" num="1987" class="description-paragraph style-scope patent-text">Anti- CD33</div>
      <div id="p1988" num="1988" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">CD33 Hum195VH</u>
      </div>
      <div id="p1989" num="1989" class="description-paragraph style-scope patent-text">
        <span class="patent-image-not-available style-scope patent-text"></span>
      </div>
      <div id="p1990" num="1990" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">CD33 Hum195VK</u>
      </div>
      <div id="p1991" num="1991" class="description-paragraph style-scope patent-text">
        <span class="patent-image-not-available style-scope patent-text"></span>
      </div>
      <div id="p1992" num="1992" class="description-paragraph style-scope patent-text">Anti- CD19</div>
      <div id="p1993" num="1993" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">The VH of CD19 B4 resurfacing</u>
      </div>
      <div id="p1994" num="1994" class="description-paragraph style-scope patent-text">
        <span class="patent-image-not-available style-scope patent-text"></span>
      </div>
      <div id="p1995" num="1995" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">The VK of CD19 B4 resurfacing</u>
      </div>
      <div id="p1996" num="1996" class="description-paragraph style-scope patent-text">
        <span class="patent-image-not-available style-scope patent-text"></span>
      </div>
      <div id="p1997" num="1997" class="description-paragraph style-scope patent-text">Anti- Her2</div>
      <div id="p1998" num="1998" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Herceptin VH chain</u>
      </div>
      <div id="p1999" num="1999" class="description-paragraph style-scope patent-text">
        <span class="patent-image-not-available style-scope patent-text"></span>
      </div>
      <div id="p2000" num="2000" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Herceptin VL chain</u>
      </div>
      <div id="p2001" num="2001" class="description-paragraph style-scope patent-text">
        <span class="patent-image-not-available style-scope patent-text"></span>
      </div>
      <div id="p2002" num="2002" class="description-paragraph style-scope patent-text">Anti- CD25</div>
      <div id="p2003" num="2003" class="description-paragraph style-scope patent-text">Shu Lai VK (also referred to as basiliximab)</div>
      <div id="p2004" num="2004" class="description-paragraph style-scope patent-text">
        <span class="patent-image-not-available style-scope patent-text"></span>
      </div>
      <div id="p2005" num="2005" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Shu Lai VH</u>
      </div>
      <div id="p2006" num="2006" class="description-paragraph style-scope patent-text">
        <span class="patent-image-not-available style-scope patent-text"></span>
      </div>
      <div id="p2007" num="2007" class="description-paragraph style-scope patent-text">Anti- PSMA</div>
      <div id="p2008" num="2008" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Remove immune VH ' 1</u>
      </div>
      <div id="p2009" num="2009" class="description-paragraph style-scope patent-text">
        <span class="patent-image-not-available style-scope patent-text"></span>
      </div>
      <div id="p2010" num="2010" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Remove immune VK ' 1</u>
      </div>
      <div id="p2011" num="2011" class="description-paragraph style-scope patent-text">
        <span class="patent-image-not-available style-scope patent-text"></span>
      </div>
      <div id="p2012" num="2012" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Remove immune VH1 ' 5</u>
      </div>
      <div id="p2013" num="2013" class="description-paragraph style-scope patent-text">
        <span class="patent-image-not-available style-scope patent-text"></span>
      </div>
      <div id="p2014" num="2014" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Remove immune VH2 ' 5</u>
      </div>
      <div id="p2015" num="2015" class="description-paragraph style-scope patent-text">
        <span class="patent-image-not-available style-scope patent-text"></span>
      </div>
      <div id="p2016" num="2016" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Remove immune VH3 ' 5</u>
      </div>
      <div id="p2017" num="2017" class="description-paragraph style-scope patent-text">
        <span class="patent-image-not-available style-scope patent-text"></span>
      </div>
      <div id="p2018" num="2018" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Remove immune VH4 ' 5</u>
      </div>
      <div id="p2019" num="2019" class="description-paragraph style-scope patent-text">
        <span class="patent-image-not-available style-scope patent-text"></span>
      </div>
      <div id="p2020" num="2020" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Remove immune VK1 ' 5</u>
      </div>
      <div id="p2021" num="2021" class="description-paragraph style-scope patent-text">
        <span class="patent-image-not-available style-scope patent-text"></span>
      </div>
      <div id="p2022" num="2022" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Remove immune VK2 ' 5</u>
      </div>
      <div id="p2023" num="2023" class="description-paragraph style-scope patent-text">
        <span class="patent-image-not-available style-scope patent-text"></span>
      </div>
      <div id="p2024" num="2024" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Remove immune VK3 ' 5</u>
      </div>
      <div id="p2025" num="2025" class="description-paragraph style-scope patent-text">
        <span class="patent-image-not-available style-scope patent-text"></span>
      </div>
      <div id="p2026" num="2026" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Remove immune VK4 ' 5</u>
      </div>
      <div id="p2027" num="2027" class="description-paragraph style-scope patent-text">
        <span class="patent-image-not-available style-scope patent-text"></span>
      </div>
      <div id="p2028" num="2028" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Remove immune VK DI ' 5</u>
      </div>
      <div id="p2029" num="2029" class="description-paragraph style-scope patent-text">
        <span class="patent-image-not-available style-scope patent-text"></span>
      </div>
      <div id="p2030" num="2030" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Remove immune VH DI ' 5</u>
      </div>
      <div id="p2031" num="2031" class="description-paragraph style-scope patent-text">
        <span class="patent-image-not-available style-scope patent-text"></span>
      </div>
      <div id="p2032" num="2032" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Humanization RHA ' 5</u>
      </div>
      <div id="p2033" num="2033" class="description-paragraph style-scope patent-text">
        <span class="patent-image-not-available style-scope patent-text"></span>
      </div>
      <div id="p2034" num="2034" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Humanization RHB ' 5</u>
      </div>
      <div id="p2035" num="2035" class="description-paragraph style-scope patent-text">
        <span class="patent-image-not-available style-scope patent-text"></span>
      </div>
      <div id="p2036" num="2036" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Humanization RHC ' 5</u>
      </div>
      <div id="p2037" num="2037" class="description-paragraph style-scope patent-text">
        <span class="patent-image-not-available style-scope patent-text"></span>
      </div>
      <div id="p2038" num="2038" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Humanization RHD ' 5</u>
      </div>
      <div id="p2039" num="2039" class="description-paragraph style-scope patent-text">
        <span class="patent-image-not-available style-scope patent-text"></span>
      </div>
      <div id="p2040" num="2040" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Humanization RHE ' 5</u>
      </div>
      <div id="p2041" num="2041" class="description-paragraph style-scope patent-text">
        <span class="patent-image-not-available style-scope patent-text"></span>
      </div>
      <div id="p2042" num="2042" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Humanization RHF ' 5</u>
      </div>
      <div id="p2043" num="2043" class="description-paragraph style-scope patent-text">
        <span class="patent-image-not-available style-scope patent-text"></span>
      </div>
      <div id="p2044" num="2044" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Humanization RHG ' 5</u>
      </div>
      <div id="p2045" num="2045" class="description-paragraph style-scope patent-text">
        <span class="patent-image-not-available style-scope patent-text"></span>
      </div>
      <div id="p2046" num="2046" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Humanization RKA ' 5</u>
      </div>
      <div id="p2047" num="2047" class="description-paragraph style-scope patent-text">
        <span class="patent-image-not-available style-scope patent-text"></span>
      </div>
      <div id="p2048" num="2048" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Humanization RKB ' 5</u>
      </div>
      <div id="p2049" num="2049" class="description-paragraph style-scope patent-text">
        <span class="patent-image-not-available style-scope patent-text"></span>
      </div>
      <div id="p2050" num="2050" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Humanization RKC ' 5</u>
      </div>
      <div id="p2051" num="2051" class="description-paragraph style-scope patent-text">
        <span class="patent-image-not-available style-scope patent-text"></span>
      </div>
      <div id="p2052" num="2052" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Humanization RKD ' 5</u>
      </div>
      <div id="p2053" num="2053" class="description-paragraph style-scope patent-text">
        <span class="patent-image-not-available style-scope patent-text"></span>
      </div>
      <div id="p2054" num="2054" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Humanization RKE ' 5</u>
      </div>
      <div id="p2055" num="2055" class="description-paragraph style-scope patent-text">
        <span class="patent-image-not-available style-scope patent-text"></span>
      </div>
      <div id="p2056" num="2056" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Humanization RKF ' 5</u>
      </div>
      <div id="p2057" num="2057" class="description-paragraph style-scope patent-text">
        <span class="patent-image-not-available style-scope patent-text"></span>
      </div>
      <div id="p2058" num="2058" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Humanization RKG ' 5</u>
      </div>
      <div id="p2059" num="2059" class="description-paragraph style-scope patent-text">
        <span class="patent-image-not-available style-scope patent-text"></span>
      </div>
      <div id="p2060" num="2060" class="description-paragraph style-scope patent-text">Maternal antibody is also possible to fused protein (the Dennis et al. comprising albumin binding peptide (ABP) sequence
(2002)“Albumin Binding As A General Strategy For Improving The
Pharmacokinetics Of Proteins"J Biol Chem.277:35035-35043；WO 01/45746).The present invention
Antibody include following introduction the fused protein with ABP sequence: (i) Dennis et al (2002) J Biol
Chem.277:35035-35043 is in Table III and IV, and page 35038；(ii) US 2004/0001827 is in [0076]；And
(iii) WO 01/45746 is at the 12-13 pages, and all is hereby incorporated by its by reference.</div>
      <div id="p2061" num="2061" class="description-paragraph style-scope patent-text">In one embodiment, antibody has been lifted to selectively targeted tumor associated antigen α<sub class="style-scope patent-text">ν</sub>β<sub class="style-scope patent-text">6</sub>。</div>
      <div id="p2062" num="2062" class="description-paragraph style-scope patent-text">Cell binding agent can be marked, such as is facilitated before being combined as conjugate or as one of conjugate
The detection or purifying of the reagent divided.Label can be biotin labeling.It in another embodiment, can be same with radioactivity
Position element label cell binding agent.</div>
      <div id="p2063" num="2063" class="description-paragraph style-scope patent-text">Cell binding agent is connected to connector.In one embodiment, cell binding agent is connected to the A of connector (if deposited
).</div>
      <div id="p2064" num="2064" class="description-paragraph style-scope patent-text">In one embodiment, it is keyed between cell binding agent and connector by thioether.</div>
      <div id="p2065" num="2065" class="description-paragraph style-scope patent-text">In one embodiment, it is connected between cell binding agent and connector by disulfide bond.</div>
      <div id="p2066" num="2066" class="description-paragraph style-scope patent-text">In one embodiment, it is keyed between cell binding agent and connector by amide.</div>
      <div id="p2067" num="2067" class="description-paragraph style-scope patent-text">In one embodiment, it is connected between cell binding agent and connector by ester bond.</div>
      <div id="p2068" num="2068" class="description-paragraph style-scope patent-text">In one embodiment, the cysteine for being connected to the cell binding agent between cell binding agent and connector
It is formed between the thiol group of residue and the maleimide base group of the connector.</div>
      <div id="p2069" num="2069" class="description-paragraph style-scope patent-text">The cysteine residues of cell binding agent can be used for and R<sup class="style-scope patent-text">L</sup>Functional group reactions formed connection.In other embodiment party
In formula, such as in the case where cell binding agent is antibody, the thiol group of the antibody can participate in intrachain disulfide bond.With
R<sup class="style-scope patent-text">L</sup>Functional group reactions before, these chain internal keies can be converted to free thiol group, such as anti-by being handled with DTT
Body.</div>
      <div id="p2070" num="2070" class="description-paragraph style-scope patent-text">Cell binding agent can be marked, such as is facilitated before being combined as conjugate or as one of conjugate
The detection or purifying of the reagent divided.Label can be biotin labeling.It in another embodiment, can be same with radioactivity
Position element label cell binding agent.</div>
      <div id="p2071" num="2071" class="description-paragraph style-scope patent-text">Drugloading rate</div>
      <div id="p2072" num="2072" class="description-paragraph style-scope patent-text">Drugloading rate is the average number of every cell binding agent (for example, antibody) PBD drug.When the compound of the present invention knot
When being bonded to cysteine, drugloading rate can be in the range of 1 to 8 drug of every cell binding agent (D), that is, 1,2,3,4,5,6,
7 and 8 drug moieties are covalently attached to cell binding agent.The composition of conjugate includes being combined with drug within the scope of 1 to 8
Cell binding agent (for example, antibody) set.When the compound of the present invention is bound to lysine, drugloading rate can be every
In the range of 1 to 80 drug of cell binding agent (D), although 40,20,10 or 8 upper limits may be preferred.Conjugate
Composition include the cell binding agent (example for being combined with drug within the scope of 1 to 80,1 to 40,1 to 20,1 to 10 or 1 to 8
Such as, antibody) set.</div>
      <div id="p2073" num="2073" class="description-paragraph style-scope patent-text">Prepared in product in the ADC from association reaction, the average number of every antibody drug can by usual manner such as UV,
Reverse hplc, HIC, mass spectrum, ELISA measurement and electrophoresis characterization.It can also determine with the quantitative distribution of the p ADC indicated.Pass through
ELISA can determine average value (Hamblett et al (2004) Clin.Cancer for preparing p in product in specific ADC
Res.10:7063-7070；Sanderson et al(2005)Clin.Cancer Res.11:843-852).However, p (medicine
Object) value distribution can not pass through the detection of antibody-antigen binding and ELISA limit identification.In addition, for detecting antibody-drug knot
The ELISA measurement for closing object not can determine where drug moiety is being attached to antibody, such as heavy chain or light chain segments or specifically
Amino acid residue.In some cases, it can realize that (wherein, p is homogeneous ADC by way of such as reversed-phase HPLC or electrophoresis
Specific value) separation, purifying and characterization with the ADC with other drugloading rates.This technology is also applied for other kinds of
Conjugate.</div>
      <div id="p2074" num="2074" class="description-paragraph style-scope patent-text">For certain antibody-drug conjugates, p can be attached site number on antibody is limited.For example, antibody can
With with only one or have multiple cysteine thiol groups, can have only one or have multiple abundant reactivity
Thiol group, connector can connect by the thiol group.Higher drugloading rate, such as p &gt; 5 can cause certain antibody-
The aggregation of drug conjugates, insoluble, toxicity or cell permeability are lost.</div>
      <div id="p2075" num="2075" class="description-paragraph style-scope patent-text">In general, the drug moiety less than theoretical maximum amount is bound to antibody by association reaction.For example, antibody can be with
The lysine residue not reacted with agent-linker intermediate (D-L) or linker reagents comprising many.It is only most reactive to rely
Propylhomoserin group can be reacted with amine reactivity linker reagents.In addition, only most reactive cysteine residues can be with mercaptan
Reactive linker reagents reaction.In general, antibody does not include, many (if any) is free to be can connect with reactive to medicine
The cysteine thiol group of object part.Most of cysteine mercaptan residues in the antibody of compound are deposited as disulphide bridges
, and (such as dithiothreitol (DTT) (DTT) or must TCEP) be restored under part or all of reducing condition with reducing agent.
The drugloading rate (drug/antibody ratio) of ADC can be controlled in many ways, comprising: (i) limits agent-linker intermediate (D-L)
Or molar excess of the linker reagents relative to antibody, (ii) limit association reaction time or temperature, and (iii) is used for half Guang
The part of propylhomoserin mercaptan modification or restricted reducing condition.</div>
      <div id="p2076" num="2076" class="description-paragraph style-scope patent-text">Certain antibody have disulphide in reducible chain, that is, cysteine bridge.For and linker reagents combination,
Antibody can be made to become that there is reactivity by being handled with reducing agent such as DTT (dithiothreitol (DTT)).Therefore, theoretically each half
Cystine bridge will form two reactive nucleophilic thiol bodies.By obtaining the lysine and 2- imino group of the conversion of amine to mercaptan
The reaction of thiophene (TrautShi reagent), other nucleophilic group can be introduced in antibody.By design 1,2,3,4 or more
Most cystine residues (for example, the mutant antibodies of preparation comprising one or more non-natural cysteine residues) can be by sulphur
Alcohol groups are introduced to antibody (or their segment).The introduction of US 7521541 is set by introducing reactive cysteine amino acids
Count antibody.</div>
      <div id="p2077" num="2077" class="description-paragraph style-scope patent-text">Cysteine residues can be designed at the reaction site in antibody and it is not formed in chain or intramolecular disulfide
Key (Junutula, et al., 2008b Nature Biotech., 26 (8): 925-932；Dornan et al(2009)
Blood 114(13):2721-2729；US 7521541；US 7723485； WO2009/052249).The cysteine of design
Mercaptan can be with linker reagents or this hair with thiol reactivity, electrophilic group (such as maleimide or alpha-halogenate amide)
Bright agent-linker reagent reaction, to form the antibody of the cysteine with design and the ADC of PBD drug moiety.Therefore,
It can design, control and the position of known drug part.Due to design cysteine thiol group usually with high yield with
Thiol reactivity linker reagents or the reaction of agent-linker reagent, it is all to can control drugloading rate.By in heavy chain or light chain
Single site replaces to design IgG antibody to introduce cysteine amino acids on symmetrical antibody and generate two half new Guang ammonia
Acid.By combination product ADC close to homogeney, the drugloading rate close to 2 may be implemented.</div>
      <div id="p2078" num="2078" class="description-paragraph style-scope patent-text">Before the more than one nucleophilic or electrophilic group and agent-linker intermediate or drug moiety reagent of antibody
When linker reagents react, then obtained product is point with the drug moiety (for example, 1,2,3 etc.) for being connected to antibody
The mixture of the ADC compound of cloth.Liquid chromatography, as polymer reverse phase (PLRP) and hydrophobic interaction (HIC) can lead to
Cross the compound in drugloading rate value separating mixture.The product that prepare of the ADC with single drugloading rate value (p) can be separated, so
And these single drugloading rate value ADC still can be a variety of mixtures, because drug moiety can be attached at via connector
In the different loci of antibody.</div>
      <div id="p2079" num="2079" class="description-paragraph style-scope patent-text">Therefore, antibody-drug combining compositions of the invention include the mixture of antibody-drug conjugates compound,
In, antibody has one or more PBD drug moiety, and wherein, drug moiety can be attached at different aminoacids residue
To antibody.</div>
      <div id="p2080" num="2080" class="description-paragraph style-scope patent-text">In one embodiment, in every cell binding agent dimer Pyrrolobenzodiazepines Zhuo group average
Mesh is in the range of 1 to 20.In some embodiments, range is selected from 1 to 8,2 to 8,2 to 6,2 to 4 and 4 to 8.</div>
      <div id="p2081" num="2081" class="description-paragraph style-scope patent-text">In some embodiments, there are a dimer Pyrrolobenzodiazepines are tall and erect in every cell binding agent.</div>
      <div id="p2082" num="2082" class="description-paragraph style-scope patent-text">Including other forms</div>
      <div id="p2083" num="2083" class="description-paragraph style-scope patent-text">Otherwise include above unless otherwise specified, is well-known ion, salt, the solvate of these substituent groups
And protected form.For example, referring to that carboxylic acid (- COOH) further includes its anion (carboxylate radical) form (- COO<sup class="style-scope patent-text">-</sup>), salt or solvent
The protected form of compound and routine.Similarly, refer to that amino group includes the protonated form (- N of amino group<sup class="style-scope patent-text">+</sup>
HR<sup class="style-scope patent-text">1</sup>R<sup class="style-scope patent-text">2</sup>), the conventional protected form of salt or solvate (for example, hydrochloride) and amino group.Similarly, hydroxyl is referred to
Group further includes its anionic form (- O<sup class="style-scope patent-text">-</sup>), the protected form of salt or solvate and routine.</div>
      <div id="p2084" num="2084" class="description-paragraph style-scope patent-text">Salt</div>
      <div id="p2085" num="2085" class="description-paragraph style-scope patent-text">Corresponding salt that is can be convenient or being contemplated to be preparation, purifying and/or processing reactive compound, for example, pharmaceutical salts.
The example of pharmaceutical salts is discussed in Berge, et al., J.Pharm.Sci., 66,1-19 (1977).</div>
      <div id="p2086" num="2086" class="description-paragraph style-scope patent-text">For example, if compound be anion or with can be anion functional group (for example,-COOH can be-
COO<sup class="style-scope patent-text">-</sup>), then it can be with suitable salt forming cation.The example of suitable inorganic cation includes but is not limited to alkali gold
Belong to ion such as Na<sup class="style-scope patent-text">+</sup>And K<sup class="style-scope patent-text">+</sup>, alkaline earth metal cation such as Ca<sup class="style-scope patent-text">2+</sup>And Mg<sup class="style-scope patent-text">2+</sup>And its cation such as Al<sup class="style-scope patent-text">+3</sup>.Suitable organic cation
Example includes but is not limited to ammonium ion (that is, NH<sub class="style-scope patent-text">4</sub> <sup class="style-scope patent-text">+</sup>) and replace ammonium ion (for example, NH<sub class="style-scope patent-text">3</sub>R<sup class="style-scope patent-text">+</sup>、NH<sub class="style-scope patent-text">2</sub>R<sub class="style-scope patent-text">2</sub> <sup class="style-scope patent-text">+</sup>、NHR<sub class="style-scope patent-text">3</sub> <sup class="style-scope patent-text">+</sup>、 NR<sub class="style-scope patent-text">4</sub> <sup class="style-scope patent-text">+</sup>).One
The example of ammonium ions suitably replaced a bit is derived from those of following: ethamine, diethylamine, dicyclohexyl amine, triethylamine, butylamine,
Ethylenediamine, ethanol amine, diethanol amine, piperazine, benzylamine, phenylbenzylamine, choline, meglumine and tromethamine and amino acid,
Such as lysine and arginine.The example of common quaternary ammonium ion is N (CH<sub class="style-scope patent-text">3</sub>)<sub class="style-scope patent-text">4</sub> <sup class="style-scope patent-text">+</sup>。</div>
      <div id="p2087" num="2087" class="description-paragraph style-scope patent-text">If compound be cationic compound or with can be cation functional group (for example,-NH<sub class="style-scope patent-text">2</sub>Can be-
NH<sub class="style-scope patent-text">3</sub> <sup class="style-scope patent-text">+</sup>), then can be with suitable anion forming salt.The example of suitable inorganic anion include but is not limited to be originated from it is following
Those of inorganic acid: hydrochloric acid, hydrobromic acid, hydroiodic acid, sulfuric acid, sulfurous acid, nitric acid, nitrous acid, phosphoric acid and phosphorous acid.</div>
      <div id="p2088" num="2088" class="description-paragraph style-scope patent-text">The example of suitable organic anion includes but is not limited to be originated from those of following organic acid: 2- acetyloxy phenyl
Formic acid, acetic acid, ascorbic acid, aspartic acid, benzoic acid, camphorsulfonic acid, cinnamic acid, citric acid, ethylenediamine tetra-acetic acid, second two
Sulfonic acid, ethanesulfonic acid, fumaric acid, heptonic acid, gluconic acid, glutamic acid, glycolic, hydroxymaleic acid, naphthol carboxylic acid, ethoxy
Sulfonic acid, lactic acid, lactobionic acid, lauric acid, maleic acid, malic acid, methane sulfonic acid, glactaric acid, oleic acid, oxalic acid, palmitinic acid, pa are not
Acid, pantothenic acid, phenylacetic acid, phenylbenzimidazole sulfonic acid, propionic acid, pyruvic acid, salicylic acid, stearic acid, succinic acid, p-aminobenzene sulfonic acid, winestone
Acid, toluenesulfonic acid, trifluoroacetic acid and valeric acid.The example of suitable polymer organic anion include but is not limited to be originated from
Those of lower polymeric acid: tannic acid, carboxymethyl cellulose.</div>
      <div id="p2089" num="2089" class="description-paragraph style-scope patent-text">Solvate</div>
      <div id="p2090" num="2090" class="description-paragraph style-scope patent-text">Coordinative solvent compound that is can be convenient or desirably preparing, purify and/or handle reactive compound.Term
" solvate " is used herein with conventional sense, indicate solute (for example, salt of reactive compound, reactive compound) and
The compound of solvent.If solvent is water, which is known as hydrate with can be convenient, for example, monohydrate, two
Hydrate, trihydrate etc..</div>
      <div id="p2091" num="2091" class="description-paragraph style-scope patent-text">The present invention includes such compound, and wherein solvent is by the imine linkage addition of the part PBD described below,
In the solvent be water or alcohol (R<sup class="style-scope patent-text">A</sup>OH, wherein R<sup class="style-scope patent-text">A</sup>It is C<sub class="style-scope patent-text">1-4</sub>Alkyl):</div>
      <div id="p2092" num="2092" class="description-paragraph style-scope patent-text">
        <span class="patent-image-not-available style-scope patent-text"></span>
      </div>
      <div id="p2093" num="2093" class="description-paragraph style-scope patent-text">The carbinolamine and methanol amidogen ether form that these forms are properly termed as PBD are (such as about above R<sup class="style-scope patent-text">10</sup>Section described in)
The balance of these equatioies depends on the condition of discovery compound and the property of the part itself.</div>
      <div id="p2094" num="2094" class="description-paragraph style-scope patent-text">For example, these specific compounds of solid form can be separated by being freeze-dried.</div>
      <div id="p2095" num="2095" class="description-paragraph style-scope patent-text">Isomers</div>
      <div id="p2096" num="2096" class="description-paragraph style-scope patent-text">Certain compounds of the invention can be with one or more specific geometric formats, optical form, the mapping bodily form
Formula, diastereomer form, epimeric form, dystopy isomers (atropic) form, stereoisomer form, mutually variation
Structure body form, conformational forms or different head isomers (anomeric) form, including but not limited to cis and trans；E type and Z-type；
C formula, t formula and r formula；Interior form and outer form；R type, S type and meso-form；D type and L-type；D type and l type；(+) and (-) shape
Formula；Keto-acid, enol form and enolate-forms；Cis and trans；To oblique formula and anticline form；Alpha form and beta form；It is axial
Form and calm form；Boat form, turns round formula, envelope type and half-chair at chair form；And their combination is hereinafter collectively referred to as " different
Structure body " (or " isomeric forms ").</div>
      <div id="p2097" num="2097" class="description-paragraph style-scope patent-text">Term " chirality " refers to the molecule of the non-overlap property with mirror image companion, and term " achirality " refer to
It is the molecule of overlapping on their mirror image companion.</div>
      <div id="p2098" num="2098" class="description-paragraph style-scope patent-text">Term " stereoisomer " refers to identical chemical component, but spatially atom or group arrangement are different
Compound.</div>
      <div id="p2099" num="2099" class="description-paragraph style-scope patent-text">" diastereoisomer " refers to two or more chiral centres, and its molecule is not mutual mirror image
Stereoisomer.Diastereoisomer has different physical properties, for example, fusing point, boiling point, spectral property and reactivity.
Under electrophoresis and chromatography, the mixture of diastereoisomer can be separated under high redissolution analytical procedure.</div>
      <div id="p2100" num="2100" class="description-paragraph style-scope patent-text">" enantiomter " refers to two kinds of stereoisomers of compound, is mutual non-superimposable mirror images.</div>
      <div id="p2101" num="2101" class="description-paragraph style-scope patent-text">Stereochemical definitions used herein and regulation usually follow S.P.Parker, Ed., McGraw-Hill
Dictionary of Chemical Terms(1984)McGraw-Hill Book Company,New York；And Eliel,
E.and Wilen, S., " Stereochemistry of Organic Compounds ", John Wiley&amp;Sons, Inc.,
New York,1994.The compound of the present invention may include asymmetric or chiral centre, therefore with different stereoisomers
Form exists.It is intended to all stereoisomer forms of the compound of the present invention, including but not limited to diastereoisomer, right
Isomers and steric hindrance isomers and their mixture (such as racemic mixture) are reflected, a part of the invention is formed.Perhaps
More organic compounds exist with optical active forms, that is, they have the ability for the Plane Rotation for making linearly polarized light.It is retouching
It states in optically active compound, prefix D and L or R and S are for indicating absolute configuration of the molecule about its chiral centre.It uses
The symbol of the linearly polarized light of prefix d and l or (+) and (-) Lai Zhiming compound rotation, (-) or l refer to that compound is left-handed
's.Prefix is (+) or the compound of d is dextrorotation.For given chemical structure, these stereoisomers are in addition to them
Mutual mirror image is identical.Specific stereoisomer can also be referred to as enantiomter, and often will be this different
The mixture of structure body is known as enantiomeric mixture.The 50:50 mixture of enantiomter is known as racemic mixture or outer
Raceme, this can occur in the chemical reaction for not having stereoselectivity or stereospecificity or in the process.Term " disappears outside
Rotation mixture " and " racemic modification " refer to two kinds of equimolar mixtures without optically active enantiomter substance.</div>
      <div id="p2102" num="2102" class="description-paragraph style-scope patent-text">It should be noted that unless (such as existing as discussed below for tautomeric forms from term " isomers "
It is used herein) clearly exclude structure (or construction) isomers (that is, its difference be connection from atom to atom without
It is only that the isomers of the position of atom in space).For example, referring to methoxy group (- OCH<sub class="style-scope patent-text">3</sub>) be not construed as referring to it
Constitutional isomer methylol groups (- CH<sub class="style-scope patent-text">2</sub>OH).Similarly, refer to that Chloro-O-Phenyl is not construed as referring to its structural isomerism
Chlorphenyl between body.However, referring to that a class formation can also include the structural isomerism bodily form fallen within the scope of the above-mentioned type
Formula is (for example, C<sub class="style-scope patent-text">1-7</sub>Alkyl includes n-propyl and isopropyl；Butyl includes normal-butyl, isobutyl group, sec-butyl and tert-butyl；Methoxy
Base phenyl includes o-methoxyphenyl, m-methoxyphenyl and p-methoxyphenyl).</div>
      <div id="p2103" num="2103" class="description-paragraph style-scope patent-text">It is above to exclude to be not related to tautomeric forms, such as in for example following tautomer pair: ketone/enol (with
Under show), imines/enamine, amide/imino group alcohol, amidine/amidine, nitroso/oxime, thioketones/alkene mercaptan, N- nitroso/hydroxyl it is even
Nitrogen and nitro/isonitro are for example, keto-acid, enol form and enolate-forms.</div>
      <div id="p2104" num="2104" class="description-paragraph style-scope patent-text">
        <span class="patent-image-not-available style-scope patent-text"></span>
      </div>
      <div id="p2105" num="2105" class="description-paragraph style-scope patent-text">Term " tautomer " or " tautomeric forms " refer to the constitutional isomer of different energy, pass through low energy
Obstacle is interconvertible.For example, proton tautomer (the also referred to as tautomer of proton) includes by the mutual of the migration of proton
It cashes as such as keto-enol and imine-enamine isomerizations.Valence tautomers include having again by some bonding electrons
The enantiotropy of machine.</div>
      <div id="p2106" num="2106" class="description-paragraph style-scope patent-text">It should be noted that term " isomers " particularly including the compound that there are one or more isotopes to replace.Example
Such as, H can with any isotope form, including<sup class="style-scope patent-text">1</sup>H、<sup class="style-scope patent-text">2</sup>H (D) and<sup class="style-scope patent-text">3</sup>H(T)；C can with any isotope form, including<sup class="style-scope patent-text">12</sup>C、<sup class="style-scope patent-text">13</sup>C, and<sup class="style-scope patent-text">14</sup>C；O can with any isotope form, including<sup class="style-scope patent-text">16</sup>O and<sup class="style-scope patent-text">18</sup>O；Deng.</div>
      <div id="p2107" num="2107" class="description-paragraph style-scope patent-text">The example that the isotope of the compound of the present invention can be bound to includes the same of hydrogen, carbon, nitrogen, oxygen, phosphorus, fluorine and chlorine
Position element, such as, but not limited to,<sup class="style-scope patent-text">2</sup>H (deuterium, D),<sup class="style-scope patent-text">3</sup>H (tritium),<sup class="style-scope patent-text">11</sup>C、<sup class="style-scope patent-text">13</sup>C、<sup class="style-scope patent-text">14</sup>C、<sup class="style-scope patent-text">15</sup>N、 <sup class="style-scope patent-text">18</sup>F、<sup class="style-scope patent-text">31</sup>P、<sup class="style-scope patent-text">32</sup>P、<sup class="style-scope patent-text">35</sup>S、<sup class="style-scope patent-text">36</sup>Cl and<sup class="style-scope patent-text">125</sup>I.Of the invention
The compound of various isotope labellings, such as radioactive isotope such as 3H, 13C and 14C are incorporated into these compounds.In this way
The compound of isotope labelling can be used for being metabolized research, Reaction kinetics research, detection or imaging technique, such as positive electron
Tomography (PET) or single photon emission computed tomography (SPECT), including drug or substrate tissue distribution
Measurement, or radioactive treatment in patients.The deuterium-labeled or substituted therapeutic compounds of the present invention has improved DMPK
(drug metabolism and pharmacokinetics) property is related to distribution, metabolism and excretion (ADME).With heavier isotope (such as deuterium)
Substitution can provide certain treatment advantages generated by higher metabolic stability, for example, Half-life in vivo increases or institute
The dosage needed is reduced.The compound of 18F label is useful to PET or SPECT research.The chemical combination of isotope labelling of the present invention
Object and its prodrug usually can pass through following preparation: carry out public in scheme or embodiment discussed below and preparation example
The step of opening replaces isotope-labeled reagent with the reagent for the isotope labelling being easy to get.In addition, with heavier same
Position element, especially deuterium (that is, 2H or D) substitution can provide certain treatment advantages generated by higher metabolic stability, example
Such as, Half-life in vivo increases or required dosage reduces or therapeutic index increases.It should be understood that the deuterium in context is regarded
Make substituent group.The concentration of this higher isotope (especially deuterium) can be defined by isotope enrichment factor.In the present invention
Compound in, it is any not clearly indicate any stable isotope that the atom is represented for the atom of specific isotope.</div>
      <div id="p2108" num="2108" class="description-paragraph style-scope patent-text">The specific compound otherwise mentioned unless otherwise specified, includes these whole isomeric forms, including it is (all
Or partly) racemic and other mixtures.Preparation (for example, asymmetric syntheses) and separation for this isomeric forms
The method of (for example, fractional crystallization and chromatography) is known in the art, or is adjusted by known methods teaching herein
Method or known method are readily available.</div>
      <div id="p2109" num="2109" class="description-paragraph style-scope patent-text">Bioactivity</div>
      <div id="p2110" num="2110" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">In vitro cell proliferation assay</u>
      </div>
      <div id="p2111" num="2111" class="description-paragraph style-scope patent-text">In general, passing through the cytotoxicity or cell inhibitory activity of following measurement antibody-drug conjugates (ADC): will have
The mammalian cell of receptor protein is exposed to the antibody of the ADC in cell culture medium, such as HER2；It is small to cultivate one section of cell about 6
Up to about 5 days periods；And measurement cell viability.External test based on cell is for measuring ADC of the invention
Survival ability (proliferation), cytotoxicity and the induction of cell death (caspase activation).</div>
      <div id="p2112" num="2112" class="description-paragraph style-scope patent-text">The vitro efficacy of antibody-drug conjugates can be measured by cell proliferating determining. CellTiter-<span class="patent-image-not-available style-scope patent-text"></span>It is cold
Light (electroluminescent, Luminescent) cell viability analyzer be it is commercially available (Promega Corp.,
Madison, WI), measuring method of the same race is based on recombinant expression (the US patent No. of coleoptera (Coleoptera) luciferase
5583024；5674713 and 5700670).The cell proliferating determining is survived based on quantitatively determining in culture medium for existing ATP
The number of cell, the ATP be metabolic active cells instruction (Crouch et al (1993) J.Immunol. Meth.160:
81-88；US 6602677).CellTiter- is carried out in 96 orifice plates<span class="patent-image-not-available style-scope patent-text"></span>Measurement, makes it that can be subjected to automatic high throughput
Screen (Cree et al (1995) the AntiCancer Drugs 6:398-404) of (HTS).Determination step of the same race is related to directly
Add single agents (CellTiter-<span class="patent-image-not-available style-scope patent-text"></span>Reagent) to culture supplement serum medium cell.Do not need cell washing,
Remove medium and multiple liquid relief step.After adding reagent and mixing, system detects in 384 orifice plates low in 10 minutes
To 15 cells/wells.ADC continuous processing cell can be used, or can handle cell and separate it with ADC.In general, simple place
The cell of reason (that is, 3 hours) shows effect identical as the cell of continuous processing.</div>
      <div id="p2113" num="2113" class="description-paragraph style-scope patent-text">" addition-mixing-measurement " mode of the same race leads to cell lysis effect and the cold light proportional to the amount of existing ATP
The generation of signal.The amount of ATP and the number for the cell being present in culture medium are directly proportional.CellTiter-<span class="patent-image-not-available style-scope patent-text"></span>Measurement
Generation is usually had by " growth type " luminescence signal that luciferase reaction generates according to the cell type and medium used
Half-life period greater than 5 hours.Survival Cells react on relatively cool light unit (RLU).By recombination firefly luciferase with
The adjoint conversion of ATP to AMP and the generation of photon, substrate beetle luciferin (Beetle Luciferin) are oxidized decarboxylation
Base.</div>
      <div id="p2114" num="2114" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">In vivo efficacy</u>
      </div>
      <div id="p2115" num="2115" class="description-paragraph style-scope patent-text">The internal effect of measurement antibody-drug conjugates (ADC) can be studied by the tumor xenogeneic graft in mouse
Power.For example, the high internal effect expressed HER2 transgenosis explant mouse model and measure anti-HER2ADC of the invention can be passed through
Power.Allograft, the mouse pair are bred by Fo5mmtv transgenic mice<span class="patent-image-not-available style-scope patent-text"></span>Therapy does not respond to
Or difference in response.With certain dosage level (mg/kg) and PBD drug exposure (μ g/m<sup class="style-scope patent-text">2</sup>) at ADC and placebo buffer control
It is primary to manage subject；And it monitors and two weeks or more doubles measuring tumour, the time of log cell death and tumor regression.</div>
      <div id="p2116" num="2116" class="description-paragraph style-scope patent-text">Purposes</div>
      <div id="p2117" num="2117" class="description-paragraph style-scope patent-text">Conjugate of the invention can be used for providing PBD compound in target location.</div>
      <div id="p2118" num="2118" class="description-paragraph style-scope patent-text">Target location is preferably the cell mass being proliferated.Antibody is the anti-of the antigen for being present on proliferating-cell population
Body.</div>
      <div id="p2119" num="2119" class="description-paragraph style-scope patent-text">In one embodiment, with the amount phase for the antigen being present in proliferating-cell population (for example, tumor cell group)
Than antigen is not present in or is present in non-proliferative cell mass with reduction level.</div>
      <div id="p2120" num="2120" class="description-paragraph style-scope patent-text">In target location, connector can be cut, thus the compound of release type (D).Therefore, conjugate can be used for
Selectivity provides the compound of formula (D) to target location.</div>
      <div id="p2121" num="2121" class="description-paragraph style-scope patent-text">The digestion that connector can be present in target location is cut.</div>
      <div id="p2122" num="2122" class="description-paragraph style-scope patent-text">Target location can be external, internal or external.</div>
      <div id="p2123" num="2123" class="description-paragraph style-scope patent-text">Antibody-drug conjugates (ADC) compound of the invention includes having for those of anticancer activity effectiveness.Tool
Body, compound includes combining, that is, the antibody of PBD drug moiety (that is, toxin) is covalently attached to by connector.Work as drug
When being not bound to antibody, PBD drug has cytotoxic effect.Therefore, PBD drug moiety is adjusted by being bound to antibody
Bioactivity.Antibody-drug conjugates (ADC) of the invention selectively deliver the cytotoxic reagent of effective dose to swollen
Tumor tissue, it is thus possible to realize higher selectivity, that is, less effective dose.</div>
      <div id="p2124" num="2124" class="description-paragraph style-scope patent-text">Therefore, on the one hand, the present invention provides the combination compounds for being described herein for therapeutical uses.</div>
      <div id="p2125" num="2125" class="description-paragraph style-scope patent-text">In a further aspect, the combination for being described herein for proliferative diseases treatment purposes is additionally provided
Compounds.The second aspect of the present invention is provided in conjunction with compounds in manufacturing the medicament for treating proliferative diseases
Purposes.</div>
      <div id="p2126" num="2126" class="description-paragraph style-scope patent-text">Those of ordinary skill in the art can be readily determined whether candidate conjugate treats any particular cell types
Proliferative disorders.For example, describing measuring method below in an example, they may be conveniently used the specific chemical combination of evaluation
Activity provided by object.</div>
      <div id="p2127" num="2127" class="description-paragraph style-scope patent-text">Term " proliferative diseases " be related to unwanted over or abnormal cell be not intended to or cell Proliferation out of control,
Such as tumour or Hyperplastic growth, either in vitro or in vivo.</div>
      <div id="p2128" num="2128" class="description-paragraph style-scope patent-text">The example of proliferative disorders is including but not limited to benign, before cancer and the proliferation of malignant cell, including but not limited to tumor
With tumour (for example, histocytoma, glioma, astrocytoma, osteoma), cancer (for example, lung cancer, cellule lung
Cancer, human primary gastrointestinal cancers, intestinal cancer, colon cancer, breast cancer, oophoroma, prostate cancer, carcinoma of testis, liver cancer, kidney, bladder cancer, cancer of pancreas,
The cancer of the brain, sarcoma, osteosarcoma, Kaposi sarcoma, melanoma), leukaemia, psoriasis, bone disease, fibroproliferative disorders
(for example, connective tissue) and atherosclerosis.Cancer of special interest includes but is not limited to leukaemia and oophoroma.</div>
      <div id="p2129" num="2129" class="description-paragraph style-scope patent-text">It can treat any kind of cell, including but not limited to lung, gastrointestinal tract (including for example, intestines, colon), mammary gland
(breast), ovary, prostate, liver (liver), kidney (kidney), bladder, pancreas, brain and skin.</div>
      <div id="p2130" num="2130" class="description-paragraph style-scope patent-text">In one embodiment, which is treatment cancer of pancreas.</div>
      <div id="p2131" num="2131" class="description-paragraph style-scope patent-text">In one embodiment, which is that treatment has α on cell surface<sub class="style-scope patent-text">ν</sub>β<sub class="style-scope patent-text">6</sub>The tumour of integral protein.</div>
      <div id="p2132" num="2132" class="description-paragraph style-scope patent-text">It is expected that antibody-drug conjugates (ADC) of the invention can be used for treatment for example by the overexpression table of tumour antigen
The a variety of diseases or disorder of sign.Exemplary conditions or hyperproliferative disorders include benign or malignant tumour；Leukaemia, blood
And lymphoid malignancies.Other include disorder below: neuron, Deiter's cells, astrocyte, under
Thalamus, body of gland, macrophage, epithelium, matrix, blastocoele, inflammatory, blood vessel generates and immunology
, including autoimmune disorders.</div>
      <div id="p2133" num="2133" class="description-paragraph style-scope patent-text">In general, the disease or disorder for the treatment of are excess proliferative diseases, such as cancer.The example for the cancer treated herein
Including but not limited to cancer, lymthoma, blastoma, sarcoma and leukaemia or lymphoid malignancy.This cancer it is more specific
Example includes squamous cell carcinoma (for example, epithelial squamous cell cancer), lung cancer (including Small Cell Lung Cancer, non-small cell lung cancer), lung
Squamous cell carcinoma and the gland cancer of lung, peritoneal cancer, hepatocellular carcinoma, gastric cancer or stomach cancer (including human primary gastrointestinal cancers), cancer of pancreas, plastic
Cell plastid tumor, cervical carcinoma, oophoroma, liver cancer, bladder cancer, hepatoma, breast cancer, colon and rectum carcinoma, colorectum
Cancer, carcinoma of endometrium or uterine cancer, salivary-gland carcinoma, kidney or renal cancer, prostate cancer, carcinoma of vulva, thyroid cancer, liver tumour,
Cancer of anus, carcinoma of penis and head and neck cancer.</div>
      <div id="p2134" num="2134" class="description-paragraph style-scope patent-text">The autoimmune disease that ADC can be used in the treatment includes rheumatic disease (as example, rheumatoid arthrosis
Inflammation, Sjogren syndrome, chorionitis, lupus such as SLE and lupus nephritis, polymyositis/dermatomyositis, cryoglobulinemia, anti-phosphatide are anti-
Body syndrome and psoriatic arthritis), osteoarthritis, autoimmune gastrointestinal and liver disorder are (as example, inflammatory bowel disease
(for example, ulcerative colitis and Crohn disease), autoimmune gastritis and pernicious anaemia, oneself immunity hepatitis, primary
Biliary cirrhosis, primary sclerotic cholangitis and chylous diarrhea, vasculitis (as example, the relevant vasculitis of ANCA, including
Qiu-applies vasculitis, Wegner's granulomatosis and panarteritis), Autoimmune neuropathies disorder (e.g., for example, multiple sclerosis,
Slanting eye myoclonic syndrome, myasthenia gravis, neuromyelitis optica, Parkinson's disease, Alzheimer's disease and itself exempt from
Epidemic disease polyneuropathy), kidney trouble (as example, glomerulonephritis, Goodpasture's syndrome and Bei Geershi disease), from
The disorder of body immune dermatosis is (as example, psoriasis, nettle rash, morbilli, pemphigus vulgaris, bullous pemphigoid and skin
Lupus erythematosus), hematology disorder (as example, after thrombocytopenic purpura, thrombotic thrombocytopenic purpura, blood transfusion it is purple
Purplish or white patches on the skin and autoimmune hemolytic anemia), atherosclerosis, uveitis, autoimmune auditory disorder is (as example, interior
Otopathy and hearing loss), Behcet's disease, Raynaud's syndrome, organ transplant and autoimmune endocrine disturbance be (such as example
Such as, diabetes associated autoimmune disease such as insulin-dependent diabetes mellitus (IDDM), Addison's disease and autoimmune first
Shape adenopathy (for example, Graves disease and thyroiditis)).Preferred this disease includes such as rheumatic arthritis, ulcer
It is property colitis, the relevant vasculitis of ANCA, lupus, multiple sclerosis, Sjogren syndrome, Graves disease, IDDM, pernicious
Anaemia, thyroiditis and glomerulonephritis.</div>
      <div id="p2135" num="2135" class="description-paragraph style-scope patent-text">Treatment method</div>
      <div id="p2136" num="2136" class="description-paragraph style-scope patent-text">Conjugate of the invention can use in treatment method.There is also provided a kind of method for the treatment of, including to needing
The subject wanted gives the combination compounds of the invention of therapeutically effective amount.Term " therapeutically effective amount " is to be enough to show pair
Amount at benefits subjects.This benefit, which can be, at least alleviates at least one symptom.The actual amount given and the rate given
Property to be treated and seriousness will be depended on time-histories.Treatment prescription (for example, dosage decision) is by general practitioner and other doctors
It is raw to be responsible for.</div>
      <div id="p2137" num="2137" class="description-paragraph style-scope patent-text">It can individually give or be combined with other treatment and give the compound of the present invention, while give and still sequentially giving
Depending on illness to be treated.The example for the treatment of and therapy includes but is not limited to that chemotherapy (gives activating agent, including for example
Drug, such as chemotherapy)；Operation；And radiotherapy.</div>
      <div id="p2138" num="2138" class="description-paragraph style-scope patent-text">Do not consider mechanism of action, " chemotherapeutics " is chemical compound useful in cancer treatment.The classification packet of chemotherapeutics
It is different to include but be not limited to Alkylators, antimetabolite, spindle poisonous plant alkaloid, cytotoxicity/antitumor antibiotics, topology
Structure enzyme inhibitor, antibody, photosensitizer and kinase inhibitor.Chemotherapeutics is included in used in " targeted therapies " and conventional chemotherapy
Compound.</div>
      <div id="p2139" num="2139" class="description-paragraph style-scope patent-text">The example of chemotherapeutics include: Tarceva (<span class="patent-image-not-available style-scope patent-text"></span>Genentech/OSI Pharm.), more west he
Match (<span class="patent-image-not-available style-scope patent-text"></span>Sanofi-Aventis), 5-FU (fluorouracil, 5 FU 5 fluorouracil, CAS No.51-21-8),
Gemcitabine (<span class="patent-image-not-available style-scope patent-text"></span>Lilly), PD-0325901 (CAS No.391210-10-9, Pfizer), cis-platinum (cis- two
Amine, dichloro platinum (II), CAS No. 15663-27-1), carboplatin (CAS No.41575-94-4), taxol (<span class="patent-image-not-available style-scope patent-text"></span>
Bristol-Myers Squibb Oncology, Princeton, N.J.), Herceptin (<span class="patent-image-not-available style-scope patent-text"></span>
Genentech), Temozolomide (bicyclic [4.3.0] the nonyl- 2,7,9- triolefin-of 4- methyl -5- oxygroup -2,3,4,6,8- pentaaza
9- formamide, CAS 85622-93-1,<span class="patent-image-not-available style-scope patent-text"></span>Schering Plough), tamoxifen
Fragrant ((Z) -2- [4- (1,2- diphenyl but-1-ene base) phenoxy group]-N, N- dimethyl amine,<span class="patent-image-not-available style-scope patent-text"></span>) and Doxorubicin<span class="patent-image-not-available style-scope patent-text"></span>Akti-1/2, HPPD and rapamycin.</div>
      <div id="p2140" num="2140" class="description-paragraph style-scope patent-text">More examples of chemotherapeutics include: oxaliplatin (<span class="patent-image-not-available style-scope patent-text"></span>Sanofi), bortezomib (<span class="patent-image-not-available style-scope patent-text"></span>Millennium Pharm.), sotan (<span class="patent-image-not-available style-scope patent-text"></span>SU11248, Pfizer), Letrozole (<span class="patent-image-not-available style-scope patent-text"></span>Novartis), imatinib mesylate (<span class="patent-image-not-available style-scope patent-text"></span> Novartis)、XL-518(Mek
Inhibitor, Exelixis, WO 2007/044515), ARRY-886 (Mek inhibitor, AZD6244, Array
BioPharma, Astra Zeneca), SF-1126 (PI3K inhibitor, Semafore Pharmaceuticals), BEZ-235
(PI3K inhibitor, Novartis), XL-147 (PI3K inhibitor, Exelixis), PTK787/ZK 222584
(Novartis), fulvestrant (<span class="patent-image-not-available style-scope patent-text"></span>AstraZeneca), Calciumlevofolinate (folinic acid), rapamycin (west
Luo Mosi,<span class="patent-image-not-available style-scope patent-text"></span>Wyeth), Lapatinib (<span class="patent-image-not-available style-scope patent-text"></span>GSK572016, Glaxo Smith
Kline), Luo Nafani (SARASAR<sup class="style-scope patent-text">TM</sup>, SCH 66336, Schering Plough), Sorafenib (<span class="patent-image-not-available style-scope patent-text"></span>
BAY43-9006, Bayer Labs), Gefitinib (<span class="patent-image-not-available style-scope patent-text"></span>AstraZeneca), Irinotecan (<span class="patent-image-not-available style-scope patent-text"></span>CPT-11, Pfizer), replace pyrrole method Buddhist nun (ZARNESTRA<sup class="style-scope patent-text">TM</sup>, Johnson&amp;Johnson),
ABRAXANE<sup class="style-scope patent-text">TM</sup>The albumin nano of (being free of Emulsifier EL-60), taxol designs preparation (American
Pharmaceutical Partners, Schaumberg, Il), Vande Thani (rINN, ZD6474,<span class="patent-image-not-available style-scope patent-text"></span>
AstraZeneca), Chlorambucil, AG1478, AG1571 (SU 5271；Sugen), sirolimus (<span class="patent-image-not-available style-scope patent-text"></span>
Wyeth), pazopanib (GlaxoSmithKline), camphane Buddhist (<span class="patent-image-not-available style-scope patent-text"></span>Telik), phosphinothioylidynetrisaziridine and cyclophosphamide<span class="patent-image-not-available style-scope patent-text"></span>Alkyl sulfonic ester, such as busulfan, Improsulfan and piposulfan；Aziridine
Class, such as Benzodepa (benzodopa), carboquone, Meturedepa (meturedopa) and urethimine (uredopa)；Second
Support imines and methylmelamine (methylamelamines), including hemel, triethylenemelamine, triethylphosphoramide, three
Ethylene thio-phosphamide and tri methylol melamine (trimethylolomelamine)；Lactone (especially its pungent and Bradley of Bradley
Its octanone)；Camptothecine (the class topotecan including synthesis)；Bryostatin；callystatin；CC-1065 (including it Ah
More next new, Carzelesins and Bizelesin synthetic analogues)；Cryptophycin (especially cryptophycin 1 and cryptophycin 8)；Duola department
Statin；Times carcinomycin (including synthetic analogues, KW-2189 and CB1-TM1)；Ai Liusu (eleutherobin)；Water ghost any of several broadleaf plants
Alkali；sarcodictyin；Sponge inhibin (spongistatin)；Mustargen such as Chlorambucil, Chlornaphazine, cyclophosphamide, female
Mo Siting, ifosfamide, mechlorethamine, mustargen oxide hydrochloride, melphalan, novembichin, phenesterin,
Pennisetum mustard, trofosfamide, uracil mastard；Nitroso ureas such as Carmustine, chloramphenicol, Fotemustine, Lip river are not
Take charge of spit of fland, Nimustine and Ranimustine (ranimnustine)；Antibiotic such as enediyne antibiotic (such as calicheamycin plus benefit
Vehicle mycin γ 1I, calicheamicin Ω I1 (Angew Chem.Intl.Ed.Engl. (1994) 33:183-186)；Anthracycline antibiosis
Plain (dynemicin), endomycin (dynemicin A) is reached；Diphosphonate, such as clodronate；Ai Sipeila mycin；And it is new
Carcinostain chromophore and related chromoprotein enediyne antibiotic chromophore), aclacinomycin, D actinomycin D, anthramycin
(authramycin), azaserine, bleomycin, D actinomycin D, Carubicin (carabicin), carminomycin, thermophilic cancer
Rhzomorph, chromomycin (chromomycinis), dactinomycin D, daunorubicin, Detorubicin, the just bright ammonia of 6- diazonium -5- oxygroup-L-
Acid, morpholinyl-adriamycin, cyano morpholinyl-adriamycin, 2- pyrrolino-doxorubicin and deoxy doxorubicin, epirubicin, according to
Rope for example than star, idarubicin, Nemorubicin, marcellomycin, mitomycin mitomycin C, mycophenolic acid, nogalamycin,
Olivomycin class, Peplomycin, porphyromycin, puromycin, triferricdoxorubicin, rodorubicin, streptonigrin, streptozotocin,
Tuberculin, ubenimex, neoearcinostain, zorubicin；Antimetabolite, such as methotrexate (MTX) and 5 FU 5 fluorouracil (5-FU)；
Folacin, such as denopterin, methotrexate (MTX), pteropterin, Trimetrexate；Purine analogue, such as fludarabine, 6- sulfydryl
Purine, thiapurine, thioguanine；Pyrimidine analogue, such as ancitabine, azacitidine, 6- azauridine, Carmofur, arabinose born of the same parents
Glycosides, di-deoxyuridine, doxifluridine, enocitabine, floxuridine；Androgen, such as Calusterone, Masterone, ring
Sulphur hero alcohol, Mepitiostane, Testolactone；Anti- adrenal gland, such as Rumi spy, mitotane, Trilostane；Folic acid supplement, such as folinic acid；
Aceglatone；Aldophosphamideglycoside；Amino-laevulic acid；Eniluracil；Amsacrine； bestrabucil；Verapamil；According to
Up to Qu Sha (edatraxate)；Defosfamide (defofamine)；Demecolcine；Aziridinyl Benzoquinone；Eflornithine
(elfornithine)；Elliptinium Acetate；Epothilones；Ethoglucid；Gallium nitrate；Hydroxycarbamide；Lentinan；
lonidainine；CHROMATOGRAPHIC FRACTIONATION AND MASS, such as maytansine and ansamitocin；Mitoguazone；Mitoxantrone；Mopidamol
(mopidanmol)；Nitrazine；Pentostatin；Benzene carrys out beautiful spy；Pirarubicin；Luo Suo；Podophyllin acid；2- ethyl hydrazine；Methyl benzyl
Hydrazine；<span class="patent-image-not-available style-scope patent-text"></span>Polysaccharide compound (JHS Natural Products, Eugene, OR)；Razoxane；Rhizomycin；Sizofiran；Spiral shell
Ring germanium；Tenuazonic acid；Triethyleneiminobenzoquinone；2,2 ', 2 "-trichlorotriethylamines；Single-ended spore (especially T-2 toxin, wart spore bacterium
Element (verracurin) A, Roridine A and anguidin)；Urethane；Eldisine；Dacarbazine；Mannomustin；Two
Bromine mannitol；Mitolactol；Pipobroman；gacytosine；Cytarabine (" Ara-C ")；Cyclophosphamide；Phosphinothioylidynetrisaziridine；
6- thioguanine；Purinethol；Methotrexate (MTX)；Platinum analogs, such as cis-platinum and carboplatin；Vincaleukoblastinum；Etoposide (VP-16)；It is different
Cyclophosphamide；Mitoxantrone；Vincristine；Vinorelbine<span class="patent-image-not-available style-scope patent-text"></span>Nuo Xiaolin；Teniposide；It is bent according to reaching
It is husky；Daunorubicin；Aminopterin；Capecitabine (<span class="patent-image-not-available style-scope patent-text"></span>Roche)；Ibandronate；CPT-11；Topoisomerase
Enzyme inhibitor RFS2000；Difluoromethylornithine (DFMO)；Retinoic acid-like, such as retinoic acid；Any of the above pharmaceutically may be used
The salt of receiving, acid and derivative.</div>
      <div id="p2141" num="2141" class="description-paragraph style-scope patent-text">Further include in the definition of " chemotherapeutics ": (i) acts on adjusting or inhibits the anti-of the hormonal action in tumour
Hormone agents such as antiestrogenic and selective estrogen receptor modulators (SERM), for example including tamosifen (including<span class="patent-image-not-available style-scope patent-text"></span>Tamoxifen citrate), Raloxifene, Droloxifene, 4- hydroxy tamoxifen, Trioxifene, that
Lip river former times sweet smell (keoxifene), LY117018, Onapristone and<span class="patent-image-not-available style-scope patent-text"></span>(Toremifene Citrate)；(ii) inhibit
The aromatase inhibitor of enzyme aromatase enzyme, adjusting result from adrenal estrogen such as such as 4 (5)-imidazoles, aminoglutethimide,<span class="patent-image-not-available style-scope patent-text"></span>(megestrol acetate),<span class="patent-image-not-available style-scope patent-text"></span>(Exemestane；Pfizer), Formestane
(formestanie), Fadrozole,<span class="patent-image-not-available style-scope patent-text"></span>(Vorozole),<span class="patent-image-not-available style-scope patent-text"></span>(Letrozole；Novartis) and<span class="patent-image-not-available style-scope patent-text"></span>(Anastrozole；AstraZeneca)；(iii) antiandrogen such as Drogenil, Nilutamide, than card Shandong
Amine, Leuprorelin and Goserelin；And troxacitabine (1,3- dioxolane nucleoside acid analogue of cytosine)；(iv) albumen
Matter kinase inhibitor such as MEK inhibitor (WO 2007/044515)；(v) lipid kinase inhibitors；(vi) antisense oligonucleotides,
Especially inhibit those of the gene expression of signal path impacted in distortion cell Proliferation, such as PKC- α, Raf and H-
Ras, as oblimersen (<span class="patent-image-not-available style-scope patent-text"></span>Genta Inc.)；(vii) ribozyme such as vegf expression inhibitor (example
Such as,<span class="patent-image-not-available style-scope patent-text"></span>) and HER2 expression inhibiting agent；(viii) vaccine such as gene therapy vaccine, such as<span class="patent-image-not-available style-scope patent-text"></span>With<span class="patent-image-not-available style-scope patent-text"></span>rIL-2；Topology is different
1 inhibitor of structure enzyme, such as<span class="patent-image-not-available style-scope patent-text"></span> <span class="patent-image-not-available style-scope patent-text"></span>rmRH；(ix) anti-angiogenic agent such as Avastin
(<span class="patent-image-not-available style-scope patent-text"></span>) and the pharmaceutically acceptable salt of any of the above, acid and derivative Genentech.</div>
      <div id="p2142" num="2142" class="description-paragraph style-scope patent-text">Further include in the definition of " chemotherapeutics " be therapeutic antibodies such as alemtuzumab (Campath), bevacizumab (<span class="patent-image-not-available style-scope patent-text"></span>Genentech)；Cetuximab (<span class="patent-image-not-available style-scope patent-text"></span>Imclone)；Victibix (<span class="patent-image-not-available style-scope patent-text"></span>Amgen), Rituximab (<span class="patent-image-not-available style-scope patent-text"></span>Genentech/Biogen Idec), the appropriate pearl of pa
Monoclonal antibody (OMNITARG<sup class="style-scope patent-text">TM</sup>, 2C4, Genentech), trastuzumab (<span class="patent-image-not-available style-scope patent-text"></span>Genentech), tositumomab
(Bexxar, Corixia) and antibody drug conjugate, WAY-CMA 676 (<span class="patent-image-not-available style-scope patent-text"></span>Wyeth)。</div>
      <div id="p2143" num="2143" class="description-paragraph style-scope patent-text">Include: with the Humanized monoclonal antibodies for combining the treatment potentiality as chemotherapeutics with conjugate of the invention
Alemtuzumab, A Bozhu monoclonal antibody, A Saizhu monoclonal antibody, Torr pearl monoclonal antibody (atlizumab), Ba Pinzhu monoclonal antibody (bapineuzumab),
Bevacizumab, not than cut down pearl monoclonal antibody, not bank trastuzumab, cedelizumab, match trastuzumab, cidfusituzumab,
The sharp pearl monoclonal antibody of cidtuzumab, daclizumab, Yi Kuli monoclonal antibody, efalizumab, epratuzumab, strategic point, non-dimension pearl are single
Anti-, fragrant trastuzumab (fontolizumab), lucky trastuzumab, English trastuzumab (inotuzumab ozogamicin), she
Monoclonal antibody, draw shellfish pearl monoclonal antibody, lintuzumab, matuzumab, mepolizumab, Mo Weizhu monoclonal antibody, motovizumab, that
His pearl monoclonal antibody, Buddhist nun's trastuzumab, nolovizumab, numavizumab, auspicious pearl monoclonal antibody (ocrelizumab) difficult to understand, Ma Zhudan
Anti-, palivizumab, pa examine pearl monoclonal antibody, pecfusituzumab, pectuzumab, handkerchief trastuzumab, training gram pearl monoclonal antibody,
Ralivizumab, Lucentis, reslivizumab, Rayleigh pearl monoclonal antibody, resyvizumab, rovelizumab, Lu Lidan
Anti-, sibrotuzumab, cedelizumab (siplizumab), Suo Tuzhu monoclonal antibody, his pearl monoclonal antibody (tacatuzumab
Tetraxetan), he spends that pearl monoclonal antibody, his sharp pearl monoclonal antibody, special non-pearl monoclonal antibody, tower Xidan is anti-, holds in the palm sharp pearl monoclonal antibody
(toralizumab), trastuzumab, tucotuzumab Celmoleukin (celmoleukin), tucusituzumab,
Umavizumab, black pearl monoclonal antibody and Wei Xi pearl monoclonal antibody (visilizumab).</div>
      <div id="p2144" num="2144" class="description-paragraph style-scope patent-text">According to the invention and pharmaceutical composition used according to the present invention is removed active constituent (that is, in conjunction with compounds)
It in addition, can also include pharmaceutical excipient, carrier, buffer, stabilizer or other objects well known to the skilled person
Matter.Such substance should be effect that is nontoxic, and should not interfere with active constituent.The definite property of carrier or other substances
It will depend on giving approach, this is given approach and can be orally or through injection (such as skin, subcutaneous or intravenous).</div>
      <div id="p2145" num="2145" class="description-paragraph style-scope patent-text">The oral pharmaceutical composition given can be tablet, capsule, powder or liquid form.Tablet may include solid
Body carrier or adjuvant.Composition of liquid medicine generally comprises liquid-carrier such as water, petroleum (petroleum), animal or plant
Oil, mineral oil or synthetic oil.May include normal saline solution, dextrose or other saccharide solutions or glycols such as ethylene glycol,
Propylene glycol or polyethylene glycol.Capsule may include solid carrier such as gelatin.</div>
      <div id="p2146" num="2146" class="description-paragraph style-scope patent-text">Injection for intravenous injection, skin or subcutaneous injection or at painful position, active constituent can be parenteral
The form of acceptable aqueous solution, the aqueous solution are pyrogen-free and have suitable pH, isotonicity and stability.Ability
Domain related technical personnel are fully able to prepare suitable solution, such as are injected using isotonic vehicle such as sodium chloride injection, woods lattice
Liquid, lactated ringers injection.It as needed may include preservative, stabilizer, buffer, antioxidant and/or other add
Add agent.</div>
      <div id="p2147" num="2147" class="description-paragraph style-scope patent-text">Preparation</div>
      <div id="p2148" num="2148" class="description-paragraph style-scope patent-text">Although can be used alone (for example, giving) in conjunction with compounds, often preferably make it as combination
Object or preparation exist.</div>
      <div id="p2149" num="2149" class="description-paragraph style-scope patent-text">In one embodiment, composition is comprising combination compounds described herein and pharmaceutically acceptable
Carrier, diluent or excipient pharmaceutical composition (for example, preparation, preparation, drug).</div>
      <div id="p2150" num="2150" class="description-paragraph style-scope patent-text">In one embodiment, composition is comprising at least one combination compounds described herein and one kind
Or the pharmaceutical composition of a variety of pharmaceutically acceptable ingredients well known to the skilled person, the ingredient include but not
It is limited to pharmaceutically acceptable carrier, diluent, excipient, adjuvant, filler, buffer, preservative, antioxidant, lubrication
Agent, stabilizer, solubilizer, surfactant (for example, wetting agent), screening agent, colorant, flavoring agent and sweetener.</div>
      <div id="p2151" num="2151" class="description-paragraph style-scope patent-text">In one embodiment, composition further includes other activating agents, such as other therapeutic agents or prophylactic.</div>
      <div id="p2152" num="2152" class="description-paragraph style-scope patent-text">Suitable carrier, diluent, excipient etc. can be found in standard pharmaceutical text.See, e.g.,<u class="style-scope patent-text">Handbook of Pharmaceutical Additives</u>, second edition (eds.M.Ash and I.Ash), 2001 (Synapse
Information Resources,Inc.,Endicott,New York,USA), <u class="style-scope patent-text">Remington's Pharmaceutical </u> <u class="style-scope patent-text">Sciences</u>, the 20th edition, pub.Lippincott, Williams&amp; Wilkins, 2000；With<u class="style-scope patent-text">Handbook of </u> <u class="style-scope patent-text">Pharmaceutical Excipients</u>, second edition, 1994.</div>
      <div id="p2153" num="2153" class="description-paragraph style-scope patent-text">Another aspect of the present invention relates to the methods of production pharmaceutical composition, including by least one defined herein
[<sup class="style-scope patent-text">11</sup>C]-radioactive isotope tracer conjugate or combine class compound and one or more those skilled in the art many institute's weeks
Other the pharmaceutically acceptable ingredients known mix, for example, carrier, diluent, excipient etc..If be formulated as from
Throwaway member (for example, tablet etc.), then each unit includes the reactive compound of predetermined amount (dosage).</div>
      <div id="p2154" num="2154" class="description-paragraph style-scope patent-text">As it is used herein, term " pharmaceutically acceptable " is related to compound, ingredient, material, composition, dosage form
Deng not having within a reasonable range of medical judgment, suitable for being contacted with the tissue of the subject (for example, mankind) discussed
There are excessive toxicity, stimulation, allergic reaction or other problems or complication, and matches with reasonable interests/Hazard ratio.Every kind
Carrier, diluent, excipient etc. also must be " acceptable " in the sense that compatible with the other compositions of preparation.</div>
      <div id="p2155" num="2155" class="description-paragraph style-scope patent-text">Said preparation can be prepared by the well-known any method of pharmaceutical field.Such method includes making to activate
It closes object and constitutes the carrier-bound step of one or more auxiliary elements.In general, preparation by make reactive compound with
Carrier (for example, liquid-carrier, fine solid carrier etc.) is uniform closely to be combined, then make if necessary product at
It is prepared by shape.</div>
      <div id="p2156" num="2156" class="description-paragraph style-scope patent-text">Preparation can be prepared as discharging quickly or at a slow speed；Immediately, delay, instant or slow release；Or their group
It closes.</div>
      <div id="p2157" num="2157" class="description-paragraph style-scope patent-text">Preparation suitable for parenterally giving (for example, passing through injection) include it is aqueous or non-aqueous, isotonic, pyrogen-free,
Sterile liquid (such as solution, suspension), wherein active constituent is dissolved, suspends or otherwise provides (for example, in rouge
In plastid or other particles).In addition this liquid can contain other pharmaceutically acceptable ingredients, such as antioxidant, buffering
Agent, preservative, stabilizer, bacteriostatic agent, suspending agent, thickener and makes the blood of preparation and intended recipient (or other are related
Body fluid) isotonic solute.The example of excipient includes, for example, water, alcohol, polyalcohol, glycerol, vegetable oil etc..For such system
The example of the suitable isotonic vehicle of agent includes sodium chloride injection, ringer's solution (Ringer's Solution) or lactated Ringer's
Family name's injection.In general, the concentration of active constituent is about 1ng/ml to about 10 μ g/mL, for example, about 10ng/mL to about 1 μ in liquid
g/mL.Said preparation may be present in unit dose or multi-dose sealing container, such as in ampoule and phial, and can freeze
It is stored under the conditions of dry (freeze-drying), it is only necessary to sterile liquid carrier such as water for injection be added before use.It can be by aseptic powder
End, particle and tablet prepare injection solution and suspension on the spot.</div>
      <div id="p2158" num="2158" class="description-paragraph style-scope patent-text">Dosage</div>
      <div id="p2159" num="2159" class="description-paragraph style-scope patent-text">It will be apparent to a skilled person that combining the composition of compounds in conjunction with compounds and comprising this
Suitable dosage can be different because of patient.The horizontal and any risk for making treatment benefit will be involved or have by determining optimal dose generally
Evil side effect balance.The dosage level of selection depend on Multiple factors, including but not limited to the activity of specific compound, give
Approach is given time, the excretion time of compound, the duration for the treatment of, other drugs, compound, and/or is applied in combination
Substance, illness seriousness and species, gender, age, weight, illness, general health and the medical history of patient.Chemical combination
It the amount of object and gives approach and finally will cautiously be determined by doctor, animal doctor or clinician, but in general, dosage will be selected
The desired local concentration acted on without will cause material injury or harmful side effect is realized to reach in site of action.</div>
      <div id="p2160" num="2160" class="description-paragraph style-scope patent-text">During the entire course for the treatment of, can with single dose, continuously or intermittently (for example, with appropriate time interval divided dose)
Realization is given.Determine that the most effective means and the method for dosage given are well known to the skilled person, and will be with
Change for the preparation of therapy, therapy purpose, (a variety of) target cell treated and the difference of the subject treated.It can
Single or multiple give is carried out with the dosage level and mode that are selected with treating physician, animal doctor or clinician.</div>
      <div id="p2161" num="2161" class="description-paragraph style-scope patent-text">In general, the suitable dose of reactive compound is in every kg of body's weight about 100 ng to about 25mg daily
(more generally in the range of about 1 μ g to about 10mg).In the case where the compound is salt, ester, amide, prodrug etc., based on mother
Body compound calculates administered dose, so the proportional increase of actual weight used.</div>
      <div id="p2162" num="2162" class="description-paragraph style-scope patent-text">In one embodiment, reactive compound is given to human patients according to following dosage: about 100mg,
3 times a day.</div>
      <div id="p2163" num="2163" class="description-paragraph style-scope patent-text">In one embodiment, reactive compound is given to human patients according to following dosage: about 150mg,
2 times a day.</div>
      <div id="p2164" num="2164" class="description-paragraph style-scope patent-text">In one embodiment, reactive compound is given to human patients according to following dosage: about 200mg,
2 times a day.</div>
      <div id="p2165" num="2165" class="description-paragraph style-scope patent-text">However, in one embodiment, will be given in conjunction with compounds to human patients according to following dosage:
About 50 or about 75mg, daily 3 or 4 times.</div>
      <div id="p2166" num="2166" class="description-paragraph style-scope patent-text">In one embodiment, it will be given in conjunction with compounds to human patients according to following dosage: about 100
Or about 125mg, 2 times a day.</div>
      <div id="p2167" num="2167" class="description-paragraph style-scope patent-text">Dosage described above can be adapted for conjugate (comprising the part PBD and to the connector of antibody) or suitable for mentioning
The effective quantity of the PBD compound of confession, for example, the amount of the compound discharged after joint cutting.</div>
      <div id="p2168" num="2168" class="description-paragraph style-scope patent-text">For preventing or treating disease, the suitable dosage of ADC of the invention will depend on disease defined above to be treated
Sick type, the severity of disease and situation (no matter giving molecule is for prevention or therapeutic purposes), prior treatment, patient
Clinical medical history and to the reaction of antibody and the judgement of attending physician.Once or by a series of treat molecule suitably
It gives to patient.According to disease type and severity, no matter, such as individually given or by one or many by continuous
Infusion, about 1 μ g/kg to 15mg/kg (for example, 0.1-20mg/kg) molecule is for giving to the initial candidate dosage of patient.
Common daily dosage can be in the range of about 1 μ g/kg to 100mg/kg or more, this depends on above-mentioned factor.Give to
The exemplary dose of the ADC of patient is within the scope of about the 0.1 to about 10mg/kg of patient weight.For several days or longer repetition
It gives, according to illness, treatment, which continues to, realizes that the expectation of disease symptoms inhibits.Exemplary dose scheme includes giving about 4mg/
The case where kg initial drugloading rate, then weekly, every two weeks or the ADC of the every three weeks other dosage of addition.Other dosages can
To be useful.The progress of the therapy is easy to monitor by routine techniques and measuring method.</div>
      <div id="p2169" num="2169" class="description-paragraph style-scope patent-text">Treatment</div>
      <div id="p2170" num="2170" class="description-paragraph style-scope patent-text">In the case where treating illness term as used herein " treatment " be usually directed to no matter mankind or animal (for example,
Veterinary application) treatment and therapy, wherein wherein realize some desired curative effects, for example, the inhibition to ongoing disease, and
And including development speed reduce, development speed halves, illness is restored, illness improves and illness rehabilitation.It further include as preventative
The treatment of measure (that is, prevent, prevent).</div>
      <div id="p2171" num="2171" class="description-paragraph style-scope patent-text">As it is used herein, term " therapeutically effective amount " be related to reactive compound or substance comprising reactive compound,
The amount of composition or dosage form is effective for generating some desired curative effects when being given according to desired therapeutic scheme
, it is suitable with reasonable interests/Hazard ratio.</div>
      <div id="p2172" num="2172" class="description-paragraph style-scope patent-text">Similarly, as it is used herein, term " prevention effective dose " is related to reactive compound or comprising reactive compound
Substance, composition or dosage form amount, when being given according to desired therapeutic scheme, for generating some desired preventions
Effect is effective, suitable with reasonable interests/Hazard ratio.The preparation of antibody drug conjugate</div>
      <div id="p2173" num="2173" class="description-paragraph style-scope patent-text">It can be by number of ways well known by persons skilled in the art, using organic chemical reactions, condition and reagent, system
Standby antibody drug conjugate, comprising: (1) nucleophilic group of antibody or electrophilic group are via covalent bond and bivalent linker reagent shape
At the reaction of antibody-linker intermediate A b-L, it is followed by and is reacted with the drug moiety reagent of activation；(2) drug moiety tries
Agent forms reacting for agent-linker reagent D-L with linker reagents via covalent bond, is followed by and the nucleophilic group of antibody or parent
The reaction of electric group.Antibody-drug of the invention can be prepared using Multiple Antibodies and connector in conjunction with method (1) and (2)
Conjugate.</div>
      <div id="p2174" num="2174" class="description-paragraph style-scope patent-text">Nucleophilic group on antibody includes but is not limited to: (i) N-terminal amine groups, (ii) side chain amine groups, such as lysine,
(iii) side chain thiol moiety, such as cysteine, and (iv) sugared hydroxyl or amino group, wherein antibody is glycosylated.
Amine, mercaptan and hydroxyl group are nucleophilicities and can form covalent bond, and connector with the electrophilic group reactions on junction portion
Reagent includes: (i) active ester such as NHS ester, HOBt ester, haloformate and acyl halide；(ii) alkyl and benzylic halides such as halogen
For acetamide；(iii) aldehyde, ketone, carboxyl and maleimide base group.Certain antibody have disulphide in reducible chain,
That is, cysteine bridge.By with reducing agent, such as DTT (Cleland's reagent, dithiothreitol dithio) or TCEP (three (2- carboxylic second
Base) phosphine hydrochloride；Getz et al(1999) Anal.Biochem.Vol 273:73-80；Soltec Ventures,
Beverly, MA) processing the combination of antibody and linker reagents can be made to become easily to react.Therefore, each cysteine curing
Object bridge will form theoretic two reactive nucleophilic thiol substances.By obtaining the lysine and 2- of the conversion of amine to mercaptan
The reaction of imino group thiophene (Traut ' s reagent), other nucleophilic group can be introduced in antibody.</div>
      <div id="p2175" num="2175" class="description-paragraph style-scope patent-text">Subject/patient</div>
      <div id="p2176" num="2176" class="description-paragraph style-scope patent-text">Subject/patient can be animal, mammal, placental mammals, marsupial (for example, kangaroo, bag
Bear), monotreme (for example, platypus), rodent (for example, cavy, hamster, rat, mouse), murine (example
Such as, mouse), Lagomorph (for example, rabbit), birds (for example, bird), canid (for example, dog), felid (example
Such as, cat), equid (for example, horse), porcine animals (for example, domestic pig), sheep (for example, sheep), bovid
(for example, milk cow), primate, apes (for example, monkey or anthropoid), monkey class (for example, marmoset, baboon), anthropoid
(for example, gorilla, chimpanzee, orangutan, gibbon) or the mankind.</div>
      <div id="p2177" num="2177" class="description-paragraph style-scope patent-text">In addition, subject/patient can be any form of its development, such as fetus.In a preferred embodiment
In, subject/patient is people.</div>
      <div id="p2178" num="2178" class="description-paragraph style-scope patent-text">In one embodiment, patient be wherein each patient on cell surface have α<sub class="style-scope patent-text">ν</sub>β<sub class="style-scope patent-text">6</sub>Integral protein
The group of tumour.</div>
      <div id="p2179" num="2179" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">General route of synthesis</u>
      </div>
      <div id="p2180" num="2180" class="description-paragraph style-scope patent-text">The extensive discussions synthesis of the PBD compound comprising two imine moieties, passes through reference in below with reference to document
Discussion therein is hereby incorporated by:</div>
      <div id="p2181" num="2181" class="description-paragraph style-scope patent-text">A) WO 00/12508 (page 14 to 30)；</div>
      <div id="p2182" num="2182" class="description-paragraph style-scope patent-text">B) WO 2005/023814 (page 3 to 10)；</div>
      <div id="p2183" num="2183" class="description-paragraph style-scope patent-text">C) WO 2004/043963 (page 28 to 29)；</div>
      <div id="p2184" num="2184" class="description-paragraph style-scope patent-text">D) WO 2005/085251 (page 30 to 39)；With</div>
      <div id="p2185" num="2185" class="description-paragraph style-scope patent-text">E) WO 2011/130598 (page 126 to 150).</div>
      <div id="p2186" num="2186" class="description-paragraph style-scope patent-text">Route of synthesis</div>
      <div id="p2187" num="2187" class="description-paragraph style-scope patent-text">The compound of Formulas I can be by the compound synthesis of Formulas I P:</div>
      <div id="p2188" num="2188" class="description-paragraph style-scope patent-text">
        <span class="patent-image-not-available style-scope patent-text"></span>
      </div>
      <div id="p2189" num="2189" class="description-paragraph style-scope patent-text">Wherein, R<sup class="style-scope patent-text">L-pre</sup>Represent group R<sup class="style-scope patent-text">L</sup>Precursor.</div>
      <div id="p2190" num="2190" class="description-paragraph style-scope patent-text">For example, working as R<sup class="style-scope patent-text">L</sup>When being following group:</div>
      <div id="p2191" num="2191" class="description-paragraph style-scope patent-text">
        <span class="patent-image-not-available style-scope patent-text"></span>
      </div>
      <div id="p2192" num="2192" class="description-paragraph style-scope patent-text">R<sup class="style-scope patent-text">L-pre</sup>It can be H-L<sup class="style-scope patent-text">1</sup>-L<sup class="style-scope patent-text">2</sup>- C (=O)-*.The addition of G can be realized by way of conventional, it is suitable as needed
Amine/amido functional group in protection PBD ring.</div>
      <div id="p2193" num="2193" class="description-paragraph style-scope patent-text">By super hydride reduction, the compound of Formulas I P can be by the compound synthesis of the following Expression 2:</div>
      <div id="p2194" num="2194" class="description-paragraph style-scope patent-text">
        <span class="patent-image-not-available style-scope patent-text"></span>
      </div>
      <div id="p2195" num="2195" class="description-paragraph style-scope patent-text">Wherein, R<sup class="style-scope patent-text">20</sup>It is H, R<sup class="style-scope patent-text">21a</sup>And R<sup class="style-scope patent-text">21b</sup>It is all H and R<sup class="style-scope patent-text">11b</sup>It is OH.The case where substituent group can be subjected to reducing condition
Under, which is suitable.It can be according to WO 2011/130598 (page 126 to 150) and there are also the Shen co-pending PCT
Please PCT/US2012/59864, in submission on October 12nd, 2012 apply, described in technology synthesis formula 2 compound,
It is incorporated by reference herein.</div>
      <div id="p2196" num="2196" class="description-paragraph style-scope patent-text">It alternatively, can be by being coupled the compound of the compound synthesis Formulas I P of the following Expression 3 and 4:</div>
      <div id="p2197" num="2197" class="description-paragraph style-scope patent-text">
        <span class="patent-image-not-available style-scope patent-text"></span>
      </div>
      <div id="p2198" num="2198" class="description-paragraph style-scope patent-text">Wherein, R<sup class="style-scope patent-text">20</sup>It is H and R<sup class="style-scope patent-text">21a</sup>And R<sup class="style-scope patent-text">21b</sup>It is all H, wherein Prot<sup class="style-scope patent-text">N</sup>Represent the nitrogen-protecting group group for synthesis, Hal choosing
From I, Cl and Br and Prot<sup class="style-scope patent-text">O</sup>The oxygen blocking group for synthesis is represented, then removes Prot at the standard conditions<sup class="style-scope patent-text">O</sup>Group.</div>
      <div id="p2199" num="2199" class="description-paragraph style-scope patent-text">Such as acetone and alkali (such as K in reflux<sub class="style-scope patent-text">2</sub>CO<sub class="style-scope patent-text">3</sub>) in may be implemented to be coupled.</div>
      <div id="p2200" num="2200" class="description-paragraph style-scope patent-text">By being coupled the compound of the following Expression 6, the compound of formula 3 can be by the compound synthesis of formula 5:</div>
      <div id="p2201" num="2201" class="description-paragraph style-scope patent-text">
        <span class="patent-image-not-available style-scope patent-text"></span>
      </div>
      <div id="p2202" num="2202" class="description-paragraph style-scope patent-text">Hal-R "-Q formula 6</div>
      <div id="p2203" num="2203" class="description-paragraph style-scope patent-text">Wherein, Q is selected from I, Cl and Br.Such as acetone and alkali (such as K in reflux<sub class="style-scope patent-text">2</sub>CO<sub class="style-scope patent-text">3</sub>) in may be implemented to react.It needed
The compound of the formula 6 of amount realizes desired product.</div>
      <div id="p2204" num="2204" class="description-paragraph style-scope patent-text">The compound of formula 5 can be by the compound synthesis of the following Expression 7:</div>
      <div id="p2205" num="2205" class="description-paragraph style-scope patent-text">
        <span class="patent-image-not-available style-scope patent-text"></span>
      </div>
      <div id="p2206" num="2206" class="description-paragraph style-scope patent-text">Wherein, Prot<sup class="style-scope patent-text">Y</sup>' it is the blocking group for Y ' orthogonal with other blocking groups in compound.In standard bar
Under part, synthesis is realized by being deprotected to Y '.</div>
      <div id="p2207" num="2207" class="description-paragraph style-scope patent-text">At the standard conditions, by with Prot<sup class="style-scope patent-text">N</sup>NH group is protected, the compound of formula 7 can be by the compound of the following Expression 8
Synthesis:</div>
      <div id="p2208" num="2208" class="description-paragraph style-scope patent-text">
        <span class="patent-image-not-available style-scope patent-text"></span>
      </div>
      <div id="p2209" num="2209" class="description-paragraph style-scope patent-text">By reduction amination, the compound of formula 8 can be by the compound synthesis of the following Expression 9:</div>
      <div id="p2210" num="2210" class="description-paragraph style-scope patent-text">
        <span class="patent-image-not-available style-scope patent-text"></span>
      </div>
      <div id="p2211" num="2211" class="description-paragraph style-scope patent-text">By the oxidation of alcohol, the compound of formula 9 can be by the compound synthesis of the following Expression 10:</div>
      <div id="p2212" num="2212" class="description-paragraph style-scope patent-text">
        <span class="patent-image-not-available style-scope patent-text"></span>
      </div>
      <div id="p2213" num="2213" class="description-paragraph style-scope patent-text">By being deprotected at the standard conditions to OH group, the compound of formula 10 can be closed by the compound of the following Expression 11
At:</div>
      <div id="p2214" num="2214" class="description-paragraph style-scope patent-text">
        <span class="patent-image-not-available style-scope patent-text"></span>
      </div>
      <div id="p2215" num="2215" class="description-paragraph style-scope patent-text">Include-R by palladium mediated<sup class="style-scope patent-text">12</sup>Appropriate compound coupling, there are the changes of the formula of double bond 11 between C2 ' and C3 '
Closing object can be by the compound synthesis of formula 12:</div>
      <div id="p2216" num="2216" class="description-paragraph style-scope patent-text">
        <span class="patent-image-not-available style-scope patent-text"></span>
      </div>
      <div id="p2217" num="2217" class="description-paragraph style-scope patent-text">The coupling includes but is not limited to: being coupled with the Suzuki of boron derivative appropriate；With alkene include acrylamide and
The Hcek of acrylate is coupled；It is coupled with the Stille of organotin reagent such as alkyl tin reagent；With the Sonagishira of alkynes
Coupling；With the hydrogen migration for using triethylsilane.</div>
      <div id="p2218" num="2218" class="description-paragraph style-scope patent-text">Under an inert atmosphere, in the drying organic solvent of -35 DEG C of temperature below, by using trifluoromethanesulfanhydride anhydride
With anhydrous 2,6- lutidines or anhydrous 2,6- tert-Butyl-pyridin trifluoro Mesylation, the compound of formula 12 can be by following
The compound synthesis of formula 13:</div>
      <div id="p2219" num="2219" class="description-paragraph style-scope patent-text">
        <span class="patent-image-not-available style-scope patent-text"></span>
      </div>
      <div id="p2220" num="2220" class="description-paragraph style-scope patent-text">In C2 ' and C3 ' between there is no double bond formula 11 compound synthesis in, correlation can be introduced at this stage
R<sup class="style-scope patent-text">12</sup>。</div>
      <div id="p2221" num="2221" class="description-paragraph style-scope patent-text">The compound of formula 4 can be by the compound synthesis of formula 14:</div>
      <div id="p2222" num="2222" class="description-paragraph style-scope patent-text">
        <span class="patent-image-not-available style-scope patent-text"></span>
      </div>
      <div id="p2223" num="2223" class="description-paragraph style-scope patent-text">Wherein, Prot<sup class="style-scope patent-text">Y</sup>It is the blocking group for Y orthogonal with other blocking groups in compound.In standard conditions
Under, synthesis is realized by being deprotected to Y.</div>
      <div id="p2224" num="2224" class="description-paragraph style-scope patent-text">By using Prot at the standard conditions<sup class="style-scope patent-text">O</sup>OH group is protected, the compound of formula 14 can be closed by the compound of formula 15
At:</div>
      <div id="p2225" num="2225" class="description-paragraph style-scope patent-text">
        <span class="patent-image-not-available style-scope patent-text"></span>
      </div>
      <div id="p2226" num="2226" class="description-paragraph style-scope patent-text">It can be by the compound synthesis of formula 16 by the compound of oxidation-type 15:</div>
      <div id="p2227" num="2227" class="description-paragraph style-scope patent-text">
        <span class="patent-image-not-available style-scope patent-text"></span>
      </div>
      <div id="p2228" num="2228" class="description-paragraph style-scope patent-text">Such as Dess-Martin high price iodide (or alternative TPAP/NMO, TFAA/DMSO, SO can be used<sub class="style-scope patent-text">3</sub>, pyrrole
Pyridine complex compound/DMSO, PDC, PCC, BAIB/TEMPO or under the conditions of Swern) aoxidized.</div>
      <div id="p2229" num="2229" class="description-paragraph style-scope patent-text">By being deprotected at the standard conditions to OH group, the compound of formula 16 can be by the compound synthesis of formula 17:</div>
      <div id="p2230" num="2230" class="description-paragraph style-scope patent-text">
        <span class="patent-image-not-available style-scope patent-text"></span>
      </div>
      <div id="p2231" num="2231" class="description-paragraph style-scope patent-text">At the standard conditions, under those, pass through coupling group Prot as described in WO 2005/023814<sup class="style-scope patent-text">L-pre</sup>, formula 17
Compound can be by the compound synthesis of formula 18:</div>
      <div id="p2232" num="2232" class="description-paragraph style-scope patent-text">
        <span class="patent-image-not-available style-scope patent-text"></span>
      </div>
      <div id="p2233" num="2233" class="description-paragraph style-scope patent-text">By restoring nitryl group, the compound of formula 18 can be by the compound synthesis of formula 19:</div>
      <div id="p2234" num="2234" class="description-paragraph style-scope patent-text">
        <span class="patent-image-not-available style-scope patent-text"></span>
      </div>
      <div id="p2235" num="2235" class="description-paragraph style-scope patent-text">Such as it can be realized and be restored by standard mode with Zn dust and 5% formic acid in methyl alcohol.</div>
      <div id="p2236" num="2236" class="description-paragraph style-scope patent-text">Include-R by palladium mediated<sup class="style-scope patent-text">2</sup>Appropriate compound coupling, there are the chemical combination of the formula of double bond 19 between C2 and C3
Object can be by the compound synthesis of formula 20:</div>
      <div id="p2237" num="2237" class="description-paragraph style-scope patent-text">
        <span class="patent-image-not-available style-scope patent-text"></span>
      </div>
      <div id="p2238" num="2238" class="description-paragraph style-scope patent-text">The coupling includes but is not limited to: being coupled with the Suzuki of boron derivative appropriate；With alkene include acrylamide and
The Hcek of acrylate is coupled；It is coupled with the Stille of organotin reagent such as alkyl tin reagent；With the Sonagishira of alkynes
Coupling；With the hydrogen migration for using triethylsilane.</div>
      <div id="p2239" num="2239" class="description-paragraph style-scope patent-text">By under an inert atmosphere, in the drying organic solvent of -35 DEG C of temperature below, by using trifluoro methylsulphur
The trifluoro Mesylation of acid anhydrides and anhydrous 2,6- lutidines or anhydrous 2,6- tert-Butyl-pyridin, the compound of formula 20 can be with
By the compound synthesis of formula 21:</div>
      <div id="p2240" num="2240" class="description-paragraph style-scope patent-text">
        <span class="patent-image-not-available style-scope patent-text"></span>
      </div>
      <div id="p2241" num="2241" class="description-paragraph style-scope patent-text">In C2 ' and C3 ' between there is no double bond formula 19 compound synthesis in, correlation can be introduced at this stage
R<sup class="style-scope patent-text">2</sup>。</div>
      <div id="p2242" num="2242" class="description-paragraph style-scope patent-text">It can be by being coupled the compound of the compound synthesis Formulas I P of the following Expression 22 and 4, wherein R<sup class="style-scope patent-text">20</sup>It is H and R<sup class="style-scope patent-text">21a</sup>With
R<sup class="style-scope patent-text">21b</sup>It is formed together=O:</div>
      <div id="p2243" num="2243" class="description-paragraph style-scope patent-text">
        <span class="patent-image-not-available style-scope patent-text"></span>
      </div>
      <div id="p2244" num="2244" class="description-paragraph style-scope patent-text">Wherein, Prot<sup class="style-scope patent-text">N- amine</sup>Represent the half-aminal nitrogen-protecting group group for synthesis.</div>
      <div id="p2245" num="2245" class="description-paragraph style-scope patent-text">Such as acetone and alkali (such as K in reflux<sub class="style-scope patent-text">2</sub>CO<sub class="style-scope patent-text">3</sub>) in may be implemented to be coupled.</div>
      <div id="p2246" num="2246" class="description-paragraph style-scope patent-text">By being coupled the compound of formula 6, the compound of formula 22 can be by the compound synthesis of formula 23:</div>
      <div id="p2247" num="2247" class="description-paragraph style-scope patent-text">
        <span class="patent-image-not-available style-scope patent-text"></span>
      </div>
      <div id="p2248" num="2248" class="description-paragraph style-scope patent-text">Hal-R "-Q formula 6</div>
      <div id="p2249" num="2249" class="description-paragraph style-scope patent-text">Such as acetone and alkali (such as K in reflux<sub class="style-scope patent-text">2</sub>CO<sub class="style-scope patent-text">3</sub>) in the reaction may be implemented.The compound of excessive formula 6 is needed
Realize desired product.</div>
      <div id="p2250" num="2250" class="description-paragraph style-scope patent-text">At the standard conditions, by being deprotected to Y ', the compound of formula 23 can be by the compound synthesis of formula 24:</div>
      <div id="p2251" num="2251" class="description-paragraph style-scope patent-text">
        <span class="patent-image-not-available style-scope patent-text"></span>
      </div>
      <div id="p2252" num="2252" class="description-paragraph style-scope patent-text">Include-R by palladium mediated<sup class="style-scope patent-text">12</sup>The coupling of the appropriate compound of (as described above), is deposited between C2 ' and C3 '
The compound of the formula 24 of double bond can be by the compound synthesis of formula 25:</div>
      <div id="p2253" num="2253" class="description-paragraph style-scope patent-text">
        <span class="patent-image-not-available style-scope patent-text"></span>
      </div>
      <div id="p2254" num="2254" class="description-paragraph style-scope patent-text">By trifluoro Mesylation, the compound of formula 25 can be by the compound synthesis of formula 26:</div>
      <div id="p2255" num="2255" class="description-paragraph style-scope patent-text">
        <span class="patent-image-not-available style-scope patent-text"></span>
      </div>
      <div id="p2256" num="2256" class="description-paragraph style-scope patent-text">This can be carried out under condition or standard conditions described above.</div>
      <div id="p2257" num="2257" class="description-paragraph style-scope patent-text">By aoxidizing alcohol groups, the compound of formula 26 can be by the compound synthesis of formula 27:</div>
      <div id="p2258" num="2258" class="description-paragraph style-scope patent-text">
        <span class="patent-image-not-available style-scope patent-text"></span>
      </div>
      <div id="p2259" num="2259" class="description-paragraph style-scope patent-text">By removing Prot<sup class="style-scope patent-text">O</sup>The compound of group, formula 27 can be by the compound synthesis of formula 28:</div>
      <div id="p2260" num="2260" class="description-paragraph style-scope patent-text">
        <span class="patent-image-not-available style-scope patent-text"></span>
      </div>
      <div id="p2261" num="2261" class="description-paragraph style-scope patent-text">The Prot<sup class="style-scope patent-text">O</sup>Group is the alcohol protection group group orthogonal with other blocking groups in compound.</div>
      <div id="p2262" num="2262" class="description-paragraph style-scope patent-text">By protecting amine with half-aminal nitrogen-protecting group group, the compound of formula 28 can be by the compound synthesis of formula 29:</div>
      <div id="p2263" num="2263" class="description-paragraph style-scope patent-text">
        <span class="patent-image-not-available style-scope patent-text"></span>
      </div>
      <div id="p2264" num="2264" class="description-paragraph style-scope patent-text">By realizing closed loop with hydrogen and Pd/C ester reduction functional group, the compound of formula 29 can be closed by the compound of formula 30
At:</div>
      <div id="p2265" num="2265" class="description-paragraph style-scope patent-text">
        <span class="patent-image-not-available style-scope patent-text"></span>
      </div>
      <div id="p2266" num="2266" class="description-paragraph style-scope patent-text">Under amide coupling conditions, the compound of formula 29 can be synthesized by the compound of coupling formula 31 and 32:</div>
      <div id="p2267" num="2267" class="description-paragraph style-scope patent-text">
        <span class="patent-image-not-available style-scope patent-text"></span>
      </div>
      <div id="p2268" num="2268" class="description-paragraph style-scope patent-text">In C2 ' and C3 ' between there is no double bond formula 24 compound synthesis in, correlation can be introduced at this stage
R<sup class="style-scope patent-text">2</sup>。</div>
      <div id="p2269" num="2269" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Further preference</u>
      </div>
      <div id="p2270" num="2270" class="description-paragraph style-scope patent-text">Following preference can be adapted for all aspects of invention as described above or can be related to single aspect.This is excellent
Option can be combined with any combination.</div>
      <div id="p2271" num="2271" class="description-paragraph style-scope patent-text">In some embodiments, R<sup class="style-scope patent-text">6’</sup>、R<sup class="style-scope patent-text">7’</sup>、R<sup class="style-scope patent-text">9’</sup>And Y ' preferably respectively with R<sup class="style-scope patent-text">6</sup>、R<sup class="style-scope patent-text">7</sup>、R<sup class="style-scope patent-text">9</sup>It is identical with Y.</div>
      <div id="p2272" num="2272" class="description-paragraph style-scope patent-text">Dimer connection</div>
      <div id="p2273" num="2273" class="description-paragraph style-scope patent-text">Y and Y ' is preferably O.</div>
      <div id="p2274" num="2274" class="description-paragraph style-scope patent-text">R " is preferably the C without substituent group<sub class="style-scope patent-text">3-7</sub>Alkylidene group.It is highly preferred that R " is C<sub class="style-scope patent-text">3</sub>、 C<sub class="style-scope patent-text">5</sub>Or C<sub class="style-scope patent-text">7</sub>Alkylidene.Most
Preferably, R " is C<sub class="style-scope patent-text">3</sub>Or C<sub class="style-scope patent-text">5</sub>Alkylidene.</div>
      <div id="p2275" num="2275" class="description-paragraph style-scope patent-text">R<sup class="style-scope patent-text">6</sup>To R<sup class="style-scope patent-text">9</sup> </div>
      <div id="p2276" num="2276" class="description-paragraph style-scope patent-text">R<sup class="style-scope patent-text">9</sup>Preferably H.</div>
      <div id="p2277" num="2277" class="description-paragraph style-scope patent-text">R<sup class="style-scope patent-text">6</sup>It is preferably chosen from H, OH, OR, SH, NH<sub class="style-scope patent-text">2</sub>, nitro and halogen, and more preferably H or halogen and optimal
Selection of land is H.</div>
      <div id="p2278" num="2278" class="description-paragraph style-scope patent-text">R<sup class="style-scope patent-text">7</sup>It is preferably chosen from H, OH, OR, SH, SR, NH<sub class="style-scope patent-text">2</sub>, NHR, NRR ' and halogen, and more preferably independently selected from H,
OH and OR, wherein R is preferably chosen from optionally substituted C<sub class="style-scope patent-text">1-7</sub>Alkyl, C<sub class="style-scope patent-text">3-10</sub>Heterocycle and C<sub class="style-scope patent-text">5-10</sub>Aryl group.It can be more preferable
Be C<sub class="style-scope patent-text">1-4</sub>Alkyl group, can with or cannot be substituted.Interested substituent group is C<sub class="style-scope patent-text">5-6</sub>Aryl group (for example, phenyl).
Particularly preferred substituent group at the position 7- is OMe and OCH<sub class="style-scope patent-text">2</sub>Ph.Other substituent groups of special interest are dimethylaminos
(that is,-NMe<sub class="style-scope patent-text">2</sub>)；-(OC<sub class="style-scope patent-text">2</sub>H<sub class="style-scope patent-text">4</sub>)<sub class="style-scope patent-text">q</sub>OMe, wherein q is 0 to 2；Nitrogenous C<sub class="style-scope patent-text">6</sub>Heterocycle, including morpholinyl, piperidyl and N- methyl-
Piperazinyl.</div>
      <div id="p2279" num="2279" class="description-paragraph style-scope patent-text">These preferences are respectively suitable for R<sup class="style-scope patent-text">9’</sup>、R<sup class="style-scope patent-text">6’</sup>And R<sup class="style-scope patent-text">7’</sup>。</div>
      <div id="p2280" num="2280" class="description-paragraph style-scope patent-text">R<sup class="style-scope patent-text">12</sup> </div>
      <div id="p2281" num="2281" class="description-paragraph style-scope patent-text">As C2 ' and C3 ' between there are when double bond, R<sup class="style-scope patent-text">12</sup>It is selected from:</div>
      <div id="p2282" num="2282" class="description-paragraph style-scope patent-text">(a)C<sub class="style-scope patent-text">5-10</sub>Aryl group, the one or more substituent groups being optionally chosen in self-contained below group replace: halogen
Element, nitro, cyano, ether, C<sub class="style-scope patent-text">1-7</sub>Alkyl, C<sub class="style-scope patent-text">3-7</sub>Heterocycle and double-oxygroup-C<sub class="style-scope patent-text">1-3</sub>Alkylidene；</div>
      <div id="p2283" num="2283" class="description-paragraph style-scope patent-text">(b)C<sub class="style-scope patent-text">1-5</sub>Representative examples of saturated aliphatic alkyl；</div>
      <div id="p2284" num="2284" class="description-paragraph style-scope patent-text">(c)C<sub class="style-scope patent-text">3-6</sub>Saturated cyclic alkyls；</div>
      <div id="p2285" num="2285" class="description-paragraph style-scope patent-text">(d)<span class="patent-image-not-available style-scope patent-text"></span>Wherein, R<sup class="style-scope patent-text">21</sup>、R<sup class="style-scope patent-text">22</sup>And R<sup class="style-scope patent-text">23</sup>Each of independently selected from H, C<sub class="style-scope patent-text">1-3</sub>Saturated alkyl, C<sub class="style-scope patent-text">2-3</sub>Alkene
Base, C<sub class="style-scope patent-text">2-3</sub>Alkynyl and cyclopropyl, wherein R<sup class="style-scope patent-text">12</sup>The sum of carbon atom is not more than 5 in group；</div>
      <div id="p2286" num="2286" class="description-paragraph style-scope patent-text">(e)<span class="patent-image-not-available style-scope patent-text"></span>Wherein, R<sup class="style-scope patent-text">25a</sup>And R<sup class="style-scope patent-text">25b</sup>In one be H, and another is selected from: phenyl, which can
Selection of land is replaced by the group selected from halogen, methyl, methoxyl group；Pyridyl group；And thiophenyl；With</div>
      <div id="p2287" num="2287" class="description-paragraph style-scope patent-text">(f)<span class="patent-image-not-available style-scope patent-text"></span>Wherein, R<sup class="style-scope patent-text">24</sup>It is selected from: H；C<sub class="style-scope patent-text">1-3</sub>Saturated alkyl；C<sub class="style-scope patent-text">2-3</sub>Alkenyl；C<sub class="style-scope patent-text">2-3</sub>Alkynyl；Cyclopropyl；Phenyl,
The phenyl is optionally replaced by the group selected from halogen, methyl, methoxyl group；Pyridyl group；And thiophenyl.</div>
      <div id="p2288" num="2288" class="description-paragraph style-scope patent-text">Work as R<sup class="style-scope patent-text">12</sup>It is C<sub class="style-scope patent-text">5-10</sub>When aryl group, it can be C<sub class="style-scope patent-text">5-7</sub>Aryl group.C<sub class="style-scope patent-text">5-7</sub>Aryl group can be phenyl group or
C<sub class="style-scope patent-text">5-7</sub>Heteroaryl groups, such as furyl, thiophenyl and pyridyl group.In some embodiments, R<sup class="style-scope patent-text">12</sup>Preferably phenyl.At it
In its embodiment, R<sup class="style-scope patent-text">12</sup>Preferably thiophenyl, such as thiophene -2- base and thiene-3-yl.</div>
      <div id="p2289" num="2289" class="description-paragraph style-scope patent-text">Work as R<sup class="style-scope patent-text">12</sup>It is C<sub class="style-scope patent-text">5-10</sub>When aryl group, it can be C<sub class="style-scope patent-text">8-10</sub>Aryl, for example, quinolyl or isoquinolyl group.Quinoline
Base or isoquinolyl group can be bound to PBD core by any available ring position.For example, quinolyl can be quinoline-
2- base, quinoline -3- base, quinolyl-4, quinoline -5- base, quinoline -6- base, quinoline -7- base and quinoline-8-yl.In these,
Quinoline -3- base and quinoline -6- base can be preferably.Isoquinolyl can be isoquinolyl-1, isoquinolin -3- base, isoquinoline
Quinoline -4- base, isoquinolin -5- base, isoquinolin -6- base, isoquinolin -7- base and isoquinolin -8- base.In these, isoquinolin -3-
Base and isoquinolin -6- base can be preferably.</div>
      <div id="p2290" num="2290" class="description-paragraph style-scope patent-text">Work as R<sup class="style-scope patent-text">12</sup>It is C<sub class="style-scope patent-text">5-10</sub>When aryl group, it can have any amount of substituent group.Preferably, it has 1 to 3
Substituent group, wherein 1 and 2 substituent group is it is furthermore preferred that and monosubstituted group is most preferred.Substituent group can be any
Position.</div>
      <div id="p2291" num="2291" class="description-paragraph style-scope patent-text">In R<sup class="style-scope patent-text">12</sup>It is C<sub class="style-scope patent-text">5-7</sub>In the case where aryl group, monosubstituted base preferably on annular atom, not adjacent to change
Close the key of the remainder of object, that is, it is preferably β or γ with the key of the remainder of compound.Therefore, in C<sub class="style-scope patent-text">5-7</sub>Aryl
In the case that group is phenyl, substituent group is more preferably aligning preferably in meta or para position.</div>
      <div id="p2292" num="2292" class="description-paragraph style-scope patent-text">In R<sup class="style-scope patent-text">12</sup>It is C<sub class="style-scope patent-text">8-10</sub>It, can be in quinoline or isoquinolin in the case where aryl group, such as quinolyl or isoquinolyl
Any number of substituent group is had at any position of ring.In some embodiments, it takes with one, two or three
Dai Ji, and these substituent groups can be on nearside or distal loop or both (if there is more than one substituent group).</div>
      <div id="p2293" num="2293" class="description-paragraph style-scope patent-text">R<sup class="style-scope patent-text">12</sup>Substituent group works as R<sup class="style-scope patent-text">12</sup>It is C<sub class="style-scope patent-text">5-10</sub>When aryl group</div>
      <div id="p2294" num="2294" class="description-paragraph style-scope patent-text">Work as R<sup class="style-scope patent-text">12</sup>It is C<sub class="style-scope patent-text">5-10</sub>When aryl group, if R<sup class="style-scope patent-text">12</sup>On substituent group be halogen, it is more excellent then it is preferably F or Cl
Selection of land is Cl.</div>
      <div id="p2295" num="2295" class="description-paragraph style-scope patent-text">Work as R<sup class="style-scope patent-text">12</sup>It is C<sub class="style-scope patent-text">5-10</sub>When aryl group, if R<sup class="style-scope patent-text">12</sup>On substituent group be ether, then it can be in some embodiments
It is alkoxy base, such as C<sub class="style-scope patent-text">1-7</sub>Alkoxy base (such as methoxyl group, ethyoxyl), or it can be in some embodiments
C<sub class="style-scope patent-text">5-7</sub>Aryloxy group (such as phenoxy group, pyridine oxygroup, furans oxygroup).Alkoxy base itself can be further substituted,
Such as replaced by amino group (for example, dimethylamino).</div>
      <div id="p2296" num="2296" class="description-paragraph style-scope patent-text">Work as R<sup class="style-scope patent-text">12</sup>It is C<sub class="style-scope patent-text">5-10</sub>When aryl group, if R<sup class="style-scope patent-text">12</sup>On substituent group be C<sub class="style-scope patent-text">1-7</sub>Alkyl, then it can be preferred that C<sub class="style-scope patent-text">1-4</sub>
Alkyl group (for example, methyl, ethyl, propyl, butyl).</div>
      <div id="p2297" num="2297" class="description-paragraph style-scope patent-text">Work as R<sup class="style-scope patent-text">12</sup>It is C<sub class="style-scope patent-text">5-10</sub>When aryl group, if R<sup class="style-scope patent-text">12</sup>On substituent group be C<sub class="style-scope patent-text">3-7</sub>Heterocycle, then in some embodiments
In, it can be C<sub class="style-scope patent-text">6</sub>Nitrogen heterocycle group, for example, morpholinyl, thio-morpholinyl, piperidyl, piperazinyl.These groups can
To be bound to the remainder of the part PBD via nitrogen-atoms.These groups can be further substituted, for example, by C<sub class="style-scope patent-text">1-4</sub>Alkyl
Group replaces.If C<sub class="style-scope patent-text">6</sub>Nitrogen heterocycle group is piperazinyl, then the further substituent group can be in second nitrogen
On annular atom.</div>
      <div id="p2298" num="2298" class="description-paragraph style-scope patent-text">Work as R<sup class="style-scope patent-text">12</sup>It is C<sub class="style-scope patent-text">5-10</sub>When aryl group, if R<sup class="style-scope patent-text">12</sup>On substituent group be double-oxygroup-C<sub class="style-scope patent-text">1-3</sub>Alkylidene, then it is preferably
Ground is double-oxygroup-methylene or double-oxygroup-ethylidene.</div>
      <div id="p2299" num="2299" class="description-paragraph style-scope patent-text">Work as R<sup class="style-scope patent-text">12</sup>It is C<sub class="style-scope patent-text">5-10</sub>When aryl group, if R<sup class="style-scope patent-text">12</sup>On substituent group be ester, then it is preferably methyl ester or ethyl
Ester.</div>
      <div id="p2300" num="2300" class="description-paragraph style-scope patent-text">Work as R<sup class="style-scope patent-text">12</sup>It is C<sub class="style-scope patent-text">5-10</sub>When aryl group, particularly preferred substituent group include methoxyl group, ethyoxyl, fluorine, chlorine, cyano,
Double-oxygroup-methylene, methyl-piperazinyl group, morpholinyl and methyl-phenylsulfanyl.Other are for R<sup class="style-scope patent-text">12</sup>Particularly preferred substituent group is
Dimethylamino propoxy and carboxyl.</div>
      <div id="p2301" num="2301" class="description-paragraph style-scope patent-text">Work as R<sup class="style-scope patent-text">12</sup>It is C<sub class="style-scope patent-text">5-10</sub>When aryl group, particularly preferred substituted R<sup class="style-scope patent-text">12</sup>Group includes but is not limited to 4- methoxyl group-benzene
Base, 3- methoxyphenyl, 4- ethyoxyl-phenyl, 3- ethyoxyl-phenyl, 4- fluoro-phenyl, the chloro- phenyl of 4-, 3,4- dioxy methylene
Base-phenyl, 4- methylphenyl-sulfanyl, 4- cyano-phenyl, 4- Phenoxyphenyl, quinoline -3- base and quinoline -6- base, isoquinolin -3-
Base and isoquinolin -6- base, 2- thienyl, 2- furyl, methoxyl group naphthalene and naphthalene.Alternatively possible substituted R<sup class="style-scope patent-text">12</sup>Group
It is 4- nitrobenzophenone.R of special interest<sup class="style-scope patent-text">12</sup>Group includes 4- (4- methylpiperazine-1-yl) phenyl and 3,4- dioxymethylene-
Phenyl.</div>
      <div id="p2302" num="2302" class="description-paragraph style-scope patent-text">Work as R<sup class="style-scope patent-text">12</sup>It is C<sub class="style-scope patent-text">1-5</sub>When representative examples of saturated aliphatic alkyl, it can be methyl, ethyl, propyl, butyl or amyl.In some realities
It applies in mode, it can be methyl, ethyl or propyl (n-pentyl or isopropyl).These embodiments it is some in, it can
To be methyl.In other embodiments, it can be butyl or amyl, can be linear chain or branched chain.</div>
      <div id="p2303" num="2303" class="description-paragraph style-scope patent-text">Work as R<sup class="style-scope patent-text">12</sup>It is C<sub class="style-scope patent-text">3-6</sub>When saturated cyclic alkyls, it can be cyclopropyl, cyclobutyl, cyclopenta or cyclohexyl.In some realities
It applies in mode, it can be cyclopropyl.</div>
      <div id="p2304" num="2304" class="description-paragraph style-scope patent-text">Work as R<sup class="style-scope patent-text">12</sup>It is<span class="patent-image-not-available style-scope patent-text"></span>When, R<sup class="style-scope patent-text">21</sup>、R<sup class="style-scope patent-text">22</sup>And R<sup class="style-scope patent-text">23</sup>Each of independently selected from H, C<sub class="style-scope patent-text">1-3</sub>Saturated alkyl, C<sub class="style-scope patent-text">2-3</sub>Alkenyl,
C<sub class="style-scope patent-text">2-3</sub>Alkynyl and cyclopropyl, wherein R<sup class="style-scope patent-text">12</sup>The sum of carbon atom is not more than 5 in group.In some embodiments, R<sup class="style-scope patent-text">12</sup>In group
Carbon atom sum no more than 4 or be not more than 3.</div>
      <div id="p2305" num="2305" class="description-paragraph style-scope patent-text">In some embodiments, R<sup class="style-scope patent-text">21</sup>、R<sup class="style-scope patent-text">22</sup>And R<sup class="style-scope patent-text">23</sup>In one be H, other two group be selected from H, C<sub class="style-scope patent-text">1-3</sub>It is saturated alkane
Base, C<sub class="style-scope patent-text">2-3</sub>Alkenyl, C<sub class="style-scope patent-text">2-3</sub>Alkynyl and cyclopropyl.</div>
      <div id="p2306" num="2306" class="description-paragraph style-scope patent-text">In other embodiments, R<sup class="style-scope patent-text">21</sup>、R<sup class="style-scope patent-text">22</sup>And R<sup class="style-scope patent-text">23</sup>In two be H, another group be selected from H, C<sub class="style-scope patent-text">1-3</sub>It is saturated alkane
Base, C<sub class="style-scope patent-text">2-3</sub>Alkenyl, C<sub class="style-scope patent-text">2-3</sub>Alkynyl and cyclopropyl.</div>
      <div id="p2307" num="2307" class="description-paragraph style-scope patent-text">It in some embodiments, is not the group of H selected from methyl and ethyl.These embodiments it is some in, no
The group for being H is methyl.</div>
      <div id="p2308" num="2308" class="description-paragraph style-scope patent-text">In some embodiments, R<sup class="style-scope patent-text">21</sup>It is H.</div>
      <div id="p2309" num="2309" class="description-paragraph style-scope patent-text">In some embodiments, R<sup class="style-scope patent-text">22</sup>It is H.</div>
      <div id="p2310" num="2310" class="description-paragraph style-scope patent-text">In some embodiments, R<sup class="style-scope patent-text">23</sup>It is H.</div>
      <div id="p2311" num="2311" class="description-paragraph style-scope patent-text">In some embodiments, R<sup class="style-scope patent-text">21</sup>And R<sup class="style-scope patent-text">22</sup>It is H.</div>
      <div id="p2312" num="2312" class="description-paragraph style-scope patent-text">In some embodiments, R<sup class="style-scope patent-text">21</sup>And R<sup class="style-scope patent-text">23</sup>It is H.</div>
      <div id="p2313" num="2313" class="description-paragraph style-scope patent-text">In some embodiments, R<sup class="style-scope patent-text">22</sup>And R<sup class="style-scope patent-text">23</sup>It is H.</div>
      <div id="p2314" num="2314" class="description-paragraph style-scope patent-text">R of special interest<sup class="style-scope patent-text">12</sup>Group is:<span class="patent-image-not-available style-scope patent-text"></span> </div>
      <div id="p2315" num="2315" class="description-paragraph style-scope patent-text">Work as R<sup class="style-scope patent-text">12</sup>It is<span class="patent-image-not-available style-scope patent-text"></span>When, R<sup class="style-scope patent-text">25a</sup>And R<sup class="style-scope patent-text">25b</sup>In one be H, and another is selected from: phenyl, which can
Selection of land is replaced by the group selected from halogen, methyl, methoxyl group；Pyridyl group；And thiophenyl.It in some embodiments, is not H
Group be optionally substituted phenyl.If the optional substituent group of phenyl is halogen, it is preferably fluorine.In some realities
It applies in mode, phenyl group is unsubstituted.</div>
      <div id="p2316" num="2316" class="description-paragraph style-scope patent-text">Work as R<sup class="style-scope patent-text">12</sup>It is<span class="patent-image-not-available style-scope patent-text"></span>When, R<sup class="style-scope patent-text">24</sup>It is selected from: H；C<sub class="style-scope patent-text">1-3</sub>Saturated alkyl；C<sub class="style-scope patent-text">2-3</sub>Alkenyl；C<sub class="style-scope patent-text">2-3</sub>Alkynyl；Cyclopropyl；Phenyl,
The phenyl is optionally replaced by the group selected from halogen, methyl, methoxyl group；Pyridyl group；And thiophenyl.If phenyl is optional
Substituent group is halogen, then it is preferably fluorine.In some embodiments, phenyl group is unsubstituted.</div>
      <div id="p2317" num="2317" class="description-paragraph style-scope patent-text">In some embodiments, R<sup class="style-scope patent-text">24</sup>Selected from H, methyl, ethyl, vinyl and acetenyl.The one of these embodiments
In a little, R<sup class="style-scope patent-text">24</sup>Selected from H and methyl.</div>
      <div id="p2318" num="2318" class="description-paragraph style-scope patent-text">As C2 ' and C3 ' between there are when singly-bound,</div>
      <div id="p2319" num="2319" class="description-paragraph style-scope patent-text">R<sup class="style-scope patent-text">12</sup>It is<span class="patent-image-not-available style-scope patent-text"></span>Wherein, R<sup class="style-scope patent-text">26a</sup>And R<sup class="style-scope patent-text">26b</sup>Independently selected from H, F, C<sub class="style-scope patent-text">1-4</sub>Saturated alkyl, C<sub class="style-scope patent-text">2-3</sub>Alkenyl, the alkyl and
Alkenyl group is optionally selected from C<sub class="style-scope patent-text">1-4</sub>Alkyl amino and C<sub class="style-scope patent-text">1-4</sub>The group of Arrcostab replaces；Or work as R<sup class="style-scope patent-text">26a</sup>And R<sup class="style-scope patent-text">26b</sup>In one be H
When, another is selected from nitrile and C<sub class="style-scope patent-text">1-4</sub>Arrcostab.</div>
      <div id="p2320" num="2320" class="description-paragraph style-scope patent-text">In some embodiments, it may be preferable that R<sup class="style-scope patent-text">26a</sup>And R<sup class="style-scope patent-text">26b</sup>It is all H.</div>
      <div id="p2321" num="2321" class="description-paragraph style-scope patent-text">In other embodiments, preferably R<sup class="style-scope patent-text">26a</sup>And R<sup class="style-scope patent-text">26b</sup>It is all methyl.</div>
      <div id="p2322" num="2322" class="description-paragraph style-scope patent-text">In further embodiment, preferably R<sup class="style-scope patent-text">26a</sup>And R<sup class="style-scope patent-text">26b</sup>In one be H, and another be selected from C<sub class="style-scope patent-text">1-4</sub>Saturation
Alkyl, C<sub class="style-scope patent-text">2-3</sub>Alkenyl, the alkyl and alkenyl group are optionally substituted.It, can be into one in these further embodiments
Step is preferred, and whether the group of H is selected from methyl and ethyl.</div>
      <div id="p2323" num="2323" class="description-paragraph style-scope patent-text">R<sup class="style-scope patent-text">2</sup> </div>
      <div id="p2324" num="2324" class="description-paragraph style-scope patent-text">Above for R<sup class="style-scope patent-text">12</sup>Preference be equally applicable to R<sup class="style-scope patent-text">2</sup>。</div>
      <div id="p2325" num="2325" class="description-paragraph style-scope patent-text">R<sup class="style-scope patent-text">20</sup>、R<sup class="style-scope patent-text">21a</sup>、R<sup class="style-scope patent-text">21b</sup> </div>
      <div id="p2326" num="2326" class="description-paragraph style-scope patent-text">In some embodiments, R<sup class="style-scope patent-text">20</sup>It is H and R<sup class="style-scope patent-text">21a</sup>And R<sup class="style-scope patent-text">21b</sup>It is all H.Alternatively, work as R<sup class="style-scope patent-text">21a</sup>And R<sup class="style-scope patent-text">21b</sup>When being all H,
R<sup class="style-scope patent-text">20</sup>It can be Me.</div>
      <div id="p2327" num="2327" class="description-paragraph style-scope patent-text">In some embodiments, R<sup class="style-scope patent-text">20</sup>It is H and R<sup class="style-scope patent-text">21a</sup>And R<sup class="style-scope patent-text">21b</sup>It is formed together=O.Alternatively, work as R<sup class="style-scope patent-text">21a</sup>And R<sup class="style-scope patent-text">21b</sup>One
When playing formation=O, R<sup class="style-scope patent-text">20</sup>It can be Me.</div>
      <div id="p2328" num="2328" class="description-paragraph style-scope patent-text">R<sup class="style-scope patent-text">11b</sup> </div>
      <div id="p2329" num="2329" class="description-paragraph style-scope patent-text">In some embodiments, R<sup class="style-scope patent-text">11b</sup>It is OH.</div>
      <div id="p2330" num="2330" class="description-paragraph style-scope patent-text">In some embodiments, R<sup class="style-scope patent-text">11b</sup>It is OR<sup class="style-scope patent-text">A</sup>.These embodiments it is some in, R<sup class="style-scope patent-text">A</sup>It is methyl.</div>
      <div id="p2331" num="2331" class="description-paragraph style-scope patent-text">In some embodiments, R<sup class="style-scope patent-text">11b</sup>Selected from OH, OR<sup class="style-scope patent-text">A</sup>, wherein R<sup class="style-scope patent-text">A</sup>It is C<sub class="style-scope patent-text">1-4</sub>Alkyl and SO<sub class="style-scope patent-text">z</sub>M, wherein z is 2 or 3 simultaneously
And M is the pharmaceutically acceptable cation of unit price.</div>
      <div id="p2332" num="2332" class="description-paragraph style-scope patent-text">M and z</div>
      <div id="p2333" num="2333" class="description-paragraph style-scope patent-text">Preferably, M is the pharmaceutically acceptable cation of unit price, and more preferably Na<sup class="style-scope patent-text">+</sup>。</div>
      <div id="p2334" num="2334" class="description-paragraph style-scope patent-text">Z is preferably 3.</div>
      <div id="p2335" num="2335" class="description-paragraph style-scope patent-text">The particularly preferred compound of the first aspect of the present invention is following formula Ia-1 or Ia-2:</div>
      <div id="p2336" num="2336" class="description-paragraph style-scope patent-text">
        <span class="patent-image-not-available style-scope patent-text"></span>
      </div>
      <div id="p2337" num="2337" class="description-paragraph style-scope patent-text">Wherein,</div>
      <div id="p2338" num="2338" class="description-paragraph style-scope patent-text">R<sup class="style-scope patent-text">L</sup>As defined above；</div>
      <div id="p2339" num="2339" class="description-paragraph style-scope patent-text">N is 1 or 3；</div>
      <div id="p2340" num="2340" class="description-paragraph style-scope patent-text">R<sup class="style-scope patent-text">1a</sup>It is methyl or phenyl；And</div>
      <div id="p2341" num="2341" class="description-paragraph style-scope patent-text">R<sup class="style-scope patent-text">2a</sup>It is selected from:</div>
      <div id="p2342" num="2342" class="description-paragraph style-scope patent-text">(a)<span class="patent-image-not-available style-scope patent-text"></span> </div>
      <div id="p2343" num="2343" class="description-paragraph style-scope patent-text">(b)<span class="patent-image-not-available style-scope patent-text"></span> </div>
      <div id="p2344" num="2344" class="description-paragraph style-scope patent-text">(c)<span class="patent-image-not-available style-scope patent-text"></span> </div>
      <div id="p2345" num="2345" class="description-paragraph style-scope patent-text">(d)<span class="patent-image-not-available style-scope patent-text"></span> </div>
      <div id="p2346" num="2346" class="description-paragraph style-scope patent-text">(e)<span class="patent-image-not-available style-scope patent-text"></span> </div>
      <div id="p2347" num="2347" class="description-paragraph style-scope patent-text">(f)<span class="patent-image-not-available style-scope patent-text"></span> </div>
      <div id="p2348" num="2348" class="description-paragraph style-scope patent-text">(g)<span class="patent-image-not-available style-scope patent-text"></span>With</div>
      <div id="p2349" num="2349" class="description-paragraph style-scope patent-text">(h)<span class="patent-image-not-available style-scope patent-text"></span> </div>
      <div id="p2350" num="2350" class="description-paragraph style-scope patent-text">The particularly preferred compound of the first aspect of the present invention is following formula Ib-1 or Ib-2:</div>
      <div id="p2351" num="2351" class="description-paragraph style-scope patent-text">
        <span class="patent-image-not-available style-scope patent-text"></span>
      </div>
      <div id="p2352" num="2352" class="description-paragraph style-scope patent-text">Wherein,</div>
      <div id="p2353" num="2353" class="description-paragraph style-scope patent-text">R<sup class="style-scope patent-text">L</sup>As defined above；</div>
      <div id="p2354" num="2354" class="description-paragraph style-scope patent-text">N is 1 or 3；And</div>
      <div id="p2355" num="2355" class="description-paragraph style-scope patent-text">R<sup class="style-scope patent-text">1a</sup>It is methyl or phenyl.</div>
      <div id="p2356" num="2356" class="description-paragraph style-scope patent-text">Illustrative synthetic schemes</div>
      <div id="p2357" num="2357" class="description-paragraph style-scope patent-text">Following scheme shows the mode for making certain compounds of the invention, wherein generally as R, R ' and R<sub class="style-scope patent-text">2</sub>It shows
Certain groups.Should disclosure according to the present invention understand these formed a part group.It is being expressly recited blocking group
In scheme, these can also change within the scope of the invention.Scheme 1- is restored in the presence of peptamine</div>
      <div id="p2358" num="2358" class="description-paragraph style-scope patent-text">
        <span class="patent-image-not-available style-scope patent-text"></span>
      </div>
      <div id="p2359" num="2359" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Linear synthetic strategy</u>
      </div>
      <div id="p2360" num="2360" class="description-paragraph style-scope patent-text">Scheme 2a</div>
      <div id="p2361" num="2361" class="description-paragraph style-scope patent-text">
        <span class="patent-image-not-available style-scope patent-text"></span>
      </div>
      <div id="p2362" num="2362" class="description-paragraph style-scope patent-text">The coupling of scheme 2a-1- connector remainder</div>
      <div id="p2363" num="2363" class="description-paragraph style-scope patent-text">
        <span class="patent-image-not-available style-scope patent-text"></span>
      </div>
      <div id="p2364" num="2364" class="description-paragraph style-scope patent-text">The alternative coupling of scheme 2a-2- connector remainder</div>
      <div id="p2365" num="2365" class="description-paragraph style-scope patent-text">
        <span class="patent-image-not-available style-scope patent-text"></span>
      </div>
      <div id="p2366" num="2366" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Reducing-pitch thread synthetic strategy</u>
      </div>
      <div id="p2367" num="2367" class="description-paragraph style-scope patent-text">Scheme 3a</div>
      <div id="p2368" num="2368" class="description-paragraph style-scope patent-text">
        <span class="patent-image-not-available style-scope patent-text"></span>
      </div>
      <div id="p2369" num="2369" class="description-paragraph style-scope patent-text">Scheme 3b</div>
      <div id="p2370" num="2370" class="description-paragraph style-scope patent-text">
        <span class="patent-image-not-available style-scope patent-text"></span>
      </div>
      <div id="p2371" num="2371" class="description-paragraph style-scope patent-text">
        <u class="style-scope patent-text">Two lactams synthetic strategies</u>
      </div>
      <div id="p2372" num="2372" class="description-paragraph style-scope patent-text">Scheme 4a</div>
      <div id="p2373" num="2373" class="description-paragraph style-scope patent-text">
        <span class="patent-image-not-available style-scope patent-text"></span>
      </div>
      <div id="p2374" num="2374" class="description-paragraph style-scope patent-text">Scheme 4b</div>
      <div id="p2375" num="2375" class="description-paragraph style-scope patent-text">
        <span class="patent-image-not-available style-scope patent-text"></span>
      </div>
      <div id="p2376" num="2376" class="description-paragraph style-scope patent-text">Abbreviation</div>
      <div id="p2377" num="2377" class="description-paragraph style-scope patent-text">Ac acetyl group</div>
      <div id="p2378" num="2378" class="description-paragraph style-scope patent-text">Acm acetyl aminomethyl</div>
      <div id="p2379" num="2379" class="description-paragraph style-scope patent-text">Alloc allyloxy carbonyl</div>
      <div id="p2380" num="2380" class="description-paragraph style-scope patent-text">Two carbonic ester of Boc di-t-butyl</div>
      <div id="p2381" num="2381" class="description-paragraph style-scope patent-text">T-Bu tert-butyl</div>
      <div id="p2382" num="2382" class="description-paragraph style-scope patent-text">Bzl benzyl, wherein Bzl-OMe is methoxy-benzyl and Bzl-Me is methylbenzyl</div>
      <div id="p2383" num="2383" class="description-paragraph style-scope patent-text">Cbz or Z benzyloxy-carbonyl, wherein Z-Cl and Z-Br is chloro- and bromo- benzyloxycarbonyl respectively</div>
      <div id="p2384" num="2384" class="description-paragraph style-scope patent-text">DMF N,N-dimethylformamide</div>
      <div id="p2385" num="2385" class="description-paragraph style-scope patent-text">Dnp dinitrophenyl</div>
      <div id="p2386" num="2386" class="description-paragraph style-scope patent-text">DTT dithiothreitol (DTT) base</div>
      <div id="p2387" num="2387" class="description-paragraph style-scope patent-text">Fmoc 9H- fluorenes -9- ylmeth-oxycarbonyl</div>
      <div id="p2388" num="2388" class="description-paragraph style-scope patent-text">Imp N-10 imines blocking group: 3- (2- methoxy ethoxy (propionic ester-Val-Ala-PAB</div>
      <div id="p2389" num="2389" class="description-paragraph style-scope patent-text">MC-OSu maleimide acetyl group-O-N- succinimide</div>
      <div id="p2390" num="2390" class="description-paragraph style-scope patent-text">Moc methoxycarbonyl</div>
      <div id="p2391" num="2391" class="description-paragraph style-scope patent-text">MP maleimide propionamide</div>
      <div id="p2392" num="2392" class="description-paragraph style-scope patent-text">Mtr 4- methoxyl group -2,3,6- trimethylphenysulfonyl</div>
      <div id="p2393" num="2393" class="description-paragraph style-scope patent-text">The p- aminobenzyloxycarbonyl of PAB</div>
      <div id="p2394" num="2394" class="description-paragraph style-scope patent-text">PEG ethyleneoxy</div>
      <div id="p2395" num="2395" class="description-paragraph style-scope patent-text">PNZ is to nitrobenzylamino formic acid esters</div>
      <div id="p2396" num="2396" class="description-paragraph style-scope patent-text">Psec 2- (phenyl sulfonyl) ethoxy carbonyl</div>
      <div id="p2397" num="2397" class="description-paragraph style-scope patent-text">TBDMS tert-butyl dimetylsilyl</div>
      <div id="p2398" num="2398" class="description-paragraph style-scope patent-text">TBDPS tert-butyl diphenylsilyl group</div>
      <div id="p2399" num="2399" class="description-paragraph style-scope patent-text">Teoc 2- (trimethyl silyl) ethoxy carbonyl</div>
      <div id="p2400" num="2400" class="description-paragraph style-scope patent-text">Tos tosyl</div>
      <div id="p2401" num="2401" class="description-paragraph style-scope patent-text">Troc 2,2,2- tri-chloroethoxy base carbonyl chloride</div>
      <div id="p2402" num="2402" class="description-paragraph style-scope patent-text">Trt trityl</div>
      <div id="p2403" num="2403" class="description-paragraph style-scope patent-text">Xan xanthyl</div>
      <div id="p2404" num="2404" class="description-paragraph style-scope patent-text">Bibliography</div>
      <div id="p2405" num="2405" class="description-paragraph style-scope patent-text">It is incorporated by reference following all referring to document.</div>
      <div id="p2406" num="2406" class="description-paragraph style-scope patent-text">EP 0522868</div>
      <div id="p2407" num="2407" class="description-paragraph style-scope patent-text">EP 0875569</div>
      <div id="p2408" num="2408" class="description-paragraph style-scope patent-text">EP 1295944</div>
      <div id="p2409" num="2409" class="description-paragraph style-scope patent-text">EP 1347046</div>
      <div id="p2410" num="2410" class="description-paragraph style-scope patent-text">EP 1394274</div>
      <div id="p2411" num="2411" class="description-paragraph style-scope patent-text">EP 1394274</div>
      <div id="p2412" num="2412" class="description-paragraph style-scope patent-text">EP 1439393</div>
      <div id="p2413" num="2413" class="description-paragraph style-scope patent-text">JP 05003790</div>
      <div id="p2414" num="2414" class="description-paragraph style-scope patent-text">JP 2004113151</div>
      <div id="p2415" num="2415" class="description-paragraph style-scope patent-text">JP 58180487</div>
      <div id="p2416" num="2416" class="description-paragraph style-scope patent-text">US 2001/055751</div>
      <div id="p2417" num="2417" class="description-paragraph style-scope patent-text">US 2002/034749</div>
      <div id="p2418" num="2418" class="description-paragraph style-scope patent-text">US 2002/042366</div>
      <div id="p2419" num="2419" class="description-paragraph style-scope patent-text">US 2002/150573</div>
      <div id="p2420" num="2420" class="description-paragraph style-scope patent-text">US 2002/193567</div>
      <div id="p2421" num="2421" class="description-paragraph style-scope patent-text">US 2003/0228319</div>
      <div id="p2422" num="2422" class="description-paragraph style-scope patent-text">US 2003/060612</div>
      <div id="p2423" num="2423" class="description-paragraph style-scope patent-text">US 2003/064397</div>
      <div id="p2424" num="2424" class="description-paragraph style-scope patent-text">US 2003/065143</div>
      <div id="p2425" num="2425" class="description-paragraph style-scope patent-text">US 2003/091580</div>
      <div id="p2426" num="2426" class="description-paragraph style-scope patent-text">US 2003/096961</div>
      <div id="p2427" num="2427" class="description-paragraph style-scope patent-text">US 2003/105292</div>
      <div id="p2428" num="2428" class="description-paragraph style-scope patent-text">US 2003/109676</div>
      <div id="p2429" num="2429" class="description-paragraph style-scope patent-text">US 2003/118592</div>
      <div id="p2430" num="2430" class="description-paragraph style-scope patent-text">US 2003/119121</div>
      <div id="p2431" num="2431" class="description-paragraph style-scope patent-text">US 2003/119122</div>
      <div id="p2432" num="2432" class="description-paragraph style-scope patent-text">US 2003/119125</div>
      <div id="p2433" num="2433" class="description-paragraph style-scope patent-text">US 2003/119126</div>
      <div id="p2434" num="2434" class="description-paragraph style-scope patent-text">US 2003/119128</div>
      <div id="p2435" num="2435" class="description-paragraph style-scope patent-text">US 2003/119129</div>
      <div id="p2436" num="2436" class="description-paragraph style-scope patent-text">US 2003/119130</div>
      <div id="p2437" num="2437" class="description-paragraph style-scope patent-text">US 2003/119131</div>
      <div id="p2438" num="2438" class="description-paragraph style-scope patent-text">US 2003/124140</div>
      <div id="p2439" num="2439" class="description-paragraph style-scope patent-text">US 2003/124579</div>
      <div id="p2440" num="2440" class="description-paragraph style-scope patent-text">US 2003/129192</div>
      <div id="p2441" num="2441" class="description-paragraph style-scope patent-text">US 2003/134790-A1 US 2003/143557</div>
      <div id="p2442" num="2442" class="description-paragraph style-scope patent-text">US 2003/157089</div>
      <div id="p2443" num="2443" class="description-paragraph style-scope patent-text">US 2003/165504</div>
      <div id="p2444" num="2444" class="description-paragraph style-scope patent-text">US 2003/185830</div>
      <div id="p2445" num="2445" class="description-paragraph style-scope patent-text">US 2003/186372</div>
      <div id="p2446" num="2446" class="description-paragraph style-scope patent-text">US 2003/186373</div>
      <div id="p2447" num="2447" class="description-paragraph style-scope patent-text">US 2003/194704</div>
      <div id="p2448" num="2448" class="description-paragraph style-scope patent-text">US 2003/206918</div>
      <div id="p2449" num="2449" class="description-paragraph style-scope patent-text">US 2003/219806</div>
      <div id="p2450" num="2450" class="description-paragraph style-scope patent-text">US 2003/224411</div>
      <div id="p2451" num="2451" class="description-paragraph style-scope patent-text">US 2003/224454</div>
      <div id="p2452" num="2452" class="description-paragraph style-scope patent-text">US 2003/232056</div>
      <div id="p2453" num="2453" class="description-paragraph style-scope patent-text">US 2003/232350</div>
      <div id="p2454" num="2454" class="description-paragraph style-scope patent-text">US 20030096743</div>
      <div id="p2455" num="2455" class="description-paragraph style-scope patent-text">US 20030130189</div>
      <div id="p2456" num="2456" class="description-paragraph style-scope patent-text">US 2003096743</div>
      <div id="p2457" num="2457" class="description-paragraph style-scope patent-text">US 2003130189</div>
      <div id="p2458" num="2458" class="description-paragraph style-scope patent-text">US 2004/0001827</div>
      <div id="p2459" num="2459" class="description-paragraph style-scope patent-text">US 2004/005320</div>
      <div id="p2460" num="2460" class="description-paragraph style-scope patent-text">US 2004/005538</div>
      <div id="p2461" num="2461" class="description-paragraph style-scope patent-text">US 2004/005563</div>
      <div id="p2462" num="2462" class="description-paragraph style-scope patent-text">US 2004/005598</div>
      <div id="p2463" num="2463" class="description-paragraph style-scope patent-text">US 2004/0101899</div>
      <div id="p2464" num="2464" class="description-paragraph style-scope patent-text">US 2004/018553</div>
      <div id="p2465" num="2465" class="description-paragraph style-scope patent-text">US 2004/022727</div>
      <div id="p2466" num="2466" class="description-paragraph style-scope patent-text">US 2004/044179</div>
      <div id="p2467" num="2467" class="description-paragraph style-scope patent-text">US 2004/044180</div>
      <div id="p2468" num="2468" class="description-paragraph style-scope patent-text">US 2004/101874</div>
      <div id="p2469" num="2469" class="description-paragraph style-scope patent-text">US 2004/197325</div>
      <div id="p2470" num="2470" class="description-paragraph style-scope patent-text">US 2004/249130</div>
      <div id="p2471" num="2471" class="description-paragraph style-scope patent-text">US 20040018194</div>
      <div id="p2472" num="2472" class="description-paragraph style-scope patent-text">US 20040052793</div>
      <div id="p2473" num="2473" class="description-paragraph style-scope patent-text">US 20040052793</div>
      <div id="p2474" num="2474" class="description-paragraph style-scope patent-text">US 20040121940</div>
      <div id="p2475" num="2475" class="description-paragraph style-scope patent-text">US 2005/271615</div>
      <div id="p2476" num="2476" class="description-paragraph style-scope patent-text">US 2006/116422</div>
      <div id="p2477" num="2477" class="description-paragraph style-scope patent-text">US 4816567</div>
      <div id="p2478" num="2478" class="description-paragraph style-scope patent-text">US 5362852</div>
      <div id="p2479" num="2479" class="description-paragraph style-scope patent-text">US 5440021</div>
      <div id="p2480" num="2480" class="description-paragraph style-scope patent-text">US 5583024</div>
      <div id="p2481" num="2481" class="description-paragraph style-scope patent-text">US 5621002</div>
      <div id="p2482" num="2482" class="description-paragraph style-scope patent-text">US 5644033</div>
      <div id="p2483" num="2483" class="description-paragraph style-scope patent-text">US 5674713</div>
      <div id="p2484" num="2484" class="description-paragraph style-scope patent-text">US 5700670</div>
      <div id="p2485" num="2485" class="description-paragraph style-scope patent-text">US 5773223</div>
      <div id="p2486" num="2486" class="description-paragraph style-scope patent-text">US 5792616</div>
      <div id="p2487" num="2487" class="description-paragraph style-scope patent-text">US 5854399</div>
      <div id="p2488" num="2488" class="description-paragraph style-scope patent-text">US 5869445</div>
      <div id="p2489" num="2489" class="description-paragraph style-scope patent-text">US 5976551</div>
      <div id="p2490" num="2490" class="description-paragraph style-scope patent-text">US 6011146</div>
      <div id="p2491" num="2491" class="description-paragraph style-scope patent-text">US 6153408</div>
      <div id="p2492" num="2492" class="description-paragraph style-scope patent-text">US 6214345</div>
      <div id="p2493" num="2493" class="description-paragraph style-scope patent-text">US 6218519</div>
      <div id="p2494" num="2494" class="description-paragraph style-scope patent-text">US 6268488</div>
      <div id="p2495" num="2495" class="description-paragraph style-scope patent-text">US 6518404</div>
      <div id="p2496" num="2496" class="description-paragraph style-scope patent-text">US 6534482</div>
      <div id="p2497" num="2497" class="description-paragraph style-scope patent-text">US 6555339</div>
      <div id="p2498" num="2498" class="description-paragraph style-scope patent-text">US 6602677</div>
      <div id="p2499" num="2499" class="description-paragraph style-scope patent-text">US 6677435</div>
      <div id="p2500" num="2500" class="description-paragraph style-scope patent-text">US 6759509</div>
      <div id="p2501" num="2501" class="description-paragraph style-scope patent-text">US 6835807</div>
      <div id="p2502" num="2502" class="description-paragraph style-scope patent-text">US 7223837</div>
      <div id="p2503" num="2503" class="description-paragraph style-scope patent-text">US 7375078</div>
      <div id="p2504" num="2504" class="description-paragraph style-scope patent-text">US 7521541</div>
      <div id="p2505" num="2505" class="description-paragraph style-scope patent-text">US 7723485</div>
      <div id="p2506" num="2506" class="description-paragraph style-scope patent-text">WO 00/012508</div>
      <div id="p2507" num="2507" class="description-paragraph style-scope patent-text">WO 00/12507</div>
      <div id="p2508" num="2508" class="description-paragraph style-scope patent-text">WO 00/12508</div>
      <div id="p2509" num="2509" class="description-paragraph style-scope patent-text">WO 01/16318</div>
      <div id="p2510" num="2510" class="description-paragraph style-scope patent-text">WO 01/45746</div>
      <div id="p2511" num="2511" class="description-paragraph style-scope patent-text">WO 02/088172</div>
      <div id="p2512" num="2512" class="description-paragraph style-scope patent-text">WO 03/026577</div>
      <div id="p2513" num="2513" class="description-paragraph style-scope patent-text">WO 03/043583</div>
      <div id="p2514" num="2514" class="description-paragraph style-scope patent-text">WO 04/032828</div>
      <div id="p2515" num="2515" class="description-paragraph style-scope patent-text">WO 2000/12130</div>
      <div id="p2516" num="2516" class="description-paragraph style-scope patent-text">WO 2000/14228</div>
      <div id="p2517" num="2517" class="description-paragraph style-scope patent-text">WO 2000/20579</div>
      <div id="p2518" num="2518" class="description-paragraph style-scope patent-text">WO 2000/22129</div>
      <div id="p2519" num="2519" class="description-paragraph style-scope patent-text">WO 2000/32752</div>
      <div id="p2520" num="2520" class="description-paragraph style-scope patent-text">WO 2000/36107</div>
      <div id="p2521" num="2521" class="description-paragraph style-scope patent-text">WO 2000/40614</div>
      <div id="p2522" num="2522" class="description-paragraph style-scope patent-text">WO 2000/44899</div>
      <div id="p2523" num="2523" class="description-paragraph style-scope patent-text">WO 2000/55351</div>
      <div id="p2524" num="2524" class="description-paragraph style-scope patent-text">WO 2000/75655</div>
      <div id="p2525" num="2525" class="description-paragraph style-scope patent-text">WO 200053216</div>
      <div id="p2526" num="2526" class="description-paragraph style-scope patent-text">WO 2001/00244</div>
      <div id="p2527" num="2527" class="description-paragraph style-scope patent-text">WO 2001/38490</div>
      <div id="p2528" num="2528" class="description-paragraph style-scope patent-text">WO 2001/40269</div>
      <div id="p2529" num="2529" class="description-paragraph style-scope patent-text">WO 2001/40309</div>
      <div id="p2530" num="2530" class="description-paragraph style-scope patent-text">WO 2001/41787</div>
      <div id="p2531" num="2531" class="description-paragraph style-scope patent-text">WO 2001/46232</div>
      <div id="p2532" num="2532" class="description-paragraph style-scope patent-text">WO 2001/46261</div>
      <div id="p2533" num="2533" class="description-paragraph style-scope patent-text">WO 2001/48204</div>
      <div id="p2534" num="2534" class="description-paragraph style-scope patent-text">WO 2001/53463</div>
      <div id="p2535" num="2535" class="description-paragraph style-scope patent-text">WO 2001/57188</div>
      <div id="p2536" num="2536" class="description-paragraph style-scope patent-text">WO 2001/62794</div>
      <div id="p2537" num="2537" class="description-paragraph style-scope patent-text">WO 2001/66689</div>
      <div id="p2538" num="2538" class="description-paragraph style-scope patent-text">WO 2001/72830</div>
      <div id="p2539" num="2539" class="description-paragraph style-scope patent-text">WO 2001/72962</div>
      <div id="p2540" num="2540" class="description-paragraph style-scope patent-text">WO2001/75177</div>
      <div id="p2541" num="2541" class="description-paragraph style-scope patent-text">WO 2001/77172</div>
      <div id="p2542" num="2542" class="description-paragraph style-scope patent-text">WO2001/88133</div>
      <div id="p2543" num="2543" class="description-paragraph style-scope patent-text">WO 2001/90304</div>
      <div id="p2544" num="2544" class="description-paragraph style-scope patent-text">WO 2001/94641</div>
      <div id="p2545" num="2545" class="description-paragraph style-scope patent-text">WO 2001/98351</div>
      <div id="p2546" num="2546" class="description-paragraph style-scope patent-text">WO 2002/02587</div>
      <div id="p2547" num="2547" class="description-paragraph style-scope patent-text">WO 2002/02624</div>
      <div id="p2548" num="2548" class="description-paragraph style-scope patent-text">WO2002/06317</div>
      <div id="p2549" num="2549" class="description-paragraph style-scope patent-text">WO 2002/06339</div>
      <div id="p2550" num="2550" class="description-paragraph style-scope patent-text">WO 2002/101075</div>
      <div id="p2551" num="2551" class="description-paragraph style-scope patent-text">WO 2002/10187</div>
      <div id="p2552" num="2552" class="description-paragraph style-scope patent-text">WO 2002/102235</div>
      <div id="p2553" num="2553" class="description-paragraph style-scope patent-text">WO 2002/10382</div>
      <div id="p2554" num="2554" class="description-paragraph style-scope patent-text">WO2002/12341</div>
      <div id="p2555" num="2555" class="description-paragraph style-scope patent-text">WO 2002/13847</div>
      <div id="p2556" num="2556" class="description-paragraph style-scope patent-text">WO 2002/14503</div>
      <div id="p2557" num="2557" class="description-paragraph style-scope patent-text">WO 2002/16413</div>
      <div id="p2558" num="2558" class="description-paragraph style-scope patent-text">WO 2002/16429</div>
      <div id="p2559" num="2559" class="description-paragraph style-scope patent-text">WO 2002/22153</div>
      <div id="p2560" num="2560" class="description-paragraph style-scope patent-text">WO 2002/22636</div>
      <div id="p2561" num="2561" class="description-paragraph style-scope patent-text">WO 2002/22660</div>
      <div id="p2562" num="2562" class="description-paragraph style-scope patent-text">WO 2002/22808</div>
      <div id="p2563" num="2563" class="description-paragraph style-scope patent-text">WO 2002/24909</div>
      <div id="p2564" num="2564" class="description-paragraph style-scope patent-text">WO 2002/26822</div>
      <div id="p2565" num="2565" class="description-paragraph style-scope patent-text">WO 2002/30268</div>
      <div id="p2566" num="2566" class="description-paragraph style-scope patent-text">WO 2002/38766</div>
      <div id="p2567" num="2567" class="description-paragraph style-scope patent-text">WO 2002/54940</div>
      <div id="p2568" num="2568" class="description-paragraph style-scope patent-text">WO 2002/59377</div>
      <div id="p2569" num="2569" class="description-paragraph style-scope patent-text">WO 2002/60317</div>
      <div id="p2570" num="2570" class="description-paragraph style-scope patent-text">WO 2002/61087；</div>
      <div id="p2571" num="2571" class="description-paragraph style-scope patent-text">WO 2002/64798</div>
      <div id="p2572" num="2572" class="description-paragraph style-scope patent-text">WO2002/71928</div>
      <div id="p2573" num="2573" class="description-paragraph style-scope patent-text">WO2002/72596</div>
      <div id="p2574" num="2574" class="description-paragraph style-scope patent-text">WO2002/78524</div>
      <div id="p2575" num="2575" class="description-paragraph style-scope patent-text">WO2002/81646</div>
      <div id="p2576" num="2576" class="description-paragraph style-scope patent-text">WO2002/83866</div>
      <div id="p2577" num="2577" class="description-paragraph style-scope patent-text">WO2002/86443</div>
      <div id="p2578" num="2578" class="description-paragraph style-scope patent-text">WO 2002/88170</div>
      <div id="p2579" num="2579" class="description-paragraph style-scope patent-text">WO 2002/89747</div>
      <div id="p2580" num="2580" class="description-paragraph style-scope patent-text">WO 2002/92836</div>
      <div id="p2581" num="2581" class="description-paragraph style-scope patent-text">WO 2002/94852</div>
      <div id="p2582" num="2582" class="description-paragraph style-scope patent-text">WO 2002/98358</div>
      <div id="p2583" num="2583" class="description-paragraph style-scope patent-text">WO 2002/99074</div>
      <div id="p2584" num="2584" class="description-paragraph style-scope patent-text">WO 2002/99122</div>
      <div id="p2585" num="2585" class="description-paragraph style-scope patent-text">WO 2003/000842</div>
      <div id="p2586" num="2586" class="description-paragraph style-scope patent-text">WO 2003/002717</div>
      <div id="p2587" num="2587" class="description-paragraph style-scope patent-text">WO 2003/003906</div>
      <div id="p2588" num="2588" class="description-paragraph style-scope patent-text">WO 2003/003984</div>
      <div id="p2589" num="2589" class="description-paragraph style-scope patent-text">WO2003/004989</div>
      <div id="p2590" num="2590" class="description-paragraph style-scope patent-text">WO2003/008537</div>
      <div id="p2591" num="2591" class="description-paragraph style-scope patent-text">WO 2003/009814</div>
      <div id="p2592" num="2592" class="description-paragraph style-scope patent-text">WO 2003/014294</div>
      <div id="p2593" num="2593" class="description-paragraph style-scope patent-text">WO 2003/016475</div>
      <div id="p2594" num="2594" class="description-paragraph style-scope patent-text">WO 2003/016494</div>
      <div id="p2595" num="2595" class="description-paragraph style-scope patent-text">WO 2003/018621</div>
      <div id="p2596" num="2596" class="description-paragraph style-scope patent-text">WO2003/022995</div>
      <div id="p2597" num="2597" class="description-paragraph style-scope patent-text">WO 2003/023013</div>
      <div id="p2598" num="2598" class="description-paragraph style-scope patent-text">WO 2003/024392</div>
      <div id="p2599" num="2599" class="description-paragraph style-scope patent-text">WO 2003/025138</div>
      <div id="p2600" num="2600" class="description-paragraph style-scope patent-text">WO 2003/025148</div>
      <div id="p2601" num="2601" class="description-paragraph style-scope patent-text">WO 2003/025228</div>
      <div id="p2602" num="2602" class="description-paragraph style-scope patent-text">WO 2003/026493</div>
      <div id="p2603" num="2603" class="description-paragraph style-scope patent-text">WO 2003/029262</div>
      <div id="p2604" num="2604" class="description-paragraph style-scope patent-text">WO 2003/029277</div>
      <div id="p2605" num="2605" class="description-paragraph style-scope patent-text">WO 2003/029421</div>
      <div id="p2606" num="2606" class="description-paragraph style-scope patent-text">WO 2003/034984</div>
      <div id="p2607" num="2607" class="description-paragraph style-scope patent-text">WO 2003/035846</div>
      <div id="p2608" num="2608" class="description-paragraph style-scope patent-text">WO 2003/042661</div>
      <div id="p2609" num="2609" class="description-paragraph style-scope patent-text">WO 2003/045422</div>
      <div id="p2610" num="2610" class="description-paragraph style-scope patent-text">WO 2003/048202</div>
      <div id="p2611" num="2611" class="description-paragraph style-scope patent-text">WO 2003/054152</div>
      <div id="p2612" num="2612" class="description-paragraph style-scope patent-text">WO 2003/055439</div>
      <div id="p2613" num="2613" class="description-paragraph style-scope patent-text">WO 2003/055443</div>
      <div id="p2614" num="2614" class="description-paragraph style-scope patent-text">WO 2003/062401</div>
      <div id="p2615" num="2615" class="description-paragraph style-scope patent-text">WO 2003/062401</div>
      <div id="p2616" num="2616" class="description-paragraph style-scope patent-text">WO 2003/072035</div>
      <div id="p2617" num="2617" class="description-paragraph style-scope patent-text">WO 2003/072036</div>
      <div id="p2618" num="2618" class="description-paragraph style-scope patent-text">WO 2003/077836</div>
      <div id="p2619" num="2619" class="description-paragraph style-scope patent-text">WO 2003/081210</div>
      <div id="p2620" num="2620" class="description-paragraph style-scope patent-text">WO 2003/083041</div>
      <div id="p2621" num="2621" class="description-paragraph style-scope patent-text">WO 2003/083047</div>
      <div id="p2622" num="2622" class="description-paragraph style-scope patent-text">WO 2003/083074</div>
      <div id="p2623" num="2623" class="description-paragraph style-scope patent-text">WO 2003/087306</div>
      <div id="p2624" num="2624" class="description-paragraph style-scope patent-text">WO 2003/087768</div>
      <div id="p2625" num="2625" class="description-paragraph style-scope patent-text">WO 2003/088808</div>
      <div id="p2626" num="2626" class="description-paragraph style-scope patent-text">WO 2003/089624</div>
      <div id="p2627" num="2627" class="description-paragraph style-scope patent-text">WO 2003/089904</div>
      <div id="p2628" num="2628" class="description-paragraph style-scope patent-text">WO 2003/093444</div>
      <div id="p2629" num="2629" class="description-paragraph style-scope patent-text">WO 2003/097803</div>
      <div id="p2630" num="2630" class="description-paragraph style-scope patent-text">WO 2003/101283</div>
      <div id="p2631" num="2631" class="description-paragraph style-scope patent-text">WO 2003/101400</div>
      <div id="p2632" num="2632" class="description-paragraph style-scope patent-text">WO 2003/104270</div>
      <div id="p2633" num="2633" class="description-paragraph style-scope patent-text">WO 2003/104275</div>
      <div id="p2634" num="2634" class="description-paragraph style-scope patent-text">WO 2003/105758</div>
      <div id="p2635" num="2635" class="description-paragraph style-scope patent-text">WO 2003004529</div>
      <div id="p2636" num="2636" class="description-paragraph style-scope patent-text">WO 2003042661</div>
      <div id="p2637" num="2637" class="description-paragraph style-scope patent-text">WO 2003104399</div>
      <div id="p2638" num="2638" class="description-paragraph style-scope patent-text">WO 2004/000997</div>
      <div id="p2639" num="2639" class="description-paragraph style-scope patent-text">WO 2004/001004</div>
      <div id="p2640" num="2640" class="description-paragraph style-scope patent-text">WO 2004/009622</div>
      <div id="p2641" num="2641" class="description-paragraph style-scope patent-text">WO 2004/011611</div>
      <div id="p2642" num="2642" class="description-paragraph style-scope patent-text">WO 2004/015426</div>
      <div id="p2643" num="2643" class="description-paragraph style-scope patent-text">WO 2004/016225</div>
      <div id="p2644" num="2644" class="description-paragraph style-scope patent-text">WO 2004/020595</div>
      <div id="p2645" num="2645" class="description-paragraph style-scope patent-text">WO 2004/022709</div>
      <div id="p2646" num="2646" class="description-paragraph style-scope patent-text">WO 2004/022778</div>
      <div id="p2647" num="2647" class="description-paragraph style-scope patent-text">WO 2004/027049</div>
      <div id="p2648" num="2648" class="description-paragraph style-scope patent-text">WO 2004/031238</div>
      <div id="p2649" num="2649" class="description-paragraph style-scope patent-text">WO 2004/032828</div>
      <div id="p2650" num="2650" class="description-paragraph style-scope patent-text">WO 2004/032842</div>
      <div id="p2651" num="2651" class="description-paragraph style-scope patent-text">WO 2004/040000</div>
      <div id="p2652" num="2652" class="description-paragraph style-scope patent-text">WO 2004/043361</div>
      <div id="p2653" num="2653" class="description-paragraph style-scope patent-text">WO 2004/043963</div>
      <div id="p2654" num="2654" class="description-paragraph style-scope patent-text">WO 2004/044178</div>
      <div id="p2655" num="2655" class="description-paragraph style-scope patent-text">WO 2004/045516</div>
      <div id="p2656" num="2656" class="description-paragraph style-scope patent-text">WO 2004/045520</div>
      <div id="p2657" num="2657" class="description-paragraph style-scope patent-text">WO 2004/045553</div>
      <div id="p2658" num="2658" class="description-paragraph style-scope patent-text">WO 2004/046342</div>
      <div id="p2659" num="2659" class="description-paragraph style-scope patent-text">WO 2004/047749</div>
      <div id="p2660" num="2660" class="description-paragraph style-scope patent-text">WO 2004/048938</div>
      <div id="p2661" num="2661" class="description-paragraph style-scope patent-text">WO 2004/053079</div>
      <div id="p2662" num="2662" class="description-paragraph style-scope patent-text">WO 2004/063355</div>
      <div id="p2663" num="2663" class="description-paragraph style-scope patent-text">WO 2004/063362</div>
      <div id="p2664" num="2664" class="description-paragraph style-scope patent-text">WO 2004/063709</div>
      <div id="p2665" num="2665" class="description-paragraph style-scope patent-text">WO 2004/065577</div>
      <div id="p2666" num="2666" class="description-paragraph style-scope patent-text">WO 2004/074320</div>
      <div id="p2667" num="2667" class="description-paragraph style-scope patent-text">WO 2004000221</div>
      <div id="p2668" num="2668" class="description-paragraph style-scope patent-text">WO 2004020583</div>
      <div id="p2669" num="2669" class="description-paragraph style-scope patent-text">WO 2004042346</div>
      <div id="p2670" num="2670" class="description-paragraph style-scope patent-text">WO 2004065576</div>
      <div id="p2671" num="2671" class="description-paragraph style-scope patent-text">WO 2005/023814</div>
      <div id="p2672" num="2672" class="description-paragraph style-scope patent-text">WO 2005/082023</div>
      <div id="p2673" num="2673" class="description-paragraph style-scope patent-text">WO 2005/085251</div>
      <div id="p2674" num="2674" class="description-paragraph style-scope patent-text">WO 2006/111759</div>
      <div id="p2675" num="2675" class="description-paragraph style-scope patent-text">WO 2007/044515</div>
      <div id="p2676" num="2676" class="description-paragraph style-scope patent-text">WO 2007/085930</div>
      <div id="p2677" num="2677" class="description-paragraph style-scope patent-text">WO 2009/052249</div>
      <div id="p2678" num="2678" class="description-paragraph style-scope patent-text">WO 2010/091150</div>
      <div id="p2679" num="2679" class="description-paragraph style-scope patent-text">WO 91/02536</div>
      <div id="p2680" num="2680" class="description-paragraph style-scope patent-text">WO 92/07574</div>
      <div id="p2681" num="2681" class="description-paragraph style-scope patent-text">WO 92/17497</div>
      <div id="p2682" num="2682" class="description-paragraph style-scope patent-text">WO 94/10312</div>
      <div id="p2683" num="2683" class="description-paragraph style-scope patent-text">WO 94/28931</div>
      <div id="p2684" num="2684" class="description-paragraph style-scope patent-text">WO 9630514</div>
      <div id="p2685" num="2685" class="description-paragraph style-scope patent-text">WO 97/07198</div>
      <div id="p2686" num="2686" class="description-paragraph style-scope patent-text">WO 97/44452</div>
      <div id="p2687" num="2687" class="description-paragraph style-scope patent-text">WO 98/13059</div>
      <div id="p2688" num="2688" class="description-paragraph style-scope patent-text">WO 98/37193</div>
      <div id="p2689" num="2689" class="description-paragraph style-scope patent-text">WO 98/40403</div>
      <div id="p2690" num="2690" class="description-paragraph style-scope patent-text">WO 98/51805</div>
      <div id="p2691" num="2691" class="description-paragraph style-scope patent-text">WO 98/51824</div>
      <div id="p2692" num="2692" class="description-paragraph style-scope patent-text">WO 99/28468</div>
      <div id="p2693" num="2693" class="description-paragraph style-scope patent-text">WO 99/46284</div>
      <div id="p2694" num="2694" class="description-paragraph style-scope patent-text">WO 99/58658</div>
      <div id="p2695" num="2695" class="description-paragraph style-scope patent-text">Am.J.Hum.Genet.49 (3): 555-565 (1991)</div>
      <div id="p2696" num="2696" class="description-paragraph style-scope patent-text">Amiel J., et al Hum.Mol.Genet.5,355-357,1996</div>
      <div id="p2697" num="2697" class="description-paragraph style-scope patent-text">Amir et al (2003) Angew.Chem.Int.Ed.42:4494-4499</div>
      <div id="p2698" num="2698" class="description-paragraph style-scope patent-text">Amsberry, et al (1990) J.Org.Chem.55:5867</div>
      <div id="p2699" num="2699" class="description-paragraph style-scope patent-text">Angew Chem.Intl.Ed.Engl. (1994) 33:183-186</div>
      <div id="p2700" num="2700" class="description-paragraph style-scope patent-text">Annu.Rev.Neurosci.21:309-345 (1998)</div>
      <div id="p2701" num="2701" class="description-paragraph style-scope patent-text">Arai H., et al J.Biol.Chem.268,3463-3470,1993</div>
      <div id="p2702" num="2702" class="description-paragraph style-scope patent-text">Arai H.,et al Jpn.Circ.J.56,1303-1307,1992</div>
      <div id="p2703" num="2703" class="description-paragraph style-scope patent-text">Arima, et al., J.Antibiotics, 25,437-444 (1972)</div>
      <div id="p2704" num="2704" class="description-paragraph style-scope patent-text">Attie T., et al, Hum.Mol.Genet.4,2407-2409,1995</div>
      <div id="p2705" num="2705" class="description-paragraph style-scope patent-text">Auricchio A., et al Hum.Mol.Genet.5:351-354,1996</div>
      <div id="p2706" num="2706" class="description-paragraph style-scope patent-text">Barel M., et al Mol.Immunol.35,1025-1031,1998</div>
      <div id="p2707" num="2707" class="description-paragraph style-scope patent-text">Barella et al (1995) Biochem.J.309:773-779</div>
      <div id="p2708" num="2708" class="description-paragraph style-scope patent-text">Barnett T.,et al Genomics 3,59-66,1988</div>
      <div id="p2709" num="2709" class="description-paragraph style-scope patent-text">Beck et al (1992) J.Mol.Biol.228:433-441</div>
      <div id="p2710" num="2710" class="description-paragraph style-scope patent-text">Beck et al (1996) J.Mol.Biol.255:1-13</div>
      <div id="p2711" num="2711" class="description-paragraph style-scope patent-text">Berge, et al., J.Pharm.Sci., 66,1-19 (1977)</div>
      <div id="p2712" num="2712" class="description-paragraph style-scope patent-text">Biochem.Biophys.Res.Commun. (2000) 275 (3): 783-788</div>
      <div id="p2713" num="2713" class="description-paragraph style-scope patent-text">Biochem.Biophys.Res.Commun.255(2),283-288(1999)</div>
      <div id="p2714" num="2714" class="description-paragraph style-scope patent-text">Blood (2002) 100 (9): 3068-3076</div>
      <div id="p2715" num="2715" class="description-paragraph style-scope patent-text">(2002) Blood 99 (8): 2662-2669</div>
      <div id="p2716" num="2716" class="description-paragraph style-scope patent-text">Blumberg H., et al Cell 104,9-19,2001</div>
      <div id="p2717" num="2717" class="description-paragraph style-scope patent-text">Bose, et al., Tetrahedron, 48,751-758 (1992)</div>
      <div id="p2718" num="2718" class="description-paragraph style-scope patent-text">Bourgeois C., et al J.Clin.Endocrinol.Metab.82,3116-3123,1997</div>
      <div id="p2719" num="2719" class="description-paragraph style-scope patent-text">Brinster et al (1988) Proc.Natl.Acad.Sci.USA 85:836</div>
      <div id="p2720" num="2720" class="description-paragraph style-scope patent-text">Buchman and Berg (1988) Mol.Cell.Biol.8:4395</div>
      <div id="p2721" num="2721" class="description-paragraph style-scope patent-text">Cancer Res.61(15),5857-5860(2001)</div>
      <div id="p2722" num="2722" class="description-paragraph style-scope patent-text">Carl et al (1981) J.Med.Chem.24:479-480</div>
      <div id="p2723" num="2723" class="description-paragraph style-scope patent-text">Carlsson et al (1978) Biochem.J.173:723-737</div>
      <div id="p2724" num="2724" class="description-paragraph style-scope patent-text">Carter, P. (2006) Nature Reviews Immunology 6:343-357</div>
      <div id="p2725" num="2725" class="description-paragraph style-scope patent-text">(2002) Cell 109 (3): 397-407</div>
      <div id="p2726" num="2726" class="description-paragraph style-scope patent-text">CellTiter Glo Luminescent Cell Viability Assay,Promega Corp.Technical
Bulletin TB288</div>
      <div id="p2727" num="2727" class="description-paragraph style-scope patent-text">Chakravarty et al (1983) J.Med.Chem.26:638-644</div>
      <div id="p2728" num="2728" class="description-paragraph style-scope patent-text">Chan, J.and Watt, V.M., Oncogene 6 (6), 1057-1061 (1991)</div>
      <div id="p2729" num="2729" class="description-paragraph style-scope patent-text">Child et al (1999) J.Biol.Chem.274:24335-24341</div>
      <div id="p2730" num="2730" class="description-paragraph style-scope patent-text">Cho H.-S.,et al Nature 421,756-760,2003</div>
      <div id="p2731" num="2731" class="description-paragraph style-scope patent-text">Ciccodicola, A., et al EMBO is J.8 (7): 1987-1991 (1989)</div>
      <div id="p2732" num="2732" class="description-paragraph style-scope patent-text">Clackson et al (1991) Nature, 352:624-628</div>
      <div id="p2733" num="2733" class="description-paragraph style-scope patent-text">Clark H.F., et al Genome Res.13,2265-2270,2003</div>
      <div id="p2734" num="2734" class="description-paragraph style-scope patent-text">Corey E, Quinn JE, Buhler KR, et al.LuCap35:a new model of prostate
cancer</div>
      <div id="p2735" num="2735" class="description-paragraph style-scope patent-text">progression to androgen independence.The Prostate 2003；55:239-46</div>
      <div id="p2736" num="2736" class="description-paragraph style-scope patent-text">Coussens L., et al Science (1985) 230 (4730): 1132-1139</div>
      <div id="p2737" num="2737" class="description-paragraph style-scope patent-text">Cree et al (1995) AntiCancer Drugs 6:398-404</div>
      <div id="p2738" num="2738" class="description-paragraph style-scope patent-text">Crouch et al (1993) J.Immunol.Meth.160:81-88</div>
      <div id="p2739" num="2739" class="description-paragraph style-scope patent-text">Davis et al (2001) Proc.Natl.Acad.Sci USA 98 (17): 9772-9777</div>
      <div id="p2740" num="2740" class="description-paragraph style-scope patent-text">De Groot et al (2001) J.Org.Chem.66:8815-8830</div>
      <div id="p2741" num="2741" class="description-paragraph style-scope patent-text">De Groot et al (2003) Angew.Chem.Int.Ed.42:4490-4494</div>
      <div id="p2742" num="2742" class="description-paragraph style-scope patent-text">Dennis et al.(2002)″Albumin Binding As A General Strategy For
Improving The</div>
      <div id="p2743" num="2743" class="description-paragraph style-scope patent-text">Pharmacokinetics Of Proteins " J Biol Chem.277:35035-35043</div>
      <div id="p2744" num="2744" class="description-paragraph style-scope patent-text">Dobner et al (1992) Eur.J.Immunol.22:2795-2799</div>
      <div id="p2745" num="2745" class="description-paragraph style-scope patent-text">Dornan et al (2009) Blood 114 (13): 2721-2729</div>
      <div id="p2746" num="2746" class="description-paragraph style-scope patent-text">Doronina et al (2006) Bioconj.Chem.17:114-124</div>
      <div id="p2747" num="2747" class="description-paragraph style-scope patent-text">Dubowchik et al.Bioconjugate Chemistry, 2002,13,855-869</div>
      <div id="p2748" num="2748" class="description-paragraph style-scope patent-text">Dubowchik, et al. (1997) Tetrahedron Letters, 38:5257-60</div>
      <div id="p2749" num="2749" class="description-paragraph style-scope patent-text">Dumoutier L.,et al J.Immunol.167,3545-3549,2001</div>
      <div id="p2750" num="2750" class="description-paragraph style-scope patent-text">E.<span class="patent-image-not-available style-scope patent-text"></span>and K.Lübke,The Peptides,volume 1,pp 76-136(1965)Academic
Press Ehsani A., et al (1993) Genomics 15,426-429</div>
      <div id="p2751" num="2751" class="description-paragraph style-scope patent-text">Eliel, E.and Wilen, S., " Stereochemistry of Organic Compounds ", John
Wiley&amp;Sons, Inc., New York, 1994</div>
      <div id="p2752" num="2752" class="description-paragraph style-scope patent-text">Elshourbagy N.A., et al J.Biol.Chem.268,3873-3879,1993</div>
      <div id="p2753" num="2753" class="description-paragraph style-scope patent-text">Erickson et al (2006) Cancer Res.66 (8): 1-8</div>
      <div id="p2754" num="2754" class="description-paragraph style-scope patent-text">Feild, J.A., et al (1999) Biochem.Biophys.Res.Commun.258 (3): 578-582</div>
      <div id="p2755" num="2755" class="description-paragraph style-scope patent-text">Fields, G.and Noble, R. (1990) " Solid phase peptide synthesis utilizing
9- fluoroenylmethoxycarbonyl amino acids ", Int.J.Peptide Protein Res.35:161-
214</div>
      <div id="p2756" num="2756" class="description-paragraph style-scope patent-text">Fuchs S., et al Mol.Med.7,115-124,2001</div>
      <div id="p2757" num="2757" class="description-paragraph style-scope patent-text">Fujisaku et al (1989) J.Biol.Chem.264 (4): 2118-2125)</div>
      <div id="p2758" num="2758" class="description-paragraph style-scope patent-text">Gary S.C., et al Gene 256,139-147,2000</div>
      <div id="p2759" num="2759" class="description-paragraph style-scope patent-text">Gaugitsch, H.W., et al (1992) J.Biol.Chem.267 (16): 11267-11273)</div>
      <div id="p2760" num="2760" class="description-paragraph style-scope patent-text">Geiser et al″Automation of solid-phase peptide synthesis″in
Macromolecular</div>
      <div id="p2761" num="2761" class="description-paragraph style-scope patent-text">Sequencing and Synthesis, Alan R.Liss, Inc., 1988, pp.199-218</div>
      <div id="p2762" num="2762" class="description-paragraph style-scope patent-text">Genome Res.13 (10): 2265-2270 (2003)</div>
      <div id="p2763" num="2763" class="description-paragraph style-scope patent-text">(1999) Genomics 62 (2): 281-284</div>
      <div id="p2764" num="2764" class="description-paragraph style-scope patent-text">Geoghegan&amp;Stroh, (1992) Bioconjugate Chem.3:138-146</div>
      <div id="p2765" num="2765" class="description-paragraph style-scope patent-text">Getz et al (1999) Anal.Biochem.Vol 273:73-80</div>
      <div id="p2766" num="2766" class="description-paragraph style-scope patent-text">Glynne-Jones et al(2001)Int J Cancer.Oct 15；94 (2): 178-84</div>
      <div id="p2767" num="2767" class="description-paragraph style-scope patent-text">Gregson et al., Chem.Commun.1999,797-798</div>
      <div id="p2768" num="2768" class="description-paragraph style-scope patent-text">Gregson et al., J.Med.Chem.2001,44,1161-1174</div>
      <div id="p2769" num="2769" class="description-paragraph style-scope patent-text">Gu Z., et al Oncogene 19,1288-1296,2000</div>
      <div id="p2770" num="2770" class="description-paragraph style-scope patent-text">Ha et al (1992) J.Immunol.148 (5): 1526-1531</div>
      <div id="p2771" num="2771" class="description-paragraph style-scope patent-text">Haendler B., et al J.Cardiovasc.Pharmacol.20, s1-S4,1992</div>
      <div id="p2772" num="2772" class="description-paragraph style-scope patent-text">Hamann P. (2005) Expert Opin.Ther.Patents 15 (9): 1087-1103</div>
      <div id="p2773" num="2773" class="description-paragraph style-scope patent-text">Hamblett et al (2004) Clin.Cancer Res.10:7063-7070</div>
      <div id="p2774" num="2774" class="description-paragraph style-scope patent-text">Handbook of Pharmaceutical Additives, 2nd Edition (eds.M.Ash and
I.Ash), 2001</div>
      <div id="p2775" num="2775" class="description-paragraph style-scope patent-text">(Synapse Information Resources, Inc., Endicott, New York, USA)</div>
      <div id="p2776" num="2776" class="description-paragraph style-scope patent-text">Handbook of Pharmaceutical Excipients,2nd edition,1994</div>
      <div id="p2777" num="2777" class="description-paragraph style-scope patent-text">Hara,et al.,J.Antibiotics,41,702-704(1988)</div>
      <div id="p2778" num="2778" class="description-paragraph style-scope patent-text">Hashimoto et al (1994) Immunogenetics 40 (4): 287-295</div>
      <div id="p2779" num="2779" class="description-paragraph style-scope patent-text">Hay et al. (1999) Bioorg.Med.Chem.Lett.9:2237</div>
      <div id="p2780" num="2780" class="description-paragraph style-scope patent-text">Herdwijn,P.et al.,Canadian Journal of Chemistry.1982,60,2903-7</div>
      <div id="p2781" num="2781" class="description-paragraph style-scope patent-text">Hermanson,G.T.(1996)Bioconjugate Techniques；Academic Press:New York, p
234- 242</div>
      <div id="p2782" num="2782" class="description-paragraph style-scope patent-text">Hochlowski, et al., J.Antibiotics, 40,145-148 (1987)</div>
      <div id="p2783" num="2783" class="description-paragraph style-scope patent-text">Hofstra R.M.W., et al Eur.J.Hum.Genet.5,180-185,1997</div>
      <div id="p2784" num="2784" class="description-paragraph style-scope patent-text">Hofstra R.M.W.,et al Nat.Genet.12,445-447,1996</div>
      <div id="p2785" num="2785" class="description-paragraph style-scope patent-text">Horie et al (2000) Genomics 67:146-152</div>
      <div id="p2786" num="2786" class="description-paragraph style-scope patent-text">Hubert, R.S., et al (1999) Proc.Natl.Acad.Sci.U.S.A.96 (25): 14523-14528)</div>
      <div id="p2787" num="2787" class="description-paragraph style-scope patent-text">Hurley and Needham-VanDevanter, Acc.Chem.Res., 19,230-237 (1986)</div>
      <div id="p2788" num="2788" class="description-paragraph style-scope patent-text">(2002) Immunogenetics 54 (2): 87-95</div>
      <div id="p2789" num="2789" class="description-paragraph style-scope patent-text">Int.Rev.Cytol.196:177-244 (2000)</div>
      <div id="p2790" num="2790" class="description-paragraph style-scope patent-text">Itoh, et al., J.Antibiotics, 41,1281-1284 (1988)</div>
      <div id="p2791" num="2791" class="description-paragraph style-scope patent-text">J.Biol.Chem.270 (37): 21984-21990 (1995)</div>
      <div id="p2792" num="2792" class="description-paragraph style-scope patent-text">J.Biol.Chem.276 (29): 27371-27375 (2001)</div>
      <div id="p2793" num="2793" class="description-paragraph style-scope patent-text">J.Biol.Chem.277 (22): 19665-19672 (2002)</div>
      <div id="p2794" num="2794" class="description-paragraph style-scope patent-text">J.Biol.Chem.278 (33): 30813-30820 (2003)</div>
      <div id="p2795" num="2795" class="description-paragraph style-scope patent-text">Janeway,C.,Travers,P.,Walport,M.,Shlomchik(2001)Immuno Biology,5th
Ed.,</div>
      <div id="p2796" num="2796" class="description-paragraph style-scope patent-text">Garland Publishing,New York</div>
      <div id="p2797" num="2797" class="description-paragraph style-scope patent-text">Jeffrey et al (2005) J.Med.Chem.48:1344-1358</div>
      <div id="p2798" num="2798" class="description-paragraph style-scope patent-text">Jonsson et al (1989) Immunogenetics 29 (6): 411-413</div>
      <div id="p2799" num="2799" class="description-paragraph style-scope patent-text">Junutula, et al., 2008b Nature Biotech., 26 (8): 925-932</div>
      <div id="p2800" num="2800" class="description-paragraph style-scope patent-text">Kang, G-D., et al., Chem.Commun., 2003,1680-1689</div>
      <div id="p2801" num="2801" class="description-paragraph style-scope patent-text">Kasahara et al (1989) Immunogenetics 30 (1): 66-68</div>
      <div id="p2802" num="2802" class="description-paragraph style-scope patent-text">King et al (2002) Tetrahedron Letters 43:1987-1990</div>
      <div id="p2803" num="2803" class="description-paragraph style-scope patent-text">Kingsbury et al (1984) J.Med.Chem.27:1447</div>
      <div id="p2804" num="2804" class="description-paragraph style-scope patent-text">Kohler et al (1975) Nature 256:495</div>
      <div id="p2805" num="2805" class="description-paragraph style-scope patent-text">Kohn, in Antibiotics III.Springer-Verlag, New York, pp.3-11 (1975)</div>
      <div id="p2806" num="2806" class="description-paragraph style-scope patent-text">Konishi, et al., J.Antibiotics, 37,200-206 (1984)</div>
      <div id="p2807" num="2807" class="description-paragraph style-scope patent-text">Kovtun et al (2006) Cancer Res.66 (6): 3214-3121</div>
      <div id="p2808" num="2808" class="description-paragraph style-scope patent-text">Kuhns J.J., et al J.Biol.Chem.274,36422-36427,1999</div>
      <div id="p2809" num="2809" class="description-paragraph style-scope patent-text">Kuminoto, et al., J.Antibiotics, 33,665-667 (1980)</div>
      <div id="p2810" num="2810" class="description-paragraph style-scope patent-text">79 (5-6): 707-717 of Kurebayashi et al (1999) Brit.Jour.Cancer</div>
      <div id="p2811" num="2811" class="description-paragraph style-scope patent-text">Lab.Invest.82 (11): 1573-1582 (2002)</div>
      <div id="p2812" num="2812" class="description-paragraph style-scope patent-text">Lambert J. (2005) Current Opin.in Pharmacol.5:543-549</div>
      <div id="p2813" num="2813" class="description-paragraph style-scope patent-text">Langley and Thurston,J.Org.Chem.,52,91-97(1987)</div>
      <div id="p2814" num="2814" class="description-paragraph style-scope patent-text">Larhammar et al (1985) J.Biol.Chem.260 (26): 14111-14119</div>
      <div id="p2815" num="2815" class="description-paragraph style-scope patent-text">Law et al (2006) Cancer Res.66 (4): 2328-2337</div>
      <div id="p2816" num="2816" class="description-paragraph style-scope patent-text">Le et al (1997) FEBS Lett.418 (1-2): 195-199</div>
      <div id="p2817" num="2817" class="description-paragraph style-scope patent-text">Leber,et al.,J.Am.Chem.Soc.,110,2992-2993(1988)</div>
      <div id="p2818" num="2818" class="description-paragraph style-scope patent-text">Leimgruber, et al., J.Am.Chem.Soc., 87,5791-5793 (1965)</div>
      <div id="p2819" num="2819" class="description-paragraph style-scope patent-text">Leimgruber, et al., J.Am.Chem.Soc., 87,5793-5795 (1965)</div>
      <div id="p2820" num="2820" class="description-paragraph style-scope patent-text">Levenson et al (1997) Cancer Res.57 (15): 3071-3078</div>
      <div id="p2821" num="2821" class="description-paragraph style-scope patent-text">Liang et al (2000) Cancer Res.60:4907-12</div>
      <div id="p2822" num="2822" class="description-paragraph style-scope patent-text">Manfr é, F.et al., J.Org.Chem.1992,57,2060-2065</div>
      <div id="p2823" num="2823" class="description-paragraph style-scope patent-text">Marks et al (1991) J.Mol.Biol., 222:581-597</div>
      <div id="p2824" num="2824" class="description-paragraph style-scope patent-text">McDonagh (2006) Protein Eng.Design&amp;Sel., 19 (7): 299-307</div>
      <div id="p2825" num="2825" class="description-paragraph style-scope patent-text">Mendoza et al (2002) Cancer Res.62:5485-5488</div>
      <div id="p2826" num="2826" class="description-paragraph style-scope patent-text">Miller et al (2003) Jour.of Immunology 170:4854-4861</div>
      <div id="p2827" num="2827" class="description-paragraph style-scope patent-text">Miura et al (1996) Genomics 38 (3): 299-304</div>
      <div id="p2828" num="2828" class="description-paragraph style-scope patent-text">Miura et al (1998) Blood 92:2815-2822</div>
      <div id="p2829" num="2829" class="description-paragraph style-scope patent-text">Moore M.,et al Proc.Natl.Acad.Sci.U.S.A.84,9194-9198,1987</div>
      <div id="p2830" num="2830" class="description-paragraph style-scope patent-text">Morrison et al (1984) Proc.Natl.Acad.Sci.USA, 81:6851-6855</div>
      <div id="p2831" num="2831" class="description-paragraph style-scope patent-text">Muller et al (1992) Eur.J.Immunol.22 (6): 1621-1625</div>
      <div id="p2832" num="2832" class="description-paragraph style-scope patent-text">Mungall A.J., et al Nature 425,805-811,2003</div>
      <div id="p2833" num="2833" class="description-paragraph style-scope patent-text">Nagase T., et al (2000) DNA Res.7 (2): 143-150)</div>
      <div id="p2834" num="2834" class="description-paragraph style-scope patent-text">Nakamuta M.,et al Biochem.Biophys.Res.Commun.177,34-39,1991</div>
      <div id="p2835" num="2835" class="description-paragraph style-scope patent-text">Nakayama et al (2000) Biochem.Biophys.Res.Commun.277 (1): 124-127</div>
      <div id="p2836" num="2836" class="description-paragraph style-scope patent-text">Naruse et al (2002) Tissue Antigens 59:512-519</div>
      <div id="p2837" num="2837" class="description-paragraph style-scope patent-text">(1998) Nature 395 (6699): 288-291</div>
      <div id="p2838" num="2838" class="description-paragraph style-scope patent-text">Neuberger and Williams (1988) Nucleic Acids Res.16:6713</div>
      <div id="p2839" num="2839" class="description-paragraph style-scope patent-text">Novabiochem Catalog 2006/2007</div>
      <div id="p2840" num="2840" class="description-paragraph style-scope patent-text">Ogawa Y.,et al Biochem.Biophys.Res.Commun.178,248-255,1991</div>
      <div id="p2841" num="2841" class="description-paragraph style-scope patent-text">Okamoto Y., et al Biol.Chem.272,21589-21596,1997</div>
      <div id="p2842" num="2842" class="description-paragraph style-scope patent-text">(1995) Oncogene 10 (5): 897-905</div>
      <div id="p2843" num="2843" class="description-paragraph style-scope patent-text">(1997) Oncogene 14 (11): 1377-1382)</div>
      <div id="p2844" num="2844" class="description-paragraph style-scope patent-text">Parrish-Novak J., et al J.Biol.Chem.277,47517-47523,2002</div>
      <div id="p2845" num="2845" class="description-paragraph style-scope patent-text">Payne, G. (2003) Cancer Cell 3:207-212</div>
      <div id="p2846" num="2846" class="description-paragraph style-scope patent-text">Pingault V., et al (2002) Hum.Genet.111,198-206</div>
      <div id="p2847" num="2847" class="description-paragraph style-scope patent-text">Pletnev S., et al (2003) Biochemistry 42:12617-12624</div>
      <div id="p2848" num="2848" class="description-paragraph style-scope patent-text">Preud ' homme et al (1992) Clin.Exp.Immunol.90 (1): 141-146</div>
      <div id="p2849" num="2849" class="description-paragraph style-scope patent-text">Proc.Natl.Acad.Sci.U.S.A. (2003) 100 (7): 4126-4131</div>
      <div id="p2850" num="2850" class="description-paragraph style-scope patent-text">Proc.Natl.Acad.Sci.U.S.A.93 (1): 136-140 (1996)</div>
      <div id="p2851" num="2851" class="description-paragraph style-scope patent-text">Proc.Natl.Acad.Sci.U.S.A.98 (17): 9772-9777 (2001)</div>
      <div id="p2852" num="2852" class="description-paragraph style-scope patent-text">Proc.Natl.Acad.Sci.U.S.A.99 (26): 16899-16903 (2002)</div>
      <div id="p2853" num="2853" class="description-paragraph style-scope patent-text">Proc.Natl.Acad.Sci.U.S.A.96 (20): 11531-11536 (1999)</div>
      <div id="p2854" num="2854" class="description-paragraph style-scope patent-text">Protective Groups in Organic Synthesis, Greene and Wuts, 3<sup class="style-scope patent-text">rd</sup>Edition,
1999, John Wiley&amp;Sons Inc.</div>
      <div id="p2855" num="2855" class="description-paragraph style-scope patent-text">Puffenberger E.G.,et al Cell 79,1257-1266,1994</div>
      <div id="p2856" num="2856" class="description-paragraph style-scope patent-text">Rao et al (1997) Breast Cancer Res.and Treatment 45:149-158</div>
      <div id="p2857" num="2857" class="description-paragraph style-scope patent-text">Reiter R.E., et al Proc.Natl.Acad.Sci.U.S.A.95,1735-1740,1998</div>
      <div id="p2858" num="2858" class="description-paragraph style-scope patent-text">Remington′s Pharmaceutical Sciences,20th edition,pub.Lippincott,
Williams&amp; Wilkins,2000</div>
      <div id="p2859" num="2859" class="description-paragraph style-scope patent-text">Rodrigues et al (1995) Chemistry Biology 2:223</div>
      <div id="p2860" num="2860" class="description-paragraph style-scope patent-text">Ross et al (2002) Cancer Res.62:2546-2553</div>
      <div id="p2861" num="2861" class="description-paragraph style-scope patent-text">S.P.Parker, Ed., McGraw-Hill Dictionary of Chemical Terms (1984) McGraw-
Hill Book Company, New York</div>
      <div id="p2862" num="2862" class="description-paragraph style-scope patent-text">Sakaguchi et al (1988) EMBO is J.7 (11): 3457-3464</div>
      <div id="p2863" num="2863" class="description-paragraph style-scope patent-text">Sakamoto A., Yanagisawa M., et al Biochem.Biophys.Res.Commun.178,656-
663,1991</div>
      <div id="p2864" num="2864" class="description-paragraph style-scope patent-text">Sanderson et al (2005) Clin.Cancer Res.11:843-852</div>
      <div id="p2865" num="2865" class="description-paragraph style-scope patent-text">Semba K., et al Proc.Natl.Acad.Sci.U.S.A.82,6497-6501,1985</div>
      <div id="p2866" num="2866" class="description-paragraph style-scope patent-text">Servenius et al (1987) J.Biol.Chem.262:8759-8766</div>
      <div id="p2867" num="2867" class="description-paragraph style-scope patent-text">Shamis et al (2004) J.Am.Chem.Soc.126:1726-1731</div>
      <div id="p2868" num="2868" class="description-paragraph style-scope patent-text">Sheikh F.,et al(2004)J.Immunol.172,2006-2010</div>
      <div id="p2869" num="2869" class="description-paragraph style-scope patent-text">Shimizu,et al,J.Antibiotics,29,2492-2503(1982)</div>
      <div id="p2870" num="2870" class="description-paragraph style-scope patent-text">Sinha S.K., et al (1993) J.Immunol.150,5311-5320</div>
      <div id="p2871" num="2871" class="description-paragraph style-scope patent-text">Storm et al (1972) J.Amer.Chem.Soc.94:5815</div>
      <div id="p2872" num="2872" class="description-paragraph style-scope patent-text">Strausberg et al (2002) Proc.Natl.Acad.Sci USA 99:16899-16903</div>
      <div id="p2873" num="2873" class="description-paragraph style-scope patent-text">Sun et al (2002) Bioorganic&amp;Medicinal Chemistry Letters 12:2213-2215</div>
      <div id="p2874" num="2874" class="description-paragraph style-scope patent-text">Sun et al (2003) Bioorganic&amp;Medicinal Chemistry 11:1761-1768</div>
      <div id="p2875" num="2875" class="description-paragraph style-scope patent-text">Svensson P.J., et al Hum.Genet.103,145-148,1998</div>
      <div id="p2876" num="2876" class="description-paragraph style-scope patent-text">Swiercz J.M., et al J.Cell Biol.165,869-880,2004</div>
      <div id="p2877" num="2877" class="description-paragraph style-scope patent-text">Syrigos and Epenetos (1999) Anticancer Research 19:605-614</div>
      <div id="p2878" num="2878" class="description-paragraph style-scope patent-text">Takeuchi,et al.,J.Antibiotics,29,93-96(1976)</div>
      <div id="p2879" num="2879" class="description-paragraph style-scope patent-text">Tawaragi Y.,et al Biochem.Biophys.Res.Commun.150,89-96,1988</div>
      <div id="p2880" num="2880" class="description-paragraph style-scope patent-text">(1994) ten Dijke, P., et al Science 264 (5155): 101-104</div>
      <div id="p2881" num="2881" class="description-paragraph style-scope patent-text">Thompson, J.S., et al Science 293 (5537), 2108-2111 (2001) WO 2004/058309</div>
      <div id="p2882" num="2882" class="description-paragraph style-scope patent-text">Thurston, et al., Chem.Brit., 26,767-772 (1990)</div>
      <div id="p2883" num="2883" class="description-paragraph style-scope patent-text">Thurston, et al., Chem.Rev.1994,433-465 (1994)</div>
      <div id="p2884" num="2884" class="description-paragraph style-scope patent-text">Toki et al (2002) J.Org.Chem.67:1866-1872</div>
      <div id="p2885" num="2885" class="description-paragraph style-scope patent-text">Tonnelle et al (1985) EMBO is J.4 (11): 2839-2847</div>
      <div id="p2886" num="2886" class="description-paragraph style-scope patent-text">Touchman et al (2000) Genome Res.10:165-173</div>
      <div id="p2887" num="2887" class="description-paragraph style-scope patent-text">Trail et al (2003) Cancer Immunol.Immunother.52:328-337</div>
      <div id="p2888" num="2888" class="description-paragraph style-scope patent-text">Tsunakawa,et al.,J.Antibiotics,41,1366-1373(1988)</div>
      <div id="p2889" num="2889" class="description-paragraph style-scope patent-text">Tsutsumi M.,et al Gene 228,43-49,1999</div>
      <div id="p2890" num="2890" class="description-paragraph style-scope patent-text">Uchida et al (1999) Biochem.Biophys.Res.Commun.266:593-602</div>
      <div id="p2891" num="2891" class="description-paragraph style-scope patent-text">Verheij J.B., et al Am.J.Med.Genet.108,223-225,2002</div>
      <div id="p2892" num="2892" class="description-paragraph style-scope patent-text">Von Hoegen et al (1990) J.Immunol.144 (12): 4870-4877</div>
      <div id="p2893" num="2893" class="description-paragraph style-scope patent-text">Webster et al (1994) Semin.Cancer Biol.5:69-76</div>
      <div id="p2894" num="2894" class="description-paragraph style-scope patent-text">Weis J.J.,et al J.Exp.Med.167,1047-1066,1988</div>
      <div id="p2895" num="2895" class="description-paragraph style-scope patent-text">Weis J.J.,et al Proc.Natl.Acad.Sci.U.S.A.83,5639-5643,1986</div>
      <div id="p2896" num="2896" class="description-paragraph style-scope patent-text">Wilson et al (1991) J.Exp.Med.173:137-146</div>
      <div id="p2897" num="2897" class="description-paragraph style-scope patent-text">Wu et al (2005) Nature Biotech.23 (9): 1137-1145</div>
      <div id="p2898" num="2898" class="description-paragraph style-scope patent-text">Xie et al (2006) Expert.Opin.Biol.Ther.6 (3): 281-291</div>
      <div id="p2899" num="2899" class="description-paragraph style-scope patent-text">Xu, M.J., et al (2001) Biochem.Biophys.Res.Commun.280 (3): 768-775 WO 2004/
016225</div>
      <div id="p2900" num="2900" class="description-paragraph style-scope patent-text">Xu, X.Z., et al Proc.Natl.Acad.Sci.U.S.A.98 (19): 10692-10697 (2001)</div>
      <div id="p2901" num="2901" class="description-paragraph style-scope patent-text">Yamaguchi, N., et al Biol.Chem.269 (2), 805-808 (1994)</div>
      <div id="p2902" num="2902" class="description-paragraph style-scope patent-text">Yamamoto T., et al Nature 319,230-234,1986</div>
      <div id="p2903" num="2903" class="description-paragraph style-scope patent-text">Yu et al(1992)J.Immunol.148(2)633-637 o</div>
    </mode-for-invention>
  </div>
  </section>
      <div id="margin" class="style-scope patent-text">
        <div id="createHighlight" style="top: 0px;" class="style-scope patent-text" hidden="">
          <iron-icon id="comment" icon="editor:insert-comment" class="style-scope patent-text x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M20 2H4c-1.1 0-2 .9-2 2v12c0 1.1.9 2 2 2h14l4 4V4c0-1.1-.9-2-2-2zm-2 12H6v-2h12v2zm0-3H6V9h12v2zm0-3H6V6h12v2z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
        </div>
      </div>
    </div>
  </patent-text>
              </section>
            </div>
            <div class="flex flex-width style-scope patent-result">
              <section id="claims" class="style-scope patent-result">
                <h3 class="style-scope patent-result">
                  <div class="layout horizontal style-scope patent-result">
                    <div class="flex style-scope patent-result">Claims <span class="style-scope patent-result">(24)</span></div>
                    <div class="collapse style-scope patent-result">
                      Hide Dependent <iron-icon style="height: 15px; width: 15px;" icon="expand-less" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M12 8l-6 6 1.41 1.41L12 10.83l4.59 4.58L18 14z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon><template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </div>
                  </div>
                  <div class="layout horizontal style-scope patent-result">
                    <div class="flex style-scope patent-result"></div>
                    <div class="righthead style-scope patent-result" hidden="">translated from </div>
                  </div>
                </h3>
                <patent-text name="claims" enable-text-selection="" class="style-scope patent-result" style="padding-top: 0px;">
    
    
    <template is="dom-if" restamp="" class="style-scope patent-text"></template>
    <overlay-tooltip id="tooltip" class="style-scope patent-text" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
    </div>
  </overlay-tooltip>
    <div class="layout horizontal style-scope patent-text">
      <section id="text" class="flex style-scope patent-text"><div mxw-id="PCLM218325027" lang="EN" load-source="patent-office" class="claims style-scope patent-text">
    <div class="claim style-scope patent-text"> <div id="en-cl0001" num="0001" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text">1. a kind of compound of following formula I:</div>
      <div class="claim-text style-scope patent-text">
        <span class="patent-image-not-available style-scope patent-text"></span>
      </div>
      <div class="claim-text style-scope patent-text">And its salt and solvate, in which:</div>
      <div class="claim-text style-scope patent-text">When between C2 and C3 there are when double bond, R<sup class="style-scope patent-text">2</sup>Selected from the group being made up of:</div>
      <div class="claim-text style-scope patent-text">(ia)C<sub class="style-scope patent-text">5-10</sub>Aryl group, optionally by selected from include below group in one or more substituent groups replace: halogen, nitre
Base, cyano, ether, C<sub class="style-scope patent-text">1-7</sub>Alkyl, C<sub class="style-scope patent-text">3-7</sub>Heterocycle and double-oxygroup-C<sub class="style-scope patent-text">1-3</sub>Alkylidene；</div>
      <div class="claim-text style-scope patent-text">(ib)C<sub class="style-scope patent-text">1-5</sub>Representative examples of saturated aliphatic alkyl；</div>
      <div class="claim-text style-scope patent-text">(ic)C<sub class="style-scope patent-text">3-6</sub>Saturated cyclic alkyls；</div>
      <div class="claim-text style-scope patent-text">(id)<span class="patent-image-not-available style-scope patent-text"></span>Wherein, R<sup class="style-scope patent-text">11</sup>、R<sup class="style-scope patent-text">12</sup>And R<sup class="style-scope patent-text">13</sup>Each of independently selected from H, C<sub class="style-scope patent-text">1-3</sub>Saturated alkyl, C<sub class="style-scope patent-text">2-3</sub>Alkenyl,
C<sub class="style-scope patent-text">2-3</sub>Alkynyl and cyclopropyl, wherein R<sup class="style-scope patent-text">2</sup>The sum of carbon atom is not more than 5 in group；</div>
      <div class="claim-text style-scope patent-text">(ie)<span class="patent-image-not-available style-scope patent-text"></span>Wherein, R<sup class="style-scope patent-text">15a</sup>And R<sup class="style-scope patent-text">15b</sup>In one be H, and another is selected from: phenyl, and the phenyl can
Selection of land is replaced by the group selected from halogen, methyl, methoxyl group；Pyridyl group；And thiophenyl；With</div>
      <div class="claim-text style-scope patent-text">(if)<span class="patent-image-not-available style-scope patent-text"></span>Wherein, R<sup class="style-scope patent-text">14</sup>It is selected from: H；C<sub class="style-scope patent-text">1-3</sub>Saturated alkyl；C<sub class="style-scope patent-text">2-3</sub>Alkenyl；C<sub class="style-scope patent-text">2-3</sub>Alkynyl；Cyclopropyl；Phenyl, institute
Phenyl is stated optionally to be replaced by the group selected from halogen, methyl, methoxyl group；Pyridyl group；And thiophenyl；</div>
      <div class="claim-text style-scope patent-text">When between C2 and C3 there are when singly-bound,</div>
      <div class="claim-text style-scope patent-text">R<sup class="style-scope patent-text">2</sup>It is<span class="patent-image-not-available style-scope patent-text"></span>Wherein, R<sup class="style-scope patent-text">16a</sup>And R<sup class="style-scope patent-text">16b</sup>Independently selected from H, F, C<sub class="style-scope patent-text">1-4</sub>Saturated alkyl, C<sub class="style-scope patent-text">2-3</sub>Alkenyl, the alkyl and
Alkenyl group is optionally selected from C<sub class="style-scope patent-text">1-4</sub>Alkyl amino and C<sub class="style-scope patent-text">1-4</sub>The group of Arrcostab replaces；Or work as R<sup class="style-scope patent-text">16a</sup>And R<sup class="style-scope patent-text">16b</sup>In one be H
When, another is selected from nitrile and C<sub class="style-scope patent-text">1-4</sub>Arrcostab；</div>
      <div class="claim-text style-scope patent-text">As C2 ' and C3 ' between there are when double bond, R<sup class="style-scope patent-text">12</sup>Selected from the group being made up of:</div>
      <div class="claim-text style-scope patent-text">(ia)C<sub class="style-scope patent-text">5-10</sub>Aryl group, optionally by selected from include below group in one or more substituent groups replace: halogen, nitre
Base, cyano, ether, carboxyl, ester, C<sub class="style-scope patent-text">1-7</sub>Alkyl, C<sub class="style-scope patent-text">3-7</sub>Heterocycle and double-oxygroup-C<sub class="style-scope patent-text">1-3</sub>Alkylidene；</div>
      <div class="claim-text style-scope patent-text">(ib)C<sub class="style-scope patent-text">1-5</sub>Representative examples of saturated aliphatic alkyl；</div>
      <div class="claim-text style-scope patent-text">(ic)C<sub class="style-scope patent-text">3-6</sub>Saturated cyclic alkyls；</div>
      <div class="claim-text style-scope patent-text">(id)<span class="patent-image-not-available style-scope patent-text"></span>Wherein, R<sup class="style-scope patent-text">21</sup>、R<sup class="style-scope patent-text">22</sup>And R<sup class="style-scope patent-text">23</sup>Each of independently selected from H, C<sub class="style-scope patent-text">1-3</sub>Saturated alkyl, C<sub class="style-scope patent-text">2-3</sub>Alkenyl, C<sub class="style-scope patent-text">2-3</sub>
Alkynyl and cyclopropyl, wherein R<sup class="style-scope patent-text">12</sup>The sum of carbon atom is not more than 5 in group；</div>
      <div class="claim-text style-scope patent-text">(ie)<span class="patent-image-not-available style-scope patent-text"></span>Wherein, R<sup class="style-scope patent-text">25a</sup>And R<sup class="style-scope patent-text">25b</sup>In one be H, and another is selected from: phenyl, and the phenyl is optional
Ground is replaced by the group selected from halogen, methyl, methoxyl group；Pyridyl group；And thiophenyl；With</div>
      <div class="claim-text style-scope patent-text">(if)<span class="patent-image-not-available style-scope patent-text"></span>Wherein, R<sup class="style-scope patent-text">24</sup>It is selected from: H；C<sub class="style-scope patent-text">1-3</sub>Saturated alkyl；C<sub class="style-scope patent-text">2-3</sub>Alkenyl；C<sub class="style-scope patent-text">2-3</sub>Alkynyl；Cyclopropyl；Phenyl, it is described
Phenyl is optionally replaced by the group selected from halogen, methyl, methoxyl group；Pyridyl group；And thiophenyl；</div>
      <div class="claim-text style-scope patent-text">As C2 ' and C3 ' between there are when singly-bound,</div>
      <div class="claim-text style-scope patent-text">R<sup class="style-scope patent-text">12</sup>It is<span class="patent-image-not-available style-scope patent-text"></span>Wherein, R<sup class="style-scope patent-text">26a</sup>And R<sup class="style-scope patent-text">26b</sup>Independently selected from H, F, C<sub class="style-scope patent-text">1-4</sub>Saturated alkyl, C<sub class="style-scope patent-text">2-3</sub>Alkenyl, the alkyl and alkene
Base group is optionally selected from C<sub class="style-scope patent-text">1-4</sub>Alkyl amino and C<sub class="style-scope patent-text">1-4</sub>The group of Arrcostab replaces；Alternatively, working as R<sup class="style-scope patent-text">26a</sup>And R<sup class="style-scope patent-text">26b</sup>In one be H
When, another is selected from nitrile and C<sub class="style-scope patent-text">1-4</sub>Arrcostab；</div>
      <div class="claim-text style-scope patent-text">R<sup class="style-scope patent-text">6</sup>And R<sup class="style-scope patent-text">9</sup>Independently selected from H, R, OH, OR, SH, SR, NH<sub class="style-scope patent-text">2</sub>, NHR, NRR ', nitro, Me<sub class="style-scope patent-text">3</sub>Sn and halogen；</div>
      <div class="claim-text style-scope patent-text">Wherein, R and R ' is independently selected from optionally substituted C<sub class="style-scope patent-text">1-12</sub>Alkyl, C<sub class="style-scope patent-text">3-20</sub>Heterocycle and C<sub class="style-scope patent-text">5-20</sub>Aryl group；</div>
      <div class="claim-text style-scope patent-text">R<sup class="style-scope patent-text">7</sup>Selected from H, R, OH, OR, SH, SR, NH<sub class="style-scope patent-text">2</sub>, NHR, NHRR ', nitro, Me<sub class="style-scope patent-text">3</sub>Sn and halogen；</div>
      <div class="claim-text style-scope patent-text">R " is C<sub class="style-scope patent-text">3-12</sub>Alkylidene group, chain can be interrupted by item below one or more: hetero atom, such as O, S, NR<sup class="style-scope patent-text">N2</sup>(its
In, R<sup class="style-scope patent-text">N2</sup>It is H or C<sub class="style-scope patent-text">1-4</sub>Alkyl) and/or aromatic ring, such as benzene or pyridine；</div>
      <div class="claim-text style-scope patent-text">Y and Y ' is selected from O, S or NH；</div>
      <div class="claim-text style-scope patent-text">R<sup class="style-scope patent-text">6’</sup>、R<sup class="style-scope patent-text">7’</sup>、R<sup class="style-scope patent-text">9’</sup>Selected from respectively with R<sup class="style-scope patent-text">6</sup>、R<sup class="style-scope patent-text">7</sup>And R<sup class="style-scope patent-text">9</sup>Identical group；</div>
      <div class="claim-text style-scope patent-text">R<sup class="style-scope patent-text">20</sup>It is H or Me and R<sup class="style-scope patent-text">21a</sup>And R<sup class="style-scope patent-text">21b</sup>All it is H or is formed together=O；</div>
      <div class="claim-text style-scope patent-text">R<sup class="style-scope patent-text">L</sup>It is the connector for being connected to cell binding agent；</div>
      <div class="claim-text style-scope patent-text">R<sup class="style-scope patent-text">11b</sup>Selected from OH, OR<sup class="style-scope patent-text">A</sup>, wherein R<sup class="style-scope patent-text">A</sup>It is C<sub class="style-scope patent-text">1-4</sub>Alkyl and SO<sub class="style-scope patent-text">z</sub>M, wherein z is that 2 or 3 and M is monovalent medicinal cation.</div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div id="en-cl0002" num="0002" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text">
        <claim-ref idref="en-cl0001" class="style-scope patent-text"> </claim-ref>
      </div>
      <div class="claim-text style-scope patent-text">2. compound according to claim 1, wherein R<sup class="style-scope patent-text">7</sup>It is C<sub class="style-scope patent-text">1-4</sub>Alkoxy base.</div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div id="en-cl0003" num="0003" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text">
        <claim-ref idref="en-cl0001" class="style-scope patent-text"> </claim-ref>
        <claim-ref idref="en-cl0002" class="style-scope patent-text"> </claim-ref>
      </div>
      <div class="claim-text style-scope patent-text">3. according to claim 1 or compound as claimed in claim 2, wherein Y is O, and R " is C<sub class="style-scope patent-text">3-7</sub>Alkylidene.</div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div id="en-cl0004" num="0004" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text">
        <claim-ref idref="en-cl0001" class="style-scope patent-text"> </claim-ref>
        <claim-ref idref="en-cl0002" class="style-scope patent-text"> </claim-ref>
        <claim-ref idref="en-cl0003" class="style-scope patent-text"> </claim-ref>
      </div>
      <div class="claim-text style-scope patent-text">4. compound according to any one of claim 1 to 3, wherein R<sup class="style-scope patent-text">6</sup>And R<sup class="style-scope patent-text">9</sup>It is H.</div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div id="en-cl0005" num="0005" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text">
        <claim-ref idref="en-cl0001" class="style-scope patent-text"> </claim-ref>
        <claim-ref idref="en-cl0002" class="style-scope patent-text"> </claim-ref>
        <claim-ref idref="en-cl0003" class="style-scope patent-text"> </claim-ref>
        <claim-ref idref="en-cl0004" class="style-scope patent-text"> </claim-ref>
      </div>
      <div class="claim-text style-scope patent-text">5. compound according to any one of claim 1 to 4, wherein there are double bond between C2 ' and C3 ', and R<sup class="style-scope patent-text">12</sup>
It is:</div>
      <div class="claim-text style-scope patent-text">(a)C<sub class="style-scope patent-text">5-7</sub>Aryl group, can have 1 to 3 substituent group group selected from the following: methoxyl group, ethyoxyl, fluorine, chlorine,
Cyano, double-oxygroup-methylene, methyl-piperazinyl group, morpholinyl and methyl-phenylsulfanyl；Or</div>
      <div class="claim-text style-scope patent-text">(b) methyl, ethyl or propyl；Or</div>
      <div class="claim-text style-scope patent-text">(c) cyclopropyl；</div>
      <div class="claim-text style-scope patent-text">(d) group of following formula:<span class="patent-image-not-available style-scope patent-text"></span>Wherein, the R<sup class="style-scope patent-text">12</sup>The sum of carbon atom is not more than 4 in group；Or</div>
      <div class="claim-text style-scope patent-text">(e) group:<span class="patent-image-not-available style-scope patent-text"></span>Or</div>
      <div class="claim-text style-scope patent-text">(f) group of following formula:<span class="patent-image-not-available style-scope patent-text"></span>Wherein, R<sup class="style-scope patent-text">24</sup>Selected from H and methyl.</div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div id="en-cl0006" num="0006" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text">
        <claim-ref idref="en-cl0001" class="style-scope patent-text"> </claim-ref>
        <claim-ref idref="en-cl0002" class="style-scope patent-text"> </claim-ref>
        <claim-ref idref="en-cl0003" class="style-scope patent-text"> </claim-ref>
        <claim-ref idref="en-cl0004" class="style-scope patent-text"> </claim-ref>
      </div>
      <div class="claim-text style-scope patent-text">6. compound according to any one of claim 1 to 4, wherein there are singly-bound, R between C2 ' and C3 '<sup class="style-scope patent-text">12</sup>It is<span class="patent-image-not-available style-scope patent-text"></span>And:</div>
      <div class="claim-text style-scope patent-text">(a)R<sup class="style-scope patent-text">26a</sup>And R<sup class="style-scope patent-text">26b</sup>It is all H；Or</div>
      <div class="claim-text style-scope patent-text">(b)R<sup class="style-scope patent-text">26a</sup>And R<sup class="style-scope patent-text">26b</sup>It is all methyl；Or</div>
      <div class="claim-text style-scope patent-text">(c)R<sup class="style-scope patent-text">26a</sup>And R<sup class="style-scope patent-text">26b</sup>In one be H, and another be selected from C<sub class="style-scope patent-text">1-4</sub>Saturated alkyl, C<sub class="style-scope patent-text">2-3</sub>Alkenyl, the alkyl and alkenyl base
Group is optionally substituted.</div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div id="en-cl0007" num="0007" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text">
        <claim-ref idref="en-cl0001" class="style-scope patent-text"> </claim-ref>
        <claim-ref idref="en-cl0002" class="style-scope patent-text"> </claim-ref>
        <claim-ref idref="en-cl0003" class="style-scope patent-text"> </claim-ref>
        <claim-ref idref="en-cl0004" class="style-scope patent-text"> </claim-ref>
        <claim-ref idref="en-cl0005" class="style-scope patent-text"> </claim-ref>
        <claim-ref idref="en-cl0006" class="style-scope patent-text"> </claim-ref>
      </div>
      <div class="claim-text style-scope patent-text">7. compound according to any one of claim 1 to 6, wherein there are double bond between C2 and C3, and R<sup class="style-scope patent-text">2</sup>It is:</div>
      <div class="claim-text style-scope patent-text">(a)C<sub class="style-scope patent-text">5-7</sub>Aryl group, can have 1 to 3 substituent group group selected from the following: methoxyl group, ethyoxyl, fluorine, chlorine,
Cyano, double-oxygroup-methylene, methyl-piperazinyl group, morpholinyl and methyl-phenylsulfanyl；Or</div>
      <div class="claim-text style-scope patent-text">(b) methyl, ethyl or propyl；Or</div>
      <div class="claim-text style-scope patent-text">(c) cyclopropyl；Or</div>
      <div class="claim-text style-scope patent-text">(d) group of following formula:<span class="patent-image-not-available style-scope patent-text"></span>Wherein, the R<sup class="style-scope patent-text">2</sup>The sum of carbon atom is not more than 4 in group；Or</div>
      <div class="claim-text style-scope patent-text">(e)<span class="patent-image-not-available style-scope patent-text"></span>Or</div>
      <div class="claim-text style-scope patent-text">(f)<span class="patent-image-not-available style-scope patent-text"></span>Wherein, R<sup class="style-scope patent-text">14</sup>Selected from H and methyl.</div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div id="en-cl0008" num="0008" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text">
        <claim-ref idref="en-cl0001" class="style-scope patent-text"> </claim-ref>
        <claim-ref idref="en-cl0002" class="style-scope patent-text"> </claim-ref>
        <claim-ref idref="en-cl0003" class="style-scope patent-text"> </claim-ref>
        <claim-ref idref="en-cl0004" class="style-scope patent-text"> </claim-ref>
        <claim-ref idref="en-cl0005" class="style-scope patent-text"> </claim-ref>
        <claim-ref idref="en-cl0006" class="style-scope patent-text"> </claim-ref>
      </div>
      <div class="claim-text style-scope patent-text">8. compound according to any one of claim 1 to 6, wherein there are singly-bound, R between C2 and C3<sup class="style-scope patent-text">2</sup>It is<span class="patent-image-not-available style-scope patent-text"></span>And:</div>
      <div class="claim-text style-scope patent-text">(a)R<sup class="style-scope patent-text">16a</sup>And R<sup class="style-scope patent-text">16b</sup>It is all H；Or</div>
      <div class="claim-text style-scope patent-text">(b)R<sup class="style-scope patent-text">16a</sup>And R<sup class="style-scope patent-text">16b</sup>It is all methyl；Or</div>
      <div class="claim-text style-scope patent-text">(c)R<sup class="style-scope patent-text">16a</sup>And R<sup class="style-scope patent-text">16b</sup>In one be H, and another be selected from C<sub class="style-scope patent-text">1-4</sub>Saturated alkyl, C<sub class="style-scope patent-text">2-3</sub>Alkenyl, the alkyl and alkenyl base
Group is optionally substituted.</div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div id="en-cl0009" num="0009" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text">
        <claim-ref idref="en-cl0001" class="style-scope patent-text"> </claim-ref>
        <claim-ref idref="en-cl0002" class="style-scope patent-text"> </claim-ref>
        <claim-ref idref="en-cl0003" class="style-scope patent-text"> </claim-ref>
        <claim-ref idref="en-cl0004" class="style-scope patent-text"> </claim-ref>
        <claim-ref idref="en-cl0005" class="style-scope patent-text"> </claim-ref>
        <claim-ref idref="en-cl0006" class="style-scope patent-text"> </claim-ref>
        <claim-ref idref="en-cl0007" class="style-scope patent-text"> </claim-ref>
        <claim-ref idref="en-cl0008" class="style-scope patent-text"> </claim-ref>
      </div>
      <div class="claim-text style-scope patent-text">9. compound according to any one of claim 1 to 8, wherein R<sup class="style-scope patent-text">20</sup>It is H or Me and R<sup class="style-scope patent-text">21a</sup>And R<sup class="style-scope patent-text">21b</sup>It is all H.</div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div id="en-cl0010" num="0010" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text">
        <claim-ref idref="en-cl0001" class="style-scope patent-text"> </claim-ref>
        <claim-ref idref="en-cl0002" class="style-scope patent-text"> </claim-ref>
        <claim-ref idref="en-cl0003" class="style-scope patent-text"> </claim-ref>
        <claim-ref idref="en-cl0004" class="style-scope patent-text"> </claim-ref>
        <claim-ref idref="en-cl0005" class="style-scope patent-text"> </claim-ref>
        <claim-ref idref="en-cl0006" class="style-scope patent-text"> </claim-ref>
        <claim-ref idref="en-cl0007" class="style-scope patent-text"> </claim-ref>
        <claim-ref idref="en-cl0008" class="style-scope patent-text"> </claim-ref>
      </div>
      <div class="claim-text style-scope patent-text">10. compound according to any one of claim 1 to 8, wherein R<sup class="style-scope patent-text">20</sup>It is H or Me and R<sup class="style-scope patent-text">21a</sup>And R<sup class="style-scope patent-text">21b</sup>Shape together
At=O.</div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div id="en-cl0011" num="0011" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text">
        <claim-ref idref="en-cl0009" class="style-scope patent-text"> </claim-ref>
        <claim-ref idref="en-cl0010" class="style-scope patent-text"> </claim-ref>
      </div>
      <div class="claim-text style-scope patent-text">11. according to claim 9 or compound described in any one of claim 10, wherein R<sup class="style-scope patent-text">20</sup>It is H.</div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div id="en-cl0012" num="0012" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text">
        <claim-ref idref="en-cl0001" class="style-scope patent-text"> </claim-ref>
        <claim-ref idref="en-cl0002" class="style-scope patent-text"> </claim-ref>
        <claim-ref idref="en-cl0003" class="style-scope patent-text"> </claim-ref>
        <claim-ref idref="en-cl0004" class="style-scope patent-text"> </claim-ref>
        <claim-ref idref="en-cl0005" class="style-scope patent-text"> </claim-ref>
        <claim-ref idref="en-cl0006" class="style-scope patent-text"> </claim-ref>
        <claim-ref idref="en-cl0007" class="style-scope patent-text"> </claim-ref>
        <claim-ref idref="en-cl0008" class="style-scope patent-text"> </claim-ref>
        <claim-ref idref="en-cl0009" class="style-scope patent-text"> </claim-ref>
        <claim-ref idref="en-cl0010" class="style-scope patent-text"> </claim-ref>
        <claim-ref idref="en-cl0011" class="style-scope patent-text"> </claim-ref>
      </div>
      <div class="claim-text style-scope patent-text">12. compound according to any one of claim 1 to 11, wherein R<sup class="style-scope patent-text">11b</sup>It is OH.</div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div id="en-cl0013" num="0013" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text">
        <claim-ref idref="en-cl0001" class="style-scope patent-text"> </claim-ref>
        <claim-ref idref="en-cl0002" class="style-scope patent-text"> </claim-ref>
        <claim-ref idref="en-cl0003" class="style-scope patent-text"> </claim-ref>
        <claim-ref idref="en-cl0004" class="style-scope patent-text"> </claim-ref>
        <claim-ref idref="en-cl0005" class="style-scope patent-text"> </claim-ref>
        <claim-ref idref="en-cl0006" class="style-scope patent-text"> </claim-ref>
        <claim-ref idref="en-cl0007" class="style-scope patent-text"> </claim-ref>
        <claim-ref idref="en-cl0008" class="style-scope patent-text"> </claim-ref>
        <claim-ref idref="en-cl0009" class="style-scope patent-text"> </claim-ref>
        <claim-ref idref="en-cl0010" class="style-scope patent-text"> </claim-ref>
        <claim-ref idref="en-cl0011" class="style-scope patent-text"> </claim-ref>
      </div>
      <div class="claim-text style-scope patent-text">13. compound according to any one of claim 1 to 11, wherein R<sup class="style-scope patent-text">11b</sup>It is OR<sup class="style-scope patent-text">A</sup>。</div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div id="en-cl0014" num="0014" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text">
        <claim-ref idref="en-cl0001" class="style-scope patent-text"> </claim-ref>
        <claim-ref idref="en-cl0002" class="style-scope patent-text"> </claim-ref>
        <claim-ref idref="en-cl0003" class="style-scope patent-text"> </claim-ref>
        <claim-ref idref="en-cl0004" class="style-scope patent-text"> </claim-ref>
        <claim-ref idref="en-cl0005" class="style-scope patent-text"> </claim-ref>
        <claim-ref idref="en-cl0006" class="style-scope patent-text"> </claim-ref>
        <claim-ref idref="en-cl0007" class="style-scope patent-text"> </claim-ref>
        <claim-ref idref="en-cl0008" class="style-scope patent-text"> </claim-ref>
        <claim-ref idref="en-cl0009" class="style-scope patent-text"> </claim-ref>
        <claim-ref idref="en-cl0010" class="style-scope patent-text"> </claim-ref>
        <claim-ref idref="en-cl0011" class="style-scope patent-text"> </claim-ref>
      </div>
      <div class="claim-text style-scope patent-text">14. compound according to any one of claim 1 to 11, wherein R<sup class="style-scope patent-text">11b</sup>It is SO<sub class="style-scope patent-text">z</sub>M。</div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div id="en-cl0015" num="0015" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text">
        <claim-ref idref="en-cl0014" class="style-scope patent-text"> </claim-ref>
      </div>
      <div class="claim-text style-scope patent-text">15. compound according to claim 14, wherein M is Na<sup class="style-scope patent-text">+</sup>And z is 3.</div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div id="en-cl0016" num="0016" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text">
        <claim-ref idref="en-cl0001" class="style-scope patent-text"> </claim-ref>
        <claim-ref idref="en-cl0002" class="style-scope patent-text"> </claim-ref>
        <claim-ref idref="en-cl0003" class="style-scope patent-text"> </claim-ref>
        <claim-ref idref="en-cl0004" class="style-scope patent-text"> </claim-ref>
        <claim-ref idref="en-cl0005" class="style-scope patent-text"> </claim-ref>
        <claim-ref idref="en-cl0006" class="style-scope patent-text"> </claim-ref>
        <claim-ref idref="en-cl0007" class="style-scope patent-text"> </claim-ref>
        <claim-ref idref="en-cl0008" class="style-scope patent-text"> </claim-ref>
        <claim-ref idref="en-cl0009" class="style-scope patent-text"> </claim-ref>
        <claim-ref idref="en-cl0010" class="style-scope patent-text"> </claim-ref>
        <claim-ref idref="en-cl0011" class="style-scope patent-text"> </claim-ref>
        <claim-ref idref="en-cl0012" class="style-scope patent-text"> </claim-ref>
        <claim-ref idref="en-cl0013" class="style-scope patent-text"> </claim-ref>
        <claim-ref idref="en-cl0014" class="style-scope patent-text"> </claim-ref>
        <claim-ref idref="en-cl0015" class="style-scope patent-text"> </claim-ref>
      </div>
      <div class="claim-text style-scope patent-text">16. according to claim 1 to compound described in any one of 15, for being used in the treatment of proliferative diseases.</div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div id="en-cl0017" num="0017" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text">17. a kind of conjugate, comprising be connected to target reagent according to claim 1 to the chemical combination of Formulas I described in any one of 15
Object or its pharmaceutical salts or solvate.</div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div id="en-cl0018" num="0018" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text">18. a kind of conjugate of formula IV:</div>
      <div class="claim-text style-scope patent-text">L-(R<sup class="style-scope patent-text">L</sup>’-D)<sub class="style-scope patent-text">p</sub>(IV),</div>
      <div class="claim-text style-scope patent-text">Or its pharmaceutical salts or solvate, wherein L is with body unit, R<sup class="style-scope patent-text">L</sup>' it is connector unit and D is following formula II:</div>
      <div class="claim-text style-scope patent-text">
        <span class="patent-image-not-available style-scope patent-text"></span>
      </div>
      <div class="claim-text style-scope patent-text">Wherein, wave indicates R<sup class="style-scope patent-text">L’</sup>Attachment point, and remaining group such as any one of claims 1 to 15 is defined.</div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div id="en-cl0019" num="0019" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text">
        <claim-ref idref="en-cl0018" class="style-scope patent-text"> </claim-ref>
      </div>
      <div class="claim-text style-scope patent-text">19. conjugate according to claim 18, wherein L-R<sup class="style-scope patent-text">L’</sup>It is following group:</div>
      <div class="claim-text style-scope patent-text">
        <span class="patent-image-not-available style-scope patent-text"></span>
      </div>
      <div class="claim-text style-scope patent-text">Wherein, asterisk indicates the point for being attached to the position N10, and CBA is cell binding agent, L<sup class="style-scope patent-text">1</sup>It is the cleavable connector comprising dipeptides,
And dipeptides-NH-X<sub class="style-scope patent-text">1</sub>-X<sub class="style-scope patent-text">2</sub>Group-X in-CO-<sub class="style-scope patent-text">1</sub>-X<sub class="style-scope patent-text">2</sub>It is selected from:</div>
      <div class="claim-text style-scope patent-text">-Phe-Lys-、</div>
      <div class="claim-text style-scope patent-text">-Val-Ala-、</div>
      <div class="claim-text style-scope patent-text">-Val-Lys-、</div>
      <div class="claim-text style-scope patent-text">-Ala-Lys-、</div>
      <div class="claim-text style-scope patent-text">-Val-Cit-、</div>
      <div class="claim-text style-scope patent-text">-Phe-Cit-、</div>
      <div class="claim-text style-scope patent-text">-Leu-Cit-、</div>
      <div class="claim-text style-scope patent-text">-Ile-Cit-、</div>
      <div class="claim-text style-scope patent-text">-Phe-Arg-、</div>
      <div class="claim-text style-scope patent-text">- Trp-Cit-,</div>
      <div class="claim-text style-scope patent-text">A is by L<sup class="style-scope patent-text">1</sup>It is connected to the linking group of the cell binding agent, L<sup class="style-scope patent-text">2</sup>Be covalent bond or with-OC (=O)-be formed together from point
The connector of solution.</div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div id="en-cl0020" num="0020" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text">
        <claim-ref idref="en-cl0019" class="style-scope patent-text"> </claim-ref>
      </div>
      <div class="claim-text style-scope patent-text">20. conjugate according to claim 19, wherein C (=O) O and L<sup class="style-scope patent-text">2</sup>It is formed together following group:</div>
      <div class="claim-text style-scope patent-text">
        <span class="patent-image-not-available style-scope patent-text"></span>
      </div>
      <div class="claim-text style-scope patent-text">Wherein, asterisk indicates the point for being attached to the position N10, and wave expression is attached to the connector L<sup class="style-scope patent-text">1</sup>Point, Y be NH, O,
C (=O) NH or C (=O) O, and n is 0 to 3.</div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div id="en-cl0021" num="0021" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text">
        <claim-ref idref="en-cl0019" class="style-scope patent-text"> </claim-ref>
        <claim-ref idref="en-cl0020" class="style-scope patent-text"> </claim-ref>
      </div>
      <div class="claim-text style-scope patent-text">21. according to claim 19 or claim 20 described in conjugate, wherein A is:</div>
      <div class="claim-text style-scope patent-text">(i)</div>
      <div class="claim-text style-scope patent-text">
        <span class="patent-image-not-available style-scope patent-text"></span>
      </div>
      <div class="claim-text style-scope patent-text">Wherein, asterisk expression is attached to L<sup class="style-scope patent-text">1</sup>Point, wave indicates to be attached to the point of the cell binding agent, and n is 0 to 6；
Or</div>
      <div class="claim-text style-scope patent-text">(ii)</div>
      <div class="claim-text style-scope patent-text">
        <span class="patent-image-not-available style-scope patent-text"></span>
      </div>
      <div class="claim-text style-scope patent-text">Wherein, asterisk expression is attached to L<sup class="style-scope patent-text">1</sup>Point, wave indicates to be attached to the point of the cell binding agent, and n is 0 or 1, and m
It is 0 to 30.</div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div id="en-cl0022" num="0022" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text">
        <claim-ref idref="en-cl0018" class="style-scope patent-text"> </claim-ref>
        <claim-ref idref="en-cl0019" class="style-scope patent-text"> </claim-ref>
        <claim-ref idref="en-cl0020" class="style-scope patent-text"> </claim-ref>
        <claim-ref idref="en-cl0021" class="style-scope patent-text"> </claim-ref>
      </div>
      <div class="claim-text style-scope patent-text">22. conjugate described in any one of 8 to 21 according to claim 1, wherein R<sup class="style-scope patent-text">10</sup>The cell binding agent be antibody or
Its active fragment.</div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div id="en-cl0023" num="0023" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text">
        <claim-ref idref="en-cl0022" class="style-scope patent-text"> </claim-ref>
      </div>
      <div class="claim-text style-scope patent-text">23. conjugate according to claim 22, wherein the antibody or antibody fragment are for tumor associated antigen
Antibody or antibody fragment.</div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div id="en-cl0024" num="0024" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text">24. a kind of compound of formula A:</div>
      <div class="claim-text style-scope patent-text">
        <span class="patent-image-not-available style-scope patent-text"></span>
      </div>
      <div class="claim-text style-scope patent-text">And its salt and solvate, wherein all substituent groups such as any one of claims 1 to 15 is defined.</div>
    </div>
  </div> </div>
  </section>
      <div id="margin" class="style-scope patent-text">
        <div id="createHighlight" style="top: 0px;" class="style-scope patent-text" hidden="">
          <iron-icon id="comment" icon="editor:insert-comment" class="style-scope patent-text x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M20 2H4c-1.1 0-2 .9-2 2v12c0 1.1.9 2 2 2h14l4 4V4c0-1.1-.9-2-2-2zm-2 12H6v-2h12v2zm0-3H6V9h12v2zm0-3H6V6h12v2z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
        </div>
      </div>
    </div>
  </patent-text>
              </section>
            </div>
          </div>

          <div class="footer style-scope patent-result">

            
            <h3 id="patentCitations" class="scroll-target style-scope patent-result">
              Patent Citations (329)
              <a href="#title" class="style-scope patent-result"><iron-icon icon="arrow-drop-up" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M7 14l5-5 5 5z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon></a>
            </h3>
            <div class="responsive-table style-scope patent-result">
              <div class="table style-scope patent-result">
                <div class="thead style-scope patent-result">
                  <div class="tr style-scope patent-result">
                    <span class="th style-scope patent-result">Publication number</span>
                    <span class="th style-scope patent-result">Priority date</span>
                    <span class="th style-scope patent-result">Publication date</span>
                    <span class="th style-scope patent-result">Assignee</span>
                    <span class="th style-scope patent-result">Title</span>
                  </div>
                </div>
                <div class="tbody style-scope patent-result">
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2011130598A1/en"><a id="link" href="#" class="style-scope state-modifier">WO2011130598A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2010-04-15</span>
                    <span class="td style-scope patent-result">2011-10-20</span>
                    <span class="td style-scope patent-result">Spirogen Limited</span>
                    <span class="td style-scope patent-result">Pyrrolobenzodiazepines and conjugates thereof 
       </span>
                  </div>
                  <template is="dom-repeat" class="style-scope patent-result"></template>

                  <div class="tr style-scope patent-result">
                    <span class="td famheader style-scope patent-result">Family To Family Citations</span>
                    <span class="td famheader style-scope patent-result"></span>
                    <span class="td famheader style-scope patent-result"></span>
                    <span class="td famheader style-scope patent-result"></span>
                    <span class="td famheader style-scope patent-result"></span>
                  </div>

                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/JPS58180487U/en"><a id="link" href="#" class="style-scope state-modifier">JPS58180487U</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1982-05-28</span>
                    <span class="td style-scope patent-result">1983-12-02</span>
                    <span class="td style-scope patent-result">松下電工株式会社</span>
                    <span class="td style-scope patent-result">
  Light beam alarm assembly
 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US4816567A/en"><a id="link" href="#" class="style-scope state-modifier">US4816567A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1983-04-08</span>
                    <span class="td style-scope patent-result">1989-03-28</span>
                    <span class="td style-scope patent-result">Genentech, Inc.</span>
                    <span class="td style-scope patent-result">Recombinant immunoglobin preparations 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US5583024A/en"><a id="link" href="#" class="style-scope state-modifier">US5583024A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1985-12-02</span>
                    <span class="td style-scope patent-result">1996-12-10</span>
                    <span class="td style-scope patent-result">The Regents Of The University Of California</span>
                    <span class="td style-scope patent-result">Recombinant expression of Coleoptera luciferase 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/JPH053790Y2/en"><a id="link" href="#" class="style-scope state-modifier">JPH053790Y2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1988-08-03</span>
                    <span class="td style-scope patent-result">1993-01-29</span>
                    <span class="td style-scope patent-result"></span>
                    <span class="td style-scope patent-result"></span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO1991002536A1/en"><a id="link" href="#" class="style-scope state-modifier">WO1991002536A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1989-08-23</span>
                    <span class="td style-scope patent-result">1991-03-07</span>
                    <span class="td style-scope patent-result">Scripps Clinic And Research Foundation</span>
                    <span class="td style-scope patent-result">Compositions and methods for detection and treatment of epstein-barr virus infection and immune disorders 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US5256643A/en"><a id="link" href="#" class="style-scope state-modifier">US5256643A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1990-05-29</span>
                    <span class="td style-scope patent-result">1993-10-26</span>
                    <span class="td style-scope patent-result">The Government Of The United States</span>
                    <span class="td style-scope patent-result">Human cripto protein 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO1992007574A1/en"><a id="link" href="#" class="style-scope state-modifier">WO1992007574A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1990-10-25</span>
                    <span class="td style-scope patent-result">1992-05-14</span>
                    <span class="td style-scope patent-result">Tanox Biosystems, Inc.</span>
                    <span class="td style-scope patent-result">Glycoproteins associated with membrane-bound immunoglobulins as antibody targets on b cells 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO1992017497A1/en"><a id="link" href="#" class="style-scope state-modifier">WO1992017497A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1991-03-29</span>
                    <span class="td style-scope patent-result">1992-10-15</span>
                    <span class="td style-scope patent-result">Genentech, Inc.</span>
                    <span class="td style-scope patent-result">Human pf4a receptors and their use 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US5440021A/en"><a id="link" href="#" class="style-scope state-modifier">US5440021A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1991-03-29</span>
                    <span class="td style-scope patent-result">1995-08-08</span>
                    <span class="td style-scope patent-result">Chuntharapai; Anan</span>
                    <span class="td style-scope patent-result">Antibodies to human IL-8 type B receptor 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US5543503A/en"><a id="link" href="#" class="style-scope state-modifier">US5543503A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1991-03-29</span>
                    <span class="td style-scope patent-result">1996-08-06</span>
                    <span class="td style-scope patent-result">Genentech Inc.</span>
                    <span class="td style-scope patent-result">Antibodies to human IL-8 type A receptor 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/JP3050424B2/en"><a id="link" href="#" class="style-scope state-modifier">JP3050424B2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1991-07-12</span>
                    <span class="td style-scope patent-result">2000-06-12</span>
                    <span class="td style-scope patent-result">塩野義製薬株式会社</span>
                    <span class="td style-scope patent-result">
  Human endothelin receptor
 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US5264557A/en"><a id="link" href="#" class="style-scope state-modifier">US5264557A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1991-08-23</span>
                    <span class="td style-scope patent-result">1993-11-23</span>
                    <span class="td style-scope patent-result">The United States Of America As Represented By The Department Of Health And Human Services</span>
                    <span class="td style-scope patent-result">Polypeptide of a human cripto-related gene, CR-3 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US5362852A/en"><a id="link" href="#" class="style-scope state-modifier">US5362852A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1991-09-27</span>
                    <span class="td style-scope patent-result">1994-11-08</span>
                    <span class="td style-scope patent-result">Pfizer Inc.</span>
                    <span class="td style-scope patent-result">Modified peptide derivatives conjugated at 2-hydroxyethylamine moieties 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US5976551A/en"><a id="link" href="#" class="style-scope state-modifier">US5976551A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1991-11-15</span>
                    <span class="td style-scope patent-result">1999-11-02</span>
                    <span class="td style-scope patent-result">Institut Pasteur And Institut Nationale De La Sante Et De La Recherche Medicale</span>
                    <span class="td style-scope patent-result">Altered major histocompatibility complex (MHC) determinant and method of using the determinant 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US6153408A/en"><a id="link" href="#" class="style-scope state-modifier">US6153408A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1991-11-15</span>
                    <span class="td style-scope patent-result">2000-11-28</span>
                    <span class="td style-scope patent-result">Institut Pasteur And Institut National De La Sante Et De La Recherche Medicale</span>
                    <span class="td style-scope patent-result">Altered major histocompatibility complex (MHC) determinant and methods of using the determinant 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/IL107366A/en"><a id="link" href="#" class="style-scope state-modifier">IL107366A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1992-10-23</span>
                    <span class="td style-scope patent-result">2003-03-12</span>
                    <span class="td style-scope patent-result">Chugai Pharmaceutical Co Ltd</span>
                    <span class="td style-scope patent-result">Genes coding for megakaryocyte potentiator 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US5644033A/en"><a id="link" href="#" class="style-scope state-modifier">US5644033A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1992-12-22</span>
                    <span class="td style-scope patent-result">1997-07-01</span>
                    <span class="td style-scope patent-result">Health Research, Inc.</span>
                    <span class="td style-scope patent-result">Monoclonal antibodies that define a unique antigen of human B cell antigen receptor complex and methods of using same for diagnosis and treatment 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US5801005A/en"><a id="link" href="#" class="style-scope state-modifier">US5801005A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1993-03-17</span>
                    <span class="td style-scope patent-result">1998-09-01</span>
                    <span class="td style-scope patent-result">University Of Washington</span>
                    <span class="td style-scope patent-result">Immune reactivity to HER-2/neu protein for diagnosis of malignancies in which the HER-2/neu oncogene is associated 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US5869445A/en"><a id="link" href="#" class="style-scope state-modifier">US5869445A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1993-03-17</span>
                    <span class="td style-scope patent-result">1999-02-09</span>
                    <span class="td style-scope patent-result">University Of Washington</span>
                    <span class="td style-scope patent-result">Methods for eliciting or enhancing reactivity to HER-2/neu protein 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US6214345B1/en"><a id="link" href="#" class="style-scope state-modifier">US6214345B1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1993-05-14</span>
                    <span class="td style-scope patent-result">2001-04-10</span>
                    <span class="td style-scope patent-result">Bristol-Myers Squibb Co.</span>
                    <span class="td style-scope patent-result">Lysosomal enzyme-cleavable antitumor drug conjugates 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US5773223A/en"><a id="link" href="#" class="style-scope state-modifier">US5773223A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1993-09-02</span>
                    <span class="td style-scope patent-result">1998-06-30</span>
                    <span class="td style-scope patent-result">Chiron Corporation</span>
                    <span class="td style-scope patent-result">Endothelin B1, (ETB1) receptor polypeptide and its encoding nucleic acid methods, and uses thereof 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/EP0647450A1/en"><a id="link" href="#" class="style-scope state-modifier">EP0647450A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1993-09-09</span>
                    <span class="td style-scope patent-result">1995-04-12</span>
                    <span class="td style-scope patent-result">BEHRINGWERKE Aktiengesellschaft</span>
                    <span class="td style-scope patent-result">Improved prodrugs for enzyme mediated activation 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US5750370A/en"><a id="link" href="#" class="style-scope state-modifier">US5750370A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1995-06-06</span>
                    <span class="td style-scope patent-result">1998-05-12</span>
                    <span class="td style-scope patent-result">Human Genome Sciences, Inc.</span>
                    <span class="td style-scope patent-result">Nucleic acid encoding human endothlein-bombesin receptor and method of producing the receptor 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/JPH08336393A/en"><a id="link" href="#" class="style-scope state-modifier">JPH08336393A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1995-04-13</span>
                    <span class="td style-scope patent-result">1996-12-24</span>
                    <span class="td style-scope patent-result">Mitsubishi Chem Corp</span>
                    <span class="td style-scope patent-result">Production of optically active gamma-substituted-beta-hydroxybutyric ester 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US5707829A/en"><a id="link" href="#" class="style-scope state-modifier">US5707829A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1995-08-11</span>
                    <span class="td style-scope patent-result">1998-01-13</span>
                    <span class="td style-scope patent-result">Genetics Institute, Inc.</span>
                    <span class="td style-scope patent-result">DNA sequences and secreted proteins encoded thereby 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20020193567A1/en"><a id="link" href="#" class="style-scope state-modifier">US20020193567A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1995-08-11</span>
                    <span class="td style-scope patent-result">2002-12-19</span>
                    <span class="td style-scope patent-result">Genetics Institute, Inc.</span>
                    <span class="td style-scope patent-result">Secreted proteins and polynucleotides encoding them 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/JP3646191B2/en"><a id="link" href="#" class="style-scope state-modifier">JP3646191B2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1996-03-19</span>
                    <span class="td style-scope patent-result">2005-05-11</span>
                    <span class="td style-scope patent-result">大塚製薬株式会社</span>
                    <span class="td style-scope patent-result">
  Human gene
 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US6218519B1/en"><a id="link" href="#" class="style-scope state-modifier">US6218519B1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1996-04-12</span>
                    <span class="td style-scope patent-result">2001-04-17</span>
                    <span class="td style-scope patent-result">Pro-Neuron, Inc.</span>
                    <span class="td style-scope patent-result">Compounds and methods for the selective treatment of cancer and bacterial infections 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO1997044452A1/en"><a id="link" href="#" class="style-scope state-modifier">WO1997044452A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1996-05-17</span>
                    <span class="td style-scope patent-result">1997-11-27</span>
                    <span class="td style-scope patent-result">Schering Corporation</span>
                    <span class="td style-scope patent-result">Human b-cell antigens, related reagents 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/CA2264227A1/en"><a id="link" href="#" class="style-scope state-modifier">CA2264227A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1996-09-27</span>
                    <span class="td style-scope patent-result">1998-04-02</span>
                    <span class="td style-scope patent-result">Raymond A. Firestone</span>
                    <span class="td style-scope patent-result">Hydrolyzable prodrugs for delivery of anticancer drugs to metastatic cells 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US6759509B1/en"><a id="link" href="#" class="style-scope state-modifier">US6759509B1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1996-11-05</span>
                    <span class="td style-scope patent-result">2004-07-06</span>
                    <span class="td style-scope patent-result">Bristol-Myers Squibb Company</span>
                    <span class="td style-scope patent-result">Branched peptide linkers 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US5945511A/en"><a id="link" href="#" class="style-scope state-modifier">US5945511A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1997-02-20</span>
                    <span class="td style-scope patent-result">1999-08-31</span>
                    <span class="td style-scope patent-result">Zymogenetics, Inc.</span>
                    <span class="td style-scope patent-result">Class II cytokine receptor 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US7033827B2/en"><a id="link" href="#" class="style-scope state-modifier">US7033827B2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1997-02-25</span>
                    <span class="td style-scope patent-result">2006-04-25</span>
                    <span class="td style-scope patent-result">Corixa Corporation</span>
                    <span class="td style-scope patent-result">Prostate-specific polynucleotide compositions 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20030185830A1/en"><a id="link" href="#" class="style-scope state-modifier">US20030185830A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1997-02-25</span>
                    <span class="td style-scope patent-result">2003-10-02</span>
                    <span class="td style-scope patent-result">Corixa Corporation</span>
                    <span class="td style-scope patent-result">Compositions and methods for the therapy and diagnosis of prostate cancer 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/CA2281877C/en"><a id="link" href="#" class="style-scope state-modifier">CA2281877C</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1997-03-10</span>
                    <span class="td style-scope patent-result">2010-01-05</span>
                    <span class="td style-scope patent-result">The Regents Of The University Of California</span>
                    <span class="td style-scope patent-result">Psca: prostate stem cell antigen 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US6261791B1/en"><a id="link" href="#" class="style-scope state-modifier">US6261791B1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1997-03-10</span>
                    <span class="td style-scope patent-result">2001-07-17</span>
                    <span class="td style-scope patent-result">The Regents Of The University Of California</span>
                    <span class="td style-scope patent-result">Method for diagnosing cancer using specific PSCA antibodies 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US6541212B2/en"><a id="link" href="#" class="style-scope state-modifier">US6541212B2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1997-03-10</span>
                    <span class="td style-scope patent-result">2003-04-01</span>
                    <span class="td style-scope patent-result">The Regents Of The University Of California</span>
                    <span class="td style-scope patent-result">Methods for detecting prostate stem cell antigen protein 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US6555339B1/en"><a id="link" href="#" class="style-scope state-modifier">US6555339B1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1997-04-14</span>
                    <span class="td style-scope patent-result">2003-04-29</span>
                    <span class="td style-scope patent-result">Arena Pharmaceuticals, Inc.</span>
                    <span class="td style-scope patent-result">Non-endogenous, constitutively activated human protein-coupled receptors 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US6319688B1/en"><a id="link" href="#" class="style-scope state-modifier">US6319688B1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1997-04-28</span>
                    <span class="td style-scope patent-result">2001-11-20</span>
                    <span class="td style-scope patent-result">Smithkline Beecham Corporation</span>
                    <span class="td style-scope patent-result">Polynucleotide encoding human sodium dependent phosphate transporter (IPT-1) 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US6890749B2/en"><a id="link" href="#" class="style-scope state-modifier">US6890749B2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1997-05-15</span>
                    <span class="td style-scope patent-result">2005-05-10</span>
                    <span class="td style-scope patent-result">Abbott Laboratories</span>
                    <span class="td style-scope patent-result">Reagents and methods useful for detecting diseases of the prostate 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO1998051824A1/en"><a id="link" href="#" class="style-scope state-modifier">WO1998051824A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1997-05-15</span>
                    <span class="td style-scope patent-result">1998-11-19</span>
                    <span class="td style-scope patent-result">Abbott Laboratories</span>
                    <span class="td style-scope patent-result">Reagents and methods useful for detecting disease of the urinary tract 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US6602677B1/en"><a id="link" href="#" class="style-scope state-modifier">US6602677B1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1997-09-19</span>
                    <span class="td style-scope patent-result">2003-08-05</span>
                    <span class="td style-scope patent-result">Promega Corporation</span>
                    <span class="td style-scope patent-result">Thermostable luciferases and methods of production 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20030060612A1/en"><a id="link" href="#" class="style-scope state-modifier">US20030060612A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1997-10-28</span>
                    <span class="td style-scope patent-result">2003-03-27</span>
                    <span class="td style-scope patent-result">Genentech, Inc.</span>
                    <span class="td style-scope patent-result">Compositions and methods for the diagnosis and treatment of tumor 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20020034749A1/en"><a id="link" href="#" class="style-scope state-modifier">US20020034749A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1997-11-18</span>
                    <span class="td style-scope patent-result">2002-03-21</span>
                    <span class="td style-scope patent-result">Billing-Medel Patricia A.</span>
                    <span class="td style-scope patent-result">Reagents and methods useful for detecting diseases of the breast 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US6110695A/en"><a id="link" href="#" class="style-scope state-modifier">US6110695A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1997-12-02</span>
                    <span class="td style-scope patent-result">2000-08-29</span>
                    <span class="td style-scope patent-result">The Regents Of The University Of California</span>
                    <span class="td style-scope patent-result">Modulating the interaction of the chemokine, B Lymphocyte Hemoattractant, and its Receptor, BLR1 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/AU762991B2/en"><a id="link" href="#" class="style-scope state-modifier">AU762991B2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1998-03-13</span>
                    <span class="td style-scope patent-result">2003-07-10</span>
                    <span class="td style-scope patent-result">Burnham Institute, The</span>
                    <span class="td style-scope patent-result">Molecules that home to various selected organs or tissues 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/CA2685270C/en"><a id="link" href="#" class="style-scope state-modifier">CA2685270C</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1998-05-13</span>
                    <span class="td style-scope patent-result">2014-07-29</span>
                    <span class="td style-scope patent-result">Pharmexa Inc.</span>
                    <span class="td style-scope patent-result">Expression vectors for stimulating an immune response and methods of using the same 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20030064397A1/en"><a id="link" href="#" class="style-scope state-modifier">US20030064397A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1998-05-22</span>
                    <span class="td style-scope patent-result">2003-04-03</span>
                    <span class="td style-scope patent-result">Incyte Genomics, Inc.</span>
                    <span class="td style-scope patent-result">Transmembrane protein differentially expressed in prostate and lung tumors 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/EP1080732A4/en"><a id="link" href="#" class="style-scope state-modifier">EP1080732A4</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1998-05-22</span>
                    <span class="td style-scope patent-result">2004-08-25</span>
                    <span class="td style-scope patent-result">Daiichi Seiyaku Co</span>
                    <span class="td style-scope patent-result">Drug composites 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20020187472A1/en"><a id="link" href="#" class="style-scope state-modifier">US20020187472A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001-03-09</span>
                    <span class="td style-scope patent-result">2002-12-12</span>
                    <span class="td style-scope patent-result">Preeti Lal</span>
                    <span class="td style-scope patent-result">Steap-related protein 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2000012130A1/en"><a id="link" href="#" class="style-scope state-modifier">WO2000012130A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1998-08-27</span>
                    <span class="td style-scope patent-result">2000-03-09</span>
                    <span class="td style-scope patent-result">Smithkline Beecham Corporation</span>
                    <span class="td style-scope patent-result">Rp105 agonists and antagonists 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/GB9818730D0/en"><a id="link" href="#" class="style-scope state-modifier">GB9818730D0</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1998-08-27</span>
                    <span class="td style-scope patent-result">1998-10-21</span>
                    <span class="td style-scope patent-result">Univ Portsmouth</span>
                    <span class="td style-scope patent-result">Collections of compounds 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/EP1193270B1/en"><a id="link" href="#" class="style-scope state-modifier">EP1193270B1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1998-08-27</span>
                    <span class="td style-scope patent-result">2003-05-14</span>
                    <span class="td style-scope patent-result">Spirogen Limited</span>
                    <span class="td style-scope patent-result">Pyrrolobenzodiazepines 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/GB9818732D0/en"><a id="link" href="#" class="style-scope state-modifier">GB9818732D0</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1998-08-27</span>
                    <span class="td style-scope patent-result">1998-10-21</span>
                    <span class="td style-scope patent-result">Univ Portsmouth</span>
                    <span class="td style-scope patent-result">Collection of compounds 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/GB9818731D0/en"><a id="link" href="#" class="style-scope state-modifier">GB9818731D0</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1998-08-27</span>
                    <span class="td style-scope patent-result">1998-10-21</span>
                    <span class="td style-scope patent-result">Univ Portsmouth</span>
                    <span class="td style-scope patent-result">Compounds 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/JP4689781B2/en"><a id="link" href="#" class="style-scope state-modifier">JP4689781B2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1998-09-03</span>
                    <span class="td style-scope patent-result">2011-05-25</span>
                    <span class="td style-scope patent-result">独立行政法人科学技術振興機構</span>
                    <span class="td style-scope patent-result">
  Amino acid transport protein and its gene
 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/AU5963699A/en"><a id="link" href="#" class="style-scope state-modifier">AU5963699A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1998-10-02</span>
                    <span class="td style-scope patent-result">2000-04-26</span>
                    <span class="td style-scope patent-result">Mcmaster University</span>
                    <span class="td style-scope patent-result">Spliced form of (erb)b-2/neu oncogene 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2001057188A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2001057188A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2000-02-03</span>
                    <span class="td style-scope patent-result">2001-08-09</span>
                    <span class="td style-scope patent-result">Hyseq, Inc.</span>
                    <span class="td style-scope patent-result">Novel nucleic acids and polypeptides 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20020119158A1/en"><a id="link" href="#" class="style-scope state-modifier">US20020119158A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1998-12-17</span>
                    <span class="td style-scope patent-result">2002-08-29</span>
                    <span class="td style-scope patent-result">Corixa Corporation</span>
                    <span class="td style-scope patent-result">Compositions and methods for the therapy and diagnosis of ovarian cancer 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US6858710B2/en"><a id="link" href="#" class="style-scope state-modifier">US6858710B2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1998-12-17</span>
                    <span class="td style-scope patent-result">2005-02-22</span>
                    <span class="td style-scope patent-result">Corixa Corporation</span>
                    <span class="td style-scope patent-result">Compositions and methods for the therapy and diagnosis of ovarian cancer 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20030091580A1/en"><a id="link" href="#" class="style-scope state-modifier">US20030091580A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001-06-18</span>
                    <span class="td style-scope patent-result">2003-05-15</span>
                    <span class="td style-scope patent-result">Mitcham Jennifer L.</span>
                    <span class="td style-scope patent-result">Compositions and methods for the therapy and diagnosis of ovarian cancer 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US6468546B1/en"><a id="link" href="#" class="style-scope state-modifier">US6468546B1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1998-12-17</span>
                    <span class="td style-scope patent-result">2002-10-22</span>
                    <span class="td style-scope patent-result">Corixa Corporation</span>
                    <span class="td style-scope patent-result">Compositions and methods for therapy and diagnosis of ovarian cancer 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US6962980B2/en"><a id="link" href="#" class="style-scope state-modifier">US6962980B2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1999-09-24</span>
                    <span class="td style-scope patent-result">2005-11-08</span>
                    <span class="td style-scope patent-result">Corixa Corporation</span>
                    <span class="td style-scope patent-result">Compositions and methods for the therapy and diagnosis of ovarian cancer 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/EP1141017B1/en"><a id="link" href="#" class="style-scope state-modifier">EP1141017B1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1998-12-30</span>
                    <span class="td style-scope patent-result">2008-09-10</span>
                    <span class="td style-scope patent-result">Beth Israel Deaconess Medical Center, Inc.</span>
                    <span class="td style-scope patent-result">Characterization of the soc/crac calcium channel protein family 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/CZ20012587A3/en"><a id="link" href="#" class="style-scope state-modifier">CZ20012587A3</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1999-01-29</span>
                    <span class="td style-scope patent-result">2002-05-15</span>
                    <span class="td style-scope patent-result">Corixa Corporation</span>
                    <span class="td style-scope patent-result">Isolated protein, nucleic acid, virus vector, pharmaceutical preparation, isolated population of T cells, method of reinforcing immune response, method of removing tumor cells, method of stimulating and/or propagating T cells and process for preparing a fusion protein 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/GB9905124D0/en"><a id="link" href="#" class="style-scope state-modifier">GB9905124D0</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1999-03-05</span>
                    <span class="td style-scope patent-result">1999-04-28</span>
                    <span class="td style-scope patent-result">Smithkline Beecham Biolog</span>
                    <span class="td style-scope patent-result">Novel compounds 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US7232889B2/en"><a id="link" href="#" class="style-scope state-modifier">US7232889B2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1999-03-08</span>
                    <span class="td style-scope patent-result">2007-06-19</span>
                    <span class="td style-scope patent-result">Genentech, Inc.</span>
                    <span class="td style-scope patent-result">PRO300 antibodies 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/AU3395900A/en"><a id="link" href="#" class="style-scope state-modifier">AU3395900A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1999-03-12</span>
                    <span class="td style-scope patent-result">2000-10-04</span>
                    <span class="td style-scope patent-result">Human Genome Sciences, Inc.</span>
                    <span class="td style-scope patent-result">Human lung cancer associated gene sequences and polypeptides 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US7312303B2/en"><a id="link" href="#" class="style-scope state-modifier">US7312303B2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1999-05-11</span>
                    <span class="td style-scope patent-result">2007-12-25</span>
                    <span class="td style-scope patent-result">Genentech, Inc.</span>
                    <span class="td style-scope patent-result">Anti-PRO4980 antibodies 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US6268488B1/en"><a id="link" href="#" class="style-scope state-modifier">US6268488B1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1999-05-25</span>
                    <span class="td style-scope patent-result">2001-07-31</span>
                    <span class="td style-scope patent-result">Barbas, Iii Carlos F.</span>
                    <span class="td style-scope patent-result">Prodrug activation using catalytic antibodies 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2000075655A1/en"><a id="link" href="#" class="style-scope state-modifier">WO2000075655A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1999-06-03</span>
                    <span class="td style-scope patent-result">2000-12-14</span>
                    <span class="td style-scope patent-result">Takeda Chemical Industries, Ltd.</span>
                    <span class="td style-scope patent-result">Screening method with the use of cd100 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/DK2803367T3/en"><a id="link" href="#" class="style-scope state-modifier">DK2803367T3</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1999-06-25</span>
                    <span class="td style-scope patent-result">2018-04-16</span>
                    <span class="td style-scope patent-result">Immunogen Inc</span>
                    <span class="td style-scope patent-result">
  Methods of treatment using anti-ERBB antibody-maytansinoid conjugates
 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20030119113A1/en"><a id="link" href="#" class="style-scope state-modifier">US20030119113A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1999-07-20</span>
                    <span class="td style-scope patent-result">2003-06-26</span>
                    <span class="td style-scope patent-result">Genentech, Inc.</span>
                    <span class="td style-scope patent-result">Secreted and transmembrane polypeptides and nucleic acids encoding the same 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US7297770B2/en"><a id="link" href="#" class="style-scope state-modifier">US7297770B2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1999-08-10</span>
                    <span class="td style-scope patent-result">2007-11-20</span>
                    <span class="td style-scope patent-result">Genentech, Inc.</span>
                    <span class="td style-scope patent-result">PRO6496 polypeptides 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US7294696B2/en"><a id="link" href="#" class="style-scope state-modifier">US7294696B2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1999-08-17</span>
                    <span class="td style-scope patent-result">2007-11-13</span>
                    <span class="td style-scope patent-result">Genentech Inc.</span>
                    <span class="td style-scope patent-result">PRO7168 polypeptides 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US6909006B1/en"><a id="link" href="#" class="style-scope state-modifier">US6909006B1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1999-08-27</span>
                    <span class="td style-scope patent-result">2005-06-21</span>
                    <span class="td style-scope patent-result">Spirogen Limited</span>
                    <span class="td style-scope patent-result">Cyclopropylindole derivatives 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/EP1208202A2/en"><a id="link" href="#" class="style-scope state-modifier">EP1208202A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1999-09-01</span>
                    <span class="td style-scope patent-result">2002-05-29</span>
                    <span class="td style-scope patent-result">Genentech, Inc.</span>
                    <span class="td style-scope patent-result">Secreted and transmembrane polypeptides and nucleic acids encoding the same 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20030232056A1/en"><a id="link" href="#" class="style-scope state-modifier">US20030232056A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1999-09-10</span>
                    <span class="td style-scope patent-result">2003-12-18</span>
                    <span class="td style-scope patent-result">Corixa Corporation</span>
                    <span class="td style-scope patent-result">Compositions and methods for the therapy and diagnosis of ovarian cancer 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20030206918A1/en"><a id="link" href="#" class="style-scope state-modifier">US20030206918A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1999-09-10</span>
                    <span class="td style-scope patent-result">2003-11-06</span>
                    <span class="td style-scope patent-result">Corixa Corporation</span>
                    <span class="td style-scope patent-result">Compositions and methods for the therapy and diagnosis of ovarian cancer 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20030129192A1/en"><a id="link" href="#" class="style-scope state-modifier">US20030129192A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1999-09-10</span>
                    <span class="td style-scope patent-result">2003-07-10</span>
                    <span class="td style-scope patent-result">Corixa Corporation</span>
                    <span class="td style-scope patent-result">Compositions and methods for the therapy and diagnosis of ovarian cancer 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US6750054B2/en"><a id="link" href="#" class="style-scope state-modifier">US6750054B2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2000-05-18</span>
                    <span class="td style-scope patent-result">2004-06-15</span>
                    <span class="td style-scope patent-result">Lexicon Genetics Incorporated</span>
                    <span class="td style-scope patent-result">Human semaphorin homologs and polynucleotides encoding the same 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/BR0015224A/en"><a id="link" href="#" class="style-scope state-modifier">BR0015224A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1999-10-29</span>
                    <span class="td style-scope patent-result">2002-07-09</span>
                    <span class="td style-scope patent-result">Genentech Inc</span>
                    <span class="td style-scope patent-result">
  Isolated prostatic stem cell (psca) anti-antigen, monoclonal anti-psca antibody, isolated nucleic acid, expression vector, cell, host cell, antibody production method, in vitro method composition to kill a cancer cell that expresses psca , use of an anti-psca monoclonal antibody and industrialized article
 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/CA2393126C/en"><a id="link" href="#" class="style-scope state-modifier">CA2393126C</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1999-11-29</span>
                    <span class="td style-scope patent-result">2016-05-24</span>
                    <span class="td style-scope patent-result">The Trustees Of Columbia University In The City Of New York</span>
                    <span class="td style-scope patent-result">Isolation of five novel genes coding for new fc receptors-type melanoma involved in the pathogenesis of lymphoma/melanoma 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/CA2392510A1/en"><a id="link" href="#" class="style-scope state-modifier">CA2392510A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1999-11-30</span>
                    <span class="td style-scope patent-result">2001-06-07</span>
                    <span class="td style-scope patent-result">Corixa Corporation</span>
                    <span class="td style-scope patent-result">Compositions and methods for therapy and diagnosis of breast cancer 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/CA2393738A1/en"><a id="link" href="#" class="style-scope state-modifier">CA2393738A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1999-12-10</span>
                    <span class="td style-scope patent-result">2001-06-14</span>
                    <span class="td style-scope patent-result">Epimmune Inc.</span>
                    <span class="td style-scope patent-result">Inducing cellular immune responses to her2/neu using peptide and nucleic acid compositions 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/EP2295079A3/en"><a id="link" href="#" class="style-scope state-modifier">EP2295079A3</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1999-12-23</span>
                    <span class="td style-scope patent-result">2011-03-23</span>
                    <span class="td style-scope patent-result">ZymoGenetics, L.L.C.</span>
                    <span class="td style-scope patent-result">Method for treating inflammation 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/CA2395539C/en"><a id="link" href="#" class="style-scope state-modifier">CA2395539C</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1999-12-23</span>
                    <span class="td style-scope patent-result">2009-08-25</span>
                    <span class="td style-scope patent-result">Zymogenetics, Inc.</span>
                    <span class="td style-scope patent-result">Soluble interleukin-20 receptor 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/NZ502058A/en"><a id="link" href="#" class="style-scope state-modifier">NZ502058A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1999-12-23</span>
                    <span class="td style-scope patent-result">2003-11-28</span>
                    <span class="td style-scope patent-result">Ovita Ltd</span>
                    <span class="td style-scope patent-result">Isolated mutated nucleic acid molecule for regulation of ovulation rate 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US6610286B2/en"><a id="link" href="#" class="style-scope state-modifier">US6610286B2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1999-12-23</span>
                    <span class="td style-scope patent-result">2003-08-26</span>
                    <span class="td style-scope patent-result">Zymogenetics, Inc.</span>
                    <span class="td style-scope patent-result">Method for treating inflammation using soluble receptors to interleukin-20 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/EP1240337B1/en"><a id="link" href="#" class="style-scope state-modifier">EP1240337B1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1999-12-24</span>
                    <span class="td style-scope patent-result">2006-08-23</span>
                    <span class="td style-scope patent-result">Genentech, Inc.</span>
                    <span class="td style-scope patent-result">Methods and compositions for prolonging elimination half-times of bioactive compounds 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20040001827A1/en"><a id="link" href="#" class="style-scope state-modifier">US20040001827A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2002-06-28</span>
                    <span class="td style-scope patent-result">2004-01-01</span>
                    <span class="td style-scope patent-result">Dennis Mark S.</span>
                    <span class="td style-scope patent-result">Serum albumin binding peptides for tumor targeting 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US7297333B2/en"><a id="link" href="#" class="style-scope state-modifier">US7297333B2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2000-01-20</span>
                    <span class="td style-scope patent-result">2007-11-20</span>
                    <span class="td style-scope patent-result">Genentech, Inc.</span>
                    <span class="td style-scope patent-result">Anti-PRO10268 antibodies 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20030224379A1/en"><a id="link" href="#" class="style-scope state-modifier">US20030224379A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2000-01-21</span>
                    <span class="td style-scope patent-result">2003-12-04</span>
                    <span class="td style-scope patent-result">Tang Y. Tom</span>
                    <span class="td style-scope patent-result">Novel nucleic acids and polypeptides 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2001053463A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2001053463A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2000-01-21</span>
                    <span class="td style-scope patent-result">2001-07-26</span>
                    <span class="td style-scope patent-result">Corixa Corporation</span>
                    <span class="td style-scope patent-result">COMPOUNDS AND METHODS FOR PREVENTION AND TREATMENT OF HER-2/neu ASSOCIATED MALIGNANCIES 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2001062794A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2001062794A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2000-02-22</span>
                    <span class="td style-scope patent-result">2001-08-30</span>
                    <span class="td style-scope patent-result">Millennium Pharmaceuticals, Inc.</span>
                    <span class="td style-scope patent-result">18607, a human calcium channel 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20030219806A1/en"><a id="link" href="#" class="style-scope state-modifier">US20030219806A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2000-02-22</span>
                    <span class="td style-scope patent-result">2003-11-27</span>
                    <span class="td style-scope patent-result">Millennium Pharmaceuticals, Inc.</span>
                    <span class="td style-scope patent-result">Novel 18607, 15603, 69318, 12303, 48000, 52920, 5433, 38554, 57301, 58324, 55063, 52991, 59914, 59921 and 33751 molecules and uses therefor 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20040052793A1/en"><a id="link" href="#" class="style-scope state-modifier">US20040052793A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001-02-22</span>
                    <span class="td style-scope patent-result">2004-03-18</span>
                    <span class="td style-scope patent-result">Carter Paul J.</span>
                    <span class="td style-scope patent-result">Caspase activivated prodrugs therapy 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20040002068A1/en"><a id="link" href="#" class="style-scope state-modifier">US20040002068A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2000-03-01</span>
                    <span class="td style-scope patent-result">2004-01-01</span>
                    <span class="td style-scope patent-result">Corixa Corporation</span>
                    <span class="td style-scope patent-result">Compositions and methods for the detection, diagnosis and therapy of hematological malignancies 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20040005561A1/en"><a id="link" href="#" class="style-scope state-modifier">US20040005561A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2000-03-01</span>
                    <span class="td style-scope patent-result">2004-01-08</span>
                    <span class="td style-scope patent-result">Corixa Corporation</span>
                    <span class="td style-scope patent-result">Compositions and methods for the detection, diagnosis and therapy of hematological malignancies 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/CA2402293A1/en"><a id="link" href="#" class="style-scope state-modifier">CA2402293A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2000-03-07</span>
                    <span class="td style-scope patent-result">2001-09-13</span>
                    <span class="td style-scope patent-result">Hyseq, Inc.</span>
                    <span class="td style-scope patent-result">Novel nucleic acids and polypeptides 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/AU2001249411B2/en"><a id="link" href="#" class="style-scope state-modifier">AU2001249411B2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2000-03-24</span>
                    <span class="td style-scope patent-result">2007-02-15</span>
                    <span class="td style-scope patent-result">Fahri Saatcioglu</span>
                    <span class="td style-scope patent-result">Novel prostate-specific or testis-specific nucleic acid molecules, polypeptides,and diagnostic and therapeutic methods 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/EP1268554A2/en"><a id="link" href="#" class="style-scope state-modifier">EP1268554A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2000-03-31</span>
                    <span class="td style-scope patent-result">2003-01-02</span>
                    <span class="td style-scope patent-result">IPF Pharmaceuticals GmbH</span>
                    <span class="td style-scope patent-result">Diagnostic and medicament for analysing the cell surface proteome of tumour and inflammatory cells and for treating tumorous and inflammatory diseases, preferably using a specific chemokine receptor analysis and the chemokine receptor-ligand interaction 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/AU2001253140A1/en"><a id="link" href="#" class="style-scope state-modifier">AU2001253140A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2000-04-03</span>
                    <span class="td style-scope patent-result">2001-10-15</span>
                    <span class="td style-scope patent-result">The Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services</span>
                    <span class="td style-scope patent-result">Tumor markers in ovarian cancer 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/IL152136A0/en"><a id="link" href="#" class="style-scope state-modifier">IL152136A0</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2000-04-07</span>
                    <span class="td style-scope patent-result">2003-05-29</span>
                    <span class="td style-scope patent-result">Arena Pharm Inc</span>
                    <span class="td style-scope patent-result">Non-endogenous, constitutively activated known g protein-coupled receptors 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20030119115A1/en"><a id="link" href="#" class="style-scope state-modifier">US20030119115A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2000-05-17</span>
                    <span class="td style-scope patent-result">2003-06-26</span>
                    <span class="td style-scope patent-result">Genentech, Inc.</span>
                    <span class="td style-scope patent-result">Secreted and transmembrane polypeptides and nucleic acids encoding the same 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/AU2001274888A1/en"><a id="link" href="#" class="style-scope state-modifier">AU2001274888A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2000-05-19</span>
                    <span class="td style-scope patent-result">2001-12-03</span>
                    <span class="td style-scope patent-result">Human Genome Sciences, Inc.</span>
                    <span class="td style-scope patent-result">Nucleic acids, proteins, and antibodies 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2001094641A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2001094641A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2000-06-09</span>
                    <span class="td style-scope patent-result">2001-12-13</span>
                    <span class="td style-scope patent-result">Idec Pharmaceuticals Corporation</span>
                    <span class="td style-scope patent-result">Gene targets and ligands that bind thereto for treatment and diagnosis of ovarian carcinomas 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/EP1297130A2/en"><a id="link" href="#" class="style-scope state-modifier">EP1297130A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2000-06-16</span>
                    <span class="td style-scope patent-result">2003-04-02</span>
                    <span class="td style-scope patent-result">Incyte Genomics, Inc.</span>
                    <span class="td style-scope patent-result">G-protein coupled receptors 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/CA2413262A1/en"><a id="link" href="#" class="style-scope state-modifier">CA2413262A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2000-06-30</span>
                    <span class="td style-scope patent-result">2002-01-10</span>
                    <span class="td style-scope patent-result">Amgen, Inc.</span>
                    <span class="td style-scope patent-result">B7-like molecules and uses thereof 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/AU2001271714A1/en"><a id="link" href="#" class="style-scope state-modifier">AU2001271714A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2000-06-30</span>
                    <span class="td style-scope patent-result">2002-01-14</span>
                    <span class="td style-scope patent-result">Human Genome Sciences, Inc.</span>
                    <span class="td style-scope patent-result">B7-like polynucleotides, polypeptides, and antibodies 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2002006339A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2002006339A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2000-07-03</span>
                    <span class="td style-scope patent-result">2002-01-24</span>
                    <span class="td style-scope patent-result">Curagen Corporation</span>
                    <span class="td style-scope patent-result">Proteins and nucleic acids encoding same 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20040044179A1/en"><a id="link" href="#" class="style-scope state-modifier">US20040044179A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2000-07-25</span>
                    <span class="td style-scope patent-result">2004-03-04</span>
                    <span class="td style-scope patent-result">Genentech, Inc.</span>
                    <span class="td style-scope patent-result">Secreted and transmembrane polypeptides and nucleic acids encoding the same 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2002010187A1/en"><a id="link" href="#" class="style-scope state-modifier">WO2002010187A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2000-07-27</span>
                    <span class="td style-scope patent-result">2002-02-07</span>
                    <span class="td style-scope patent-result">Mayo Foundation For Medical Education And Research</span>
                    <span class="td style-scope patent-result">B7-h3 and b7-h4, novel immunoregulatory molecules 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/AU2001287639A1/en"><a id="link" href="#" class="style-scope state-modifier">AU2001287639A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2000-07-28</span>
                    <span class="td style-scope patent-result">2002-02-13</span>
                    <span class="td style-scope patent-result">Ulrich Wissenbach</span>
                    <span class="td style-scope patent-result">Trp8, trp9 and trp10, markers for cancer 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US7229623B1/en"><a id="link" href="#" class="style-scope state-modifier">US7229623B1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2000-08-03</span>
                    <span class="td style-scope patent-result">2007-06-12</span>
                    <span class="td style-scope patent-result">Corixa Corporation</span>
                    <span class="td style-scope patent-result">Her-2/neu fusion proteins 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/AU2001283360A1/en"><a id="link" href="#" class="style-scope state-modifier">AU2001283360A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2000-08-14</span>
                    <span class="td style-scope patent-result">2002-02-25</span>
                    <span class="td style-scope patent-result">Corixa Corporation</span>
                    <span class="td style-scope patent-result">Methods for diagnosis and therapy of hematological and virus-associated malignancies 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/KR20030048009A/en"><a id="link" href="#" class="style-scope state-modifier">KR20030048009A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2000-08-14</span>
                    <span class="td style-scope patent-result">2003-06-18</span>
                    <span class="td style-scope patent-result">코릭사 코포레이션</span>
                    <span class="td style-scope patent-result">Compositions and methods for the therapy and diagnosis of HER-2/NEU-associated malignancies 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/GB0020953D0/en"><a id="link" href="#" class="style-scope state-modifier">GB0020953D0</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2000-08-24</span>
                    <span class="td style-scope patent-result">2000-10-11</span>
                    <span class="td style-scope patent-result">Smithkline Beecham Biolog</span>
                    <span class="td style-scope patent-result">Vaccine 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/KR20030029847A/en"><a id="link" href="#" class="style-scope state-modifier">KR20030029847A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2000-08-24</span>
                    <span class="td style-scope patent-result">2003-04-16</span>
                    <span class="td style-scope patent-result">제넨테크, 인크.</span>
                    <span class="td style-scope patent-result">Compositions and methods for the diagnosis and treatment of tumor 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/CA2421949A1/en"><a id="link" href="#" class="style-scope state-modifier">CA2421949A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2000-09-11</span>
                    <span class="td style-scope patent-result">2002-03-21</span>
                    <span class="td style-scope patent-result">Hyseq, Inc.</span>
                    <span class="td style-scope patent-result">Novel nucleic acids and polypeptides 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/EP1351703B1/en"><a id="link" href="#" class="style-scope state-modifier">EP1351703B1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2000-09-15</span>
                    <span class="td style-scope patent-result">2006-07-26</span>
                    <span class="td style-scope patent-result">ZymoGenetics, Inc.</span>
                    <span class="td style-scope patent-result">Use of a polypeptide comprising the extracellular domains of il-20ra and il-20rb for the treatment of inflammation 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US7491797B2/en"><a id="link" href="#" class="style-scope state-modifier">US7491797B2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2000-09-15</span>
                    <span class="td style-scope patent-result">2009-02-17</span>
                    <span class="td style-scope patent-result">Genentech, Inc.</span>
                    <span class="td style-scope patent-result">PRO6308 polypeptide 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US6613567B1/en"><a id="link" href="#" class="style-scope state-modifier">US6613567B1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2000-09-15</span>
                    <span class="td style-scope patent-result">2003-09-02</span>
                    <span class="td style-scope patent-result">Isis Pharmaceuticals, Inc.</span>
                    <span class="td style-scope patent-result">Antisense inhibition of Her-2 expression 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/NZ525380A/en"><a id="link" href="#" class="style-scope state-modifier">NZ525380A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2000-09-18</span>
                    <span class="td style-scope patent-result">2008-06-30</span>
                    <span class="td style-scope patent-result">Biogen Idec Inc</span>
                    <span class="td style-scope patent-result">Non-fucosylated forms of Cripto and their use as tumor blocking agents 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/UA83458C2/en"><a id="link" href="#" class="style-scope state-modifier">UA83458C2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2000-09-18</span>
                    <span class="td style-scope patent-result">2008-07-25</span>
                    <span class="td style-scope patent-result">Байоджен Айдек Ма Інк.</span>
                    <span class="td style-scope patent-result">The isolated polypeptide baff-r (the receptor of the factor of activation of b-cells of the family tnf) 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2002030894A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2002030894A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2000-09-19</span>
                    <span class="td style-scope patent-result">2002-04-18</span>
                    <span class="td style-scope patent-result">Taiho Pharmaceutical Co., Ltd.</span>
                    <span class="td style-scope patent-result">Compositions and methods of the use thereof achiral analogues of cc-1065 and the duocarmycins 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/CA2425569A1/en"><a id="link" href="#" class="style-scope state-modifier">CA2425569A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2000-10-13</span>
                    <span class="td style-scope patent-result">2002-04-18</span>
                    <span class="td style-scope patent-result">Eos Biotechnology, Inc.</span>
                    <span class="td style-scope patent-result">Methods of diagnosis of prostate cancer, compositions and methods of screening for modulators of prostate cancer 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2002038766A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2002038766A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2000-11-07</span>
                    <span class="td style-scope patent-result">2002-05-16</span>
                    <span class="td style-scope patent-result">Zymogenetics, Inc.</span>
                    <span class="td style-scope patent-result">Human tumor necrosis factor receptor 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20020150573A1/en"><a id="link" href="#" class="style-scope state-modifier">US20020150573A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2000-11-10</span>
                    <span class="td style-scope patent-result">2002-10-17</span>
                    <span class="td style-scope patent-result">The Rockefeller University</span>
                    <span class="td style-scope patent-result">Anti-Igalpha-Igbeta antibody for lymphoma therapy 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20040018194A1/en"><a id="link" href="#" class="style-scope state-modifier">US20040018194A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2000-11-28</span>
                    <span class="td style-scope patent-result">2004-01-29</span>
                    <span class="td style-scope patent-result">Francisco Joseph A.</span>
                    <span class="td style-scope patent-result">Recombinant anti-CD30 antibodies and uses thereof 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2002061087A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2002061087A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2000-12-19</span>
                    <span class="td style-scope patent-result">2002-08-08</span>
                    <span class="td style-scope patent-result">Lifespan Biosciences, Inc.</span>
                    <span class="td style-scope patent-result">Antigenic peptides, such as for g protein-coupled receptors (gpcrs), antibodies thereto, and systems for identifying such antigenic peptides 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/AU2002243495A1/en"><a id="link" href="#" class="style-scope state-modifier">AU2002243495A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001-01-12</span>
                    <span class="td style-scope patent-result">2002-07-24</span>
                    <span class="td style-scope patent-result">University Of Medicine And Dentistry Of New Jersey</span>
                    <span class="td style-scope patent-result">Bone morphogenetic protein-2 in the treatment and diagnosis of cancer 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20030119133A1/en"><a id="link" href="#" class="style-scope state-modifier">US20030119133A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001-01-16</span>
                    <span class="td style-scope patent-result">2003-06-26</span>
                    <span class="td style-scope patent-result">Genentech, Inc.</span>
                    <span class="td style-scope patent-result">Secreted and transmembrane polypeptides and nucleic acids encoding the same 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20030119125A1/en"><a id="link" href="#" class="style-scope state-modifier">US20030119125A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001-01-16</span>
                    <span class="td style-scope patent-result">2003-06-26</span>
                    <span class="td style-scope patent-result">Genentech, Inc.</span>
                    <span class="td style-scope patent-result">Secreted and transmembrane polypeptides and nucleic acids encoding the same 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US7754208B2/en"><a id="link" href="#" class="style-scope state-modifier">US7754208B2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001-01-17</span>
                    <span class="td style-scope patent-result">2010-07-13</span>
                    <span class="td style-scope patent-result">Trubion Pharmaceuticals, Inc.</span>
                    <span class="td style-scope patent-result">Binding domain-immunoglobulin fusion proteins 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/EP1425302A2/en"><a id="link" href="#" class="style-scope state-modifier">EP1425302A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001-01-24</span>
                    <span class="td style-scope patent-result">2004-06-09</span>
                    <span class="td style-scope patent-result">Protein Design Labs</span>
                    <span class="td style-scope patent-result">Methods of diagnosis of breast cancer, compositions and methods of screening for modulators of breast cancer 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20030073144A1/en"><a id="link" href="#" class="style-scope state-modifier">US20030073144A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001-01-30</span>
                    <span class="td style-scope patent-result">2003-04-17</span>
                    <span class="td style-scope patent-result">Corixa Corporation</span>
                    <span class="td style-scope patent-result">Compositions and methods for the therapy and diagnosis of pancreatic cancer 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2002064798A1/en"><a id="link" href="#" class="style-scope state-modifier">WO2002064798A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001-02-12</span>
                    <span class="td style-scope patent-result">2002-08-22</span>
                    <span class="td style-scope patent-result">Bionomics Limited</span>
                    <span class="td style-scope patent-result">Dna sequences differentially expressed in tumour cell lines 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/AU2002258518A1/en"><a id="link" href="#" class="style-scope state-modifier">AU2002258518A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001-03-14</span>
                    <span class="td style-scope patent-result">2002-09-24</span>
                    <span class="td style-scope patent-result">Millennium Pharmaceuticals, Inc.</span>
                    <span class="td style-scope patent-result">Nucleic acid molecules and proteins for the identification, assessment, prevention, and therapy of ovarian cancer 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/EP1243276A1/en"><a id="link" href="#" class="style-scope state-modifier">EP1243276A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001-03-23</span>
                    <span class="td style-scope patent-result">2002-09-25</span>
                    <span class="td style-scope patent-result">Franciscus Marinus Hendrikus De Groot</span>
                    <span class="td style-scope patent-result">Elongated and multiple spacers containing activatible prodrugs 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/AU2002311787A1/en"><a id="link" href="#" class="style-scope state-modifier">AU2002311787A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001-03-28</span>
                    <span class="td style-scope patent-result">2002-10-15</span>
                    <span class="td style-scope patent-result">Zycos Inc.</span>
                    <span class="td style-scope patent-result">Translational profiling 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US6362331B1/en"><a id="link" href="#" class="style-scope state-modifier">US6362331B1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001-03-30</span>
                    <span class="td style-scope patent-result">2002-03-26</span>
                    <span class="td style-scope patent-result">Council Of Scientific And Industrial Research</span>
                    <span class="td style-scope patent-result">Process for the preparation of antitumor agents 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2003008537A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2003008537A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001-04-06</span>
                    <span class="td style-scope patent-result">2003-01-30</span>
                    <span class="td style-scope patent-result">Mannkind Corporation</span>
                    <span class="td style-scope patent-result">Epitope sequences 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US6820011B2/en"><a id="link" href="#" class="style-scope state-modifier">US6820011B2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001-04-11</span>
                    <span class="td style-scope patent-result">2004-11-16</span>
                    <span class="td style-scope patent-result">The Regents Of The University Of Colorado</span>
                    <span class="td style-scope patent-result">Three-dimensional structure of complement receptor type 2 and uses thereof 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/AU2002254615A1/en"><a id="link" href="#" class="style-scope state-modifier">AU2002254615A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001-04-17</span>
                    <span class="td style-scope patent-result">2002-10-28</span>
                    <span class="td style-scope patent-result">The Board Of Trustees Of The University Of Arkansas</span>
                    <span class="td style-scope patent-result">Repeat sequences of the ca125 gene and their use for diagnostic and therapeutic interventions 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/AU2002309583A1/en"><a id="link" href="#" class="style-scope state-modifier">AU2002309583A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001-04-18</span>
                    <span class="td style-scope patent-result">2002-11-05</span>
                    <span class="td style-scope patent-result">Protein Desing Labs, Inc.</span>
                    <span class="td style-scope patent-result">Methods of diagnosis of lung cancer, compositions and methods of screening for modulators of lung cancer 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2003083041A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2003083041A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2002-03-22</span>
                    <span class="td style-scope patent-result">2003-10-09</span>
                    <span class="td style-scope patent-result">Biogen, Inc.</span>
                    <span class="td style-scope patent-result">Cripto-specific antibodies 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/DK1390389T3/en"><a id="link" href="#" class="style-scope state-modifier">DK1390389T3</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001-04-26</span>
                    <span class="td style-scope patent-result">2009-04-20</span>
                    <span class="td style-scope patent-result">Biogen Idec Inc</span>
                    <span class="td style-scope patent-result">
  Crypto-blocking antibodies and uses thereof
 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US6884869B2/en"><a id="link" href="#" class="style-scope state-modifier">US6884869B2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001-04-30</span>
                    <span class="td style-scope patent-result">2005-04-26</span>
                    <span class="td style-scope patent-result">Seattle Genetics, Inc.</span>
                    <span class="td style-scope patent-result">Pentapeptide compounds and uses related thereto 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2002089747A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2002089747A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001-05-09</span>
                    <span class="td style-scope patent-result">2002-11-14</span>
                    <span class="td style-scope patent-result">Corixa Corporation</span>
                    <span class="td style-scope patent-result">Compositions and methods for the therapy and diagnosis of prostate cancer 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20030078399A1/en"><a id="link" href="#" class="style-scope state-modifier">US20030078399A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001-05-11</span>
                    <span class="td style-scope patent-result">2003-04-24</span>
                    <span class="td style-scope patent-result">Sloan-Kettering Institute For Cancer Research</span>
                    <span class="td style-scope patent-result">Nucleic acid sequence encoding ovarian antigen, CA125, and uses thereof 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/PT1436003E/en"><a id="link" href="#" class="style-scope state-modifier">PT1436003E</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001-05-24</span>
                    <span class="td style-scope patent-result">2010-03-12</span>
                    <span class="td style-scope patent-result">Zymogenetics Inc</span>
                    <span class="td style-scope patent-result">Taci-immunoglobulin fusion proteins 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2002098358A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2002098358A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001-06-04</span>
                    <span class="td style-scope patent-result">2002-12-12</span>
                    <span class="td style-scope patent-result">Eos Biotechnology, Inc.</span>
                    <span class="td style-scope patent-result">Methods of diagnosis and treatment of androgen-dependent prostate cancer, prostate cancer undergoing androgen-withdrawal, and androgen-independent prostate cancer 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2003000842A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2003000842A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001-06-04</span>
                    <span class="td style-scope patent-result">2003-01-03</span>
                    <span class="td style-scope patent-result">Curagen Corporation</span>
                    <span class="td style-scope patent-result">Novel proteins and nucleic acids encoding same 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/JP2004528046A/en"><a id="link" href="#" class="style-scope state-modifier">JP2004528046A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001-06-05</span>
                    <span class="td style-scope patent-result">2004-09-16</span>
                    <span class="td style-scope patent-result">エクセリクシス・インコーポレイテッド</span>
                    <span class="td style-scope patent-result">
  DGKs as Modifiers of the p53 Pathway and Methods of Use
 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/CA2449289A1/en"><a id="link" href="#" class="style-scope state-modifier">CA2449289A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001-06-05</span>
                    <span class="td style-scope patent-result">2002-12-12</span>
                    <span class="td style-scope patent-result">Exelixis, Inc.</span>
                    <span class="td style-scope patent-result">Gfats as modifiers of the p53 pathway and methods of use 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US7235358B2/en"><a id="link" href="#" class="style-scope state-modifier">US7235358B2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001-06-08</span>
                    <span class="td style-scope patent-result">2007-06-26</span>
                    <span class="td style-scope patent-result">Expression Diagnostics, Inc.</span>
                    <span class="td style-scope patent-result">Methods and compositions for diagnosing and monitoring transplant rejection 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US7125663B2/en"><a id="link" href="#" class="style-scope state-modifier">US7125663B2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001-06-13</span>
                    <span class="td style-scope patent-result">2006-10-24</span>
                    <span class="td style-scope patent-result">Millenium Pharmaceuticals, Inc.</span>
                    <span class="td style-scope patent-result">Genes, compositions, kits and methods for identification, assessment, prevention, and therapy of cervical cancer 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US7189507B2/en"><a id="link" href="#" class="style-scope state-modifier">US7189507B2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001-06-18</span>
                    <span class="td style-scope patent-result">2007-03-13</span>
                    <span class="td style-scope patent-result">Pdl Biopharma, Inc.</span>
                    <span class="td style-scope patent-result">Methods of diagnosis of ovarian cancer, compositions and methods of screening for modulators of ovarian cancer 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/EP1517998A2/en"><a id="link" href="#" class="style-scope state-modifier">EP1517998A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001-06-18</span>
                    <span class="td style-scope patent-result">2005-03-30</span>
                    <span class="td style-scope patent-result">EOS Biotechnology, Inc.</span>
                    <span class="td style-scope patent-result">Methods of diagnosis of ovarian cancer, compositions and methods of screening for modulators of ovarian cancer 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2003004989A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2003004989A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001-06-21</span>
                    <span class="td style-scope patent-result">2003-01-16</span>
                    <span class="td style-scope patent-result">Millennium Pharmaceuticals, Inc.</span>
                    <span class="td style-scope patent-result">Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20030108958A1/en"><a id="link" href="#" class="style-scope state-modifier">US20030108958A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001-06-28</span>
                    <span class="td style-scope patent-result">2003-06-12</span>
                    <span class="td style-scope patent-result">Rene De Waal Malefyt</span>
                    <span class="td style-scope patent-result">Biological activity of AK155 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20030120040A1/en"><a id="link" href="#" class="style-scope state-modifier">US20030120040A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001-06-29</span>
                    <span class="td style-scope patent-result">2003-06-26</span>
                    <span class="td style-scope patent-result">Genentech, Inc.</span>
                    <span class="td style-scope patent-result">Secreted and Transmembrane polypeptides and nucleic acids encoding the same 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2003004529A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2003004529A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001-07-02</span>
                    <span class="td style-scope patent-result">2003-01-16</span>
                    <span class="td style-scope patent-result">Licentia Ltd.</span>
                    <span class="td style-scope patent-result">Ephrin-tie receptor materials and methods 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20040076955A1/en"><a id="link" href="#" class="style-scope state-modifier">US20040076955A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001-07-03</span>
                    <span class="td style-scope patent-result">2004-04-22</span>
                    <span class="td style-scope patent-result">Eos Biotechnology, Inc.</span>
                    <span class="td style-scope patent-result">Methods of diagnosis of bladder cancer, compositions and methods of screening for modulators of bladder cancer 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2003003984A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2003003984A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001-07-05</span>
                    <span class="td style-scope patent-result">2003-01-16</span>
                    <span class="td style-scope patent-result">Curagen Corporation</span>
                    <span class="td style-scope patent-result">Novel proteins and nucleic acids encoding same 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2003055439A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2003055439A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001-07-18</span>
                    <span class="td style-scope patent-result">2003-07-10</span>
                    <span class="td style-scope patent-result">The Regents Of The University Of California</span>
                    <span class="td style-scope patent-result">Her2/neu target antigen and use of same to stimulate an immune response 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2003009814A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2003009814A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001-07-25</span>
                    <span class="td style-scope patent-result">2003-02-06</span>
                    <span class="td style-scope patent-result">Millennium Pharmaceuticals, Inc.</span>
                    <span class="td style-scope patent-result">Novel genes, compositions, kits, and methods for identification, assessment, prevention, and therapy of prostate cancer 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/KR20040019105A/en"><a id="link" href="#" class="style-scope state-modifier">KR20040019105A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001-08-03</span>
                    <span class="td style-scope patent-result">2004-03-04</span>
                    <span class="td style-scope patent-result">제넨테크, 인크.</span>
                    <span class="td style-scope patent-result">TACIs and BR3 Polypeptides and Uses Thereof 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/AU2002324700A1/en"><a id="link" href="#" class="style-scope state-modifier">AU2002324700A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001-08-14</span>
                    <span class="td style-scope patent-result">2003-03-03</span>
                    <span class="td style-scope patent-result">Bayer Ag</span>
                    <span class="td style-scope patent-result">Nucleic acid and amino acid sequences involved in pain 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20030092013A1/en"><a id="link" href="#" class="style-scope state-modifier">US20030092013A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001-08-16</span>
                    <span class="td style-scope patent-result">2003-05-15</span>
                    <span class="td style-scope patent-result">Vitivity, Inc.</span>
                    <span class="td style-scope patent-result">Diagnosis and treatment of vascular disease 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2003018621A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2003018621A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001-08-23</span>
                    <span class="td style-scope patent-result">2003-03-06</span>
                    <span class="td style-scope patent-result">Oxford Biomedica (Uk) Limited</span>
                    <span class="td style-scope patent-result">Genes 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US6902930B2/en"><a id="link" href="#" class="style-scope state-modifier">US6902930B2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001-08-29</span>
                    <span class="td style-scope patent-result">2005-06-07</span>
                    <span class="td style-scope patent-result">Vanderbilt University</span>
                    <span class="td style-scope patent-result">Human Mob-5 (IL-24) receptors and uses thereof 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20030124579A1/en"><a id="link" href="#" class="style-scope state-modifier">US20030124579A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001-09-05</span>
                    <span class="td style-scope patent-result">2003-07-03</span>
                    <span class="td style-scope patent-result">Eos Biotechnology, Inc.</span>
                    <span class="td style-scope patent-result">Methods of diagnosis of ovarian cancer, compositions and methods of screening for modulators of ovarian cancer 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/JP2005505271A/en"><a id="link" href="#" class="style-scope state-modifier">JP2005505271A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001-09-06</span>
                    <span class="td style-scope patent-result">2005-02-24</span>
                    <span class="td style-scope patent-result">アジェンシス，  インコーポレイテッド</span>
                    <span class="td style-scope patent-result">
  Nucleic acids and corresponding proteins given the name STEAP-1 useful in the treatment and detection of cancer
 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/JP2005518782A/en"><a id="link" href="#" class="style-scope state-modifier">JP2005518782A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001-09-17</span>
                    <span class="td style-scope patent-result">2005-06-30</span>
                    <span class="td style-scope patent-result">プロテイン  デザイン  ラブス，  インコーポレイテッド</span>
                    <span class="td style-scope patent-result">
  Cancer diagnosis method, cancer modulator screening composition and method
 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/IL160933A0/en"><a id="link" href="#" class="style-scope state-modifier">IL160933A0</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001-09-18</span>
                    <span class="td style-scope patent-result">2004-08-31</span>
                    <span class="td style-scope patent-result">Proteologics Inc</span>
                    <span class="td style-scope patent-result">Methods and compositions for treating ?cap associated diseases 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/NZ573740A/en"><a id="link" href="#" class="style-scope state-modifier">NZ573740A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001-09-18</span>
                    <span class="td style-scope patent-result">2010-07-30</span>
                    <span class="td style-scope patent-result">Genentech Inc</span>
                    <span class="td style-scope patent-result">Compositions and methods for the diagnosis and treatment of tumor, particularly kidney tumor - TAT184 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/CA2460621A1/en"><a id="link" href="#" class="style-scope state-modifier">CA2460621A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001-09-19</span>
                    <span class="td style-scope patent-result">2003-03-27</span>
                    <span class="td style-scope patent-result">Nuvelo, Inc.</span>
                    <span class="td style-scope patent-result">Novel nucleic acids and polypeptides 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2003026577A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2003026577A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001-09-24</span>
                    <span class="td style-scope patent-result">2003-04-03</span>
                    <span class="td style-scope patent-result">Seattle Genetics, Inc.</span>
                    <span class="td style-scope patent-result">P-amidobenzylethers in drug delivery agents 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US7091186B2/en"><a id="link" href="#" class="style-scope state-modifier">US7091186B2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001-09-24</span>
                    <span class="td style-scope patent-result">2006-08-15</span>
                    <span class="td style-scope patent-result">Seattle Genetics, Inc.</span>
                    <span class="td style-scope patent-result">p-Amidobenzylethers in drug delivery agents 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20030077644A1/en"><a id="link" href="#" class="style-scope state-modifier">US20030077644A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001-09-28</span>
                    <span class="td style-scope patent-result">2003-04-24</span>
                    <span class="td style-scope patent-result">Bing Yang</span>
                    <span class="td style-scope patent-result">Diagnosis and treatment of diseases caused by mutations in CD72 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/AU2002362436A1/en"><a id="link" href="#" class="style-scope state-modifier">AU2002362436A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001-10-03</span>
                    <span class="td style-scope patent-result">2003-04-14</span>
                    <span class="td style-scope patent-result">Rigel Pharmaceuticals, Inc.</span>
                    <span class="td style-scope patent-result">Modulators of lymphocyte activation and migration 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20040249144A1/en"><a id="link" href="#" class="style-scope state-modifier">US20040249144A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001-10-03</span>
                    <span class="td style-scope patent-result">2004-12-09</span>
                    <span class="td style-scope patent-result">Zairen Sun</span>
                    <span class="td style-scope patent-result">Regulated breast cancer genes 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20050123925A1/en"><a id="link" href="#" class="style-scope state-modifier">US20050123925A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2002-11-15</span>
                    <span class="td style-scope patent-result">2005-06-09</span>
                    <span class="td style-scope patent-result">Genentech, Inc.</span>
                    <span class="td style-scope patent-result">Compositions and methods for the diagnosis and treatment of tumor 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/JP2005522986A/en"><a id="link" href="#" class="style-scope state-modifier">JP2005522986A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001-10-19</span>
                    <span class="td style-scope patent-result">2005-08-04</span>
                    <span class="td style-scope patent-result">ジェネンテック・インコーポレーテッド</span>
                    <span class="td style-scope patent-result">
  Compositions and methods for diagnosis and treatment of inflammatory bowel disease
 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/CA2465268A1/en"><a id="link" href="#" class="style-scope state-modifier">CA2465268A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001-10-24</span>
                    <span class="td style-scope patent-result">2003-05-01</span>
                    <span class="td style-scope patent-result">National Jewish Medical And Research Center</span>
                    <span class="td style-scope patent-result">Three-dimensional structures of tall-1 and its cognate receptors and modified proteins and methods related thereto 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/ES2278079T3/en"><a id="link" href="#" class="style-scope state-modifier">ES2278079T3</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001-10-31</span>
                    <span class="td style-scope patent-result">2007-08-01</span>
                    <span class="td style-scope patent-result">Alcon, Inc.</span>
                    <span class="td style-scope patent-result">
  OSEAS MORPHOGENIC PROTEINS (BMP), BMP RECEPTORS AND BMP UNION PROTEINS AND ITS USE IN DIAGNOSIS AND GLAUCOMA TREATMENT.
 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2003042661A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2003042661A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001-11-13</span>
                    <span class="td style-scope patent-result">2003-05-22</span>
                    <span class="td style-scope patent-result">Protein Design Labs, Inc.</span>
                    <span class="td style-scope patent-result">Methods of diagnosis of cancer, compositions and methods of screening for modulators of cancer 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20030232350A1/en"><a id="link" href="#" class="style-scope state-modifier">US20030232350A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001-11-13</span>
                    <span class="td style-scope patent-result">2003-12-18</span>
                    <span class="td style-scope patent-result">Eos Biotechnology, Inc.</span>
                    <span class="td style-scope patent-result">Methods of diagnosis of cancer, compositions and methods of screening for modulators of cancer 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/EP1482972A4/en"><a id="link" href="#" class="style-scope state-modifier">EP1482972A4</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001-11-20</span>
                    <span class="td style-scope patent-result">2005-11-23</span>
                    <span class="td style-scope patent-result">Seattle Genetics Inc</span>
                    <span class="td style-scope patent-result">Treatment of immunological disorders using anti-cd30 antibodies 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/AU2002339691A1/en"><a id="link" href="#" class="style-scope state-modifier">AU2002339691A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001-11-29</span>
                    <span class="td style-scope patent-result">2003-06-10</span>
                    <span class="td style-scope patent-result">Genset</span>
                    <span class="td style-scope patent-result">Agonists and antagonists of prolixin for the treatment of metabolic disorders 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2003048202A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2003048202A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001-12-03</span>
                    <span class="td style-scope patent-result">2003-06-12</span>
                    <span class="td style-scope patent-result">Asahi Kasei Pharma Corporation</span>
                    <span class="td style-scope patent-result">Nf-kappab activating genes 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2003054152A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2003054152A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001-12-10</span>
                    <span class="td style-scope patent-result">2003-07-03</span>
                    <span class="td style-scope patent-result">Nuvelo, Inc.</span>
                    <span class="td style-scope patent-result">Novel nucleic acids and polypeptides 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20030134790A1/en"><a id="link" href="#" class="style-scope state-modifier">US20030134790A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2002-01-11</span>
                    <span class="td style-scope patent-result">2003-07-17</span>
                    <span class="td style-scope patent-result">University Of Medicine And Dentistry Of New Jersey</span>
                    <span class="td style-scope patent-result">Bone Morphogenetic Protein-2 And Bone Morphogenetic Protein-4 In The Treatment And Diagnosis Of Cancer 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US7452675B2/en"><a id="link" href="#" class="style-scope state-modifier">US7452675B2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2002-01-25</span>
                    <span class="td style-scope patent-result">2008-11-18</span>
                    <span class="td style-scope patent-result">The Queen's Medical Center</span>
                    <span class="td style-scope patent-result">Methods of screening for TRPM4b modulators 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/CA2476776A1/en"><a id="link" href="#" class="style-scope state-modifier">CA2476776A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2002-02-21</span>
                    <span class="td style-scope patent-result">2003-09-04</span>
                    <span class="td style-scope patent-result">Duke University</span>
                    <span class="td style-scope patent-result">Reagents and treatment methods for autoimmune diseases 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20040258678A1/en"><a id="link" href="#" class="style-scope state-modifier">US20040258678A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2002-02-22</span>
                    <span class="td style-scope patent-result">2004-12-23</span>
                    <span class="td style-scope patent-result">Genentech, Inc.</span>
                    <span class="td style-scope patent-result">Compositions and methods for the treatment of immune related diseases 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20030215849A1/en"><a id="link" href="#" class="style-scope state-modifier">US20030215849A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2002-03-01</span>
                    <span class="td style-scope patent-result">2003-11-20</span>
                    <span class="td style-scope patent-result">Marcia Belvin</span>
                    <span class="td style-scope patent-result">PDPK1s as modifiers of the p53 pathway and methods of use 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/EP2258712A3/en"><a id="link" href="#" class="style-scope state-modifier">EP2258712A3</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2002-03-15</span>
                    <span class="td style-scope patent-result">2011-05-04</span>
                    <span class="td style-scope patent-result">Multicell Immunotherapeutics, Inc.</span>
                    <span class="td style-scope patent-result">Compositions and Methods to Initiate or Enhance Antibody and Major-histocompatibility Class I or Class II-restricted T Cell Responses by Using Immunomodulatory, Non-coding RNA Motifs 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/CA2486490A1/en"><a id="link" href="#" class="style-scope state-modifier">CA2486490A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2002-03-19</span>
                    <span class="td style-scope patent-result">2003-12-31</span>
                    <span class="td style-scope patent-result">Curagen Corporation</span>
                    <span class="td style-scope patent-result">Therapeutic polypeptides, nucleic acids encoding same, and methods of use 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/CA2478981A1/en"><a id="link" href="#" class="style-scope state-modifier">CA2478981A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2002-03-21</span>
                    <span class="td style-scope patent-result">2003-10-02</span>
                    <span class="td style-scope patent-result">Sunesis Pharmaceuticals, Inc.</span>
                    <span class="td style-scope patent-result">Identification of kinase inhibitors 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US7193069B2/en"><a id="link" href="#" class="style-scope state-modifier">US7193069B2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2002-03-22</span>
                    <span class="td style-scope patent-result">2007-03-20</span>
                    <span class="td style-scope patent-result">Research Association For Biotechnology</span>
                    <span class="td style-scope patent-result">Full-length cDNA 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/AU2003245239A1/en"><a id="link" href="#" class="style-scope state-modifier">AU2003245239A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2002-03-25</span>
                    <span class="td style-scope patent-result">2003-11-03</span>
                    <span class="td style-scope patent-result">Uab Research Foundation</span>
                    <span class="td style-scope patent-result">FC receptor homolog, reagents, and uses thereof 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/AU2003222103A1/en"><a id="link" href="#" class="style-scope state-modifier">AU2003222103A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2002-03-28</span>
                    <span class="td style-scope patent-result">2003-10-13</span>
                    <span class="td style-scope patent-result">Idec Pharmaceuticals Corporation</span>
                    <span class="td style-scope patent-result">Novel gene targets and ligands that bind thereto for treatment and diagnosis of colon carcinomas 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20030194704A1/en"><a id="link" href="#" class="style-scope state-modifier">US20030194704A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2002-04-03</span>
                    <span class="td style-scope patent-result">2003-10-16</span>
                    <span class="td style-scope patent-result">Penn Sharron Gaynor</span>
                    <span class="td style-scope patent-result">Human genome-derived single exon nucleic acid probes useful for gene expression analysis two 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2003087306A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2003087306A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2002-04-05</span>
                    <span class="td style-scope patent-result">2003-10-23</span>
                    <span class="td style-scope patent-result">Agensys, Inc.</span>
                    <span class="td style-scope patent-result">Nucleic acid and corresponding protein entitled 98p4b6 useful in treatment and detection of cancer 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20040101874A1/en"><a id="link" href="#" class="style-scope state-modifier">US20040101874A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2002-04-12</span>
                    <span class="td style-scope patent-result">2004-05-27</span>
                    <span class="td style-scope patent-result">Mitokor Inc.</span>
                    <span class="td style-scope patent-result">Targets for therapeutic intervention identified in the mitochondrial proteome 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/AU2003230874A1/en"><a id="link" href="#" class="style-scope state-modifier">AU2003230874A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2002-04-16</span>
                    <span class="td style-scope patent-result">2003-11-03</span>
                    <span class="td style-scope patent-result">Genentech, Inc.</span>
                    <span class="td style-scope patent-result">Compositions and methods for the diagnosis and treatment of tumor 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2003089904A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2003089904A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2002-04-17</span>
                    <span class="td style-scope patent-result">2003-10-30</span>
                    <span class="td style-scope patent-result">Baylor College Of Medicine</span>
                    <span class="td style-scope patent-result">Aib1 as a prognostic marker and predictor of resistance to encocrine therapy 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/AU2003228869A1/en"><a id="link" href="#" class="style-scope state-modifier">AU2003228869A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2002-05-03</span>
                    <span class="td style-scope patent-result">2003-11-17</span>
                    <span class="td style-scope patent-result">Incyte Corporation</span>
                    <span class="td style-scope patent-result">Transporters and ion channels 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/CA2485983A1/en"><a id="link" href="#" class="style-scope state-modifier">CA2485983A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2002-05-15</span>
                    <span class="td style-scope patent-result">2003-11-27</span>
                    <span class="td style-scope patent-result">Avalon Pharmaceuticals</span>
                    <span class="td style-scope patent-result">Cancer-linked gene as target for chemotherapy 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20030224454A1/en"><a id="link" href="#" class="style-scope state-modifier">US20030224454A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2002-05-30</span>
                    <span class="td style-scope patent-result">2003-12-04</span>
                    <span class="td style-scope patent-result">Ryseck Rolf Peter</span>
                    <span class="td style-scope patent-result">Human solute carrier family 7, member 11 (hSLC7A11) 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/CA2488284A1/en"><a id="link" href="#" class="style-scope state-modifier">CA2488284A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2002-06-04</span>
                    <span class="td style-scope patent-result">2003-12-11</span>
                    <span class="td style-scope patent-result">Avalon Pharmaceuticals, Inc.</span>
                    <span class="td style-scope patent-result">Cancer-linked gene as target for chemotherapy 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2003101283A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2003101283A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2002-06-04</span>
                    <span class="td style-scope patent-result">2003-12-11</span>
                    <span class="td style-scope patent-result">Incyte Corporation</span>
                    <span class="td style-scope patent-result">Diagnostics markers for lung cancer 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2003104270A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2003104270A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2002-06-06</span>
                    <span class="td style-scope patent-result">2003-12-18</span>
                    <span class="td style-scope patent-result">Ingenium Pharmaceuticals Ag</span>
                    <span class="td style-scope patent-result">Dudulin 2 genes, expression products, non-human animal model: uses in human hematological disease 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/CA2488404C/en"><a id="link" href="#" class="style-scope state-modifier">CA2488404C</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2002-06-06</span>
                    <span class="td style-scope patent-result">2012-11-27</span>
                    <span class="td style-scope patent-result">Oncotherapy Science, Inc.</span>
                    <span class="td style-scope patent-result">Genes and polypeptides relating to human colon cancers 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/CA2488629A1/en"><a id="link" href="#" class="style-scope state-modifier">CA2488629A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2002-06-07</span>
                    <span class="td style-scope patent-result">2003-12-18</span>
                    <span class="td style-scope patent-result">Avalon Pharmaceuticals, Inc</span>
                    <span class="td style-scope patent-result">Cancer-linked gene as target for chemotherapy 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/AU2003245441A1/en"><a id="link" href="#" class="style-scope state-modifier">AU2003245441A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2002-06-12</span>
                    <span class="td style-scope patent-result">2003-12-31</span>
                    <span class="td style-scope patent-result">Avalon Pharmaceuticals, Inc.</span>
                    <span class="td style-scope patent-result">Cancer-linked gene as target for chemotherapy 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/EP1552002A4/en"><a id="link" href="#" class="style-scope state-modifier">EP1552002A4</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2002-06-18</span>
                    <span class="td style-scope patent-result">2006-02-08</span>
                    <span class="td style-scope patent-result">Archemix Corp</span>
                    <span class="td style-scope patent-result">Aptamer-toxin molecules and methods for using same 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20040249130A1/en"><a id="link" href="#" class="style-scope state-modifier">US20040249130A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2002-06-18</span>
                    <span class="td style-scope patent-result">2004-12-09</span>
                    <span class="td style-scope patent-result">Martin Stanton</span>
                    <span class="td style-scope patent-result">Aptamer-toxin molecules and methods for using same 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2004000221A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2004000221A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2002-06-20</span>
                    <span class="td style-scope patent-result">2003-12-31</span>
                    <span class="td style-scope patent-result">The Regents Of The University Of California</span>
                    <span class="td style-scope patent-result">Compositions and methods for modulating lymphocyte activity 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20060275287A1/en"><a id="link" href="#" class="style-scope state-modifier">US20060275287A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2002-06-21</span>
                    <span class="td style-scope patent-result">2006-12-07</span>
                    <span class="td style-scope patent-result">Brad St Croix</span>
                    <span class="td style-scope patent-result">Scroll compressor 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2004009622A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2004009622A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2002-07-19</span>
                    <span class="td style-scope patent-result">2004-01-29</span>
                    <span class="td style-scope patent-result">Cellzome Ag</span>
                    <span class="td style-scope patent-result">Protein complexes of cellular networks underlying the development of cancer and other diseases 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20050043516A1/en"><a id="link" href="#" class="style-scope state-modifier">US20050043516A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2002-07-25</span>
                    <span class="td style-scope patent-result">2005-02-24</span>
                    <span class="td style-scope patent-result">Genentech, Inc.</span>
                    <span class="td style-scope patent-result">TACI antibodies and uses thereof 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/AU2003294210A1/en"><a id="link" href="#" class="style-scope state-modifier">AU2003294210A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2002-07-31</span>
                    <span class="td style-scope patent-result">2004-05-04</span>
                    <span class="td style-scope patent-result">Seattle Genetics, Inc</span>
                    <span class="td style-scope patent-result">Anti-cd20 antibody-drug conjugates for the treatment of cancer and immune disorders 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2004015426A1/en"><a id="link" href="#" class="style-scope state-modifier">WO2004015426A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2002-08-06</span>
                    <span class="td style-scope patent-result">2004-02-19</span>
                    <span class="td style-scope patent-result">Bayer Healthcare Ag</span>
                    <span class="td style-scope patent-result">Diagnostics and therapeutics for diseases associated with human cxc chemokine receptor 5(cxcr5) 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/JP2004121218A/en"><a id="link" href="#" class="style-scope state-modifier">JP2004121218A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2002-08-06</span>
                    <span class="td style-scope patent-result">2004-04-22</span>
                    <span class="td style-scope patent-result">Jenokkusu Soyaku Kenkyusho:Kk</span>
                    <span class="td style-scope patent-result">Method for testing bronchial asthma or chronic obstructive pulmonary disease 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/MXPA05001933A/en"><a id="link" href="#" class="style-scope state-modifier">MXPA05001933A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2002-08-19</span>
                    <span class="td style-scope patent-result">2005-04-28</span>
                    <span class="td style-scope patent-result">Genentech Inc</span>
                    <span class="td style-scope patent-result">Compositions and methods for the diagnosis and treatment of tumor. 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US7504211B2/en"><a id="link" href="#" class="style-scope state-modifier">US7504211B2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2002-08-27</span>
                    <span class="td style-scope patent-result">2009-03-17</span>
                    <span class="td style-scope patent-result">Bristol-Myers Squibb Company</span>
                    <span class="td style-scope patent-result">Methods of using EPHA2 for predicting activity of compounds that interact with and/or modulate protein tyrosine kinases and/or protein tyrosine kinase pathways in breast cells 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2004020595A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2004020595A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2002-08-29</span>
                    <span class="td style-scope patent-result">2004-03-11</span>
                    <span class="td style-scope patent-result">Five Prime Therapeutics, Inc.</span>
                    <span class="td style-scope patent-result">Novel human polypeptides encoded by polynucleotides 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2004019993A1/en"><a id="link" href="#" class="style-scope state-modifier">WO2004019993A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2002-08-30</span>
                    <span class="td style-scope patent-result">2004-03-11</span>
                    <span class="td style-scope patent-result">Ramot At Tel Aviv University Ltd.</span>
                    <span class="td style-scope patent-result">Self-immolative dendrimers releasing many active moieties upon a single activating event 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/AU2002951346A0/en"><a id="link" href="#" class="style-scope state-modifier">AU2002951346A0</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2002-09-05</span>
                    <span class="td style-scope patent-result">2002-09-26</span>
                    <span class="td style-scope patent-result">Garvan Institute Of Medical Research</span>
                    <span class="td style-scope patent-result">Diagnosis of ovarian cancer 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20040180354A1/en"><a id="link" href="#" class="style-scope state-modifier">US20040180354A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2002-09-06</span>
                    <span class="td style-scope patent-result">2004-09-16</span>
                    <span class="td style-scope patent-result">Simard John J.L.</span>
                    <span class="td style-scope patent-result">Epitope sequences 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/JP2006513702A/en"><a id="link" href="#" class="style-scope state-modifier">JP2006513702A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2002-09-09</span>
                    <span class="td style-scope patent-result">2006-04-27</span>
                    <span class="td style-scope patent-result">ヌラ  インコーポレーティッド</span>
                    <span class="td style-scope patent-result">
  G protein-coupled receptor and use thereof
 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/JP2004113151A/en"><a id="link" href="#" class="style-scope state-modifier">JP2004113151A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2002-09-27</span>
                    <span class="td style-scope patent-result">2004-04-15</span>
                    <span class="td style-scope patent-result">Sankyo Co Ltd</span>
                    <span class="td style-scope patent-result">Oncogene and its application 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/EP1554309A2/en"><a id="link" href="#" class="style-scope state-modifier">EP1554309A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2002-10-03</span>
                    <span class="td style-scope patent-result">2005-07-20</span>
                    <span class="td style-scope patent-result">McGILL UNIVERSITY</span>
                    <span class="td style-scope patent-result">Antibodies and cyclic peptides which bind cea (carcinoembryonic antigen) and their use as cancer therapeutics 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/CA2501131A1/en"><a id="link" href="#" class="style-scope state-modifier">CA2501131A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2002-10-04</span>
                    <span class="td style-scope patent-result">2004-04-22</span>
                    <span class="td style-scope patent-result">Van Andel Research Institute</span>
                    <span class="td style-scope patent-result">Molecular sub-classification of kidney tumors and the discovery of new diagnostic markers 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/JP2006516094A/en"><a id="link" href="#" class="style-scope state-modifier">JP2006516094A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2002-11-08</span>
                    <span class="td style-scope patent-result">2006-06-22</span>
                    <span class="td style-scope patent-result">ジェネンテック・インコーポレーテッド</span>
                    <span class="td style-scope patent-result">
  Compositions and methods for treatment of natural killer cell related diseases
 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/EP1578940A4/en"><a id="link" href="#" class="style-scope state-modifier">EP1578940A4</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2002-11-13</span>
                    <span class="td style-scope patent-result">2007-12-12</span>
                    <span class="td style-scope patent-result">Genentech Inc</span>
                    <span class="td style-scope patent-result">Methods and compositions for diagnosing dysplasia 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/JP2006507322A/en"><a id="link" href="#" class="style-scope state-modifier">JP2006507322A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2002-11-14</span>
                    <span class="td style-scope patent-result">2006-03-02</span>
                    <span class="td style-scope patent-result">シンタルガ・ビーブイ</span>
                    <span class="td style-scope patent-result">
  Prodrugs constructed as multiple self-detaching release spacers
 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/GB0226593D0/en"><a id="link" href="#" class="style-scope state-modifier">GB0226593D0</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2002-11-14</span>
                    <span class="td style-scope patent-result">2002-12-24</span>
                    <span class="td style-scope patent-result">Consultants Ltd</span>
                    <span class="td style-scope patent-result">Compounds 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/AU2003298650B2/en"><a id="link" href="#" class="style-scope state-modifier">AU2003298650B2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2002-11-15</span>
                    <span class="td style-scope patent-result">2010-03-11</span>
                    <span class="td style-scope patent-result">Musc Foundation For Research Development</span>
                    <span class="td style-scope patent-result">Complement receptor 2 targeted complement modulators 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/MXPA05005237A/en"><a id="link" href="#" class="style-scope state-modifier">MXPA05005237A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2002-11-15</span>
                    <span class="td style-scope patent-result">2005-08-16</span>
                    <span class="td style-scope patent-result">Univ Arkansas</span>
                    <span class="td style-scope patent-result">Ca125 gene and its use for diagnostic and therapeutic interventions. 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2004046342A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2004046342A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2002-11-20</span>
                    <span class="td style-scope patent-result">2004-06-03</span>
                    <span class="td style-scope patent-result">Biogen Idec Inc.</span>
                    <span class="td style-scope patent-result">Novel gene targets and ligands that bind thereto for treatment and diagnosis of carcinomas 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/CA2507044A1/en"><a id="link" href="#" class="style-scope state-modifier">CA2507044A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2002-11-21</span>
                    <span class="td style-scope patent-result">2004-06-10</span>
                    <span class="td style-scope patent-result">Mary Lucero</span>
                    <span class="td style-scope patent-result">Purinergic modulation of smell 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/AU2003298786A1/en"><a id="link" href="#" class="style-scope state-modifier">AU2003298786A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2002-11-26</span>
                    <span class="td style-scope patent-result">2004-06-18</span>
                    <span class="td style-scope patent-result">Protein Design Labs, Inc.</span>
                    <span class="td style-scope patent-result">Methods of detecting soft tissue sarcoma, compositions and methods of screening for soft tissue sarcoma modulators 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2004053079A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2004053079A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2002-12-06</span>
                    <span class="td style-scope patent-result">2004-06-24</span>
                    <span class="td style-scope patent-result">Diadexus, Inc.</span>
                    <span class="td style-scope patent-result">Compositions, splice variants and methods relating to ovarian specific genes and proteins 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20040157278A1/en"><a id="link" href="#" class="style-scope state-modifier">US20040157278A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2002-12-13</span>
                    <span class="td style-scope patent-result">2004-08-12</span>
                    <span class="td style-scope patent-result">Bayer Corporation</span>
                    <span class="td style-scope patent-result">Detection methods using TIMP 1 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/JP4898120B2/en"><a id="link" href="#" class="style-scope state-modifier">JP4898120B2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2002-12-20</span>
                    <span class="td style-scope patent-result">2012-03-14</span>
                    <span class="td style-scope patent-result">アボット  バイオセラピューティクス  コーポレイション</span>
                    <span class="td style-scope patent-result">
  Antibodies against GPR64 and methods of use thereof
 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2004058309A1/en"><a id="link" href="#" class="style-scope state-modifier">WO2004058309A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2002-12-23</span>
                    <span class="td style-scope patent-result">2004-07-15</span>
                    <span class="td style-scope patent-result">Human Genome Sciences, Inc.</span>
                    <span class="td style-scope patent-result">Neutrokine-alpha conjugate, neutrokine-alpha complex, and uses thereof 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/JP2007520995A/en"><a id="link" href="#" class="style-scope state-modifier">JP2007520995A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2003-01-08</span>
                    <span class="td style-scope patent-result">2007-08-02</span>
                    <span class="td style-scope patent-result">ブリストル−マイヤーズ　スクイブ　カンパニー</span>
                    <span class="td style-scope patent-result">
  Biomarkers and methods for determining susceptibility to epidermal growth factor receptor modulators
 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20050181375A1/en"><a id="link" href="#" class="style-scope state-modifier">US20050181375A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2003-01-10</span>
                    <span class="td style-scope patent-result">2005-08-18</span>
                    <span class="td style-scope patent-result">Natasha Aziz</span>
                    <span class="td style-scope patent-result">Novel methods of diagnosis of metastatic cancer, compositions and methods of screening for modulators of metastatic cancer 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20050227301A1/en"><a id="link" href="#" class="style-scope state-modifier">US20050227301A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2003-01-10</span>
                    <span class="td style-scope patent-result">2005-10-13</span>
                    <span class="td style-scope patent-result">Polgen</span>
                    <span class="td style-scope patent-result">Cell cycle progression proteins 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2004065577A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2004065577A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2003-01-14</span>
                    <span class="td style-scope patent-result">2004-08-05</span>
                    <span class="td style-scope patent-result">Bristol-Myers Squibb Company</span>
                    <span class="td style-scope patent-result">Polynucleotides and polypeptides associated with the nf-kb pathway 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2004065576A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2004065576A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2003-01-15</span>
                    <span class="td style-scope patent-result">2004-08-05</span>
                    <span class="td style-scope patent-result">Millennium Pharmaceuticals, Inc.</span>
                    <span class="td style-scope patent-result">Methods and compositions for the treatment of urological disorder using differential expressed polypeptides 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/CA2516128A1/en"><a id="link" href="#" class="style-scope state-modifier">CA2516128A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2003-02-14</span>
                    <span class="td style-scope patent-result">2004-09-02</span>
                    <span class="td style-scope patent-result">Sagres Discovery, Inc.</span>
                    <span class="td style-scope patent-result">Therapeutic targets in cancer 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20030224411A1/en"><a id="link" href="#" class="style-scope state-modifier">US20030224411A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2003-03-13</span>
                    <span class="td style-scope patent-result">2003-12-04</span>
                    <span class="td style-scope patent-result">Stanton Lawrence W.</span>
                    <span class="td style-scope patent-result">Genes that are up- or down-regulated during differentiation of human embryonic stem cells 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/CA2520898C/en"><a id="link" href="#" class="style-scope state-modifier">CA2520898C</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2003-03-31</span>
                    <span class="td style-scope patent-result">2009-10-20</span>
                    <span class="td style-scope patent-result">Council Of Scientific And Industrial Research</span>
                    <span class="td style-scope patent-result">Non-cross-linking pyrrolo(2,1-c)(1,4)benzodiazepines as potential antitumour agents and process thereof 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/GB0321295D0/en"><a id="link" href="#" class="style-scope state-modifier">GB0321295D0</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2003-09-11</span>
                    <span class="td style-scope patent-result">2003-10-15</span>
                    <span class="td style-scope patent-result">Spirogen Ltd</span>
                    <span class="td style-scope patent-result">Synthesis of protected pyrrolobenzodiazepines 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/GB0416511D0/en"><a id="link" href="#" class="style-scope state-modifier">GB0416511D0</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2003-10-22</span>
                    <span class="td style-scope patent-result">2004-08-25</span>
                    <span class="td style-scope patent-result">Spirogen Ltd</span>
                    <span class="td style-scope patent-result">Pyrrolobenzodiazepines 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US7375078B2/en"><a id="link" href="#" class="style-scope state-modifier">US7375078B2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2004-02-23</span>
                    <span class="td style-scope patent-result">2008-05-20</span>
                    <span class="td style-scope patent-result">Genentech, Inc.</span>
                    <span class="td style-scope patent-result">Heterocyclic self-immolative linkers and conjugates 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/GB0404574D0/en"><a id="link" href="#" class="style-scope state-modifier">GB0404574D0</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2004-03-01</span>
                    <span class="td style-scope patent-result">2004-04-07</span>
                    <span class="td style-scope patent-result">Spirogen Ltd</span>
                    <span class="td style-scope patent-result">Amino acids 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2005085251A1/en"><a id="link" href="#" class="style-scope state-modifier">WO2005085251A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2004-03-01</span>
                    <span class="td style-scope patent-result">2005-09-15</span>
                    <span class="td style-scope patent-result">Spirogen Limited</span>
                    <span class="td style-scope patent-result">11-hydroxy-5h-pyrrolo[2,1-c][1,4]benzodiazepin-5-one derivatives as key intermediates for the preparation of c2 substituted pyrrolobenzodiazepines 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/GB0404577D0/en"><a id="link" href="#" class="style-scope state-modifier">GB0404577D0</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2004-03-01</span>
                    <span class="td style-scope patent-result">2004-04-07</span>
                    <span class="td style-scope patent-result">Spirogen Ltd</span>
                    <span class="td style-scope patent-result">Pyrrolobenzodiazepines 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/GB0404578D0/en"><a id="link" href="#" class="style-scope state-modifier">GB0404578D0</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2004-03-01</span>
                    <span class="td style-scope patent-result">2004-04-07</span>
                    <span class="td style-scope patent-result">Spirogen Ltd</span>
                    <span class="td style-scope patent-result">Pyrrolobenzodiazepines 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US7528126B2/en"><a id="link" href="#" class="style-scope state-modifier">US7528126B2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2004-03-09</span>
                    <span class="td style-scope patent-result">2009-05-05</span>
                    <span class="td style-scope patent-result">Spirogen Limited</span>
                    <span class="td style-scope patent-result">Pyrrolobenzodiazepines 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/FR2869231B1/en"><a id="link" href="#" class="style-scope state-modifier">FR2869231B1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2004-04-27</span>
                    <span class="td style-scope patent-result">2008-03-14</span>
                    <span class="td style-scope patent-result">Sod Conseils Rech Applic</span>
                    <span class="td style-scope patent-result">
  THERAPEUTIC COMPOSITION CONTAINING AT LEAST ONE PYRROLOBENZODIAZEPINE DERIVATIVE AND FLUDARABINE
 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/GB0410725D0/en"><a id="link" href="#" class="style-scope state-modifier">GB0410725D0</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2004-05-13</span>
                    <span class="td style-scope patent-result">2004-06-16</span>
                    <span class="td style-scope patent-result">Spirogen Ltd</span>
                    <span class="td style-scope patent-result">Pyrrolobenzodiazepine therapeutic agents 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/KR101270829B1/en"><a id="link" href="#" class="style-scope state-modifier">KR101270829B1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2004-09-23</span>
                    <span class="td style-scope patent-result">2013-06-07</span>
                    <span class="td style-scope patent-result">제넨테크, 인크.</span>
                    <span class="td style-scope patent-result">Cystein engineered antibodies and conjugates 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/DK1879901T3/en"><a id="link" href="#" class="style-scope state-modifier">DK1879901T3</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2005-04-21</span>
                    <span class="td style-scope patent-result">2010-05-03</span>
                    <span class="td style-scope patent-result">Spirogen Ltd</span>
                    <span class="td style-scope patent-result">
  pyrrolobenzodiazepines
 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/GB0508084D0/en"><a id="link" href="#" class="style-scope state-modifier">GB0508084D0</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2005-04-21</span>
                    <span class="td style-scope patent-result">2005-06-01</span>
                    <span class="td style-scope patent-result">Spirogen Ltd</span>
                    <span class="td style-scope patent-result">Pyrrolobenzodiazepines 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20070154906A1/en"><a id="link" href="#" class="style-scope state-modifier">US20070154906A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2005-10-05</span>
                    <span class="td style-scope patent-result">2007-07-05</span>
                    <span class="td style-scope patent-result">Spirogen Ltd.</span>
                    <span class="td style-scope patent-result">Methods to identify therapeutic candidates 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/ATE427949T1/en"><a id="link" href="#" class="style-scope state-modifier">ATE427949T1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2005-10-05</span>
                    <span class="td style-scope patent-result">2009-04-15</span>
                    <span class="td style-scope patent-result">Spirogen Ltd</span>
                    <span class="td style-scope patent-result">
  4-A4-(5-OXO-2,3,5,11A-TETRAHYDRO-5H-PYRROLO A2, 1-CUA1,4UBENZODIAZEPINE-8-YLOXY)-BUTYRYLAMINOU-1 - PYRROLE-2-CARBONATE ALKYL ESTER DERIVATIVES AND RELATED COMPOUND FOR THE TREATMENT OF A PROLIFERATIVE DISEASE
 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/ATE504565T1/en"><a id="link" href="#" class="style-scope state-modifier">ATE504565T1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2005-10-07</span>
                    <span class="td style-scope patent-result">2011-04-15</span>
                    <span class="td style-scope patent-result">Exelixis Inc</span>
                    <span class="td style-scope patent-result">
  AZETIDINES AS MEK INHIBITORS IN THE TREATMENT OF PROLIFERATIVE DISEASES
 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/ES2374964T3/en"><a id="link" href="#" class="style-scope state-modifier">ES2374964T3</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2006-01-25</span>
                    <span class="td style-scope patent-result">2012-02-23</span>
                    <span class="td style-scope patent-result">Sanofi</span>
                    <span class="td style-scope patent-result">
  CYTOTOXIC AGENTS UNDERSTANDING NEW TOMAIMYCIN DERIVATIVES.
 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2008050140A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2008050140A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2006-10-27</span>
                    <span class="td style-scope patent-result">2008-05-02</span>
                    <span class="td style-scope patent-result">Spirogen Limited</span>
                    <span class="td style-scope patent-result">Compounds for treatment of parasitic infection 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/JP5290276B2/en"><a id="link" href="#" class="style-scope state-modifier">JP5290276B2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2007-05-08</span>
                    <span class="td style-scope patent-result">2013-09-18</span>
                    <span class="td style-scope patent-result">ジェネンテック，  インコーポレイテッド</span>
                    <span class="td style-scope patent-result">
  Cysteine-modified anti-MUC16 antibody and antibody-drug conjugate
 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/MX2010003718A/en"><a id="link" href="#" class="style-scope state-modifier">MX2010003718A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2007-10-19</span>
                    <span class="td style-scope patent-result">2010-04-21</span>
                    <span class="td style-scope patent-result">Genentech Inc</span>
                    <span class="td style-scope patent-result">Cysteine engineered anti-tenb2 antibodies and antibody drug conjugates. 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/GB0722087D0/en"><a id="link" href="#" class="style-scope state-modifier">GB0722087D0</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2007-11-09</span>
                    <span class="td style-scope patent-result">2007-12-19</span>
                    <span class="td style-scope patent-result">Spirogen Ltd</span>
                    <span class="td style-scope patent-result">Polyamides 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/GB0722088D0/en"><a id="link" href="#" class="style-scope state-modifier">GB0722088D0</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2007-11-09</span>
                    <span class="td style-scope patent-result">2007-12-19</span>
                    <span class="td style-scope patent-result">Spirogen Ltd</span>
                    <span class="td style-scope patent-result">Pyrrolobenzodiazepines 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/GB0813432D0/en"><a id="link" href="#" class="style-scope state-modifier">GB0813432D0</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2008-07-22</span>
                    <span class="td style-scope patent-result">2008-08-27</span>
                    <span class="td style-scope patent-result">Spirogen Ltd</span>
                    <span class="td style-scope patent-result">Pyrrolobenzodiazepines 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/GB0819097D0/en"><a id="link" href="#" class="style-scope state-modifier">GB0819097D0</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2008-10-17</span>
                    <span class="td style-scope patent-result">2008-11-26</span>
                    <span class="td style-scope patent-result">Spirogen Ltd</span>
                    <span class="td style-scope patent-result">Pyrrolobenzodiazepines 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/GB0819095D0/en"><a id="link" href="#" class="style-scope state-modifier">GB0819095D0</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2008-10-17</span>
                    <span class="td style-scope patent-result">2008-11-26</span>
                    <span class="td style-scope patent-result">Spirogen Ltd</span>
                    <span class="td style-scope patent-result">Pyrrolobenzodiazepines 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/AU2010210646B2/en"><a id="link" href="#" class="style-scope state-modifier">AU2010210646B2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2009-02-05</span>
                    <span class="td style-scope patent-result">2015-10-29</span>
                    <span class="td style-scope patent-result">Immunogen, Inc.</span>
                    <span class="td style-scope patent-result">Novel benzodiazepine derivatives 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/GB201006340D0/en"><a id="link" href="#" class="style-scope state-modifier">GB201006340D0</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2010-04-15</span>
                    <span class="td style-scope patent-result">2010-06-02</span>
                    <span class="td style-scope patent-result">Spirogen Ltd</span>
                    <span class="td style-scope patent-result">Synthesis method and intermediates 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/EP2558475A1/en"><a id="link" href="#" class="style-scope state-modifier">EP2558475A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2010-04-15</span>
                    <span class="td style-scope patent-result">2013-02-20</span>
                    <span class="td style-scope patent-result">Spirogen Sàrl</span>
                    <span class="td style-scope patent-result">Pyrrolobenzodiazepines used to treat proliferative diseases 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/JP5870400B2/en"><a id="link" href="#" class="style-scope state-modifier">JP5870400B2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2010-04-15</span>
                    <span class="td style-scope patent-result">2016-03-01</span>
                    <span class="td style-scope patent-result">シアトル ジェネティクス，インコーポレーテッド</span>
                    <span class="td style-scope patent-result">
  Targeted pyrrolobenzodiazepine conjugates
 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/SI2675479T1/en"><a id="link" href="#" class="style-scope state-modifier">SI2675479T1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2011-02-15</span>
                    <span class="td style-scope patent-result">2016-04-29</span>
                    <span class="td style-scope patent-result">Immunogen, Inc.</span>
                    <span class="td style-scope patent-result">Cytotoxic benzodiazepine derivatives 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/AU2012311505B2/en"><a id="link" href="#" class="style-scope state-modifier">AU2012311505B2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2011-09-20</span>
                    <span class="td style-scope patent-result">2016-09-29</span>
                    <span class="td style-scope patent-result">Medimmune Limited</span>
                    <span class="td style-scope patent-result">Pyrrolobenzodiazepines as unsymmetrical dimeric PBD compounds for inclusion in targeted conjugates 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2013055990A1/en"><a id="link" href="#" class="style-scope state-modifier">WO2013055990A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2011-10-14</span>
                    <span class="td style-scope patent-result">2013-04-18</span>
                    <span class="td style-scope patent-result">Seattle Genetics, Inc.</span>
                    <span class="td style-scope patent-result">Pyrrolobenzodiazepines and targeted conjugates 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/CN110183470A/en"><a id="link" href="#" class="style-scope state-modifier">CN110183470A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2011-10-14</span>
                    <span class="td style-scope patent-result">2019-08-30</span>
                    <span class="td style-scope patent-result">麦迪穆有限责任公司</span>
                    <span class="td style-scope patent-result">Pyrrolobenzodiazepines are tall and erect 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/CN103997893B/en"><a id="link" href="#" class="style-scope state-modifier">CN103997893B</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2011-10-14</span>
                    <span class="td style-scope patent-result">2019-04-12</span>
                    <span class="td style-scope patent-result">西雅图基因公司</span>
                    <span class="td style-scope patent-result">Pyrrolobenzodiazepines Zhuo and targeting conjugate 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2013053872A1/en"><a id="link" href="#" class="style-scope state-modifier">WO2013053872A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2011-10-14</span>
                    <span class="td style-scope patent-result">2013-04-18</span>
                    <span class="td style-scope patent-result">Spirogen Sàrl</span>
                    <span class="td style-scope patent-result">Synthesis method and intermediates useful in the preparation of pyrrolobenzodiazepines 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/KR101891859B1/en"><a id="link" href="#" class="style-scope state-modifier">KR101891859B1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2011-10-14</span>
                    <span class="td style-scope patent-result">2018-08-24</span>
                    <span class="td style-scope patent-result">메디뮨 리미티드</span>
                    <span class="td style-scope patent-result">Pyrrolobenzodiazepines 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/AU2012322607B2/en"><a id="link" href="#" class="style-scope state-modifier">AU2012322607B2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2011-10-14</span>
                    <span class="td style-scope patent-result">2017-02-16</span>
                    <span class="td style-scope patent-result">Genentech, Inc.</span>
                    <span class="td style-scope patent-result">Pyrrolobenzodiazepines and conjugates thereof 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/CA2871172C/en"><a id="link" href="#" class="style-scope state-modifier">CA2871172C</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2012-04-30</span>
                    <span class="td style-scope patent-result">2020-08-25</span>
                    <span class="td style-scope patent-result">Spirogen Sarl</span>
                    <span class="td style-scope patent-result">Pyrrolobenzodiazepines 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/MX2014013144A/en"><a id="link" href="#" class="style-scope state-modifier">MX2014013144A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2012-04-30</span>
                    <span class="td style-scope patent-result">2015-05-11</span>
                    <span class="td style-scope patent-result">Ucl Business Plc</span>
                    <span class="td style-scope patent-result">Pyrrolobenzodiazepines. 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2013177481A1/en"><a id="link" href="#" class="style-scope state-modifier">WO2013177481A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2012-05-25</span>
                    <span class="td style-scope patent-result">2013-11-28</span>
                    <span class="td style-scope patent-result">Immunogen, Inc.</span>
                    <span class="td style-scope patent-result">Benzodiazepines and conjugates thereof 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/EP2869849A1/en"><a id="link" href="#" class="style-scope state-modifier">EP2869849A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2012-07-09</span>
                    <span class="td style-scope patent-result">2015-05-13</span>
                    <span class="td style-scope patent-result">Genentech, Inc.</span>
                    <span class="td style-scope patent-result">Immunoconjugates comprising anti-cd22 antibodies 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/AR091700A1/en"><a id="link" href="#" class="style-scope state-modifier">AR091700A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2012-07-09</span>
                    <span class="td style-scope patent-result">2015-02-25</span>
                    <span class="td style-scope patent-result">Genentech Inc</span>
                    <span class="td style-scope patent-result">
  ANTI-CD79B ANTIBODIES AND IMMUNOCATION
 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/MX2015001399A/en"><a id="link" href="#" class="style-scope state-modifier">MX2015001399A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2012-08-02</span>
                    <span class="td style-scope patent-result">2015-09-07</span>
                    <span class="td style-scope patent-result">Genentech Inc</span>
                    <span class="td style-scope patent-result">Anti-etbr antibodies and immunoconjugates. 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/ME03486B/en"><a id="link" href="#" class="style-scope state-modifier">ME03486B</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2012-10-12</span>
                    <span class="td style-scope patent-result">2020-01-20</span>
                    <span class="td style-scope patent-result">Medimmune Ltd</span>
                    <span class="td style-scope patent-result">Pyrrolobenzodiazepines and conjugates thereof 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/CA3060520C/en"><a id="link" href="#" class="style-scope state-modifier">CA3060520C</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2012-10-12</span>
                    <span class="td style-scope patent-result">2022-05-17</span>
                    <span class="td style-scope patent-result">Medimmune Limited</span>
                    <span class="td style-scope patent-result">Pyrrolobenzodiazepines and conjugates thereof 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/EP2906249B1/en"><a id="link" href="#" class="style-scope state-modifier">EP2906249B1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2012-10-12</span>
                    <span class="td style-scope patent-result">2018-06-27</span>
                    <span class="td style-scope patent-result">MedImmune Limited</span>
                    <span class="td style-scope patent-result">Synthesis and intermediates of pyrrolobenzodiazepine derivatives for conjugation 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/PT2906296T/en"><a id="link" href="#" class="style-scope state-modifier">PT2906296T</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2012-10-12</span>
                    <span class="td style-scope patent-result">2018-06-01</span>
                    <span class="td style-scope patent-result">Medimmune Ltd</span>
                    <span class="td style-scope patent-result">Pyrrolobenzodiazepine-antibody conjugates 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/EP2906298B1/en"><a id="link" href="#" class="style-scope state-modifier">EP2906298B1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2012-10-12</span>
                    <span class="td style-scope patent-result">2018-10-03</span>
                    <span class="td style-scope patent-result">ADC Therapeutics SA</span>
                    <span class="td style-scope patent-result">Pyrrolobenzodiazepine-antibody conjugates 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2014057118A1/en"><a id="link" href="#" class="style-scope state-modifier">WO2014057118A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2012-10-12</span>
                    <span class="td style-scope patent-result">2014-04-17</span>
                    <span class="td style-scope patent-result">Adc Therapeutics Sarl</span>
                    <span class="td style-scope patent-result">Pyrrolobenzodiazepine-anti-cd22 antibody conjugates 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/CA2887899C/en"><a id="link" href="#" class="style-scope state-modifier">CA2887899C</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2012-10-12</span>
                    <span class="td style-scope patent-result">2020-03-31</span>
                    <span class="td style-scope patent-result">Adc Therapeutics Sarl</span>
                    <span class="td style-scope patent-result">Pyrrolobenzodiazepine-anti-cd22 antibody conjugates 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/EP2906297B1/en"><a id="link" href="#" class="style-scope state-modifier">EP2906297B1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2012-10-12</span>
                    <span class="td style-scope patent-result">2017-12-06</span>
                    <span class="td style-scope patent-result">ADC Therapeutics SA</span>
                    <span class="td style-scope patent-result">Pyrrolobenzodiazepine-antibody conjugates 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/JP2016502504A/en"><a id="link" href="#" class="style-scope state-modifier">JP2016502504A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2012-10-12</span>
                    <span class="td style-scope patent-result">2016-01-28</span>
                    <span class="td style-scope patent-result">エイディーシー・セラピューティクス・エス・アー・エール・エルＡｄｃ Ｔｈｅｒａｐｅｕｔｉｃｓ Ｓａｒｌ</span>
                    <span class="td style-scope patent-result">
  Pyrrolobenzodiazepine-antibody conjugate
 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/LT2906253T/en"><a id="link" href="#" class="style-scope state-modifier">LT2906253T</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2012-10-12</span>
                    <span class="td style-scope patent-result">2018-10-10</span>
                    <span class="td style-scope patent-result">Adc Therapeutics Sa</span>
                    <span class="td style-scope patent-result">Pyrrolobenzodiazepine - anti-psma antibody conjugates 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/ES2680153T3/en"><a id="link" href="#" class="style-scope state-modifier">ES2680153T3</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2012-10-12</span>
                    <span class="td style-scope patent-result">2018-09-04</span>
                    <span class="td style-scope patent-result">Adc Therapeutics Sa</span>
                    <span class="td style-scope patent-result">
  Anti-PSMA-pyrrolobenzodiazepine antibody conjugates
 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US9567340B2/en"><a id="link" href="#" class="style-scope state-modifier">US9567340B2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2012-12-21</span>
                    <span class="td style-scope patent-result">2017-02-14</span>
                    <span class="td style-scope patent-result">Medimmune Limited</span>
                    <span class="td style-scope patent-result">Unsymmetrical pyrrolobenzodiazepines-dimers for use in the treatment of proliferative and autoimmune diseases 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/EA031585B1/en"><a id="link" href="#" class="style-scope state-modifier">EA031585B1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2012-12-21</span>
                    <span class="td style-scope patent-result">2019-01-31</span>
                    <span class="td style-scope patent-result">Медимьюн Лимитед</span>
                    <span class="td style-scope patent-result">Pyrrolobenzodiazepines and conjugates thereof 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/RS58873B1/en"><a id="link" href="#" class="style-scope state-modifier">RS58873B1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2013-02-22</span>
                    <span class="td style-scope patent-result">2019-08-30</span>
                    <span class="td style-scope patent-result">Abbvie Stemcentrx Llc</span>
                    <span class="td style-scope patent-result">Antidll3-antibody-pbd conjugates and uses thereof 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/AR096287A1/en"><a id="link" href="#" class="style-scope state-modifier">AR096287A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2013-03-13</span>
                    <span class="td style-scope patent-result">2015-12-23</span>
                    <span class="td style-scope patent-result">Spirogen Sàrl</span>
                    <span class="td style-scope patent-result">
  PIRROLOBENZODIACEPINS AND CONJUGATES
 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/CA2904044C/en"><a id="link" href="#" class="style-scope state-modifier">CA2904044C</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2013-03-13</span>
                    <span class="td style-scope patent-result">2020-03-31</span>
                    <span class="td style-scope patent-result">Medimmune Limited</span>
                    <span class="td style-scope patent-result">Pyrrolobenzodiazepines and conjugates thereof 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/CN105209077B/en"><a id="link" href="#" class="style-scope state-modifier">CN105209077B</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2013-03-13</span>
                    <span class="td style-scope patent-result">2019-06-11</span>
                    <span class="td style-scope patent-result">麦迪穆有限责任公司</span>
                    <span class="td style-scope patent-result">Pyrrolobenzodiazepines Zhuo and its conjugate 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20160106861A1/en"><a id="link" href="#" class="style-scope state-modifier">US20160106861A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2013-04-26</span>
                    <span class="td style-scope patent-result">2016-04-21</span>
                    <span class="td style-scope patent-result">Spirogen Sarl</span>
                    <span class="td style-scope patent-result">Axl antibody-drug conjugate and its use for the treatment of cancer 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2015052532A1/en"><a id="link" href="#" class="style-scope state-modifier">WO2015052532A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2013-10-11</span>
                    <span class="td style-scope patent-result">2015-04-16</span>
                    <span class="td style-scope patent-result">Spirogen Sàrl</span>
                    <span class="td style-scope patent-result">Pyrrolobenzodiazepine-antibody conjugates 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/EP3054986B1/en"><a id="link" href="#" class="style-scope state-modifier">EP3054986B1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2013-10-11</span>
                    <span class="td style-scope patent-result">2019-03-20</span>
                    <span class="td style-scope patent-result">Medimmune Limited</span>
                    <span class="td style-scope patent-result">Pyrrolobenzodiazepine-antibody conjugates 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2015052534A1/en"><a id="link" href="#" class="style-scope state-modifier">WO2015052534A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2013-10-11</span>
                    <span class="td style-scope patent-result">2015-04-16</span>
                    <span class="td style-scope patent-result">Spirogen Sàrl</span>
                    <span class="td style-scope patent-result">Pyrrolobenzodiazepine-antibody conjugates 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20160256561A1/en"><a id="link" href="#" class="style-scope state-modifier">US20160256561A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2013-10-11</span>
                    <span class="td style-scope patent-result">2016-09-08</span>
                    <span class="td style-scope patent-result">Medimmune Limited</span>
                    <span class="td style-scope patent-result">Pyrrolobenzodiazepine-antibody conjugates 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/GB201317982D0/en"><a id="link" href="#" class="style-scope state-modifier">GB201317982D0</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2013-10-11</span>
                    <span class="td style-scope patent-result">2013-11-27</span>
                    <span class="td style-scope patent-result">Spirogen Sarl</span>
                    <span class="td style-scope patent-result">Pyrrolobenzodiazepines and conjugates thereof 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/GB201317981D0/en"><a id="link" href="#" class="style-scope state-modifier">GB201317981D0</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2013-10-11</span>
                    <span class="td style-scope patent-result">2013-11-27</span>
                    <span class="td style-scope patent-result">Spirogen Sarl</span>
                    <span class="td style-scope patent-result">Pyrrolobenzodiazepines and conjugates thereof 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US10533058B2/en"><a id="link" href="#" class="style-scope state-modifier">US10533058B2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2013-12-16</span>
                    <span class="td style-scope patent-result">2020-01-14</span>
                    <span class="td style-scope patent-result">Genentech Inc.</span>
                    <span class="td style-scope patent-result">Peptidomimetic compounds and antibody-drug conjugates thereof 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/GB201406767D0/en"><a id="link" href="#" class="style-scope state-modifier">GB201406767D0</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2014-04-15</span>
                    <span class="td style-scope patent-result">2014-05-28</span>
                    <span class="td style-scope patent-result">Cancer Rec Tech Ltd</span>
                    <span class="td style-scope patent-result">Humanized anti-Tn-MUC1 antibodies anf their conjugates 
     </span>
                  </div>
                  <template is="dom-repeat" class="style-scope patent-result"></template>

                </div>
              </div>
            </div>
            <div style="padding: 10px 12px; font-size: 11px;" class="style-scope patent-result">* Cited by examiner, † Cited by third party</div>
            <template is="dom-if" class="style-scope patent-result"></template>

            
            <h3 id="nplCitations" class="scroll-target style-scope patent-result">
              Non-Patent Citations (3)
              <a href="#title" class="style-scope patent-result"><iron-icon icon="arrow-drop-up" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M7 14l5-5 5 5z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon></a>
            </h3>
            <div class="responsive-table style-scope patent-result">
              <div class="table style-scope patent-result">
                <div class="thead style-scope patent-result">
                  <div class="tr style-scope patent-result">
                    <span class="th style-scope patent-result">Title</span>
                  </div>
                </div>
                <div class="tbody style-scope patent-result">
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      AHMED KAMAL等: "Design, synthesis, and evaaffinity and potent cytotoxicityluation of mixed imine–amine pyrrolobenzodiazepine dimers with efficient DNA binding", 《BIOORGANIC&amp; MEDICINAL CHEMISTRY》
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      AHMED KAMAL等: "Design, Synthesis, and Evaluation of New Noncross-Linking Pyrrolobenzodiazepine Dimers with Efficient DNA Binding Ability and Potent Antitumor Activity", 《J. MED. CHEM.》
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      AHMED KAMAL等: "Pyrrolo[2,1-c][1,4]benzodiazepine-b-glucuronide prodrugs with a potential for selective therapy of solid tumors by PMT and ADEPT strategies", 《BIOORGANIC &amp; MEDICINAL CHEMISTRY LETTERS》
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  <template is="dom-repeat" class="style-scope patent-result"></template>
                </div>
              </div>
            </div>
            <div style="padding: 10px 12px; font-size: 11px;" class="style-scope patent-result">* Cited by examiner, † Cited by third party</div>
            <template is="dom-if" class="style-scope patent-result"></template>

            
            <h3 id="citedBy" class="scroll-target style-scope patent-result">
              Cited By (58)
              <a href="#title" class="style-scope patent-result"><iron-icon icon="arrow-drop-up" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M7 14l5-5 5 5z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon></a>
            </h3>
            <div class="responsive-table style-scope patent-result">
              <div class="table style-scope patent-result">
                <div class="thead style-scope patent-result">
                  <div class="tr style-scope patent-result">
                    <span class="th style-scope patent-result">Publication number</span>
                    <span class="th style-scope patent-result">Priority date</span>
                    <span class="th style-scope patent-result">Publication date</span>
                    <span class="th style-scope patent-result">Assignee</span>
                    <span class="th style-scope patent-result">Title</span>
                  </div>
                </div>
                <div class="tbody style-scope patent-result">
                  <template is="dom-repeat" class="style-scope patent-result"></template>

                  <div class="tr style-scope patent-result">
                    <span class="td famheader style-scope patent-result">Family To Family Citations</span>
                    <span class="td famheader style-scope patent-result"></span>
                    <span class="td famheader style-scope patent-result"></span>
                    <span class="td famheader style-scope patent-result"></span>
                    <span class="td famheader style-scope patent-result"></span>
                  </div>

                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/GB0819095D0/en"><a id="link" href="#" class="style-scope state-modifier">GB0819095D0</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2008-10-17</span>
                    <span class="td style-scope patent-result">2008-11-26</span>
                    <span class="td style-scope patent-result">Spirogen Ltd</span>
                    <span class="td style-scope patent-result">Pyrrolobenzodiazepines 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/JP5870400B2/en"><a id="link" href="#" class="style-scope state-modifier">JP5870400B2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2010-04-15</span>
                    <span class="td style-scope patent-result">2016-03-01</span>
                    <span class="td style-scope patent-result">シアトル ジェネティクス，インコーポレーテッド</span>
                    <span class="td style-scope patent-result">
  Targeted pyrrolobenzodiazepine conjugates
 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/EP2558475A1/en"><a id="link" href="#" class="style-scope state-modifier">EP2558475A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2010-04-15</span>
                    <span class="td style-scope patent-result">2013-02-20</span>
                    <span class="td style-scope patent-result">Spirogen Sàrl</span>
                    <span class="td style-scope patent-result">Pyrrolobenzodiazepines used to treat proliferative diseases 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/AU2012311505B2/en"><a id="link" href="#" class="style-scope state-modifier">AU2012311505B2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2011-09-20</span>
                    <span class="td style-scope patent-result">2016-09-29</span>
                    <span class="td style-scope patent-result">Medimmune Limited</span>
                    <span class="td style-scope patent-result">Pyrrolobenzodiazepines as unsymmetrical dimeric PBD compounds for inclusion in targeted conjugates 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2013055990A1/en"><a id="link" href="#" class="style-scope state-modifier">WO2013055990A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2011-10-14</span>
                    <span class="td style-scope patent-result">2013-04-18</span>
                    <span class="td style-scope patent-result">Seattle Genetics, Inc.</span>
                    <span class="td style-scope patent-result">Pyrrolobenzodiazepines and targeted conjugates 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/CN103997893B/en"><a id="link" href="#" class="style-scope state-modifier">CN103997893B</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2011-10-14</span>
                    <span class="td style-scope patent-result">2019-04-12</span>
                    <span class="td style-scope patent-result">西雅图基因公司</span>
                    <span class="td style-scope patent-result">Pyrrolobenzodiazepines Zhuo and targeting conjugate 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/KR101891859B1/en"><a id="link" href="#" class="style-scope state-modifier">KR101891859B1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2011-10-14</span>
                    <span class="td style-scope patent-result">2018-08-24</span>
                    <span class="td style-scope patent-result">메디뮨 리미티드</span>
                    <span class="td style-scope patent-result">Pyrrolobenzodiazepines 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/CN110183470A/en"><a id="link" href="#" class="style-scope state-modifier">CN110183470A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2011-10-14</span>
                    <span class="td style-scope patent-result">2019-08-30</span>
                    <span class="td style-scope patent-result">麦迪穆有限责任公司</span>
                    <span class="td style-scope patent-result">Pyrrolobenzodiazepines are tall and erect 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/CA3060520C/en"><a id="link" href="#" class="style-scope state-modifier">CA3060520C</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2012-10-12</span>
                    <span class="td style-scope patent-result">2022-05-17</span>
                    <span class="td style-scope patent-result">Medimmune Limited</span>
                    <span class="td style-scope patent-result">Pyrrolobenzodiazepines and conjugates thereof 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/ES2680153T3/en"><a id="link" href="#" class="style-scope state-modifier">ES2680153T3</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2012-10-12</span>
                    <span class="td style-scope patent-result">2018-09-04</span>
                    <span class="td style-scope patent-result">Adc Therapeutics Sa</span>
                    <span class="td style-scope patent-result">
  Anti-PSMA-pyrrolobenzodiazepine antibody conjugates
 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/EP2906249B1/en"><a id="link" href="#" class="style-scope state-modifier">EP2906249B1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2012-10-12</span>
                    <span class="td style-scope patent-result">2018-06-27</span>
                    <span class="td style-scope patent-result">MedImmune Limited</span>
                    <span class="td style-scope patent-result">Synthesis and intermediates of pyrrolobenzodiazepine derivatives for conjugation 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/ME03486B/en"><a id="link" href="#" class="style-scope state-modifier">ME03486B</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2012-10-12</span>
                    <span class="td style-scope patent-result">2020-01-20</span>
                    <span class="td style-scope patent-result">Medimmune Ltd</span>
                    <span class="td style-scope patent-result">Pyrrolobenzodiazepines and conjugates thereof 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/LT2906253T/en"><a id="link" href="#" class="style-scope state-modifier">LT2906253T</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2012-10-12</span>
                    <span class="td style-scope patent-result">2018-10-10</span>
                    <span class="td style-scope patent-result">Adc Therapeutics Sa</span>
                    <span class="td style-scope patent-result">Pyrrolobenzodiazepine - anti-psma antibody conjugates 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/EP2906297B1/en"><a id="link" href="#" class="style-scope state-modifier">EP2906297B1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2012-10-12</span>
                    <span class="td style-scope patent-result">2017-12-06</span>
                    <span class="td style-scope patent-result">ADC Therapeutics SA</span>
                    <span class="td style-scope patent-result">Pyrrolobenzodiazepine-antibody conjugates 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/EA031585B1/en"><a id="link" href="#" class="style-scope state-modifier">EA031585B1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2012-12-21</span>
                    <span class="td style-scope patent-result">2019-01-31</span>
                    <span class="td style-scope patent-result">Медимьюн Лимитед</span>
                    <span class="td style-scope patent-result">Pyrrolobenzodiazepines and conjugates thereof 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US9567340B2/en"><a id="link" href="#" class="style-scope state-modifier">US9567340B2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2012-12-21</span>
                    <span class="td style-scope patent-result">2017-02-14</span>
                    <span class="td style-scope patent-result">Medimmune Limited</span>
                    <span class="td style-scope patent-result">Unsymmetrical pyrrolobenzodiazepines-dimers for use in the treatment of proliferative and autoimmune diseases 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/AR096287A1/en"><a id="link" href="#" class="style-scope state-modifier">AR096287A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2013-03-13</span>
                    <span class="td style-scope patent-result">2015-12-23</span>
                    <span class="td style-scope patent-result">Spirogen Sàrl</span>
                    <span class="td style-scope patent-result">
  PIRROLOBENZODIACEPINS AND CONJUGATES
 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/CA2904044C/en"><a id="link" href="#" class="style-scope state-modifier">CA2904044C</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2013-03-13</span>
                    <span class="td style-scope patent-result">2020-03-31</span>
                    <span class="td style-scope patent-result">Medimmune Limited</span>
                    <span class="td style-scope patent-result">Pyrrolobenzodiazepines and conjugates thereof 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/GB201317981D0/en"><a id="link" href="#" class="style-scope state-modifier">GB201317981D0</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2013-10-11</span>
                    <span class="td style-scope patent-result">2013-11-27</span>
                    <span class="td style-scope patent-result">Spirogen Sarl</span>
                    <span class="td style-scope patent-result">Pyrrolobenzodiazepines and conjugates thereof 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/GB201317982D0/en"><a id="link" href="#" class="style-scope state-modifier">GB201317982D0</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2013-10-11</span>
                    <span class="td style-scope patent-result">2013-11-27</span>
                    <span class="td style-scope patent-result">Spirogen Sarl</span>
                    <span class="td style-scope patent-result">Pyrrolobenzodiazepines and conjugates thereof 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US10188746B2/en"><a id="link" href="#" class="style-scope state-modifier">US10188746B2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2014-09-10</span>
                    <span class="td style-scope patent-result">2019-01-29</span>
                    <span class="td style-scope patent-result">Medimmune Limited</span>
                    <span class="td style-scope patent-result">Pyrrolobenzodiazepines and conjugates thereof 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/MX2017003126A/en"><a id="link" href="#" class="style-scope state-modifier">MX2017003126A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2014-09-12</span>
                    <span class="td style-scope patent-result">2017-08-28</span>
                    <span class="td style-scope patent-result">Genentech Inc</span>
                    <span class="td style-scope patent-result">Anti-her2 antibodies and immunoconjugates. 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/GB201416112D0/en"><a id="link" href="#" class="style-scope state-modifier">GB201416112D0</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2014-09-12</span>
                    <span class="td style-scope patent-result">2014-10-29</span>
                    <span class="td style-scope patent-result">Medimmune Ltd</span>
                    <span class="td style-scope patent-result">Pyrrolobenzodiazepines and conjugates thereof 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/CN107124870A/en"><a id="link" href="#" class="style-scope state-modifier">CN107124870A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2014-09-17</span>
                    <span class="td style-scope patent-result">2017-09-01</span>
                    <span class="td style-scope patent-result">基因泰克公司</span>
                    <span class="td style-scope patent-result">Immunoconjugates comprising Anti-HER 2 and Pyrrolobenzodiazepines * 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/CA2968447A1/en"><a id="link" href="#" class="style-scope state-modifier">CA2968447A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2014-11-25</span>
                    <span class="td style-scope patent-result">2016-06-02</span>
                    <span class="td style-scope patent-result">Adc Therapeutics Sa</span>
                    <span class="td style-scope patent-result">Pyrrolobenzodiazepine-antibody conjugates and their use to treat neoplasms 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2016115201A1/en"><a id="link" href="#" class="style-scope state-modifier">WO2016115201A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2015-01-14</span>
                    <span class="td style-scope patent-result">2016-07-21</span>
                    <span class="td style-scope patent-result">Bristol-Myers Squibb Company</span>
                    <span class="td style-scope patent-result">Heteroarylene-bridged benzodiazepine dimers, conjugates thereof, and methods of making and using 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/EA201791550A1/en"><a id="link" href="#" class="style-scope state-modifier">EA201791550A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2015-01-14</span>
                    <span class="td style-scope patent-result">2017-11-30</span>
                    <span class="td style-scope patent-result">Бристол-Маерс Сквибб Компани</span>
                    <span class="td style-scope patent-result">
  DYMERAS OF BENZODIAZEPINS, THEIR CONJUGATES AND METHODS OF THEIR RECEPTION AND APPLICATION
 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/BR112017027258A2/en"><a id="link" href="#" class="style-scope state-modifier">BR112017027258A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2015-06-23</span>
                    <span class="td style-scope patent-result">2018-08-28</span>
                    <span class="td style-scope patent-result">Bristol-Myers Squibb Company</span>
                    <span class="td style-scope patent-result">
  macrocyclic benzodiazepine dimers, conjugates thereof, preparation and uses
 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/MA43345A/en"><a id="link" href="#" class="style-scope state-modifier">MA43345A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2015-10-02</span>
                    <span class="td style-scope patent-result">2018-08-08</span>
                    <span class="td style-scope patent-result">Hoffmann La Roche</span>
                    <span class="td style-scope patent-result">
  PYRROLOBENZODIAZEPINE ANTIBODY-DRUG CONJUGATES AND METHODS OF USE
 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/KR20180079452A/en"><a id="link" href="#" class="style-scope state-modifier">KR20180079452A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2015-11-25</span>
                    <span class="td style-scope patent-result">2018-07-10</span>
                    <span class="td style-scope patent-result">주식회사 레고켐 바이오사이언스</span>
                    <span class="td style-scope patent-result">
  Conjugates comprising self-sacrificial groups and methods for their preparation
 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/CN113599533A/en"><a id="link" href="#" class="style-scope state-modifier">CN113599533A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2015-11-25</span>
                    <span class="td style-scope patent-result">2021-11-05</span>
                    <span class="td style-scope patent-result">乐高化学生物科学股份有限公司</span>
                    <span class="td style-scope patent-result">Antibody-drug conjugates comprising branched linkers and methods related thereto 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2017089894A1/en"><a id="link" href="#" class="style-scope state-modifier">WO2017089894A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2015-11-25</span>
                    <span class="td style-scope patent-result">2017-06-01</span>
                    <span class="td style-scope patent-result">Legochem Biosciences, Inc.</span>
                    <span class="td style-scope patent-result">Conjugates comprising peptide groups and methods related thereto 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/GB201601431D0/en"><a id="link" href="#" class="style-scope state-modifier">GB201601431D0</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2016-01-26</span>
                    <span class="td style-scope patent-result">2016-03-09</span>
                    <span class="td style-scope patent-result">Medimmune Ltd</span>
                    <span class="td style-scope patent-result">Pyrrolobenzodiazepines 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/GB201602356D0/en"><a id="link" href="#" class="style-scope state-modifier">GB201602356D0</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2016-02-10</span>
                    <span class="td style-scope patent-result">2016-03-23</span>
                    <span class="td style-scope patent-result">Medimmune Ltd</span>
                    <span class="td style-scope patent-result">Pyrrolobenzodiazepine Conjugates 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/GB201602359D0/en"><a id="link" href="#" class="style-scope state-modifier">GB201602359D0</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2016-02-10</span>
                    <span class="td style-scope patent-result">2016-03-23</span>
                    <span class="td style-scope patent-result">Medimmune Ltd</span>
                    <span class="td style-scope patent-result">Pyrrolobenzodiazepine Conjugates 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US10765625B2/en"><a id="link" href="#" class="style-scope state-modifier">US10765625B2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2016-03-15</span>
                    <span class="td style-scope patent-result">2020-09-08</span>
                    <span class="td style-scope patent-result">The Board Of Trustees Of The Leland Stanford Junior University</span>
                    <span class="td style-scope patent-result">Knottin-drug conjugates and methods of using the same 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/GB201607478D0/en"><a id="link" href="#" class="style-scope state-modifier">GB201607478D0</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2016-04-29</span>
                    <span class="td style-scope patent-result">2016-06-15</span>
                    <span class="td style-scope patent-result">Medimmune Ltd</span>
                    <span class="td style-scope patent-result">Pyrrolobenzodiazepine Conjugates 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/TW201808936A/en"><a id="link" href="#" class="style-scope state-modifier">TW201808936A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2016-05-18</span>
                    <span class="td style-scope patent-result">2018-03-16</span>
                    <span class="td style-scope patent-result">美商梅爾莎納醫療公司</span>
                    <span class="td style-scope patent-result">Pyrrolobenzodiazepines and conjugates thereof 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2017223275A1/en"><a id="link" href="#" class="style-scope state-modifier">WO2017223275A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2016-06-24</span>
                    <span class="td style-scope patent-result">2017-12-28</span>
                    <span class="td style-scope patent-result">Mersana Therapeutics, Inc.</span>
                    <span class="td style-scope patent-result">Pyrrolobenzodiazepines and conjugates thereof 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/GB201617466D0/en"><a id="link" href="#" class="style-scope state-modifier">GB201617466D0</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2016-10-14</span>
                    <span class="td style-scope patent-result">2016-11-30</span>
                    <span class="td style-scope patent-result">Medimmune Ltd</span>
                    <span class="td style-scope patent-result">Pyrrolobenzodiazepine conjugates 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/GB201702031D0/en"><a id="link" href="#" class="style-scope state-modifier">GB201702031D0</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2017-02-08</span>
                    <span class="td style-scope patent-result">2017-03-22</span>
                    <span class="td style-scope patent-result">Medlmmune Ltd</span>
                    <span class="td style-scope patent-result">Pyrrolobenzodiazepine-antibody conjugates 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/KR20200032243A/en"><a id="link" href="#" class="style-scope state-modifier">KR20200032243A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2017-02-08</span>
                    <span class="td style-scope patent-result">2020-03-25</span>
                    <span class="td style-scope patent-result">에이디씨 테라퓨틱스 에스에이</span>
                    <span class="td style-scope patent-result">Pyrrolobenzodiazepine-antibody conjugates 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/BR112019020136A2/en"><a id="link" href="#" class="style-scope state-modifier">BR112019020136A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2017-03-29</span>
                    <span class="td style-scope patent-result">2020-04-22</span>
                    <span class="td style-scope patent-result">Legochem Biosciences Inc</span>
                    <span class="td style-scope patent-result">
  prodrug of pyrrolobenzodiazepine dimer and compound of ligand-ligand conjugate of the same
 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/PT3612537T/en"><a id="link" href="#" class="style-scope state-modifier">PT3612537T</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2017-04-18</span>
                    <span class="td style-scope patent-result">2022-08-29</span>
                    <span class="td style-scope patent-result">Medimmune Ltd</span>
                    <span class="td style-scope patent-result">Pyrrolobenzodiazepine conjugates 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/UA127900C2/en"><a id="link" href="#" class="style-scope state-modifier">UA127900C2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2017-06-14</span>
                    <span class="td style-scope patent-result">2024-02-07</span>
                    <span class="td style-scope patent-result">Ейдісі Терапьютікс Са</span>
                    <span class="td style-scope patent-result">Dosage regimes for the administration of an anti-cd19 adc 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/DK3668874T3/en"><a id="link" href="#" class="style-scope state-modifier">DK3668874T3</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2017-08-18</span>
                    <span class="td style-scope patent-result">2022-02-14</span>
                    <span class="td style-scope patent-result">Medimmune Ltd</span>
                    <span class="td style-scope patent-result">
  Pyrrolobenzodiazepine conjugates
 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/CN117003875A/en"><a id="link" href="#" class="style-scope state-modifier">CN117003875A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2017-09-29</span>
                    <span class="td style-scope patent-result">2023-11-07</span>
                    <span class="td style-scope patent-result">第一三共株式会社</span>
                    <span class="td style-scope patent-result">Antibody or functional fragment thereof, polynucleotide, expression vector, host cell, sugar chain reconstruction antibody, pharmaceutical composition and application 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/EP3717021A1/en"><a id="link" href="#" class="style-scope state-modifier">EP3717021A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2017-11-27</span>
                    <span class="td style-scope patent-result">2020-10-07</span>
                    <span class="td style-scope patent-result">Mersana Therapeutics, Inc.</span>
                    <span class="td style-scope patent-result">Pyrrolobenzodiazepine antibody conjugates 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2019126691A1/en"><a id="link" href="#" class="style-scope state-modifier">WO2019126691A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2017-12-21</span>
                    <span class="td style-scope patent-result">2019-06-27</span>
                    <span class="td style-scope patent-result">Mersana Therapeutics, Inc.</span>
                    <span class="td style-scope patent-result">Pyrrolobenzodiazepine antibody conjugates 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/GB201803342D0/en"><a id="link" href="#" class="style-scope state-modifier">GB201803342D0</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2018-03-01</span>
                    <span class="td style-scope patent-result">2018-04-18</span>
                    <span class="td style-scope patent-result">Medimmune Ltd</span>
                    <span class="td style-scope patent-result">Methods 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/GB201806022D0/en"><a id="link" href="#" class="style-scope state-modifier">GB201806022D0</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2018-04-12</span>
                    <span class="td style-scope patent-result">2018-05-30</span>
                    <span class="td style-scope patent-result">Medimmune Ltd</span>
                    <span class="td style-scope patent-result">Pyrrolobenzodiazepines and conjugates thereof 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/AU2019266406A1/en"><a id="link" href="#" class="style-scope state-modifier">AU2019266406A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2018-05-09</span>
                    <span class="td style-scope patent-result">2020-11-26</span>
                    <span class="td style-scope patent-result">Legochem Biosciences, Inc.</span>
                    <span class="td style-scope patent-result">Compositions and methods related to anti-CD19 antibody drug conjugates 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20210283141A1/en"><a id="link" href="#" class="style-scope state-modifier">US20210283141A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2018-05-25</span>
                    <span class="td style-scope patent-result">2021-09-16</span>
                    <span class="td style-scope patent-result">Medimmune Limited</span>
                    <span class="td style-scope patent-result">Pyrrolobenzodiazepine conjugates 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2020079239A1/en"><a id="link" href="#" class="style-scope state-modifier">WO2020079239A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2018-10-19</span>
                    <span class="td style-scope patent-result">2020-04-23</span>
                    <span class="td style-scope patent-result">Medimmune Limited</span>
                    <span class="td style-scope patent-result">Pyrrolobenzodiazepine conjugates 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/KR20210028544A/en"><a id="link" href="#" class="style-scope state-modifier">KR20210028544A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2019-09-04</span>
                    <span class="td style-scope patent-result">2021-03-12</span>
                    <span class="td style-scope patent-result">주식회사 레고켐 바이오사이언스</span>
                    <span class="td style-scope patent-result">Antibody-drug conjugate comprising antibody binding to antibody against human ROR1 and its use 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2021080608A1/en"><a id="link" href="#" class="style-scope state-modifier">WO2021080608A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2019-10-25</span>
                    <span class="td style-scope patent-result">2021-04-29</span>
                    <span class="td style-scope patent-result">Medimmune, Llc</span>
                    <span class="td style-scope patent-result">Branched moiety for use in conjugates 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/GB202105186D0/en"><a id="link" href="#" class="style-scope state-modifier">GB202105186D0</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2021-04-12</span>
                    <span class="td style-scope patent-result">2021-05-26</span>
                    <span class="td style-scope patent-result">Medimmune Ltd</span>
                    <span class="td style-scope patent-result">Pyrrolobenzodiazepine conjugates 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/GB202105187D0/en"><a id="link" href="#" class="style-scope state-modifier">GB202105187D0</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2021-04-12</span>
                    <span class="td style-scope patent-result">2021-05-26</span>
                    <span class="td style-scope patent-result">Medimmune Ltd</span>
                    <span class="td style-scope patent-result">Pyrrolobenzodiazepine conjugates 
     </span>
                  </div>
                  <template is="dom-repeat" class="style-scope patent-result"></template>
                </div>

              </div>
            </div>
            <div style="padding: 10px 12px; font-size: 11px;" class="style-scope patent-result">* Cited by examiner, † Cited by third party, ‡ Family to family citation</div>
            <template is="dom-if" class="style-scope patent-result"></template>

            
            <h3 id="similarDocuments" class="scroll-target style-scope patent-result">
              Similar Documents
              <a href="#title" class="style-scope patent-result"><iron-icon icon="arrow-drop-up" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M7 14l5-5 5 5z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon></a>
            </h3>
            <div class="responsive-table style-scope patent-result">
              <div class="table style-scope patent-result">
                <div class="thead style-scope patent-result">
                  <div class="tr style-scope patent-result">
                    <span class="th style-scope patent-result">Publication</span>
                    <span class="th style-scope patent-result">Publication Date</span>
                    <span class="th style-scope patent-result">Title</span>
                  </div>
                </div>
                <div class="tbody style-scope patent-result">
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/CN106687472B/en"><a id="link" href="#" class="style-scope state-modifier">CN106687472B</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2019-01-08</span>
                    <span class="td style-scope patent-result">Pyrrolobenzodiazepines Zhuo and its conjugate 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/CN105209077B/en"><a id="link" href="#" class="style-scope state-modifier">CN105209077B</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2019-06-11</span>
                    <span class="td style-scope patent-result">Pyrrolobenzodiazepines Zhuo and its conjugate 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/CN110452242A/en"><a id="link" href="#" class="style-scope state-modifier">CN110452242A</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2019-11-15</span>
                    <span class="td style-scope patent-result">Pyrrolobenzodiazepines Zhuo and its conjugate 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/CN105142674B/en"><a id="link" href="#" class="style-scope state-modifier">CN105142674B</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2018-11-13</span>
                    <span class="td style-scope patent-result">Pyrrolobenzodiazepines Zhuo and its conjugate 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/CN105307685B/en"><a id="link" href="#" class="style-scope state-modifier">CN105307685B</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2019-03-08</span>
                    <span class="td style-scope patent-result">Pyrrolobenzodiazepines Zhuo and its conjugate 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/JP6531166B2/en"><a id="link" href="#" class="style-scope state-modifier">JP6531166B2</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2019-06-12</span>
                    <span class="td style-scope patent-result">
  Pyrrolobenzodiazepine and its conjugate
 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/AU2013366490B9/en"><a id="link" href="#" class="style-scope state-modifier">AU2013366490B9</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2018-02-01</span>
                    <span class="td style-scope patent-result">Unsymmetrical pyrrolobenzodiazepines-dimers for use in the treatment of proliferative and autoimmune diseases 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/ES2931051T3/en"><a id="link" href="#" class="style-scope state-modifier">ES2931051T3</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2022-12-23</span>
                    <span class="td style-scope patent-result">
  Pyrrolobenzodiazepine-antibody conjugates
 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/CN109843335A/en"><a id="link" href="#" class="style-scope state-modifier">CN109843335A</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2019-06-04</span>
                    <span class="td style-scope patent-result">Pyrrolobenzodiazepines Zhuo conjugate 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/CN107530442A/en"><a id="link" href="#" class="style-scope state-modifier">CN107530442A</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2018-01-02</span>
                    <span class="td style-scope patent-result">Site-specific antibodie drug conjugate 
       </span>
                  </div>
                  <template is="dom-repeat" class="style-scope patent-result"></template>
                </div>
              </div>
            </div>
            <template is="dom-if" class="style-scope patent-result"></template>

            
            <h3 id="relatedApplications" class="scroll-target style-scope patent-result">Priority And Related Applications</h3>

            
            <h3 id="parentApplications" class="scroll-target style-scope patent-result">
              Parent Applications (1)
              <a href="#title" class="style-scope patent-result"><iron-icon icon="arrow-drop-up" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M7 14l5-5 5 5z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon></a>
            </h3>
            <div class="responsive-table style-scope patent-result">
              <div class="table style-scope patent-result">
                <div class="thead style-scope patent-result">
                  <div class="tr style-scope patent-result">
                    <span class="th style-scope patent-result">Application</span>
                    <span class="th style-scope patent-result">Priority date</span>
                    <span class="th style-scope patent-result">Filing date</span>
                    <span class="th style-scope patent-result">Relation</span>
                    <span class="th style-scope patent-result">Title</span>
                  </div>
                </div>
                <div class="tbody style-scope patent-result">
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/CN105189507A/en"><a id="link" href="#" class="style-scope state-modifier">CN201380073613.1A</a></state-modifier><template is="dom-if" class="style-scope patent-result"></template>
                        <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td nowrap style-scope patent-result">2012-12-21</span>
                    <span class="td nowrap style-scope patent-result">2013-12-20</span>
                    <span class="td nowrap style-scope patent-result">
                        Division<template is="dom-if" class="style-scope patent-result"></template>
                        <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">Pyrrolobenzodiazepines and conjugates thereof 
       </span>
                  </div>
                  <template is="dom-repeat" class="style-scope patent-result"></template>
                </div>
              </div>
            </div>
            <template is="dom-if" class="style-scope patent-result"></template>

            <template is="dom-if" class="style-scope patent-result"></template>

            <template is="dom-if" class="style-scope patent-result"></template>

            
            <h3 id="appsClaimingPriority" class="scroll-target style-scope patent-result">
              Applications Claiming Priority (3)
              <a href="#title" class="style-scope patent-result"><iron-icon icon="arrow-drop-up" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M7 14l5-5 5 5z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon></a>
            </h3>
            <div class="responsive-table style-scope patent-result">
              <div class="table style-scope patent-result">
                <div class="thead style-scope patent-result">
                  <div class="tr style-scope patent-result">
                    <span class="th style-scope patent-result">Application</span>
                    <span class="th style-scope patent-result">Filing date</span>
                    <span class="th style-scope patent-result">Title</span>
                  </div>
                </div>
                <div class="tbody style-scope patent-result">
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                        <template is="dom-if" class="style-scope patent-result"></template>
                        US201261740592P<template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td nowrap style-scope patent-result">2012-12-21</span>
                    <span class="td style-scope patent-result"></span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                        <template is="dom-if" class="style-scope patent-result"></template>
                        US61/740,592<template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td nowrap style-scope patent-result">2012-12-21</span>
                    <span class="td style-scope patent-result"></span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/CN105189507A/en"><a id="link" href="#" class="style-scope state-modifier">CN201380073613.1A</a></state-modifier><template is="dom-if" class="style-scope patent-result"></template>
                        <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td nowrap style-scope patent-result">2013-12-20</span>
                    <span class="td style-scope patent-result">Pyrrolobenzodiazepines and conjugates thereof 
       </span>
                  </div>
                  <template is="dom-repeat" class="style-scope patent-result"></template>
                </div>
              </div>
            </div>
            <template is="dom-if" class="style-scope patent-result"></template>

            <template is="dom-if" class="style-scope patent-result"></template>

            
            <h3 id="legalEvents" class="scroll-target style-scope patent-result">
              Legal Events
              <a href="#title" class="style-scope patent-result"><iron-icon icon="arrow-drop-up" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M7 14l5-5 5 5z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon></a>
            </h3>
            <div class="responsive-table style-scope patent-result">
              <div class="table style-scope patent-result">
                <div class="thead style-scope patent-result">
                  <div class="tr style-scope patent-result">
                    <span class="th style-scope patent-result">Date</span>
                    <span class="th style-scope patent-result">Code</span>
                    <span class="th style-scope patent-result">Title</span>
                    <span class="th style-scope patent-result">Description</span>
                  </div>
                </div>
                <div class="tbody style-scope patent-result">
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">2019-11-15</span>
                    <span class="td nowrap style-scope patent-result">PB01</span>
                    <span class="td nowrap style-scope patent-result">Publication</span>
                    <span class="td style-scope patent-result">
                      <template is="dom-repeat" as="attr" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">2019-11-15</span>
                    <span class="td nowrap style-scope patent-result">PB01</span>
                    <span class="td nowrap style-scope patent-result">Publication</span>
                    <span class="td style-scope patent-result">
                      <template is="dom-repeat" as="attr" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">2019-12-10</span>
                    <span class="td nowrap style-scope patent-result">SE01</span>
                    <span class="td nowrap style-scope patent-result">Entry into force of request for substantive examination</span>
                    <span class="td style-scope patent-result">
                      <template is="dom-repeat" as="attr" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">2019-12-10</span>
                    <span class="td nowrap style-scope patent-result">SE01</span>
                    <span class="td nowrap style-scope patent-result">Entry into force of request for substantive examination</span>
                    <span class="td style-scope patent-result">
                      <template is="dom-repeat" as="attr" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  <template is="dom-repeat" class="style-scope patent-result"></template>
                </div>
              </div>
            </div>
            <template is="dom-if" class="style-scope patent-result"></template>

            <template is="dom-if" class="style-scope patent-result"></template>

            <div id="notices" class="vertical layout center style-scope patent-result">
              <template is="dom-if" class="style-scope patent-result"></template>
            </div>
          </div>
          <div class="bottombar style-scope patent-result">
            <bottom-bar class="style-scope patent-result"><template is="dom-if" class="style-scope bottom-bar"></template>
</bottom-bar>
          </div>
        </div>
      </div>
      <template is="dom-if" class="style-scope patent-result"></template>
    </div>
  </patent-result>
    <template is="dom-if" restamp="" class="style-scope result-container"></template>
    <template is="dom-if" restamp="" class="style-scope result-container"></template>
    <template is="dom-if" restamp="" class="style-scope result-container"></template>
  </result-container>
        </div>
      </div>
    
        </div>
      </div>
      <search-footer class="style-scope search-ui">
    
    

    <div id="footer" class="vertical layout center style-scope search-footer">
        <span class="links style-scope search-footer">
          <overlay-tooltip positioning-target="#footerAbout" direction="top" class="style-scope search-footer" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      Learn more about data coverage, search syntax and other features.
    </div>
  </overlay-tooltip>
          <a id="footerAbout" data-proto="ABOUT" href="https://support.google.com/faqs/answer/6390996" target="_blank" class="style-scope search-footer">About</a>
          <overlay-tooltip positioning-target="#footerFeedback" direction="top" class="style-scope search-footer" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      Send feedback about technical issues or feature requests for Google Patents.
    </div>
  </overlay-tooltip>
          <a id="footerFeedback" data-proto="SEND_FEEDBACK" href="#" onclick="sendFeedback();" class="style-scope search-footer">Send Feedback</a>
          <a data-proto="PUBLIC_DATASETS" href="https://console.cloud.google.com/marketplace/product/google_patents_public_datasets/google-patents-public-data" target="_blank" class="style-scope search-footer">Public Datasets</a>
          <a data-proto="TERMS" href="https://www.google.com/policies/terms/" target="_blank" class="style-scope search-footer">Terms</a>
          <a data-proto="PRIVACY_POLICY" href="https://www.google.com/privacy/privacy-policy.html" target="blank" class="style-scope search-footer">Privacy Policy</a>
          <a data-proto="SEARCH_HELP" href="https://support.google.com/websearch/" target="_blank" class="style-scope search-footer">Help</a>
        </span>
    </div>
  </search-footer>
    </div>

  </search-ui>
  </search-result>
    <template is="dom-if" restamp="" class="style-scope search-app"></template>
    <template is="dom-if" restamp="" class="style-scope search-app"></template>
    <template is="dom-if" restamp="" class="style-scope search-app"></template>
    <paper-toast id="toast" duration="3000" class="style-scope search-app x-scope paper-toast-0" aria-hidden="true" style="outline: none; display: none;">
    

    <span id="label" class="style-scope paper-toast"></span>
    
      <div id="noticeContent" class="style-scope search-app"></div>
    
  </paper-toast>
  </search-app>
    <script type="text/javascript" src="//www.gstatic.com/feedback/api.js"></script>
    <script type="text/javascript" src="//www.gstatic.com/feedback/js/help/prod/service/lazy.min.js"></script>
    <script type="text/javascript">
      if (window.help && window.help.service) {
        helpApi = window.help.service.Lazy.create(0, {apiKey: 'AIzaSyDTEI_0tLX4varJ7bwK8aT-eOI5qr3BmyI', locale: 'en-US'});
        window.requestedSurveys = new Set();
        window.requestSurvey = function(triggerId) {
          if (window.requestedSurveys.has(triggerId)) {
            return;
          }
          window.requestedSurveys.add(triggerId);
          helpApi.requestSurvey({
            triggerId: triggerId,
            enableTestingMode: false,
            callback: (requestSurveyCallbackParam) => {
              if (!requestSurveyCallbackParam.surveyData) {
                return;
              }
              helpApi.presentSurvey({
                productData: {
                  productVersion: window.version,
                  customData: {
                    "experiments": "",
                  },
                },
                surveyData: requestSurveyCallbackParam.surveyData,
                colorScheme: 1,
                customZIndex: 10000,
              });
            }
          });
        };

        window.requestSurvey('YXTwAsvoW0kedxbuTdH0RArc9VhT');
      }
    </script>
    <script src="/sw/null_loader.js"></script>
  

<iframe id="apiproxyddf475d63cd8173a637a287407211e3c7614fb050.2679550706" name="apiproxyddf475d63cd8173a637a287407211e3c7614fb050.2679550706" style="width: 1px; height: 1px; position: absolute; top: -100px; display: none;" src="https://scone-pa.clients6.google.com/static/proxy.html?usegapi=1&amp;jsh=m%3B%2F_%2Fscs%2Fabc-static%2F_%2Fjs%2Fk%3Dgapi.lb.en.IKZeRvoAYNY.O%2Fam%3DAAAQ%2Fd%3D1%2Frs%3DAHpOoo-SMWTzMRJrTty6iE5dL_aWGYOnuw%2Fm%3D__features__#parent=https%3A%2F%2Fpatents.google.com&amp;rpctoken=881062035" tabindex="-1" aria-hidden="true"></iframe><iron-a11y-announcer>
    
    <div class="style-scope iron-a11y-announcer" aria-live="polite"></div>
  </iron-a11y-announcer></body></html>